Citrus Sinensis ID: 024661
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 264 | 2.2.26 [Sep-21-2011] | |||||||
| P51566 | 467 | Serine/threonine-protein | yes | no | 0.916 | 0.518 | 0.777 | 1e-109 | |
| P51567 | 427 | Serine/threonine-protein | no | no | 0.897 | 0.555 | 0.681 | 1e-98 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.791 | 0.522 | 0.628 | 9e-78 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.625 | 0.198 | 0.481 | 1e-43 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.583 | 0.223 | 0.490 | 7e-42 | |
| O35491 | 499 | Dual specificity protein | yes | no | 0.594 | 0.314 | 0.477 | 6e-40 | |
| O35493 | 481 | Dual specificity protein | no | no | 0.598 | 0.328 | 0.493 | 8e-40 | |
| P49760 | 499 | Dual specificity protein | yes | no | 0.594 | 0.314 | 0.477 | 9e-40 | |
| Q9HAZ1 | 481 | Dual specificity protein | no | no | 0.598 | 0.328 | 0.487 | 1e-39 | |
| P22518 | 483 | Dual specificity protein | no | no | 0.606 | 0.331 | 0.481 | 4e-39 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 395 bits (1016), Expect = e-109, Method: Compositional matrix adjust.
Identities = 192/247 (77%), Positives = 216/247 (87%), Gaps = 5/247 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKVPS 242
PDYK S
Sbjct: 257 PDYKFLS 263
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (922), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 167/245 (68%), Positives = 200/245 (81%), Gaps = 8/245 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WDV P +V ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 235 VPDYK 239
+P+YK
Sbjct: 239 IPEYK 243
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 290 bits (741), Expect = 9e-78, Method: Compositional matrix adjust.
Identities = 144/229 (62%), Positives = 176/229 (76%), Gaps = 20/229 (8%)
Query: 12 KNMDK-RPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGS 70
++MDK R RKRPR+TWD P P K ++ G+ G R S
Sbjct: 7 ESMDKERVRKRPRMTWDEAPAEPEAKRA----VIKGHGSDG---------------RILS 47
Query: 71 PPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK 130
PP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VAIKI+RSI K
Sbjct: 48 PPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKK 107
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
YR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+DFL++N Y +
Sbjct: 108 YRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSA 167
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K
Sbjct: 168 FPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK 216
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 80/166 (48%), Positives = 120/166 (72%), Gaps = 1/166 (0%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGH ++ G+ L RY+I++ +GEGTFG+VV+ D E+ +A+KI++++ KYREAA
Sbjct: 461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520
Query: 136 MIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+EI+ L+++A+ D CV++ +WFDY H+CIVFE LG S++DFLR+N+Y +P+D
Sbjct: 521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
VR + QL SV F+H+ RL HTDLKPENIL V ++Y ++K+
Sbjct: 581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHKI 626
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 7e-42, Method: Compositional matrix adjust.
Identities = 76/155 (49%), Positives = 107/155 (69%), Gaps = 1/155 (0%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGHY RY ++ +G GTFG+V++C+D AIK+ R+I KYREA+
Sbjct: 344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403
Query: 136 MIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+IE+ VLQ +A D +C+Q+R++FDYR HICIV + G S++DFL+ N+Y FP+
Sbjct: 404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229
++ L +QL +SVAF+H L L+HTDLKPEN+LLVS
Sbjct: 464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVS 498
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 164 bits (415), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 76/159 (47%), Positives = 114/159 (71%), Gaps = 2/159 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 144 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEA 203
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 204 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 263
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y
Sbjct: 264 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY 302
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 8e-40, Method: Compositional matrix adjust.
Identities = 79/160 (49%), Positives = 110/160 (68%), Gaps = 2/160 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ L VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV 300
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (413), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 76/159 (47%), Positives = 114/159 (71%), Gaps = 2/159 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY 303
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (412), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 78/160 (48%), Positives = 110/160 (68%), Gaps = 2/160 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV 300
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P22518|CLK1_MOUSE Dual specificity protein kinase CLK1 OS=Mus musculus GN=Clk1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 4e-39, Method: Compositional matrix adjust.
Identities = 78/162 (48%), Positives = 113/162 (69%), Gaps = 2/162 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREA 134
DD++GH + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EA
Sbjct: 142 DDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKVGGRRVAVKIVKNVDRYCEA 201
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WF++R HICIVFE LG S YDF+++NS+ F +
Sbjct: 202 AQSEIQVLEHLNTTDPHSTFRCVQMLEWFEHRGHICIVFELLGLSTYDFIKENSFLPFRM 261
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
D +R++ Q+ +SV F+H +L HTDLKPENIL V ++Y +
Sbjct: 262 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVKSDYTEA 303
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 264 | ||||||
| 224138498 | 433 | predicted protein [Populus trichocarpa] | 0.893 | 0.545 | 0.842 | 1e-114 | |
| 147800314 | 448 | hypothetical protein VITISV_001943 [Viti | 0.901 | 0.531 | 0.859 | 1e-114 | |
| 225439856 | 429 | PREDICTED: serine/threonine-protein kina | 0.901 | 0.554 | 0.859 | 1e-114 | |
| 449439982 | 428 | PREDICTED: serine/threonine-protein kina | 0.916 | 0.565 | 0.855 | 1e-112 | |
| 449439980 | 433 | PREDICTED: serine/threonine-protein kina | 0.916 | 0.558 | 0.855 | 1e-112 | |
| 356505140 | 427 | PREDICTED: serine/threonine-protein kina | 0.890 | 0.550 | 0.793 | 1e-111 | |
| 356505138 | 444 | PREDICTED: serine/threonine-protein kina | 0.916 | 0.545 | 0.773 | 1e-109 | |
| 255638456 | 444 | unknown [Glycine max] | 0.916 | 0.545 | 0.769 | 1e-109 | |
| 255584557 | 391 | afc, putative [Ricinus communis] gi|2235 | 0.912 | 0.616 | 0.781 | 1e-109 | |
| 15231839 | 467 | serine/threonine-protein kinase AFC1 [Ar | 0.916 | 0.518 | 0.777 | 1e-108 |
| >gi|224138498|ref|XP_002322829.1| predicted protein [Populus trichocarpa] gi|222867459|gb|EEF04590.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 209/248 (84%), Positives = 221/248 (89%), Gaps = 12/248 (4%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPP----LPPPKVLPALYCVQEFGNGG--MPN 54
METQRI EFPHKNMDKRPRKR RLTWD+PPP L P KV+P ++C QEFGNG +PN
Sbjct: 1 METQRITEFPHKNMDKRPRKRQRLTWDIPPPPPPFLAPAKVVPGMFCGQEFGNGNGVIPN 60
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
Y +FY R GSPPWRPDDKDGHYVFAIG+NLTPRYRILSKMGEGTFGQV+ECFDN
Sbjct: 61 YG---LFYN---RNGSPPWRPDDKDGHYVFAIGDNLTPRYRILSKMGEGTFGQVLECFDN 114
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
EKKELVAIKIVRSI+KYREAAM EIDVLQRLARHDIG TRCVQIRNWFDYRNHICIVFEK
Sbjct: 115 EKKELVAIKIVRSIHKYREAAMTEIDVLQRLARHDIGSTRCVQIRNWFDYRNHICIVFEK 174
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH+L LIHTDLKPENILLVS+EY+K
Sbjct: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLHLIHTDLKPENILLVSSEYIK 234
Query: 235 VPDYKVPS 242
VPDYK S
Sbjct: 235 VPDYKFLS 242
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147800314|emb|CAN73108.1| hypothetical protein VITISV_001943 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1069), Expect = e-114, Method: Compositional matrix adjust.
Identities = 208/242 (85%), Positives = 226/242 (93%), Gaps = 4/242 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYK
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 241 PS 242
S
Sbjct: 237 LS 238
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439856|ref|XP_002278124.1| PREDICTED: serine/threonine-protein kinase AFC1 [Vitis vinifera] gi|297741539|emb|CBI32671.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-114, Method: Compositional matrix adjust.
Identities = 208/242 (85%), Positives = 226/242 (93%), Gaps = 4/242 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYK
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 241 PS 242
S
Sbjct: 237 LS 238
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439982|ref|XP_004137764.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1054), Expect = e-112, Method: Compositional matrix adjust.
Identities = 207/242 (85%), Positives = 222/242 (91%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
DFLRKNSYRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+K
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 241 PS 242
S
Sbjct: 241 LS 242
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439980|ref|XP_004137763.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1053), Expect = e-112, Method: Compositional matrix adjust.
Identities = 207/242 (85%), Positives = 222/242 (91%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
DFLRKNSYRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+K
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 241 PS 242
S
Sbjct: 241 LS 242
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505140|ref|XP_003521350.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1041), Expect = e-111, Method: Compositional matrix adjust.
Identities = 192/242 (79%), Positives = 213/242 (88%), Gaps = 7/242 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPH+NMDKRPRK+ RLTWD+ VLP +YC QE GNG +PN+A S+
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDM-------HVLPTMYCKQEVGNGVVPNHAYPSL 53
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+EC DNEK+E+V
Sbjct: 54 FYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLECLDNEKEEIV 113
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 114 AIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICIVFEKLGPSLY 173
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
DFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+E++KVPDYK
Sbjct: 174 DFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISSEFIKVPDYKF 233
Query: 241 PS 242
S
Sbjct: 234 LS 235
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505138|ref|XP_003521349.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1031), Expect = e-109, Method: Compositional matrix adjust.
Identities = 195/252 (77%), Positives = 217/252 (86%), Gaps = 10/252 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
VFEKLGPSLYDFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 231 EYVKVPDYKVPS 242
E++KVPDYK S
Sbjct: 241 EFIKVPDYKFLS 252
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255638456|gb|ACU19537.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-109, Method: Compositional matrix adjust.
Identities = 194/252 (76%), Positives = 216/252 (85%), Gaps = 10/252 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
VFEKLGPSLYDFLRKN YRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNCYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 231 EYVKVPDYKVPS 242
E++KVPDYK S
Sbjct: 241 EFIKVPDYKFLS 252
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584557|ref|XP_002533005.1| afc, putative [Ricinus communis] gi|223527216|gb|EEF29380.1| afc, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-109, Method: Compositional matrix adjust.
Identities = 207/265 (78%), Positives = 221/265 (83%), Gaps = 24/265 (9%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN---GGM--PNY 55
METQRI E P +NMDKRPRKRPRLTWD+PPP PP KVL A+YC Q+ GN GG+ N+
Sbjct: 1 METQRITELPLRNMDKRPRKRPRLTWDMPPPPPP-KVLSAMYCGQDLGNNDGGGIINTNF 59
Query: 56 ACSSMFYG------------------AIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRIL 97
+M+Y +PR SPPWRPDDKDGHYVFAIGENLTPRYRIL
Sbjct: 60 GYPNMYYRDVPVSVPVPVPVPIPLPITVPRNVSPPWRPDDKDGHYVFAIGENLTPRYRIL 119
Query: 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQ 157
KMGEGTFGQV+EC DNEKKE+VAIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQ
Sbjct: 120 GKMGEGTFGQVLECLDNEKKEIVAIKIVRSIHKYREAAMIEIDVLQRLARHDIGGTRCVQ 179
Query: 158 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
IRNWFDYRNHICIVFEKLGPSLYDFLRKNSY SFPIDLVRELGRQLLESVAFMH+LRLIH
Sbjct: 180 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYSSFPIDLVRELGRQLLESVAFMHDLRLIH 239
Query: 218 TDLKPENILLVSAEYVKVPDYKVPS 242
TDLKPENILLVSAEY+KVPDYK S
Sbjct: 240 TDLKPENILLVSAEYIKVPDYKFLS 264
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231839|ref|NP_190925.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|42570490|ref|NP_850695.2| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|79314891|ref|NP_001030853.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|26454604|sp|P51566.2|AFC1_ARATH RecName: Full=Serine/threonine-protein kinase AFC1 gi|642132|dbj|BAA08215.1| protein kinase [Arabidopsis thaliana] gi|6729508|emb|CAB67664.1| protein kinase (AME2/AFC1) [Arabidopsis thaliana] gi|222424132|dbj|BAH20025.1| AT3G53570 [Arabidopsis thaliana] gi|332645589|gb|AEE79110.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645590|gb|AEE79111.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645591|gb|AEE79112.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1016), Expect = e-108, Method: Compositional matrix adjust.
Identities = 192/247 (77%), Positives = 216/247 (87%), Gaps = 5/247 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKVPS 242
PDYK S
Sbjct: 257 PDYKFLS 263
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 264 | ||||||
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.905 | 0.511 | 0.758 | 1.8e-101 | |
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.897 | 0.555 | 0.669 | 7.5e-89 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.674 | 0.445 | 0.719 | 2.5e-73 | |
| FB|FBgn0259220 | 832 | Doa "Darkener of apricot" [Dro | 0.625 | 0.198 | 0.481 | 2.9e-42 | |
| ASPGD|ASPL0000062305 | 667 | AN0988 [Emericella nidulans (t | 0.655 | 0.259 | 0.491 | 2.3e-40 | |
| UNIPROTKB|E1B9M6 | 481 | CLK4 "Uncharacterized protein" | 0.598 | 0.328 | 0.487 | 2.3e-39 | |
| UNIPROTKB|E1C4D7 | 479 | LOC100859563 "Uncharacterized | 0.598 | 0.329 | 0.481 | 2.9e-39 | |
| UNIPROTKB|E1C4D8 | 477 | LOC100859563 "Uncharacterized | 0.598 | 0.331 | 0.481 | 2.9e-39 | |
| UNIPROTKB|F1RLJ5 | 500 | CLK2 "Uncharacterized protein" | 0.594 | 0.314 | 0.477 | 3.7e-39 | |
| MGI|MGI:1098551 | 481 | Clk4 "CDC like kinase 4" [Mus | 0.598 | 0.328 | 0.493 | 3.7e-39 |
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1006 (359.2 bits), Expect = 1.8e-101, P = 1.8e-101
Identities = 185/244 (75%), Positives = 209/244 (85%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXX-----XXXXXALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYK 239
PDYK
Sbjct: 257 PDYK 260
|
|
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 164/245 (66%), Positives = 196/245 (80%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXXXXXXXALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WD ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 235 VPDYK 239
+P+YK
Sbjct: 239 IPEYK 243
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 696 (250.1 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
Identities = 128/178 (71%), Positives = 156/178 (87%)
Query: 62 YGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVA 121
+G+ R SPP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VA
Sbjct: 39 HGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVA 98
Query: 122 IKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
IKI+RSI KYR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+D
Sbjct: 99 IKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFD 158
Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
FL++N Y +FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K
Sbjct: 159 FLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK 216
|
|
| FB|FBgn0259220 Doa "Darkener of apricot" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 2.9e-42, Sum P(2) = 2.9e-42
Identities = 80/166 (48%), Positives = 120/166 (72%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGH ++ G+ L RY+I++ +GEGTFG+VV+ D E+ +A+KI++++ KYREAA
Sbjct: 461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520
Query: 136 MIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+EI+ L+++A+ D CV++ +WFDY H+CIVFE LG S++DFLR+N+Y +P+D
Sbjct: 521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
VR + QL SV F+H+ RL HTDLKPENIL V ++Y ++K+
Sbjct: 581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHKI 626
|
|
| ASPGD|ASPL0000062305 AN0988 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 2.3e-40, P = 2.3e-40
Identities = 86/175 (49%), Positives = 116/175 (66%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGHY+ +T RY I+ +G+GTFG+VVE +D ++K AIKI+RSI KYR+A+
Sbjct: 283 DDDDGHYIVNPNTPITDRYSIIKLLGQGTFGKVVEAYDKQRKARCAIKIIRSIQKYRDAS 342
Query: 136 MIEIDVLQRLARHDIGG-TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
IE+ VL LA +D +C+ +R+ FD+RNHICIV + LG S++DFL+ N + FP
Sbjct: 343 RIELRVLSTLASNDKHNRNKCIHLRDCFDFRNHICIVTDLLGQSVFDFLKGNGFVPFPSS 402
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP-DYKVPSPRHAFS 248
++ RQL SVAF+H+L LIHTDLKPENILLV Y + +PS A S
Sbjct: 403 QIQSFARQLFTSVAFLHDLNLIHTDLKPENILLVKNAYQTFTYNRTIPSSSTAIS 457
|
|
| UNIPROTKB|E1B9M6 CLK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 2.3e-39, P = 2.3e-39
Identities = 78/160 (48%), Positives = 111/160 (69%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D++ + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHDMDGIHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV 300
|
|
| UNIPROTKB|E1C4D7 LOC100859563 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 2.9e-39, P = 2.9e-39
Identities = 77/160 (48%), Positives = 113/160 (70%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I++ +GEG FG+VVEC D++ + + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICESGDVLRARYEIVATLGEGAFGKVVECIDHDMRGMHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNTMDPSSTFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFHI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
+ +R + Q+ +S+ F+H +L HTDLKPENIL V ++Y+
Sbjct: 261 NDIRNMAYQICQSINFLHHNKLTHTDLKPENILFVESDYI 300
|
|
| UNIPROTKB|E1C4D8 LOC100859563 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 2.9e-39, P = 2.9e-39
Identities = 77/160 (48%), Positives = 113/160 (70%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I++ +GEG FG+VVEC D++ + + VA+KIV+++ +YREA
Sbjct: 139 DDEEGHLICESGDVLRARYEIVATLGEGAFGKVVECIDHDMRGMHVAVKIVKNVGRYREA 198
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 199 ARSEIQVLEHLNTMDPSSTFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFHI 258
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
+ +R + Q+ +S+ F+H +L HTDLKPENIL V ++Y+
Sbjct: 259 NDIRNMAYQICQSINFLHHNKLTHTDLKPENILFVESDYI 298
|
|
| UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 3.7e-39, P = 3.7e-39
Identities = 76/159 (47%), Positives = 114/159 (71%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIISTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY 303
|
|
| MGI|MGI:1098551 Clk4 "CDC like kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 3.7e-39, P = 3.7e-39
Identities = 79/160 (49%), Positives = 110/160 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ L VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV 300
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P51566 | AFC1_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.7773 | 0.9166 | 0.5182 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| eugene3.00160734 | hypothetical protein (434 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 264 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-30 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-11 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 0.001 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.001 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.003 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.003 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.004 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.004 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-38
Identities = 53/147 (36%), Positives = 84/147 (57%), Gaps = 10/147 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
Y IL K+GEG+FG+V D + +LVAIK+++ I K RE + EI +L++L +H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHP-- 57
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V++ + F+ + + +V E G L+D L+K D R RQ+L ++ ++
Sbjct: 58 --NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPD 237
H ++H DLKPENILL +VK+ D
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLAD 140
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-32
Identities = 50/142 (35%), Positives = 77/142 (54%), Gaps = 10/142 (7%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
GEG FG V D + + VAIKI++ + E + EI++L++L H V++
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F+ NH+ +V E G SL D L++N + D + + Q+LE + ++H +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 218 TDLKPENILLVSAEY-VKVPDY 238
DLKPENILL S VK+ D+
Sbjct: 116 RDLKPENILLDSDNGKVKLADF 137
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD- 149
Y +L K+G G+FG V + ++VA+KI+ RS K + A EI +L+RL H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V++ + F+ ++H+ +V E L+D+L + D +++ Q+L +
Sbjct: 60 I-----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLE 112
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPD 237
++H +IH DLKPENILL VK+ D
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIAD 141
|
Length = 260 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 64/168 (38%), Positives = 103/168 (61%), Gaps = 14/168 (8%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
++GH+ +GE++ T R++ILS +GEGTFG+VVE +D ++KE A+KIVR++ KY
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
A IEI ++++ + D ++I+ +F + H+CIV K GP L D++ K+ S
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH- 230
Query: 193 IDLVRELGRQLLESVA----FMHELRLIHTDLKPENILLVSAEYVKVP 236
R L + + ++ F EL L+HTDLKPENIL+ +++ V P
Sbjct: 231 ----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274
|
Length = 467 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY+IL ++GEG G V + D E E VA+K + R A+ EI LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ V++ + F + + +V E + L + LR + R P V+ R LL+ VA+
Sbjct: 61 V-----VKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAY 114
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
MH ++H DLKP N+L+ + +K+ D+
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADF 143
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 44/147 (29%), Positives = 80/147 (54%), Gaps = 6/147 (4%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA-AMIEIDVLQRLARHDIG 151
Y+++ ++G+GTFG V + E ELVAIK + + + E + E+ L++L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+++ F + + VFE + +LY ++ + F ++R + Q+L+ +A +H
Sbjct: 59 --NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY 238
+ H DLKPEN+L+ E VK+ D+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADF 143
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-22
Identities = 47/149 (31%), Positives = 78/149 (52%), Gaps = 13/149 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARHD 149
Y L K+GEGT+G V + D + E+VA+K +R ++ E A+ EI +L+ L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKEL-KHP 58
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V++ + + +VFE L +L K +L++ + QLL +A
Sbjct: 59 NI-----VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLA 112
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ H R++H DLKP+NIL+ +K+ D
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLAD 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 9/149 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG +G V++C + E+VAIK ++ A+ E+ VL++L +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V ++ F + + +VFE + +L + L + P D VR QLL+++A+
Sbjct: 62 I-----VNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H +IH D+KPENIL+ + +K+ D+
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 46/148 (31%), Positives = 82/148 (55%), Gaps = 9/148 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDI 150
Y+ L K+GEGT+G V + D E+VAIK ++ + + A+ EI +L+ L +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+++ + F ++ + +VFE + LY ++ R P L++ QLL+ +AF
Sbjct: 61 -----IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFC 114
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H ++H DLKPEN+L+ + +K+ D+
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADF 142
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 87.1 bits (214), Expect = 9e-20
Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
YRIL K+GEG+FG+V D + VA+K++ S +K E + EI +L L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLESV 207
V++ ++F + +V E + G SL D L+K + + Q+L ++
Sbjct: 59 ----NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 208 AFMHELRLIHTDLKPENILL 227
++H +IH D+KPENILL
Sbjct: 115 EYLHSKGIIHRDIKPENILL 134
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 2e-19
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 101 GEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQ 157
G G+FG V D + EL+A+K + + EA EI +L L +H V+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP----NIVR 63
Query: 158 IR--NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
+ +N + I E + G SL L+K + P ++R+ RQ+LE +A++H
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 215 LIHTDLKPENILLVSAEYVKVPD 237
++H D+K NIL+ S VK+ D
Sbjct: 122 IVHRDIKGANILVDSDGVVKLAD 144
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 5e-17
Identities = 42/147 (28%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGG 152
+ IL K+G+G FG+V + + VAIK+++ + +E + EI +L++ +I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-- 59
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+ + ++ + IV E G SL D L K++ ++ + + ++LL+ + ++H
Sbjct: 60 ---VKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY 238
+IH D+K NILL S VK+ D+
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDF 142
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-17
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYR--EAAMIEIDVLQRLARHD 149
++ +GEG+F VV + E + AIKI+ R + K + + IE +VL RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH- 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+++ F ++ V E L ++RK Y S R ++L ++
Sbjct: 62 ---PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALE 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H +IH DLKPENILL ++K+ D+
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDF 146
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 29/159 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
Y ++++GEGT+GQV + + + ELVA+K +R N+ A+ EI +LQ+L RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHP- 58
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY--------DF---LRKNSYRSFPIDLVREL 199
V++ IV K S+Y D L + F ++
Sbjct: 59 ---NIVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCY 105
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+QLLE + ++H ++H D+K NIL+ + +K+ D+
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADF 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 5e-16
Identities = 42/152 (27%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y I+ ++G+G+FG+V +L +K + N K RE A+ E+ +L++L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLVRELGRQLLES 206
++ F+ + +CIV E G L + +K + FP + + + QL +
Sbjct: 60 ----NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H +++H D+KP+NI L S VK+ D+
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDF 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-16
Identities = 48/155 (30%), Positives = 84/155 (54%), Gaps = 21/155 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---------IVRSINKYREAAMIEIDVLQ 143
+Y LSK+GEG++G V +C + E ++VAIK +++ I A+ EI +L+
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLK 55
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L ++ V + F + + +VFE ++ + L KN R P L++++ Q
Sbjct: 56 QLKHPNL-----VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQT 109
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L++V F H+ IH D+KPENIL+ +K+ D+
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMI-EIDVLQRLARH- 148
Y L+++GEG +G V + D VA+K VR E + + EI +L++L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFE 59
Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
D+ C R D + +VFE + L +L K P + +++L
Sbjct: 60 HPNIVRLLDV----CHGPRT--DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
RQLL V F+H R++H DLKP+NIL+ S VK+ D+
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADF 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-15
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHD 149
+Y ++++G G +G V + D VA+K VR + + E+ +L+RL D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 150 IGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
C R D + +VFE + L +L K P + +++L RQ L
Sbjct: 61 HPNIVRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ F+H ++H DLKPENIL+ S VK+ D+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADF 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-15
Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
+ K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +I
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI--- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 62 --VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
R++H DLKP+N+L+ + +K+ D+
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLARHD 149
Y++ +G G FG V + + E + VAIK + EA M EID+L+ L +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V+ + + + I+ E SL ++K + FP LV Q+L+ +A
Sbjct: 61 I-----VKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLA 113
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++HE +IH D+K NIL VK+ D+ V
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGV 145
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 41/149 (27%), Positives = 84/149 (56%), Gaps = 9/149 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ +L +GEG +G V++C E KE+VAIK + + +E + E+ +L+ L + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V+++ F R + +VFE + ++ + L + P + VR QL++++ +
Sbjct: 62 I-----VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHW 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H+ ++H D+KPEN+L+ + +K+ D+
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 15/141 (10%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
Y+IL K+GEGTF +V++ + + AIK ++ + EI L+RL+ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 150 --IGGTRCVQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + FD + + +VFE + +LY+ + K R P V+ QLL+S
Sbjct: 59 NILRLIEVL-----FDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKS 112
Query: 207 VAFMHELRLIHTDLKPENILL 227
+ MH + H D+KPENIL+
Sbjct: 113 LDHMHRNGIFHRDIKPENILI 133
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-14
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARH 148
R++ +K+G GTFG+V + + EL+A+K +R I + E+ VL+ L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHP 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
++ V++ +R + I E G +L + L R ++R QLLE +
Sbjct: 60 NLVKYYGVEV-----HREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGL 112
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
A++H ++H D+KP NI L +K+ D+
Sbjct: 113 AYLHSHGIVHRDIKPANIFLDHNGVIKLGDF 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 53/171 (30%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--IVRSINKY-REAAMIEIDVLQRLARHD 149
+Y L +GEG++G V++C E ++VAIK + +K ++ AM EI +L++L RH+
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V + F + + +VFE + ++ D L K VR+ Q+L + F
Sbjct: 61 ----NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEF 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRVY 260
H +IH D+KPENIL+ + VK+ D F F L+ VY
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCD---------FGFARTLAAPGEVY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 14/153 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY K+GEGT+ V + D E +VAIK ++ + A+ EI +LQ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H I G V F ++++I +VFE + L ++ S P D ++ L
Sbjct: 60 KHPNIIGLLDV-----FGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLR 113
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H ++H DLKP N+L+ S +K+ D+
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADF 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 13/152 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD 149
+++L K+G+G++G V + + A+K V S++ K RE A+ EI +L + +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLE 205
I + + F N +CIV E G L + K + P + + QLL
Sbjct: 61 I-----ISYKEAFLDGNKLCIVMEYAPFG-DLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ +HE +++H DLK NILLV+ + VK+ D
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGD 146
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-13
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLARHDIGGT 153
+G+G FG+V C+D + +A+K V K A EI +L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHE---- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
R VQ + I E + G S+ D L+ +Y + + R+ RQ+LE V ++H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS 122
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
++H D+K NIL SA VK+ D+
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 8e-13
Identities = 36/156 (23%), Positives = 64/156 (41%), Gaps = 24/156 (15%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH 148
+ K+GEG FG+V + + K+ VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + IV E G L D+LRKN + + +
Sbjct: 61 PNIVKLLGV--CTE-------EEPLMIVMEYMPGG-DLLDYLRKNRPKELSLSDLLSFAL 110
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ + ++ IH DL N L+ VK+ D
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD 146
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 49/177 (27%), Positives = 90/177 (50%), Gaps = 14/177 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EID+L +I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ + F Y N++ I+ E D + R +R + +Q LE++ ++HE
Sbjct: 65 ---VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQ---TFLS----MASRVYIC 262
++IH DLK NIL +K+ D+ V S ++ + Q +F+ MA V +C
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGV-SAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 41/148 (27%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
++ L K+GEGT+ V + + E+VA+K + + A+ EI +++ L +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI- 60
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLVRELGRQLLESVAFM 210
V++ + N + +VFE + L ++ + R + + V+ QLL+ +AF
Sbjct: 61 ----VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
HE R++H DLKP+N+L+ +K+ D+
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADF 144
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + K++VA+K V N+ +E A+ EI +LQ L +H
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLL-KH 70
Query: 149 D-------IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ I T+ Y+ +VFE L L N F + ++++ +
Sbjct: 71 ENVVNLIEICRTKATPYNR---YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMK 126
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
LL + ++H +++H D+K NIL+ +K+ D+
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARH 148
+ +L +G+G+FG+V + D ++VAIK++ E A EI+ +Q+ L+
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLS-- 54
Query: 149 DIGGTRCVQIRNWF-----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
R I ++ + + I+ E G S D L+ + + R+
Sbjct: 55 ---QCRSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILRE 106
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+L + ++HE IH D+K NILL VK+ D+ V
Sbjct: 107 VLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGV 144
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 48/163 (29%), Positives = 86/163 (52%), Gaps = 15/163 (9%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVL 142
G+ ++ I+ ++GEGT+GQV + D + ELVA+K VR N+ +E A+ EI +L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKIL 60
Query: 143 QRLARHDIGGTRCVQI----RNWFDYRNH---ICIVFEKLGPSLYDFLRKNSYRSFPIDL 195
++L +I +I ++ D++ +VFE + L L ++ F D
Sbjct: 61 RQLNHRNI--VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDH 117
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ +QLLE + + H+ +H D+K NILL + +K+ D+
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 40/172 (23%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----------RSINKYREA 134
I +++ +Y IL K+G+G +G V + D KE+VA+K + R+ +RE
Sbjct: 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FRE- 56
Query: 135 AMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNH--ICIVFEKLGPSLYDFLRKNSYRSF 191
I LQ L H I V++ N N I +VFE + L+ +R N
Sbjct: 57 ----IMFLQELGDHPNI-----VKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN----- 102
Query: 192 PIDLVRELGR-----QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ ++ + QLL+++ ++H +IH DLKP NILL S VK+ D+
Sbjct: 103 ---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADF 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 27/160 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMI--EIDVLQRLARH- 148
RY+I +G+G++G V D E VAIK + + ++ +A I EI +L RL RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLL-RLLRHP 59
Query: 149 DIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR- 201
DI V+I++ ++++ I +VFE + L+ ++ N DL E +
Sbjct: 60 DI-----VEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQF 107
Query: 202 ---QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
QLL ++ ++H + H DLKP+NIL + +K+ D+
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDF 147
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 47/146 (32%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHDIGG 152
L+++GEGT+G V D E+VA+K VR ++ R+ I EI +L L +I
Sbjct: 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ V + D I +V E L L N F V+ L QLL + ++HE
Sbjct: 71 LKEVVVGKHLD---SIFLVMEYCEQDLASLL-DNMPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
+IH DLK N+LL +K+ D+
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADF 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
Y L+++ EGT+G V D + E+VA+K ++ + K +E ++ EI++L +L +H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHP 64
Query: 150 IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V ++ + I +V E + L + + + F V+ L QLL V
Sbjct: 65 ----NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY----KVPSPRHAFS 248
A +H+ ++H DLK N+LL + +K+ D+ + SP ++
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-12
Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 10/149 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
Y+ + K+GEGT+G V + D E+VA+K +R + E A+ EI +L+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKEL-NHP 58
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V++ + N + +VFE L L ++ + L++ QLL+ +A+
Sbjct: 59 ----NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H R++H DLKP+N+L+ +K+ D+
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADF 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 45/177 (25%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EI++L I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-- 71
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ F + + I+ E D + R ++ + RQ+LE++ ++H
Sbjct: 72 ---VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQ---TFLS----MASRVYIC 262
+++IH DLK N+LL +K+ D+ V S ++ + Q +F+ MA V +C
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGV-SAKNVKTLQRRDSFIGTPYWMAPEVVMC 184
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-12
Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y L K+GEGT+G+V + D +LVA+K R A+ EI +LQ L+ I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESI 61
Query: 151 GGTRCVQIRNWFDYRNHICI--VFEKLGPSLYDFL---RKNSYRSFPIDLVRELGRQLLE 205
R + + + + + VFE L L F+ + R P ++ QLL+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 206 SVAFMHELRLIHTDLKPENILL 227
VA H+ ++H DLKP+N+L+
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLV 143
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y+ L K+GEG G+V + D + VAIK +R + +E + EI +++ +I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI--- 77
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE----LGRQLLESVA 208
V + + + + +V E + G SL D + +N + + + R++L+ +
Sbjct: 78 --VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLE 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H +IH D+K +NILL VK+ D+
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G+G+ G V + ++ A+K V ++R+ + E+ L+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-- 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+ F I IV E + G SL D L+K P ++ + RQ+L+ + ++H
Sbjct: 62 ---VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLH 116
Query: 212 -ELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ +IH D+KP N+L+ S VK+ D+ +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGI 146
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------EIDVLQRLARHDIGGT 153
+G G+FG V E + + + A+K V + + EI +L +L +I
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI--- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
VQ +++ I E + G SL L+K Y SFP ++R RQ+L + ++H+
Sbjct: 65 --VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
+H D+K NIL+ + VK+ D+
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADF 146
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-11
Identities = 39/143 (27%), Positives = 73/143 (51%), Gaps = 12/143 (8%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
G+G+FG+V+ + +L A+K+++ I K +E E ++L R+ H V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPF----IV 56
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + +V E G L+ L K F + R +++ ++ ++H L +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 216 IHTDLKPENILLVSAEYVKVPDY 238
I+ DLKPENILL + ++K+ D+
Sbjct: 115 IYRDLKPENILLDADGHIKLTDF 137
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 16/172 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLAR 147
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 60
Query: 148 HDIGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ C R D + +VFE + L +L K P + ++++ Q
Sbjct: 61 FEHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLS 254
LL + F+H R++H DLKP+NIL+ S+ +K+ D+ + +SFQ L+
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALT 167
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-11
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMI-----EIDVLQRLARHD 149
+G G+FG V + EL+A+K V + +K R+ +M+ EI +L+ L +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I VQ +H+ I E + G S+ L N+Y +F LVR RQ+L+ +
Sbjct: 68 I-----VQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++H +IH D+K NIL+ + +K+ D+ +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGI 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 5/153 (3%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRL 145
++ PRY+ LS +GEG +G V VAIK + + + + EI +L+R
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I G + F+ N + IV E + LY ++ + D ++ Q+L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILR 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H ++H DLKP N+LL + +K+ D+
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDF 150
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-11
Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 25/156 (16%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + + VA+K ++ + + RE + E ++++L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C Q + IV E G L DFLRK+ + + ++
Sbjct: 61 PNIVRLLGV--CTQ-------GEPLYIVTEYMPGG-DLLDFLRKHG-EKLTLKDLLQMAL 109
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ + + ++ +H DL N L+ VK+ D
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISD 145
|
Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI 150
Y ++ ++G GT+G V + D ELVAIK++ + + +I EI +L+ RH
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKE-CRHP- 60
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V + R+ + IV E G SL D + + + R+ L+ +A+
Sbjct: 61 ---NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAY 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASR 258
+HE IH D+K NILL VK+ D+ V S Q ++A R
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGV-------SAQLTATIAKR 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-11
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 16/184 (8%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
N + I+ ++G+G FG+V + E A KI++ I E M+EID+L
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEEELEDFMVEIDILSEC 59
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H V + + Y N + I+ E D + R +R + RQ+LE
Sbjct: 60 -KHP----NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQ---TFLS----MASR 258
++ F+H ++IH DLK NILL VK+ D+ V S ++ + Q TF+ MA
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 259 VYIC 262
V C
Sbjct: 174 VVAC 177
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 8e-11
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 25/156 (16%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + +KK VA+K ++ + + E + E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + IV E + G L +LRKN + DL+
Sbjct: 61 PNVVKLLGV--CTE-------EEPLYIVMEYMEGG-DLLSYLRKNRPKLSLSDLL-SFAL 109
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ + ++ IH DL N L+ VK+ D
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD 145
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHK 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-NSYRSFPIDLVRELGRQLLESV 207
+I V++ + + +VFE L + N I V+ QLL+ +
Sbjct: 60 NI-----VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI--VKSFMFQLLKGL 112
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
AF H ++H DLKP+N+L+ +K+ D+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADF 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 34/141 (24%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHDIGGTRCVQI 158
G +G+V ++ AIK+++ + R+ + E D+L + + V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKL 58
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F + ++ +V E L G L L + S D+ R +++ ++ ++H +IH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 218 TDLKPENILLVSAEYVKVPDY 238
DLKP+NIL+ S ++K+ D+
Sbjct: 117 RDLKPDNILIDSNGHLKLTDF 137
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL K+GEG++G V + E ++VAIK+V + + + + EI +L++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ--------C 55
Query: 154 RCVQIRNWFD---YRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I ++ + IV E G S+ D ++ + ++ + + + Q L+ +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAG-SVSDIMKITN-KTLTEEEIAAILYQTLKGLE 113
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASR 258
++H + IH D+K NILL K+ D+ V S Q +MA R
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGV-------SGQLTDTMAKR 156
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 25/163 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ ++ +GEGT+G+V + + +LVAIKI+ I E E ++L++ + H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH---- 62
Query: 153 TRCVQIRNWFDY------RNHIC------IVFEKL-GPSLYDFLR--KNSYRSFPIDLVR 197
N + +N +V E G S+ D ++ + + + +
Sbjct: 63 ------PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ R+ L +A++HE ++IH D+K +NILL VK+ D+ V
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-10
Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y + K+GEG+FG+ + E + IK I + K RE + E+ VL + +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I VQ + F+ ++ IV + G LY + FP D + + Q+ ++
Sbjct: 61 I-----VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+H+ +++H D+K +NI L +K+ D+ +
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGI 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-10
Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y + K+GEGT+G V + + + ++VA+K +R ++ A+ EI +L+ L +I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSL---YDFLRKNSYRSFPIDLVRELGRQLLESV 207
V +++ + + ++FE L L D L K Y +LV+ Q+L+ +
Sbjct: 62 -----VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGI 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F H R++H DLKP+N+L+ + +K+ D+
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADF 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 97 LSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++GEG FG+V C + E VA+K + ++R EI++L+ L +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 151 GGTRCVQIRNWFD--YRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVREL--GRQLLE 205
V+ + + + ++ E L SL D+L+++ + I+L R L Q+ +
Sbjct: 69 -----VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++ R IH DL NIL+ S + VK+ D+
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDF 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHDI 150
+ IL+K+G+G+FG V + K + A+K + +N + RE A+ E VL +L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
++ F + + IV E L+ L+ R P D V Q+L +A
Sbjct: 62 -----IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+H +++H D+K N+ L + + VK+ D V
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGV 147
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
G G FG+V K A+K V R I + + I E ++L+ H V
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPF----IV 56
Query: 157 QIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + +I ++ E LG L+ LR F R ++ + ++H +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 216 IHTDLKPENILLVSAEYVKVPDY----KVPSPRHAFSF 249
I+ DLKPEN+LL S YVK+ D+ K+ S + ++F
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++I K+G+G F V + +VA+K V+ K R+ + EID+L++L +
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLL 204
+ ++ F N + IV E L + D R K R P + + QL
Sbjct: 64 V-----IKYLASFIENNELNIVLE-LADA-GDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ MH R++H D+KP N+ + + VK+ D
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGD 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y ++ + G+ G+V + + V +KI + + +IE +LQ + +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ-----KGTTLIEAMLLQNVNHPSV--- 119
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+++++ C+V LY +L K S R PID + +Q+LE + ++H
Sbjct: 120 --IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
R+IH D+K ENI + + V + D
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQR 144
RY +L +G G +G V D VAIK + ++ RE I +L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKLLRH 55
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR--- 201
L +I G + + N + IV E + L+ ++ P L + +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFL 109
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+L + ++H +IH DLKP NIL+ S +K+ D
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
+ + +G G+FG+V+ + A+KI+ I K ++ + E +LQ + RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 150 IGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F D N + +V E + G L+ LRK+ FP + R Q++ ++
Sbjct: 62 F----LVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H L +++ DLKPEN+LL S Y+K+ D+
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLAR 147
+R+ +G+G FG+V C+D + +A+K V+ +K A EI +L+ L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 148 HDIGGTRCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLL 204
R VQ D +F + P S+ D L+ SY + ++ R+ RQ+L
Sbjct: 64 E-----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQIL 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
E V+++H ++H D+K NIL S VK+ D+
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + + A+KI++ I E A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF----L 57
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
++ F + +C V E G L+ L + R F D R G +++ ++ ++H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+++ DLK EN++L ++K+ D+
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDF 139
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-09
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
Y + +G+G FG+ E LV K V R K R A+ EI +L L +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + N F N + I E G +LYD + + + F ++V Q++ +V+
Sbjct: 61 I-----IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H+ ++H D+K NI L A +K+ D+
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKY-------REAAMI-----EIDVLQRLAR 147
+G+GT+G+V + E++A+K V + R+ M+ EI+ L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I VQ + ++ I E + G S+ LR Y F LVR Q+LE
Sbjct: 68 LNI-----VQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+A++H ++H DLK +N+L+ + K+ D+
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDF 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-09
Identities = 41/161 (25%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRLARHDIG 151
Y L K+GEG++ V + +LVA+K++R + A+ E +L+ L +I
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI- 65
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + + + + +VFE + L ++ K+ P + V+ QLL ++++H
Sbjct: 66 ----VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIH 120
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKVPS----PRHAFS 248
+ ++H DLKP+N+L+ +K+ D+ + P H +S
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ +G GT+GQV + + +L AIK++ E +EI++L++ + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----- 72
Query: 154 RCVQIRNWFDY------------RNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELG 200
RN Y + + +V E G S+ D ++ + D + +
Sbjct: 73 -----RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242
R++L +A +H ++IH D+K +N+LL VK+ D+ V +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREA--AMIEIDVLQRLA 146
RY + ++G+G+FG V D + +K+++ I E A E +L +L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
I V+ F R+ CI+ E G L L K++ ++ + V E QL
Sbjct: 61 HPAI-----VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
L V +MH+ R++H DLK +NI L +K+ D+ V
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGV 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-09
Identities = 36/138 (26%), Positives = 76/138 (55%), Gaps = 15/138 (10%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+Y ILS + G+ G+V C D ++K++ IV+++ + EID+L+ ++
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKV----IVKAVTGGKTPGR-EIDILKTISHRA 147
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I + + + + +++ +C+V K L+ ++ ++ P++ + R+LLE++A+
Sbjct: 148 I-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAY 200
Query: 210 MHELRLIHTDLKPENILL 227
+H +IH D+K ENI L
Sbjct: 201 LHGRGIIHRDVKTENIFL 218
|
Length = 392 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 29/173 (16%)
Query: 85 AIGENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------ 137
+ +++ RY +GEGT+G+V + +D ++VAIK V+ I +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVG 59
Query: 138 ----------EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-- 185
E+ ++ + +I G V + F I +V + + D L+K
Sbjct: 60 MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-----INLVMDIMA---SD-LKKVV 110
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ V+ + Q+L + +H+ +H DL P NI + S K+ D+
Sbjct: 111 DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163
|
Length = 335 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 12/134 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL G G C DN+ E V IK + R E +L+ + I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSI--- 145
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+Q++ F Y C++ + LY +L + R+ I + + R +L ++ ++HE
Sbjct: 146 --IQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHEN 201
Query: 214 RLIHTDLKPENILL 227
R+IH D+K ENI +
Sbjct: 202 RIIHRDIKAENIFI 215
|
Length = 391 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 38/139 (27%), Positives = 72/139 (51%), Gaps = 10/139 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEGT+G V + D E +A+K +R + + E A+ EI +L+ +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHG 61
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+I V++++ + +VFE L L + + + L++ Q+L +A
Sbjct: 62 NI-----VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 209 FMHELRLIHTDLKPENILL 227
+ H R++H DLKP+N+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLI 135
|
Length = 294 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 16/148 (10%)
Query: 99 KMGEGTFGQVVEC-FDNEKKEL--VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
K+G+G+FG V + ++ VA+K ++S + + E ++ L ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL--- 58
Query: 154 RCVQIRNWFDYRNH-ICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
IR + H + +V E L P SL D LRK++ F I + + Q+ + ++
Sbjct: 59 ----IRLYGVVLTHPLMMVTE-LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
R IH DL NILL S + VK+ D+
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDF 141
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 18/155 (11%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLAR 147
+R+ +G G FG+V C+D + +A+K V + +K A EI +L+ L R
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-R 62
Query: 148 HDIGGTRCVQ----IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
HD R VQ +R+ + + I + + G S+ D L+ +Y + ++ R RQ+
Sbjct: 63 HD----RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLK--AYGALTENVTRRYTRQI 115
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L+ V+++H ++H D+K NIL SA VK+ D+
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 93 RY-RILSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL 145
RY + + +GEG FG+V + C+D + E+VA+K ++ + EI++L+ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 146 ARHDI---------GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
+I G + +Q+ + + LG SL D+L K+ ++L
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQL----------IMEYVPLG-SLRDYLPKHK-----LNLA 107
Query: 197 REL--GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ L +Q+ E +A++H IH DL N+LL + VK+ D+
Sbjct: 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDF 151
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 15/149 (10%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
L ++G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ + + I+ E L G S D LR + F I + +++L+ + ++H
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLH 118
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ IH D+K N+LL VK+ D+ V
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGV 147
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLAR 147
+L RY L +G G+ G V D++ + VA+K IV + + + A+ EI +++RL
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH 61
Query: 148 HDI---------GGTRCVQ-IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
+I G+ + + + + + + IV E + L + L + + R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQGP---LSEEHAR 117
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV-KVPDY 238
QLL + ++H ++H DLKP N+ + + + V K+ D+
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 37/152 (24%), Positives = 78/152 (51%), Gaps = 3/152 (1%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGG 152
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H +I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 153 TRCVQIR-NWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
I+ N + + +V E G S+ D ++ + + + + R++L ++ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242
H+ ++IH D+K +N+LL VK+ D+ V +
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ + A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + + V + + G L+ L++ RSFP R ++ ++ ++H L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+I+ DLKPENILL S +V + D+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N + VA+K ++ EA + E ++++L RHD +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKL-RHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ + + + ++ Q+ E +A++
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
IH DL NIL+ K+ D+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADF 147
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 39/168 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y IL K+GEGTFG+V + + +VA+K + ++ ++ A+ EI +L++L
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHP 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI---DLVRELG----- 200
++ V + I + E+ P R + Y P DL L
Sbjct: 68 NV-----VPL---------IDMAVER--PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK 111
Query: 201 ----------RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
QLLE + ++HE ++H D+K NIL+ + +K+ D+
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF 159
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 34/150 (22%), Positives = 66/150 (44%), Gaps = 14/150 (9%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
L ++G G G V + +++A+K +R ++ + E+D+L +
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK--------CN 57
Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V F I I E + D + K P ++ ++ +L+ + ++H
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 212 E-LRLIHTDLKPENILLVSAEYVKVPDYKV 240
E ++IH D+KP NIL+ S +K+ D+ V
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGV 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 12/144 (8%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRC 155
+G G+FG+V E AIK ++ K + E +L L+ I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI----- 80
Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F N + + E +G L+ LRK FP D+ + +L+ + ++H
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+I+ DLKPEN+LL + +VKV D+
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-08
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 16/148 (10%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLARHDIGGT 153
+G+G FG+V C+D + +A K V+ +K A EI +L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64
Query: 154 RCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
R VQ D +F + P S+ D L+ +Y + + R+ RQ+LE ++++
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYL 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H ++H D+K NIL SA VK+ D+
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDF 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 37/147 (25%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 94 YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ + +G G+FG+V+ + NE VAIK ++ + + +++ + I
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-INH 90
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
CV + F +++ +V E +G + FLR+N + FP D+ Q++ ++
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY 238
L +++ DLKPEN+LL ++K+ D+
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDF 175
|
Length = 340 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 17/150 (11%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG--- 151
L ++G+G+FG+V + DN KE+VAIKI+ E I EI VL + I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G+ + W I+ E L G S D L+ I + R++L+ + ++
Sbjct: 69 GSYLKGTKLW--------IIMEYLGGGSALDLLKPGPLEETYIATIL---REILKGLDYL 117
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKV 240
H R IH D+K N+LL VK+ D+ V
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGV 147
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 32/160 (20%)
Query: 99 KMGEGTFGQVVECF---DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHD---- 149
K+GEG FG+V + + K VA+K ++ + R+ + E V+++L H
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVR 60
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+G C + + +V E + G L D+LRK+ FP L + L S
Sbjct: 61 LLGV--CTE-------EEPLYLVLEYMEGG-DLLDYLRKSR-PVFPSPEKSTLSLKDLLS 109
Query: 207 VA--------FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
A ++ + +H DL N L+ VK+ D+
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDF 149
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKNLKHAN 64
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L +L N + V+ QLL +++
Sbjct: 65 I-----VTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H+ +++H DLKP+N+L+ +K+ D+
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADF 147
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 48/236 (20%)
Query: 13 NMDKRPRKRPRLTWDVP---PPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
RPR+RP LT +P P L P LP P + SS +
Sbjct: 19 TTKSRPRRRPDLTLPLPQRDPSLAVPLPLP-------------PPSSSSSSSSSSSASGS 65
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
+P +L+ R+ +++G G G V + L A+K++
Sbjct: 66 APSAAK-------------SLSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 128 INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
+ R EI++L R H V+ + FD+ I ++ E F+ S
Sbjct: 112 EDTVRRQICREIEIL-RDVNH----PNVVKCHDMFDHNGEIQVLLE--------FMDGGS 158
Query: 188 YRSFPIDLVREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
I + L RQ+L +A++H ++H D+KP N+L+ SA+ VK+ D+ V
Sbjct: 159 LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214
|
Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 40/160 (25%)
Query: 93 RYRILSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINK---------YREAAMI-EID 140
+Y I +G GT+G+V + + + + AIK + + RE A++ E+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 141 -----VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL------RKNSYR 189
L + + V + FDY H D R+
Sbjct: 61 HENVVSLVEVFLEH--ADKSVYLL--FDYAEH-------------DLWQIIKFHRQAKRV 103
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229
S P +V+ L Q+L V ++H ++H DLKP NIL++
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 34/152 (22%), Positives = 69/152 (45%), Gaps = 12/152 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
Y+ L +G G +G V +VA+KI+ + + I E+ +L +L +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 152 GTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ + Y + I+ E G S+ ++ I ++ R++L ++
Sbjct: 63 NI----TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII---REVLVALK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++H++ +IH D+K NIL+ + VK+ D+ V
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGV 147
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 9/139 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
+Y + +G G FG V C ++LV IK + + R AA E VL+ L+ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I ++ F + IV E G +L ++++K D + Q+L ++
Sbjct: 61 I-----IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 209 FMHELRLIHTDLKPENILL 227
+H ++H DLK +NILL
Sbjct: 116 HVHTKLILHRDLKTQNILL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 12/151 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAA-MIEIDVLQRLARH 148
+ ++ +G G FG+V D + ++ A+K++R I + + A E D+L
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ F H+ +V E + G L + L + FP + R +L+ ++
Sbjct: 62 WI-----VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H+L IH D+KP+NIL+ + ++K+ D+
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADF 145
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 34/154 (22%), Positives = 64/154 (41%), Gaps = 15/154 (9%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARH 148
Y ++ +G G V C N E VAIK + + K + + E+ + +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPN--NEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLES 206
++ F + + +V L G SL D ++ ++ + +++L+
Sbjct: 60 NVVKYYTS-----FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ ++H IH D+K NILL VK+ D+ V
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGV 148
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 18/148 (12%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGT 153
++G G FG V + KK + VA+KI+++ N ++ + E +V+Q+L I
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI--V 59
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
R + I +W + + +LGP L FL+KN + + EL Q+ + ++
Sbjct: 60 RMIGICEAESWM-----LVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGMKYL 111
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
E +H DL N+LLV+ Y K+ D+
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDF 139
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L +L + S + V+ QLL + +
Sbjct: 66 I-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H +++H DLKP+N+L+ +K+ D+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADF 148
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 8/141 (5%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
++G G FG V + EK++ VAIK +R E + E V+ +L+ + VQ+
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSH-----PKLVQL 64
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
R+ IC+VFE + L D+LR F + + + + E +A++ +IH
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 218 TDLKPENILLVSAEYVKVPDY 238
DL N L+ + VKV D+
Sbjct: 124 RDLAARNCLVGENQVVKVSDF 144
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-07
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
L K+G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAF 209
+ + + I+ E L G S D L P+D + + R++L+ + +
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDY 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+H + IH D+K N+LL VK+ D+ V
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGV 147
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 32/150 (21%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMI--EIDVLQRLARHD 149
+ +G GTFG+V D + A+K+ + + + ++ + E VL+ ++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I D + + ++ E + G L+ +LR + F +++ ++
Sbjct: 63 IIRLFW----TEHD-QRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALE 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H +++ DLKPENILL ++K+ D+
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 35/143 (24%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCV 156
+G+GTFG+V+ + + A+KI++ I K A + + + RH
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF----LT 58
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F ++ +C V E + G L+ L + R F D R G +++ ++ ++H ++
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 216 IHTDLKPENILLVSAEYVKVPDY 238
++ DLK EN++L ++K+ D+
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDF 139
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
Y L K+GEG++ V + +LVA+K++ S+ A+ E +L+ L +I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + + + VFE + L ++ ++ P + VR QLL +A++
Sbjct: 66 -----VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYI 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H ++H DLKP+N+L+ +K+ D+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADF 147
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V + N + VAIK ++ + EA + E +++++L +H R
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQL-QHP----R 62
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + I I+ E + SL DFL+ I+ + ++ Q+ E +AF+
Sbjct: 63 LVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
IH DL+ NIL+ K+ D+
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V N + VA+K ++ E+ + E ++++L RHD +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKL-RHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ R+ + + ++ Q+ +A++ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
IH DL+ NIL+ K+ D+
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 94 YRILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHD 149
++I K+G G F +V D + L ++I ++ K R+ + EID+L++L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ ++ + F N + IV E L + F K R P V + QL
Sbjct: 64 V-----IKYLDSFIEDNELNIVLELADAGDLSQMIKYF--KKQKRLIPERTVWKYFVQLC 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+V MH R++H D+KP N+ + + VK+ D
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGD 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 34/152 (22%), Positives = 70/152 (46%), Gaps = 6/152 (3%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAI-KIVRSINKYREA--AMIEIDVLQRLA 146
+ RY+ + +G G +G V D + VAI KI + + A + E+ +L+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I R + D++ + +V + + L+ + + + + +R QLL
Sbjct: 63 HDNIIAIRDILRPPGADFK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRG 119
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H +IH DLKP N+L+ +++ D+
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 93 RYRILSKMGEGTFGQ---VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG+FG+ V ++K + I++ +S + E + E +L ++ +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRKEAVLLAKMKHPN 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V + F+ H+ IV E G L ++ + FP D + + Q+ V
Sbjct: 60 I-----VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+HE R++H D+K +NI L VK+ D+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 95 RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
R+ K+G+G FG+V + ++ K VAIK ++ EA + E ++++L RHD
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHD---- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ V + I IV E +G SL DFL++ + + + ++ Q+ + +A++
Sbjct: 62 KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
+ IH DL+ NIL+ K+ D+
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L ++ + + V+ Q+L +A+
Sbjct: 66 I-----VTLHDIVHTDKSLTLVFEYLDKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H +++H DLKP+N+L+ +K+ D+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADF 148
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 44/160 (27%)
Query: 100 MGEGTFGQVVECFDNEK--KEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
+G G FG VV+ K KE+ VA+K ++ I ++ + E V+ +L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 155 CVQIRNWFDYRNHICIV----------------FEKLGPSLYDFLRKNSYRSFPIDLVRE 198
+H CIV LGP L +L+K R P+ ++E
Sbjct: 54 -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L Q+ +A++ +H DL N+LLV+ K+ D+
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 12/151 (7%)
Query: 95 RILSKMGEGTFGQVVEC-FD---NEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ + ++G+G FG V C +D + E+VA+K ++ S ++ EI++L+ L +
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I + V + R ++ +V E L P SL D+L+K+ R L+ Q+ + +
Sbjct: 67 IVKYKGV---CYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLL-LYASQICKGM 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ R +H DL NIL+ S VK+ D+
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDF 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 12/144 (8%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + A+KI+R I K A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA-- 59
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
++ F + +C V E G L+ L + R F + R G +++ ++ ++H
Sbjct: 60 --LKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+++ D+K EN++L ++K+ D+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDF 139
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 40/151 (26%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI-----VRSINKYREAAMIEIDVLQRLARH 148
++IL+++G+G +GQV + E+VA+K + +N+ R + E D+L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTT-TKS 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V++ F ++ + E + G L N+ D R ++ E+V
Sbjct: 61 EW----LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAV 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+HEL IH DLKPEN L+ ++ ++K+ D+
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 14/153 (9%)
Query: 92 PR--YRILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLAR 147
PR + + K+G G FG+V E + N + VAIKI++S + ++ E+ L+RL R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-R 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + + + I+ E + SL FLR + P+ + ++ Q+ E
Sbjct: 61 HK----HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYV-KVPDY 238
+A++ E IH DL NI LV + V KV D+
Sbjct: 117 MAYLEEQNSIHRDLAARNI-LVGEDLVCKVADF 148
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDVLQRLARHDIG- 151
+G+G +G V C + +L+A+K V + K E E+D+L+ L +I
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 152 --GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
GT C+ N I I E + G S+ L N + P + + +Q+L+ VA
Sbjct: 67 YLGT-CLD-------DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H ++H D+K N++L+ +K+ D+
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDF 146
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRC 155
LS++GEG G V +C + A+K + + ++ +L+ L
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITT----DPNPDLQKQILRELEINKSCKSPYI 61
Query: 156 VQIRNWF--DYRNHICIVFEKLG----PSLYDFLRKNSYRSFPIDLVRELGR---QLLES 206
V+ F + + I I E S+Y ++K R + LG+ +L+
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE----KVLGKIAESVLKG 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++++H ++IH D+KP NILL VK+ D+ V
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV 151
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-06
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLAR 147
+ L ++G G+FG V D E+VAIK + +S K+++ + E+ LQ+L R
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQQL-R 73
Query: 148 HDIGGTRCVQIRNWFDYRNHIC-IVFEKLGPSLYDFL--RKNSYRSFPIDLVRELGRQLL 204
H ++ + + R H +V E S D L K + I + L
Sbjct: 74 H----PNTIEYKGCY-LREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GAL 125
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ +A++H IH D+K NILL VK+ D+
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-06
Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
+G+GT+G V D + +AIK I ++Y + EI + L +I VQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQY 70
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESVAFMHELRLI 216
I E++ G SL LR K + +Q+LE + ++H+ +++
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 217 HTDLKPENILLVS-AEYVKVPDY 238
H D+K +N+L+ + + VK+ D+
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDF 153
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---IN-KYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ + A+K+++ +N K ++ M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + V + + G L+ L++ RSFP R ++ ++ ++H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+++ DLKPENILL S +V + D+
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 25/146 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ L+ +G G +G V +D ++ VA+K ++ + YRE + +L+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 70
Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
+ ++ G T I N+ N + +V +G L + ++ + + V+ L
Sbjct: 71 MKHENVIGLLDVFTPATSIENF----NEVYLVTNLMGADLNNIVK---CQKLSDEHVQFL 123
Query: 200 GRQLLESVAFMHELRLIHTDLKPENI 225
QLL + ++H +IH DLKP N+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNV 149
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++L K+G G FG+V E N VA+K ++ + + E ++++L RH +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RH----PK 62
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+Q+ I IV E K G SL ++L+ + R+ + + ++ Q+ +A++
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYG-SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
IH DL N+L+ KV D+
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADF 147
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 35/145 (24%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V + N + VA+K ++ +A + E ++++ L +HD +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ I I+ E + SL DFL+ + + + + Q+ E +A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
IH DL+ N+L+ + K+ D+
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADF 147
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 40/159 (25%), Positives = 61/159 (38%), Gaps = 51/159 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ LS +G G +GQV FD + VAIK + + YRE R
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL---------R 66
Query: 145 LARHDIGGTRCVQIRNWFDYRNHIC------------------IVFEKLGPSLYDFLRKN 186
L +H D+ N I +V +G L + ++
Sbjct: 67 LLKH-------------MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC- 112
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225
+ D ++ L Q+L + ++H +IH DLKP NI
Sbjct: 113 --QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 25/99 (25%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
F+ + H+C+V E + L KN + P+D+ R + + ++ ++H ++H DLK
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 222 PENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRVY 260
P+N+L+ S ++K+ D+ S +S+ + +Y
Sbjct: 129 PDNLLITSMGHIKLTDF-------GLSKIGLMSLTTNLY 160
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 22/185 (11%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ I+ +G+GT+G+V + + + A+KI+ I+ E E ++L+ L+ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH----P 75
Query: 154 RCVQIRNWF---DYRN--HICIVFEKL-GPSLYD----FLRKNSYRSFPIDLVRELGRQL 203
V+ + D +N + +V E G S+ D FL++ PI + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEA 133
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP------RHAFSFQTFLSMAS 257
L + +H + IH D+K NILL + VK+ D+ V + R S T MA
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 258 RVYIC 262
V C
Sbjct: 194 EVIAC 198
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 41/141 (29%), Positives = 74/141 (52%), Gaps = 8/141 (5%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+G G FG+V N K VA+K ++ + EA + E +V++ L +HD + V++
Sbjct: 13 KLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKL 66
Query: 159 RNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ + I I+ E + SL DFL+ + P+ + + Q+ E +AF+ + IH
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 218 TDLKPENILLVSAEYVKVPDY 238
DL+ NIL+ ++ K+ D+
Sbjct: 126 RDLRAANILVSASLVCKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + V + + G L+ L++ R F R ++ ++ ++H L
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+I+ DLKPENILL S +V + D+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD 149
+RI K+G G F +V VA+K V+ + K R + EID+L++L +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQLLES 206
+ ++ F N + IV E L ++ K R P V + QL +
Sbjct: 64 V-----IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ MH R++H D+KP N+ + + VK+ D
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGD 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 32/141 (22%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSI---NKYREAAMIEIDVLQRLAR 147
++ + +G+G G+V +L A+K++ + + NK + E ++L L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATL-D 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + F ++C+V + G L+ L++ + ++ R ++L +
Sbjct: 60 HPF----LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 207 VAFMHELRLIHTDLKPENILL 227
+ ++H L +++ DLKPENILL
Sbjct: 116 LEYLHLLGIVYRDLKPENILL 136
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
L ++G GT GQV + + ++A+K + R+ NK E I +D+ L HD
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHD----- 72
Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
C V+ +F + + I E + L D L K P D+ LG+ + V +H
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDI---LGKMTVAIVKALH 128
Query: 212 ELR----LIHTDLKPENILLVSAEYVKVPDY 238
L+ +IH D+KP NILL ++ VK+ D+
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR------ 147
Y++ + +G G+FG V E + E VAIK V +Y+ E+ +++ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 148 HDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQL 203
D T C + +N F + +V E + +++ +++ + + P+ LV+ QL
Sbjct: 125 KDYYYTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 204 LESVAFMHELRLIHTDLKPENILL 227
++A++H + H DLKP+N+L+
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLI 203
|
Length = 440 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 22/150 (14%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V C +L A K +NK R E AM+E +L ++ I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACK---KLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F + +C+V L +Y+ +N FP Q++ +
Sbjct: 56 ---VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGL 110
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+H+ R+I+ DLKPEN+LL + V++ D
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISD 140
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 36/149 (24%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
+G+GTFGQV + + + + A+K++ + I +E A E ++L R +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58
Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V ++ F + + +V + G L+ L+K F D + +L+ ++ +H+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKVPSP 243
+++ DLKPENILL + ++ + D+ +
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKA 145
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 32/193 (16%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
T + I+ +G+GT+G+V + + + L A+KI+ I+ E E ++LQ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH-- 78
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL---GRQLLESV 207
V+ F Y+ + G L+ L + S +LV+ L G++L E++
Sbjct: 79 --PNVVKFYGMF-YKADKLV-----GGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAM 129
Query: 208 ------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP------RHAFSF 249
+H R+IH D+K NILL + VK+ D+ V + R S
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 250 QTFLSMASRVYIC 262
T MA V C
Sbjct: 190 GTPFWMAPEVIAC 202
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 24/158 (15%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVL 142
GE+ Y ++ K+G G FG+V +E K + R + K RE + +IE++V+
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVM 66
Query: 143 QRLARHDIGGTRCV-QIRNWFDYRNHICIVFEKLGPSLYDFLR--KNSYRSF-PID--LV 196
+ L +I R + + N + + +I + F G D R + Y+ F I+ +
Sbjct: 67 RELKHKNI--VRYIDRFLNKANQKLYILMEFCDAG----DLSRNIQKCYKMFGKIEEHAI 120
Query: 197 RELGRQLLESVAFMHEL-------RLIHTDLKPENILL 227
++ RQLL ++A+ H L R++H DLKP+NI L
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLAR--- 147
Y+ L K+GEG++ V + +LVA+K +R + A A+ E +L+ L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANI 65
Query: 148 ---HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
HDI T + + +VFE L L ++ + VR QLL
Sbjct: 66 VTLHDIIHT-----------KKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLL 113
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+A+ H+ R++H DLKP+N+L+ +K+ D+
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADF 147
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 19/156 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ LS +G G +G V FD + VA+K I+ + YRE ++ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL------K 71
Query: 145 LARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+H+ IG + N + +V +G L + ++ + D V+ L Q
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 128
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+L + ++H +IH DLKP N+ + +K+ D+
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 164
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
L ++G G+FG V D E+VAIK + + N+ + + E+ LQ+L RH
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+Q R + + +V E S D L + +++ + L+ +A++H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY---KVPSPRHAF 247
+IH D+K NILL VK+ D+ + +P + F
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ + + + ++ Q+ +A++ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
+H DL+ NIL+ KV D+
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADF 146
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYR--EAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ EL A+K+++ I + E M E VL +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
Q+ + F ++ + V E + G ++ R F R +++ + F+HE
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
+I+ DLK +N+LL S ++K+ D+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 33/149 (22%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGG 152
+S +G G G V + ++A K+V + + R+ + E+ ++ H+
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH- 211
V F N+IC+ E + D + K P++++ ++ ++E + +++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKV 240
R++H D+KP NIL+ S +K+ D+ V
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGV 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 35/146 (23%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V C ++ A K ++K R + A+ E +L++++ I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACK---KLDKKRLKKRKGEQMALNEKKILEKVSSRFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + F+ ++ +C+V + G L + FP Q++ + +H
Sbjct: 56 ---VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPD 237
+ R+++ DLKPEN+LL V++ D
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISD 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ I+ +G G FG+V + + A+KI +NK+ E R R+ +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI---LNKWEMLKRAETACF-REERNVLVNG 58
Query: 154 RCVQIRNW---FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
C I F N++ +V + +G L L K R P D+ R +++ ++
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHS 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H+L +H D+KP+N+LL ++++ D+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 18/162 (11%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RY L ++G G +G V D E VAIK + R + + A E+ +L+ + +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 150 IGGTRCVQI-----RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ G V + D F + P + L+K D V+ L Q+L
Sbjct: 76 VIGLLDVFTSAVSGDEFQD--------FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML 127
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246
+ ++H +IH DLKP N+ + +K+ D+ + RHA
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL--ARHA 167
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLARHDIG 151
L ++G G+FG V D E+VAIK + +S K+++ + E+ LQR+ +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVKFLQRIKHPN-- 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
++ + + + +V E S D L + +++ + L+ +A++H
Sbjct: 87 ---SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH 142
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KVPSPRHAF 247
+IH D+K NILL VK+ D+ + SP ++F
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 37/144 (25%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ +++ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + + V + + G L+ L++ R F R ++ ++ ++H L
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+++ DLKPENILL S ++ + D+
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 6e-05
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAIK + + ++ +I EI V++ L +I
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + F + + +V E L G SL D + + I V R+ L+++ F+
Sbjct: 79 ----VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFL 131
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H ++IH D+K +N+LL VK+ D+
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 27/157 (17%)
Query: 93 RYRILSKMGEGTFGQVVECF------DNEKKELVAI------KIVRSINKY-----REAA 135
+R++ + G FG++ C + E + V K R I K R A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208
Query: 136 MIE--IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS--YRSF 191
+E I L RL +I ++I + ++ +K LY F+ + ++
Sbjct: 209 QLENEILALGRLNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 192 P-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
P + R + +QLL +V ++H+ +LIH D+K ENI L
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 30/158 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHDIGGTR 154
L ++G G FG V + ++A+K +RS +E ++++DV+ R +
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR-------SSD 61
Query: 155 CVQIRNWFDYRNH-----IC-----IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
C I ++ IC I +K +Y+ L+ P ++ LG+ +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEI---LGKIAV 114
Query: 205 ESVAFMH----ELRLIHTDLKPENILLVSAEYVKVPDY 238
+V ++ EL++IH D+KP NILL +K+ D+
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDF 152
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDL--VRELGRQLLESVAFMHELRLIHTDLKPENIL 226
C+V K LY +L R P+ L V + RQLL ++ ++H +IH D+K EN+L
Sbjct: 236 CLVLPKYRSDLYTYL---GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 227 LVSAEYVKVPDY 238
+ E + + D+
Sbjct: 293 VNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-05
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+Y K+G+G G V D + VAIK + + ++ +I ++ R +H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP--- 76
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 77 ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H ++IH D+K +NILL VK+ D+
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 36/141 (25%), Positives = 69/141 (48%), Gaps = 5/141 (3%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
+ +Y + +G G +G V ++E E VAIK I + + +A + EI +L+ L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD 62
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
++ + + + N + IV+E + L+ +R + ++ D + QLL
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRG 120
Query: 207 VAFMHELRLIHTDLKPENILL 227
+ ++H ++H DLKP N+LL
Sbjct: 121 LKYIHSANVLHRDLKPSNLLL 141
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF----L 57
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-EL 213
++ F + +C V E G L+ L + R F D R G +++ ++ ++H E
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
+++ DLK EN++L ++K+ D+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDF 140
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 27/160 (16%)
Query: 100 MGEGTFGQVVECF--DNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
+GEG FGQV+ + K AIK+++ S N +R+ A E++VL +L H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-ELEVLCKLGHH----PN 64
Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
+ + + R ++ I E P +L DFLRK+ +E G +QLL+
Sbjct: 65 IINLLGACENRGYLYIAIE-YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++ E + IH DL N+L+ K+ D+
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADF 163
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMI--EIDVLQRLARHD 149
+ +L +G+G FG+V + K++ A+K + + + E +LQ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSL-YDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F ++ +V + LG L Y +K F + V+ +++ ++
Sbjct: 61 F----LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLAL 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++H +IH D+KP+NILL +V + D+ +
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI 146
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 35/152 (23%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ ++G GT+G V + + EL AIK+++ + + A+++ +++ D +
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMM---KDCKHS 66
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVAFM 210
V + R+ + I E G SL D + + P+ + + R+ L+ + ++
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYL 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242
H +H D+K NILL +VK+ D+ V +
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSA 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 35/141 (24%), Positives = 62/141 (43%), Gaps = 9/141 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY I+ K+GEG+FG++ E IK + + K +EA+ E+ +L ++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V F + IV E G L + + F D + Q+ +
Sbjct: 61 I-----VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 209 FMHELRLIHTDLKPENILLVS 229
+H+ +++H D+K +NI L
Sbjct: 116 HIHDRKILHRDIKSQNIFLSK 136
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 100 MGEGTFGQVVE--CFDNEKKEL---VAIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
+G G FG+VVE + K + VA+K+++ REA M E+ ++ L H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 153 TRCVQIRNWFDYRNH---ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I N I ++ E G L +FLR+ ++ + Q+ + +
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYG-DLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
AF+ IH DL N+LL + VK+ D+
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDF 185
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 20/64 (31%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY-VK 234
L+D L+K V+++ RQL+E++ +H+ +IH D+K EN+L A+ +
Sbjct: 93 DGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY 150
Query: 235 VPDY 238
+ DY
Sbjct: 151 LCDY 154
|
Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 27/160 (16%)
Query: 100 MGEGTFGQVVECFDNEK--KELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
+GEG FGQV++ + + AIK ++ S + +R+ A E++VL +L H
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKLGHH----PN 57
Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
+ + ++R ++ + E P +L DFLRK+ +QLL
Sbjct: 58 IINLLGACEHRGYLYLAIE-YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++ + + IH DL NIL+ K+ D+
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
+ IL +G G FG+V ++ A+KI+ + A E DVL
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 57
Query: 150 IGGTRCVQIRNW-FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G + + ++ F N++ +V + +G L L K R P D+ R +++ ++
Sbjct: 58 -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H+L +H D+KP+NIL+ ++++ D+
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 19/78 (24%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
F ++++ +V E L G ++ P D ++ +++ V +H+ +IH D+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 221 KPENILLVSAEYVKVPDY 238
KPEN+L+ ++K+ D+
Sbjct: 124 KPENLLIDQTGHLKLTDF 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 36/144 (25%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + + KK++ VAIK++++ N+ R+ M E +++ +L I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI---- 57
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V++ + + ++ G L FL + V EL Q+ + ++
Sbjct: 58 -VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
+H DL N+LLV+ Y K+ D+
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDF 139
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 10/143 (6%)
Query: 98 SKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
+ +G+G FG V+ + +K VA+K ++ + +A + E V+ L RH V
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTAAQAFLAEASVMTTL-RHP----NLV 63
Query: 157 QIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
Q+ N + IV E + SL D+LR + + E + ++ E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 216 IHTDLKPENILLVSAEYVKVPDY 238
+H DL N+L+ KV D+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDF 146
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 8/148 (5%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDI 150
Y + +G+G++G+V + IK + + + R+AA E +L +L +I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
R +W + IV G LY L++ + P + V E Q+ ++ +
Sbjct: 62 VAYR----ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+HE ++H DLK +N+ L +KV D
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGD 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 3e-04
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAIK + + ++ +I EI V++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72
Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H ++IH D+K +NILL VK+ D+
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 39/143 (27%), Positives = 61/143 (42%), Gaps = 14/143 (9%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQR 144
+T RY L +G G FG V D + VAIK + + + + E+ +L+
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
L +I + I D I V E LG L+ L R ++ Q+L
Sbjct: 66 LRHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQIL 118
Query: 205 ESVAFMHELRLIHTDLKPENILL 227
+ ++H ++H DLKP NIL+
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILI 141
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRL--AR 147
+R L+ +G G FG+V+ + EL AIK ++ E+ M E + + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
H V + F +H+C V E + D + F ++ +
Sbjct: 61 HPF----LVNLFACFQTEDHVCFVMEYA--AGGDLMMHIHTDVFSEPRAVFYAACVVLGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++HE ++++ DLK +N+LL + +VK+ D+
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADF 145
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 4e-04
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H ++IH D+K +NILL VK+ D+
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 37/158 (23%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
L ++G G+FG V ++ E+VA+K + + N+ + + E+ LQ+L +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-- 83
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
++ + + + +V E S D L + +++ + L+ +A++H
Sbjct: 84 ---IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 139
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY---KVPSPRHAF 247
+IH D+K NILL VK+ D+ SP ++F
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF 177
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 24/152 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLARHDI-- 150
+G G F + D + L+A+K V + + EA EI ++ RL I
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G T +H + E + G S+ L K Y +F ++ QLL +
Sbjct: 68 MLGATC---------EDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGL 116
Query: 208 AFMHELRLIHTDLKPENILLVS-AEYVKVPDY 238
+++HE ++IH D+K N+L+ S + +++ D+
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 18/158 (11%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
Y +L +G+G+FG V + +++ K + N K ++ + E+++L+ L +I
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 151 GGTRCVQIRNWF-DYRNH-ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLE 205
V+ + D N + IV E G L ++K + + + + QLL
Sbjct: 62 -----VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDY 238
++ H ++H DLKP NI L + VK+ D+
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
Y ++ ++G GT+G V + + EL A+KI++ + + ++I EI +++ +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNI- 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
V + R + I E G SL D + + P+ + + R+ L+ +A
Sbjct: 69 ----VAYFGSYLSREKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLA 120
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242
++H +H D+K NILL VK+ D+ V +
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 36/148 (24%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIG 151
I+ + G FG+V +L A+K+V+ INK + E D L L++
Sbjct: 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPF- 65
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + N++ +V E L G + L Y F ++ + ++ ++ ++
Sbjct: 66 ---IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYL 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H +IH DLKP+N+L+ + ++K+ D+
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 22/150 (14%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID------VLQRLARHDI 150
L ++G G FG VV K VAIK++R E AM E D V+ +L+ ++
Sbjct: 9 LKELGSGQFG-VVHLGKWRGKIDVAIKMIR------EGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ + I IV E G L ++LR+ + + + ++ + E++
Sbjct: 62 -----VQLYGVCTKQRPIFIVTEYMANG-CLLNYLRERKGK-LGTEWLLDMCSDVCEAME 114
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ IH DL N L+ VKV D+
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDF 144
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 52/192 (27%)
Query: 97 LSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
L +G+G+FG+V + + +L A+K+++ + R +E D+L
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL-------- 52
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY---DFLRKNSYRSFPIDLVRELGRQLL--- 204
++ + F + H F+ G LY DFLR DL L ++++
Sbjct: 53 -----AEVNHPFIVKLHY--AFQTEG-KLYLILDFLRGG-------DLFTRLSKEVMFTE 97
Query: 205 ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDY-----KVPSPRHAFS 248
E V F +H L +I+ DLKPENILL ++K+ D+ + + A+S
Sbjct: 98 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 249 F-QTFLSMASRV 259
F T MA V
Sbjct: 158 FCGTVEYMAPEV 169
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 36/177 (20%)
Query: 92 PRYRIL--SKMGEGTFGQVVEC---------------FDNEKKELVAIKIVRS-INKY-R 132
PR ++ K+GEG FG+V C FD + LVA+K++R+ + K R
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDG-QPVLVAVKMLRADVTKTAR 61
Query: 133 EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK------ 185
+ EI ++ RL +I V + + + +C++ E + L FL +
Sbjct: 62 NDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIEST 116
Query: 186 ----NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
N+ S I + + Q+ + ++ L +H DL N L+ + +K+ D+
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 39/144 (27%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
L ++G G FG VV+ + VAIK+++ + + + E V+ +L+ +
Sbjct: 8 FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL----- 61
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
VQ+ + I IV E + L ++LR++ R P L+ E+ + + E +A++ +
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLESKQ 120
Query: 215 LIHTDLKPENILLVSAEYVKVPDY 238
IH DL N L+ VKV D+
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDF 144
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 33/151 (21%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ + S +G G FG+V + ++ A+K+++ + + + V DI
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-----KSVLLAQETVSFFEEERDILSI 57
Query: 154 R----CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESV 207
Q++ F ++++ +V E G L L N Y F D+ + +L+ ++
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAI 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H++ +H D+KPEN+L+ ++K+ D+
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADF 146
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.002
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 10/61 (16%)
Query: 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
IV E + G L D L + DL+RE+GR V +H+ ++H DL NI+L
Sbjct: 76 IVMEYIEGELLKDALEEARP-----DLLREVGRL----VGKLHKAGIVHGDLTTSNIILS 126
Query: 229 S 229
Sbjct: 127 G 127
|
Length = 204 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.002
Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 8/67 (11%)
Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
D N I IV E + G L D + NS ++L RE+GR V +H +IH DL
Sbjct: 69 VDPENFI-IVMEYIEGEPLKDLI--NSNGMEELELSREIGRL----VGKLHSAGIIHGDL 121
Query: 221 KPENILL 227
N++L
Sbjct: 122 TTSNMIL 128
|
Length = 211 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 15/46 (32%), Positives = 31/46 (67%)
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
I++++ + RQ+L + +H + ++H D+KPEN+L+ VK+ D+
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 33/146 (22%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID--VLQRLARHDIGGTRCVQ 157
+G+G+FG+V++ K++ I +++I K + E+ + +R + V
Sbjct: 1 IGKGSFGKVMQV---RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57
Query: 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRK----NSYRSFPIDLVRELGRQLLESVAFMHE 212
++ F + +V + G L+ L++ + R+ R +LL ++ +H+
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCALENLHK 111
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
+I+ DLKPENILL ++ + D+
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDF 137
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 43/173 (24%)
Query: 100 MGEGTFGQVVECFDNEKKEL-----VAIKIVR---SINKYREAAMIEIDVLQRLARHDI- 150
+GEG FG+VV+ K VA+K+++ S ++ R + E ++L+++ +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQVNHPHVI 66
Query: 151 ---GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR---------------KNSY---- 188
G C Q D + + + K G SL FLR +NS
Sbjct: 67 KLYGA--CSQ-----DGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 189 ---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
R+ + + Q+ + ++ E++L+H DL N+L+ +K+ D+
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 24/156 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
+ L +G G FG+V + + A+KI+R +A M+E + + + A DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILV 56
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES- 206
G V++ F + ++ ++ E L G + L K D + E Q +
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAE 109
Query: 207 ----VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ +H+L IH D+KP+N+LL + +VK+ D+
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDF 145
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 19/150 (12%)
Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGT 153
+GEG FG+V C +D E E VA+K ++ + A + EI++L+ L +I
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 154 R--CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVA 208
+ C + D N I ++ E L SL ++L +N + I+L ++L Q+ + +
Sbjct: 72 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ + +H DL N+L+ S VK+ D+
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDF 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RYR L ++G G +G V D VAIK + R + + A E+ +L+ + +H+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHE 74
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
IG D + +V +G L ++ + D ++ L Q+L+ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGL 131
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H +IH DLKP N+ + +K+ D+
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDF 162
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 92 PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
PR + K+GEG+ G V D VA+K + + R + V+ R +H
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ + + + + +V E L G +L D + I V +L++++
Sbjct: 77 ----NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLAVLKALS 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H +IH D+K ++ILL S VK+ D+
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLAR 147
+ + +G+G FG+V V+ D K + A+K + +++ + E DVL A
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVL---AE 57
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
D V + F ++ ++ E L G L L K Y +F D+ R + + +
Sbjct: 58 SD--SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLA 113
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ +H+L IH D+KP+NIL+ ++K+ D+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDF 145
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 94 YRILSKMGEGTFGQVVEC-FDNEKKELVAIKIV-----------RSINKYREAAMIEIDV 141
Y +L +G G FG V + N + L+A+K + R +K + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRE 198
++ RH V+ F + + IV + + G L + K + F + +
Sbjct: 62 IKEQLRH----PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 199 LGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDY 238
+ Q++ ++ ++H E R++H DL P NI+L + V + D+
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 20/60 (33%), Positives = 37/60 (61%), Gaps = 1/60 (1%)
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L D++R+N R DL+ Q+ + ++++ E+RL+H DL N+L+ S +VK+ D+
Sbjct: 95 LLDYVRENKDRIGSQDLL-NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI----GG 152
+ +G G FG+V + K L A+K +R ++ ++ V A DI
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADN 60
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V++ F ++++ V + + G + L + FP DL R +L +V +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVH 118
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY 238
++ IH D+KP+NIL+ ++K+ D+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 31/136 (22%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V ++ A K ++K R + A++E ++L+++ I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACK---KLDKKRLKKKSGEKMALLEKEILEKVNSPFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + F+ + H+C+V + G L + R ++ V Q+ + +H
Sbjct: 56 ---VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 212 ELRLIHTDLKPENILL 227
+ +++ D+KPEN+LL
Sbjct: 113 SMDIVYRDMKPENVLL 128
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 264 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.87 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.78 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.77 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.75 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.66 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.64 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.62 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.57 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.56 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.55 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.49 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.42 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.26 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.24 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.23 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.23 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.08 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.93 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.86 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.8 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.65 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.35 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.25 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.24 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.18 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.18 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.16 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.15 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.94 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.79 | |
| PLN02236 | 344 | choline kinase | 97.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.66 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.66 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.63 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.59 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.4 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.33 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.26 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.89 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.73 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.65 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.52 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 96.25 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.15 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.1 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 96.0 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=288.67 Aligned_cols=165 Identities=28% Similarity=0.451 Sum_probs=151.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
..++|.+.++||+|+|++||+|+++.++..||||.+.+. .+..+.+..|+.+|+.++|+|+ |+++++..+.+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nI-----V~l~d~~~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNI-----VRLLDCIEDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcce-----eeEEEEEecCC
Confidence 346799999999999999999999999999999998754 4567788999999999999988 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC------CcEEeccCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA------EYVKVPDYK 239 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~------~~v~l~Dfg 239 (264)
++||||||| ||+|.+|+++.+ .+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999 999999999987 89999999999999999999999999999999999999975 358999999
Q ss_pred CCCcCCCC-----cccceeeeeceeEe
Q 024661 240 VPSPRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~~-----~~~~~~y~ape~~~ 261 (264)
+|+..++. -+|++.|||||+++
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~ 187 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIM 187 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHH
Confidence 99987764 47999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=274.26 Aligned_cols=168 Identities=29% Similarity=0.467 Sum_probs=152.2
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh--------hHHHHHHHHHHHHHHhccCCCCcceEEEc
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 159 (264)
..+.+.|.+.+.||+|+||.|.+|..+.+|+.||||++++... ......+|+++|+.++||++ |+++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I-----V~~~ 242 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI-----VRIK 242 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE-----EEEe
Confidence 3567889999999999999999999999999999999985431 22345799999999999998 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---CcEEe
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---EYVKV 235 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---~~v~l 235 (264)
++|+..+..||||||+ ||+|++.+..++ .+.+.....++.|++.|+.|||++||+||||||+|||+..+ ..+||
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999 999999999887 78889999999999999999999999999999999999977 78999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+|||+|..... ..|||+.|.|||++++
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheec
Confidence 99999988643 4589999999999976
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=272.65 Aligned_cols=165 Identities=24% Similarity=0.392 Sum_probs=150.9
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|+++++||+|+||+||+++.+.+++.+|+|++++.. ........|..+|..++||.+ |.++..|++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFi-----v~l~ysFQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFI-----VKLIYSFQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcE-----eeeEEecccCC
Confidence 367999999999999999999999999999999998643 345678899999999998887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC-
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR- 244 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~- 244 (264)
.+|+|+||+ ||.|...|++.. .|+|..++.|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999 999999999876 8999999999999999999999999999999999999999999999999999852
Q ss_pred -----CCCcccceeeeeceeEee
Q 024661 245 -----HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 -----~~~~~~~~~y~ape~~~~ 262 (264)
....+||..|||||+++.
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred cCCCccccccCCccccChHHHhc
Confidence 234589999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=280.05 Aligned_cols=163 Identities=29% Similarity=0.420 Sum_probs=153.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+|..++.||+|+|+.||.+++..+|+.||+|++.+ .....+.+.+||++.+.|+|+|| |+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnI-----V~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNI-----VQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcE-----EeeeeEeecCCc
Confidence 679999999999999999999999999999999986 45677889999999999999998 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|||+|+| .++|..+++..+ .++|.+++.++.||+.||.|||+++|+|||||..|+|++++.+|||+|||+|+....
T Consensus 93 VYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999 999999999766 899999999999999999999999999999999999999999999999999987553
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
.-|||+.|+|||++.
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred cccccceecCCCcccChhHhc
Confidence 458999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=260.24 Aligned_cols=164 Identities=24% Similarity=0.347 Sum_probs=149.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe--chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC-EE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~ 168 (264)
++.+.++.||+|+.|+||+++++.+++.+|+|++. .+....+++.+|+++++.++++++ |.+++.|.+++ .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyI-----V~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYI-----VGFYGAFYSNGEEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-----eeEeEEEEeCCceE
Confidence 45777899999999999999999999999999994 456778899999999999988877 99999999999 59
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPR-- 244 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~-- 244 (264)
+|+|||| +|+|.+++...+ +++|..+..++.+|++||.|||+ .+||||||||+|||++..|.|||||||.+...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999 999999999875 89999999999999999999995 89999999999999999999999999998763
Q ss_pred --CCCcccceeeeeceeEee
Q 024661 245 --HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 --~~~~~~~~~y~ape~~~~ 262 (264)
.....||..|||||-+.+
T Consensus 232 S~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISG 251 (364)
T ss_pred hhcccccccccccChhhhcC
Confidence 345579999999997754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=254.25 Aligned_cols=164 Identities=24% Similarity=0.388 Sum_probs=152.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||.|+||.|.+++.+.+|..+|+|++++.+ +..+...+|..+|+.+.||.+ +.+++.|.+..+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFl-----v~l~~t~~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFL-----VKLYGTFKDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCcee-----EEEEEeeccCCe
Confidence 56999999999999999999999999999999998654 456778899999999999887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+||||||+ ||.|++++++.. +|++..++.|+.||+.||+|||+++|++||+||+|||+|.+|.+||+|||+|.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999 999999999876 899999999999999999999999999999999999999999999999999988766
Q ss_pred Cc---ccceeeeeceeEee
Q 024661 247 FS---FQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~---~~~~~y~ape~~~~ 262 (264)
.+ |||+.|+|||++.+
T Consensus 197 rT~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred cEEEecCCccccChHHhhc
Confidence 44 69999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=252.97 Aligned_cols=165 Identities=28% Similarity=0.460 Sum_probs=149.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|+.+.++|+|+||.||+|+++.||+.||||.+... ....+...+|+++|++++|+|+ |.++++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NL-----VnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENL-----VNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchH-----HHHHHHHHhccee
Confidence 4688899999999999999999999999999998643 3556788999999999999998 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-C
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-F 247 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-~ 247 (264)
+||+|||..++.+.+.... .+++.+.+..|+.|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.... .
T Consensus 77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9999999999888888876 5689999999999999999999999999999999999999999999999999998662 2
Q ss_pred -----cccceeeeeceeEee
Q 024661 248 -----SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 -----~~~~~~y~ape~~~~ 262 (264)
...|.+|.|||++.+
T Consensus 156 d~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVG 175 (396)
T ss_pred chhhhhhhhhhccChhhhcc
Confidence 246788999998865
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=265.14 Aligned_cols=189 Identities=37% Similarity=0.685 Sum_probs=172.4
Q ss_pred CCCCCCceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCc
Q 024661 75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGT 153 (264)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~ 153 (264)
..+.++.+.+...+.+..+|.+.+.||+|+||.|-+|.+..|++.||||++++.+....+...|+.+|..++ |-+-...
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 444566789999999999999999999999999999999999999999999999999999999999999999 5555667
Q ss_pred ceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC--C
Q 024661 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA--E 231 (264)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~--~ 231 (264)
++|+++++|...+++|||+|++..+|+++++.++-.+++...++.++.||+.||.+||+.||||+||||+|||+..- .
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC
Confidence 88999999999999999999999999999999887889999999999999999999999999999999999999864 4
Q ss_pred cEEeccCCCCCcCCCCc---ccceeeeeceeEeec
Q 024661 232 YVKVPDYKVPSPRHAFS---FQTFLSMASRVYICI 263 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~~~---~~~~~y~ape~~~~~ 263 (264)
.|||+|||.|+...... +++.+|-|||+++++
T Consensus 329 ~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGl 363 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGL 363 (586)
T ss_pred ceeEEecccccccCCcceeeeeccccccchhhccC
Confidence 89999999998765543 477789999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=243.26 Aligned_cols=165 Identities=27% Similarity=0.400 Sum_probs=149.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh---hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|...++||+|.||.||+|++..+|+.||||.++..+. ......+|+..|+.++|+|+ +.+++.|.+.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nI-----i~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNI-----IELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcch-----hhhhhhccCCCce
Confidence 478899999999999999999999999999999985432 35677899999999999998 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
.||+||+..+|...++... ..++...+..|+.+++.||+|||++.|+||||||.|+||+++|.+||+|||+|+....
T Consensus 77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9999999999999998765 5799999999999999999999999999999999999999999999999999987442
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...-|.+|-|||+++|
T Consensus 156 ~~~~~~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFG 175 (318)
T ss_pred cccccceeeeeccChHHhcc
Confidence 2246889999998875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.10 Aligned_cols=146 Identities=23% Similarity=0.411 Sum_probs=133.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
-.++|+++.+||+|+||.||+|+.+.||+.+|+|++++... ....+..|..+|....++.+ |+++..|++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~v-----VKLyYsFQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWV-----VKLYYSFQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcE-----EEEEEEecCC
Confidence 34679999999999999999999999999999999997653 34566778888877666665 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
.++||||||+ ||++..+|.... .+++..+++|+.+++.|++.||+.|+|||||||+|+|||..|++||+|||+|.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999 999999999876 89999999999999999999999999999999999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=260.28 Aligned_cols=169 Identities=25% Similarity=0.404 Sum_probs=150.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
....+.|+.+++||+|.||.||+|++..+|+.||+|.++.. .....-..+||.+|++|.|+|| +++.+...+
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNI-----ikL~eivt~ 187 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNI-----IKLEEIVTS 187 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcc-----cceeeEEEe
Confidence 34456799999999999999999999999999999998743 3445667899999999999999 999988877
Q ss_pred C--CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 165 R--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 165 ~--~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
. ..+|||+|||..+|.-++.... ..|++.++..|+.|++.||+|+|.+||+|||||.+|||||.+|.+||+|||+|+
T Consensus 188 ~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred cCCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccccee
Confidence 6 7999999999999999988754 579999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCc-------ccceeeeeceeEee
Q 024661 243 PRHAFS-------FQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~~~-------~~~~~y~ape~~~~ 262 (264)
...... .-|.+|-+||+++|
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG 293 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLG 293 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcC
Confidence 654433 35889999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=257.37 Aligned_cols=164 Identities=24% Similarity=0.336 Sum_probs=146.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
..+|.+++.||+|+|++|++|+++.++++||||++.+.. ...+-+.+|-++|.+| .||.+ ++++..|+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgi-----vkLy~TFQD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGI-----VKLYFTFQDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCe-----EEEEEEeecc
Confidence 356999999999999999999999999999999987543 3345667899999999 45555 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..+|+|+||+ +|+|.++|.+.+ .|++..++.|+.||+.||+|||++|||||||||+|||++.+++++|+|||.|...
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999 999999999886 8999999999999999999999999999999999999999999999999998752
Q ss_pred C-------------------CCcccceeeeeceeEe
Q 024661 245 H-------------------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~-------------------~~~~~~~~y~ape~~~ 261 (264)
. ....||..|.+||++.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 2 2246899999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.85 Aligned_cols=167 Identities=30% Similarity=0.414 Sum_probs=150.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-----h-hhHHHHHHHHHHHHHHh-ccCCCCcceEEEcee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----N-KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~-~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~ 161 (264)
...++|.+++.||+|+||+|++|.+..+++.||+|++++. . ...+.+.+|+.+++.+. |+|+ ++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI-----~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNI-----IRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCE-----eEEEEE
Confidence 4557899999999999999999999999999999977653 1 23566778999999999 8877 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYK 239 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg 239 (264)
+.....+|+||||+ ||+|++++.+.. ++.|..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999 899999999954 89999999999999999999999999999999999999999 999999999
Q ss_pred CCCcCC------CCcccceeeeeceeEee
Q 024661 240 VPSPRH------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~------~~~~~~~~y~ape~~~~ 262 (264)
++.... ...+|++.|+|||++.+
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~ 195 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSG 195 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCC
Confidence 998652 25579999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=249.86 Aligned_cols=166 Identities=28% Similarity=0.353 Sum_probs=146.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe---chhhhHHHHHHHHHHHHHHhccCCCCcceEEEce-eeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-WFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~~~ 166 (264)
...|+++++||+|+||.||++.+..+|..+|.|.++ .+.+.++....|+.+|++|+|+|+ |++++ .|..++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI-----VqYy~~~f~~~~ 92 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI-----VQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH-----HHHHHHhhhccc
Confidence 356999999999999999999999999999999886 234667888999999999999998 99988 455555
Q ss_pred E-EEEEEecC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCCEEeecCCcEEeccC
Q 024661 167 H-ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE--LR--LIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 167 ~-~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~--ivH~dikp~Nili~~~~~v~l~Df 238 (264)
. ++||||+| +|+|...++. .+...++|..+|.++.|++.||.++|. .. |.||||||.||+++.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 99999999 9999999983 344679999999999999999999999 34 899999999999999999999999
Q ss_pred CCCCcCCCC------cccceeeeeceeEe
Q 024661 239 KVPSPRHAF------SFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~~------~~~~~~y~ape~~~ 261 (264)
|+++..... ..||++||+||.+.
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~ 201 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIH 201 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHh
Confidence 999876553 36999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=258.18 Aligned_cols=167 Identities=23% Similarity=0.316 Sum_probs=146.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.-.++|.++++||+|+||+|+++..+.+++.+|||++++.. ...+..+.|.+++.... .||.++.++.+|++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQT 440 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeeccccccc
Confidence 34467999999999999999999999999999999998753 45678888999888876 33556999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
++++|+||||+ ||++..+.+.. .|++..++.|+..|+.||.|||++|||+||||.+|||+|.+|++||+|||+++.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999 88855444433 699999999999999999999999999999999999999999999999999987
Q ss_pred CC------CCcccceeeeeceeEee
Q 024661 244 RH------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~------~~~~~~~~y~ape~~~~ 262 (264)
.. ...+||+.|||||++..
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e 542 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTE 542 (694)
T ss_pred cCCCCCccccccCChhhcChhhhcc
Confidence 44 45589999999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=240.43 Aligned_cols=198 Identities=57% Similarity=0.976 Sum_probs=179.2
Q ss_pred CCCCCCCCCCCCCCCceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH
Q 024661 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL 145 (264)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l 145 (264)
++...++..+++.++.+.+..++.+..+|.+.+.+|+|.||.|..+.+..++..||+|+++.-...++...-|+++++++
T Consensus 63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki 142 (415)
T KOG0671|consen 63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI 142 (415)
T ss_pred ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 56677788889999999999999999999999999999999999999999999999999998889999999999999999
Q ss_pred hccC-CCCcceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 146 ~~~~-~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
.+.. -....++++.++|+..++.|||+|.+|-++++++..+...+++...++.|+.|+++++.|||+.+++|.||||+|
T Consensus 143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 7654 334567899999999999999999999999999999888899999999999999999999999999999999999
Q ss_pred EEeecCC--------------------cEEeccCCCCCcCCCCc---ccceeeeeceeEeec
Q 024661 225 ILLVSAE--------------------YVKVPDYKVPSPRHAFS---FQTFLSMASRVYICI 263 (264)
Q Consensus 225 ili~~~~--------------------~v~l~Dfg~a~~~~~~~---~~~~~y~ape~~~~~ 263 (264)
||+.+.. .|+|+|||.|+..+... .+|..|-|||++++.
T Consensus 223 ILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGL 284 (415)
T ss_pred EEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheecc
Confidence 9996421 47999999998765544 689999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=258.99 Aligned_cols=167 Identities=28% Similarity=0.454 Sum_probs=148.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh--hHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~ 165 (264)
.+-++|.++++||.|.||.||+|+.+.+++.||||.+++.-. ..-.-.+|+..|+++. |+|+ +++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpni-----ikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNI-----IKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcc-----hhhHHHhhcc
Confidence 345789999999999999999999999999999998875432 2223368999999999 8888 9999999887
Q ss_pred C-EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 N-HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~-~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+ .+|+|||||..+|+++++.+ ...|++..++.|+.||++||+|+|.+|+.|||+||+||||.....+||+|||+|+..
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 7 99999999999999999987 478999999999999999999999999999999999999999999999999999975
Q ss_pred CC-----CcccceeeeeceeEe
Q 024661 245 HA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~-----~~~~~~~y~ape~~~ 261 (264)
.. ....|.+|.|||+++
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLL 182 (538)
T ss_pred ccCCCcchhhhcccccchHHhh
Confidence 54 225889999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=259.89 Aligned_cols=164 Identities=26% Similarity=0.424 Sum_probs=150.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+. ++....+.+|+++++.++|+|+ +.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpni-----v~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNI-----VEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcch-----hhHHHhhcccceE
Confidence 4688999999999999999999999999999999753 4556778899999999999999 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
|+|+||+-|+|..++...+ .++|+.+..++.|++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.-..
T Consensus 77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9999999669999999876 899999999999999999999999999999999999999999999999999987443
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...||+.|||||++..
T Consensus 155 ~vltsikGtPlYmAPElv~e 174 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE 174 (808)
T ss_pred eeeeeccCcccccCHHHHcC
Confidence 3359999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=240.49 Aligned_cols=166 Identities=23% Similarity=0.293 Sum_probs=150.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.|++.++||.|..+.||+|+...+++.||||+++.++ ...+.+.+|+..++.+.|||+ +.++..|..+..+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNI-----v~~~~sFvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNI-----VTYHCSFVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCc-----ceEEEEEEeccee
Confidence 367999999999999999999999999999999998543 346789999999999999999 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|+||.|| +|++.++++..-...++|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+....
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999 9999999998766789999999999999999999999999999999999999999999999999764311
Q ss_pred --------CCcccceeeeeceeEe
Q 024661 246 --------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 --------~~~~~~~~y~ape~~~ 261 (264)
....+|+.|||||+++
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred CceeeEeeccccCcccccChHHhh
Confidence 3446899999999853
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=247.75 Aligned_cols=167 Identities=29% Similarity=0.458 Sum_probs=152.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.+..+|++.+.||.|.||+|-+|.+...|+.||||.+++. ++..-.+.+|++++..|+||+| ++++++|+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhI-----I~IyEVFEN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHI-----IQIYEVFEN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCce-----eehhhhhcC
Confidence 5667899999999999999999999999999999999754 3445677899999999999998 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+.|||||. +|.|++|+...+ .+++.+++.+++||++|+.|+|.++++|||||.+|||+|.++++||+|||++..
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999 999999999876 899999999999999999999999999999999999999999999999999976
Q ss_pred CCC-----CcccceeeeeceeEee
Q 024661 244 RHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~~ 262 (264)
... ..||.+.|.+||++-+
T Consensus 203 y~~~kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 203 YADKKFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred hccccHHHHhcCCcccCCccccCC
Confidence 543 4578899999998643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=249.12 Aligned_cols=163 Identities=28% Similarity=0.378 Sum_probs=143.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcE-EEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN- 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 166 (264)
+...+.+.||+|+||+||+|.+. |.. ||+|++.... ...+.+.+|+.+|.+++|+|+ +++++.+.+..
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~f~G~~~~~~~ 113 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNI-----VQFYGACTSPPG 113 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCC
Confidence 34566677999999999999987 444 9999997533 226689999999999999998 99999999887
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEeecCC-cEEeccCCCCCc
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAE-YVKVPDYKVPSP 243 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dikp~Nili~~~~-~v~l~Dfg~a~~ 243 (264)
.+++||||+ +|+|.+++.......++...+..|+.||+.||+|||+++ |||||||++|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 799999999 999999998843358999999999999999999999999 99999999999999997 999999999987
Q ss_pred CCCC------cccceeeeeceeEe
Q 024661 244 RHAF------SFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~------~~~~~~y~ape~~~ 261 (264)
.... ..||+.|||||+++
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred eccccccccCCCCCccccChhhhc
Confidence 5542 46899999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=239.53 Aligned_cols=164 Identities=31% Similarity=0.406 Sum_probs=145.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC--EE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--~~ 168 (264)
.+|..++.||+|+||.||++.+..+|+.+|+|.+.... ...+.+.+|+.+|++++|++| |++++...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~I-----V~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNI-----VQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCE-----EeeCCccccccCeee
Confidence 45888999999999999999999999999999887542 225678999999999998887 99999855544 79
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccCCCCCcCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~~ 246 (264)
+++|||+ +|+|.+++...++ .+++..++.+.+||++||.|||++||||+||||+|||++. ++.+||+|||++.....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999 9999999998875 7999999999999999999999999999999999999999 79999999999886542
Q ss_pred ---------CcccceeeeeceeEe
Q 024661 247 ---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---------~~~~~~~y~ape~~~ 261 (264)
...||+.|||||++.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred ccccccccccccCCccccCchhhc
Confidence 235899999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=236.46 Aligned_cols=166 Identities=23% Similarity=0.367 Sum_probs=147.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~ 166 (264)
+.|+.+..|++|+||.||+|+++.+++.||+|.++.++ ...-...+||.+|.+++|+|| |.+..+... -+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NI-----V~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNI-----VEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCe-----eeeEEEEeccccc
Confidence 56999999999999999999999999999999997432 233456889999999999998 888887765 46
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.+|||||||..+|..++...+ ++|.+.++..++.|++.|++|||.+.|+|||||++|+|+...|-+||+|||+|+....
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 799999999999999999876 7899999999999999999999999999999999999999999999999999987443
Q ss_pred C------cccceeeeeceeEeec
Q 024661 247 F------SFQTFLSMASRVYICI 263 (264)
Q Consensus 247 ~------~~~~~~y~ape~~~~~ 263 (264)
- -.-|.+|-|||+++|-
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~ 252 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGA 252 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCC
Confidence 2 2368899999998863
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=240.89 Aligned_cols=167 Identities=23% Similarity=0.330 Sum_probs=142.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---------------hhHHHHHHHHHHHHHHhccCCCCc
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------------KYREAAMIEIDVLQRLARHDIGGT 153 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~ 153 (264)
...+.|++.+.||+|.||+|.+|++..+++.||||++.+.+ ...+...+|+.+++++.|+|+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV--- 170 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV--- 170 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe---
Confidence 34467999999999999999999999999999999997532 223678899999999999998
Q ss_pred ceEEEceeeee--CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC
Q 024661 154 RCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (264)
Q Consensus 154 ~~~~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~ 230 (264)
|+++++..+ .+.+|||+||| .|.+...-.... .+++.+++.|+++++.||+|||.+|||||||||+|+|++++
T Consensus 171 --V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 171 --VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred --eEEEEeecCcccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 999999988 57899999999 776654322221 38999999999999999999999999999999999999999
Q ss_pred CcEEeccCCCCCcCC-----------CCcccceeeeeceeEee
Q 024661 231 EYVKVPDYKVPSPRH-----------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~-----------~~~~~~~~y~ape~~~~ 262 (264)
|+|||+|||.+.... ....||+.+||||++..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 999999999987431 13468999999998753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=235.58 Aligned_cols=166 Identities=29% Similarity=0.480 Sum_probs=146.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh---hHHHHHHHHHHHHHHhccC-CCCcceEEEceeeeeCC-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRN- 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~-~~~~~~~~~~~~~~~~~- 166 (264)
..|..+++||+|.||+||+|+.+.+|+.||+|.++.... ......+|+.+++.++|+| + +.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~i-----v~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHI-----VRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcce-----EEEEeeeeeccc
Confidence 457888999999999999999999999999999985433 4566789999999999998 6 99999998877
Q ss_pred -----EEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 167 -----HICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 167 -----~~~lv~e~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.+++|+||+.-+|..++..... ..++...++.++.||+.||+|||+++|+||||||.||||+++|.+||+|||
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 8999999999999999997653 367788999999999999999999999999999999999999999999999
Q ss_pred CCCcCC------CCcccceeeeeceeEee
Q 024661 240 VPSPRH------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~------~~~~~~~~y~ape~~~~ 262 (264)
+|+... .....|..|.|||++.+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlG 194 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLG 194 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcC
Confidence 998543 12347889999999765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=229.08 Aligned_cols=167 Identities=23% Similarity=0.340 Sum_probs=152.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|++++.||+|.||.||+|+.+.++-.||+|++.+.. ....++.+|+++-..|.|+|| .+++++|.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpni-----lrlY~~fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNI-----LRLYGYFHDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccH-----Hhhhhheeccc
Confidence 367999999999999999999999999999999998643 445788899999999999988 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+||++||. +|+|+..|.......+++.....|+.|++.||.|+|.++|+||||||+|+|++.++.+||+|||.+....
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999 9999999997766789999999999999999999999999999999999999999999999999997653
Q ss_pred ----CCcccceeeeeceeEee
Q 024661 246 ----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ----~~~~~~~~y~ape~~~~ 262 (264)
..-+||..|.+||...+
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred CCCceeeecccccCCHhhcCC
Confidence 24479999999998754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=245.80 Aligned_cols=145 Identities=23% Similarity=0.367 Sum_probs=132.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||+||+|.+..+++.+|+|++.+.. .....+.+|+.+++.++|+++ +++++.+.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~i-----v~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWV-----VKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCCe
Confidence 36999999999999999999999999999999997532 334567789999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+|+||||+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 99999999 999999998765 799999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=244.25 Aligned_cols=144 Identities=24% Similarity=0.380 Sum_probs=132.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ...+.+.+|+++++.+.|+++ +++++++.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWV-----VSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCe
Confidence 36999999999999999999999999999999987532 234567889999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+|+||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999 999999998765 78999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.96 Aligned_cols=143 Identities=23% Similarity=0.397 Sum_probs=131.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.|++++.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.++|+++ +++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWV-----VKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCe-----eeeEEEEecCCEE
Confidence 5899999999999999999999999999999997532 334567889999999998887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+++++|+|||++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999 999999998765 78999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=242.63 Aligned_cols=145 Identities=23% Similarity=0.378 Sum_probs=132.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||.|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.++|+++ +++++.+.+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV-----VKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCe
Confidence 36999999999999999999999999999999997532 334567789999999998888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 99999999 999999998765 699999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=243.03 Aligned_cols=143 Identities=25% Similarity=0.418 Sum_probs=131.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+|+++++||+|+||.||+|.+..+++.+|+|++.+.. .....+.+|+.+++.+.|+++ +++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~i-----v~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcC-----CeEEEEEEeCCEE
Confidence 5899999999999999999999999999999997542 334577889999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999 899999998764 68999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=239.27 Aligned_cols=164 Identities=27% Similarity=0.370 Sum_probs=147.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|++..+++.+|+|++.+.. ...+.+.+|+.+++.+.|+|+ +++++.+.+++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI-----VNMMCSFQDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEcCCE
Confidence 67999999999999999999999999999999997543 234567889999999999988 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999 999999998765 789999999999999999999999999999999999999999999999999976543
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQS 189 (329)
T ss_pred CcceecCChhhcCHHHHcC
Confidence 2357889999998754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=248.21 Aligned_cols=165 Identities=24% Similarity=0.404 Sum_probs=152.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+-|++++.||.|+-|.|.+|++..||+..|||++.+. ......+.+|+-+|+-+.|||+ +++++.|++..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnV-----l~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNV-----LRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCe-----eeeeeeeccCce
Confidence 4599999999999999999999999999999999765 2345677889999999999998 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
+|+|+||+ +|.|++++...+ ++++.++..++.||+.|+.|+|..+|+|||+||+|+|++..+++||+|||+|..-.
T Consensus 87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999 999999999876 89999999999999999999999999999999999999999999999999998633
Q ss_pred ----CCcccceeeeeceeEeec
Q 024661 246 ----AFSFQTFLSMASRVYICI 263 (264)
Q Consensus 246 ----~~~~~~~~y~ape~~~~~ 263 (264)
...||.+.|.+||+++|.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~ 186 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGR 186 (786)
T ss_pred CccccccCCCcccCCchhhcCC
Confidence 467899999999999873
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=242.27 Aligned_cols=144 Identities=23% Similarity=0.394 Sum_probs=132.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .....+.+|+++++.+.|+++ +++++.+.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWV-----VKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCE
Confidence 36999999999999999999999999999999987532 234567889999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+|.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999 999999998765 68999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=240.33 Aligned_cols=170 Identities=35% Similarity=0.587 Sum_probs=145.9
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCC-CcceEEEceeeeeC-CEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRCVQIRNWFDYR-NHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~-~~~~~~~~~~~~~~-~~~ 168 (264)
.++|++.++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.|.+.. +.+++.++++|..+ .++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 5789999999999999999999999999999999976555556677899999999887743 34578888888764 689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCC----------------
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAE---------------- 231 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~---------------- 231 (264)
|+|||+++++|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 208 ~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 9999999999999998764 79999999999999999999997 5999999999999998765
Q ss_pred cEEeccCCCCCcCC---CCcccceeeeeceeEee
Q 024661 232 YVKVPDYKVPSPRH---AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~---~~~~~~~~y~ape~~~~ 262 (264)
.+||+|||.+.... ....+|..|||||++.+
T Consensus 286 ~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 286 RVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred eEEECCCCccccCccccccccCCccccCcHHhhc
Confidence 49999999886532 23468899999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=244.61 Aligned_cols=164 Identities=27% Similarity=0.366 Sum_probs=148.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhh-HHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.-...|....+||+|..|.||.|....+++.||||.+....+. .+-+.+|+.+|+..+|+|+ |.+++.|-.++.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~Ni-----Vnfl~Sylv~de 344 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNI-----VNFLDSYLVGDE 344 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHH-----HHHHHHhcccce
Confidence 3346699999999999999999999999999999999865543 4667899999999999998 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ ||+|.+.+... .++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|.....
T Consensus 345 LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999 99999999875 499999999999999999999999999999999999999999999999999986543
Q ss_pred ------CcccceeeeeceeE
Q 024661 247 ------FSFQTFLSMASRVY 260 (264)
Q Consensus 247 ------~~~~~~~y~ape~~ 260 (264)
.-.||++|||||++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVv 441 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVV 441 (550)
T ss_pred ccCccccccCCCCccchhhh
Confidence 33699999999985
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=236.63 Aligned_cols=158 Identities=25% Similarity=0.424 Sum_probs=138.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.++||+|+||.||+|.+..+++.||+|++... ......+.+|+++++.++|+|+ +++++++.+.+.+|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV-----VKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCc-----ceeeeEeccCCeEE
Confidence 4588899999999999999999999999999998643 3445678899999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+||||+ +++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999 8887642 2466788899999999999999999999999999999999999999999999875432
Q ss_pred ----CcccceeeeeceeE
Q 024661 247 ----FSFQTFLSMASRVY 260 (264)
Q Consensus 247 ----~~~~~~~y~ape~~ 260 (264)
...++..|+|||++
T Consensus 223 ~~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERI 240 (353)
T ss_pred ccccccccCccccCcccc
Confidence 33588899999986
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=238.74 Aligned_cols=145 Identities=23% Similarity=0.382 Sum_probs=132.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+.|++.+.||+|+||.||+|.+..+++.+|+|+++... .....+.+|+.++..+.|+++ +++++.+.+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV-----VKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCE
Confidence 36899999999999999999999999999999997532 334567789999999988877 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+|+||||+ +++|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 99999999 999999998765 799999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=240.54 Aligned_cols=165 Identities=19% Similarity=0.287 Sum_probs=145.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.+.. .....+.+|+.+++.+.|+++ +++++.+.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEc
Confidence 34477999999999999999999999999999999987532 234557789999999999887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
++.+|+||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999 99999999764 489999999999999999999999999999999999999999999999999975
Q ss_pred CCC-------CcccceeeeeceeEe
Q 024661 244 RHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-------~~~~~~~y~ape~~~ 261 (264)
... ...+|..|||||++.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHh
Confidence 432 335889999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.28 Aligned_cols=164 Identities=21% Similarity=0.296 Sum_probs=146.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.+++.+.|+|+ +++++.+.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI-----IRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcH-----hhhHhhhccCCe
Confidence 36999999999999999999999999999999987432 234567889999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999 899999998765 789999999999999999999999999999999999999999999999999876443
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 154 ~~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred CcccccCChhhcCHHHHcC
Confidence 2357889999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=236.97 Aligned_cols=168 Identities=29% Similarity=0.461 Sum_probs=151.2
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHh-ccCCCCcceEEEce
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLA-RHDIGGTRCVQIRN 160 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~ 160 (264)
....+...|.+.+.||+|.||.||+|+.+.+|+.+|+|++.+... ..+.+.+|+.+|+++. |+|+ +.+++
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpni-----v~l~~ 103 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNI-----VQLKD 103 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCE-----EEEEE
Confidence 345667789999999999999999999999999999999986443 3468899999999999 8877 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC----CcEEe
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA----EYVKV 235 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~----~~v~l 235 (264)
.|++...+++|||++ ||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+++
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEE
Confidence 999999999999999 99999999886 39999999999999999999999999999999999999854 47999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+|||+|..... ..+||+.|+|||++.
T Consensus 181 ~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 181 IDFGLAKFIKPGERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred eeCCCceEccCCceEeeecCCccccCchhhc
Confidence 99999987665 336999999999876
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=235.29 Aligned_cols=164 Identities=24% Similarity=0.343 Sum_probs=146.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|.+..+++.||+|++++.. .....+.+|+++++.+.|+++ +++++.+.+.+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL-----VKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEcCCE
Confidence 36999999999999999999999999999999998542 234567889999999998888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999 999999998765 789999999999999999999999999999999999999999999999999976433
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 154 ~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred ccCCcccCccccChhHhcC
Confidence 3458899999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=223.76 Aligned_cols=167 Identities=26% Similarity=0.449 Sum_probs=149.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---------hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+-.+|.-.+.||+|..+.|.++.++.+|..+|+|++... ....+....|+.+|+++..+ ++++.+.+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GH----P~II~l~D 90 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGH----PYIIDLQD 90 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCC----CcEEEeee
Confidence 345688889999999999999999999999999998621 23456677899999998643 45599999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
+|+.+.++|+|+|.| .|.|+|++.+.. .++++..+.|++|+++|++|||.++||||||||+|||++++.+++|+|||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 999999999999999 999999999876 89999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC-----cccceeeeeceeEee
Q 024661 240 VPSPRHAF-----SFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~~-----~~~~~~y~ape~~~~ 262 (264)
+|+...+. -|||+.|+|||.+.|
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC 196 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKC 196 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheee
Confidence 99987653 489999999999988
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.40 Aligned_cols=167 Identities=24% Similarity=0.320 Sum_probs=149.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
..|.-++.||.|+||.||.|++..+.+.||||...- ....=+++..|+.+|+++.|||. +.+.++|-.+..
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnt-----ieYkgCyLre~T 100 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNT-----IEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCc-----ccccceeeccch
Confidence 348889999999999999999999999999998751 12233578899999999999998 999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
.|||||||-|+-.|++.-.+ .++.+..+..|+.+.+.||.|||+.+.||||||..|||+.+.|.|||+|||.|....
T Consensus 101 aWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99999999888888887665 479999999999999999999999999999999999999999999999999998754
Q ss_pred CCcccceeeeeceeEeecC
Q 024661 246 AFSFQTFLSMASRVYICIN 264 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~~~ 264 (264)
....||++|||||+++.||
T Consensus 180 nsFvGTPywMAPEVILAMD 198 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMD 198 (948)
T ss_pred hcccCCccccchhHheecc
Confidence 4667999999999999886
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=238.03 Aligned_cols=174 Identities=22% Similarity=0.305 Sum_probs=149.6
Q ss_pred eEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhh-HHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+.+......++.|.-...||+|+||.||+|....+ ..||||.+...... ..+|.+|++++.+++|+|+ +++++
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl-----v~LlG 138 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL-----VKLLG 138 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc-----ccEEE
Confidence 34444456668899999999999999999986544 88999988765443 5569999999999999998 99999
Q ss_pred eeeeCC-EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEeecCCcEEe
Q 024661 161 WFDYRN-HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 161 ~~~~~~-~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~Nili~~~~~v~l 235 (264)
+|.+.+ ..+||+||+ +|+|.+.+.......++|.....|+.+++.||+|||.. .|+|||||++|||+|++.++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999988 599999999 99999999876532789999999999999999999975 3999999999999999999999
Q ss_pred ccCCCCCcCCC-Cc------ccceeeeeceeEe
Q 024661 236 PDYKVPSPRHA-FS------FQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~~-~~------~~~~~y~ape~~~ 261 (264)
+|||+|+.... .. .||..|++||++.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhc
Confidence 99999976543 22 6888999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=232.06 Aligned_cols=165 Identities=24% Similarity=0.420 Sum_probs=144.8
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++|++.+.||+|+||.||+|.+..+++.+|+|+++... .......+|+.+++.+.|+|+ +++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI-----VLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCc-----CeEEEEEecCCeE
Confidence 367999999999999999999999999999999987432 223456789999999999988 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
|+||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9999999889999887653 468999999999999999999999999999999999999999999999999986432
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|||||++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~ 176 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLL 176 (303)
T ss_pred ccCCCCcccCCCCChHHHc
Confidence 2235678899999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=232.59 Aligned_cols=165 Identities=22% Similarity=0.321 Sum_probs=145.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|.+.+.||+|+||.||+|.+..+++.+|+|++++... ....+.+|+.+++.+.|+++ +.+++.+.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i-----~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI-----PQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCe
Confidence 369999999999999999999999999999999985432 44567889999999888887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999 999999998763 3699999999999999999999999999999999999999999999999999975432
Q ss_pred -------CcccceeeeeceeEee
Q 024661 247 -------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -------~~~~~~~y~ape~~~~ 262 (264)
...+|..|+|||++.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred CCceeeecccCCccccCHHHhcc
Confidence 2257889999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=236.32 Aligned_cols=164 Identities=24% Similarity=0.386 Sum_probs=146.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|.+.+.||+|+||.||+|.+..+++.||+|++++.. .....+.+|+.++..+.|+++ +++++.+.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI-----VKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCc-----cchhhheecCCe
Confidence 46999999999999999999999999999999998543 344567889999999998888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999 999999998764 799999999999999999999999999999999999999999999999999875432
Q ss_pred C-----------------------------------cccceeeeeceeEee
Q 024661 247 F-----------------------------------SFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~-----------------------------------~~~~~~y~ape~~~~ 262 (264)
. ..+|..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG 204 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 2 247889999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=236.59 Aligned_cols=164 Identities=27% Similarity=0.391 Sum_probs=146.6
Q ss_pred eEE--EeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 94 YRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 94 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
|++ .+.||+|.||+||-|+++.+|+.||||+|.+. .+....+.+|+.+|+.+.||.+ |.+.--|+..+.+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGi-----V~le~M~ET~erv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGI-----VNLECMFETPERV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCe-----eEEEEeecCCceE
Confidence 555 36899999999999999999999999999753 3445788999999999999988 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEeccCCCCCcCC
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l~Dfg~a~~~~ 245 (264)
|+|||-+.|++.+.+-+....++++.....++.||+.||.|||.++|+|+||||+|||+.+.. ++||||||+|+.+.
T Consensus 639 FVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred EEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 999999988888888776667999999999999999999999999999999999999998653 89999999999876
Q ss_pred CC-----cccceeeeeceeEee
Q 024661 246 AF-----SFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~-----~~~~~~y~ape~~~~ 262 (264)
+. ..||+.|+|||+++.
T Consensus 719 EksFRrsVVGTPAYLaPEVLrn 740 (888)
T KOG4236|consen 719 EKSFRRSVVGTPAYLAPEVLRN 740 (888)
T ss_pred hhhhhhhhcCCccccCHHHHhh
Confidence 53 358999999999863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=234.97 Aligned_cols=166 Identities=23% Similarity=0.372 Sum_probs=145.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCC-cEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.+.. ...+.+.+|+.+++.+.|+|+ +++++++.+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC-----VNLYGSFKD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCC-----cceEEEEEe
Confidence 3467999999999999999999876654 689999987532 334567889999999999988 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999 999999998765 799999999999999999999999999999999999999999999999999976
Q ss_pred CCC---CcccceeeeeceeEee
Q 024661 244 RHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~---~~~~~~~y~ape~~~~ 262 (264)
... ...+|..|||||++.+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 181 VDTRTYTLCGTPEYIAPEILLN 202 (340)
T ss_pred cCCCcceecCChhhcCHHHHhC
Confidence 433 3357889999998653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=238.94 Aligned_cols=164 Identities=23% Similarity=0.334 Sum_probs=143.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
+...+...++..||+|+||+||+|++-++ ||||+++. .....+.|++|+.++++-+|.|| +-|.+++..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI-----lLFMG~~~~ 459 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI-----LLFMGACMN 459 (678)
T ss_pred ccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh-----eeeehhhcC
Confidence 34445577889999999999999998744 99999974 34577899999999999999998 999999988
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
... .||+.+| |-+|+.+++... ..|+......|++||++|+.|||.++|||+|||..||++.++++|||+|||+++.
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 777 9999999 889999998655 4699999999999999999999999999999999999999999999999999986
Q ss_pred CCC--------CcccceeeeeceeEe
Q 024661 244 RHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~--------~~~~~~~y~ape~~~ 261 (264)
... ...+...|||||+++
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIR 563 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIR 563 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHh
Confidence 443 224566799999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=229.11 Aligned_cols=165 Identities=25% Similarity=0.408 Sum_probs=144.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.++||.|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.++|+|+ +++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-----VTLHDIIHTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCE-----eeEEEEEcCCCeEE
Confidence 56999999999999999999999999999999987432 234567789999999999887 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 80 LVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999999779999987654 3578999999999999999999999999999999999999999999999999865321
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred cccCceecccccChHHhcC
Confidence 2346888999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=232.15 Aligned_cols=158 Identities=23% Similarity=0.345 Sum_probs=139.3
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
+.||+|+||.||+|.+..+|+.+|+|++++.. .....+.+|+.+++.+.|+++ +.+++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL-----TALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CCEEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999998532 233566789999999999988 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------C
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------A 246 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------~ 246 (264)
|+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 99 899999998765 78999999999999999999999999999999999999999999999999987532 1
Q ss_pred CcccceeeeeceeEee
Q 024661 247 FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~~~~~~y~ape~~~~ 262 (264)
...+|..|||||++.+
T Consensus 154 ~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 154 TFCGTPEYLAPEVLED 169 (323)
T ss_pred ceecCccccChhhhcC
Confidence 2357889999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=232.97 Aligned_cols=164 Identities=23% Similarity=0.336 Sum_probs=144.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+.+|+.+++.++|+++ +.+++++.++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI-----TNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CceEEEEecCCe
Confidence 46999999999999999999999999999999997532 234557789999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999 999999997643 3689999999999999999999999999999999999999999999999999865322
Q ss_pred -------CcccceeeeeceeEe
Q 024661 247 -------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -------~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCCccccceeccccccCHHHHh
Confidence 124788999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=227.29 Aligned_cols=164 Identities=21% Similarity=0.295 Sum_probs=143.5
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
|++.+.||+|+||.||+|.+..+++.||+|.+.+.. .....+.+|+.+++.+.|+++ +.+++.+.+.+.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----v~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-----VSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcE-----EEEEEEEccCCeEE
Confidence 788999999999999999999999999999987432 223456789999999998877 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+||||+ +++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999 89999888755444689999999999999999999999999999999999999999999999999875322
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred eecCCCCCCCccCHhhhcC
Confidence 2357889999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=235.96 Aligned_cols=164 Identities=21% Similarity=0.326 Sum_probs=144.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.+.. .....+.+|+.+++.++|+++ +.+++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~i-----v~~~~~~~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI-----VQLHYAFQDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEecC
Confidence 3467999999999999999999999999999999997532 233456789999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999 99999998764 4889999999999999999999999999999999999999999999999998754
Q ss_pred CC-------CcccceeeeeceeEe
Q 024661 245 HA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~-------~~~~~~~y~ape~~~ 261 (264)
.. ...+|..|||||++.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhc
Confidence 32 235889999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=225.88 Aligned_cols=170 Identities=22% Similarity=0.333 Sum_probs=148.4
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe---chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
....+..+|...+.||.|+||.|+.+.++.+|+.||||.+. ......++..+|+.+|+.++|+|+ +.+.+.+
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNI-----i~l~di~ 90 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENI-----IGLLDIF 90 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCc-----ceEEeec
Confidence 33456677888899999999999999999999999999886 234556788999999999999998 7877776
Q ss_pred ee-----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 163 DY-----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 163 ~~-----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
.- -+.+|+|+|+|+.+|.+.+++.+ .++++.+..++.||+.||.|+|+.+|+|||+||.|+|++.++.+||+|
T Consensus 91 ~p~~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 91 RPPSRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred ccccccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 54 46799999999999999999876 699999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCC--------CcccceeeeeceeEee
Q 024661 238 YKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
||+|+.... ....|.+|-|||++.+
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLN 201 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence 999998753 2235778999998754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=235.31 Aligned_cols=165 Identities=19% Similarity=0.296 Sum_probs=145.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.+.. .....+.+|+.+++.+.|+++ +++++.+.+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEc
Confidence 34478999999999999999999999999999999987532 233456789999999999888 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...+|+||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999 89999998764 489999999999999999999999999999999999999999999999999875
Q ss_pred CCC-------CcccceeeeeceeEe
Q 024661 244 RHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-------~~~~~~~y~ape~~~ 261 (264)
... ...+|..|||||++.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHh
Confidence 432 335889999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=229.72 Aligned_cols=162 Identities=23% Similarity=0.390 Sum_probs=138.1
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-----CE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----NH 167 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-----~~ 167 (264)
.|.-.+.+|+|+||.||+|....+++.||||.+-.+.... .+|+++|+.+.|+|+ |++.-+|... -+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNI-----V~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNI-----VRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCe-----eeEEEEEEecCCCchhH
Confidence 4888999999999999999999999999999876544433 349999999999998 9998887652 25
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCCCcC
Q 024661 168 ICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a~~~ 244 (264)
..+||||+..+|.++++.. .+..++...++.+..||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|...
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 6789999999999999842 23478888999999999999999999999999999999999976 89999999999874
Q ss_pred CC-----CcccceeeeeceeEee
Q 024661 245 HA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~-----~~~~~~~y~ape~~~~ 262 (264)
.. +.+-+.+|-|||++.+
T Consensus 177 ~~~epniSYicSRyYRaPELifg 199 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFG 199 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcC
Confidence 43 3346778999998765
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=231.23 Aligned_cols=165 Identities=21% Similarity=0.313 Sum_probs=144.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.++..+.|+++ +.+++++.+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWI-----TTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCE
Confidence 46999999999999999999999999999999987532 233456778888888888877 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+ +|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999 999999998643 3689999999999999999999999999999999999999999999999999865332
Q ss_pred -------CcccceeeeeceeEee
Q 024661 247 -------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -------~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CCceeeccccCCcccCCHHHHhc
Confidence 2357889999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=235.35 Aligned_cols=162 Identities=23% Similarity=0.324 Sum_probs=144.2
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
.++++++||+|.||.||.|.+..+. .||+|.++......+.+.+|+++|+.|+|+++ |++++++..++.+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~l-----V~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKL-----VKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCe-----EEEEEEEecCCceEEEE
Confidence 3566889999999999999997552 49999998777777889999999999999998 99999999989999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCcc--
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSF-- 249 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~~-- 249 (264)
||+ .|+|.++|+......++....+.++.||++||+||+++++|||||..+|||++++..+||+|||+|+......+
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 999 99999999986667899999999999999999999999999999999999999999999999999996443332
Q ss_pred -----cceeeeeceeE
Q 024661 250 -----QTFLSMASRVY 260 (264)
Q Consensus 250 -----~~~~y~ape~~ 260 (264)
....|.|||.+
T Consensus 361 ~~~~kfPIkWtAPEa~ 376 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEAL 376 (468)
T ss_pred cCCCCCCceecCHHHH
Confidence 12359999975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=236.12 Aligned_cols=167 Identities=26% Similarity=0.429 Sum_probs=153.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH- 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~- 167 (264)
++|..++++|+|+||.+++++++..+..+++|.++.. ...++....|+.+++++.|||+ |.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~i-----v~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNI-----VEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCe-----eeeccchhcCCce
Confidence 5799999999999999999999999999999998743 3455678899999999999998 999999999887
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+||||+|| ||+|.+.+...++..|+++.++.|+.|++.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999 99999999988777899999999999999999999999999999999999999999999999999987655
Q ss_pred C------cccceeeeeceeEeec
Q 024661 247 F------SFQTFLSMASRVYICI 263 (264)
Q Consensus 247 ~------~~~~~~y~ape~~~~~ 263 (264)
. ..||++||.||++.++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~ 181 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDI 181 (426)
T ss_pred chhhhheecCCCcccCHHHhCCC
Confidence 4 4699999999998765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=259.92 Aligned_cols=166 Identities=21% Similarity=0.317 Sum_probs=148.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|.+++.||+|+||.|.+++.+.+++.||+|++++... ....|..|.++|..... .++++++..|+++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns-----~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS-----EWIVQLHYAFQDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc-----HHHHHHHHHhcCcc
Confidence 4679999999999999999999999999999999987543 34567788888876654 45599999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
++|+||||+ ||+|..++.+.. .++++.+++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.|-...
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999 999999999886 89999999999999999999999999999999999999999999999999986644
Q ss_pred -------CCcccceeeeeceeEeec
Q 024661 246 -------AFSFQTFLSMASRVYICI 263 (264)
Q Consensus 246 -------~~~~~~~~y~ape~~~~~ 263 (264)
....||+.|++||++.++
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhh
Confidence 344699999999998765
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=229.25 Aligned_cols=164 Identities=22% Similarity=0.293 Sum_probs=142.0
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.. ...+.+..|.+++..+.|++ +++.+++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP----FLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCC----ceeeeEEEEEcCCEE
Confidence 4889999999999999999999999999999997532 33456778888888887764 248889999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999 999999998765 68999999999999999999999999999999999999999999999999986421
Q ss_pred ----CCcccceeeeeceeEee
Q 024661 246 ----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ----~~~~~~~~y~ape~~~~ 262 (264)
....+|..|+|||++.+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred CCceeeecCCccccChhhhcC
Confidence 12347889999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=229.27 Aligned_cols=158 Identities=22% Similarity=0.334 Sum_probs=138.9
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
+.||+|+||.||++.+..+|..||+|+++... .....+.+|+.+++.+.|+++ +++++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCEEEEEEe
Confidence 46899999999999999999999999997532 234556789999999999988 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------C
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------A 246 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------~ 246 (264)
|+ +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 99 899999887754 78999999999999999999999999999999999999999999999999986521 1
Q ss_pred CcccceeeeeceeEee
Q 024661 247 FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++..
T Consensus 154 ~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 154 TFCGTPEYLAPEVLED 169 (323)
T ss_pred cccCCcCcCCcccccC
Confidence 2357889999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=234.58 Aligned_cols=160 Identities=24% Similarity=0.413 Sum_probs=142.8
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
..+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+++++.++|+|+ ++++++|......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSI-----IQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCC-----CCEeEEEEECCeeEE
Confidence 467999999999999999999999999999999654 2456789999999999988 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|.....
T Consensus 161 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999889999987764 689999999999999999999999999999999999999999999999999864221
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...+|..|+|||++.+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 239 KYYGWAGTIATNAPELLAR 257 (391)
T ss_pred ccccccCccCCCChhhhcC
Confidence 2358899999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=229.37 Aligned_cols=158 Identities=22% Similarity=0.354 Sum_probs=139.2
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
+.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.+++.+.|+++ +.+++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL-----TSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCEEEEEEe
Confidence 36899999999999999999999999997532 334567789999999999888 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------C
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------A 246 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------~ 246 (264)
|+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .
T Consensus 76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 99 999999987754 79999999999999999999999999999999999999999999999999987522 1
Q ss_pred CcccceeeeeceeEee
Q 024661 247 FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++.+
T Consensus 154 ~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 154 TFCGTPEYLAPEVLED 169 (328)
T ss_pred cccCCcCccChhhhcC
Confidence 2357889999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-31 Score=232.37 Aligned_cols=161 Identities=22% Similarity=0.310 Sum_probs=141.8
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
...|.+.+.||+|+||.||+|.+..+++.|++|.... ..+.+|+++++.++|+|+ +++++++...+..|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnI-----v~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAV-----LALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCC-----CcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999996432 235679999999999988 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 238 v~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 99999889999987643 3699999999999999999999999999999999999999999999999999875322
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...+|..|||||++.+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred ccccccCCCcCCcCHHHHcC
Confidence 2247899999998754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=228.96 Aligned_cols=164 Identities=22% Similarity=0.325 Sum_probs=142.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.++||+|+||.||++.+..+++.+|+|++.+.. .....+.+|+.++..+.|+++ +.+++.+.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI-----TTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecCCE
Confidence 36999999999999999999999999999999987532 223456778888888888776 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999 999999998643 3689999999999999999999999999999999999999999999999999864321
Q ss_pred -------CcccceeeeeceeEe
Q 024661 247 -------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -------~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CCcceecccccCccccCHHHHh
Confidence 235788999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=228.28 Aligned_cols=163 Identities=22% Similarity=0.352 Sum_probs=140.2
Q ss_pred CeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee
Q 024661 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~ 163 (264)
+|++.+.||+|+||.||++++. .+++.+|+|++.+.. ...+.+..|+.+++.+. |+++ +.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL-----VTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----ccEEEEEe
Confidence 4899999999999999999864 468899999987532 23456778999999985 5555 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
.++.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999 899999998765 68999999999999999999999999999999999999999999999999987
Q ss_pred cCCC-------CcccceeeeeceeEee
Q 024661 243 PRHA-------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~-------~~~~~~~y~ape~~~~ 262 (264)
.... ...+|..|||||++.+
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcC
Confidence 5321 2347889999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=227.04 Aligned_cols=156 Identities=23% Similarity=0.359 Sum_probs=138.0
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||+|+||.||+|.+..+++.||+|++++. ......+.+|+.+++.++|+|+ +++++.+.+.+..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI-----VPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcE-----eceeeEEecCCeEEEEEcCC
Confidence 79999999999999999999999999753 2334567789999999998887 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC------Cc
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA------FS 248 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~------~~ 248 (264)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ..
T Consensus 76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 999999998754 799999999999999999999999999999999999999999999999999875321 23
Q ss_pred ccceeeeeceeEee
Q 024661 249 FQTFLSMASRVYIC 262 (264)
Q Consensus 249 ~~~~~y~ape~~~~ 262 (264)
.+|..|||||++.+
T Consensus 154 ~gt~~y~aPE~~~~ 167 (312)
T cd05585 154 CGTPEYLAPELLLG 167 (312)
T ss_pred cCCcccCCHHHHcC
Confidence 57889999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-34 Score=244.81 Aligned_cols=165 Identities=25% Similarity=0.448 Sum_probs=149.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe-chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+.|.|+..||.|+||+||+|..+.++-..|.|+|. +.....+.+.-|++||..+.||++ +.+++.|..++.+||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~i-----vkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVI-----VKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHH-----HHHHHHHhccCceEE
Confidence 56999999999999999999999888888899887 455677889999999999999988 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC-----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR----- 244 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~----- 244 (264)
+.||| ||-...++-... ..+++..+..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+...
T Consensus 107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999 777776665543 57999999999999999999999999999999999999999999999999998653
Q ss_pred -CCCcccceeeeeceeEee
Q 024661 245 -HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 -~~~~~~~~~y~ape~~~~ 262 (264)
....+||++|||||+++|
T Consensus 186 kRDsFIGTPYWMAPEVvmC 204 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMC 204 (1187)
T ss_pred hhccccCCcccccchheee
Confidence 346689999999999998
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=228.96 Aligned_cols=163 Identities=26% Similarity=0.379 Sum_probs=140.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC----
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---- 165 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~---- 165 (264)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-----VEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCE-----eeecceEeccCCCC
Confidence 599999999999999999999999999999988642 2234567889999999999988 8888877542
Q ss_pred -CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 -NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..+|+||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 3589999999889999998765 6999999999999999999999999999999999999999999999999998753
Q ss_pred CC---------CcccceeeeeceeEee
Q 024661 245 HA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~---------~~~~~~~y~ape~~~~ 262 (264)
.. ...++..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc
Confidence 21 2357888999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=226.55 Aligned_cols=158 Identities=23% Similarity=0.337 Sum_probs=137.6
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
+.||+|+||.||+|.+..+++.+|+|++.+.. .....+.+|+++++.+.|+++ +.+++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i-----~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997532 233556778899999988888 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
|+ +++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 99 899999887655 78999999999999999999997 799999999999999999999999999986422
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (325)
T cd05594 154 KTFCGTPEYLAPEVLED 170 (325)
T ss_pred ccccCCcccCCHHHHcc
Confidence 12348889999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=226.84 Aligned_cols=164 Identities=23% Similarity=0.297 Sum_probs=140.9
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+|++.+.||+|+||.||+|.++.+++.||+|++.+.. ...+.+..|..+++.+.|++ +++.+++++.+.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FLTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCC----chhheeeEEecCCEE
Confidence 3788999999999999999999999999999997542 23345677888888877653 237788999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999 899999998765 79999999999999999999999999999999999999999999999999987532
Q ss_pred ----CCcccceeeeeceeEee
Q 024661 246 ----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ----~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++.+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CccccCccCCccccCHHHHcC
Confidence 12347889999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=226.20 Aligned_cols=158 Identities=19% Similarity=0.280 Sum_probs=137.4
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.||+|++++.. .....+.+|..+++.+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~I-----v~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL-----VGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCC-----CceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998532 2335577888888888 57777 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC------C
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR------H 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~------~ 245 (264)
||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .
T Consensus 76 e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 76 EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 999 899999887654 7999999999999999999999999999999999999999999999999998642 1
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (329)
T cd05588 154 STFCGTPNYIAPEILRG 170 (329)
T ss_pred ccccCCccccCHHHHcC
Confidence 23357889999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=224.15 Aligned_cols=164 Identities=23% Similarity=0.293 Sum_probs=139.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+|.+.+.||+|+||.||+|.+..+++.+|+|++.+.. ........|..++..+.++ ++++.+++++.+.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~----~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP----PFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCC----CeEeeEEEEEecCCEE
Confidence 4889999999999999999999999999999988542 2233456677777776543 3458899999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999 899999988765 68999999999999999999999999999999999999999999999999987532
Q ss_pred ----CCcccceeeeeceeEee
Q 024661 246 ----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ----~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++.+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CCccccCCCChhhcCHHHhcC
Confidence 12357889999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=224.87 Aligned_cols=161 Identities=24% Similarity=0.346 Sum_probs=137.3
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHH---HhccCCCCcceEEEceeeeeCC
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQR---LARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~---l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
|++.+.||+|+||.||+|.+..+++.||+|++++.. ...+.+.+|++++.. +.|+|+ +++++++.+.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i-----~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL-----VNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCCh-----hceeeEEEcCC
Confidence 788999999999999999999999999999997532 233556667666543 456665 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|+||||+ +++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999 89999887653 59999999999999999999999999999999999999999999999999986532
Q ss_pred ------CCcccceeeeeceeEee
Q 024661 246 ------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ------~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred CCCCcccccccCccccCHhHhcC
Confidence 12357889999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-33 Score=231.65 Aligned_cols=164 Identities=28% Similarity=0.374 Sum_probs=148.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..|+..+.||+|+||.||+|.+..+++.||+|++..+. ...+.+..|+.++.++.++++ ..+|+.|..+..+|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~i-----t~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNI-----TEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchH-----HhhhhheeecccHH
Confidence 34888899999999999999999999999999998543 445788899999999999887 89999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC----
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR---- 244 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~---- 244 (264)
++|||| ||++.+.++... .+++..+..++++++.||.|||.++.+|||||+.|||+..+|.|||+|||++...
T Consensus 88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999 999999998765 5589999999999999999999999999999999999999999999999998643
Q ss_pred --CCCcccceeeeeceeEee
Q 024661 245 --HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 --~~~~~~~~~y~ape~~~~ 262 (264)
.....||++|||||++.+
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQ 185 (467)
T ss_pred hccccccccccccchhhhcc
Confidence 345679999999999865
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=227.18 Aligned_cols=168 Identities=25% Similarity=0.342 Sum_probs=153.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.-.+.|.+.+.||+|.|+.|.+|++.-++..||||++++. ....+.+.+|+++++.+.|||+ |+++.+.+..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnI-----vkl~~v~~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNI-----VKLFSVIETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcce-----eeeeeeeeec
Confidence 3346699999999999999999999999999999999854 2344568999999999999998 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..+|+||||+ +|.+++++.++. +..+..+..++.|++.|++|||+++|||||||.+|||++.+.++||+|||++...
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 9999999999 999999999987 7888999999999999999999999999999999999999999999999999874
Q ss_pred C-----CCcccceeeeeceeEeec
Q 024661 245 H-----AFSFQTFLSMASRVYICI 263 (264)
Q Consensus 245 ~-----~~~~~~~~y~ape~~~~~ 263 (264)
. ...+|++.|.|||++.+.
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred cccccccccCCCCCccChHhhcCc
Confidence 4 356789999999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=222.56 Aligned_cols=166 Identities=23% Similarity=0.319 Sum_probs=147.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
..++|++.+.||+|+||.||++.+..++..+|+|++... ....+.+.+|+++++.++|+|+ +++++++.+++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 77 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGE 77 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCE
Confidence 347899999999999999999999999999999998743 3445678999999999999988 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+++||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999 899999998765 689999999999999999999986 69999999999999999999999999986542
Q ss_pred C----CcccceeeeeceeEee
Q 024661 246 A----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~----~~~~~~~y~ape~~~~ 262 (264)
. ...++..|+|||++.+
T Consensus 156 ~~~~~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 156 DSMANSFVGTRSYMSPERLQG 176 (331)
T ss_pred ccccccCCCCcCcCCHhHhcC
Confidence 2 3357889999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=221.80 Aligned_cols=166 Identities=22% Similarity=0.352 Sum_probs=139.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC----------------CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGG 152 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~ 152 (264)
.++|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.+++.+.|+|+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-- 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI-- 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe--
Confidence 4679999999999999999998532 3457999988753 3345678899999999999887
Q ss_pred cceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 024661 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----------------RSFPIDLVRELGRQLLESVAFMHELR 214 (264)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ 214 (264)
+++++++.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 82 ---v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 82 ---IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred ---eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999 9999999875321 23677889999999999999999999
Q ss_pred CeecCCCCCCEEeecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 215 LIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 215 ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
|+||||||+|||++.++.+||+|||+++..... ..++..|||||++.
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence 999999999999999999999999999754321 22356799999764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=226.02 Aligned_cols=165 Identities=24% Similarity=0.326 Sum_probs=141.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+.|+|+ +++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 92 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI-----ISLLNVFTPQ 92 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCE-----eeeeeeeccC
Confidence 4568899999999999999999999999999999998642 2345667789999999999888 9999888653
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 93 KSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 35799999998888887743 48889999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC-----CcccceeeeeceeEee
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
++..... ...+|..|+|||++.+
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccC
Confidence 9975432 2356888999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=224.72 Aligned_cols=158 Identities=20% Similarity=0.280 Sum_probs=136.7
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.+|+|++++.. .....+.+|+.++..+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcC-----CceeeEEEeCCEEEEEE
Confidence 46999999999999999999999999998532 2344567788887776 57776 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 76 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 999 899999887654 79999999999999999999999999999999999999999999999999986521
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|+|||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (329)
T cd05618 154 STFCGTPNYIAPEILRG 170 (329)
T ss_pred ccccCCccccCHHHHcC
Confidence 23357889999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=218.51 Aligned_cols=149 Identities=23% Similarity=0.345 Sum_probs=137.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.-.++|++++.||.|.-|+||+|+.+.++..+|+|++.+.. ....+...|-+||+.++||.+ +.+|..|+.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFl-----PTLYa~fet 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFL-----PTLYASFET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCcc-----chhhheeec
Confidence 33467999999999999999999999999999999998643 334566779999999999988 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+++.|++|||| ||+|..+++++....|++..++.|+.+++.||+|||-.|||+|||||+||||.++|+|.|+||-++.
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999 9999999999988899999999999999999999999999999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=226.28 Aligned_cols=166 Identities=22% Similarity=0.297 Sum_probs=136.9
Q ss_pred CCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~ 162 (264)
.++|++.++||.|+||.||+|.+. .+++.||+|+++.. ......+.+|+.+++.+ +|+|+ +++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~ 80 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV-----VNLLGAC 80 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcce-----eeEEeEe
Confidence 367999999999999999999752 34567999998743 23446788999999999 78877 9999987
Q ss_pred ee-CCEEEEEEecC-CCCHHHHHHhcC-----------------------------------------------------
Q 024661 163 DY-RNHICIVFEKL-GPSLYDFLRKNS----------------------------------------------------- 187 (264)
Q Consensus 163 ~~-~~~~~lv~e~~-~~~L~~~l~~~~----------------------------------------------------- 187 (264)
.. .+.++++|||+ +|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 66 45689999999 999999997532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--------Ccccce
Q 024661 188 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--------FSFQTF 252 (264)
Q Consensus 188 -------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~ 252 (264)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...++.
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 12477888999999999999999999999999999999999999999999999975321 122346
Q ss_pred eeeeceeEe
Q 024661 253 LSMASRVYI 261 (264)
Q Consensus 253 ~y~ape~~~ 261 (264)
.|||||++.
T Consensus 241 ~y~aPE~~~ 249 (338)
T cd05102 241 KWMAPESIF 249 (338)
T ss_pred cccCcHHhh
Confidence 799999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=224.07 Aligned_cols=158 Identities=21% Similarity=0.261 Sum_probs=135.6
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|++..+++.||+|++.+.. .....+..|.++++.+ .|+++ +.+++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i-----~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-----TALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999997542 2334566788888765 56666 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 76 EYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999 899999988765 78999999999999999999999999999999999999999999999999986421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (321)
T cd05591 154 TTFCGTPDYIAPEILQE 170 (321)
T ss_pred cccccCccccCHHHHcC
Confidence 12347889999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=220.66 Aligned_cols=165 Identities=25% Similarity=0.497 Sum_probs=141.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|+||.||+|+++.+++.+|+|+++.. ....+.+.+|+.+++.++|+|+ +++++++..++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI-----VELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccc-----cchhhhEecCCEE
Confidence 4699999999999999999999999999999998743 2335667889999999999988 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
|+||||+.+++.+.+.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999999555555554432 3689999999999999999999999999999999999999999999999999976432
Q ss_pred -----CcccceeeeeceeEee
Q 024661 247 -----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLG 175 (287)
T ss_pred cccccccccccccCCcHHHcC
Confidence 2247888999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=223.32 Aligned_cols=158 Identities=22% Similarity=0.284 Sum_probs=134.9
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.||+|++++.. ........|..++... .|+++ +++++.+.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL-----THLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCc-----cCeeEEEEeCCEEEEEE
Confidence 46999999999999999999999999998542 2334556677777654 56666 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 76 EFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 999 899999988754 78999999999999999999999999999999999999999999999999986421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|+|||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (316)
T cd05620 154 STFCGTPDYIAPEILQG 170 (316)
T ss_pred eccCCCcCccCHHHHcC
Confidence 23357889999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=222.93 Aligned_cols=166 Identities=22% Similarity=0.319 Sum_probs=146.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
..++|++.++||.|+||.||++.+..++..+++|++... ......+.+|+++++.++|+|+ +++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 77 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGE 77 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcc-----cceeEEEEECCE
Confidence 457899999999999999999999999999999988743 3345678899999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999 899999998765 689999999999999999999975 79999999999999999999999999987532
Q ss_pred ----CCcccceeeeeceeEee
Q 024661 246 ----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ----~~~~~~~~y~ape~~~~ 262 (264)
....++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 156 DSMANSFVGTRSYMSPERLQG 176 (333)
T ss_pred hhccccCCCCccccCHHHhcC
Confidence 23357889999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=223.73 Aligned_cols=158 Identities=22% Similarity=0.356 Sum_probs=132.8
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHH-HHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||+||+|.+..+++.+|+|++.+.. .....+..|.. +++.+.|+++ +++++.+...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~I-----v~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL-----VGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCC-----CceeEEEEcCCeEEEEE
Confidence 46999999999999999999999999997532 12223333433 4566777777 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 999 899999998754 68899999999999999999999999999999999999999999999999987421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 154 STFCGTPEYLAPEVLHK 170 (325)
T ss_pred ccccCCccccCHHHHcC
Confidence 22357889999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=218.51 Aligned_cols=165 Identities=21% Similarity=0.304 Sum_probs=143.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++|+++ +.+++.+.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCE-----eeeeeeecCCCeE
Confidence 3889999999999999999999999999999987432 223456789999999999887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999 89999988765445699999999999999999999999999999999999999999999999999875322
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...++..||+||++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred CccccccCCCCccCcHHhcC
Confidence 2357788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-34 Score=219.83 Aligned_cols=167 Identities=22% Similarity=0.339 Sum_probs=147.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..+.+.|++.++||+|.|+.|+++.+..+|+.+|+|+++.. ....+.+.+|+++.+.++||+| +++.+.+..
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~I-----vrL~~ti~~ 81 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQE 81 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcE-----eehhhhhcc
Confidence 35667899999999999999999999999999999988743 2356788999999999999998 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEeccCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKVPDYKV 240 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l~Dfg~ 240 (264)
+.+.|||+|++ |++|..-+-+.- .++|..+-.+++||+++|.|+|.+||||||+||+|+|+.+.. -+||+|||+
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccce
Confidence 99999999999 999887766553 689999999999999999999999999999999999998653 699999999
Q ss_pred CCcCCCC-----cccceeeeeceeEe
Q 024661 241 PSPRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~~-----~~~~~~y~ape~~~ 261 (264)
|...... ..||+.|||||+++
T Consensus 160 Ai~l~~g~~~~G~~GtP~fmaPEvvr 185 (355)
T KOG0033|consen 160 AIEVNDGEAWHGFAGTPGYLSPEVLK 185 (355)
T ss_pred EEEeCCccccccccCCCcccCHHHhh
Confidence 9876642 25899999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=222.93 Aligned_cols=158 Identities=23% Similarity=0.332 Sum_probs=136.9
Q ss_pred eecccCccEEEEEEEeC---CCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 98 SKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+.||+|+||.||++.+. .+++.||+|++++.. .....+.+|+.+++.++|+|+ +++++.+..++.+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI-----VDLIYAFQTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCch-----hceeeEEecCCeEE
Confidence 67999999999999864 468899999997532 233456789999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 77 LILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred EEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999 899999998765 68899999999999999999999999999999999999999999999999986421
Q ss_pred ---CCcccceeeeeceeEee
Q 024661 246 ---AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMR 174 (323)
T ss_pred CcccccCCCccccChhhccC
Confidence 12357889999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=223.35 Aligned_cols=158 Identities=22% Similarity=0.278 Sum_probs=136.0
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.++.+++.||+|++.+.. .....+..|..+++.+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----v~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCch-----hceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999987532 2344566788887766 46666 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 76 EFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred cCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999 899999988765 79999999999999999999999999999999999999999999999999986421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++..
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (320)
T cd05590 154 STFCGTPDYIAPEILQE 170 (320)
T ss_pred cccccCccccCHHHHcC
Confidence 23357889999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=235.43 Aligned_cols=174 Identities=21% Similarity=0.334 Sum_probs=138.2
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCC-cEEEEE------------------EEechhhhHHHHHHHHHHHHH
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIK------------------IVRSINKYREAAMIEIDVLQR 144 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~~~~~~~~~~e~~~l~~ 144 (264)
+..++.+.++|+++++||+|+||+||+|..+... +..+.| .+.........+.+|+.+++.
T Consensus 140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~ 219 (501)
T PHA03210 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR 219 (501)
T ss_pred cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence 3445566789999999999999999998764332 111212 122222344567889999999
Q ss_pred HhccCCCCcceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 024661 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (264)
Q Consensus 145 l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 221 (264)
++|+|+ +++++++.+.+..|+++++++++|.+++.... ........++.++.||+.||+|||++||+|||||
T Consensus 220 l~HpnI-----v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK 294 (501)
T PHA03210 220 LNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294 (501)
T ss_pred CCCCCc-----CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999988 99999999999999999999889998876432 1123466788899999999999999999999999
Q ss_pred CCCEEeecCCcEEeccCCCCCcCCC-------CcccceeeeeceeEee
Q 024661 222 PENILLVSAEYVKVPDYKVPSPRHA-------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 222 p~Nili~~~~~v~l~Dfg~a~~~~~-------~~~~~~~y~ape~~~~ 262 (264)
|+|||++.++.+||+|||++..... ...||..|+|||++.+
T Consensus 295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 9999999999999999999975332 2358899999998754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=221.87 Aligned_cols=158 Identities=23% Similarity=0.299 Sum_probs=133.8
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.||+|+++... ...+....|..++..+ .|+++ +++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL-----THLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999998542 2233445566666543 56666 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 76 EYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 999 999999998755 79999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (316)
T cd05592 154 STFCGTPDYIAPEILKG 170 (316)
T ss_pred ccccCCccccCHHHHcC
Confidence 22357889999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=221.77 Aligned_cols=158 Identities=24% Similarity=0.352 Sum_probs=133.8
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHH-HHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|++..+++.+|+|++.+.. .....+..|.. +++.+.|+|+ +++++.+.+.+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~i-----v~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL-----VGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999987532 22334444543 5677888877 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 999 899998887654 78999999999999999999999999999999999999999999999999987521
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|+|||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (321)
T cd05603 154 STFCGTPEYLAPEVLRK 170 (321)
T ss_pred ccccCCcccCCHHHhcC
Confidence 12347889999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=221.69 Aligned_cols=158 Identities=25% Similarity=0.376 Sum_probs=133.5
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHH-HHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||+||+|.+..+|+.||+|++.+.. .....+..|.. +++.+.|+++ +++++.+.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~i-----v~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCC-----CCeeEEEEeCCEEEEEE
Confidence 46999999999999999999999999997532 12233444444 4566777777 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 999 999999998755 78999999999999999999999999999999999999999999999999986421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++..
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 154 STFCGTPEYLAPEVLRK 170 (323)
T ss_pred ccccCChhhcChhhhcC
Confidence 12347889999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=219.48 Aligned_cols=164 Identities=24% Similarity=0.407 Sum_probs=143.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|.+.++||+|+||.||+|.+..+++.+|+|.++... .....+.+|+.+++.++|+|+ +++++++..++..|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIVHTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCc-----ceEEEEEeeCCeEE
Confidence 57999999999999999999999999999999987432 233466789999999999888 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH---- 245 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~---- 245 (264)
+||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999999889999887654 358899999999999999999999999999999999999999999999999986532
Q ss_pred --CCcccceeeeeceeEe
Q 024661 246 --AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 --~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~ 177 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLL 177 (309)
T ss_pred ccccccccccccCCHHHh
Confidence 1234678899999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=221.71 Aligned_cols=158 Identities=23% Similarity=0.345 Sum_probs=133.8
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHH-HHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+|+.+|+|++.+.. .....+..|.. +++.+.|+|+ +++++.+..++.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEecCCEEEEEE
Confidence 46999999999999999999999999997532 22334444544 4566778777 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 999 899999887654 79999999999999999999999999999999999999999999999999987532
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (325)
T cd05604 154 TTFCGTPEYLAPEVIRK 170 (325)
T ss_pred ccccCChhhCCHHHHcC
Confidence 12347889999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=227.40 Aligned_cols=164 Identities=22% Similarity=0.349 Sum_probs=146.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHH---------HHHHHHHHHh---ccCCCCcceEEEc
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM---------IEIDVLQRLA---RHDIGGTRCVQIR 159 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~e~~~l~~l~---~~~~~~~~~~~~~ 159 (264)
..|..++.+|+|+||.|++|.++....+|+||.+.++.-..+.+. .|+++|..++ |+|| ++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI-----lKlL 635 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI-----LKLL 635 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch-----hhhh
Confidence 459999999999999999999999999999999987654333333 4999999998 6666 9999
Q ss_pred eeeeeCCEEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 160 NWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~--~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
++|++++++||+||-- +.+|++++.... +++|.++..|+.|++.|+++||++||||||||-+|++++.+|-+||+|
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 9999999999999999 679999999877 899999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCCC----cccceeeeeceeEee
Q 024661 238 YKVPSPRHAF----SFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~~~----~~~~~~y~ape~~~~ 262 (264)
||.|...... ..||..|.|||++.+
T Consensus 714 fgsaa~~ksgpfd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 714 FGSAAYTKSGPFDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred ccchhhhcCCCcceeeeeccccchhhhCC
Confidence 9999765442 348999999999875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=221.62 Aligned_cols=158 Identities=20% Similarity=0.291 Sum_probs=137.0
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.+|+|++++.. ...+.+.+|+.++..+. |+++ +.+++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL-----VGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCE-----eeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999998542 23455778888888874 5555 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 76 EYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 999 999999887654 79999999999999999999999999999999999999999999999999987421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....+|..|||||++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~ 170 (327)
T cd05617 154 STFCGTPNYIAPEILRG 170 (327)
T ss_pred ecccCCcccCCHHHHCC
Confidence 12357889999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=231.28 Aligned_cols=166 Identities=19% Similarity=0.204 Sum_probs=143.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC-CcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..|.+.+.||+|++|.||+|....+ ++.+++|.+... ......+.+|+.+++.++|+|+ +++++++...+.+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpni-----v~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI-----VKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEEECCEEE
Confidence 3499999999999999999998877 788899976533 3344567789999999999988 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 170 IVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
|||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999 99999988642 223689999999999999999999999999999999999999999999999999975432
Q ss_pred --------CcccceeeeeceeEee
Q 024661 247 --------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~~ 262 (264)
...||..|||||++.+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred ccccccccccCCCccccCHhHhCC
Confidence 2348889999998653
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=223.67 Aligned_cols=160 Identities=24% Similarity=0.385 Sum_probs=140.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.+.|+|+ +++++++...+..|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSV-----IRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCC-----cChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999975432 23458999999999888 9999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9999889999987643 4689999999999999999999999999999999999999999999999999975321
Q ss_pred CcccceeeeeceeEee
Q 024661 247 FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~~~~~~y~ape~~~~ 262 (264)
...+|..|+|||++..
T Consensus 215 ~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 215 GLAGTVETNAPEVLAR 230 (357)
T ss_pred cccccccccCCeecCC
Confidence 2347889999998753
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=220.93 Aligned_cols=157 Identities=21% Similarity=0.297 Sum_probs=134.5
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.||+|+++... ........|..+++.. .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcC-----cceEEEEEeCCEEEEEE
Confidence 46999999999999999999999999998542 2334556677777654 67776 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 76 EYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 999 999999998754 68999999999999999999999999999999999999999999999999986422
Q ss_pred CCcccceeeeeceeEe
Q 024661 246 AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~ 261 (264)
....+|..|||||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (316)
T cd05619 154 CTFCGTPDYIAPEILL 169 (316)
T ss_pred eeecCCccccCHHHHc
Confidence 1234788999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=228.00 Aligned_cols=166 Identities=22% Similarity=0.345 Sum_probs=137.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee----
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~---- 164 (264)
....+|++++.||+|+||.||+|.+..+++.||+|.+..... ...+|+.+++.+.|+|+ +++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~ni-----v~l~~~~~~~~~~ 134 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINI-----IFLKDYYYTECFK 134 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCC-----cceeeeEeecccc
Confidence 345679999999999999999999999999999998864332 33569999999999998 888776643
Q ss_pred ----CCEEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEecc
Q 024661 165 ----RNHICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPD 237 (264)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~D 237 (264)
...+++||||++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 2357899999988898887632 234689999999999999999999999999999999999999665 799999
Q ss_pred CCCCCcCCC-----CcccceeeeeceeEee
Q 024661 238 YKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
||+|+.... ...++..|||||++.+
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLG 244 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcC
Confidence 999975322 3357888999998754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=221.11 Aligned_cols=157 Identities=26% Similarity=0.378 Sum_probs=136.8
Q ss_pred eecccCccEEEEEEEe---CCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 98 SKMGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
+.||+|+||.||++.+ ..+|+.+|+|++.+.. .....+..|+++++.+.|+|+ +++++.+.+.+.+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI-----VKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcCCEEEEE
Confidence 5799999999999986 3578999999998533 234456789999999999888 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999 899999997654 689999999999999999999999999999999999999999999999999875322
Q ss_pred --CcccceeeeeceeEe
Q 024661 247 --FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 --~~~~~~~y~ape~~~ 261 (264)
...++..|||||++.
T Consensus 155 ~~~~~g~~~y~aPE~~~ 171 (318)
T cd05582 155 AYSFCGTVEYMAPEVVN 171 (318)
T ss_pred eecccCChhhcCHHHHc
Confidence 234788899999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=223.89 Aligned_cols=165 Identities=23% Similarity=0.329 Sum_probs=142.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 88 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-----ISLLNVFTPQ 88 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCch-----hceeeeeecc
Confidence 3568899999999999999999999999999999998642 2344677789999999999988 8888887543
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..+|+||||+.++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 89 KSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 35799999998888887754 48899999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC-----CcccceeeeeceeEee
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+++.... ...+|..|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHHcC
Confidence 9976433 2357889999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=220.94 Aligned_cols=155 Identities=24% Similarity=0.354 Sum_probs=131.3
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHH---hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l---~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
||+|+||+||+|++..+++.||+|++.+... .......|..++... .|+++ +.+++.+.+.+.+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i-----~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI-----VGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcC-----cceEEEEecCCeEEEEE
Confidence 7999999999999999999999999875321 223344566666655 35555 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 76 DYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred cCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 999 899999988754 79999999999999999999999999999999999999999999999999986521
Q ss_pred CCcccceeeeeceeEe
Q 024661 246 AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~ 261 (264)
....+|..|||||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 154 NTFCGTTEYLAPEVLL 169 (330)
T ss_pred cCccCCccccCHHHHc
Confidence 1235788999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=220.94 Aligned_cols=161 Identities=25% Similarity=0.404 Sum_probs=146.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
-|.++++||+|+||.||+|.++.+|..+|||.+.. ....+.+..|+.+++++..+.+ |++|+.|.....+|+||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yV-----VKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYV-----VKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchh-----hhhhhhhccCCceEeeh
Confidence 38889999999999999999999999999998764 4456788899999999998877 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC------C
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR------H 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~------~ 245 (264)
||| .|++.++++.+. ..+++.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|-.. .
T Consensus 108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999 799999998654 58999999999999999999999999999999999999999999999999999653 3
Q ss_pred CCcccceeeeeceeE
Q 024661 246 AFSFQTFLSMASRVY 260 (264)
Q Consensus 246 ~~~~~~~~y~ape~~ 260 (264)
....||+.|||||++
T Consensus 187 NTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVI 201 (502)
T ss_pred CccccCcccccHHHH
Confidence 456799999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=219.86 Aligned_cols=164 Identities=25% Similarity=0.395 Sum_probs=146.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|..+++||.|.||+|-+|+.+.+++.+|+|++++.- ........|-++|+...||.+ ..+...|+..+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFL-----t~LKYsFQt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFL-----TSLKYSFQTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHH-----HHhhhhhccCce
Confidence 56999999999999999999999999999999988642 334455678889999999876 888888999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc---
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP--- 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~--- 243 (264)
+|+||||. ||.|+-.+.... .|++..++.+..+|+.||.|||+++||.||||.+|+|+|.+|++||+|||++..
T Consensus 243 lCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999 999998888765 899999999999999999999999999999999999999999999999999975
Q ss_pred ---CCCCcccceeeeeceeEee
Q 024661 244 ---RHAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ---~~~~~~~~~~y~ape~~~~ 262 (264)
.....|||+.|+|||++--
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred ccceeccccCChhhcCchhhcc
Confidence 2345689999999999743
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=216.89 Aligned_cols=165 Identities=27% Similarity=0.464 Sum_probs=136.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCC-CCcEEEEEEEechh---hhHHHHHHHHHHHHHH---hccCCCCcceEEEceeee-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFD- 163 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~~~~~~~~~~~~~~~~~~- 163 (264)
++|++.+.||+|+||.||+|.+.. ++..+|+|.++... .......+|+.+++.+ .|+|+ +++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpni-----v~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCc-----ceEEEEEec
Confidence 369999999999999999999865 46889999887432 2234566788877776 46666 99988875
Q ss_pred ----eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 164 ----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 164 ----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
....+++|||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 76 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 76 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred ccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 3467999999998899999987654568999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC-----CcccceeeeeceeEe
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLL 182 (290)
T ss_pred ceEeccCCcccccccccccccChHHHh
Confidence 9875432 234788899999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=226.10 Aligned_cols=163 Identities=19% Similarity=0.273 Sum_probs=141.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC---
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--- 166 (264)
.|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+++++.++|+|+ +++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-----LSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCc-----CCHhheecCCCccc
Confidence 378899999999999999999999999999988642 2334577889999999999988 99999988766
Q ss_pred --EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 167 --~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..|+||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 76 FEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred cceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 899999999889999887654 7999999999999999999999999999999999999999999999999998753
Q ss_pred CC-------CcccceeeeeceeEee
Q 024661 245 HA-------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~-------~~~~~~~y~ape~~~~ 262 (264)
.. ...++..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcC
Confidence 22 2246778999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=223.76 Aligned_cols=168 Identities=21% Similarity=0.388 Sum_probs=152.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.+-|.+.+.||+|.|..|.+|++.-+|+.||||++.+.+ .....+..|++.++-++|+|+ |++|++....
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNi-----VRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNI-----VRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCe-----eeeeehhccc
Confidence 45567999999999999999999999999999999998654 345678899999999999999 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccCCCCCc
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKVPSP 243 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~ 243 (264)
..+|||+|+- +|+|++|+-++. ..++|+.+..|+.||+.|+.|+|...+|||||||+|+++.+ -|-|||+|||++..
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 9999999999 899999999876 57999999999999999999999999999999999998775 58999999999987
Q ss_pred CCC-----CcccceeeeeceeEee
Q 024661 244 RHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~~ 262 (264)
..+ ..+|...|-|||++++
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLG 192 (864)
T ss_pred CCCcchhhcccchhhccCchhhhc
Confidence 554 5578889999999876
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=221.77 Aligned_cols=165 Identities=24% Similarity=0.450 Sum_probs=142.1
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeC--CCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...+..+|.+.+.||.|+||.||+|... .++..|++|.+... ....+|+++++.++|+++ +++++.+..
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~i-----v~~~~~~~~ 157 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAI-----INLIHAYRW 157 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCc-----cceeeeEee
Confidence 3455678999999999999999999764 34678999987643 234579999999999988 999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
...+|++||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 158 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 158 KSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred CCEEEEEehhcCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99999999999889999996544 7999999999999999999999999999999999999999999999999998653
Q ss_pred CC--------CcccceeeeeceeEee
Q 024661 245 HA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~--------~~~~~~~y~ape~~~~ 262 (264)
.. ...+|..|+|||++.+
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred CcccccccccccccccCccCHhHhcC
Confidence 32 2357889999998753
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=215.49 Aligned_cols=158 Identities=25% Similarity=0.340 Sum_probs=135.8
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||+|+||+||++.+..+++.+|+|.+.+... ..+.+..|+.+++.++|+++ +.+.+++..+..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-----VSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcE-----eeeeEEEcCCCeEEEEEeCC
Confidence 7999999999999999999999999874322 23456789999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC------
Q 024661 176 -GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA------ 246 (264)
Q Consensus 176 -~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~------ 246 (264)
+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 89998887532 224689999999999999999999999999999999999999999999999999865332
Q ss_pred CcccceeeeeceeEee
Q 024661 247 FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~~~~~~y~ape~~~~ 262 (264)
...++..|||||++.+
T Consensus 156 ~~~g~~~y~aPE~~~~ 171 (280)
T cd05608 156 GYAGTPGFMAPELLQG 171 (280)
T ss_pred ccCCCcCccCHHHhcC
Confidence 2257889999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=231.22 Aligned_cols=165 Identities=25% Similarity=0.277 Sum_probs=141.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe-chhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEcee-eee---
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW-FDY--- 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~-~~~--- 164 (264)
.-++++.+.|.+|||+.||+|++...|..+|+|.+. .++...+...+|+++++.|+ |+|| |.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nI-----V~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNI-----VSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCce-----eeEeccccccccC
Confidence 356899999999999999999999988889999765 45667788999999999998 6666 999993 221
Q ss_pred ---CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEeccC
Q 024661 165 ---RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 165 ---~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l~Df 238 (264)
..+++|+|||| ||+|.+++..+...+|++.++++|+.|+++|+.+||.+. |||||||-+||||..+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 24789999999 799999999776678999999999999999999999997 999999999999999999999999
Q ss_pred CCCCcCCC---------------CcccceeeeeceeE
Q 024661 239 KVPSPRHA---------------FSFQTFLSMASRVY 260 (264)
Q Consensus 239 g~a~~~~~---------------~~~~~~~y~ape~~ 260 (264)
|.|+-... ..+-|+.|.+||++
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 99875321 11347889999963
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=229.90 Aligned_cols=173 Identities=24% Similarity=0.375 Sum_probs=153.7
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
..-.+.|++.+.||.|.+|+||+++.+.+++..|+|+........+++..|.++++...++ +|++.++++|..
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~h----pnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHH----PNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCC----CCcceEEEEEEEecC
Confidence 3445679999999999999999999999999999999887777778888899999987643 344999988865
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
.+.+||||||| +|+.-|+++...+.++.|..+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 57899999999 999999999887889999999999999999999999999999999999999999999999999998
Q ss_pred CcC------CCCcccceeeeeceeEeecC
Q 024661 242 SPR------HAFSFQTFLSMASRVYICIN 264 (264)
Q Consensus 242 ~~~------~~~~~~~~~y~ape~~~~~~ 264 (264)
... .....||++|||||+++|.+
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred eeeecccccccCcCCCcccccceeeeccc
Confidence 653 34567999999999999963
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=223.18 Aligned_cols=166 Identities=20% Similarity=0.366 Sum_probs=142.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++|+|+ +++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV-----IGLLDVFTPA 86 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCch-----hhhhhhhccc
Confidence 45578999999999999999999999999999999987432 234567789999999999988 8888877542
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
...|++|++++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 87 TSIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence 457999999999999888643 59999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC---cccceeeeeceeEee
Q 024661 240 VPSPRHAF---SFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~~---~~~~~~y~ape~~~~ 262 (264)
++...... ..++..|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 164 LARQADDEMTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cceecCCCcCCccccccccCchHhcC
Confidence 99765432 347889999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=214.12 Aligned_cols=164 Identities=21% Similarity=0.305 Sum_probs=142.9
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.|+..+.||.|+||+||+|.+..+++.+|+|.+.... .....+.+|+++++.++|+++ +.+.+.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV-----VNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCc-----eeEEEEEecCCEE
Confidence 3788899999999999999999999999999987532 223456789999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|++|||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999 8899988876544579999999999999999999999999999999999999999999999999986532
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 156 ~~~~~~~g~~~~~aPE~~~ 174 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLN 174 (285)
T ss_pred CcccCCCCCcCccChHHhc
Confidence 1235788999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=229.67 Aligned_cols=169 Identities=24% Similarity=0.265 Sum_probs=142.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...++|.+.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.++..+.|+++ +++++.+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~i-----v~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI-----VKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcE-----EEeecceecc
Confidence 4457899999999999999999999999999999998743 3344567789999988888877 8877766432
Q ss_pred C--------EEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEE
Q 024661 166 N--------HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (264)
Q Consensus 166 ~--------~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~ 234 (264)
+ .+++||||+ +|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 478999999 999999987532 34689999999999999999999999999999999999999999999
Q ss_pred eccCCCCCcCC--------CCcccceeeeeceeEee
Q 024661 235 VPDYKVPSPRH--------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 235 l~Dfg~a~~~~--------~~~~~~~~y~ape~~~~ 262 (264)
|+|||+++... ....+|..|||||++.+
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence 99999986532 12357889999998754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=211.80 Aligned_cols=161 Identities=34% Similarity=0.496 Sum_probs=141.6
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHH---HHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
|++.+.||+|+||+||++.+..+++.+|+|++........ ...+|+.+++.+.|+++ +++++++.+....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNI-----VQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTB-----CHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccc-----ccccccccccccccc
Confidence 7899999999999999999999999999999986543332 33559999999999888 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC-----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR----- 244 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~----- 244 (264)
|||++ +++|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999 669999998544 7999999999999999999999999999999999999999999999999998641
Q ss_pred -CCCcccceeeeeceeEe
Q 024661 245 -HAFSFQTFLSMASRVYI 261 (264)
Q Consensus 245 -~~~~~~~~~y~ape~~~ 261 (264)
.....++..|+|||++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp EBSSSSSSGGGSCHHHHT
T ss_pred cccccccccccccccccc
Confidence 12335778899999854
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=218.22 Aligned_cols=158 Identities=23% Similarity=0.320 Sum_probs=136.3
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..+++.+|+|++++.. .....+..|..+++.+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i-----~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL-----TQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999998542 2345566788888877 46666 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH------ 245 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~------ 245 (264)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 76 EYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 999 899999988764 79999999999999999999999999999999999999999999999999986421
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 154 ~~~~g~~~y~aPE~~~~ 170 (318)
T cd05570 154 STFCGTPDYIAPEILSY 170 (318)
T ss_pred cceecCccccCHHHhcC
Confidence 12347889999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=236.73 Aligned_cols=166 Identities=20% Similarity=0.272 Sum_probs=143.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.++||+|+||.||+|.+..+++.||+|++... ....+.+.+|+++++.+.|+|+ +++++++.+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNI-----Vkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI-----VPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCc-----CeEEEEEeeCCE
Confidence 5799999999999999999999999999999998642 2345678899999999999988 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
.|++|||+ |++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999 999999987421 12355677889999999999999999999999999999999999999999
Q ss_pred CCCCCcCC------------------------CCcccceeeeeceeEee
Q 024661 238 YKVPSPRH------------------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~------------------------~~~~~~~~y~ape~~~~ 262 (264)
||++.... ....||..|||||.+.+
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 99997541 01247889999998654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=214.01 Aligned_cols=164 Identities=28% Similarity=0.471 Sum_probs=137.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHh---ccCCCCcceEEEceeeee--
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~---~~~~~~~~~~~~~~~~~~-- 164 (264)
+|++.+.||+|+||.||+|.+..+++.+|+|.++... .......+|+.+++.+. |+|+ +++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni-----~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI-----VRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCe-----eeeeeeecccc
Confidence 5899999999999999999999999999999887432 22345567888777764 5555 999988764
Q ss_pred ---CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 165 ---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 165 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...++++||++.++|.+++.......+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 76 TDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 35689999999889999998765456899999999999999999999999999999999999999999999999998
Q ss_pred CcCCC-----CcccceeeeeceeEe
Q 024661 242 SPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~-----~~~~~~~y~ape~~~ 261 (264)
..... ...++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLL 180 (288)
T ss_pred ccccCcccCCCccccccccCchHhh
Confidence 75432 234678899999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=213.51 Aligned_cols=164 Identities=21% Similarity=0.308 Sum_probs=143.0
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.|++.+.||+|+||.||++.+..+++.+|+|.+.... .....+..|+.+++.++|+++ +.+++.+.+++.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFV-----VSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCe-----eeeeEEEecCCEE
Confidence 3788899999999999999999999999999886432 223456789999999998887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999 89999998765545699999999999999999999999999999999999999999999999999865332
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|||||++.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVK 174 (285)
T ss_pred ccccCCCCCccccChHHHc
Confidence 235788999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=227.21 Aligned_cols=144 Identities=23% Similarity=0.394 Sum_probs=130.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
-|..++.||-|+||+|.++....|...||+|.+++.. ........|.+||......-+ |+++..|++++.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV-----VrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce-----EEEEEEeccCCce
Confidence 3888999999999999999999999999999987543 233456778889888877655 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
|+||||+ ||++..+|.+.. -|.|..+++|+.++..|++++|..|+|||||||+|||||.+|++||+|||+|+-
T Consensus 705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence 9999999 999999999876 899999999999999999999999999999999999999999999999999963
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=207.29 Aligned_cols=165 Identities=24% Similarity=0.354 Sum_probs=145.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+|++.+.||.|+||.||++.+..+++.+++|.++.. ....+.+.+|+.+++.++|+|+ +++.+.+.+++.+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI-----VAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEE
Confidence 488999999999999999999999999999988632 3445677889999999999888 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+|||+ +++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999 89999998865555689999999999999999999999999999999999999999999999999875432
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 156 YACTYVGTPYYVPPEIWEN 174 (255)
T ss_pred ccccccCCccccCHHHHcc
Confidence 2346778999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=212.23 Aligned_cols=167 Identities=19% Similarity=0.288 Sum_probs=143.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
..+|.++.+||+|+|.+|.+++.+++.+.+|+|+++++- ...+-...|-.++.+... ++.+|.+..+|+.+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn----~pflvglhscfqtes 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN----NPFLVGLHSCFQTES 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccC----CCeEEehhhhhcccc
Confidence 367999999999999999999999999999999998542 223344556555555432 366799999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc--
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP-- 243 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~-- 243 (264)
.+|+|.||+ ||+|.-.+++.. .++++.++.+..+|+.||.|||+.||+.||||.+|+|++..|++||+|+|++..
T Consensus 325 rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999 999987777655 799999999999999999999999999999999999999999999999999975
Q ss_pred ----CCCCcccceeeeeceeEeec
Q 024661 244 ----RHAFSFQTFLSMASRVYICI 263 (264)
Q Consensus 244 ----~~~~~~~~~~y~ape~~~~~ 263 (264)
.....+||+.|+|||++++=
T Consensus 403 ~~gd~tstfcgtpnyiapeilrge 426 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGE 426 (593)
T ss_pred CCCcccccccCCCcccchhhhccc
Confidence 23456899999999999873
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=211.80 Aligned_cols=158 Identities=21% Similarity=0.338 Sum_probs=136.9
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||+|+||.||++.+..+|+.+|+|.+.... ........|+++++.++|+++ +.+++.+.++..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFI-----VNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcE-----EEEEEEEecCCeEEEEEecC
Confidence 799999999999999999999999986422 123445669999999998887 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----Ccc
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-----FSF 249 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-----~~~ 249 (264)
+++|.+++.......+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 89999988765545689999999999999999999999999999999999999999999999999875432 234
Q ss_pred cceeeeeceeEee
Q 024661 250 QTFLSMASRVYIC 262 (264)
Q Consensus 250 ~~~~y~ape~~~~ 262 (264)
++..|+|||++.+
T Consensus 156 ~~~~y~aPE~~~~ 168 (277)
T cd05607 156 GTNGYMAPEILKE 168 (277)
T ss_pred CCCCccCHHHHcc
Confidence 7789999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=214.23 Aligned_cols=164 Identities=25% Similarity=0.403 Sum_probs=143.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|.+.++||.|+||.||+|.+..+++.||+|.++.. ......+.+|+.+++.++|+|+ +.+++++...+..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----~~~~~~~~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCc-----ceEEEEEecCCeEE
Confidence 5799999999999999999999999999999998743 2334567789999999999988 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 999999889999987653 3688999999999999999999999999999999999999999999999999865321
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|++||++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~ 177 (301)
T cd07873 160 TYSNEVVTLWYRPPDILL 177 (301)
T ss_pred cccccceeecccCcHHHh
Confidence 234577899999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=222.71 Aligned_cols=165 Identities=23% Similarity=0.315 Sum_probs=138.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~ 163 (264)
++|++.+.||+|+||.||+|.+... +..||+|.++.. ....+.+.+|+.+++.+ .|+|+ +++++++.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nI-----v~~~~~~~ 112 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI-----VNLLGACT 112 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCce-----eeEeeEec
Confidence 4699999999999999999986544 357999998743 23456788899999999 78887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcC-------------------------------------------------------
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (264)
..+.+|+||||+ +|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999 999999986421
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-------
Q 024661 188 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF------- 247 (264)
Q Consensus 188 -------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~------- 247 (264)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 124788889999999999999999999999999999999999999999999998753321
Q ss_pred -cccceeeeeceeEe
Q 024661 248 -SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -~~~~~~y~ape~~~ 261 (264)
..++..|||||++.
T Consensus 273 ~~~~~~~y~aPE~~~ 287 (374)
T cd05106 273 NARLPVKWMAPESIF 287 (374)
T ss_pred CCCCccceeCHHHhc
Confidence 12345699999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=220.81 Aligned_cols=164 Identities=24% Similarity=0.321 Sum_probs=141.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
+.++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+.|+|+ +.+++.+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-----IGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCc-----cccceeecccc
Confidence 457899999999999999999999999999999998642 2344667889999999999988 777777644
Q ss_pred ----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
...+|+||||++++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346899999998889888754 478899999999999999999999999999999999999999999999999
Q ss_pred CCcCCC-----CcccceeeeeceeEee
Q 024661 241 PSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
++.... ...++..|+|||++.+
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhC
Confidence 976433 2357889999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=221.66 Aligned_cols=168 Identities=23% Similarity=0.348 Sum_probs=149.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.-.+.|+.-+.||+|+||.||-++.+.||+.+|+|.+.+. ........+|-.+|+.++.+.+ |.+-..|++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi-----VslaYAfeT 256 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI-----VSLAYAFET 256 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE-----EEEeeeecC
Confidence 3446689999999999999999999999999999988643 2334566789999999988866 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||..| ||+|.-.|.+.....|+++.++.|+.+|+.||++||+.+||+||+||+|||+|+.|+|+|+|+|+|..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999 99999888887777899999999999999999999999999999999999999999999999999987
Q ss_pred CCC-----CcccceeeeeceeEe
Q 024661 244 RHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~ 261 (264)
... ...||..|||||++.
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred cCCCCccccccCcccccCHHHHc
Confidence 543 337999999999874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=228.50 Aligned_cols=165 Identities=25% Similarity=0.327 Sum_probs=143.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC---
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--- 166 (264)
.-|...+.||.|+||.||+++++.+|+.||||.+++. ....+...+|++++++++|+|| |++++.-+...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NI-----Vk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNI-----VKLFDIEETKFLGL 87 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhh-----hhhcccCCccccCc
Confidence 4477788999999999999999999999999998853 4567888999999999999998 99888765543
Q ss_pred ---EEEEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC--C--cEEecc
Q 024661 167 ---HICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA--E--YVKVPD 237 (264)
Q Consensus 167 ---~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~--~--~v~l~D 237 (264)
...+||||| +|+|...+++-. ..++++..++.++..++.||.|||++||+||||||.||++..+ | -.||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 578999999 999999998542 3579999999999999999999999999999999999998743 4 469999
Q ss_pred CCCCCcCCCCc-----ccceeeeeceeEe
Q 024661 238 YKVPSPRHAFS-----FQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~~~-----~~~~~y~ape~~~ 261 (264)
||.|+.....+ +||..|.+||+|-
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYE 196 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHh
Confidence 99999876543 6899999999863
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=211.06 Aligned_cols=164 Identities=26% Similarity=0.443 Sum_probs=146.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||.|+||.||++.+..+++.+++|++.... ...+.+.+|+++++++.|+|+ +.+++++.+.+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL-----VNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCe
Confidence 36999999999999999999999999999999987532 345678889999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999 999999998765 789999999999999999999999999999999999999999999999999876443
Q ss_pred C---cccceeeeeceeEee
Q 024661 247 F---SFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~---~~~~~~y~ape~~~~ 262 (264)
. ..++..|++||.+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 154 RTYTLCGTPEYLAPEIILS 172 (290)
T ss_pred CCCCCCCCccccChhhhcC
Confidence 2 346788999997653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=228.62 Aligned_cols=163 Identities=25% Similarity=0.376 Sum_probs=142.4
Q ss_pred CCCe-EEEeecccCccEEEEEEEeCCCCcEEEEEEEe-----chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++| +...+||+|+|.+||+|.|..+|..||.-.++ +.....+++..|+.+|+.|+|+|| ++++++|.+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NI-----irfy~SW~d 112 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNI-----IRFYDSWVD 112 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCce-----eeeeeheec
Confidence 3444 44568999999999999999999999966544 234556899999999999999998 999999988
Q ss_pred CC--EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecC-CcEEeccC
Q 024661 165 RN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSA-EYVKVPDY 238 (264)
Q Consensus 165 ~~--~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~-~~v~l~Df 238 (264)
.. .+.+|+|++ .|+|..|+++.+ ..+.+.+..|++||+.||.|||++. |+|||||.+||+|+.+ |.|||+|+
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence 55 489999999 999999999987 8999999999999999999999984 9999999999999865 89999999
Q ss_pred CCCCcCCC----CcccceeeeeceeE
Q 024661 239 KVPSPRHA----FSFQTFLSMASRVY 260 (264)
Q Consensus 239 g~a~~~~~----~~~~~~~y~ape~~ 260 (264)
|+|+.... .-+||+.+||||+|
T Consensus 191 GLAtl~r~s~aksvIGTPEFMAPEmY 216 (632)
T KOG0584|consen 191 GLATLLRKSHAKSVIGTPEFMAPEMY 216 (632)
T ss_pred hHHHHhhccccceeccCccccChHHH
Confidence 99986432 34799999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=221.02 Aligned_cols=163 Identities=23% Similarity=0.334 Sum_probs=141.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCc---E-EEEEEEec----hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKE---L-VAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
+-.+.++||+|.||.||+|..+..+. . ||+|..+. .......+.+|.++++.++|+|+ ++++|+..+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV-----Vr~yGVa~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV-----VRFYGVAVL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEcC
Confidence 34456899999999999999866432 3 89998773 24567889999999999999998 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+..+++|||+| ||+|.++|++.+. .++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+|||+++.
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999 9999999998763 589999999999999999999999999999999999999999999999999988
Q ss_pred CCCCcccc------eeeeeceeEe
Q 024661 244 RHAFSFQT------FLSMASRVYI 261 (264)
Q Consensus 244 ~~~~~~~~------~~y~ape~~~ 261 (264)
...+.... ..|+|||.+-
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLN 335 (474)
T ss_pred CcceeeccccccCcceecChhhhc
Confidence 76444332 4599999753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=209.64 Aligned_cols=164 Identities=20% Similarity=0.280 Sum_probs=140.2
Q ss_pred CCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.+|++.+.||+|+||.||+|.+. ..+..+|+|.++.. ......+.+|+..++.++|+|+ +++++++...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI-----VRLEGVITRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEecCC
Confidence 56999999999999999999865 34668999988753 2344678889999999998888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999 889999998653 368999999999999999999999999999999999999999999999999876532
Q ss_pred CC-------cccceeeeeceeEe
Q 024661 246 AF-------SFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~-------~~~~~~y~ape~~~ 261 (264)
.. ..++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~ 181 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQ 181 (266)
T ss_pred ccchhcccCCCCceeecCHHHHh
Confidence 21 22356799999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=220.59 Aligned_cols=166 Identities=24% Similarity=0.306 Sum_probs=138.9
Q ss_pred CCeEEEeecccCccEEEEEEEe-----CCCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~ 163 (264)
++|++.+.||+|+||.||+|++ ..++..||+|+++.. ....+.+.+|+.+++.+ .|+|+ +++++++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnI-----v~l~~~~~ 109 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI-----VNLLGACT 109 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcce-----eeeeeeec
Confidence 4699999999999999999974 345678999998643 23456788999999999 78877 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcC-------------------------------------------------------
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (264)
+.+..++||||+ +|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999 999999987432
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC--
Q 024661 188 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF-- 247 (264)
Q Consensus 188 ------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~-- 247 (264)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124778889999999999999999999999999999999999999999999998754321
Q ss_pred ------cccceeeeeceeEee
Q 024661 248 ------SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 ------~~~~~~y~ape~~~~ 262 (264)
..++..|||||++.+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred ccccCCCCCCcceeChhHhcC
Confidence 123456999998643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=210.70 Aligned_cols=164 Identities=26% Similarity=0.436 Sum_probs=142.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||+|++|.||+|.+..++..|++|.+... ......+.+|+.+++.+.|+++ +++++++.+++.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI-----VCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCE-----eeeEEEEeeCCeEE
Confidence 488999999999999999999999999999988643 2234567889999999998887 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 170 IVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
+||||+.++|.+++.... ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999999889999887543 2468999999999999999999999999999999999999999999999999986432
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLL 174 (285)
T ss_pred ccccCCcccccccChHHhc
Confidence 1224577899999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=208.53 Aligned_cols=164 Identities=26% Similarity=0.324 Sum_probs=144.0
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.++|++.+.||+|+||.||+|.+..+++.+++|++.... .....+.+|+.+++.+.|+++ +++++.+..++.+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----i~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI-----VAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCe-----eeeeEEEEeCCEEE
Confidence 457999999999999999999999999999999987432 334567789999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999 889999987654 689999999999999999999999999999999999999999999999999875321
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cccCccccCccccCHhHcc
Confidence 224677899999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=210.19 Aligned_cols=167 Identities=23% Similarity=0.351 Sum_probs=145.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee----
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~---- 164 (264)
..+.|++.+.||.|+||.||+|.+..+++.+++|++.........+..|+.+++.+ .|+|+ +++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCe-----eeEeeEEeecCCC
Confidence 34679999999999999999999999999999999976555566788899999998 57777 999998865
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...+|++|||+ +++|.+++.......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 35789999999 889999998765557899999999999999999999999999999999999999999999999998
Q ss_pred CcCCC------CcccceeeeeceeEe
Q 024661 242 SPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~------~~~~~~~y~ape~~~ 261 (264)
..... ...++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred eecccccccCCcccccccccCHhHhc
Confidence 75322 234678899999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=205.90 Aligned_cols=164 Identities=25% Similarity=0.417 Sum_probs=139.5
Q ss_pred ccCCCeEEE-eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 89 NLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 89 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
.+.++|.+. ++||-|-.|+|..|.++.+++.+|+|++... +...+|++.......+ +++|+++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h----~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGH----PHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCC----CceEEeehhhhhhcc
Confidence 456778875 4799999999999999999999999987643 3456688766655422 445999998865
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---CcEEeccCC
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---EYVKVPDYK 239 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---~~v~l~Dfg 239 (264)
...+.+|||++ ||.|++.++++....|+|.++..|+.||..|+.|||+.+|.||||||+|+|.... ..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 56789999999 9999999999988889999999999999999999999999999999999999854 579999999
Q ss_pred CCCcCCC-----CcccceeeeeceeE
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVY 260 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~ 260 (264)
+|..... ..+.|++|.|||++
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevl 235 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVL 235 (400)
T ss_pred cccccCCCccccCCcccccccCHHHh
Confidence 9987552 44689999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=192.43 Aligned_cols=164 Identities=27% Similarity=0.437 Sum_probs=145.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|.-.++||+|.||+||+|+...+++.||+|.++.. +.......+|+-+++.++|.|+ +++++....++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhkni-----vrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcce-----eehhhhhccCceeE
Confidence 467788999999999999999999999999998743 3445677899999999999998 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+|+|||..+|..+..+.. ..++.+.++.++.|++.||.|+|++++.|||+||.|+||+.+|.+||+|||+++....
T Consensus 78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 999999999999998765 4699999999999999999999999999999999999999999999999999975322
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
-..-|.+|..|.++.+
T Consensus 157 cysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred eeeceeeeeeccCcceeee
Confidence 2235778989988765
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=210.96 Aligned_cols=164 Identities=23% Similarity=0.339 Sum_probs=144.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||+|+||.||++.+..++..+++|.+... ......+.+|+++++.++|+|+ +++++.+.+++.+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI-----VGFYGAFYSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCEEE
Confidence 3599999999999999999999999999999988643 3345668889999999999988 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+|||++.++.++|+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999 899999998764 78999999999999999999997 6999999999999999999999999999865432
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|++||.+.+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG 172 (308)
T ss_pred ccccCCCCcCccChhHhcC
Confidence 3346788999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=207.60 Aligned_cols=165 Identities=19% Similarity=0.246 Sum_probs=145.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
..|.+.+.||+|+||.||+|.+..+++.+++|.+.........+.+|+++++.+.|+++ +++++++..++.++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCCh-----hheEEEEcCCCCcEEE
Confidence 45899999999999999999999999999999988665556778899999999999888 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc--
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS-- 248 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~-- 248 (264)
|||+ +++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999 8999999986554568999999999999999999999999999999999999999999999999987644321
Q ss_pred -----ccceeeeeceeEe
Q 024661 249 -----FQTFLSMASRVYI 261 (264)
Q Consensus 249 -----~~~~~y~ape~~~ 261 (264)
..+..|+|||.+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~ 178 (263)
T cd05052 161 AHAGAKFPIKWTAPESLA 178 (263)
T ss_pred ccCCCCCccccCCHHHhc
Confidence 1245699999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=219.46 Aligned_cols=167 Identities=22% Similarity=0.285 Sum_probs=139.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEech--hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~ 162 (264)
.++|++++.||+|+||.||+|.+... +..||+|+++.. ....+.+.+|+.+++.+. |+|+ +++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnI-----v~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI-----VNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCe-----eeEEEEE
Confidence 35789999999999999999987533 346999998643 334567889999999996 8877 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcC------------------------------------------------------
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------ 187 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------ 187 (264)
.+.+.+|+||||+ +|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999 999999886431
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe
Q 024661 188 ----------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (264)
Q Consensus 188 ----------------------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili 227 (264)
...+++..+..++.||+.||.|||+++|+|+||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 1247788889999999999999999999999999999999
Q ss_pred ecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 228 VSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 228 ~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
+.++.+||+|||++..... ...++..|||||.+.+
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 9999999999999875321 2235567999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=206.91 Aligned_cols=165 Identities=21% Similarity=0.316 Sum_probs=143.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.++|++.++||+|+||.||+|.+. ++..+++|.+.......+.+.+|+.+++.++|+++ +++++.+.+.+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL-----VRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCcEE
Confidence 367999999999999999999865 45679999887655556788999999999999887 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC--
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF-- 247 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~-- 247 (264)
+|||+ +++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999 899999998765557899999999999999999999999999999999999999999999999999764321
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|+|||.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05072 159 TAREGAKFPIKWTAPEAIN 177 (261)
T ss_pred eccCCCccceecCCHHHhc
Confidence 12345799999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=210.11 Aligned_cols=164 Identities=26% Similarity=0.423 Sum_probs=142.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||.|++|.||+|.+..+++.|++|.+.... .....+.+|+++++.++|+++ +++++++.+.+..|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI-----VTLHDIIHTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcce-----eeEEEEEecCCeEE
Confidence 67999999999999999999999899999999986432 223456789999999999887 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||+.++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++....
T Consensus 80 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 80 LVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 999999779999987654 3689999999999999999999999999999999999999999999999999865321
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~aPE~~~ 176 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLL 176 (291)
T ss_pred cccccccccccCCcHHhh
Confidence 223567899999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=208.86 Aligned_cols=162 Identities=25% Similarity=0.421 Sum_probs=140.2
Q ss_pred CeEE-EeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
-|++ .+.||+|+|+.|-.|....+|.++|||++.+.. ..+.++.+|++++.+++.+ +|+++++++|+++..+||
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh----~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGH----KNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCC----ccHHHHHHHhcccceEEE
Confidence 3555 357999999999999999999999999998764 4567889999999998743 445999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEeccCCCCCcCCC
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKVPDYKVPSPRHA 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l~Dfg~a~~~~~ 246 (264)
|||-+ ||+|...+.+++ .|++.++.++..+|+.||.|||.+||.|||+||+|||..... -||||||.+..-.+.
T Consensus 154 VfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999 999999999887 799999999999999999999999999999999999998766 479999987653221
Q ss_pred -------------CcccceeeeeceeE
Q 024661 247 -------------FSFQTFLSMASRVY 260 (264)
Q Consensus 247 -------------~~~~~~~y~ape~~ 260 (264)
..+|...|||||++
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHH
Confidence 23566679999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=211.70 Aligned_cols=163 Identities=28% Similarity=0.448 Sum_probs=142.4
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||+|+||.||+|.+..+|+.+++|.+.... .....+.+|+.+++.++|+|+ +++++++.+...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCe-----eeHHHHhccCCceE
Confidence 5899999999999999999999999999999986432 223566789999999999887 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+++||++++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 999999889999887643 3689999999999999999999999999999999999999999999999999875432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~ 172 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLF 172 (284)
T ss_pred CcCCCccccCCcChHHHh
Confidence 224577899999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=206.03 Aligned_cols=167 Identities=21% Similarity=0.300 Sum_probs=143.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..++|++.+.||+|++|.||+|.+.. ++.|++|.++......+.+.+|+.+++.++|+|+ +++++++...+..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL-----IQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCc-----cceeEEEecCCCee
Confidence 34679999999999999999999754 5679999987655556778899999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS 248 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~ 248 (264)
++||++ +++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999 9999999987554578999999999999999999999999999999999999999999999999987643221
Q ss_pred -------ccceeeeeceeEee
Q 024661 249 -------FQTFLSMASRVYIC 262 (264)
Q Consensus 249 -------~~~~~y~ape~~~~ 262 (264)
.....|++||.+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALY 178 (261)
T ss_pred ccccCCCcCceeccCcccccc
Confidence 12346999997653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=232.60 Aligned_cols=173 Identities=24% Similarity=0.420 Sum_probs=146.0
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+..++...++|++++.||+|+||.||+|.+..++..+|+|++... ......+..|+.+++.+.|+++ +++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNI-----Vrl~d 79 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI-----VRYID 79 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCc-----CeEEE
Confidence 445667778999999999999999999999999999999998742 3445678899999999999988 99999
Q ss_pred eeee--CCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCCEEee
Q 024661 161 WFDY--RNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-------RLIHTDLKPENILLV 228 (264)
Q Consensus 161 ~~~~--~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-------~ivH~dikp~Nili~ 228 (264)
+|.+ ...+||||||+ +++|.++|... ....+++..++.|+.||+.||.|||+. +|||+||||+||||+
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 8855 46799999999 89999999753 123699999999999999999999984 499999999999996
Q ss_pred cC-----------------CcEEeccCCCCCcCC-----CCcccceeeeeceeEe
Q 024661 229 SA-----------------EYVKVPDYKVPSPRH-----AFSFQTFLSMASRVYI 261 (264)
Q Consensus 229 ~~-----------------~~v~l~Dfg~a~~~~-----~~~~~~~~y~ape~~~ 261 (264)
.+ +.+||+|||++.... ....+|..|||||++.
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL 214 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHh
Confidence 53 348999999997643 2335889999999874
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-29 Score=206.85 Aligned_cols=173 Identities=23% Similarity=0.358 Sum_probs=145.7
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceee
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~ 162 (264)
+.......++|++.+.||+|+||.||+|.+..+++.+++|++.........+.+|+.+++.+ .|+|+ +++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV-----VKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCe-----eeeeeee
Confidence 34444566889999999999999999999999999999998875444456778899999999 58877 9998877
Q ss_pred e-----eCCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEE
Q 024661 163 D-----YRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (264)
Q Consensus 163 ~-----~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~ 234 (264)
. ..+.+++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEE
Confidence 3 456799999999 89999987632 224688999999999999999999999999999999999999999999
Q ss_pred eccCCCCCcCCC------CcccceeeeeceeEe
Q 024661 235 VPDYKVPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 235 l~Dfg~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
|+|||++..... ...++..|+|||++.
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhc
Confidence 999999865322 234778899999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=208.50 Aligned_cols=166 Identities=25% Similarity=0.422 Sum_probs=144.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
..+.|+++++||.|+||.||+|.+..+++.+++|.+... ....+.+.+|+.+++.+.|+++ +++++.+..++.+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-----VKLLGAFYWDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcE-----eeeEEEEEeCCeE
Confidence 346799999999999999999999999999999998743 3445678889999999999887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +++|..++.+.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999 888988876543 3689999999999999999999999999999999999999999999999998865322
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred ccccceecCCccccCceeec
Confidence 224677899999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-29 Score=207.91 Aligned_cols=165 Identities=24% Similarity=0.382 Sum_probs=142.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|.+.+.||+|+||.||+|.+..+++.+++|++.... .....+.+|+.+++.+.|+|+ +++++++.+++..|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCE-----eEEEEEEecCCeEE
Confidence 67999999999999999999999999999999986432 223456789999999999887 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||++++|.+++.... ..+.+..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++....
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 999999888888876543 3578888999999999999999999999999999999999999999999999875321
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||.+.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCCCccccccccCCceeec
Confidence 2235778999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=228.80 Aligned_cols=161 Identities=20% Similarity=0.317 Sum_probs=143.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|.+.++||+|+||.||+|.+..+++.||+|+++... .....+..|+.+++.++|+++ +.+++.+.....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI-----VHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCc-----CeEEEEEEECCE
Confidence 57999999999999999999999999999999987532 334677889999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... .+++..++.|+.||+.||+|||.+||+||||||+|||++.++.++|+|||+++....
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999 999999998754 689999999999999999999999999999999999999999999999999986432
Q ss_pred ------Ccccceeeeecee
Q 024661 247 ------FSFQTFLSMASRV 259 (264)
Q Consensus 247 ------~~~~~~~y~ape~ 259 (264)
...+|..|++||.
T Consensus 157 ~~~~~~~~~~t~~~~~pe~ 175 (669)
T cd05610 157 RELNMMDILTTPSMAKPKN 175 (669)
T ss_pred CcccccccccCccccCccc
Confidence 3357778888874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=208.75 Aligned_cols=162 Identities=24% Similarity=0.341 Sum_probs=143.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
++|.+.+.||+|+||.||+|.+..+++.+++|+++... .....+.+|+.+++.++|+++ +++++.+...+.+|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----i~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI-----VAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEeCCEEEE
Confidence 57999999999999999999999999999999987543 334567789999999998888 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH---- 245 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~---- 245 (264)
||||+ +++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999 889999988765 79999999999999999999999999999999999999999999999999986432
Q ss_pred --CCcccceeeeeceeE
Q 024661 246 --AFSFQTFLSMASRVY 260 (264)
Q Consensus 246 --~~~~~~~~y~ape~~ 260 (264)
....++..|+|||++
T Consensus 162 ~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 162 KRKSFIGTPYWMAPEVA 178 (267)
T ss_pred ccccccCcccccChhhh
Confidence 233578899999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-29 Score=204.29 Aligned_cols=164 Identities=29% Similarity=0.373 Sum_probs=143.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
+.|.+.+.||+|++|.||+|.+..+++.+++|.+.... .....+.+|+++++.+.|+++ +++++++.++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI-----VQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEccC
Confidence 45899999999999999999999999999999886321 223567889999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+++|||++ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999 899999998765 6899999999999999999999999999999999999999999999999998643
Q ss_pred CC---------CcccceeeeeceeEee
Q 024661 245 HA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~---------~~~~~~~y~ape~~~~ 262 (264)
.. ...++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISG 181 (263)
T ss_pred cccccccccccCCCcCccccCcceecc
Confidence 22 2235678999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-29 Score=202.85 Aligned_cols=165 Identities=26% Similarity=0.350 Sum_probs=146.2
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||.|+||.||.+++..+++.+++|.+... ......+.+|++++++++|+|+ +++++++.+.+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI-----IAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCe-----eEEEeEEecCCeEE
Confidence 589999999999999999999999999999987642 3445678899999999998887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
++|||+ +++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999 89999999876445789999999999999999999999999999999999999999999999999875432
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||.+.+
T Consensus 156 ~~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQG 175 (256)
T ss_pred ccccccCCCccccCHhhcCC
Confidence 2347888999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=202.57 Aligned_cols=164 Identities=26% Similarity=0.359 Sum_probs=145.1
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.|.+.+.||+|++|.||+|.+..+++.+++|.+... ......+.+|+++++.++|+|+ +++++++...+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI-----IRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCe-----ehheeeeccCCEEE
Confidence 388899999999999999999999999999998642 3456778889999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
+||||+ +++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999 899999998764457899999999999999999999999999999999999999999999999998754322
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|+|||++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08529 156 NFANTIVGTPYYLSPELCE 174 (256)
T ss_pred chhhccccCccccCHHHhc
Confidence 24677899999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=210.44 Aligned_cols=147 Identities=20% Similarity=0.412 Sum_probs=133.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+..|+++++.+.|+++ +++++.+.+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL-----PTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCc-----hhheeeeecCCE
Confidence 36999999999999999999999999999999987532 244567889999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.|++|||+ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 99999999 89999999876555799999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=205.91 Aligned_cols=159 Identities=21% Similarity=0.317 Sum_probs=139.4
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+++++.+.|+++ +.+++.+...+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-----IGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEECCEEEE
Confidence 588899999999999999999999999999998643 2344678899999999999888 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH---- 245 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~---- 245 (264)
||||+ +++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence 99999 88886542 47888999999999999999999999999999999999999999999999987532
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|+|||.+.+
T Consensus 151 ~~~~~~~~y~aPE~~~~ 167 (279)
T cd06619 151 KTYVGTNAYMAPERISG 167 (279)
T ss_pred cCCCCChhhcCceeecC
Confidence 23457889999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=203.93 Aligned_cols=163 Identities=21% Similarity=0.280 Sum_probs=140.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
+.|++.+.||+|+||.||++.+.. +..+++|.+.........+.+|+.+++.++|+++ +++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKL-----VQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCc-----eeEEEEEccCCCEEEE
Confidence 458999999999999999998754 4579999887655556678889999999999888 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc--
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS-- 248 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~-- 248 (264)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.++......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999 899999987644 258999999999999999999999999999999999999999999999999987543211
Q ss_pred -----ccceeeeeceeEe
Q 024661 249 -----FQTFLSMASRVYI 261 (264)
Q Consensus 249 -----~~~~~y~ape~~~ 261 (264)
.++..|+|||.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFN 174 (256)
T ss_pred ccCCCCCchhhCChhhcc
Confidence 2344699999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=212.76 Aligned_cols=160 Identities=23% Similarity=0.380 Sum_probs=132.3
Q ss_pred EeecccCccEEEEEEEeC--CCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CCEEEEEE
Q 024661 97 LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVF 172 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~lv~ 172 (264)
+.+||+|+||.||+|.++ .+++.+|+|.+.... ......+|+.+++.++|+|+ +++++.+.. +..+|++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCC-----cceeeeEecCCCcEEEEEE
Confidence 468999999999999965 467889999886432 23457789999999999988 899888854 56789999
Q ss_pred ecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee----cCCcEEeccCCCC
Q 024661 173 EKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV----SAEYVKVPDYKVP 241 (264)
Q Consensus 173 e~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~----~~~~v~l~Dfg~a 241 (264)
||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 999889999886421 23588999999999999999999999999999999999994 5578999999999
Q ss_pred CcCCC---------CcccceeeeeceeEee
Q 024661 242 SPRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 242 ~~~~~---------~~~~~~~y~ape~~~~ 262 (264)
..... ...+|..|||||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcC
Confidence 75322 2346888999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=207.85 Aligned_cols=165 Identities=25% Similarity=0.339 Sum_probs=144.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...+|++.+.||+|+||.||+|.+..+++.+++|.+.... ...+.+.+|+.+++.+.|+|+ +.+++.+......
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCE-----eeEEEEEEeCCEE
Confidence 3468999999999999999999999999999999887432 334677889999999998887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999 89999998754 488999999999999999999999999999999999999999999999999875322
Q ss_pred -----CcccceeeeeceeEee
Q 024661 247 -----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||.+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~ 190 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTR 190 (296)
T ss_pred ccccCcccCCccccCHHHHcC
Confidence 2357788999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=211.27 Aligned_cols=163 Identities=20% Similarity=0.283 Sum_probs=138.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcE----EEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+|++.+.||+|+||.||+|.+..+++. ||+|+++.. ....+.+.+|+.+++.+.|+|+ +++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEcCC
Confidence 5699999999999999999998766553 899988643 3445678899999999999988 9999988764
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..++++|++ +|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 577899999 999999998754 35889999999999999999999999999999999999999999999999999864
Q ss_pred CCC--------cccceeeeeceeEe
Q 024661 245 HAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~--------~~~~~~y~ape~~~ 261 (264)
... ...+..||+||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~ 184 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESIL 184 (316)
T ss_pred cCCCcceeccCCccceeecChHHhc
Confidence 321 12345799999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=202.38 Aligned_cols=165 Identities=30% Similarity=0.378 Sum_probs=145.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
++|++.+.||.|+||.||+|.+..+++.+++|++.... ...+.+.+|+++++.++|+++ +++++.+.+.+.+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI-----VAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCCh-----hceEEEEEeCCEEEE
Confidence 57999999999999999999999899999999987532 345778899999999999988 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+|||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999 889999987652 3689999999999999999999999999999999999999999999999999875432
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|++||.+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~ 175 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAV 175 (262)
T ss_pred ccccccCCccccCchhhcc
Confidence 2246778999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=203.84 Aligned_cols=165 Identities=25% Similarity=0.318 Sum_probs=143.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|++..+++.+++|.+.. .......+.+|+++++.++|+++ +++++++.+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV-----IKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcce-----eeeeeeEEECCe
Confidence 579999999999999999999999999999998753 23445567889999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+++|||+ +++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999 88999988642 2235889999999999999999999999999999999999999999999999998764
Q ss_pred CC------CcccceeeeeceeEe
Q 024661 245 HA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~------~~~~~~~y~ape~~~ 261 (264)
.. ...++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~ 179 (267)
T cd08228 157 SSKTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred cchhHHHhcCCCCccccChhhhc
Confidence 32 234677899999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=208.46 Aligned_cols=163 Identities=26% Similarity=0.397 Sum_probs=142.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh------hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... ....+..|+++++.++|+++ +++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI-----IGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCC-----hhhhheeecCC
Confidence 48899999999999999999999999999999874322 24556789999999999888 99999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
..++||||++++|.+++.... ..+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999999889999997653 3689999999999999999999999999999999999999999999999999875432
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~ 175 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLF 175 (298)
T ss_pred CCccccccccceeeeCHHHHh
Confidence 223567899999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=203.02 Aligned_cols=158 Identities=19% Similarity=0.306 Sum_probs=136.4
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+++++.+.|+++ +++++++......|+||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcCCCCeEEEEeec
Confidence 4699999999999999999999999987643 3345678899999999999888 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc------
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS------ 248 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~------ 248 (264)
+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 899999997543 358999999999999999999999999999999999999999999999999987543221
Q ss_pred --ccceeeeeceeEe
Q 024661 249 --FQTFLSMASRVYI 261 (264)
Q Consensus 249 --~~~~~y~ape~~~ 261 (264)
..+..|+|||.+.
T Consensus 155 ~~~~~~~y~aPE~~~ 169 (252)
T cd05084 155 MKQIPVKWTAPEALN 169 (252)
T ss_pred CCCCceeecCchhhc
Confidence 1234699999764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=206.49 Aligned_cols=164 Identities=28% Similarity=0.448 Sum_probs=140.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++.+.|+|+ +++++.+......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL-----VNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCE-----eeeeeEEeeCCEE
Confidence 46999999999999999999999999999999886432 234567889999999998887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
++||||+ ++.|..++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999999 666666555433 6899999999999999999999999999999999999999999999999999764332
Q ss_pred ------cccceeeeeceeEee
Q 024661 248 ------SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 ------~~~~~~y~ape~~~~ 262 (264)
..++..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVG 174 (286)
T ss_pred cccccCcccccccCCHHHHhC
Confidence 246678999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=208.07 Aligned_cols=164 Identities=30% Similarity=0.441 Sum_probs=144.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
++|++.+.||.|+||.||+|.+..++..+++|++... ....+.+.+|+++++.++|+++ +++++.+......|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI-----VGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEecCCeEEE
Confidence 5699999999999999999999889999999998743 3445678889999999998887 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999 889999987653 3689999999999999999999999999999999999999999999999998865332
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|++||++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred ccceeecchhhcCHHHHh
Confidence 224678899999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=221.95 Aligned_cols=156 Identities=24% Similarity=0.355 Sum_probs=141.4
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEe-chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-C
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (264)
+||.|.||+||-|++..+...+|||.+. +.....+.+++|+.+.++++|.|| |++++.+..++++-|.||-+ |
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNI-----VrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNI-----VRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhH-----HHHhhccCCCCeEEEEeecCCC
Confidence 6999999999999999999999999886 445677889999999999999999 99999999999999999999 9
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee-cCCcEEeccCCCCCcC------CCC
Q 024661 177 PSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPDYKVPSPR------HAF 247 (264)
Q Consensus 177 ~~L~~~l~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~-~~~~v~l~Dfg~a~~~------~~~ 247 (264)
|+|.++++.. +.++ +|..+-.|..||++||.|||++.|||||||-+|+||+ ..|.+||+|||.+... .+.
T Consensus 657 GSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999999865 3566 8999999999999999999999999999999999998 5799999999988753 345
Q ss_pred cccceeeeeceeE
Q 024661 248 SFQTFLSMASRVY 260 (264)
Q Consensus 248 ~~~~~~y~ape~~ 260 (264)
..||..|||||++
T Consensus 736 FTGTLQYMAPEvI 748 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVI 748 (1226)
T ss_pred cccchhhhChHhh
Confidence 5689999999985
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=204.45 Aligned_cols=164 Identities=24% Similarity=0.318 Sum_probs=139.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.++|++.++||+|+||.||+|.+..++ .+++|.++......+.+.+|+++++.+.|+++ +++++.+. +...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCc-----ceEEEEEC-CCCcEE
Confidence 467999999999999999999987654 59999988655555678899999999999887 88888764 456899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc-
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS- 248 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~- 248 (264)
||||+ +++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999 8899999987544468999999999999999999999999999999999999999999999999987543221
Q ss_pred ------ccceeeeeceeEe
Q 024661 249 ------FQTFLSMASRVYI 261 (264)
Q Consensus 249 ------~~~~~y~ape~~~ 261 (264)
.++..|++||.+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~ 176 (262)
T cd05071 158 TARQGAKFPIKWTAPEAAL 176 (262)
T ss_pred ccccCCcccceecCHhHhc
Confidence 2345699999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=214.93 Aligned_cols=164 Identities=23% Similarity=0.317 Sum_probs=142.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+|..+.+||.|+||+|.+|..+.+.+.+|||++++.- ...+..+.|-++|.-...+ +.+++++.+|+.-+.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kp----pFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP----PFLVQLHSCFQTMDR 424 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCC----chHHHHHHHhhhhhh
Confidence 56899999999999999999999999999999998642 2233445566666554444 567999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC--
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR-- 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~-- 244 (264)
+|+||||+ ||+|.-.+++.. .+.|..+..|+.+|+-||-|||++||+.||||.+|||++.+|++||+|||++...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999 999999998876 8999999999999999999999999999999999999999999999999999752
Q ss_pred ----CCCcccceeeeeceeEe
Q 024661 245 ----HAFSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ----~~~~~~~~~y~ape~~~ 261 (264)
....+||+.|||||+++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred CCcceeeecCCCcccccceEE
Confidence 23557999999999875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=203.04 Aligned_cols=164 Identities=28% Similarity=0.405 Sum_probs=141.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech------hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~- 164 (264)
..|++.+.||+|+||.||+|.+..+++.|++|.+... ....+.+.+|+.+++.+.|+++ +++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI-----VQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCe-----eeEEeEeccC
Confidence 4699999999999999999999999999999987532 1234577889999999999888 999998876
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
...++++|||+ +++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 35789999999 899999998764 68899999999999999999999999999999999999999999999999987
Q ss_pred cCCC---------CcccceeeeeceeEee
Q 024661 243 PRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~---------~~~~~~~y~ape~~~~ 262 (264)
.... ...++..|+|||.+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcC
Confidence 5321 2246778999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=210.72 Aligned_cols=190 Identities=28% Similarity=0.501 Sum_probs=166.9
Q ss_pred CCCCCCCceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCC-CC
Q 024661 74 RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GG 152 (264)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~ 152 (264)
..++..+.|.+.+|+.+.++|.+....|.|-|++|..|.+...|..||||+|..++.....-..|+++|+.|....- ..
T Consensus 414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhh
Confidence 34555678999999999999999999999999999999999999999999999877777777899999999986542 23
Q ss_pred cceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.++++++..|...+++|||+|-+.-+|.++|++.+ +.++....++.|+.|++.||..|..+||+|.||||+|||+++..
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 46689999999999999999999999999999653 45688899999999999999999999999999999999999764
Q ss_pred -cEEeccCCCCCcCCCCcccc----eeeeeceeEeec
Q 024661 232 -YVKVPDYKVPSPRHAFSFQT----FLSMASRVYICI 263 (264)
Q Consensus 232 -~v~l~Dfg~a~~~~~~~~~~----~~y~ape~~~~~ 263 (264)
.+||||||.|.......+-. ..|-|||+++|+
T Consensus 574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~ 610 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITPYLVSRFYRAPEIILGL 610 (752)
T ss_pred ceeeeccCccccccccccccHHHHHHhccCcceeecC
Confidence 68999999998877765543 359999999885
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=210.97 Aligned_cols=161 Identities=16% Similarity=0.197 Sum_probs=138.4
Q ss_pred EEeecccC--ccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 96 ILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 96 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
++++||+| +|++||++.++.+|+.||+|.++.. ....+.+.+|+++++.++|+|+ +++++++..++..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-----v~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEEECCEEEE
Confidence 46789999 6899999999999999999998743 2344567789999999999988 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH---- 245 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~---- 245 (264)
||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999 8999999976543468999999999999999999999999999999999999999999999998653321
Q ss_pred ---------CCcccceeeeeceeEe
Q 024661 246 ---------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---------~~~~~~~~y~ape~~~ 261 (264)
....++..|||||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQ 181 (327)
T ss_pred cccccccccccccceecccChHHhh
Confidence 1224566799999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=206.25 Aligned_cols=164 Identities=21% Similarity=0.390 Sum_probs=142.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||.|+||.||++.+..+++.|++|.+.... .....+.+|+++++.++|+|+ +++++.+..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFV-----VSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEecCCE
Confidence 35899999999999999999999999999999987543 234567789999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
+|+||||+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999 899999998765 68999999999999999999999999999999999999999999999999886311
Q ss_pred --------------------CCcccceeeeeceeEee
Q 024661 246 --------------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 --------------------~~~~~~~~y~ape~~~~ 262 (264)
....++..|+|||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccC
Confidence 11235667999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=204.60 Aligned_cols=164 Identities=22% Similarity=0.278 Sum_probs=140.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.+|++.+.||+|+||.||+|.+. ++..+++|++.+.......+.+|+++++.++|+++ +++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNL-----VQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----EEEEEEEcCCCceEEE
Confidence 35889999999999999999876 45679999987655555678889999999998887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc--
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS-- 248 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~-- 248 (264)
|||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999 899999998654 368999999999999999999999999999999999999999999999999987543211
Q ss_pred -----ccceeeeeceeEee
Q 024661 249 -----FQTFLSMASRVYIC 262 (264)
Q Consensus 249 -----~~~~~y~ape~~~~ 262 (264)
..+..|++||.+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~ 175 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDY 175 (256)
T ss_pred ccCCCCCCccccCHHHhcc
Confidence 12346999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=204.55 Aligned_cols=163 Identities=30% Similarity=0.445 Sum_probs=144.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||.|++|.||+|.+..++..+++|++.... .....+.+|+.+++.+.|+++ +++++++.+....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV-----VKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCC-----cceeeEEecCCeeE
Confidence 5899999999999999999999999999999987432 335678899999999998888 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||++++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999999999987654 4699999999999999999999999999999999999999999999999999876433
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 155 RLYSHQVATRWYRAPELLY 173 (286)
T ss_pred CccccccCcccccCceeee
Confidence 234677899999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=204.09 Aligned_cols=168 Identities=27% Similarity=0.416 Sum_probs=145.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC---
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR--- 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~--- 165 (264)
..++|++.+.||.|++|.||+|.+..+++.+++|++.......+.+.+|+.+++++ .|+|+ +++++++...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI-----ATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCCh-----heEEEEEEecCCC
Confidence 34789999999999999999999998999999999887666667889999999998 58877 9999998664
Q ss_pred ---CEEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ---NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ---~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..+|+||||+ +++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4589999999 889999987532 3578999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC------CcccceeeeeceeEee
Q 024661 240 VPSPRHA------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~------~~~~~~~y~ape~~~~ 262 (264)
++..... ...++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcc
Confidence 9865332 3346778999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=205.86 Aligned_cols=169 Identities=24% Similarity=0.311 Sum_probs=146.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.....+|.+.+.||+|+||.||+|.+..+++.|++|.+... ....+.+.+|+++++.++|+|+ +++.+++.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~~~~~~~ 85 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT-----IEYKGCYL 85 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEE
Confidence 34446799999999999999999999989999999988632 2334567889999999999887 99999999
Q ss_pred eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+.+..|+||||+.++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 999999999999888888887543 3689999999999999999999999999999999999999999999999999876
Q ss_pred CCC--CcccceeeeeceeEee
Q 024661 244 RHA--FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~--~~~~~~~y~ape~~~~ 262 (264)
... ...++..|+|||++.+
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 165 VSPANSFVGTPYWMAPEVILA 185 (307)
T ss_pred cCCCCCccCCccccCceeeec
Confidence 433 3347788999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=204.49 Aligned_cols=162 Identities=28% Similarity=0.458 Sum_probs=141.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
|++.+.||.|+||.||+|.+..++..+++|.+... ....+.+.+|+++++.+.|+|+ +.+++.+...+..|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCe-----eeEEEEEeeCCEEEEEE
Confidence 78889999999999999999999999999988643 3445678889999999999888 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
||+ +++|..++.... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999 889988876533 3689999999999999999999999999999999999999999999999999865322
Q ss_pred -CcccceeeeeceeEe
Q 024661 247 -FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -~~~~~~~y~ape~~~ 261 (264)
...++..||+||++.
T Consensus 161 ~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 161 DSFIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccccCHhhcc
Confidence 234778899999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=206.69 Aligned_cols=166 Identities=26% Similarity=0.339 Sum_probs=145.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
....+|++.+.||+|+||.||+|.+..+++.|++|.+.... ...+.+.+|+.+++.+.|+++ +.+++.+...+.
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~ 90 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDE 90 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCE
Confidence 34478999999999999999999999999999999987432 334667889999999999887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999 99999998754 488999999999999999999999999999999999999999999999999875432
Q ss_pred ------CcccceeeeeceeEee
Q 024661 247 ------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~~ 262 (264)
...++..|++||.+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTR 189 (297)
T ss_pred CccCcCcccCCccccCHHHHcC
Confidence 2346778999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=205.01 Aligned_cols=168 Identities=17% Similarity=0.277 Sum_probs=139.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
...++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+|+.+++.+.|+|+ ++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~ 77 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGV 77 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEE
Confidence 345789999999999999999998653 35679999886422 344567889999999988887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY--------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~ 232 (264)
+......++||||+ +++|.+++.+... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 99999999999999 8999999975321 23577889999999999999999999999999999999999999
Q ss_pred EEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 233 VKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 233 v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
++|+|||++...... ..++..|||||.+.
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 999999998753221 12356799999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=206.18 Aligned_cols=164 Identities=24% Similarity=0.333 Sum_probs=144.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..+|++.++||.|+||.||+|.+.. +..+++|++..... ..+.+.+|+.+++.++|+++ +++++++.+....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL-----ISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcch-----hheeeeEecCCCeE
Confidence 3569999999999999999999887 88899999875543 56778899999999998887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS 248 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~ 248 (264)
+||||+ +++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999 8899999987655678999999999999999999999999999999999999999999999999987543221
Q ss_pred ------ccceeeeeceeE
Q 024661 249 ------FQTFLSMASRVY 260 (264)
Q Consensus 249 ------~~~~~y~ape~~ 260 (264)
.++..|++||.+
T Consensus 159 ~~~~~~~~~~~~~~PE~~ 176 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAA 176 (261)
T ss_pred ccccCCCCceEecCHHHH
Confidence 245679999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=201.32 Aligned_cols=157 Identities=39% Similarity=0.671 Sum_probs=142.2
Q ss_pred CCCCCCCceEEeeCCccC-CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccC---
Q 024661 74 RPDDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149 (264)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~--- 149 (264)
......+..++.+|+.+. +||.+.++||+|.|++||+|.|....+.||+|+++......+....||.+|+++....
T Consensus 59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~ 138 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPND 138 (590)
T ss_pred hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCC
Confidence 344455678999999999 9999999999999999999999999999999999988888999999999999997644
Q ss_pred CCCcceEEEceeeee----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCC
Q 024661 150 IGGTRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPEN 224 (264)
Q Consensus 150 ~~~~~~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~N 224 (264)
.....+|++++.|.. ..++|+|+|++|.+|..+|.....+.++...++.|++||+.||.||| ++||||.||||+|
T Consensus 139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 334678999999976 46899999999999999999988889999999999999999999999 5799999999999
Q ss_pred EEeecC
Q 024661 225 ILLVSA 230 (264)
Q Consensus 225 ili~~~ 230 (264)
||+..+
T Consensus 219 vLl~~~ 224 (590)
T KOG1290|consen 219 VLLCST 224 (590)
T ss_pred eeeecc
Confidence 999765
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=200.41 Aligned_cols=165 Identities=24% Similarity=0.352 Sum_probs=142.0
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-CCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~ 168 (264)
.|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+++++.++|+++ +.+.+.+.. +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-----VAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeecCCCCEE
Confidence 4899999999999999999999999999999987432 344567889999999999887 888887764 5578
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|++||++ +++|.+++.......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999 89999999875545689999999999999999999999999999999999999999999999999865321
Q ss_pred -----CcccceeeeeceeEee
Q 024661 247 -----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred CCccccccCCcCccChhHhcC
Confidence 2346778999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=205.80 Aligned_cols=165 Identities=23% Similarity=0.324 Sum_probs=140.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCC-----cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
++|++.+.||+|+||.||+|.+...+ ..+++|.++.. ......+.+|+.+++.+.|+++ +.+++++.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI-----VCLLGVCTK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCccc-----ceEEEEEcC
Confidence 46899999999999999999976554 67999988643 2345678899999999999888 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
....|++|||+ +++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999 8999999976421 35788999999999999999999999999999999999999
Q ss_pred CCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 230 AEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
++.++|+|||++..... ...++..|||||.+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL 199 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence 99999999999875322 223466799999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=204.87 Aligned_cols=165 Identities=22% Similarity=0.323 Sum_probs=138.5
Q ss_pred CCeEEEeecccCccEEEEEEEeC----CCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
+.|++.+.||+|+||.||+|... .++..+++|.+.... .....+.+|+.+++.++|+|+ +++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI-----VCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCe-----eeEEEEEecC
Confidence 46899999999999999999853 356789999886422 334577889999999999887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNS---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
...|++|||+ +++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999 899999986321 124788889999999999999999999999999999999999
Q ss_pred CCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 230 AEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
++.++|+|||+++.... ...++..|+|||.+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence 99999999999975322 223456799999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=211.53 Aligned_cols=165 Identities=23% Similarity=0.329 Sum_probs=141.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.+. ......+.+|+.+++.++|+|+ ++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 87 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI-----IGLLNVFTPQ 87 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCC-----cceeeeeccC
Confidence 4568899999999999999999999999999999998642 2334567789999999999988 8888887543
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
...|+||||+.++|.+.+.. .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 88 KSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999998899988864 38899999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC-----cccceeeeeceeEee
Q 024661 240 VPSPRHAF-----SFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~~-----~~~~~~y~ape~~~~ 262 (264)
++...... ..++..|+|||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhC
Confidence 99764432 236778999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=202.24 Aligned_cols=167 Identities=23% Similarity=0.278 Sum_probs=144.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.+.||+|+||.||+|.+. .+..+++|.+.........+.+|+.+++.+.|+++ +++++++......
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL-----VQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCE-----eeeeeeeecCCce
Confidence 34578999999999999999999975 45779999988666666788999999999998887 9999999998999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
+++||++ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999 899999998765557899999999999999999999999999999999999999999999999998764421
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
...+..|++||.+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~ 177 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAAN 177 (261)
T ss_pred hhhhhhccCCCccccCHHHhc
Confidence 12345699999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=204.40 Aligned_cols=167 Identities=24% Similarity=0.363 Sum_probs=144.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee----
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~---- 164 (264)
..+.|++.+.||.|+||.||+|.+..+++.+++|++.........+..|+.+++.+ .|+|+ +++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI-----ATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcE-----EEEeeehhccccc
Confidence 34679999999999999999999999999999999876665666788899999998 46666 999988853
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...+|++|||+ +++|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 56899999999 889999998765556889999999999999999999999999999999999999999999999998
Q ss_pred CcCC------CCcccceeeeeceeEe
Q 024661 242 SPRH------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~------~~~~~~~~y~ape~~~ 261 (264)
.... ....++..|+|||.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcC
Confidence 6532 2234778899999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=202.92 Aligned_cols=163 Identities=23% Similarity=0.309 Sum_probs=140.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||+|.+.. +..+|+|.++......+.+.+|+.+++.+.|+++ +++++++.....+|++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL-----VQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCe-----eeEEEEEccCCCcEEE
Confidence 469999999999999999998754 4459999887655555678899999999998887 9999999998999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+......
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999 889999998654 26899999999999999999999999999999999999999999999999998753321
Q ss_pred ----cccceeeeeceeEe
Q 024661 248 ----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ----~~~~~~y~ape~~~ 261 (264)
..++..|++||.+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred ecCCCccChhhCCHHHHh
Confidence 12345699999764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=204.60 Aligned_cols=162 Identities=27% Similarity=0.374 Sum_probs=143.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.+|++.+.||.|++|.||+|.+..+++.+++|.+.... ...+.+.+|+.+++.++|+|+ +.+++.+...+.+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI-----VNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCce-----eeeeeeEecCceEEE
Confidence 56999999999999999999999999999999886432 335677889999999999887 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999 99999988754 589999999999999999999999999999999999999999999999999875432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~ 188 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVT 188 (296)
T ss_pred cCCCcCCCccccCcchhc
Confidence 224677899999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=204.38 Aligned_cols=165 Identities=25% Similarity=0.416 Sum_probs=141.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|+++++.+.|+++ +++++++.+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-----VRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCE-----eeEEEEEecCCeE
Confidence 46999999999999999999999999999999886432 234567889999999999887 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||++++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999999889999887655445788999999999999999999999999999999999995 56799999999865321
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~ 176 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILL 176 (294)
T ss_pred ccccccCceeecccCHHHHh
Confidence 223567899999764
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=203.13 Aligned_cols=164 Identities=23% Similarity=0.344 Sum_probs=137.5
Q ss_pred CCeEEEeecccCccEEEEEEEe----CCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 92 PRYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
.+|++.+.||+|+||.||+|.. ..+++.|++|.+.... ...+.+.+|+++++.++|+|+ +++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEccCC
Confidence 4699999999999999999974 4568899999987433 345678899999999999888 888887643
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...+++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 45789999999 899999997643 3589999999999999999999999999999999999999999999999999986
Q ss_pred CCCC---------cccceeeeeceeEe
Q 024661 244 RHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~---------~~~~~~y~ape~~~ 261 (264)
.... ...+..|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLT 184 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhc
Confidence 4321 12334699999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=218.16 Aligned_cols=151 Identities=25% Similarity=0.357 Sum_probs=135.9
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (264)
++.||+|+.|.||+|+.. ++.||||.++. .-..+|.-|++|+|+|| +.|.++|.....+|||||||
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NI-----I~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNI-----ITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcce-----eeEeeeecCCceeEEeeeccc
Confidence 678999999999999876 77899997652 22347889999999998 99999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----Cccc
Q 024661 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-----FSFQ 250 (264)
Q Consensus 176 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-----~~~~ 250 (264)
.|.|...|+... .++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.+..... ..+|
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhh
Confidence 999999999876 899999999999999999999999999999999999999999999999999876443 5579
Q ss_pred ceeeeeceeEee
Q 024661 251 TFLSMASRVYIC 262 (264)
Q Consensus 251 ~~~y~ape~~~~ 262 (264)
|..|||||+++.
T Consensus 274 TVaWMAPEvIrn 285 (904)
T KOG4721|consen 274 TVAWMAPEVIRN 285 (904)
T ss_pred hHhhhCHHHhhc
Confidence 999999999863
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=203.55 Aligned_cols=162 Identities=23% Similarity=0.365 Sum_probs=144.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+|++.+.||.|+||.||+|.+..+++.+++|++.+.. ...+.+.+|++++++++|+|+ +.+++.+......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL-----VNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCCh-----HHHHHhhcCCCeE
Confidence 4899999999999999999999999999999997532 345678899999999999988 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
|+||||+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999 999999998763 6899999999999999999999999999999999999999999999999998764432
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|++||.+.
T Consensus 154 ~~~~~~~~~~~y~~PE~~~ 172 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLC 172 (258)
T ss_pred ccccccCCChhhcCHHHHc
Confidence 34677899999764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=211.47 Aligned_cols=166 Identities=20% Similarity=0.283 Sum_probs=136.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~ 162 (264)
.++|++.+.||.|+||.||+|.+.. +++.||+|+++.. ....+.+..|+.+++++ .|+|+ +.+++++
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~ni-----v~~~~~~ 80 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV-----VNLLGAC 80 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcch-----hheeeeE
Confidence 3579999999999999999997543 4578999988742 23345677899999999 67777 9999877
Q ss_pred ee-CCEEEEEEecC-CCCHHHHHHhcCC----------------------------------------------------
Q 024661 163 DY-RNHICIVFEKL-GPSLYDFLRKNSY---------------------------------------------------- 188 (264)
Q Consensus 163 ~~-~~~~~lv~e~~-~~~L~~~l~~~~~---------------------------------------------------- 188 (264)
.. +..++++|||+ +++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 56789999999 9999999864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--------Cccccee
Q 024661 189 -------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFL 253 (264)
Q Consensus 189 -------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~ 253 (264)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ...++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578899999999999999999999999999999999999999999999999976421 1223567
Q ss_pred eeeceeEe
Q 024661 254 SMASRVYI 261 (264)
Q Consensus 254 y~ape~~~ 261 (264)
|||||++.
T Consensus 241 y~aPE~~~ 248 (337)
T cd05054 241 WMAPESIF 248 (337)
T ss_pred ccCcHHhc
Confidence 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=188.60 Aligned_cols=165 Identities=21% Similarity=0.322 Sum_probs=138.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+...-+..||+|++|.|=+.++..+|..+|+|.+.. ..+...+..+|+++..+.... ++.|.|++.+..+..+|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~C----Pf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDC----PFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCC----CeEEEeehhhhccccEE
Confidence 445567889999999999999999999999999873 345556777788776654432 67799999999999999
Q ss_pred EEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 170 IVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+.||.|..+|..+-.. ..+..++|..+-+|+..++.||.|||++ .++|||+||+||||+.+|+||+||||++-....
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999999999877653 2345799999999999999999999976 899999999999999999999999999976544
Q ss_pred C-----cccceeeeeceeE
Q 024661 247 F-----SFQTFLSMASRVY 260 (264)
Q Consensus 247 ~-----~~~~~~y~ape~~ 260 (264)
+ ..|-..|||||.+
T Consensus 202 SiAkt~daGCkpYmaPEri 220 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERI 220 (282)
T ss_pred hhHHHHhcCCCccCChhhc
Confidence 3 4566789999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=204.82 Aligned_cols=166 Identities=22% Similarity=0.384 Sum_probs=140.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCC----cEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..|++..+||+|.||.||+|..+.++ +.+|||.++.+ ........+|+.+++.++|+|+ +.+..+|-.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nv-----i~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNV-----ISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcc-----hhHHHHHhc
Confidence 45999999999999999999665543 26899988743 2456778899999999999998 777777766
Q ss_pred -CCEEEEEEecCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC----CcEEec
Q 024661 165 -RNHICIVFEKLGPSLYDFLRKN---SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA----EYVKVP 236 (264)
Q Consensus 165 -~~~~~lv~e~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~----~~v~l~ 236 (264)
+..+++++||...+|+++++-+ ....++...+..|+.||+.|+.|||++.|+||||||.|||+..+ |.|||+
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 8899999999999999999733 22458889999999999999999999999999999999999987 899999
Q ss_pred cCCCCCcCCC---------CcccceeeeeceeEee
Q 024661 237 DYKVPSPRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 237 Dfg~a~~~~~---------~~~~~~~y~ape~~~~ 262 (264)
|||+++..+. ...-|.+|.|||++++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 9999987432 2246889999999876
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=211.24 Aligned_cols=164 Identities=26% Similarity=0.436 Sum_probs=140.1
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 165 (264)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~ 77 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI-----IGILDIIRPPSF 77 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCc-----Cchhheeecccc
Confidence 457899999999999999999999999999999998632 2345667889999999999888 7777765543
Q ss_pred ---CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 166 ---NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 166 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
...|+++|+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 468999999988999888653 59999999999999999999999999999999999999999999999999986
Q ss_pred cCCC---------CcccceeeeeceeEe
Q 024661 243 PRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~---------~~~~~~~y~ape~~~ 261 (264)
.... ...++..|||||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhh
Confidence 5322 124677899999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=200.52 Aligned_cols=165 Identities=24% Similarity=0.328 Sum_probs=143.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||.|+||.||+|.+..+++.+++|.++.. ....+.+.+|+++++.+.|+++ +.+++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i-----~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV-----IKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCe-----eeeeeeeecCCe
Confidence 5799999999999999999999999999999988632 2345678899999999999887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+++|||+ +++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999 89999998753 2245899999999999999999999999999999999999999999999999998653
Q ss_pred CC------CcccceeeeeceeEe
Q 024661 245 HA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~------~~~~~~~y~ape~~~ 261 (264)
.. ...++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~y~apE~~~ 179 (267)
T cd08224 157 SSKTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred cCCCcccceecCCccccCHHHhc
Confidence 32 224677899999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=206.20 Aligned_cols=166 Identities=19% Similarity=0.307 Sum_probs=138.4
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-------CCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEce
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~ 160 (264)
.++|.+.+.||+|+||.||+|.+.. ....+|+|.++.. ......+.+|+.+++.+ .|+++ +++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~ 91 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG 91 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCE-----eeEEE
Confidence 4679999999999999999998643 2346999988743 23345678899999998 67777 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Ni 225 (264)
++...+..|+||||+ +++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999 8999999986421 2478889999999999999999999999999999999
Q ss_pred EeecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 226 LLVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 226 li~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
+++.++.++|+|||++...... ...+..|||||.+.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc
Confidence 9999999999999998754321 12335799999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=202.19 Aligned_cols=166 Identities=23% Similarity=0.331 Sum_probs=141.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.++||+|+||.||+|... +++.+++|.+.........+.+|+.+++.++|+++ +.+++++. .+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRL-----VRLYAVVT-QEPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCe-----eeEEEEEc-cCCc
Confidence 34577999999999999999999864 56789999988666556788899999999999887 88888764 4678
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
+++||++ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999 899999998765557899999999999999999999999999999999999999999999999998754421
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
..++..|++||++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred CcccccCCcccccccCHHHhc
Confidence 12345799999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=237.20 Aligned_cols=167 Identities=28% Similarity=0.348 Sum_probs=148.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+.-+|....+||.|.||.||.|....+|+..|+|-++- .......+.+|+.++..+.|+|+ |+++++-.+.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNl-----V~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNL-----VRYYGVEVHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccc-----cccCceeecHH
Confidence 33468888999999999999999999999999997763 23455678899999999999999 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.++|.|||| +|+|.+++.... ..++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|....
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999 999999998764 67888889999999999999999999999999999999999999999999998754
Q ss_pred CCc----------ccceeeeeceeEeec
Q 024661 246 AFS----------FQTFLSMASRVYICI 263 (264)
Q Consensus 246 ~~~----------~~~~~y~ape~~~~~ 263 (264)
... .||+.|||||++.+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhccc
Confidence 422 589999999998764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=196.06 Aligned_cols=163 Identities=21% Similarity=0.336 Sum_probs=138.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
..+.+..||+|+-|.||+++.+.+|..+|||...+. +.+.+++.+.++++...... ++||+.+++|..+..+++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dc----pyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDC----PYIVQCFGYFITNTDVFI 168 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCC----CeeeeeeeEEeeCchHHH
Confidence 355677899999999999999999999999998753 34556777777776654322 667999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCc-----C
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSP-----R 244 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~-----~ 244 (264)
.||.|..-+..+++..+ .+++|..+-.+...++.||.||.+ +||+|||+||+|||+|+.|++||||||++-. .
T Consensus 169 cMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 99999777777777655 479999999999999999999985 5899999999999999999999999999854 4
Q ss_pred CCCcccceeeeeceeE
Q 024661 245 HAFSFQTFLSMASRVY 260 (264)
Q Consensus 245 ~~~~~~~~~y~ape~~ 260 (264)
+..+.|-..|||||-+
T Consensus 248 htrsAGC~~YMaPERi 263 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERI 263 (391)
T ss_pred cccccCCccccCcccc
Confidence 5566788899999965
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=201.52 Aligned_cols=164 Identities=23% Similarity=0.329 Sum_probs=138.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.++|.+.++||+|++|.||+|.+..++ .+++|.+.......+.+.+|+.+++.+.|+++ +.+++++. .+..|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKL-----VPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCe-----eeEEEEEc-CCCcEE
Confidence 467999999999999999999876654 58999887655556778899999999999887 88888775 456899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC--
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF-- 247 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~-- 247 (264)
+|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999 789999998765456899999999999999999999999999999999999999999999999999754321
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|++||...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 158 TARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred cccCCCccchhhCCHHHhc
Confidence 12345699999653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=200.88 Aligned_cols=164 Identities=22% Similarity=0.292 Sum_probs=140.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++.+.||+|+||.||+|.+..+ ...+++|.++.. ......+.+|+.+++.++|+++ +++++.+...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI-----IRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCc-----ceEeEEEecCC
Confidence 5699999999999999999998644 457999988643 3345678889999999999888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..+++|||+ +++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999 889999998654 368999999999999999999999999999999999999999999999999998653
Q ss_pred C--------CcccceeeeeceeEe
Q 024661 246 A--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--------~~~~~~~y~ape~~~ 261 (264)
. ....+..|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~ 181 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIA 181 (266)
T ss_pred ccccceeccCCCCCccccChhhhc
Confidence 1 112345699999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=206.31 Aligned_cols=164 Identities=26% Similarity=0.388 Sum_probs=142.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--C
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~--~ 166 (264)
+.|++.+.||.|+||.||+|.+..+++.+++|.++... .....+.+|+.+++.+.|+|+ +.+++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI-----VTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCE-----EEEEEEEEecCCC
Confidence 46999999999999999999999999999999987432 223356789999999998887 9999988877 8
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
..|+||||++++|.+++.... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999999999879999988654 3689999999999999999999999999999999999999999999999999875433
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred CccccccccccccccCchhhc
Confidence 234677899999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=203.78 Aligned_cols=165 Identities=28% Similarity=0.472 Sum_probs=143.9
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.|++.+.||.|++|.||+|++..+++.+++|.+.... .....+.+|+++++.++|+|+ +++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCC-----cchhhhcccCCcEE
Confidence 3889999999999999999999999999999886432 233567889999999999988 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||+.++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 99999977999998876556789999999999999999999999999999999999999999999999999865322
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||.+.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred ccccccccccccCCeEEec
Confidence 1235678999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=203.63 Aligned_cols=168 Identities=18% Similarity=0.281 Sum_probs=138.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
..++|++.+.||+|+||.||+|..+. .+..+|+|.+.... .....+.+|+.+++.+.|+++ +++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~ 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV-----VRLLGVV 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEE
Confidence 45789999999999999999997642 24579999876432 234467789999999998887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
.+.+..|+||||+ +++|.+++.... ...++...+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 9999999999999 999999997532 1234677889999999999999999999999999999999999999
Q ss_pred EeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 234 KVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 234 ~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
+|+|||+++.... ...++..|++||.+.+
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 195 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence 9999999875322 1123567999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=202.99 Aligned_cols=165 Identities=25% Similarity=0.315 Sum_probs=143.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|++|.||+|.+..+++.+++|.+... ......+.+|+.+++.+.|+|+ +++++++..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCch-----hhhhheeEeCCe
Confidence 4688999999999999999999999999999987642 2344677889999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+++||++ +++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999 88999998742 2246899999999999999999999999999999999999999999999999988654
Q ss_pred CC------CcccceeeeeceeEe
Q 024661 245 HA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~------~~~~~~~y~ape~~~ 261 (264)
.. ...++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred ccCCcccccccCCcCccCHHHhc
Confidence 32 235777899999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=202.18 Aligned_cols=162 Identities=25% Similarity=0.357 Sum_probs=141.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
+|+..+.||+|++|.||++.+..+++.+++|++.... ...+.+.+|+.+++.++|+++ +++++.+.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI-----IRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCce-----ehhhceeccC
Confidence 4788899999999999999999999999999986422 235678899999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCc
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSP 243 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~ 243 (264)
+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999 899999998755 789999999999999999999999999999999999998776 699999999865
Q ss_pred CCC----------CcccceeeeeceeEe
Q 024661 244 RHA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~----------~~~~~~~y~ape~~~ 261 (264)
... ...++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 181 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLR 181 (268)
T ss_pred cccccccCCccccccccccceeCHhHhc
Confidence 432 224677899999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=203.49 Aligned_cols=163 Identities=23% Similarity=0.341 Sum_probs=138.1
Q ss_pred CeEEEeecccCccEEEEEEEe----CCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-
Q 024661 93 RYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~- 165 (264)
-|++.+.||+|+||.||+|.. ..++..+++|.++.. ......+.+|+.+++.+.|+|+ +++.+++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEecCC
Confidence 378999999999999999984 456788999998633 3345678899999999999887 8898888774
Q ss_pred -CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 166 -NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 166 -~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 6789999999 999999997653 3589999999999999999999999999999999999999999999999999875
Q ss_pred CCC---------CcccceeeeeceeEe
Q 024661 244 RHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~---------~~~~~~~y~ape~~~ 261 (264)
... ...++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhc
Confidence 432 223455799999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=205.60 Aligned_cols=165 Identities=21% Similarity=0.308 Sum_probs=137.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcE--EEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++.+.||+|+||.||+|.+..++.. +++|.++.. ......+.+|++++.++ .|+++ +++++++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~i-----v~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEEECCCC
Confidence 4699999999999999999998877754 566665532 33456778899999999 78877 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.+|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999 899999997542 12578999999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCCC-----cccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~~-----~~~~~~y~ape~~~ 261 (264)
.++|+|||++...... ...+..|+|||.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 196 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence 9999999998643211 12345699999753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=206.91 Aligned_cols=165 Identities=25% Similarity=0.386 Sum_probs=141.2
Q ss_pred CeEEEeecccCccEEEEEEEeCC--CCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-
Q 024661 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~- 165 (264)
+|++.++||+|+||.||+|.+.. +++.+|+|.+... ....+...+|+.+++.++|+++ +++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV-----VSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCc-----cceEEEEeCCC
Confidence 58999999999999999999988 7899999998752 2334667889999999999988 9999999888
Q ss_pred -CEEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec----CCcEEecc
Q 024661 166 -NHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS----AEYVKVPD 237 (264)
Q Consensus 166 -~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~----~~~v~l~D 237 (264)
..+|+|||+++++|.+++.... ...+++..++.++.||+.||.|||+.+|+|+||||+||+++. ++.+||+|
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 8899999999888888876432 236899999999999999999999999999999999999999 89999999
Q ss_pred CCCCCcCCC---------CcccceeeeeceeEee
Q 024661 238 YKVPSPRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~~---------~~~~~~~y~ape~~~~ 262 (264)
||++..... ...++..|+|||++.+
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhC
Confidence 999875422 1235678999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=200.96 Aligned_cols=164 Identities=22% Similarity=0.313 Sum_probs=140.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCc---EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+.|++.+.||+|+||.||+|.+..+++ .|++|.+... ......+..|+.+++.+.|+|+ +++.+++.++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCc-----ceEEEEECCCC
Confidence 458999999999999999999877654 5999988743 3445688999999999999988 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999 889999988654 368999999999999999999999999999999999999999999999999986533
Q ss_pred CCc--------c---cceeeeeceeEe
Q 024661 246 AFS--------F---QTFLSMASRVYI 261 (264)
Q Consensus 246 ~~~--------~---~~~~y~ape~~~ 261 (264)
... . .+..|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIA 184 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhc
Confidence 211 1 134699999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=204.28 Aligned_cols=165 Identities=23% Similarity=0.399 Sum_probs=140.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCC----------------cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCc
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKK----------------ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGT 153 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~ 153 (264)
++|++.+.||+|+||.||+|.+...+ ..+++|.+... ....+.+.+|+++++.+.|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--- 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI--- 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE---
Confidence 57999999999999999999876543 45799988743 2445678899999999999887
Q ss_pred ceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024661 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (264)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 223 (264)
+++++++..+...+++||++ +++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+
T Consensus 82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 --ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred --eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999 899999997643 125889999999999999999999999999999999
Q ss_pred CEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 224 NILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 224 Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
||+++.++.++|+|||++..... ...++..|||||.+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence 99999999999999999875322 122456799999754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=210.09 Aligned_cols=166 Identities=21% Similarity=0.285 Sum_probs=135.1
Q ss_pred CCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~ 163 (264)
++|++.+.||.|+||.||+|.+. .+++.||+|+++.. ......+.+|+.++.++. |+|+ +++++++.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~ 81 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGACT 81 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccH-----hhhcceee
Confidence 67999999999999999999853 45788999998743 234457888999999994 5666 89988775
Q ss_pred e-CCEEEEEEecC-CCCHHHHHHhcC------------------------------------------------------
Q 024661 164 Y-RNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------ 187 (264)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------ 187 (264)
. ...++++|||+ +|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 45789999999 999999987532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--------Cc
Q 024661 188 -----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--------FS 248 (264)
Q Consensus 188 -----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--------~~ 248 (264)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01367788899999999999999999999999999999999999999999999875321 11
Q ss_pred ccceeeeeceeEee
Q 024661 249 FQTFLSMASRVYIC 262 (264)
Q Consensus 249 ~~~~~y~ape~~~~ 262 (264)
.++..||+||.+.+
T Consensus 242 ~~~~~y~aPE~~~~ 255 (343)
T cd05103 242 RLPLKWMAPETIFD 255 (343)
T ss_pred CCCcceECcHHhcC
Confidence 23456999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=202.00 Aligned_cols=165 Identities=22% Similarity=0.328 Sum_probs=139.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..++|++.++||+|+||.||+|.+. .+..+++|.+.......+.+.+|+.+++.++|+++ +.+++++. ....|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL-----VQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCce-----EEEEeEEC-CCCcE
Confidence 3467999999999999999999865 45669999987655556778999999999999887 88888775 45689
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS 248 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~ 248 (264)
++|||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999 8999999987554568999999999999999999999999999999999999999999999999987533211
Q ss_pred -------ccceeeeeceeEe
Q 024661 249 -------FQTFLSMASRVYI 261 (264)
Q Consensus 249 -------~~~~~y~ape~~~ 261 (264)
.++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~ 176 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred cccccCCCCCccccChHHHh
Confidence 2345699999753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=198.94 Aligned_cols=163 Identities=21% Similarity=0.270 Sum_probs=143.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||.|+||.||+|... ++.+++|.+.......+.+.+|+.+++.+.|+++ +++++++.+.+..++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNL-----VQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcce-----eeeEEEEcCCCCeEEE
Confidence 56899999999999999999875 7889999998665556788999999999999887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
||++ +++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~ 158 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS 158 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccccc
Confidence 9999 789999998765446899999999999999999999999999999999999999999999999998765322
Q ss_pred cccceeeeeceeEe
Q 024661 248 SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ~~~~~~y~ape~~~ 261 (264)
...+..|+|||.+.
T Consensus 159 ~~~~~~~~ape~~~ 172 (256)
T cd05039 159 GKLPVKWTAPEALR 172 (256)
T ss_pred CCCcccccCchhhc
Confidence 12345699999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=202.06 Aligned_cols=165 Identities=18% Similarity=0.322 Sum_probs=137.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHH-HHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~-l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... .....+..|+.. ++.+.|+|+ +++++++..++.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----v~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT-----VTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCe-----eeeeEEEecCCcE
Confidence 36999999999999999999999999999999987532 223445556654 455566766 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 169 CIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
|++|||+.++|.+++... ....+++..++.++.||+.||+|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999988998888642 224689999999999999999999997 99999999999999999999999999987543
Q ss_pred C-----CcccceeeeeceeEe
Q 024661 246 A-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~-----~~~~~~~y~ape~~~ 261 (264)
. ...++..|++||.+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERIN 176 (283)
T ss_pred cccccccccCCccccChhhcC
Confidence 2 234677899999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=204.85 Aligned_cols=165 Identities=21% Similarity=0.341 Sum_probs=143.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++++.||+|+||.||+|.+..++..+++|.+... ......+.+|+++++.+.|+|+ +++++.+...+.+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI-----VDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcH-----HhhhhheecCCeEE
Confidence 3688999999999999999999999999999988642 2334678889999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999 889999887642 2368999999999999999999997 599999999999999999999999999986532
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIK 174 (286)
T ss_pred CccccCCCccCccCcchhc
Confidence 2334677899999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=202.88 Aligned_cols=166 Identities=20% Similarity=0.311 Sum_probs=140.6
Q ss_pred CCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+|.+.+.||+|+||.||++.+. .++..+++|.+... ....+.+.+|+++++.+.|+++ +++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecC
Confidence 46999999999999999999853 34567899988643 3445678899999999999988 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
+.+|+||||+ +++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999 899999997542 1248999999999999999999999999999999999999999999
Q ss_pred EeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 234 KVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 234 ~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
+|+|||++..... ...++..|+|||.+.+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 9999999875422 1223567999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=204.82 Aligned_cols=165 Identities=23% Similarity=0.373 Sum_probs=138.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC--------------CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcce
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK--------------KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRC 155 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~ 155 (264)
++|++.+.||+|+||.||+|.+..+ ...||+|.++.. ....+.+.+|+++++.+.|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i----- 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNI----- 79 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCc-----
Confidence 5799999999999999999987543 235899988643 3345678899999999999888
Q ss_pred EEEceeeeeCCEEEEEEecC-CCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNS----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 156 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
+++++++...+..++||||+ +++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999 899999986532 1136788899999999999999999999999999999
Q ss_pred EEeecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 225 ILLVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
|+++.++.+||+|||++...... ..++..|+|||++.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 99999999999999998754321 12356799999764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=199.05 Aligned_cols=164 Identities=28% Similarity=0.385 Sum_probs=141.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech------hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+|++.+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+.+++.++|+++ +++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI-----VQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEEcC
Confidence 4699999999999999999999999999999987521 2344578889999999999888 8999888663
Q ss_pred --CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 166 --NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 166 --~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+.++++||++ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 5789999999 889999998754 58899999999999999999999999999999999999999999999999997
Q ss_pred cCCC---------CcccceeeeeceeEee
Q 024661 243 PRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~---------~~~~~~~y~ape~~~~ 262 (264)
.... ...++..|++||.+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcC
Confidence 5422 1246778999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=210.15 Aligned_cols=167 Identities=25% Similarity=0.348 Sum_probs=143.2
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
+--.++..+.++||+|.||.|.+|.-. .+..||+|.++.. ...+..|.+|+++|.+|+|||+ +.+++.|..+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNI-----veLvGVC~~D 607 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNI-----VELLGVCVQD 607 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCe-----eEEEeeeecC
Confidence 344467889999999999999999854 3688999999843 3456899999999999999998 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+++||+ .|+|.+++..+.......+....|+.||+.||+||.+.++|||||.++|+|++.++++||+|||+++..
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 9999999999 999999999886445566677889999999999999999999999999999999999999999999864
Q ss_pred CCCcc--------cceeeeeceeE
Q 024661 245 HAFSF--------QTFLSMASRVY 260 (264)
Q Consensus 245 ~~~~~--------~~~~y~ape~~ 260 (264)
-...+ -...|||+|.+
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsi 711 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESI 711 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHH
Confidence 33221 12469999964
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=198.17 Aligned_cols=164 Identities=24% Similarity=0.385 Sum_probs=144.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||+|+||.+|++.+..+++.+++|.+... ......+.+|+.+++.++|+++ +++.+++...+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI-----VQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCe-----eeeEeeecCCCeEE
Confidence 589999999999999999999999999999998743 2345678899999999999887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
+||||+ +++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999 899999998755456899999999999999999999999999999999999999999999999998754332
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|++||++.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~ 174 (256)
T cd08218 156 ELARTCIGTPYYLSPEICE 174 (256)
T ss_pred hhhhhccCCccccCHHHhC
Confidence 23667899999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=201.63 Aligned_cols=162 Identities=28% Similarity=0.382 Sum_probs=141.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----------hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
+|.+...||.|++|.||+|.+..+++.+++|.+.... ...+.+.+|+.+++.++|+++ +++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENI-----VQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEE
Confidence 4788899999999999999998889999999886321 223567889999999999888 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...+..+++|||+ +++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999 889999998764 6899999999999999999999999999999999999999999999999998
Q ss_pred CcCCC------------CcccceeeeeceeEe
Q 024661 242 SPRHA------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~------------~~~~~~~y~ape~~~ 261 (264)
..... ...++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 185 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhc
Confidence 76542 123567799999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=200.96 Aligned_cols=168 Identities=26% Similarity=0.382 Sum_probs=143.1
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC--
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR-- 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~-- 165 (264)
...++|.+.+.||+|+||.||+|.+..+++.+++|++.........+.+|+.+++.+ +|+|+ +++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni-----~~~~~~~~~~~~ 93 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV-----VKFYGMFYKADK 93 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEEeccc
Confidence 456789999999999999999999999999999999876544556778899999988 67776 9999888653
Q ss_pred ---CEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ---NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ---~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
+.+|+||||+ +++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 4689999999 88999988642 22468999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC------CcccceeeeeceeEe
Q 024661 240 VPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|++||.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred cchhcccccccccCccCCccccChhhhc
Confidence 9875332 234677899999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=203.93 Aligned_cols=169 Identities=17% Similarity=0.262 Sum_probs=140.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeC-------CCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQI 158 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~ 158 (264)
...++|.+.+.||+|+||.||+|++. ..+..+++|.+... ......+.+|+.+++.+ .|+|+ +++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~ 86 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INL 86 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCc-----hhe
Confidence 34567999999999999999999753 23457999988643 33456788999999999 78887 999
Q ss_pred ceeeeeCCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024661 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (264)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 223 (264)
++++......|++|||+ +++|.+++.+.. ...+++..+..++.||+.||.|||++|++|+||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999 889999998642 124778889999999999999999999999999999
Q ss_pred CEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 224 NILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 224 Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
||+++.++.++|+|||+++.... ...++..|+|||++.+
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc
Confidence 99999999999999999875432 1224567999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=202.69 Aligned_cols=166 Identities=21% Similarity=0.331 Sum_probs=139.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~ 162 (264)
.++|++.+.||+|+||.||++.+... ...+++|.+... ......+.+|+++++.+ +|+|+ +++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~ 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLGVC 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEE
Confidence 36799999999999999999987643 367999988743 23345678899999999 68777 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili 227 (264)
..++.++++|||+ +++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999 89999999742 23468899999999999999999999999999999999999
Q ss_pred ecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 228 VSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 228 ~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
+.++.++|+|||++...... ..++..|+|||++.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 207 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence 99999999999999764321 12345699999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=201.96 Aligned_cols=162 Identities=24% Similarity=0.365 Sum_probs=136.5
Q ss_pred CCe-EEEeecccCccEEEEEEEe----CCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRY-RILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
++| ++.+.||+|+||+||++.. ..++..+|+|.++... .....+.+|+++++.++|+++ +++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 77 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI-----VKYKGCCSE 77 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 456 9999999999999988753 3467889999987532 345677889999999999887 999988765
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...++++|||+ +++|.+++... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccc
Confidence 34689999999 89999999764 4899999999999999999999999999999999999999999999999998
Q ss_pred CcCCC---------CcccceeeeeceeEe
Q 024661 242 SPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~---------~~~~~~~y~ape~~~ 261 (264)
..... ...++..|++||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 76432 123456799999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=199.97 Aligned_cols=164 Identities=22% Similarity=0.284 Sum_probs=139.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCC---cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++.+.||+|+||.||+|.+..++ ..+++|.++.. ....+.+.+|+.+++.++|+|+ +++++++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence 56999999999999999999986544 36899988643 2345678889999999999888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999 889999998654 358999999999999999999999999999999999999999999999999987533
Q ss_pred CCc---------ccceeeeeceeEe
Q 024661 246 AFS---------FQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~~---------~~~~~y~ape~~~ 261 (264)
... ..+..|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~ 182 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIA 182 (267)
T ss_pred cccceeeecCCCccceeecCHhHhc
Confidence 211 1235699999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=203.57 Aligned_cols=165 Identities=21% Similarity=0.311 Sum_probs=140.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
++|.+.+.||+|+||.||+|.+.. +++.+++|.++... ...+.+.+|+++++.+.|+++ +.+++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI-----VKFYGVCTE 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCc-----hheeeEEec
Confidence 568999999999999999998743 35789999987532 245788999999999999888 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
....|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 99999999999 999999997542 13478889999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
.++|+|||++..... ....+..|+|||++.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhc
Confidence 999999999875322 122356799999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=211.63 Aligned_cols=165 Identities=22% Similarity=0.339 Sum_probs=137.8
Q ss_pred CCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~ 163 (264)
++|.+.++||+|+||.||+|++. .+++.||+|+++.. ....+.+.+|+.++..+. |+|+ +++++.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ni-----v~~~~~~~ 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNI-----VNLLGACT 111 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCe-----EEEEEEEc
Confidence 46888999999999999999864 34568999999743 233457889999999997 8877 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCC------------------------------------------------------
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSY------------------------------------------------------ 188 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~------------------------------------------------------ 188 (264)
..+..++||||+ +|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999 9999999975321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024661 189 ------------------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (264)
Q Consensus 189 ------------------------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nil 226 (264)
..+++..++.++.||+.||.|||+.+++||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 13567778899999999999999999999999999999
Q ss_pred eecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 227 LVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
++.++.++|+|||+++.... ...++..||+||.+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 99999999999999875321 223556799999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=203.93 Aligned_cols=167 Identities=23% Similarity=0.325 Sum_probs=141.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEcee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~ 161 (264)
..++|.+.+.||+|+||.||+|.+. .++..+|+|.++.. ....+.+.+|+.+++++ +|+|+ ++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 107 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI-----VNLLGA 107 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCc-----ceEEEE
Confidence 3367999999999999999999853 34567999988743 33456788999999999 68887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
+...+..|++|||+ +++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999 89999999865433489999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC--------CcccceeeeeceeEe
Q 024661 241 PSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+..... ...++..|+|||.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 216 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIF 216 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhc
Confidence 875322 122456799999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=208.27 Aligned_cols=165 Identities=22% Similarity=0.383 Sum_probs=142.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.+.|+|+ +++++.+...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV-----IGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----cceeeeecCC
Confidence 4678899999999999999999999999999999988642 2334567889999999999988 8888888654
Q ss_pred C------EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 N------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ~------~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
. .+++|||+++++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 3 46999999998999888753 58999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC---cccceeeeeceeEe
Q 024661 240 VPSPRHAF---SFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~~---~~~~~~y~ape~~~ 261 (264)
++...... ..++..|++||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (343)
T cd07880 164 LARQTDSEMTGYVVTRWYRAPEVIL 188 (343)
T ss_pred cccccccCccccccCCcccCHHHHh
Confidence 99765432 23577899999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=201.40 Aligned_cols=164 Identities=26% Similarity=0.441 Sum_probs=142.2
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+|++.+.||.|++|.||+|++..+|+.+++|.++... .....+.+|+.+++.++|+|+ +++++++.+.+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI-----VRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCE-----eeeeeeEeeCCcEEE
Confidence 4899999999999999999999999999999987432 234566789999999998887 999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+.++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 99999779999887543 23589999999999999999999999999999999999999999999999999864321
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~ 173 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLL 173 (284)
T ss_pred ccccccccccccChHHhc
Confidence 234577899999764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=198.20 Aligned_cols=166 Identities=24% Similarity=0.329 Sum_probs=141.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.++||+|+||.||++.+. .+..+++|.+.......+.+.+|+.+++.+.|+++ +++++.+.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~-~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVTK-EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCc-----ceEEEEEcC-CCe
Confidence 34578999999999999999999865 44569999887655556788899999999999988 888888877 788
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
+++|||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999 889999998765556888999999999999999999999999999999999999999999999998654321
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
..++..|++||++.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~ 176 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred CcccccCCcccccccCHhHhc
Confidence 12345699999764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=201.93 Aligned_cols=163 Identities=23% Similarity=0.361 Sum_probs=140.1
Q ss_pred CeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee
Q 024661 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~ 163 (264)
.|++.+.||.|+||.||+|.+. .+|+.||+|++.... ...+.+.+|+.+++.+. |+++ +.+++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCCh-----hceeeEee
Confidence 3889999999999999999875 468899999987432 23466788999999995 6666 88999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
.+..+|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999 899999998765 68899999999999999999999999999999999999999999999999987
Q ss_pred cCCC-------CcccceeeeeceeEee
Q 024661 243 PRHA-------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~-------~~~~~~~y~ape~~~~ 262 (264)
.... ...++..|++||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred ecccccccccccccCCcccCChhhccC
Confidence 6433 1236778999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=201.25 Aligned_cols=167 Identities=19% Similarity=0.297 Sum_probs=140.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
..++|++.+.||+|+||.||+|.+... +..+++|.+.... .....+.+|+.+++.+.|+++ +++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~ 78 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-----VRLLGVV 78 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEE
Confidence 346799999999999999999998644 3789999986432 334567889999999998887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
......|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 9999999999999 899999997532 1236788999999999999999999999999999999999999999
Q ss_pred EeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 234 KVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 234 ~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+|+|||+++.... ...++..|+|||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence 9999999875322 223466799999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=200.61 Aligned_cols=163 Identities=26% Similarity=0.383 Sum_probs=141.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----------hhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
+|.+.+.||.|+||.||+|.+..+++.+++|.++... ...+.+.+|+.+++.++|+++ ++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI-----VQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEE
Confidence 5889999999999999999999899999999875321 123467789999999999888 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
+...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999 999999998764 789999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC--------CcccceeeeeceeEee
Q 024661 241 PSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
+..... ...++..|++||.+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184 (272)
T ss_pred cccccccccccccccccCCccccCHHHhcc
Confidence 875432 1236678999997653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=205.90 Aligned_cols=160 Identities=23% Similarity=0.383 Sum_probs=131.3
Q ss_pred EeecccCccEEEEEEEeCC--CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CCEEEEEE
Q 024661 97 LSKMGEGTFGQVVECFDNE--KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVF 172 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~lv~ 172 (264)
..+||+|+||.||+|.+.. ++..+|+|.+.... ....+.+|+.+++.++|+|+ +++++++.. +..+|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNV-----IALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCe-----eeEEEEEeccCCCeEEEEE
Confidence 4689999999999999654 56789999886533 23457789999999999988 999988743 57889999
Q ss_pred ecCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe----ecCCcEEeccCCCC
Q 024661 173 EKLGPSLYDFLRKN-------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL----VSAEYVKVPDYKVP 241 (264)
Q Consensus 173 e~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili----~~~~~v~l~Dfg~a 241 (264)
||++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 99988999888632 12248899999999999999999999999999999999999 45679999999999
Q ss_pred CcCCC---------CcccceeeeeceeEee
Q 024661 242 SPRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 242 ~~~~~---------~~~~~~~y~ape~~~~ 262 (264)
+.... ...+|..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcC
Confidence 75432 1246788999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=200.92 Aligned_cols=159 Identities=19% Similarity=0.240 Sum_probs=130.2
Q ss_pred eecccCccEEEEEEEeCC--CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
++||+|+||.||+|.... ....+++|.+... ......+.+|+.+++.++|+|+ +++++.+.+...+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----i~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV-----LQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCc-----ceEEEEECCCCceEEEEE
Confidence 369999999999997533 3456888876532 2334567889999999999888 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 174 KL-GPSLYDFLRKNSY---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
|+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99 8999999986531 2346788899999999999999999999999999999999999999999999865322
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVE 175 (269)
T ss_pred eeccCCCCCcccccCHHHHh
Confidence 122455699999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=198.18 Aligned_cols=162 Identities=21% Similarity=0.320 Sum_probs=137.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceee-eeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~l 170 (264)
++|++.+.||+|+||.||++... +..+++|.++.. ...+.+.+|+.+++.+.|+++ +++++++ ...+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCe-----eeEEEEEEcCCCceEE
Confidence 46999999999999999999765 677999988643 335678899999999999887 8888865 45677999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+|||+ +++|.+++.......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 99999 88999999876545688999999999999999999999999999999999999999999999999876433
Q ss_pred CcccceeeeeceeEe
Q 024661 247 FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~~~~~~~y~ape~~~ 261 (264)
....+..|||||++.
T Consensus 158 ~~~~~~~y~aPE~~~ 172 (256)
T cd05082 158 TGKLPVKWTAPEALR 172 (256)
T ss_pred CCccceeecCHHHHc
Confidence 223455799999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=191.48 Aligned_cols=167 Identities=20% Similarity=0.196 Sum_probs=144.4
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-----
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~----- 164 (264)
.+||++.+.||+|+|+.||+++...+++.+|+|.+.-. ....+..++|++..+.++|+|+ ++++++...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~v-----l~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNV-----LRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcch-----HHHHHHHHHhhccC
Confidence 47899999999999999999999999999999988743 4667888999999999999988 777776533
Q ss_pred CCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEeccCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
....||+++|. .|+|.+.+... ++..+++..++.|+.+|++||++||+.. +.||||||.|||+.+++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 45699999999 99999999854 3446999999999999999999999998 9999999999999999999999999
Q ss_pred CCCcCCC---------------CcccceeeeeceeEee
Q 024661 240 VPSPRHA---------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~---------------~~~~~~~y~ape~~~~ 262 (264)
.++...- ...-|..|.|||++-|
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v 212 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV 212 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheec
Confidence 9976322 1124677999999865
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=202.34 Aligned_cols=165 Identities=30% Similarity=0.526 Sum_probs=141.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|++|.||+|.+..+++.|++|.++.. ....+.+.+|+++++.+.|+++ +++++++...+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI-----VNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCe-----eehhheEEECCEE
Confidence 4699999999999999999999999999999988643 2345678899999999998887 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
+++|||+++++.+.+.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9999999555555444332 36899999999999999999999999999999999999999999999999998764332
Q ss_pred ------cccceeeeeceeEee
Q 024661 248 ------SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 ------~~~~~~y~ape~~~~ 262 (264)
..++..|+|||++..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~ 175 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVG 175 (288)
T ss_pred cccccCcccccCCcCCchhcC
Confidence 235678999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=199.42 Aligned_cols=158 Identities=16% Similarity=0.253 Sum_probs=134.5
Q ss_pred eecccCccEEEEEEEeCCCC----------cEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 98 SKMGEGTFGQVVECFDNEKK----------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+.||+|+||.||+|.+..++ ..+++|.+.........+.+|+.+++.+.|+++ +.+++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL-----VKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcch-----hheeeEEec-CC
Confidence 46899999999999998766 357888776544436788899999999999888 899998877 77
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-------cEEeccCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-------YVKVPDYK 239 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-------~v~l~Dfg 239 (264)
.++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++ .++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 89999999 899999998754 2688999999999999999999999999999999999999888 89999999
Q ss_pred CCCcCCC--CcccceeeeeceeEee
Q 024661 240 VPSPRHA--FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~--~~~~~~~y~ape~~~~ 262 (264)
++..... ...++..|+|||.+.+
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRN 178 (259)
T ss_pred cccccccccccccCCCccChhhhcC
Confidence 9976443 3345667999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=205.66 Aligned_cols=168 Identities=18% Similarity=0.287 Sum_probs=139.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCC-------CcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEc
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIR 159 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~ 159 (264)
...+|++.+.||+|+||.||+|.+... +..+++|.++.. ....+.+.+|+.+++++ .|+|+ ++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~ 84 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNI-----INLL 84 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeee
Confidence 345799999999999999999986432 236899987743 33456788999999999 68887 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
+++...+.++++|||+ +++|.+++.... ...++...+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 9999999999999999 889999997532 1247788899999999999999999999999999999
Q ss_pred EEeecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEee
Q 024661 225 ILLVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYIC 262 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~~ 262 (264)
||++.++.++|+|||+++..... ..++..|||||++.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 99999999999999998754321 123457999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=198.01 Aligned_cols=163 Identities=27% Similarity=0.369 Sum_probs=144.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh---hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|.+.+.||+|+||.||+|.+..+++.+++|.++.... ..+.+.+|+++++.++|+++ +++++.+.+.+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL-----VKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCCh-----hheeeeEecCCEEE
Confidence 58999999999999999999998999999999875433 56788999999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+|+||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999 899999998754 588999999999999999999999999999999999999999999999999876432
Q ss_pred --------CcccceeeeeceeEee
Q 024661 247 --------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~~ 262 (264)
...++..|++||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred CcccccccCCcCCcCccChhhccC
Confidence 1235678999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=204.04 Aligned_cols=166 Identities=28% Similarity=0.391 Sum_probs=141.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 165 (264)
.++|++.+.||.|+||.||+|.+..+|+.||+|.++... .......+|+.+++.++|+++ +++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI-----VELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCC-----cceEEEEecCCC
Confidence 357999999999999999999999999999999987432 222345679999999999988 8999888764
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+.+++||||++++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 5789999999889999988643 468999999999999999999999999999999999999999999999999987643
Q ss_pred CC------cccceeeeeceeEee
Q 024661 246 AF------SFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~------~~~~~~y~ape~~~~ 262 (264)
.. ...+..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred CccCCCCcccccccccChhhhcC
Confidence 21 124667999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=198.19 Aligned_cols=163 Identities=28% Similarity=0.374 Sum_probs=140.2
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech------hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
.|++.+.||+|+||.||+|.+..++..+++|.+... ......+.+|+.+++.++|+|+ +.+++++.+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI-----VQYYGCLRDRA 77 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCe-----eeEEEEEEcCC
Confidence 588999999999999999999999999999988632 1234567889999999999888 999988865
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...++++||++ +++|.+++.... .+++..++.++.|++.||+|||+++|+|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 46789999999 889999998765 689999999999999999999999999999999999999999999999999864
Q ss_pred CCC---------CcccceeeeeceeEee
Q 024661 244 RHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~---------~~~~~~~y~ape~~~~ 262 (264)
... ...++..|+|||.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCC
Confidence 321 1236778999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=200.06 Aligned_cols=163 Identities=27% Similarity=0.465 Sum_probs=142.7
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--CEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NHI 168 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~--~~~ 168 (264)
|++.+.||.|++|.||+|.+..+++.+++|.+... ......+.+|+++++.+.|+++ +.+++++.+. +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI-----VRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCe-----eeheeeEecCCCCcE
Confidence 67889999999999999999999999999999754 2344567889999999998887 9999999888 899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
++||||+.++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9999999779999987653 36899999999999999999999999999999999999999999999999998764432
Q ss_pred ------cccceeeeeceeEee
Q 024661 248 ------SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 ------~~~~~~y~ape~~~~ 262 (264)
..++..|++||.+.+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred cccccccccccccCCceeeEc
Confidence 245677999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=201.95 Aligned_cols=165 Identities=30% Similarity=0.438 Sum_probs=138.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhc-cCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|.+..+++.|++|.+.... .....+.+|+.+++.+.| +++ +++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI-----VRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCc-----cceeeeEeecCC
Confidence 46999999999999999999999999999999876432 233567889999999965 666 889988877655
Q ss_pred -----EEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccC
Q 024661 168 -----ICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDY 238 (264)
Q Consensus 168 -----~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Df 238 (264)
.|++|||+.++|.+++.... ...+++..++.++.||+.||.|||++||+|+||+|+||+++. ++.++|+||
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeec
Confidence 89999999779999887532 235899999999999999999999999999999999999998 889999999
Q ss_pred CCCCcCCC------CcccceeeeeceeEe
Q 024661 239 KVPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
|++..... ...++..|+|||++.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhh
Confidence 99875322 123567799999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=207.40 Aligned_cols=165 Identities=24% Similarity=0.402 Sum_probs=141.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~- 165 (264)
+..+|.+.+.||+|+||.||+|.+..+++.|++|.+... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV-----IAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCc-----cchHHheeccc
Confidence 456899999999999999999999999999999988642 2334566789999999999988 8888877543
Q ss_pred ----CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...|++|||++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 78 REAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred ccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 3589999999889999988654 7999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC------cccceeeeeceeEe
Q 024661 242 SPRHAF------SFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~~------~~~~~~y~ape~~~ 261 (264)
...... ..++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLL 181 (337)
T ss_pred cccCCCcccccccccccCccChHHHh
Confidence 764332 24677899999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=200.13 Aligned_cols=164 Identities=21% Similarity=0.273 Sum_probs=136.8
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCc----EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|++.+.||.|+||.||+|.+..+++ .||+|+++.. ......+.+|+.+++.+.|+++ +.+++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV-----CRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCC-----ceEEEEEcC
Confidence 3679999999999999999999877765 4799988632 3345677889999999988887 888888765
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...+++||++ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 4578999999 899999997653 3689999999999999999999999999999999999999999999999999875
Q ss_pred CCCC--------cccceeeeeceeEe
Q 024661 244 RHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~--------~~~~~~y~ape~~~ 261 (264)
.... ..++..||+||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESIL 184 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhc
Confidence 4311 12345799999764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=197.63 Aligned_cols=162 Identities=28% Similarity=0.388 Sum_probs=142.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+|+..+.||+|++|.||+|.+..+++.+++|.+.... ...+.+.+|+.+++.++|+++ +++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI-----VQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCc-----hheeeeEecCC
Confidence 4788899999999999999998889999999886432 245678889999999999888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|++|||+ +++|.+++.+.. .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999 889999998764 68999999999999999999999999999999999999999999999999987643
Q ss_pred C-----CcccceeeeeceeEe
Q 024661 246 A-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~-----~~~~~~~y~ape~~~ 261 (264)
. ...++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred ccccccccCCCcceeCHHHhc
Confidence 2 234677899999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=203.91 Aligned_cols=169 Identities=27% Similarity=0.474 Sum_probs=143.2
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
++...++|++.+.||.|+||.||+|.+..+++.+++|.++.. ......+.+|+++++.++|+|+ +++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----~~~~~~~~ 76 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI-----VNLKEIVT 76 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCe-----eeeeheec
Confidence 345567899999999999999999999999999999998743 2234566789999999999888 88888876
Q ss_pred eCC----------EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 164 YRN----------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 164 ~~~----------~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
+.. .+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||++++++.+
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcE
Confidence 644 899999999778888887653 468999999999999999999999999999999999999999999
Q ss_pred EeccCCCCCcCCCC-------cccceeeeeceeEe
Q 024661 234 KVPDYKVPSPRHAF-------SFQTFLSMASRVYI 261 (264)
Q Consensus 234 ~l~Dfg~a~~~~~~-------~~~~~~y~ape~~~ 261 (264)
||+|||++...... ...+..|++||.+.
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhc
Confidence 99999998764322 13466799999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=197.28 Aligned_cols=163 Identities=26% Similarity=0.378 Sum_probs=144.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||+|.+..++..+++|.+..... .+.+.+|+++++.++|+++ +.+++.+.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYI-----VKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcE-----eeeeeeeecCCcEEEE
Confidence 569999999999999999999998899999999876544 6788999999999988887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
+|++ +++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999 889999987543 46899999999999999999999999999999999999999999999999998764332
Q ss_pred ---cccceeeeeceeEe
Q 024661 248 ---SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ---~~~~~~y~ape~~~ 261 (264)
..++..|++||.+.
T Consensus 156 ~~~~~~~~~y~~PE~~~ 172 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQ 172 (256)
T ss_pred cccccCCccccCHHHHh
Confidence 23677899999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=196.20 Aligned_cols=164 Identities=26% Similarity=0.338 Sum_probs=143.2
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+++++.++|+++ +++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI-----IEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCch-----hheeeeEecCCEEE
Confidence 589999999999999999999999999999998743 2345678889999999999888 89999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCCCcCCCC
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a~~~~~~ 247 (264)
+||||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999 8899999987654568999999999999999999999999999999999999865 46899999999764432
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08220 156 SKAYTVVGTPCYISPELCE 174 (256)
T ss_pred ccccccccCCcccCchhcc
Confidence 34677899999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=200.38 Aligned_cols=163 Identities=26% Similarity=0.354 Sum_probs=144.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|+++++.++|+|+ +.+.+++.+...+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI-----TKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCe-----eeeeEEEEECCeEE
Confidence 46889999999999999999999999999999987432 334567889999999998887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+|+||+ +++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++....
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999 88999998865 689999999999999999999999999999999999999999999999999876443
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...++..|++||.+.+
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~ 172 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQ 172 (274)
T ss_pred cccccccCCccccChhhhcc
Confidence 2346778999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=198.44 Aligned_cols=166 Identities=19% Similarity=0.276 Sum_probs=140.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCc---EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|+..+.||+|+||.||+|.+..++. .+++|.++.. ....+.+..|+++++.+.|+++ +++.+++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI-----IRLEGVVTKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEccC
Confidence 3568999999999999999999876554 6899988643 3345678889999999998887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999 889999997643 36899999999999999999999999999999999999999999999999998754
Q ss_pred CCCc---------ccceeeeeceeEee
Q 024661 245 HAFS---------FQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~~~---------~~~~~y~ape~~~~ 262 (264)
.... ..+..|++||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY 184 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc
Confidence 3221 12346999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=202.78 Aligned_cols=164 Identities=24% Similarity=0.438 Sum_probs=138.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC---
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 165 (264)
++|++.++||+|+||.||+|.+..+++.+|+|.+.... .......+|+.+++.++|+++ +++++++...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCc-----cceEEEEeccccc
Confidence 56999999999999999999999999999999886422 223455679999999999988 8888877654
Q ss_pred -----CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
...|+||||++++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 3569999999889998887643 3689999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC----------CcccceeeeeceeEe
Q 024661 241 PSPRHA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~----------~~~~~~~y~ape~~~ 261 (264)
+..... ...++..|+|||.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhc
Confidence 865322 123566799999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=199.04 Aligned_cols=162 Identities=27% Similarity=0.442 Sum_probs=136.2
Q ss_pred EEEeecccCccEEEEEEEeC----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 95 RILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.+.||.|.||.||+|.+. ..+..|+||.++.. ....+.+.+|++.++.++|+|+ +++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNI-----VKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTB-----E-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccc-----ccccccccccccc
Confidence 46789999999999999988 34677999999642 3346888999999999999988 9999999988889
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
++||||+ +|+|.+++.......+++..+..|+.||+.||.|||+++++|+||+++||+++.++.+||+|||++.....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999 89999999987445799999999999999999999999999999999999999999999999999976521
Q ss_pred -------CcccceeeeeceeEe
Q 024661 247 -------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -------~~~~~~~y~ape~~~ 261 (264)
.......|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~ 178 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLK 178 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHH
T ss_pred cccccccccccccccccccccc
Confidence 223556799999753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=202.60 Aligned_cols=163 Identities=29% Similarity=0.439 Sum_probs=140.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+.+|+++++.+.|+++ +++++++.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL-----VNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcch-----hhHHHhcccCCeE
Confidence 36999999999999999999999899999999875422 234567889999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ ++.|.++..... .+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999 667776665443 589999999999999999999999999999999999999999999999999875322
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLV 173 (286)
T ss_pred ccccCcccceeeccCcHHhc
Confidence 123677899999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=198.17 Aligned_cols=162 Identities=25% Similarity=0.336 Sum_probs=139.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-------hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
+|++.+.||.|+||.||+|.. .+++.+|+|.+... ......+.+|+++++.++|+|+ +++.+++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI-----VQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCE-----eeEeeEeecC
Confidence 488899999999999999986 47888999988632 1233567889999999999887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|++|||+ +++|.+++.+.. .+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999 899999998754 6889999999999999999999999999999999999999999999999988643
Q ss_pred C------------CCcccceeeeeceeEee
Q 024661 245 H------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~------------~~~~~~~~y~ape~~~~ 262 (264)
. ....++..|++||.+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcC
Confidence 1 12246778999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=207.20 Aligned_cols=168 Identities=24% Similarity=0.334 Sum_probs=141.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe---chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
-+..|+++++||+|+.+.||++.... ...+|+|.+. .+.+....+..|+..|..|+.+ ..++++++|-..++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~----~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH----DKIIQLYDYEVTDG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC----ceEEEEeeeeccCc
Confidence 34559999999999999999998543 3456666544 3456778899999999999876 45699999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
++|||||+-..+|..+|++... ....-.++.|..||+.|+.++|.+||||.||||.|+|+- +|.+||+|||+|....
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9999999999999999998762 233348899999999999999999999999999999996 6899999999997643
Q ss_pred -------CCcccceeeeeceeEeecC
Q 024661 246 -------AFSFQTFLSMASRVYICIN 264 (264)
Q Consensus 246 -------~~~~~~~~y~ape~~~~~~ 264 (264)
...+||..||+||.+.|++
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred cccceeeccccCcccccCHHHHhhcc
Confidence 4557999999999998874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=204.38 Aligned_cols=155 Identities=19% Similarity=0.140 Sum_probs=122.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCC-CCcEEEEEEEech------hhhHHHHHHHHHHHHHHhccCCCCcceE-EEc
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCV-QIR 159 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~-~~~ 159 (264)
..+.++|.+.+.||+|+||+||+|.+.. +++.+|||++... ......+.+|+++++.+.|+++ + .++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~i-----v~~l~ 88 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGV-----VPQLL 88 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCC-----CcEEE
Confidence 3556789999999999999999999876 6777899986522 2235678999999999999987 4 343
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEeecCCcEEecc
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPD 237 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di-kp~Nili~~~~~v~l~D 237 (264)
+. +..|+||||+ |++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.+++++|+|
T Consensus 89 ~~----~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 89 AT----GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred Ec----CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 32 4579999999 888862 211 11 1467899999999999999999999 99999999999999999
Q ss_pred CCCCCcCCCCc--------------ccceeeeeceeE
Q 024661 238 YKVPSPRHAFS--------------FQTFLSMASRVY 260 (264)
Q Consensus 238 fg~a~~~~~~~--------------~~~~~y~ape~~ 260 (264)
||+|+...... .+++.|+|||++
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 99998543322 345668999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=197.55 Aligned_cols=159 Identities=22% Similarity=0.336 Sum_probs=139.5
Q ss_pred eecccCccEEEEEEEeCCC---CcEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+... +..+++|++..... ..+.+.+|++.++.+.|+++ +++++++.+...++++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV-----VRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCCh-----heeeeeecCCCceEEEE
Confidence 4699999999999999866 88899999875433 35788899999999998887 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 173 EKL-GPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
||+ +++|.+++.... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 999 999999998751 247899999999999999999999999999999999999999999999999999865
Q ss_pred CCC--------cccceeeeeceeEe
Q 024661 245 HAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~--------~~~~~~y~ape~~~ 261 (264)
... ..++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLK 180 (262)
T ss_pred ccccccccccCCCcCccccCHHHhc
Confidence 432 34677899999764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=199.93 Aligned_cols=165 Identities=21% Similarity=0.316 Sum_probs=139.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ...+.+.+|+++++.+.|+++ +++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI-----VKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccC
Confidence 459999999999999999998543 45568889876433 334678899999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~ 230 (264)
...++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+|+||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999 999999997542 1247899999999999999999999999999999999999999
Q ss_pred CcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 231 EYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+.++|+|||++..... ...++..|||||.+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 198 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence 9999999999865322 233567899999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=201.05 Aligned_cols=166 Identities=21% Similarity=0.310 Sum_probs=137.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCc--EEEEEEEec--hhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRS--INKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~--~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++.+.||.|+||.||+|.+..++. .+++|.++. .....+.+.+|+.++.++ .|+++ +++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI-----INLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCch-----hheEEEEccCC
Confidence 469999999999999999999877664 468887763 233456788899999999 57777 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.+|++|||+ +++|.+++.... ...+++..++.++.|++.||+|||++||+|+||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 999999999 899999997532 12478899999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 232 YVKVPDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
.+||+|||++..... ....+..|++||.+.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY 192 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhcc
Confidence 999999999864321 1122456999997653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=200.01 Aligned_cols=163 Identities=28% Similarity=0.460 Sum_probs=142.0
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
|++.+.||.|++|.||+|.+..+|..|++|++.... .....+.+|+++++.++|+++ +++++++.+.+..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-----v~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI-----VRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCc-----cCHhheeccCCeEEE
Confidence 677889999999999999999999999999887432 233567889999999999888 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-----
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH----- 245 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~----- 245 (264)
+|||++++|.+++.......+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 999998899999887654468999999999999999999999999999999999999999999999999986532
Q ss_pred -CCcccceeeeeceeEe
Q 024661 246 -AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 -~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~aPE~~~ 172 (283)
T cd07835 156 YTHEVVTLWYRAPEILL 172 (283)
T ss_pred cCccccccCCCCCceee
Confidence 1223577899999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=206.60 Aligned_cols=167 Identities=21% Similarity=0.379 Sum_probs=142.2
Q ss_pred ccCCCeEE-EeecccCccEEEEEEEeCCCCcEEEEEEEechhhh---------------HHHHHHHHHHHHHHhccCCCC
Q 024661 89 NLTPRYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------------REAAMIEIDVLQRLARHDIGG 152 (264)
Q Consensus 89 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~~~~~~~ 152 (264)
.+.++|.. .+.||.|+||.||+|.+..+++.||+|.+...... ...+.+|+++++.+.|+++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-- 82 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI-- 82 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce--
Confidence 45577875 56799999999999999999999999988643221 1246789999999999887
Q ss_pred cceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc
Q 024661 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (264)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~ 232 (264)
+.+++++..++..|+|||++.++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 83 ---v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 83 ---MGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred ---eeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC
Confidence 99999999999999999999889999998654 6899999999999999999999999999999999999999999
Q ss_pred EEeccCCCCCcCC--------------------CCcccceeeeeceeEee
Q 024661 233 VKVPDYKVPSPRH--------------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 233 v~l~Dfg~a~~~~--------------------~~~~~~~~y~ape~~~~ 262 (264)
++|+|||++.... ....++..|++||.+.+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 9999999886543 01134667999998753
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=202.32 Aligned_cols=165 Identities=20% Similarity=0.331 Sum_probs=137.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCC-------CCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEcee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~ 161 (264)
++|.+.++||+|+||.||+|++.. ....+++|.++.. ......+..|+.+++.+ .|+|+ ++++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 86 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNI-----INLLGV 86 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCe-----eeEEEE
Confidence 679999999999999999998642 3456899988743 23345678899999998 48777 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nil 226 (264)
+.+.+.+|++|||+ +++|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999 899999997632 134888999999999999999999999999999999999
Q ss_pred eecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 227 LVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
++.++.+||+|||+++..... ...+..||+||.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence 999999999999999764321 11235699999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=198.90 Aligned_cols=163 Identities=27% Similarity=0.385 Sum_probs=142.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..|+..+.||.|+||.||+|.+..++..+|+|++... ......+.+|+.+++.+.|+++ +++++.+.+.+..|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCEEE
Confidence 4588889999999999999999999999999998743 2445678889999999988887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999 89999998753 5889999999999999999999999999999999999999999999999998654322
Q ss_pred -----cccceeeeeceeEee
Q 024661 248 -----SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 -----~~~~~~y~ape~~~~ 262 (264)
..++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~y~apE~~~~ 175 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQ 175 (277)
T ss_pred cccccccCcccccCHhHhcc
Confidence 235678999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=207.83 Aligned_cols=166 Identities=20% Similarity=0.390 Sum_probs=141.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
+.++|++.+.||.|++|.||+|.+..+++.|++|.+.... .....+.+|+.+++.+.|+++ +++++++..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 77 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI-----IAIRDILRPPG 77 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCc-----cCHHHhccccC
Confidence 3467999999999999999999999999999999987432 334567789999999999888 888887753
Q ss_pred --CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 165 --RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 165 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 45789999999889999987654 69999999999999999999999999999999999999999999999999986
Q ss_pred cCCC----------CcccceeeeeceeEee
Q 024661 243 PRHA----------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~----------~~~~~~~y~ape~~~~ 262 (264)
.... ...++..|++||.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcC
Confidence 5321 2246778999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=201.42 Aligned_cols=164 Identities=21% Similarity=0.356 Sum_probs=137.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCC----------------CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCc
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGT 153 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~ 153 (264)
++|++.+.||+|+||.||++.+.. ++..+|+|++... ....+.+.+|+.+++.++|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i--- 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI--- 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc---
Confidence 579999999999999999986432 3456899988743 3345678899999999999888
Q ss_pred ceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024661 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY---------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (264)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 223 (264)
+++++++...+..|++|||+ +++|.+++..... ..+++..+..++.|++.||+|||++|++|+||||+
T Consensus 82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 82 --IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred --ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999999999999999999 8999999976431 23677889999999999999999999999999999
Q ss_pred CEEeecCCcEEeccCCCCCcCCCC--------cccceeeeeceeE
Q 024661 224 NILLVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVY 260 (264)
Q Consensus 224 Nili~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~ 260 (264)
|||++.++.++|+|||++...... ...+..|++||..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 999999999999999998754221 1224569999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=199.49 Aligned_cols=157 Identities=24% Similarity=0.358 Sum_probs=136.2
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||+|+||+||+|.+..+|+.+++|.+.... .....+.+|+++++.++|+++ +.+++.+...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI-----VSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCE-----eeeeeEEecCCeEEEEEecC
Confidence 689999999999999999999999987432 234455789999999998877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----Ccc
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-----FSF 249 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-----~~~ 249 (264)
+++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..... ...
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 89999999876545789999999999999999999999999999999999999999999999999875432 223
Q ss_pred cceeeeeceeEe
Q 024661 250 QTFLSMASRVYI 261 (264)
Q Consensus 250 ~~~~y~ape~~~ 261 (264)
++..|++||.+.
T Consensus 156 ~~~~y~~PE~~~ 167 (277)
T cd05577 156 GTPGYMAPEVLQ 167 (277)
T ss_pred CCCCcCCHHHhc
Confidence 567799999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=201.91 Aligned_cols=166 Identities=25% Similarity=0.363 Sum_probs=143.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~- 164 (264)
.+.++|++.+.||.|+||.||+|.+..+++.+++|.+.+. ....+.+..|+++++.+.|+|+ +++.+++..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-----ISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCe-----eeEeeeEecC
Confidence 4668899999999999999999999999999999987542 2345677889999999999888 999998865
Q ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
....|++||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 5688999999988999888753 5888899999999999999999999999999999999999999999999998764
Q ss_pred CCC---cccceeeeeceeEee
Q 024661 245 HAF---SFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~~---~~~~~~y~ape~~~~ 262 (264)
... ..++..|++||.+.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 159 DPQMTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CCCcCCCcccccccCceeeec
Confidence 432 246778999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=197.99 Aligned_cols=159 Identities=19% Similarity=0.204 Sum_probs=131.9
Q ss_pred eecccCccEEEEEEEeC--CCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
+.||+|+||.||+|... .++..+++|.++... .....+.+|+.+++.++|+|+ +++++.+.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL-----LQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCCCcEEEEE
Confidence 36899999999999864 345679999886432 334567889999999999888 999999999999999999
Q ss_pred cC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 174 KL-GPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
|+ +++|.+++.... ....++..+..++.|++.||+|||+.|++|+||||+||+++.+++++|+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 99 899999997532 12456778889999999999999999999999999999999999999999999865322
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVD 175 (269)
T ss_pred eecCCCcCCcccccCHhHhc
Confidence 123456799999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=197.48 Aligned_cols=159 Identities=23% Similarity=0.312 Sum_probs=129.8
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEec
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 174 (264)
.||+|+||.||++.+..+++.+|+|.+.+.. .......+|..+++.+.+. .+++++.+++.+..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhC--CCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999999999999999886432 1222334455444444321 124559999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----CCcc
Q 024661 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH----AFSF 249 (264)
Q Consensus 175 ~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~----~~~~ 249 (264)
+ +++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+|||+++++.++|+|||++.... ....
T Consensus 79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (279)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcC
Confidence 9 899999988765 69999999999999999999999999999999999999999999999999986432 2335
Q ss_pred cceeeeeceeEe
Q 024661 250 QTFLSMASRVYI 261 (264)
Q Consensus 250 ~~~~y~ape~~~ 261 (264)
++..|||||.+.
T Consensus 157 ~~~~y~aPE~~~ 168 (279)
T cd05633 157 GTHGYMAPEVLQ 168 (279)
T ss_pred CCcCccCHHHhc
Confidence 788999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=199.47 Aligned_cols=164 Identities=21% Similarity=0.238 Sum_probs=134.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcE----EEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
++|++.+.||.|+||.||+|.+..+++. +++|.+... ......+..|+..++.+.|+|+ +++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~i-----v~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI-----VRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEC-C
Confidence 5689999999999999999999777763 667766432 2233566777778888888887 99998875 4
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
...++++|++ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 5678899999 999999998654 36899999999999999999999999999999999999999999999999999753
Q ss_pred CC--------CcccceeeeeceeEee
Q 024661 245 HA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~--------~~~~~~~y~ape~~~~ 262 (264)
.. ...++..||+||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~ 185 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILF 185 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhcc
Confidence 21 1224567999998643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=194.24 Aligned_cols=162 Identities=30% Similarity=0.424 Sum_probs=144.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+++++.+.|+++ +.+++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI-----VKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCc-----cEEEEEEEeCCEEE
Confidence 4889999999999999999999899999999987543 456788999999999999887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
++||++ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999 889999998764 7899999999999999999999999999999999999999999999999999765432
Q ss_pred -----cccceeeeeceeEe
Q 024661 248 -----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -----~~~~~~y~ape~~~ 261 (264)
..++..|++||.+.
T Consensus 154 ~~~~~~~~~~~y~~pe~~~ 172 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIE 172 (254)
T ss_pred ccccccccchhhcCHhhhc
Confidence 24677899999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=198.86 Aligned_cols=166 Identities=21% Similarity=0.315 Sum_probs=139.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.+.|.+.+.||+|++|.||+|.+.. ++..+++|.+... ......+.+|+.+++.+.|+++ +++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI-----VRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEc
Confidence 3669999999999999999999977 6788999987632 3344568889999999998887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEE
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVK 234 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~ 234 (264)
+.+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++++|+||||+||+++.++ .++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 989999999999 9999999976431 2588999999999999999999999999999999999998765 699
Q ss_pred eccCCCCCcCCCCc--------ccceeeeeceeEe
Q 024661 235 VPDYKVPSPRHAFS--------FQTFLSMASRVYI 261 (264)
Q Consensus 235 l~Dfg~a~~~~~~~--------~~~~~y~ape~~~ 261 (264)
|+|||+++...... ..+..|||||++.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL 194 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHh
Confidence 99999997653211 1235699999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=198.30 Aligned_cols=164 Identities=21% Similarity=0.303 Sum_probs=140.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.|++.+.||+|+||.||+|.+..+++.+++|.++.. ......+.+|+.+++.+.+ ..+++++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence 478889999999999999999999999999998643 3345667889999999973 122444999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999 88999998764 589999999999999999999999999999999999999999999999999875432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 157 KRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred ccccccCCcceeCHHHhc
Confidence 224677899999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=200.99 Aligned_cols=163 Identities=22% Similarity=0.341 Sum_probs=144.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||+|+||+||++.+..+++.+++|++... ......+.+|+++++.++|+++ +++++.+...+.+|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI-----VSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCc-----ceEeeeEecCCEEE
Confidence 5689999999999999999999999999999987643 3445778899999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
+||||+ +++|.+++.... .+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999 889999987754 68999999999999999999996 699999999999999999999999999986532
Q ss_pred --CCcccceeeeeceeEe
Q 024661 246 --AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 --~~~~~~~~y~ape~~~ 261 (264)
....++..|++||.+.
T Consensus 158 ~~~~~~~~~~~~aPE~~~ 175 (284)
T cd06620 158 IADTFVGTSTYMSPERIQ 175 (284)
T ss_pred ccCccccCcccCCHHHHc
Confidence 2235788999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=196.94 Aligned_cols=163 Identities=23% Similarity=0.311 Sum_probs=141.1
Q ss_pred eEEEeecccCccEEEEEEEeCCCC----cEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+++.+.||.|+||.||++.+...+ ..+++|.+..... ....+..|+.+++.+.|+++ +++++.+.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNI-----VKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCch-----heEEEEEcCCCe
Confidence 356789999999999999998766 8899999875433 56788899999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|++||++ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999 89999999875522389999999999999999999999999999999999999999999999999976443
Q ss_pred C-------cccceeeeeceeEe
Q 024661 247 F-------SFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~-------~~~~~~y~ape~~~ 261 (264)
. ..++..|++||.+.
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~ 177 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLK 177 (258)
T ss_pred ccccccccCCCcccccChHHhc
Confidence 2 23557899999753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=195.69 Aligned_cols=163 Identities=26% Similarity=0.354 Sum_probs=140.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.+|++.+.||+|+||.||+|.+.. +..+++|.+.........+.+|+++++.+.|+++ +++++++......|++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL-----VQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCe-----eeEEEEEccCCceEEE
Confidence 468999999999999999998753 6679999887655555678899999999998887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
|||+ +++|.+++.... ..++++.++.++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999 899999987654 35889999999999999999999999999999999999999999999999998753221
Q ss_pred ----cccceeeeeceeEe
Q 024661 248 ----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ----~~~~~~y~ape~~~ 261 (264)
...+..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~ 174 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFS 174 (256)
T ss_pred ccCCCccchhhcCHhHhc
Confidence 12345799999765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=197.79 Aligned_cols=164 Identities=20% Similarity=0.288 Sum_probs=138.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCc----EEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|++.+.||+|+||.||+|.+..+++ .+++|.+.... .....+.+|+.+++.+.|+|+ +++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV-----VRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEec
Confidence 3679999999999999999999876654 58899876432 345678889999999999888 999988877
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||+++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 7899999999 999999998754 3589999999999999999999999999999999999999999999999999976
Q ss_pred CCCCc--------ccceeeeeceeEe
Q 024661 244 RHAFS--------FQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~~--------~~~~~y~ape~~~ 261 (264)
..... ..+..|++||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESIL 184 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhh
Confidence 43211 1245699999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=198.80 Aligned_cols=163 Identities=28% Similarity=0.490 Sum_probs=141.0
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh--hHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
|++.+.||+|++|.||+|....+++.+++|.+..... ......+|+..++.+. |+++ +.+++.+.+++..|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI-----VKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCc-----hhHHHHhhcCCcEEE
Confidence 6788999999999999999998899999998864322 2234456888898888 8877 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
||||++++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999988999998876545789999999999999999999999999999999999999999999999999976443
Q ss_pred -CcccceeeeeceeEe
Q 024661 247 -FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 156 ~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 156 TDYVSTRWYRAPEILL 171 (283)
T ss_pred CCCCCcccccCceeee
Confidence 234677899999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=204.17 Aligned_cols=165 Identities=22% Similarity=0.368 Sum_probs=141.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++|+|+ +++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----v~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc-----cceeeeeeec
Confidence 45688999999999999999999999999999999986432 234567789999999999988 8888877542
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
...|+++++++++|.+++... .+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 457899999999999888653 58999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC---cccceeeeeceeEe
Q 024661 240 VPSPRHAF---SFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~~---~~~~~~y~ape~~~ 261 (264)
++...... ..++..|+|||++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 166 LARHTDDEMTGYVATRWYRAPEIML 190 (345)
T ss_pred ccccccccccccccCCCccCHHHHh
Confidence 98764432 24677899999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=196.84 Aligned_cols=159 Identities=22% Similarity=0.286 Sum_probs=130.0
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEec
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 174 (264)
.||+|+||.||+|.+..+++.||+|.+.+.. ........|..+++.+.+. .+++++.+.+.+...+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC--CCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999999999999999886432 1122234444444444331 234559999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----Ccc
Q 024661 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----FSF 249 (264)
Q Consensus 175 ~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----~~~ 249 (264)
+ +++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++..... ...
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcC
Confidence 9 999999887654 799999999999999999999999999999999999999999999999999865332 335
Q ss_pred cceeeeeceeEe
Q 024661 250 QTFLSMASRVYI 261 (264)
Q Consensus 250 ~~~~y~ape~~~ 261 (264)
++..|+|||.+.
T Consensus 157 ~~~~y~aPE~~~ 168 (278)
T cd05606 157 GTHGYMAPEVLQ 168 (278)
T ss_pred CCcCCcCcHHhc
Confidence 788999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=199.79 Aligned_cols=163 Identities=26% Similarity=0.352 Sum_probs=142.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.++|.+.+.||+|+||.||++.+..++..+++|.+... ....+.+.+|+.+++.+.|+++ +.+++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI-----VNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCe-----eehhheeeeCCcEE
Confidence 46899999999999999999999888999999998642 3345677889999999988887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+|+||+ +++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999 99999998764 478999999999999999999999999999999999999999999999998765332
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 170 ~~~~~~~~~~~y~~PE~~~ 188 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVT 188 (293)
T ss_pred cccccccCChhhcCchhhc
Confidence 224667799999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=199.07 Aligned_cols=163 Identities=27% Similarity=0.382 Sum_probs=143.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|.+.+.||+|+||.||+|.+..+++.+++|++.+. ......+.+|+.+++.+. |+|+ +++++.+.+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI-----IKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCc-----hhHHHHhcCCc
Confidence 3699999999999999999999999999999998752 233466788999999998 7777 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..++|||++ +++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999 999999998765 79999999999999999999999999999999999999999999999999987543
Q ss_pred CCc--------------------------ccceeeeeceeEe
Q 024661 246 AFS--------------------------FQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~~--------------------------~~~~~y~ape~~~ 261 (264)
... .++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 195 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhC
Confidence 322 3567799999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=197.17 Aligned_cols=165 Identities=18% Similarity=0.259 Sum_probs=140.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
++|++...||+|+||.||+|+.+.+ .+.+++|.+..... ..+.+.+|+++++.+.|+++ +.+++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV-----VRLLGLCRE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcce-----eeeEEEECC
Confidence 5699999999999999999997543 46799998764332 45678999999999999887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSY-------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
....|+||||+ +++|.+++..... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 99999999999 8999999986541 158999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCC-------CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~-------~~~~~~~y~ape~~~ 261 (264)
|||++..... ...++..|++||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 191 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhc
Confidence 9999864321 223466799999754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=200.14 Aligned_cols=166 Identities=25% Similarity=0.326 Sum_probs=143.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
....|...+.||+|+||.||++.+..++..+++|.+... ......+.+|+++++.++|+|+ +++++++.++
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 97 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNS-----IEYKGCYLRE 97 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEeeC
Confidence 334488899999999999999999999999999998642 2334567889999999999887 9999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+..|+||||+.++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9999999999778888876543 368999999999999999999999999999999999999999999999999987544
Q ss_pred C--CcccceeeeeceeEe
Q 024661 246 A--FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--~~~~~~~y~ape~~~ 261 (264)
. ...++..|+|||.+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 177 PANSFVGTPYWMAPEVIL 194 (317)
T ss_pred CcccccCCccccChhhhh
Confidence 3 335788899999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=198.13 Aligned_cols=165 Identities=21% Similarity=0.316 Sum_probs=139.1
Q ss_pred CCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+|++.++||+|+||.||++... .++..+++|.+... ....+.+.+|+++++.++|+|+ +++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-----VRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCC-----ceEEEEEecC
Confidence 46888999999999999999743 34667899987643 3445678899999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSY-------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
...+++|||+ +++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999 8999999976431 2478899999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
.++|+|||++..... ...++..|+|||.+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 197 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhc
Confidence 999999999864322 222356799999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=201.31 Aligned_cols=163 Identities=29% Similarity=0.398 Sum_probs=142.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+.|+..+.||.|+||.||+|.+..+++.+++|.+... ....+.+.+|+.+++.+.|+++ +++++.+...+..|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI-----TRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCcc-----HhhhcccccCCceE
Confidence 3477788999999999999999989999999988743 3345678899999999998888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
+||||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 79 IIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999 88999988653 5899999999999999999999999999999999999999999999999998764332
Q ss_pred -----cccceeeeeceeEee
Q 024661 248 -----SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 -----~~~~~~y~ape~~~~ 262 (264)
..++..|++||.+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hhhhcccCcccccCHHHhCc
Confidence 236778999998654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=199.57 Aligned_cols=156 Identities=11% Similarity=0.110 Sum_probs=134.3
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeee----CCEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHIC 169 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~----~~~~~ 169 (264)
..||+|+++.||+|.+ +|+.||+|.++.... ..+.+.+|+.++++++|+|+ +++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNI-----LKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCE-----EEEeeeEEecccCCCceE
Confidence 4689999999999987 588999999875432 24667799999999999988 999999876 45789
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
+||||+ +|+|.+++.... .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999 899999998765 78899999999999999999998 4999999999999999999999999999875332
Q ss_pred --CcccceeeeeceeEee
Q 024661 247 --FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 177 ~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred cccccCcccccCHHHhhh
Confidence 2347888999998753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=195.81 Aligned_cols=155 Identities=26% Similarity=0.328 Sum_probs=137.8
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||.|++|.||+|.+..+++.+++|++.+.. ...+.+.+|+.+++.+.|+++ +.+++.+.++..+|++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI-----VKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCE-----eeeeeeEEcCCccEEEEecC
Confidence 689999999999999999999999987432 345678899999999999887 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-----cc
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF-----SF 249 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~-----~~ 249 (264)
+++|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 899999998765 6899999999999999999999999999999999999999999999999998765432 34
Q ss_pred cceeeeeceeEe
Q 024661 250 QTFLSMASRVYI 261 (264)
Q Consensus 250 ~~~~y~ape~~~ 261 (264)
++..|++||.+.
T Consensus 154 ~~~~~~~PE~~~ 165 (262)
T cd05572 154 GTPEYVAPEIIL 165 (262)
T ss_pred CCcCccChhHhc
Confidence 677899999763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=204.51 Aligned_cols=167 Identities=30% Similarity=0.426 Sum_probs=141.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~ 163 (264)
..+.++|++.+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+.+++++ +|+|+ +++++++.
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----~~~~~~~~ 77 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI-----VKLLNVIK 77 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCc-----cceeeeec
Confidence 35668899999999999999999999989999999987532 23345677899999999 88888 99999876
Q ss_pred e--CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 164 Y--RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 164 ~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
. ...+|+||||++++|.+++... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 78 AENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred cCCCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 4 3478999999988999988764 5788899999999999999999999999999999999999999999999998
Q ss_pred CcCCCC-----------cccceeeeeceeEee
Q 024661 242 SPRHAF-----------SFQTFLSMASRVYIC 262 (264)
Q Consensus 242 ~~~~~~-----------~~~~~~y~ape~~~~ 262 (264)
...... ..++..|++||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeec
Confidence 753221 236778999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=204.55 Aligned_cols=163 Identities=24% Similarity=0.372 Sum_probs=143.0
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC---
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--- 166 (264)
+|++.+.||.|++|.||+|.+..+++.+++|.+... ....+.+.+|+.+++.++|+++ +.+.+++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI-----IGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcch-----hhhhhhhcccCccc
Confidence 589999999999999999999988999999988753 2345678889999999998887 88888887765
Q ss_pred --EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 167 --~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+|++|||++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 889999999889999987654 7999999999999999999999999999999999999999999999999999764
Q ss_pred CCC---------cccceeeeeceeEee
Q 024661 245 HAF---------SFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~~---------~~~~~~y~ape~~~~ 262 (264)
... ..++..|+|||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLS 180 (330)
T ss_pred cccccccccccccccccCcCCceeeec
Confidence 332 246778999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=202.73 Aligned_cols=165 Identities=22% Similarity=0.314 Sum_probs=141.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
..+.|.....||.|+||.||++.+..++..++||.+... ....+.+.+|+.+++.++|+|+ +.+++.+...+..
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~ 94 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV-----VDMYNSYLVGDEL 94 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcH-----HHHHHheecCCeE
Confidence 334566678899999999999999999999999998643 3445678899999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 95 WVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9999999 88999988643 589999999999999999999999999999999999999999999999999864321
Q ss_pred -----CcccceeeeeceeEee
Q 024661 247 -----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||.+.+
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~ 192 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISR 192 (292)
T ss_pred cccCceeecCccccCHHHHcc
Confidence 2246778999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=197.47 Aligned_cols=162 Identities=27% Similarity=0.382 Sum_probs=141.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
-|++.+.||.|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.+.|+++ +++++++..++..|+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCE-----eEEEEEEEeCCeEEE
Confidence 378889999999999999999889999999987643 2344678889999999998887 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC--
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF-- 247 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~-- 247 (264)
||||+ +++|.+++... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999 88999998754 5899999999999999999999999999999999999999999999999998654332
Q ss_pred ----cccceeeeeceeEee
Q 024661 248 ----SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 ----~~~~~~y~ape~~~~ 262 (264)
..++..|++||.+.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hhccccCCccccChhhhcc
Confidence 236778999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=194.75 Aligned_cols=165 Identities=22% Similarity=0.292 Sum_probs=143.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||.|+||.||+|....++..+++|++.... ...+.+.+|+.+++.++|+++ +++++.+...+..|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV-----VKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCE-----EEEEEEEeeCCEEE
Confidence 46999999999999999999998899999999986432 345678899999999998887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
++||++ +++|.+++..... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999 8999999986432 3689999999999999999999999999999999999999999999999998864322
Q ss_pred ---------CcccceeeeeceeEe
Q 024661 247 ---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---------~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred ccccccccccccCChhhcChHHHc
Confidence 123677899999764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=201.28 Aligned_cols=165 Identities=21% Similarity=0.269 Sum_probs=138.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.+|++.++||.|+||.||+|.+..+ +..+|+|+++... ...+.+.+|+.+++.++|+++ +++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI-----VCLLGVVTK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcC
Confidence 4588899999999999999987543 5789999987432 334668889999999999888 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
....++++||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999 899999986321 124788889999999999999999999999999999999999
Q ss_pred CCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 230 AEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
++.+||+|||+++.... ...++..|||||.+.
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM 199 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence 99999999999875322 223456899999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=199.13 Aligned_cols=164 Identities=19% Similarity=0.309 Sum_probs=136.7
Q ss_pred CeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... ...+.+.+|+.+++.+.|+|+ +++++.+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV-----IKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecC
Confidence 47889999999999999998753 23568888876432 334678889999999998887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 222 (264)
+..+++|||+ +++|.+++.... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 9999999999 899999987431 12478889999999999999999999999999999
Q ss_pred CCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 223 ENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 223 ~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+|||+++++.++|+|||+++.... ....+..|++||.+.
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 999999999999999999875321 123456799999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=202.66 Aligned_cols=161 Identities=21% Similarity=0.324 Sum_probs=139.7
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
|.....||.|+||.||+|.+..+++.+++|++... ....+.+.+|+.+++.+.|+|+ +++++.+..++..|++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV-----VEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCch-----hhhhhheeeCCeEEEEE
Confidence 55566899999999999999989999999998643 2345667889999999999887 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
||+ +++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 999 88999887653 589999999999999999999999999999999999999999999999999864322
Q ss_pred -CcccceeeeeceeEee
Q 024661 247 -FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 175 ~~~~~~~~y~aPE~~~~ 191 (297)
T cd06659 175 KSLVGTPYWMAPEVISR 191 (297)
T ss_pred cceecCccccCHHHHcc
Confidence 2347788999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=198.56 Aligned_cols=167 Identities=23% Similarity=0.327 Sum_probs=144.1
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...+.|...++||+|+||.||+|.+..+++.+++|.+... ......+.+|+++++.++|+++ +.+++++.+
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 92 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-----IEYKGCYLK 92 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEe
Confidence 3345588888999999999999999999999999998632 2333567889999999999888 999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
....|+||||+.++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 93 ~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 93 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 99999999999888988887543 36899999999999999999999999999999999999999999999999998754
Q ss_pred CC--CcccceeeeeceeEe
Q 024661 245 HA--FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~--~~~~~~~y~ape~~~ 261 (264)
.. ...++..|++||++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 172 SPANSFVGTPYWMAPEVIL 190 (313)
T ss_pred CCCCCccccccccChhhcc
Confidence 32 335778899999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=194.03 Aligned_cols=162 Identities=24% Similarity=0.382 Sum_probs=144.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|+..++.++|+++ +++++++...+..++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-----VKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEccCCeEEE
Confidence 5889999999999999999999999999999987543 356778899999999998887 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+|||+ +++|.+++.... .+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999 899999998764 78999999999999999999999 9999999999999999999999999999876433
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~ 173 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQ 173 (264)
T ss_pred CcccceeecccccCHhhhC
Confidence 223567899999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=194.40 Aligned_cols=155 Identities=25% Similarity=0.362 Sum_probs=130.5
Q ss_pred ecccCccEEEEEEEe--CCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 99 KMGEGTFGQVVECFD--NEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
+||+|+||.||+|.+ ..++..+|+|+++.. ....+.+.+|+.+++.+.|+++ +++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI-----VRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEc-CCCcEEEEe
Confidence 689999999999965 456788999988643 2345678899999999999888 88888775 456789999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-----
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF----- 247 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~----- 247 (264)
|+ +++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99 889999997654 6899999999999999999999999999999999999999999999999998754321
Q ss_pred ----cccceeeeeceeEe
Q 024661 248 ----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ----~~~~~~y~ape~~~ 261 (264)
..++..|||||.+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 154 AKTHGKWPVKWYAPECMN 171 (257)
T ss_pred ecCCCCCCccccCHhHhc
Confidence 12246799999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=196.90 Aligned_cols=161 Identities=29% Similarity=0.449 Sum_probs=136.4
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeC--CEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR--NHI 168 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~--~~~ 168 (264)
|++.++||+|+||.||+|.+..++..+|+|.+++.. .......+|+.+++++. |+|+ +++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI-----LRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCc-----cceEEEEecCCCCcE
Confidence 678899999999999999999999999999887432 22233456888888885 7777 9999999887 899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
++||||+.++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.....
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9999999889999887643 36899999999999999999999999999999999999999 9999999999975432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 154 PYTEYISTRWYRAPECLL 171 (282)
T ss_pred CcCCCCCCcccCChhHhh
Confidence 223677899999753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=194.72 Aligned_cols=161 Identities=21% Similarity=0.288 Sum_probs=137.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||++.. +++.+++|.+... ...+.+.+|+.+++.++|+++ +++++++..+ ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNL-----VRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCc-----CeEEEEEcCC-CcEEE
Confidence 5699999999999999999864 5778999988643 334678889999999999888 8888888654 47999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---C
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---F 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---~ 247 (264)
|||+ +++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~ 156 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCC
Confidence 9999 89999999876545689999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccceeeeeceeEe
Q 024661 248 SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ~~~~~~y~ape~~~ 261 (264)
...+..|++||.+.
T Consensus 157 ~~~~~~y~~pe~~~ 170 (254)
T cd05083 157 SKLPVKWTAPEALK 170 (254)
T ss_pred CCCCceecCHHHhc
Confidence 23456799999764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=214.81 Aligned_cols=165 Identities=22% Similarity=0.355 Sum_probs=142.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
..+-++.++||+|.||+||+|+... ....||||.++.. .+..++|++|++++..++|+|| |++++.+.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nI-----VrLlGVC~ 559 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNI-----VRLLGVCR 559 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCe-----EEEEEEEc
Confidence 3457778999999999999998643 3456999999854 3468899999999999999999 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcC--------CCC----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRS----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~ 230 (264)
.++.+|+|+||| .|||.++|.... +.. ++..+.+.|+.||+.||+||-++.+|||||..+|+||+++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 999999999999 999999998431 223 8899999999999999999999999999999999999999
Q ss_pred CcEEeccCCCCCcCCCCcc--------cceeeeeceeE
Q 024661 231 EYVKVPDYKVPSPRHAFSF--------QTFLSMASRVY 260 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~~~~--------~~~~y~ape~~ 260 (264)
-.|||+|||+++..-..++ -...||+||.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI 677 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence 9999999999997544332 12359999965
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=194.50 Aligned_cols=164 Identities=23% Similarity=0.345 Sum_probs=143.1
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|.+.+.||.|+||.||+|.+..++..+++|.+... ....+.+.+|+.+++.++|+|+ +++++.+.+....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI-----VTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCCh-----hhhhheeccCCeEE
Confidence 589999999999999999999999999999998753 2345677889999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCcCCCC
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPRHAF 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~~~~ 247 (264)
+++||+ +++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||++++++ .++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999 89999999876545689999999999999999999999999999999999999886 5699999998764332
Q ss_pred ------cccceeeeeceeEe
Q 024661 248 ------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ------~~~~~~y~ape~~~ 261 (264)
..++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred cccccccCCCccccCHHHHc
Confidence 24677899999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=200.63 Aligned_cols=167 Identities=22% Similarity=0.276 Sum_probs=140.1
Q ss_pred eEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHH--HhccCCCCcceEEEc
Q 024661 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIR 159 (264)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~~~~~~~~~~~~~~ 159 (264)
.++.....+.....+.+.||+|.||.||+|.++ |+.||||++...+ ...+.+|.++.+. ++|.|| ..|+
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENI-----LgFI 271 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENI-----LGFI 271 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc--hhhhhhHHHHHHHHHhccchh-----hhhh
Confidence 445666777888999999999999999999988 7789999997543 3567777777776 678887 7776
Q ss_pred eeeeeC----CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEE
Q 024661 160 NWFDYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENIL 226 (264)
Q Consensus 160 ~~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dikp~Nil 226 (264)
+.=..+ ..+|||++|- .|+|+|||... .++......++..++.||+|||.. .|.|||||..|||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 653222 3689999999 99999999985 589999999999999999999974 4999999999999
Q ss_pred eecCCcEEeccCCCCCcC----------CCCcccceeeeeceeE
Q 024661 227 LVSAEYVKVPDYKVPSPR----------HAFSFQTFLSMASRVY 260 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~----------~~~~~~~~~y~ape~~ 260 (264)
+.+++.+.|+|+|+|... .....||..|||||++
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvL 392 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVL 392 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHh
Confidence 999999999999999653 2344799999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=195.67 Aligned_cols=166 Identities=23% Similarity=0.306 Sum_probs=141.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~~ 167 (264)
++|+..+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|+++++.++|+|+ +.+++++.+ .+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI-----VKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEEccCCCe
Confidence 46899999999999999999999999999999987432 345678899999999999888 999988865 347
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+|+||||+ +++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 89999999 89999887632 2346899999999999999999999999999999999999999999999999998653
Q ss_pred CC----CcccceeeeeceeEee
Q 024661 245 HA----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~----~~~~~~~y~ape~~~~ 262 (264)
.. ...++..|++||.+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 156 VNSLAGTFTGTSFYMAPERIQG 177 (287)
T ss_pred cccccccccCCccccCHHHhcC
Confidence 32 2246778999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=207.15 Aligned_cols=161 Identities=21% Similarity=0.249 Sum_probs=133.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC----E
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----H 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~----~ 167 (264)
...++.+.||+|.||.||+|+.. ++.||||++.. ...+.+..|-++.+-. +..|++|++|++.-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~--~~kqs~~~Ek~Iy~lp---~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE--QEKQSFQNEKNIYSLP---GMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCH--HHHHHHHhHHHHHhcc---CccchhHHHhhchhccCCccccc
Confidence 44777899999999999999876 58899999874 4446677777666542 333344499988765544 8
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEeecCCcEEecc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~ivH~dikp~Nili~~~~~v~l~D 237 (264)
++||++|. .|+|.+||..+ .+++....+++..++.||+|||+. .|+|||||.+|||+.+|++..|+|
T Consensus 283 ywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999 99999999987 499999999999999999999974 599999999999999999999999
Q ss_pred CCCCCcCCC--------CcccceeeeeceeEee
Q 024661 238 YKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
||+|..... ...||..|||||++-+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence 999976432 2468999999998754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=197.15 Aligned_cols=164 Identities=23% Similarity=0.383 Sum_probs=139.8
Q ss_pred CCeEEEeecccCccEEEEEEEeC----CCCcEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~- 164 (264)
+.|++.+.||+|+||.||+|... .+++.+|+|++..... ..+.+.+|+++++.+.|+++ +++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i-----~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI-----VKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCCh-----heEEeeeecC
Confidence 45888899999999999999864 3478899999875444 46788999999999999888 899888877
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
....+++|||+ +++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 66899999999 899999998654 358999999999999999999999999999999999999999999999999998
Q ss_pred cCCCC---------cccceeeeeceeEe
Q 024661 243 PRHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~~---------~~~~~~y~ape~~~ 261 (264)
..... ...+..|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHc
Confidence 65421 12345699999653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=222.79 Aligned_cols=168 Identities=27% Similarity=0.346 Sum_probs=134.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
+...+|+.++.||+|+||.||+++.+-+|+.||||.|... .+....+.+|+.++.+|+|+|+ |+++..|..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNV-----VRYysAWVEs~ 550 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNV-----VRYYSAWVEST 550 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcce-----eeeehhhhccC
Confidence 4456688899999999999999999999999999998754 4555678899999999999987 433332200
Q ss_pred --------------------------------------------------------------------------------
Q 024661 165 -------------------------------------------------------------------------------- 164 (264)
Q Consensus 165 -------------------------------------------------------------------------------- 164 (264)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred -----------------------------C--------CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 024661 165 -----------------------------R--------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206 (264)
Q Consensus 165 -----------------------------~--------~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~ 206 (264)
+ ..+||-|||| ...|.+++..+. ..-....+|++++||++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cchhhHHHHHHHHHHHHH
Confidence 0 2379999999 555555555543 211467899999999999
Q ss_pred HHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC------------------------CCCcccceeeeeceeEee
Q 024661 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR------------------------HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 207 l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~------------------------~~~~~~~~~y~ape~~~~ 262 (264)
|.|+|++|||||||||.||++++++.|||+|||+|+.. .....||..|+|||++-.
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999999999999999999999999999999999761 112358999999998643
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=196.48 Aligned_cols=158 Identities=16% Similarity=0.194 Sum_probs=129.5
Q ss_pred ecccCccEEEEEEEeCCC------------------------CcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCc
Q 024661 99 KMGEGTFGQVVECFDNEK------------------------KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGT 153 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~ 153 (264)
.||+|+||.||+|....+ ...|++|++.... .....+.+|+.+++.+.|+|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~ni--- 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHL--- 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCe---
Confidence 699999999999974321 2358888886432 334567788899999998888
Q ss_pred ceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-
Q 024661 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE- 231 (264)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~- 231 (264)
+++++++......|+||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 --v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 --AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred --eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99999999999999999999 899998887543 3689999999999999999999999999999999999998654
Q ss_pred ------cEEeccCCCCCcCC--CCcccceeeeeceeEee
Q 024661 232 ------YVKVPDYKVPSPRH--AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 232 ------~v~l~Dfg~a~~~~--~~~~~~~~y~ape~~~~ 262 (264)
.++++|||++.... ....++..|+|||.+.+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPG 194 (274)
T ss_pred ccCccceeeecCCccccccccccccccCCcccCchhhcC
Confidence 48999999875432 23346778999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=193.82 Aligned_cols=162 Identities=24% Similarity=0.308 Sum_probs=138.0
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.....||+|+||.||+|.+..++..+++|.+... ....+.+.+|+.+++.++|+|+ +++++++...+..++++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQYLGSDSENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCe-----eeeeeeeccCCEEEEEE
Confidence 33345899999999999999999999999988643 3445678899999999999887 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccCCCCCcCCC--
Q 024661 173 EKL-GPSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~~-- 246 (264)
||+ +++|.+++.... ..+ ++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999 899999998642 234 78889999999999999999999999999999999986 67999999999865422
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 164 ~~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 164 PCTETFTGTLQYMAPEVID 182 (268)
T ss_pred CccccCCCCccccChhhhc
Confidence 223677899999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=194.96 Aligned_cols=163 Identities=16% Similarity=0.195 Sum_probs=134.2
Q ss_pred eEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC-
Q 024661 94 YRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN- 166 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 166 (264)
|++.+.||+|+||.||+|....+ +..+|+|.++.. ......+.+|++.++.++|+++ +++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV-----MKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEeeeccCCc
Confidence 56789999999999999987643 478999998743 2334678899999999999888 89888775544
Q ss_pred -----EEEEEEecC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 167 -----HICIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 167 -----~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
..+++|||+ +++|..++.... ...+++..+..++.|++.||.|||+++++|+||||+||++++++.+||+
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEEC
Confidence 389999999 999999986431 2358999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 237 DYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
|||+++..... ...+..|++||.+.
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcc
Confidence 99998753321 12345799999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=193.63 Aligned_cols=156 Identities=25% Similarity=0.376 Sum_probs=129.5
Q ss_pred ecccCccEEEEEEEeC--CCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEec
Q 024661 99 KMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 174 (264)
.||+|+||.||+|.+. ..+..+|+|++.... ...+.+.+|+.+++.++|+++ +++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI-----VRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEc-CCCeEEEEEe
Confidence 4899999999999775 345679999886432 334678899999999999887 99998875 4578999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC------
Q 024661 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF------ 247 (264)
Q Consensus 175 ~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~------ 247 (264)
+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+|||++.++.++|+|||++......
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9 899999987543 36899999999999999999999999999999999999999999999999998743221
Q ss_pred ---cccceeeeeceeEe
Q 024661 248 ---SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ---~~~~~~y~ape~~~ 261 (264)
..++..|+|||.+.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (257)
T cd05115 155 RSAGKWPLKWYAPECIN 171 (257)
T ss_pred cCCCCCCcccCCHHHHc
Confidence 11245799999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=193.34 Aligned_cols=156 Identities=24% Similarity=0.333 Sum_probs=131.8
Q ss_pred eecccCccEEEEEEEeCCCC---cEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKK---ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
++||+|+||.||+|.+..++ ..+++|.+..... ..+.+.+|+.+++.+.|+++ +++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI-----VRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEc-CCceEEEE
Confidence 47999999999999876554 7899999875443 55678889999999998887 99988776 45689999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc---
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS--- 248 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~--- 248 (264)
||+ +++|.+++.... .+++..+..++.|++.||+|||+++++|+||||+|||++.++.++|+|||+++......
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999 899999998765 78999999999999999999999999999999999999999999999999987542211
Q ss_pred ------ccceeeeeceeEe
Q 024661 249 ------FQTFLSMASRVYI 261 (264)
Q Consensus 249 ------~~~~~y~ape~~~ 261 (264)
.++..|++||.+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05060 153 RATTAGRWPLKWYAPECIN 171 (257)
T ss_pred ccccCccccccccCHHHhc
Confidence 1234699999754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=197.55 Aligned_cols=164 Identities=24% Similarity=0.375 Sum_probs=144.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||.|++|.||+|.+..+++.+++|.+... ......+.+|+++++.+.|+++ +.+++.+...+.++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI-----VGFYGAFYNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCch-----hhhheeeecCCEEE
Confidence 3588889999999999999999999999999988754 3445678889999999998888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
+++|++ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999 799999998763 478999999999999999999999 9999999999999999999999999999865422
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~ 172 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQ 172 (265)
T ss_pred HhhcccCChhccCHHHHc
Confidence 245777899999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=200.69 Aligned_cols=162 Identities=21% Similarity=0.344 Sum_probs=136.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCC--CcEEEEEEEech---hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee---
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEK--KELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD--- 163 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~--- 163 (264)
+|++.+.||+|+||.||++.+..+ +..+|+|.+... ....+.+.+|+.+++.+. |+|+ +++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI-----TCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCCh-----heeeeeeeecc
Confidence 488999999999999999999888 889999988642 223456788999999984 7777 88877543
Q ss_pred -eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 -YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 -~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
....+|+++|+++++|.+++.... .+++..++.++.||+.||+|||++|++|+||||+|||++.++.++|+|||++.
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 235689999999889999997654 78999999999999999999999999999999999999999999999999987
Q ss_pred cCCC----------CcccceeeeeceeEe
Q 024661 243 PRHA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~----------~~~~~~~y~ape~~~ 261 (264)
.... ...++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHh
Confidence 5321 224778899999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=195.15 Aligned_cols=163 Identities=17% Similarity=0.213 Sum_probs=132.8
Q ss_pred eEEEeecccCccEEEEEEEeCCCCc--EEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee----
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~---- 164 (264)
|.+.+.||+|+||.||+|.+..++. .+|+|.++.. ....+.+.+|+.+++.++|+|+ +++++.+..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV-----MRLIGVCLQTVES 75 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEccCCcc
Confidence 3567899999999999999877765 5899987642 3445678889999999999988 888876532
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
....+++|||+ +++|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence 23579999999 89999987532 223588999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCCC--------cccceeeeeceeEe
Q 024661 238 YKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
||++...... ...+..|++||.+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 187 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA 187 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHcc
Confidence 9998764321 12455799999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=193.79 Aligned_cols=158 Identities=18% Similarity=0.208 Sum_probs=130.4
Q ss_pred eecccCccEEEEEEEeCCC------------CcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 98 SKMGEGTFGQVVECFDNEK------------KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
+.||+|+||.||+|..... ...+++|++.... .....+.+|+.+++.+.|+|+ +++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~i-----v~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHI-----VLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 4689999999999985322 2358888876432 334577888899999999888 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc-------EEec
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY-------VKVP 236 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~-------v~l~ 236 (264)
+...+++|||+ +++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999 888888877543 36899999999999999999999999999999999999987664 8999
Q ss_pred cCCCCCcCCC--CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA--FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~--~~~~~~~y~ape~~~ 261 (264)
|||++..... ...++..|||||.+.
T Consensus 155 d~g~~~~~~~~~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 155 DPGIPITVLSRQECVERIPWIAPECVE 181 (262)
T ss_pred CCCCCccccCcccccccccccChhhhc
Confidence 9999875433 334677899999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=192.81 Aligned_cols=165 Identities=22% Similarity=0.313 Sum_probs=141.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CCE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH 167 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~~ 167 (264)
+|++.+.||.|+||.||+|.+..++..+++|.+... ....+.+..|+++++.+.|+++ +++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI-----VRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCcc-----ceeeeeeecCCCCE
Confidence 488999999999999999999999999999988632 3445678889999999999888 898887754 567
Q ss_pred EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMH-----ELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-----~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.|++|||+ +++|.+++... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence 89999999 89999999753 2346899999999999999999999 8999999999999999999999999999
Q ss_pred CCCcCCCC------cccceeeeeceeEee
Q 024661 240 VPSPRHAF------SFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~~------~~~~~~y~ape~~~~ 262 (264)
++...... ..++..|++||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcC
Confidence 98865432 246778999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=191.11 Aligned_cols=164 Identities=26% Similarity=0.469 Sum_probs=144.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.+.||.|+||.||++.+..++..+++|++... ......+.+|+++++.++|+++ +.+.+.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-----~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI-----IKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCCh-----hheEEEEecCCEEE
Confidence 589999999999999999999999999999998743 2456678889999999998887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+++|++ +++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999 889999998642 34799999999999999999999999999999999999999999999999999876433
Q ss_pred C------cccceeeeeceeEe
Q 024661 247 F------SFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~------~~~~~~y~ape~~~ 261 (264)
. ..++..|++||.+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~ 176 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQ 176 (258)
T ss_pred CcceecceeeeecccChhHhc
Confidence 2 34677899999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=192.26 Aligned_cols=158 Identities=18% Similarity=0.281 Sum_probs=130.3
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHH-HHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVL-QRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l-~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||.|+||.||+|.+..+++.+|+|++.+... ....+..|..++ ....|+|+ +++++.+..++.+|++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV-----AKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCe-----eeeeeeEEcCCeEEEEE
Confidence 579999999999999999999999999875321 112233343333 23355555 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--CCcc
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--AFSF 249 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--~~~~ 249 (264)
||+ +++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.... ....
T Consensus 77 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (260)
T cd05611 77 EYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154 (260)
T ss_pred eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence 999 999999998765 68999999999999999999999999999999999999999999999999987543 2334
Q ss_pred cceeeeeceeEee
Q 024661 250 QTFLSMASRVYIC 262 (264)
Q Consensus 250 ~~~~y~ape~~~~ 262 (264)
++..|++||.+.+
T Consensus 155 ~~~~y~~pe~~~~ 167 (260)
T cd05611 155 GTPDYLAPETILG 167 (260)
T ss_pred CCcCccChhhhcC
Confidence 7788999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=194.22 Aligned_cols=159 Identities=21% Similarity=0.315 Sum_probs=132.3
Q ss_pred eecccCccEEEEEEEeCCCCc--EEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|+||.||+|.+..++. .+++|.++.. ....+.+.+|+++++++ .|+++ +++++++...+.+|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCe-----eeEEEEEecCCCceEEE
Confidence 368999999999999987775 4688877632 34456788899999999 67777 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 173 EKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
||+ +++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 999 899999997532 12478899999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCCC-----cccceeeeeceeEe
Q 024661 238 YKVPSPRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~~-----~~~~~~y~ape~~~ 261 (264)
||++...... ...+..|+|||++.
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLN 184 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHc
Confidence 9998643211 12345699999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=204.50 Aligned_cols=171 Identities=26% Similarity=0.484 Sum_probs=147.4
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec--------hhhhHHHHHHHHHHHHHHhccCCCCcce
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQRLARHDIGGTRC 155 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 155 (264)
|.....+.++|.++..||+|+|+.||+|.+....+.||+|+-.. .....+...+|.++.+.|.|+.|
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI----- 529 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI----- 529 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee-----
Confidence 44455777899999999999999999999999999999997542 22345667889999999999888
Q ss_pred EEEceeeee-CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCCEEeecC-
Q 024661 156 VQIRNWFDY-RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSA- 230 (264)
Q Consensus 156 ~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dikp~Nili~~~- 230 (264)
|++|++|.- .+.+|-|+||| |.+|.-||+.++ -+++++++.|+.||+.||.||.+. .|||=||||.|||+.++
T Consensus 530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 999999965 57899999999 889999999887 799999999999999999999976 59999999999999865
Q ss_pred --CcEEeccCCCCCcCC-------------CCcccceeeeeceeEe
Q 024661 231 --EYVKVPDYKVPSPRH-------------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 231 --~~v~l~Dfg~a~~~~-------------~~~~~~~~y~ape~~~ 261 (264)
|.+||+|||++..-. ....||++|+.||.|.
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 689999999997633 2346899999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=193.87 Aligned_cols=159 Identities=22% Similarity=0.242 Sum_probs=130.4
Q ss_pred eecccCccEEEEEEEeCCC--CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNEK--KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
++||+|+||.||+|..... ...+++|.+... ....+.+.+|+.+++.++|+|+ +++++.+.+....|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNI-----LQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcch-----hheEEEecCCCccEEEEe
Confidence 3699999999999975433 334667766533 2345678899999999999888 999999999999999999
Q ss_pred cC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-----
Q 024661 174 KL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH----- 245 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~----- 245 (264)
|+ +++|.+++.... ....++..++.++.||+.||+|||+++++|+||||+|||++.++.++|+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 99 899999998642 1246677888999999999999999999999999999999999999999999986421
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVG 174 (268)
T ss_pred hcccCCcCcccccCchhcc
Confidence 1224667899999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=197.00 Aligned_cols=159 Identities=19% Similarity=0.280 Sum_probs=133.8
Q ss_pred eecccCccEEEEEEEeCCCCc-------EEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKE-------LVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+.||+|+||.||+|.+...+. .+++|.+.... ...+.+.+|+.+++.+.|+|+ +.+++++......+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL-----VLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCCh-----hheeeEEEeCCCcE
Confidence 469999999999999865443 38888776433 345677889999999999888 99999999989999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc--------EEeccCCC
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY--------VKVPDYKV 240 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~--------v~l~Dfg~ 240 (264)
+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999 899999998654 35899999999999999999999999999999999999987764 69999999
Q ss_pred CCcCCC--CcccceeeeeceeEee
Q 024661 241 PSPRHA--FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~--~~~~~~~y~ape~~~~ 262 (264)
+..... ...++..|||||++..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 155 SITVLPKEILLERIPWVPPECIEN 178 (258)
T ss_pred ccccCCchhccccCCccCchhccC
Confidence 876443 2346778999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=192.90 Aligned_cols=158 Identities=24% Similarity=0.307 Sum_probs=134.8
Q ss_pred eecccCccEEEEEEEeCC-CC--cEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
+.||+|++|.||+|.+.. .+ ..+++|.+.... ...+.+.+|+.++++++|+|+ +++++.+.+ ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL-----IRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCc-----cceeEEEcC-CeEEEEE
Confidence 468999999999999865 33 368999987543 356788899999999999888 999999888 8999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
|++ +++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999 89999999875434689999999999999999999999999999999999999999999999999876432
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~ 173 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLR 173 (257)
T ss_pred ecccCCCCCceecCHHHhc
Confidence 223566899999754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=197.11 Aligned_cols=166 Identities=19% Similarity=0.307 Sum_probs=139.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.++|++.+.||+|+||.||+|.+.. ++..+++|++... ......+.+|+.+++.+.|+++ +++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----v~~~~~~~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI-----VKLLGVCA 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCch-----heEEEEEc
Confidence 3579999999999999999998753 5778999988743 2345668889999999999888 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNS--------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 222 (264)
+....|++|||+ +++|.+++.... ...+++..++.++.|++.||.|||+++++|+||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 999999999999 889999997432 12367888999999999999999999999999999
Q ss_pred CCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 223 ENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 223 ~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+||+++.++.++|+|||++..... ....+..|+|||.+.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 999999999999999999875322 112345699999754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=191.60 Aligned_cols=157 Identities=21% Similarity=0.305 Sum_probs=133.4
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
+.||+|+||.||+|... ++..+++|.++.. ......+.+|+++++.+.|+|+ +.+++++...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI-----VKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCc-----CeEEEEEecCCccEEEEECC
Confidence 46899999999999854 6788999988643 2334568889999999999888 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc------
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS------ 248 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~------ 248 (264)
+++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999999987654 358899999999999999999999999999999999999999999999999986533221
Q ss_pred -ccceeeeeceeEe
Q 024661 249 -FQTFLSMASRVYI 261 (264)
Q Consensus 249 -~~~~~y~ape~~~ 261 (264)
..+..|+|||++.
T Consensus 154 ~~~~~~y~aPE~~~ 167 (250)
T cd05085 154 KQIPIKWTAPEALN 167 (250)
T ss_pred CCCcccccCHHHhc
Confidence 2345699999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=195.13 Aligned_cols=163 Identities=24% Similarity=0.326 Sum_probs=141.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
..|...+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.+.|+++ +++++++...+..|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----v~~~~~~~~~~~~~~ 93 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI-----VEMYSSYLVGDELWV 93 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCCh-----heEEEEEEcCCeEEE
Confidence 34666789999999999999999899999999886432 334567889999999998888 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
++||+ +++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 94 VMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999 89999998873 589999999999999999999999999999999999999999999999998764322
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...++..|++||.+.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~ 189 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISR 189 (285)
T ss_pred ccccccCCccccCHHHhcC
Confidence 2347788999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=199.12 Aligned_cols=165 Identities=25% Similarity=0.396 Sum_probs=138.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
.++|++.++||+|+||.||+|.+..+++.+++|.+.... .......+|+++++.++|+++ +++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV-----VPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCc-----cchhhheecccc
Confidence 578999999999999999999999999999999886432 223456789999999999988 888777643
Q ss_pred -----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
...+++||||+.++|.+.+.... ..+++..+..++.|+++||.|||++|++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 34579999999888888877543 469999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC-----------------cccceeeeeceeEe
Q 024661 240 VPSPRHAF-----------------SFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~~-----------------~~~~~~y~ape~~~ 261 (264)
++...... ..++..|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence 98753221 12456799999764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-30 Score=214.79 Aligned_cols=165 Identities=25% Similarity=0.340 Sum_probs=147.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...+++++..||-|+||.|=++........+|+|++++. ....+.+..|-.++..++.+.| |++|..|.+.
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fI-----vrLYrTfrd~ 492 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFI-----VRLYRTFRDS 492 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHH-----HHHHHHhccc
Confidence 335577788999999999999988777667899988753 3566778889999999887766 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.++|++||-| ||.|+..+++.+ .|++..++.|+..+++|++|||++|||+|||||+|++++.+|.+||.|||+|...
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999 999999999887 8999999999999999999999999999999999999999999999999999875
Q ss_pred CC-----CcccceeeeeceeEe
Q 024661 245 HA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~-----~~~~~~~y~ape~~~ 261 (264)
.. ..+||+.|.|||+++
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred ccCCceeeecCCcccccchhhh
Confidence 43 447999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=202.33 Aligned_cols=164 Identities=24% Similarity=0.384 Sum_probs=137.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC---
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 165 (264)
+.++|.+.+.||.|+||.||+|.+..+++.|++|.+.... ...+.+.+|+++++.++|+++ +++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~ 77 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVYEVLGPSGSD 77 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcc-----hhhHhhhcccccc
Confidence 4578999999999999999999999999999999886433 344667889999999999988 7777665443
Q ss_pred -----------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcE
Q 024661 166 -----------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYV 233 (264)
Q Consensus 166 -----------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v 233 (264)
...|+||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 468999999988999888653 5899999999999999999999999999999999999985 5678
Q ss_pred EeccCCCCCcCCC---------CcccceeeeeceeEe
Q 024661 234 KVPDYKVPSPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 234 ~l~Dfg~a~~~~~---------~~~~~~~y~ape~~~ 261 (264)
+|+|||++..... ...++..|+|||.+.
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHh
Confidence 9999999865321 124577899999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=191.92 Aligned_cols=157 Identities=22% Similarity=0.333 Sum_probs=135.2
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
++||.|+||.||+|.+.. ++.+++|.+.... .....+.+|+++++.+.|+++ +.+++++.+....++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI-----VKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----EEEEEEEecCCCeEEEEEcC
Confidence 479999999999999887 8999999887432 345678899999999999887 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-------
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF------- 247 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~------- 247 (264)
+++|.+++.... ..+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 899999997643 36889999999999999999999999999999999999999999999999998754421
Q ss_pred -cccceeeeeceeEe
Q 024661 248 -SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -~~~~~~y~ape~~~ 261 (264)
...+..|++||.+.
T Consensus 154 ~~~~~~~y~~PE~~~ 168 (251)
T cd05041 154 LKQIPIKWTAPEALN 168 (251)
T ss_pred cCcceeccCChHhhc
Confidence 12245699999764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=194.74 Aligned_cols=167 Identities=26% Similarity=0.369 Sum_probs=147.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...+.|++...||.|++|.||+|.+..++..+++|++.......+.+.+|++.++.++|+|+ +++++.+...+..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI-----VDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCe-----eEEEEEEEECCEE
Confidence 45567999999999999999999999889999999998654456678889999999999887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+++||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999 799999998764 4689999999999999999999999999999999999999999999999998765332
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~ 189 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIK 189 (286)
T ss_pred hhhhccccCCcccCCHhHhc
Confidence 223667899999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=196.94 Aligned_cols=173 Identities=19% Similarity=0.238 Sum_probs=127.2
Q ss_pred eeCCccCCCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEechhhh--HHH-------HHHHHHHHHHHhccCCCC
Q 024661 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--REA-------AMIEIDVLQRLARHDIGG 152 (264)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~-------~~~e~~~l~~l~~~~~~~ 152 (264)
.+.+...++|++.+.||+|+||.||+|.+..+ +..+++|+....... .+. ...++..+.. ..++.|
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~--~~~~~h 82 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN--IHNIDH 82 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHH--hccCCC
Confidence 34556678899999999999999999998877 667777764322111 000 0111111111 223344
Q ss_pred cceEEEceeeeeCC----EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 153 TRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 153 ~~~~~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
++++.+++++.... ..++++|++..++.+.+.... ..++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus 83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 83 LGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD 160 (294)
T ss_pred CCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 55588887655432 568899999778888877643 467888999999999999999999999999999999999
Q ss_pred cCCcEEeccCCCCCcCC-------------CCcccceeeeeceeEe
Q 024661 229 SAEYVKVPDYKVPSPRH-------------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~~-------------~~~~~~~~y~ape~~~ 261 (264)
.++.++|+|||+|+... ....+|..|+|||++.
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 99999999999986531 1224889999999764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=190.21 Aligned_cols=162 Identities=30% Similarity=0.395 Sum_probs=145.1
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--CE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NH 167 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~--~~ 167 (264)
+|++.+.||+|++|.||+|.+..++..+++|++.... ...+.+.+|+.+++++.|+++ +.+++.+.+. ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI-----VRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEecCCCCe
Confidence 4888999999999999999999999999999987544 456788899999999998887 9999999888 89
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
++++||++ +++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999 999999998765 799999999999999999999999999999999999999999999999999876433
Q ss_pred C--------cccceeeeeceeEe
Q 024661 247 F--------SFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~--------~~~~~~y~ape~~~ 261 (264)
. ..++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~ 176 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIR 176 (260)
T ss_pred ccccccccCCCCCccccCHhhhc
Confidence 2 34677899999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=192.95 Aligned_cols=164 Identities=23% Similarity=0.281 Sum_probs=137.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|.+.+.||.|+||.||+|.+... ...+++|..... ....+.+.+|+.+++.+.|+|+ +++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI-----VKLIGVITE- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCch-----hceeEEEcC-
Confidence 35699999999999999999987544 346899987643 3455678899999999999888 999988875
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
...|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 5578999999 899999998654 35899999999999999999999999999999999999999999999999998754
Q ss_pred CCC-------cccceeeeeceeEe
Q 024661 245 HAF-------SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~-------~~~~~~y~ape~~~ 261 (264)
... ......|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred ccccceecCCCCccccccChhhhc
Confidence 322 12234699999753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=192.85 Aligned_cols=163 Identities=31% Similarity=0.475 Sum_probs=137.5
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHh---ccCCCCcceEEEceeeeeCCE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~---~~~~~~~~~~~~~~~~~~~~~ 167 (264)
|++.+.||+|+||.||+|.+..++..+++|.++... .....+.+|+.+++.+. |+++ +++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i-----~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI-----VRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCc-----ceEEEEEeeccC
Confidence 678999999999999999999889999999987422 22345667888887774 6666 999999988776
Q ss_pred -----EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 168 -----ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 168 -----~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
++++||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 76 DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999997799999887554468999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC-----cccceeeeeceeEe
Q 024661 243 PRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~~-----~~~~~~y~ape~~~ 261 (264)
..... ..++..|++||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~ 179 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLL 179 (287)
T ss_pred eccCCcccccccccccccChHHhc
Confidence 64322 23567799999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=192.40 Aligned_cols=166 Identities=22% Similarity=0.307 Sum_probs=137.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+.+-+..||.|+||+|++..++.+|+.+|||.++.. +...+++..|.+...+- .+. +++|++++....++..|+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks--~~c--p~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS--SNC--PNIVKFYGALFSEGDCWI 140 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh--cCC--cHHHHHhhhhhcCCceee
Confidence 355577899999999999999999999999999854 35566777777765543 333 667999999999999999
Q ss_pred EEecCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 171 VFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 171 v~e~~~~~L~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.||+|..+|..+-+ ..+...++|..+..|....+.||+||.+ ..|+||||||+|||++..|.|||||||++-....
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999888776544 3334579999999999999999999985 5899999999999999999999999999965443
Q ss_pred -----CcccceeeeeceeEee
Q 024661 247 -----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~~ 262 (264)
...|-..|||||-+..
T Consensus 221 SiAkT~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDP 241 (361)
T ss_pred HHHhhhccCCccccChhccCC
Confidence 4456778999997643
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=198.24 Aligned_cols=166 Identities=26% Similarity=0.327 Sum_probs=142.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
....|...+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+++++.++|+++ +++.+++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLRE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcC
Confidence 334588889999999999999999999999999988632 2334567789999999999888 9999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
...|+||||+.++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9999999999778888876543 358999999999999999999999999999999999999999999999999987644
Q ss_pred C--CcccceeeeeceeEe
Q 024661 246 A--FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--~~~~~~~y~ape~~~ 261 (264)
. ...++..|+|||.+.
T Consensus 167 ~~~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 167 PANXFVGTPYWMAPEVIL 184 (308)
T ss_pred CcccccCCccccCHHHHh
Confidence 3 234778899999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=193.88 Aligned_cols=155 Identities=23% Similarity=0.383 Sum_probs=136.1
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||.|+||.||++.+..+++.+++|++.... ...+.+.+|+++++.+.|+|+ +++++.+..+...|++||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcch-----hHHHHheecCcEEEEEEecC
Confidence 689999999999999999999999987432 345678889999999999888 88999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-------
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF------- 247 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~------- 247 (264)
+++|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 889999998765 7899999999999999999999999999999999999999999999999998653222
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
..++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred ccccccCcccCccccCHHHhc
Confidence 23567799999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=197.27 Aligned_cols=163 Identities=21% Similarity=0.274 Sum_probs=135.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCc----EEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
++|+..+.||+|+||.||+|.+..+++ .+++|.+.... .....+.+|+.+++.+.|+|+ +++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL-----VRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEcCC
Confidence 568899999999999999999877775 46888776432 334467889999999999988 9999988654
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..++++|++ +|+|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 567899999 899999987654 35889999999999999999999999999999999999999999999999999754
Q ss_pred CCC--------cccceeeeeceeEe
Q 024661 245 HAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~--------~~~~~~y~ape~~~ 261 (264)
... ..++..||+||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIH 184 (303)
T ss_pred cCcccccccCCCccccccCCHHHhc
Confidence 321 12355799999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=202.26 Aligned_cols=165 Identities=23% Similarity=0.381 Sum_probs=141.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++...||+|++|.||+|.+..+++.+++|++... ....+.+.+|+.+++.+.|+++ +.+.+++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV-----IGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCH-----HHHHHHhhcc
Confidence 3567899999999999999999999999999999988642 2334567789999999999888 8887777655
Q ss_pred CE------EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 NH------ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ~~------~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
+. .|+|+|+++++|.+++... .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 44 8999999999999998763 59999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---CcccceeeeeceeEe
Q 024661 240 VPSPRHA---FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~---~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|++||++.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (343)
T cd07851 164 LARHTDDEMTGYVATRWYRAPEIML 188 (343)
T ss_pred ccccccccccCCcccccccCHHHHh
Confidence 9976432 234677899999753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=199.91 Aligned_cols=165 Identities=24% Similarity=0.375 Sum_probs=139.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.+. ......+.+|+.+++.+.|+|+ +++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~~~~~~~ 86 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV-----IGLLDVFTSA 86 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCc-----cchhheeccc
Confidence 4457899999999999999999999999999999998643 2334567889999999999988 8888887653
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..+|+|||++..+|.+++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 3579999999778877653 258999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCC---cccceeeeeceeEee
Q 024661 240 VPSPRHAF---SFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~~---~~~~~~y~ape~~~~ 262 (264)
++...... ..++..|+|||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 163 LARHADAEMTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CCcCCCCCCCCceeeecccChhhhcC
Confidence 99764332 245778999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=192.56 Aligned_cols=166 Identities=18% Similarity=0.217 Sum_probs=139.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.+... ....+.+.+|+.+++.+.|+|+ +++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI-----LPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEec
Confidence 4679999999999999999999876 3577999988643 3445678889999999999988 898887655
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSY------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
....++++|++ +++|.+++..... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 57889999999 8999999976432 358899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|||+++.... ...++..|+|||.+.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 192 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence 9999975422 123455699999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=198.86 Aligned_cols=160 Identities=15% Similarity=0.173 Sum_probs=134.8
Q ss_pred eecccC--ccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
..||+| +||+||++.+..+|+.||+|++.... ...+.+.+|+.+++.++|+|+ ++++++|...+..|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI-----MTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEeeeEecCCceEEEE
Confidence 456776 89999999999999999999986432 334678889999999999988 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
||+ +++|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.++++||+.+.....
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999 88999999876545689999999999999999999999999999999999999999999999975432111
Q ss_pred --------CcccceeeeeceeEee
Q 024661 247 --------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~~ 262 (264)
...++..||+||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred cccccccccccCccCccChhhhcC
Confidence 1123456999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=190.76 Aligned_cols=160 Identities=22% Similarity=0.284 Sum_probs=132.3
Q ss_pred CCeEEEeec--ccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKM--GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+.|.+.+.+ |+|+||.||++....++..+++|.+....... .|+.....+ .|+++ +++++.+...+.+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~i-----v~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNF-----IKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCE-----EEEEEEEecCCee
Confidence 456776666 99999999999999999999999987532211 122222222 35555 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCcCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPRHA 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~~~ 246 (264)
|+||||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999 899999998765 799999999999999999999999999999999999999998 999999999875443
Q ss_pred --CcccceeeeeceeEee
Q 024661 247 --FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 163 ~~~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 163 PSCYDGTLDYFSPEKIKG 180 (267)
T ss_pred CccCCCCCcccChhhhcC
Confidence 2347788999998753
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=187.64 Aligned_cols=163 Identities=28% Similarity=0.427 Sum_probs=144.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.|.+.+.||+|++|.||++.+..+++.+++|++..... ....+.+|++.++.+.|+++ +++.+.+......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-----VKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCeEEEE
Confidence 38889999999999999999998999999999875443 56788899999999998877 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
+||+ +++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence 9999 799999988763 3689999999999999999999999999999999999999999999999999876543
Q ss_pred -CcccceeeeeceeEe
Q 024661 247 -FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 155 ~~~~~~~~~~~PE~~~ 170 (253)
T cd05122 155 NTMVGTPYWMAPEVIN 170 (253)
T ss_pred cceecCCcccCHHHHc
Confidence 234677899999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=216.91 Aligned_cols=167 Identities=18% Similarity=0.276 Sum_probs=143.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCc-----EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
-...-++.+.||+|.||.||.|....... .||+|.+++. .+....|.+|..+++.+.|+|+ +++++.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNi-----v~liGv~ 764 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNI-----VSLIGVC 764 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcce-----eeEEEee
Confidence 34567889999999999999999865432 4899988754 5667899999999999999998 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKN-----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
-+....+|++||| +|+|..+|+.. +...++....+.++.||+.|+.||+++++|||||..+|+|++....|||+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 9999999999999 99999999975 12468999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCCCcc----c----ceeeeeceeEe
Q 024661 237 DYKVPSPRHAFSF----Q----TFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~~~~----~----~~~y~ape~~~ 261 (264)
|||+|+......+ + ...||+||.+.
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHh
Confidence 9999996443221 1 13599999864
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-27 Score=193.11 Aligned_cols=163 Identities=24% Similarity=0.337 Sum_probs=138.2
Q ss_pred CeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee
Q 024661 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~ 163 (264)
+|++.+.||.|++|.||++.+. .+++.+++|++++.. ...+.+.+|+.+++++. |+++ +.+++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL-----VTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcch-----hhhheeee
Confidence 3889999999999999999864 357889999987432 23456778999999995 6666 88899999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
.+...|+||||+ +++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999 889999987654 68999999999999999999999999999999999999999999999999986
Q ss_pred cCCC-------CcccceeeeeceeEee
Q 024661 243 PRHA-------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~-------~~~~~~~y~ape~~~~ 262 (264)
.... ...++..|++||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred ccccccccccccccCCccccCHHHhcC
Confidence 5322 1236778999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=194.97 Aligned_cols=165 Identities=22% Similarity=0.324 Sum_probs=138.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|...+.||+|+||.||++.+..+++.+|+|.+... ......+.+|+.++.++. |+++ +++++++..++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----v~~~~~~~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI-----VKFYGALFREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCE-----eeeeeEEecCCcEE
Confidence 467788999999999999999999999999988643 234567788999999886 7776 99999999999999
Q ss_pred EEEecCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 170 lv~e~~~~~L~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
++||++++++.++.. ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999999777766543 22234799999999999999999999974 99999999999999999999999999986532
Q ss_pred C-----CcccceeeeeceeEee
Q 024661 246 A-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~-----~~~~~~~y~ape~~~~ 262 (264)
. ...++..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDP 181 (288)
T ss_pred cCCccccccCccCccCHHHhcc
Confidence 2 2346778999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=190.10 Aligned_cols=158 Identities=18% Similarity=0.211 Sum_probs=129.5
Q ss_pred eecccCccEEEEEEEeCC---CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee-eCCEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHICIV 171 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~-~~~~~~lv 171 (264)
+.||+|+||.||+|.+.. .+..+|+|.+... ....+.+.+|+.+++.++|+|+ +++++.+. .++..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV-----LSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCc-----ceEEEEeecCCCCcEEE
Confidence 368999999999998653 3457999987532 3345677889999999999888 88888654 46678999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+ +++|.+++.... ...++..+..++.|++.||.|||+.+++|+||||+|||++.++.++|+|||+++....
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999 899999998653 3467788899999999999999999999999999999999999999999999875322
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred eecccccCcCCccccChhHhc
Confidence 122456799999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=188.86 Aligned_cols=165 Identities=28% Similarity=0.404 Sum_probs=142.9
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+|++.++||.|+||.||++.+..+++.+++|.+... ......+.+|+++++.++|+++ +.+.+.+.+....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI-----ISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCc-----hhhhhhhccCCEEE
Confidence 489999999999999999999999999999998743 2345567789999999998887 89999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+||||+ +++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999 899999987621 23689999999999999999999999999999999999999999999999999865433
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...++..|++||.+.+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 156 NMAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred CCcccccCCccccCHHHHCC
Confidence 2346778999997643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=194.79 Aligned_cols=159 Identities=19% Similarity=0.304 Sum_probs=135.5
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-----CEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----NHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-----~~~ 168 (264)
-+.||-|.||.||.+++..+|+.|++|.+... -...+.+.+|+.+|..++|.|+ ...++..+-. .++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNV-----LSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNV-----LSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccH-----HHHHHhcCCCCchHHHHH
Confidence 46899999999999999999999999987532 2345778899999999999987 5555444321 357
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS 248 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~ 248 (264)
|+++|++..+|..++-+-+ .++.+.+.-++.||+.||.|||+.+|.||||||.|+|++++..+||||||+|+......
T Consensus 133 YV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8999999999999988765 78999999999999999999999999999999999999999999999999998755433
Q ss_pred -------ccceeeeeceeEee
Q 024661 249 -------FQTFLSMASRVYIC 262 (264)
Q Consensus 249 -------~~~~~y~ape~~~~ 262 (264)
.-|.+|.|||++++
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhc
Confidence 35788999999886
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=193.78 Aligned_cols=163 Identities=29% Similarity=0.494 Sum_probs=142.1
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|+.+++.+.|+++ +++++.+.+....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI-----IKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCc-----chHHHhhccCCCEEE
Confidence 567889999999999999999899999999886432 235677889999999998888 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
+|||+.++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+......
T Consensus 76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 99999779999888753 46899999999999999999999999999999999999999999999999998765432
Q ss_pred ---cccceeeeeceeEee
Q 024661 248 ---SFQTFLSMASRVYIC 262 (264)
Q Consensus 248 ---~~~~~~y~ape~~~~ 262 (264)
..++..|++||.+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 155 YTHYVVTRWYRAPELLLG 172 (283)
T ss_pred ccCccCcccccCcHHHhc
Confidence 346778999997653
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=193.30 Aligned_cols=162 Identities=29% Similarity=0.472 Sum_probs=141.7
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
|++.+.||+|.+|.||+|+...+++.+++|.+... ....+.+..|+.+++.+.|+++ +++++++.+.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI-----VKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCH-----HHHHhhhhcCCceEE
Confidence 67788999999999999999999999999998753 3345677889999999998887 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99999889999998763 36999999999999999999999999999999999999999999999999998754322
Q ss_pred ---cccceeeeeceeEe
Q 024661 248 ---SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ---~~~~~~y~ape~~~ 261 (264)
...+..|+|||.+.
T Consensus 155 ~~~~~~~~~~~aPE~~~ 171 (282)
T cd07829 155 YTHEVVTLWYRAPEILL 171 (282)
T ss_pred cCccccCcCcCChHHhc
Confidence 23466799999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=193.97 Aligned_cols=160 Identities=23% Similarity=0.320 Sum_probs=138.1
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
|....+||+|+||.||++....+++.+++|.+... ......+.+|+.+++.+.|+++ +++++.+...+..|++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcch-----hheeeEEEeCCEEEEEE
Confidence 44457899999999999999999999999988632 2345678889999999998888 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
||+ +++|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 999 88999887653 589999999999999999999999999999999999999999999999998764322
Q ss_pred -CcccceeeeeceeEe
Q 024661 247 -FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -~~~~~~~y~ape~~~ 261 (264)
...++..|++||.+.
T Consensus 174 ~~~~~~~~y~~pE~~~ 189 (292)
T cd06657 174 KSLVGTPYWMAPELIS 189 (292)
T ss_pred cccccCccccCHHHhc
Confidence 224677899999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=201.89 Aligned_cols=172 Identities=22% Similarity=0.366 Sum_probs=133.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeC----------------CCCcEEEEEEEechhh-h--------------HHHHHHH
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDN----------------EKKELVAIKIVRSINK-Y--------------REAAMIE 138 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~-~--------------~~~~~~e 138 (264)
-.++|++.++||+|+||.||+|.+. ..++.||||.++.... . .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 2346799999864221 1 1223447
Q ss_pred HHHHHHHhccCCCCcceEEEceeeee--------CCEEEEEEecC-CCCHHHHHHhcC----------------------
Q 024661 139 IDVLQRLARHDIGGTRCVQIRNWFDY--------RNHICIVFEKL-GPSLYDFLRKNS---------------------- 187 (264)
Q Consensus 139 ~~~l~~l~~~~~~~~~~~~~~~~~~~--------~~~~~lv~e~~-~~~L~~~l~~~~---------------------- 187 (264)
+.++.++.|.++.+.+++.+++++.. ++..|+||||+ +++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 77888888887766667777777643 45789999999 999999886421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-------CcccceeeeeceeE
Q 024661 188 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-------FSFQTFLSMASRVY 260 (264)
Q Consensus 188 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-------~~~~~~~y~ape~~ 260 (264)
...+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.++|+|||++..... ....++.|++||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 11245678899999999999999999999999999999999999999999999865322 12246789999987
Q ss_pred e
Q 024661 261 I 261 (264)
Q Consensus 261 ~ 261 (264)
.
T Consensus 383 ~ 383 (507)
T PLN03224 383 V 383 (507)
T ss_pred c
Confidence 5
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=191.36 Aligned_cols=159 Identities=19% Similarity=0.300 Sum_probs=132.9
Q ss_pred eecccCccEEEEEEEeCCCC------cEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKK------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+.||.|+||.||+|++.... +.+++|.+.... .....+.+|+.+++.++|+++ +++++++.+....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI-----VKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCe-----eeEeeeecCCCCeE
Confidence 36899999999999976433 679999876432 345678889999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-----cEEeccC
Q 024661 170 IVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-----YVKVPDY 238 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-----~v~l~Df 238 (264)
+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999 899999997532 23478899999999999999999999999999999999999887 8999999
Q ss_pred CCCCcCCC--------CcccceeeeeceeEe
Q 024661 239 KVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|++..... ....+..|++||.+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHc
Confidence 99865321 123456799999764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=194.20 Aligned_cols=154 Identities=17% Similarity=0.158 Sum_probs=130.0
Q ss_pred ccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCH
Q 024661 104 TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSL 179 (264)
Q Consensus 104 ~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L 179 (264)
++|.||+++...+++.+|+|++... ......+.+|+++++.++|+|+ +.+++++...+..|++|||+ +++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI-----LPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcch-----hhhhheeecCCeEEEEEeccCCCCH
Confidence 4455666666778999999998743 3445678899999999999888 99999999999999999999 8999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-------------
Q 024661 180 YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA------------- 246 (264)
Q Consensus 180 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~------------- 246 (264)
.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||.+.....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9999875445689999999999999999999999999999999999999999999999998864321
Q ss_pred CcccceeeeeceeEee
Q 024661 247 FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 167 ~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 167 SSVKNLPWLSPEVLQQ 182 (314)
T ss_pred cccccccccCHHHhcC
Confidence 1235667999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=190.88 Aligned_cols=164 Identities=23% Similarity=0.338 Sum_probs=137.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+.|++.+.||+|++|.||+|.+..+++.+|+|.+++.. .....+..|+.++.... |+++ +++++++.+....
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYI-----VKCYGYFITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCch-----HhhheeeecCCeE
Confidence 66999999999999999999999889999999987532 23345566776666654 6666 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|++|||++++|.+++.... ..+++..+..++.|++.||.|||+ .||+|+||+|+||++++++.++|+|||++.....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9999999888888877643 378999999999999999999997 6999999999999999999999999999865332
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||.+.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 169 KAKTRSAGCAAYMAPERID 187 (296)
T ss_pred CcccCCCCCccccCHhhcC
Confidence 223567899999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=186.27 Aligned_cols=155 Identities=26% Similarity=0.441 Sum_probs=137.7
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
||.|+||.||++.+..+++.+++|++.+.. .....+..|+.+++.+.|+++ +.+++.+..+...|++||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI-----VKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcH-----HHHHHHeecCCeeEEEEecC
Confidence 689999999999999889999999987533 244578889999999998887 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC------Cc
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA------FS 248 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~------~~ 248 (264)
+++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 999999998765 689999999999999999999999999999999999999999999999999876443 23
Q ss_pred ccceeeeeceeEe
Q 024661 249 FQTFLSMASRVYI 261 (264)
Q Consensus 249 ~~~~~y~ape~~~ 261 (264)
.++..|++||.+.
T Consensus 154 ~~~~~~~~Pe~~~ 166 (250)
T cd05123 154 CGTPEYLAPEVLL 166 (250)
T ss_pred cCCccccChHHhC
Confidence 4677899999764
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-29 Score=195.07 Aligned_cols=167 Identities=22% Similarity=0.400 Sum_probs=140.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
..+.|.-..+||+|.||.||+|+.+.+|+.||+|.+-- .........+|+.+|+.++|+|+ +.+++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv-----~nliEic~tk~ 89 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKA 89 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhH-----HHHHHHHhhcc
Confidence 34668889999999999999999999999999886532 33455677899999999999998 444444422
Q ss_pred ------CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccC
Q 024661 165 ------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 165 ------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
...+|+||++|..+|..++.... .+++...+..++.+++.||.|+|++.|+|||+|+.|+||+.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 45699999999999999998764 57999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCCC----C------cccceeeeeceeEee
Q 024661 239 KVPSPRHA----F------SFQTFLSMASRVYIC 262 (264)
Q Consensus 239 g~a~~~~~----~------~~~~~~y~ape~~~~ 262 (264)
|+++.... . ..-|..|..||.+++
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence 99965322 1 123788999998765
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=187.43 Aligned_cols=165 Identities=21% Similarity=0.399 Sum_probs=136.2
Q ss_pred CeEEEeecccCccEEEEEEEeCC-CCcEEEEEEEech-----------hhhHHHHHHHHHHHHH-HhccCCCCcceEEEc
Q 024661 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI-----------NKYREAAMIEIDVLQR-LARHDIGGTRCVQIR 159 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-----------~~~~~~~~~e~~~l~~-l~~~~~~~~~~~~~~ 159 (264)
.|++.+.||+|+||.||+|.+.. +++.+++|.+... ......+..|+.++.. +.|+|+ +.++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI-----VRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCe-----eeEE
Confidence 37889999999999999999987 6788999987521 1223445667776664 567766 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEe
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l 235 (264)
+++..++..|++|||+ +++|.+++... ....+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 9999999999999999 88999988542 23468999999999999999999996 78999999999999999999999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+|||++..... ...++..|++||.+.+
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcC
Confidence 99999876443 2346778999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=202.02 Aligned_cols=163 Identities=20% Similarity=0.278 Sum_probs=148.7
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
.....+||.|.||.||.|.++.-.-.||||.++.+....++|..|..+++.++|+|+ |+++++|..+..+|||+|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNL-----VqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccH-----HHHhhhhccCCCeEEEEe
Confidence 455778999999999999999988899999999888999999999999999999998 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCcc---
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSF--- 249 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~~--- 249 (264)
|| .|+|.+||+......++.-.+++++.||..|++||..+++|||||..+|+|+.++..||++|||+++.-...++
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 99 99999999977656788888999999999999999999999999999999999999999999999998665543
Q ss_pred ----cceeeeeceeEe
Q 024661 250 ----QTFLSMASRVYI 261 (264)
Q Consensus 250 ----~~~~y~ape~~~ 261 (264)
....|.|||-++
T Consensus 424 AGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLA 439 (1157)
T ss_pred cCccCcccccCccccc
Confidence 233599999754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=184.35 Aligned_cols=148 Identities=16% Similarity=0.221 Sum_probs=124.0
Q ss_pred CccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHH
Q 024661 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181 (264)
Q Consensus 103 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 181 (264)
|.+|.||++.+..+++.+++|.+..... ...|...+....|+|+ +++++++.+.+..|++|||+ +++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNM-----VCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCce-----eehhhheecCCeEEEEEecCCCCCHHH
Confidence 8899999999999999999999875432 2234444444445555 99999999999999999999 899999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---Ccccceeeeece
Q 024661 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---FSFQTFLSMASR 258 (264)
Q Consensus 182 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---~~~~~~~y~ape 258 (264)
++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+..... ....+..||+||
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 998765 689999999999999999999999999999999999999999999999998765433 223456799999
Q ss_pred eEe
Q 024661 259 VYI 261 (264)
Q Consensus 259 ~~~ 261 (264)
.+.
T Consensus 153 ~~~ 155 (237)
T cd05576 153 VGG 155 (237)
T ss_pred ccC
Confidence 763
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=205.60 Aligned_cols=168 Identities=18% Similarity=0.227 Sum_probs=117.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCC----CcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEcee--ee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW--FD 163 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~ 163 (264)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+....+ .++...+.++. ..+..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~-~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCA-DFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHH-HHHHhhhcccccc
Confidence 346799999999999999999999988 89999998764221 1111111 11111111110 000111110 24
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYR------------------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
.....++||||+ +++|.+++...... ...+..+..++.||+.||+|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 567899999999 88999998754210 11234567899999999999999999999999999
Q ss_pred EEeec-CCcEEeccCCCCCcCC-------CCcccceeeeeceeEe
Q 024661 225 ILLVS-AEYVKVPDYKVPSPRH-------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 225 ili~~-~~~v~l~Dfg~a~~~~-------~~~~~~~~y~ape~~~ 261 (264)
||++. ++.+||+|||+|+... ....+++.|||||.+.
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99996 5799999999997532 2345778899999653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=174.85 Aligned_cols=149 Identities=27% Similarity=0.420 Sum_probs=128.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|.++++||+|+||-+|+|....+|+.||||+-.. +.....+..|..+.+.+++-. .+..+..++..+.+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~----GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGV----GIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCC----CCchhhhhccccccc
Confidence 455789999999999999999999999999999997543 334456778999999998742 236667777788899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---CcEEeccCCCCCc
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---EYVKVPDYKVPSP 243 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---~~v~l~Dfg~a~~ 243 (264)
.+|||++|.+|.+++.-.. ..|+.+.++.++.|++.-++|+|.++++||||||+|+|++-+ .++.|+|||+|..
T Consensus 87 vlVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999999999987543 479999999999999999999999999999999999999865 4789999999976
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=185.03 Aligned_cols=162 Identities=16% Similarity=0.207 Sum_probs=131.5
Q ss_pred eEEEeecccCccEEEEEEEeC---CCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--
Q 024661 94 YRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 165 (264)
|++.+.||+|+||.||+|.+. .+++.+|+|++... ....+.+.+|+.+++.+.|+++ +++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV-----IKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccCCC
Confidence 667889999999999999864 35788999988643 2345667889999999999988 9999887543
Q ss_pred ----CEEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 166 ----NHICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 166 ----~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
...++++||+ +++|.+++... ....+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 2357899999 89999887532 11247889999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCC--------CcccceeeeeceeE
Q 024661 237 DYKVPSPRHA--------FSFQTFLSMASRVY 260 (264)
Q Consensus 237 Dfg~a~~~~~--------~~~~~~~y~ape~~ 260 (264)
|||+++.... ...++..|++||.+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESL 187 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHH
Confidence 9999876432 11234568999964
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=175.83 Aligned_cols=137 Identities=21% Similarity=0.188 Sum_probs=107.1
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhh---h------------------------HHHHHHHHHHHHHHhccC
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---Y------------------------REAAMIEIDVLQRLARHD 149 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~------------------------~~~~~~e~~~l~~l~~~~ 149 (264)
.+.||+|++|.||+|.+. +|+.||+|+++.... . ......|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 899999999874321 0 112245999999999887
Q ss_pred CCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEe
Q 024661 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILL 227 (264)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~ivH~dikp~Nili 227 (264)
+..+.... . ...+|||||+ ++++....... ..+++..+..++.|++.+|.++ |+.||+||||||+|||+
T Consensus 81 v~~p~~~~------~-~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPIL------L-KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEE------e-cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 74444332 1 1238999999 55555443332 3689999999999999999999 79999999999999999
Q ss_pred ecCCcEEeccCCCCCcC
Q 024661 228 VSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 228 ~~~~~v~l~Dfg~a~~~ 244 (264)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 588999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=202.84 Aligned_cols=164 Identities=22% Similarity=0.304 Sum_probs=145.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCC---cEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
..-.+.++||.|.||.||+|+.+..| ..||||.++. .++.+.+|..|..|+-+++|||| +++.++.....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNI-----IrLEGVVTks~ 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IRLEGVVTKSK 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcE-----EEEEEEEecCc
Confidence 44678889999999999999987765 4699999984 35677899999999999999998 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+.||+||| +|+|+.+|+.+.++ |+..++.-+++.|+.|+.||-++++|||||..+|||++.+-.+|++|||+++...
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999 99999999988744 9999999999999999999999999999999999999999999999999999875
Q ss_pred CCcc---cc------eeeeeceeEe
Q 024661 246 AFSF---QT------FLSMASRVYI 261 (264)
Q Consensus 246 ~~~~---~~------~~y~ape~~~ 261 (264)
+..- .| ..|.|||.++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred cCCCccccccCCccceeecChhHhh
Confidence 5441 11 2499999764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=185.62 Aligned_cols=163 Identities=27% Similarity=0.348 Sum_probs=135.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec------hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+|.+.+.||+|+||.||++.+...+..+++|+++. .......+..|+.+++.++|+|+ +++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI-----VKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcH-----HHHHHHHhcCC
Confidence 58999999999999999999988777677776652 12233456678899999999888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
..++||||+ +++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 999999999 88999988642 2346899999999999999999999999999999999999975 6799999998865
Q ss_pred CCC------CcccceeeeeceeEe
Q 024661 244 RHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~------~~~~~~~y~ape~~~ 261 (264)
... ...++..|++||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHc
Confidence 422 224667899999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-28 Score=207.43 Aligned_cols=163 Identities=27% Similarity=0.357 Sum_probs=146.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
-.++|.++..+|+|.||.||+++++.+++..|+|+++.+. ....-+..|+-+++.++|+|+ +-+++.+-....+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~ni-----vay~gsylr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNI-----VAYFGSYLRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcCh-----HHHHhhhhhhcCc
Confidence 3467999999999999999999999999999999998654 334556679999999999998 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC---
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR--- 244 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~--- 244 (264)
|++|||| +|+|.+.-.-.. .+++.++..++++.+.+|+|||++|-+|||||-.|||+++.|.+||+|||.+..+
T Consensus 88 wicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999 889999876654 8999999999999999999999999999999999999999999999999988653
Q ss_pred ---CCCcccceeeeecee
Q 024661 245 ---HAFSFQTFLSMASRV 259 (264)
Q Consensus 245 ---~~~~~~~~~y~ape~ 259 (264)
..+..||++|||||+
T Consensus 166 i~KrksfiGtpywmapEv 183 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEV 183 (829)
T ss_pred hhhhhcccCCccccchhH
Confidence 346679999999997
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=170.90 Aligned_cols=138 Identities=19% Similarity=0.116 Sum_probs=108.1
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhh---------------------------hHHHHHHHHHHHHHHhccC
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQRLARHD 149 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l~~l~~~~ 149 (264)
.+.||+|++|.||+|.+. +|+.||+|+++.... .......|.+.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999874311 0123457899999999988
Q ss_pred CCCcceEEEceeeeeCCEEEEEEecC-CCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEE
Q 024661 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD-FLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226 (264)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~-~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nil 226 (264)
+..+.... .. ..||||||+ |+++.. .+.. ..++...+..++.|++.+|.++|. +||+||||||+|||
T Consensus 81 i~~p~~~~-----~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPIL-----LK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEE-----ec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 63333221 11 248999999 554433 3433 257888999999999999999999 99999999999999
Q ss_pred eecCCcEEeccCCCCCcCCC
Q 024661 227 LVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~~~ 246 (264)
++ ++.++|+|||+|.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 89999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=175.89 Aligned_cols=163 Identities=18% Similarity=0.346 Sum_probs=137.0
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeee-
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~- 164 (264)
.....++|++.+++|+|.|+.||.|....+++.++||+++.-+ ...+.+|+.+|+.+. |+|+ +.+++...+
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NI-----i~L~DiV~Dp 105 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNI-----IKLLDIVKDP 105 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCe-----eehhhhhcCc
Confidence 3345578999999999999999999999999999999997433 366889999999998 6666 999999877
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCC
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVP 241 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a 241 (264)
.....|++|++ +.+...+.. .++...++.++.|++.||.|+|++||.|||+||.|++|+.. ..++|+|+|+|
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred cccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 45688999999 666555432 57788899999999999999999999999999999999965 58999999999
Q ss_pred CcCCCCc-----ccceeeeeceeEe
Q 024661 242 SPRHAFS-----FQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~~~-----~~~~~y~ape~~~ 261 (264)
...++.. ..+.+|-+||++.
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLV 205 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLV 205 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchhee
Confidence 8876643 2456788999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=174.60 Aligned_cols=162 Identities=25% Similarity=0.340 Sum_probs=136.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++-.|+++++||+|+||.++.|...-+++.||||.-. .+....++..|.+..+.|.+. +.|.+++.+.+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~----~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGT----EGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCC----CCCCceeeeccccchh
Confidence 34567999999999999999999999999999999643 345556788899999999864 3447888777888889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-----cEEeccCCCCCc
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-----YVKVPDYKVPSP 243 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-----~v~l~Dfg~a~~ 243 (264)
.||||++|.+|.|++.-.. ..|+.+.+..++.|++.-++|+|++.+|.|||||+|+||+..+ .+.++|||+|..
T Consensus 100 iLVidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999999999988654 6799999999999999999999999999999999999998654 688999999974
Q ss_pred C-------------CCCcccceeeee
Q 024661 244 R-------------HAFSFQTFLSMA 256 (264)
Q Consensus 244 ~-------------~~~~~~~~~y~a 256 (264)
. +.+-.||..||+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hcCccccccCccccccccccceeeeE
Confidence 2 123347777875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-26 Score=177.88 Aligned_cols=165 Identities=22% Similarity=0.259 Sum_probs=137.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEce-eeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-WFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~~~~ 167 (264)
.+.+.|.+.+.||+|.||.+.+|+++.++..+++|.+.+......+|.+|...--.|.++ .+|+.-++ .|+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H----~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPH----QHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccc----hhhhHHHHHHhhcCce
Confidence 455779999999999999999999999999999999988777788899998765556543 22355444 4788889
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec--CCcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~--~~~v~l~Dfg~a~~~ 244 (264)
+++++||+ .|+|.+-+... ++-|.....++.|+++|++|+|++++||||||.+||||-. ..+|||||||.++..
T Consensus 97 YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999 89999877764 5888999999999999999999999999999999999974 359999999999876
Q ss_pred CCCcc---cceeeeeceeE
Q 024661 245 HAFSF---QTFLSMASRVY 260 (264)
Q Consensus 245 ~~~~~---~~~~y~ape~~ 260 (264)
..... .+..|.+||++
T Consensus 174 g~tV~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELC 192 (378)
T ss_pred CceehhhhhhcccCCcHHH
Confidence 55433 34568888865
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=190.11 Aligned_cols=161 Identities=21% Similarity=0.333 Sum_probs=137.3
Q ss_pred CeEEEeecccCccEEEEEEEeCCC----CcEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEK----KELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
...+.+.||.|-||.||+|.+... ...||||.-+. .....+.|..|..+++.++|++| +++++.+.. .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphI-----ikLIGv~~e-~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHI-----IKLIGVCVE-Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcch-----hheeeeeec-c
Confidence 345567899999999999987543 33588888764 23457889999999999999998 999998875 6
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..|||||++ -|.|..|++.++ ..++......++.||+.||.|||+..+|||||..+|||+.+..-|||+|||+++-..
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 789999999 999999999876 579999999999999999999999999999999999999999999999999999866
Q ss_pred CCccc-------ceeeeeceeE
Q 024661 246 AFSFQ-------TFLSMASRVY 260 (264)
Q Consensus 246 ~~~~~-------~~~y~ape~~ 260 (264)
...+- .-.|||||-+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESI 564 (974)
T ss_pred ccchhhccccccceeecCcccc
Confidence 54432 1249999953
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=193.13 Aligned_cols=165 Identities=22% Similarity=0.285 Sum_probs=140.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC-C--cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+..++.++||+|.||.|++|.++.. | ..||||.++.. .....+|.+|+.++..|+|+++ +++|+..-+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl-----iRLyGvVl~-q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL-----IRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce-----eEEeeeecc-c
Confidence 3467788999999999999998754 2 35999999743 3467899999999999999988 999999887 7
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
...+|||++ .|+|.+.|.+.....|--..+..|+.||+.||.||..+++|||||..+|+|+.....|||+|||+.+...
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 889999999 9999999998544568888899999999999999999999999999999999999999999999998755
Q ss_pred CCc--c-------cceeeeeceeEee
Q 024661 246 AFS--F-------QTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~--~-------~~~~y~ape~~~~ 262 (264)
... + -.+.|+|||.++.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc
Confidence 422 1 1245999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=187.45 Aligned_cols=161 Identities=26% Similarity=0.382 Sum_probs=136.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+.. .+..+|+.++... +|+|+ +...+.+.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~ni-----v~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNI-----VKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcc-----eeecceecCCcee
Confidence 4567999999999999999999999999999999998652 2334466555544 46666 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe-ecCCcEEeccCCCCCcCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL-VSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili-~~~~~v~l~Dfg~a~~~~~ 246 (264)
|+|||.+ |+.+.+.+.... .+. ..+..|+.||+.|+.|||++||||||+||+|||+ ++.++++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999999 887877777654 233 7788899999999999999999999999999999 5889999999999988766
Q ss_pred C---cccceeeeeceeEe
Q 024661 247 F---SFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~---~~~~~~y~ape~~~ 261 (264)
. .+-|..|.|||++.
T Consensus 469 ~~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 469 SCDTPALTLQYVAPEVLA 486 (612)
T ss_pred hhcccchhhcccChhhhc
Confidence 5 35678899999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=168.53 Aligned_cols=160 Identities=34% Similarity=0.536 Sum_probs=140.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
|.+.+.||.|++|.||++....+++.+++|.+..... ..+.+.+|++.++.+.|+++ +++++++......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i-----~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNI-----VKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCh-----hhheeeeecCCceEEE
Confidence 5678899999999999999998899999999875432 46788889999999988877 8999999888999999
Q ss_pred EecC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC--
Q 024661 172 FEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF-- 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~-- 247 (264)
+|++ +++|.+++.... . +++..+..++.+++.++.+||+++++|+||+++||+++.++.++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred EeccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999 779999998765 3 889999999999999999999999999999999999999999999999998765433
Q ss_pred -----cccceeeeeceeE
Q 024661 248 -----SFQTFLSMASRVY 260 (264)
Q Consensus 248 -----~~~~~~y~ape~~ 260 (264)
..++..|++||.+
T Consensus 154 ~~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVL 171 (225)
T ss_pred ccccceeccCCcCCHhHh
Confidence 2466679999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=176.81 Aligned_cols=149 Identities=28% Similarity=0.402 Sum_probs=127.5
Q ss_pred CeEEEeecccCccEEEEEEEeCCCC-cEEEEEEEechhh-hHHHHHHHHHHHHHHhccCCCCcceEEEceee-eeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~ 169 (264)
+|.+.++||+|+||.||+|.+..++ ..+|+|+...... ....+..|+.++..+.. .....++..+++.. ..+.+.|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988775 6789998765422 22278889999999985 22224558888888 5788999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-----CcEEeccCCCCC
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-----EYVKVPDYKVPS 242 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-----~~v~l~Dfg~a~ 242 (264)
+||+.+|.+|.++........++..++..++.|++.+|++||+.|++||||||+|++++.. ..+.|.|||+|+
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999999999876666789999999999999999999999999999999999999965 369999999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=162.65 Aligned_cols=139 Identities=20% Similarity=0.198 Sum_probs=110.5
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC---E-EEEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---H-ICIV 171 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~---~-~~lv 171 (264)
.+.||+|+||.||. +..++.. +||++... ....+.+.+|+.+++.+.|.+..++++++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 56899999999995 5556555 68987643 23456789999999999887777788899999999863 4 4478
Q ss_pred EecC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCCEEeecC----CcEEecc-CCCCC
Q 024661 172 FEKL---GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV-AFMHELRLIHTDLKPENILLVSA----EYVKVPD-YKVPS 242 (264)
Q Consensus 172 ~e~~---~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~ivH~dikp~Nili~~~----~~v~l~D-fg~a~ 242 (264)
|||. +++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. ++++|+| ||...
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 9995 58999999763 36665 35678888777 99999999999999999999843 3899999 55544
Q ss_pred c
Q 024661 243 P 243 (264)
Q Consensus 243 ~ 243 (264)
.
T Consensus 159 ~ 159 (210)
T PRK10345 159 F 159 (210)
T ss_pred e
Confidence 3
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=202.57 Aligned_cols=157 Identities=15% Similarity=0.242 Sum_probs=131.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
..|...+.||+|+||.||+|.+..++..||+|.++..... ...|++.+++++|+|+ +++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnI-----v~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNI-----VKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCc-----ceEEEEEEcCCCCEEE
Confidence 3466778899999999999999999999999988643322 2346888999999888 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCCEEeecCCcEEeccCCCCCcC--C
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH---ELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR--H 245 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~--~ 245 (264)
|||+ +++|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+... .
T Consensus 762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999 999999995 3788999999999999999999 6699999999999999998887765 5554332 2
Q ss_pred CCcccceeeeeceeEee
Q 024661 246 AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~~~~~~~y~ape~~~~ 262 (264)
....++..|||||++.+
T Consensus 836 ~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 836 TKCFISSAYVAPETRET 852 (968)
T ss_pred CCccccccccCcccccC
Confidence 23357789999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-23 Score=161.58 Aligned_cols=157 Identities=34% Similarity=0.497 Sum_probs=137.5
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-C
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (264)
||+|.+|.||++....+++.+++|++..... ..+.+.+|++.++.+.|+++ +++++++......+++||++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI-----VKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCe-----eeEeeeeecCCeEEEEEecCCC
Confidence 6899999999999988899999999875443 35778899999999998776 99999999999999999999 6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccCCCCCcCCCC------cc
Q 024661 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRHAF------SF 249 (264)
Q Consensus 177 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~~~------~~ 249 (264)
++|.+++.... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999998752 35899999999999999999999999999999999999999 899999999999765433 34
Q ss_pred cceeeeeceeEee
Q 024661 250 QTFLSMASRVYIC 262 (264)
Q Consensus 250 ~~~~y~ape~~~~ 262 (264)
....|++||.+.+
T Consensus 155 ~~~~~~~pe~~~~ 167 (215)
T cd00180 155 GTPAYMAPEVLLG 167 (215)
T ss_pred CCCCccChhHhcc
Confidence 6777999997644
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-24 Score=186.73 Aligned_cols=159 Identities=21% Similarity=0.217 Sum_probs=127.8
Q ss_pred eEEEeecccCccEE-EEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCEEEEE
Q 024661 94 YRILSKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 94 y~~~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
|.-.+.+|.|+.|+ ||+|... |+.||||.+- ........+|+..|+.-. |+|+ +++++.-.+..+.||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--~e~~~~A~rEi~lL~eSD~H~Nv-----iRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL--EEFFDFAQREIQLLQESDEHPNV-----IRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHh--hHhHHHHHHHHHHHHhccCCCce-----EEEEeeccCCceEEEE
Confidence 44466788998865 8999875 7789999765 344456788999998875 4555 9999999999999999
Q ss_pred EecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---C--CcEEeccCCCCCcC
Q 024661 172 FEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---A--EYVKVPDYKVPSPR 244 (264)
Q Consensus 172 ~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~--~~v~l~Dfg~a~~~ 244 (264)
.|+|..+|.+++... ..........+.++.|+++||++||+.+||||||||.||||.. + .+++|+|||++...
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999974 1111111346788999999999999999999999999999997 3 37899999999874
Q ss_pred CC---------CcccceeeeeceeEe
Q 024661 245 HA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~---------~~~~~~~y~ape~~~ 261 (264)
.. ...||..|+|||.+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHh
Confidence 33 334889999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=164.52 Aligned_cols=142 Identities=23% Similarity=0.127 Sum_probs=110.4
Q ss_pred CeEEEeecccCccEEEEEEE-eCCCCcEEEEEEEechhh-------------------------hHHHHHHHHHHHHHHh
Q 024661 93 RYRILSKMGEGTFGQVVECF-DNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLA 146 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~e~~~l~~l~ 146 (264)
-|.+.+.||.|++|.||+|. +..+|+.||+|+++.... ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999998 667899999999874321 1123568999999998
Q ss_pred ccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCC
Q 024661 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPEN 224 (264)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dikp~N 224 (264)
+..+.. ..+++ . ...++||||+ +.+|........ .+....+..++.||+.+|.+||++| |+|+||||+|
T Consensus 109 ~~~i~~---p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPV---PKPIA---W-RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred hcCCCC---CeeeE---e-cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 754311 23332 2 2348999999 656665543322 4666677899999999999999999 9999999999
Q ss_pred EEeecCCcEEeccCCCCCcC
Q 024661 225 ILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~~ 244 (264)
|+++ +++++|+|||.|...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=164.60 Aligned_cols=151 Identities=32% Similarity=0.506 Sum_probs=132.5
Q ss_pred ccEEEEEEEeCCCCcEEEEEEEechhhh--HHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHH
Q 024661 104 TFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLY 180 (264)
Q Consensus 104 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 180 (264)
+||.||+|.+..+++.+++|++...... .+.+.+|++.++.++|+++ +++.+.+......+++||++ +++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNI-----VRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcH-----HHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999999988999999998754322 5788899999999988887 99999999999999999999 66999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----Ccccceeee
Q 024661 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-----FSFQTFLSM 255 (264)
Q Consensus 181 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-----~~~~~~~y~ 255 (264)
+++.... .+++..++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+..... ...++..|+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 9998754 489999999999999999999999999999999999999999999999999976544 245677899
Q ss_pred eceeEe
Q 024661 256 ASRVYI 261 (264)
Q Consensus 256 ape~~~ 261 (264)
+||.+.
T Consensus 154 ~pE~~~ 159 (244)
T smart00220 154 APEVLL 159 (244)
T ss_pred CHHHHc
Confidence 999753
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-24 Score=168.81 Aligned_cols=164 Identities=23% Similarity=0.324 Sum_probs=141.3
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
...||.-+..+|.|.- .|.-|.+.-+++.|++|..-.. .....+..+|..++..+.|.|+ ++++.+|.-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~ni-----i~l~n~ftP~~ 88 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNI-----ISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccce-----eeeeeccCccc
Confidence 3467888999999998 8888999999999999976532 2334667889999999999998 999988854
Q ss_pred ----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
...+|+|||++..+|...+.. .++.+.+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+
T Consensus 89 ~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred cHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence 246899999999999998873 588899999999999999999999999999999999999999999999999
Q ss_pred CCcCCCC-----cccceeeeeceeEeec
Q 024661 241 PSPRHAF-----SFQTFLSMASRVYICI 263 (264)
Q Consensus 241 a~~~~~~-----~~~~~~y~ape~~~~~ 263 (264)
|+..... ...|.+|-|||++.++
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~ 192 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGM 192 (369)
T ss_pred hcccCcccccCchhheeeccCchheecc
Confidence 9876554 2467789999999876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=155.73 Aligned_cols=139 Identities=12% Similarity=0.143 Sum_probs=109.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHH------HHHHHHHHHHHhccCCCCcceEE
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREA------AMIEIDVLQRLARHDIGGTRCVQ 157 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~------~~~e~~~l~~l~~~~~~~~~~~~ 157 (264)
..+.++|++.+.||.|+||.||++.+ ++..+++|+++.... .... +.+|+..+.++.|+++ ..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI-----~~ 99 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL-----AS 99 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC-----Cc
Confidence 35678999999999999999999765 366799999974321 1122 5789999999999998 44
Q ss_pred Eceeeee--------CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 158 IRNWFDY--------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 158 ~~~~~~~--------~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
+.+++.. .+..+|+|||+ |.+|.++. .+++. ...+++.+|..+|+.|++|||++|+||+++
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVS 169 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEe
Confidence 4444332 35689999999 77898763 23332 356999999999999999999999999999
Q ss_pred cCCcEEeccCCCCCcC
Q 024661 229 SAEYVKVPDYKVPSPR 244 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~ 244 (264)
.+| ++|+|||.+...
T Consensus 170 ~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 170 KNG-LRIIDLSGKRCT 184 (232)
T ss_pred CCC-EEEEECCCcccc
Confidence 988 999999988654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=178.64 Aligned_cols=165 Identities=21% Similarity=0.352 Sum_probs=136.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCC-------CCcEEEEEEEech--hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEcee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~ 161 (264)
++..+.+.||+|.||.|++|.... ....||+|.++.. ....+.+..|+++++.+. |+|+ +.+.++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~ni-----v~llG~ 370 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNI-----VNLLGA 370 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcch-----hhheee
Confidence 334666799999999999997531 1456999988743 355788899999999987 5666 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNS------------Y--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nil 226 (264)
+..++.+++|+||+ .|+|.++++... . ..++....+.++.||+.|++||++.++|||||..+|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 99999999999999 999999998654 1 12888999999999999999999999999999999999
Q ss_pred eecCCcEEeccCCCCCcCCCCcc-------c--ceeeeeceeEe
Q 024661 227 LVSAEYVKVPDYKVPSPRHAFSF-------Q--TFLSMASRVYI 261 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~~~~~~-------~--~~~y~ape~~~ 261 (264)
+..+..+||+|||+|+....... + ...|||||.+.
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~ 494 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF 494 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc
Confidence 99999999999999986433221 1 23499999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=179.34 Aligned_cols=146 Identities=21% Similarity=0.289 Sum_probs=129.2
Q ss_pred eEEEeecccCccEEEEEEEeCCCCc----EEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+..++||+|+||+||+|.+...|+ .||||++.... +...++.+|.-++..+.|+|+ +++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl-----~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNL-----LRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchH-----HHHhhhcccch-
Confidence 4456789999999999999976654 68899887543 446788999999999999998 99999987765
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+.||++|+ .|.|.++++.++ ..+-.+..+.|..||++||.|||++++|||||..+|+|+.+...+|+.|||+++....
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 88999999 999999999876 4688899999999999999999999999999999999999999999999999987554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=148.20 Aligned_cols=132 Identities=16% Similarity=0.170 Sum_probs=102.0
Q ss_pred EEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhh-----HHHHHHHHHHHHHHhcc-CCCCcceEEEceeeeeCCEE
Q 024661 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-----REAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+...|++|+||+|+++.. .+..++.+.+...... ...+.+|+++|+++.|+ ++ +.++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~v-----P~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRT-----PRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCC-----CEEEEE----cCE
Confidence 3467899999999998765 5667787766643332 23578899999999764 34 666654 346
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di-kp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
|++|||+ |.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|...+.
T Consensus 74 ~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999999 8788654321 1 1357789999999999999999999 79999999999999999999985443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-21 Score=150.38 Aligned_cols=134 Identities=20% Similarity=0.229 Sum_probs=108.6
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+.||+|++|.||+|.+ .|..+++|+..... .....+.+|+.++..+.++++..+ ..++.+....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p-----~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP-----AVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC-----eEEEEeCCCC
Confidence 5799999999999987 56678999764211 123457789999999999887333 2334456678
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+++|||+ |++|.+++.... . ....++.+++.+|.++|+.|++|+|++|+|||++ ++.++|+|||.+....
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999 889999987543 1 7788999999999999999999999999999999 8899999999987643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=147.63 Aligned_cols=136 Identities=24% Similarity=0.231 Sum_probs=105.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----------------------hhHHHHHHHHHHHHHHhccCC
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~~~ 150 (264)
|.+.+.||.|+||.||++... +|+.+|+|++.... ........|..++..+.+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999874 78999999876321 011235678899999988754
Q ss_pred CCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
. +...++ ....++||||+ +++|.++... .....++.+++.++.++|+.||+|+||+|+||+++.
T Consensus 96 ~---v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 P---VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred C---CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 2 123322 23458999999 7787664321 235678899999999999999999999999999999
Q ss_pred CCcEEeccCCCCCcCC
Q 024661 230 AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~~ 245 (264)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=161.54 Aligned_cols=144 Identities=24% Similarity=0.454 Sum_probs=125.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCC---CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+...|.+.++||.|.|+.||++.+.. ..+.||+|.+... .....+.+|+++|..+... .+++.+.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~----~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGS----DNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccc----hhhhcchhhhccC
Confidence 445679999999999999999999887 7889999988743 3345688999999999765 3459999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVPS 242 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a~ 242 (264)
+.+.+||||+ ..+..++... ++...+..++..++.||.++|.+|||||||||+|+|.+.. ++-.|+|||+|.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999 6777777654 6678899999999999999999999999999999999965 688999999986
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-20 Score=145.72 Aligned_cols=130 Identities=19% Similarity=0.180 Sum_probs=103.3
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.||+|++|.||+|.+ .+..+++|...... .....+.+|+++++.+.++++..+.+ ++.+.+..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~-----~~~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVV-----YDVDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEE-----EEEECCCCE
Confidence 489999999999985 46779999854211 12356678999999999887633322 233456678
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
++|||+ |++|.+++.... . .++.|++.+|.+||+.|++|+|++|+||+++ ++.++++|||++....
T Consensus 74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999 899998876532 1 7889999999999999999999999999999 8999999999987644
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=165.50 Aligned_cols=144 Identities=20% Similarity=0.177 Sum_probs=111.5
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEe-c---h-----hhhHHHHHHHHHHHHHHhccCCCCcc
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-S---I-----NKYREAAMIEIDVLQRLARHDIGGTR 154 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~---~-----~~~~~~~~~e~~~l~~l~~~~~~~~~ 154 (264)
+.........|...+.||+|+||.||+|.+.... +++|+.. + . ....+.+.+|+++++.++|+++
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i---- 398 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGV---- 398 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCC----
Confidence 3444444555677899999999999999876443 3444321 1 1 1223567889999999999887
Q ss_pred eEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
+....+..+....++||||+ +++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.+
T Consensus 399 -~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 399 -PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred -CeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcE
Confidence 44444555566789999999 899998875 246689999999999999999999999999999 67899
Q ss_pred EeccCCCCCcCC
Q 024661 234 KVPDYKVPSPRH 245 (264)
Q Consensus 234 ~l~Dfg~a~~~~ 245 (264)
+|+|||+++...
T Consensus 467 ~liDFGla~~~~ 478 (535)
T PRK09605 467 YLIDFGLGKYSD 478 (535)
T ss_pred EEEeCcccccCC
Confidence 999999998644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-19 Score=147.71 Aligned_cols=161 Identities=33% Similarity=0.466 Sum_probs=136.5
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhcc-CCCCcceEEEceeeeeCCEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~ 168 (264)
|.+.+.||.|+||.||++.+. ..+++|.+..... ....+.+|+.+++.+.|+ ++ +.+.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI-----VKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcce-----eeEEEEEecCCEE
Confidence 788899999999999999987 6789998874332 467888999999999988 46 9999999888889
Q ss_pred EEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~~ 245 (264)
+++++++ ++++.+++..... ..+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+....
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 9999999 8899977765421 1588999999999999999999999999999999999999988 79999999986322
Q ss_pred ------------CCcccceeeeeceeEee
Q 024661 246 ------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ------------~~~~~~~~y~ape~~~~ 262 (264)
....++..|++||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcC
Confidence 34457889999997654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-19 Score=138.23 Aligned_cols=137 Identities=25% Similarity=0.228 Sum_probs=97.6
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhh----HH---------------------HHHHHHHHHHHHhccCCC
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----RE---------------------AAMIEIDVLQRLARHDIG 151 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~---------------------~~~~e~~~l~~l~~~~~~ 151 (264)
.+.||+|+||.||+|.+. +++.||+|+++..... .. ....|...+..+.+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 7899999998743211 11 113566667777665431
Q ss_pred CcceEEEceeeeeCCEEEEEEecC-CCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEee
Q 024661 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLY-DFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (264)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~-~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~ 228 (264)
+...++. ...++||||+ ++.+. ..+.... .. ..+..++.+++.++.++|. +||+|+||||+||+++
T Consensus 81 ---~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 ---VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred ---CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 1222222 2358999999 53322 1122111 11 5678899999999999999 9999999999999999
Q ss_pred cCCcEEeccCCCCCcCCC
Q 024661 229 SAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~~~ 246 (264)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 99999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=165.93 Aligned_cols=150 Identities=25% Similarity=0.340 Sum_probs=114.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.-+..|.|.+.||+|+||.||+|.... |+.||+|+-+...- .++.-=.+++.+|+ +.. .+.+..+...+...+.-
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WEfYI~~q~~~RLk-~~~-~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WEFYICLQVMERLK-PQM-LPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--eeeeehHHHHHhhc-hhh-hcchHHHHHHHccCCcc
Confidence 445679999999999999999999877 99999998653221 11111222333333 100 01124455555556777
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-------CcEEeccCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-------EYVKVPDYKV 240 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-------~~v~l~Dfg~ 240 (264)
++|+||. .|+|.+++...+ .+++..+..++.|++..+++||.++|||+||||+|+||... .-++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 8999999 999999999655 89999999999999999999999999999999999999743 3689999999
Q ss_pred CCcCC
Q 024661 241 PSPRH 245 (264)
Q Consensus 241 a~~~~ 245 (264)
+....
T Consensus 848 siDm~ 852 (974)
T KOG1166|consen 848 SIDMK 852 (974)
T ss_pred ceeee
Confidence 97643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-18 Score=135.61 Aligned_cols=135 Identities=18% Similarity=0.152 Sum_probs=99.4
Q ss_pred ecc-cCccEEEEEEEeCCCCcEEEEEEEechh--------------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 99 KMG-EGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 99 ~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.|| .|+.|+||.+... +..+++|.+.... .....+.+|++++..+.+.++.-+ ..+++..
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP---~pl~~~~ 112 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP---RPIAARV 112 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc---eeEeeee
Confidence 454 5666777777654 6778999775311 223567889999999999886333 3333322
Q ss_pred e-CC---EEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 164 Y-RN---HICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 164 ~-~~---~~~lv~e~~-~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
. .. ..++|||++ | .+|.+++... .+++.. +.||+.+|.+||++||+|+||||+|||++.++.++|+|
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 22 236999999 5 5899888653 355543 57899999999999999999999999999999999999
Q ss_pred CCCCCcCC
Q 024661 238 YKVPSPRH 245 (264)
Q Consensus 238 fg~a~~~~ 245 (264)
||.+....
T Consensus 186 fg~~~~~~ 193 (239)
T PRK01723 186 FDRGELRT 193 (239)
T ss_pred CCCcccCC
Confidence 99988754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.3e-18 Score=126.78 Aligned_cols=136 Identities=23% Similarity=0.255 Sum_probs=110.3
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.+++.+.+.+ ..+++++.++...+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~---~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKG---LPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcC---CCCCeEEEEcCCCCccEEEEEec
Confidence 35689999999999999754 6799998865433 567888999999998862 23377777777778899999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 176 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
++.+..+ +......++.+++.+|.++|.. +++|+|++|+||+++.++.++++|||.+.....
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~ 141 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence 6555543 4455677889999999999985 799999999999999999999999999876443
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-19 Score=165.70 Aligned_cols=96 Identities=16% Similarity=0.134 Sum_probs=77.4
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec----------------
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---------------- 229 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---------------- 229 (264)
..++++||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4678889999999999997543 46999999999999999999999999999999999999954
Q ss_pred ---CCcEEeccCCCCCcCCC----------------------CcccceeeeeceeEee
Q 024661 230 ---AEYVKVPDYKVPSPRHA----------------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 230 ---~~~v~l~Dfg~a~~~~~----------------------~~~~~~~y~ape~~~~ 262 (264)
++.+|++|||+++.... ...+|..|||||++.+
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 189 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG 189 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence 44567777777653210 1236778999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-18 Score=140.60 Aligned_cols=170 Identities=16% Similarity=0.159 Sum_probs=132.1
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCC-----cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEc
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 159 (264)
......|+++...+.+|.||.||.|.++... +.+.+|.++.. ......+..|--.+..+.|+|+ ..+.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl-----l~V~ 353 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL-----LSVL 353 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc-----ccee
Confidence 3455578999999999999999999876442 34556655432 2334556667777777778877 6666
Q ss_pred eee-eeCCEEEEEEecC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 160 NWF-DYRNHICIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 160 ~~~-~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
+.. ++....++++.+. -|+|..++... ..+.++..++..++.|++.|++|||+.||||.||..+|++|++.-
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 654 3456788999999 78999999822 224577788999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCCCcc--------cceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHAFSF--------QTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~~~~--------~~~~y~ape~~~ 261 (264)
+|||+|=.+++...+.++ ....||++|.+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence 999999999998665443 344699999753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-18 Score=151.38 Aligned_cols=158 Identities=20% Similarity=0.271 Sum_probs=130.1
Q ss_pred ecccCccEEEEEEEeC---CCCcEEEEEEEechh---hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCEEEEE
Q 024661 99 KMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.+|.|.||.|+++... ..+..+++|++++.. ........|..++..++ ++. ++.+...|+.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f-----~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPF-----LVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCc-----eeeeeeeeccccchhHh
Confidence 3789999999987643 236678999886432 11224555777777777 444 49999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--Cc
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--FS 248 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--~~ 248 (264)
+++. +|+|...+.... .+++.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-. ..
T Consensus 76 ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999 889998887765 788999999999999999999999999999999999999999999999999976433 33
Q ss_pred ccceeeeeceeEeec
Q 024661 249 FQTFLSMASRVYICI 263 (264)
Q Consensus 249 ~~~~~y~ape~~~~~ 263 (264)
+||..|||||++.|.
T Consensus 154 cgt~eymApEI~~gh 168 (612)
T KOG0603|consen 154 CGTYEYRAPEIINGH 168 (612)
T ss_pred ccchhhhhhHhhhcc
Confidence 779999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-17 Score=149.43 Aligned_cols=161 Identities=20% Similarity=0.220 Sum_probs=121.2
Q ss_pred EEEeecccCccEEEEEEEeCCCCcEEEEEEEe----chh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.....+|.|.+|.|+.+......+.+..|.+. ... .....+..|+-+-..+.|+++ +.....+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~-----~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNI-----IETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCch-----hhhHHHHhhccc
Confidence 45678999999988888776655555555433 111 122224556666666777765 666666665555
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
.+-.||||.++|+.++.... .++...+..++.|++.|+.|+|+.||.|||+|++|+++..+|.+||+|||.+....
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred chhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 55559999339999998763 68889999999999999999999999999999999999999999999999986522
Q ss_pred --------CCcccceeeeeceeEee
Q 024661 246 --------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 --------~~~~~~~~y~ape~~~~ 262 (264)
....|...|+|||++..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccc
Confidence 23357788999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-16 Score=132.26 Aligned_cols=108 Identities=23% Similarity=0.250 Sum_probs=87.9
Q ss_pred CCcceEEEceeeee---------------------------CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHH
Q 024661 151 GGTRCVQIRNWFDY---------------------------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203 (264)
Q Consensus 151 ~~~~~~~~~~~~~~---------------------------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi 203 (264)
.|+|++++..+|.+ ...+|+||..+..+|.+++..+. .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence 57788999988854 23589999999999999998764 7778888999999
Q ss_pred HHHHHHHHHCCCeecCCCCCCEEeecCC----cEEeccCCCCCcCCC------------CcccceeeeeceeEe
Q 024661 204 LESVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKVPSPRHA------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 204 ~~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l~Dfg~a~~~~~------------~~~~~~~y~ape~~~ 261 (264)
++|+.|||.+||.|||+|.+|||+.-+. .+.|+|||++-.... +.-|...-||||+..
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999999999999997543 678999998854222 112455689999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-15 Score=115.96 Aligned_cols=137 Identities=18% Similarity=0.180 Sum_probs=100.4
Q ss_pred EeecccCccEEEEEEEeCC------CCcEEEEEEEech-----------------------hhhHHHHH----HHHHHHH
Q 024661 97 LSKMGEGTFGQVVECFDNE------KKELVAIKIVRSI-----------------------NKYREAAM----IEIDVLQ 143 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-----------------------~~~~~~~~----~e~~~l~ 143 (264)
...||.|.-+.||.|.... .+..+|+|+.+.. ......+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998643 3578999987410 01122333 7999999
Q ss_pred HHhccCCCCcceEEEceeeeeCCEEEEEEecCCCC-HH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCC
Q 024661 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-LY-DFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDL 220 (264)
Q Consensus 144 ~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~-~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~ivH~di 220 (264)
++...+++-|..+. + ..-+|||||++++ +. ..++.. .++++.+..+..|++.+|..| |+.|+||+||
T Consensus 82 rl~~~Gv~vP~pi~---~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVV---L----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEE---e----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99988765444442 2 4568999999543 32 122221 355666778889999999998 8999999999
Q ss_pred CCCCEEeecCCcEEeccCCCCCcC
Q 024661 221 KPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 221 kp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
++.|||+. ++.+.|+|||.|...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=132.95 Aligned_cols=143 Identities=16% Similarity=0.189 Sum_probs=96.8
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhh-----------------------------------hH------HHHH
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-----------------------------------YR------EAAM 136 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~------~~~~ 136 (264)
+.||.|++|.||+|+.. +|+.||||+.+..-. .. -++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999864 689999999853210 00 0233
Q ss_pred HHHHHHHHHhccCCCCcceEEEceee-eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHHC
Q 024661 137 IEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE-SVAFMHEL 213 (264)
Q Consensus 137 ~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~-~l~~lH~~ 213 (264)
+|...+.++....- +...+.+...+ ......+|||||+ |++|.++..... ...+ ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~-~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFK-NDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcC-CCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhC
Confidence 45555555543211 11113333333 2245579999999 888888765432 1222 2345555555 46789999
Q ss_pred CCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 214 RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 214 ~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
|++|+|++|.||+++.+++++|+|||++.....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.6e-16 Score=138.08 Aligned_cols=146 Identities=15% Similarity=0.203 Sum_probs=95.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----------------------------------hhHHHH-
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------------------KYREAA- 135 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------------------~~~~~~- 135 (264)
..|+. +.||+|++|.||+|+.+.+|+.||||+++..- ...+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 78999999999999998889999999986321 111222
Q ss_pred -----HHHHHHHHHHhccCCCCcceEEEceeeee-CCEEEEEEecC-CCCHHHHHH--hcCC--CCCCHHHHHHHHHHHH
Q 024661 136 -----MIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKL-GPSLYDFLR--KNSY--RSFPIDLVRELGRQLL 204 (264)
Q Consensus 136 -----~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~--~~~~--~~~~~~~~~~i~~qi~ 204 (264)
.+|...+.++... ..+...+.+...+.+ ....+|||||+ |+.+.++.. ..+. ..+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~-f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRN-FEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHH-ccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 3344444444321 112222444444433 56678999999 889987532 2210 013333344444444
Q ss_pred HHHHHHHHCCCeecCCCCCCEEeecCC----cEEeccCCCCCcCCC
Q 024661 205 ESVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKVPSPRHA 246 (264)
Q Consensus 205 ~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l~Dfg~a~~~~~ 246 (264)
...|++|+|+||.||+++.++ +++++|||++.....
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 469999999999999999988 999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-15 Score=113.62 Aligned_cols=130 Identities=17% Similarity=0.140 Sum_probs=96.7
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (264)
.+.|+.|.++.||+++.. +..+++|+.............|+.+++.+.+.++. .+++.+.. ...++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~----P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIG----PKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCC----CceEEEeC--CCCeEEEEecC
Confidence 457889999999999865 77899998765432234567899999999876541 33443332 3357999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-----IHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 176 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-----vH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
|.++.+. . . ....+..+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+....
T Consensus 75 G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 75 GSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred CCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 6666542 0 1 113456799999999999885 9999999999999 7789999999987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-14 Score=116.65 Aligned_cols=167 Identities=19% Similarity=0.176 Sum_probs=100.5
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhc----------cC-CCCcceEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLAR----------HD-IGGTRCVQI 158 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~----------~~-~~~~~~~~~ 158 (264)
+...+.||.|+++.||.+++..|++.+++|++.... ..-+.+.+|......+.+ -. +...-++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 667889999999999999999999999999886322 223444444432222111 01 111112222
Q ss_pred ce---eeeeC---C-----EEEEEEecCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024661 159 RN---WFDYR---N-----HICIVFEKLGPSLYDFLRK---NSYR--SFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (264)
Q Consensus 159 ~~---~~~~~---~-----~~~lv~e~~~~~L~~~l~~---~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 222 (264)
.+ ++... . ..+++|+.+.++|.+++.. .... .+.......+..|++..+++||..|+||+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 21 11111 1 3478999999999888652 2211 122223345568999999999999999999999
Q ss_pred CCEEeecCCcEEeccCCCCCcCCCCc---ccceeeeeceeE
Q 024661 223 ENILLVSAEYVKVPDYKVPSPRHAFS---FQTFLSMASRVY 260 (264)
Q Consensus 223 ~Nili~~~~~v~l~Dfg~a~~~~~~~---~~~~~y~ape~~ 260 (264)
+|++++.+|.++|+||+......... ..+..|..||..
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELE 214 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHH
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhh
Confidence 99999999999999998765433322 223447777754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-13 Score=102.80 Aligned_cols=142 Identities=23% Similarity=0.175 Sum_probs=109.8
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEE-ec--------hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIV-RS--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~--------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.+..|.+|+-+.|+++.+. |+..+||.= .+ ..-...+..+|.+.+.++..-.+..|. -+|.+.+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~-----l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPR-----LIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCce-----EEEEecC
Confidence 4678889999999999775 777777742 11 224566778899999999887763332 2455667
Q ss_pred EEEEEEecCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEeccCCCC
Q 024661 167 HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKVPDYKVP 241 (264)
Q Consensus 167 ~~~lv~e~~~~--~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l~Dfg~a 241 (264)
.-+|+|||+.| ++.+++..........+....++.+|-+.+.-||.++|+|+||..+||++.+++ .+.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 77899999965 899998876544444455578899999999999999999999999999998765 4589999998
Q ss_pred CcC
Q 024661 242 SPR 244 (264)
Q Consensus 242 ~~~ 244 (264)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-15 Score=139.65 Aligned_cols=159 Identities=19% Similarity=0.271 Sum_probs=123.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.|...+.||++.|=+|.+|++.+ |. |++|++-+.. ....+..+|++ ..-++++|+ +.+.-+...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~-----lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNC-----LPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcc-----cchHHHHHhhHH
Confidence 68889999999999999998754 33 8999886433 12223333444 555667776 766666677778
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC---
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR--- 244 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~--- 244 (264)
.|||-+|+..+|+|.+..+. -+..-+.+.|+.|++.||.-+|..||+|||||.+||||++=+-+.|+||..-++.
T Consensus 96 AylvRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 89999999999999998876 5777788899999999999999999999999999999999999999999865431
Q ss_pred --CC--------CcccceeeeeceeEe
Q 024661 245 --HA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 --~~--------~~~~~~~y~ape~~~ 261 (264)
++ .+-+-..|+|||-|.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhh
Confidence 11 112334699999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-12 Score=98.76 Aligned_cols=131 Identities=18% Similarity=0.141 Sum_probs=96.9
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEE-ec--------hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIV-RS--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~--------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
..+++|+-+.+|.+.+. |..+++|.= .+ .+-......+|..++..+....+..|. -+..+.+..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~-----v~dvD~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPI-----VYDVDPDNG 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCe-----EEEEcCCCC
Confidence 35788999999998664 444666632 21 123446677899999999888763332 233456677
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.|+|||+ |..|.+++.... ..++..+-..+.-||..||+|+||.++||++..++ +.++|||++....
T Consensus 75 ~I~me~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 75 LIVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EEEEEEeCChhHHHHHHhcc---------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 8999999 666777887641 34567777888899999999999999999997655 9999999987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.1e-13 Score=103.85 Aligned_cols=77 Identities=23% Similarity=0.148 Sum_probs=67.0
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-Ccccceeee
Q 024661 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-FSFQTFLSM 255 (264)
Q Consensus 177 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-~~~~~~~y~ 255 (264)
|+|.+++...+ ..+++..++.++.||+.||.|||+++ ||+|||++.++.+++ ||++..... ...++..||
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFM 71 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCccccc
Confidence 68999998653 36999999999999999999999998 999999999999999 999876433 346889999
Q ss_pred eceeEee
Q 024661 256 ASRVYIC 262 (264)
Q Consensus 256 ape~~~~ 262 (264)
|||++.+
T Consensus 72 aPE~~~~ 78 (176)
T smart00750 72 APEVIQG 78 (176)
T ss_pred ChHHhcC
Confidence 9998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-12 Score=103.56 Aligned_cols=141 Identities=18% Similarity=0.207 Sum_probs=100.2
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhh--hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC---CEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~---~~~~lv~ 172 (264)
+.|+.|..+.+|++.... |+.+++|+...... ....+..|.++++.+.+.++.. .+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~v---p~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPV---PKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCC---CCEEEECCCCCccCCceEEE
Confidence 568999999999998643 57899998764332 3557788999999998865433 3334443332 3678999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--------------------------------------- 212 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 212 (264)
|++ |.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 999 6666554321 135555566666666666666663
Q ss_pred -----------------CCCeecCCCCCCEEeec--CCcEEeccCCCCCcCC
Q 024661 213 -----------------LRLIHTDLKPENILLVS--AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 213 -----------------~~ivH~dikp~Nili~~--~~~v~l~Dfg~a~~~~ 245 (264)
..++|+|+++.|||++. ++.+.|+||+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 24699999999999998 6678999999887644
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-11 Score=100.13 Aligned_cols=134 Identities=19% Similarity=0.083 Sum_probs=98.0
Q ss_pred EEEEEeCCCCcEEEEEEEechh--h----------hHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CCEEEEEEe
Q 024661 108 VVECFDNEKKELVAIKIVRSIN--K----------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVFE 173 (264)
Q Consensus 108 V~~~~~~~~~~~vaiK~~~~~~--~----------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~lv~e 173 (264)
|.++.. .|+.+.+|...... . ....+.+|...+..+...++..+..+-+...-.+ ...-++|||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 545543 36678888664221 1 1114789999999999888876655554321111 245789999
Q ss_pred cCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-------CCcEEeccCCCCCc
Q 024661 174 KLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-------AEYVKVPDYKVPSP 243 (264)
Q Consensus 174 ~~~~--~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-------~~~v~l~Dfg~a~~ 243 (264)
++++ +|.+++........+......++.+++..+.-||+.||+|+|+++.|||++. +..+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9943 7999886432234667778899999999999999999999999999999985 46899999998854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-13 Score=124.97 Aligned_cols=127 Identities=20% Similarity=0.383 Sum_probs=90.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.+|..++.|..|+||.||+++++.+.+.+|+| +++++..... ++..... .+.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------ilt~a~n--------------------pfvv 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------ILTFAGN--------------------PFVV 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------cccccCC--------------------ccee
Confidence 45889999999999999999999999999995 4432221111 1111111 1222
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc--------
Q 024661 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP-------- 243 (264)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~-------- 243 (264)
|+=...++..+ .+.- +++.+++|||+-||+|||+||+|.+|+.-|++|++|||++..
T Consensus 136 -----gDc~tllk~~g--~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccCC--CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33333444333 2222 237889999999999999999999999999999999999864
Q ss_pred -------------CCCCcccceeeeeceeE
Q 024661 244 -------------RHAFSFQTFLSMASRVY 260 (264)
Q Consensus 244 -------------~~~~~~~~~~y~ape~~ 260 (264)
.....++|+.|+|||++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhh
Confidence 12244789999999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.2e-12 Score=96.63 Aligned_cols=126 Identities=26% Similarity=0.287 Sum_probs=81.4
Q ss_pred EEEEEeCCCCcEEEEEEEech---------------------------hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 108 VVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 108 V~~~~~~~~~~~vaiK~~~~~---------------------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
||.|.. ..|..+|+|+.+.. ........+|.+.|+.+...++.-| ..++
T Consensus 2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP---~p~~ 77 (188)
T PF01163_consen 2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP---KPYD 77 (188)
T ss_dssp EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-----EEE
T ss_pred EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC---cEEE
Confidence 788875 45678999987410 1123456779999999988765333 3333
Q ss_pred eeeeCCEEEEEEecCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 161 WFDYRNHICIVFEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF-MHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~-lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
+. .-+|||||++ |.....+.... ++.+....++.+++..+.. +|..||+|+|+.+.|||++.+ .+.|+|
T Consensus 78 ~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 78 YN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp EE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred Ee----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence 32 2379999996 64433344322 2234456678888886665 579999999999999999987 999999
Q ss_pred CCCCCcCC
Q 024661 238 YKVPSPRH 245 (264)
Q Consensus 238 fg~a~~~~ 245 (264)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99886644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-10 Score=90.35 Aligned_cols=141 Identities=13% Similarity=0.102 Sum_probs=107.6
Q ss_pred cccCccEEEEEEEeCCCCcEEEEEEEech-------hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CCEEEE
Q 024661 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICI 170 (264)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~l 170 (264)
-|+|+-+.|+..... |..+-+|.-... ......+.+|+..++.+...+++-+..+ +.+.-.. ...-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 456888888887654 335777765310 2345788999999999999888655544 2222222 235789
Q ss_pred EEecCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc--EEeccCCCCCc
Q 024661 171 VFEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY--VKVPDYKVPSP 243 (264)
Q Consensus 171 v~e~~~--~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~--v~l~Dfg~a~~ 243 (264)
|+|.++ .+|.+++.+....+.+......++.+++..+.-||+.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999995 68999987754445677778899999999999999999999999999999987777 99999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.7e-12 Score=110.04 Aligned_cols=169 Identities=20% Similarity=0.220 Sum_probs=131.5
Q ss_pred ccCCCeEEEeeccc--CccEEEEEEEe--CCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 89 NLTPRYRILSKMGE--GTFGQVVECFD--NEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 89 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
.+...+.+...+|. |.+|.+|.+.. ..++..+|+|.-+. .......-.+|+.....+.- |.+.++.+..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~----~~~~v~~~~~ 186 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDS----HENPVRDSPA 186 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCc----cccccccCcc
Confidence 44456778889999 99999999998 78888899997432 11223333445544444331 2344888889
Q ss_pred eeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCCEEeecC-CcEEec
Q 024661 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE----SVAFMHELRLIHTDLKPENILLVSA-EYVKVP 236 (264)
Q Consensus 162 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~----~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~ 236 (264)
++..+..|+-+|+++.+|..+..... .-+....++.++.+... ||.++|..+++|.|+||.||++..+ ...+++
T Consensus 187 ~e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 187 WEGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence 99999999999999999999887654 23777888999999999 9999999999999999999999999 899999
Q ss_pred cCCCCCcCCCCc-----------ccceeeeeceeEee
Q 024661 237 DYKVPSPRHAFS-----------FQTFLSMASRVYIC 262 (264)
Q Consensus 237 Dfg~a~~~~~~~-----------~~~~~y~ape~~~~ 262 (264)
|||+........ .+...|++||+.-+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 999987755433 34556999997643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-13 Score=122.63 Aligned_cols=165 Identities=17% Similarity=0.211 Sum_probs=129.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCC-CcEEEEEEEech---hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.|.+.+.||.|+|+.|-....... ...++.|.+... .........|..+-+.+. |.|+ +.+++...+...
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~-----~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNT-----VHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccc-----cccCCccCCCcc
Confidence 377788899999999988876443 344666665432 233444455776666666 6666 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEeecCC-cEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~ 244 (264)
.++++++. ++++.+-+........+...+-.++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|+..
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999 999998883222125667778889999999999999 99999999999999999999 9999999999764
Q ss_pred CC---------Cccc-ceeeeeceeEee
Q 024661 245 HA---------FSFQ-TFLSMASRVYIC 262 (264)
Q Consensus 245 ~~---------~~~~-~~~y~ape~~~~ 262 (264)
.. ..+| ++.|+|||.+.+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc
Confidence 33 3357 888999998765
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.4e-13 Score=114.07 Aligned_cols=161 Identities=19% Similarity=0.239 Sum_probs=108.3
Q ss_pred eEEEeecccCccEEEEEEEeCCC---CcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEce---------
Q 024661 94 YRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRN--------- 160 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--------- 160 (264)
+.+.+..+..+++.+....-... .+.+.-+..+... .......+++-.+....|++. ..+.+
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~-----s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNR-----SILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCc-----ccccCCCCchhhhc
Confidence 44455555555555554432222 2333333333222 233344455555555566553 22222
Q ss_pred ---eeeeCCEEEEEEecC-CCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEe
Q 024661 161 ---WFDYRNHICIVFEKL-GPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 161 ---~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l 235 (264)
......++||.|++| ..+|.+++.. ......+......++.|++.|++| +|.+|+|+||.||++..+..+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 011134789999999 8999999973 334457778899999999999999 99999999999999999999999
Q ss_pred ccCCCCCcC------------CCCcccceeeeeceeEee
Q 024661 236 PDYKVPSPR------------HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~------------~~~~~~~~~y~ape~~~~ 262 (264)
.|||+.+.. +....+|..||+||-+.+
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 999998753 234468999999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.8e-12 Score=108.79 Aligned_cols=114 Identities=18% Similarity=0.204 Sum_probs=97.4
Q ss_pred HHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCC
Q 024661 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-IHTDL 220 (264)
Q Consensus 143 ~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-vH~di 220 (264)
+.+.|.|+ .+|++.+.+....++|.+|| .|+|.+.+.... ..+++.....++++|+.||.|||...| .|+.+
T Consensus 2 ~~l~h~n~-----~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNL-----NKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred cccchhhh-----hhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 34556666 99999999999999999999 999999999744 578899999999999999999998765 99999
Q ss_pred CCCCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 221 KPENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 221 kp~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
+..|++++....+||+|||+...... .......|.|||+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 99999999999999999999887642 1123456999998875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-12 Score=103.65 Aligned_cols=160 Identities=13% Similarity=0.171 Sum_probs=126.8
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
...+..+|.+...|..|+|++.++. ++.|+++. .......|..|.-.|+.+.|||+ +.+++.+....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpni-----lpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNI-----LPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCch-----hhhhhhccCCCCce
Confidence 3556778999999999999987554 67777653 23455778889999999999998 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEe--ccCCCCCcC
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKV--PDYKVPSPR 244 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l--~Dfg~a~~~ 244 (264)
++..|+ .|+|++.+........+..++.+++.+|+.|++|||+.. |.--.+....++||++-+.+| +|--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 999999 999999999877667888999999999999999999874 445578889999999977665 44333311
Q ss_pred CCCcccceeeeeceeE
Q 024661 245 HAFSFQTFLSMASRVY 260 (264)
Q Consensus 245 ~~~~~~~~~y~ape~~ 260 (264)
.....-.+.||+||.+
T Consensus 343 e~gr~y~pawmspeal 358 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEAL 358 (448)
T ss_pred ccccccCcccCCHHHH
Confidence 1222345679999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.7e-11 Score=93.61 Aligned_cols=136 Identities=29% Similarity=0.342 Sum_probs=100.2
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----------h-------------hhhHHHHHHHHHHHHHHhccCC
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----------I-------------NKYREAAMIEIDVLQRLARHDI 150 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~-------------~~~~~~~~~e~~~l~~l~~~~~ 150 (264)
+.++.+||-|.-+.||.|.+. .|..+++|+-+. . .-.+....+|.++|++|.....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567889999999999999875 678899996421 0 1234556789999999977632
Q ss_pred CCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
. +...+++ +.-.+|||++ |..|... +++.+..-.++..|+.-+..+-..|+||+|+++-|||+++
T Consensus 172 ~---VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 K---VPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred C---CCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 1 1333322 5567999999 6555543 2234455566777777777777999999999999999999
Q ss_pred CCcEEeccCCCCCcC
Q 024661 230 AEYVKVPDYKVPSPR 244 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~ 244 (264)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.1e-10 Score=88.28 Aligned_cols=112 Identities=28% Similarity=0.270 Sum_probs=89.1
Q ss_pred HHHHHHHHHHHHHHhccCCCCcceEEEceeeee-CCEEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 024661 132 REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208 (264)
Q Consensus 132 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~lv~e~~-~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~ 208 (264)
.....+|...+..+...+++.+..+-+...-.. ...-++|+|++ + .+|.+++.... ..+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 456788999999999988866655554332111 13468999999 4 47999988744 3666778889999999999
Q ss_pred HHHHCCCeecCCCCCCEEeecCC---cEEeccCCCCCcCC
Q 024661 209 FMHELRLIHTDLKPENILLVSAE---YVKVPDYKVPSPRH 245 (264)
Q Consensus 209 ~lH~~~ivH~dikp~Nili~~~~---~v~l~Dfg~a~~~~ 245 (264)
-||++||+|+|+++.|||++.++ .+.|+||+-+....
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999999887 89999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-10 Score=102.00 Aligned_cols=142 Identities=15% Similarity=0.189 Sum_probs=109.7
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
|.+ ....-++.+..-.|..+.++..+.+.+++..+. ..+...+-+..++.++||+| +++++.++.++.+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~I-----l~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNI-----LSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchh-----hhhhhhhcccCceEEEe
Confidence 444 344444443322466677788888888875443 33456777889999999998 99999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 173 EKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 173 e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
|.+. .|..+++. +....+...+.||+.||.||| +++++|++|.-+.|+++..|..||++|.++......
T Consensus 89 ErV~-Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~ 158 (690)
T KOG1243|consen 89 ERVR-PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF 158 (690)
T ss_pred eccc-cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC
Confidence 9993 34445543 336677888999999999998 678999999999999999999999999887654443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.2e-09 Score=83.27 Aligned_cols=137 Identities=18% Similarity=0.135 Sum_probs=96.3
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhh-------------------------hHHHHHHHHHHHHHHhccCCC
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLARHDIG 151 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~e~~~l~~l~~~~~~ 151 (264)
...|++|.-+.||+|.. ..+..+|+|+++.... ...-...|+..|+++....+.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34688888899999974 5678899999853211 112234588889988877653
Q ss_pred CcceEEEceeeeeCCEEEEEEecCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEee
Q 024661 152 GTRCVQIRNWFDYRNHICIVFEKLGPSL--YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (264)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~ 228 (264)
- .+-+.+. ...|||||+|... .-.|+. ..+..+.+..+..++++.+.-|-. .++||+||+.-|||+.
T Consensus 132 v---P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 132 V---PEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred C---CCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 2 2222222 3369999995541 111111 123444678888999999998876 8999999999999999
Q ss_pred cCCcEEeccCCCCCcCC
Q 024661 229 SAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~~ 245 (264)
++.+.++|||-|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 9999999999887543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=96.37 Aligned_cols=144 Identities=17% Similarity=0.227 Sum_probs=94.6
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEech-----------------------------------hhhHHH------HH
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------------------------------NKYREA------AM 136 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------------------------~~~~~~------~~ 136 (264)
+.|+.++-|.||+|+... |+.||||+.+.. ....+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 468999999999999765 999999987410 011122 23
Q ss_pred HHHHHHHHHhccCCCCcceEEEceee-eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 024661 137 IEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214 (264)
Q Consensus 137 ~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 214 (264)
+|...+.++.+. .....-+.+...+ +..+.-.|+|||+ |..+.++..-.. ..++.+.+.....++. +.-+-..|
T Consensus 210 ~EA~n~~~~~~n-f~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFREN-FKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHH-cCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 344444444432 2122223443333 4467779999999 777888744322 3566544433333322 33444689
Q ss_pred CeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 215 LIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 215 ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+.|.|.+|.||+++.+|++.+.|||+.....+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.1e-09 Score=91.46 Aligned_cols=137 Identities=15% Similarity=0.204 Sum_probs=109.6
Q ss_pred cEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee----CCEEEEEEecC--CC
Q 024661 105 FGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFEKL--GP 177 (264)
Q Consensus 105 ~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~----~~~~~lv~e~~--~~ 177 (264)
..+.|++....+|..|++|.++... ........-++.++++.|.|+ |.+.+.|.. +..+++|++|. .+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~Nv-----V~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNV-----VPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCce-----eehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3578999999999999999995322 112223345788999999998 999888874 56789999999 57
Q ss_pred CHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 178 SLYDFLRKN-------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 178 ~L~~~l~~~-------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+|.++.-.. .+...+|..+|.|+.|+..||.++|+.|+..+-|.+.+||++.+.+++|...|+....
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 888876432 1234678999999999999999999999999999999999998889999988877554
Q ss_pred CC
Q 024661 245 HA 246 (264)
Q Consensus 245 ~~ 246 (264)
..
T Consensus 444 ~~ 445 (655)
T KOG3741|consen 444 QE 445 (655)
T ss_pred cC
Confidence 43
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.5e-08 Score=79.30 Aligned_cols=142 Identities=17% Similarity=0.221 Sum_probs=92.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhH----------HHHHHHHHHHHHHhccCCCC---cce
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----------EAAMIEIDVLQRLARHDIGG---TRC 155 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~e~~~l~~l~~~~~~~---~~~ 155 (264)
.+.+.|.+.+.+-......|.+..- .|+.+++|..+...... ....+++..+..+...++.. +.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4557788888888877777766653 46779999776322111 12334455555554444311 122
Q ss_pred EEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEE
Q 024661 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (264)
Q Consensus 156 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~ 234 (264)
+-..-.+......+++|||+ |..|.++.. +++. +...+.+++.-||+.|+.|+|.+|.|++++.++ ++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence 22222233345678999999 777766532 3332 445677889999999999999999999998554 99
Q ss_pred eccCCCCCc
Q 024661 235 VPDYKVPSP 243 (264)
Q Consensus 235 l~Dfg~a~~ 243 (264)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.8e-10 Score=98.28 Aligned_cols=148 Identities=20% Similarity=0.174 Sum_probs=113.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeC-CCCcEEEEEEEechh---hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~ 163 (264)
....+|.++..||.|.|+.|+.+... .++..|++|.+.+.. .....-..|+.+...+. |.+. ++....|.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~-----~g~~~~W~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS-----VGKNSSWS 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc-----CCCCCCcc
Confidence 44567899999999999999998765 567778888665321 11222244565555554 3333 77777777
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVP 241 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a 241 (264)
.....|+-.||| ++++...+... ..+++...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||++
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence 777888999999 77766555333 268888999999999999999999999999999999999987 78899999998
Q ss_pred Cc
Q 024661 242 SP 243 (264)
Q Consensus 242 ~~ 243 (264)
+.
T Consensus 415 t~ 416 (524)
T KOG0601|consen 415 TR 416 (524)
T ss_pred cc
Confidence 74
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.2e-08 Score=78.61 Aligned_cols=145 Identities=22% Similarity=0.256 Sum_probs=85.4
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (264)
++.|+.|..+.||++.... ..+++|+.... .....+..|..+++.+....+.-+.++............+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678899999999998765 47999987655 5567788899999999887663333332222223345689999999
Q ss_pred CCCHHH----------------HHH---hc--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHH
Q 024661 176 GPSLYD----------------FLR---KN--SYRSFPIDL---------VREL------------GRQLLE-SVAFMHE 212 (264)
Q Consensus 176 ~~~L~~----------------~l~---~~--~~~~~~~~~---------~~~i------------~~qi~~-~l~~lH~ 212 (264)
|..+.. .+. +. ....+.... .... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 666666 111 11 101111100 0000 011222 2333332
Q ss_pred -------CCCeecCCCCCCEEee-cCCcEEeccCCCCCcC
Q 024661 213 -------LRLIHTDLKPENILLV-SAEYVKVPDYKVPSPR 244 (264)
Q Consensus 213 -------~~ivH~dikp~Nili~-~~~~v~l~Dfg~a~~~ 244 (264)
..++|+|+.+.|||++ .++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 3599999999999999 6677789999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.8e-08 Score=78.13 Aligned_cols=139 Identities=14% Similarity=0.152 Sum_probs=84.5
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-C
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (264)
..||.|..+.||+.. +..+++|+.... .......+|.++++.+...+++. ...+.+..+.+...+|||++ |
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpv---P~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPT---PHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCC---CceEEEEecCCeeeeeeeecCC
Confidence 578999999999842 445788887642 23455788999999998766533 44555556677788999999 5
Q ss_pred CC-HH--------------HHHH-------hcCCCCCCHHH-HHHHHH----------HHHHH-HHHHHH----CCCeec
Q 024661 177 PS-LY--------------DFLR-------KNSYRSFPIDL-VRELGR----------QLLES-VAFMHE----LRLIHT 218 (264)
Q Consensus 177 ~~-L~--------------~~l~-------~~~~~~~~~~~-~~~i~~----------qi~~~-l~~lH~----~~ivH~ 218 (264)
.+ +. ..+. ........... ...+.. .+... ..+|.. ..++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 43 21 1111 10000111110 001100 11111 122221 247899
Q ss_pred CCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 219 DLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 219 dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
|+.|.||+++.++ +.|+||+.+....
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCcCC
Confidence 9999999999888 9999999887644
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-08 Score=74.75 Aligned_cols=130 Identities=21% Similarity=0.186 Sum_probs=94.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
-...+.|+.|.+|.||+|.+. |..+|+|+-+ ....+..+..|.++|..++..++. .+++.+ +..++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~----p~vy~y----g~~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVT----PEVYFY----GEDFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCC----ceEEEe----chhhhhhh
Confidence 445678999999999999886 5578999654 456678889999999999887652 344443 23356699
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC-CCCEEeecCCcEEeccCCCCCc
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK-PENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik-p~Nili~~~~~v~l~Dfg~a~~ 243 (264)
|+ |..|.+.-... +.+ -+..+++.-.-|-..||-|+.|. |..+++..++.+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99 76888765421 122 23456666556778899999985 5666666777999999999984
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.8e-07 Score=71.80 Aligned_cols=137 Identities=17% Similarity=0.252 Sum_probs=103.9
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechh-----------------hhHHHHHHHHHHHHHHh-ccCCCCcceEEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------KYREAAMIEIDVLQRLA-RHDIGGTRCVQI 158 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~ 158 (264)
...||+|+.-.||.--+ ....+||+..... ....+..+|+.....+. ..+....++.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35799999999986433 3447899887543 23567788999888888 888888889999
Q ss_pred ceeeeeCCEEEEEEecC-C------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 159 RNWFDYRNHICIVFEKL-G------PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~------~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
+++.+++.-.-+|+|.+ + .+|.+++... .+++ . +...+-+-..||-+++|+.+|++|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 99999999999999998 2 3688888654 3655 2 334445566788999999999999999998543
Q ss_pred ----cEEecc-CCCCCc
Q 024661 232 ----YVKVPD-YKVPSP 243 (264)
Q Consensus 232 ----~v~l~D-fg~a~~ 243 (264)
.+.|+| ||....
T Consensus 156 ~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEKEL 172 (199)
T ss_pred CCceEEEEEeCCCCccc
Confidence 577777 676544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.9e-07 Score=82.45 Aligned_cols=140 Identities=17% Similarity=0.215 Sum_probs=87.3
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEech--------------------------------hhhHHHHHHHHHHHH--
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------------------------------NKYREAAMIEIDVLQ-- 143 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------------~~~~~~~~~e~~~l~-- 143 (264)
+.|+.-+.|.|++|+.+. |+.||||+.+.. +...+.+..|++..+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 469999999999999776 999999987421 011222222333222
Q ss_pred ----HH----hccCCCCcceEEEceeee-eCCEEEEEEecC-CCCHHH--HHHhcCCCCCCHHHHHHHHHHHHHHHH-HH
Q 024661 144 ----RL----ARHDIGGTRCVQIRNWFD-YRNHICIVFEKL-GPSLYD--FLRKNSYRSFPIDLVRELGRQLLESVA-FM 210 (264)
Q Consensus 144 ----~l----~~~~~~~~~~~~~~~~~~-~~~~~~lv~e~~-~~~L~~--~l~~~~~~~~~~~~~~~i~~qi~~~l~-~l 210 (264)
++ .|-+. ..-+.+...+. ....-.|+|||+ |..+.| .+.+. .++...+.. .+.++.. -+
T Consensus 246 ~Nae~~~~~f~~~~~--~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~---~l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSL--LTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILN---KLVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhccc--ccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHH---HHHHHHHHHH
Confidence 22 22221 11133333332 345779999999 654444 34444 466664433 3333333 24
Q ss_pred HHCCCeecCCCCCCEEeec----CCcEEeccCCCCCcCCC
Q 024661 211 HELRLIHTDLKPENILLVS----AEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 211 H~~~ivH~dikp~Nili~~----~~~v~l~Dfg~a~~~~~ 246 (264)
-..|++|+|-+|.||++.. ++.+.+-|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4679999999999999994 56899999999876544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5e-07 Score=73.19 Aligned_cols=139 Identities=16% Similarity=0.079 Sum_probs=83.4
Q ss_pred ecccCcc-EEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-C
Q 024661 99 KMGEGTF-GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (264)
Q Consensus 99 ~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (264)
.|..|.+ ..||+.... +..+.+|+..... .....+|+++++.+... +. +.+++.+....+..++|||++ |
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCC
Confidence 3444554 788988653 3568888765432 34567899999998765 32 356666666666789999999 6
Q ss_pred CCHHHHH----------------H---hcC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHH-
Q 024661 177 PSLYDFL----------------R---KNS--YRSFPID--LVRELGR--------------------QLLESVAFMHE- 212 (264)
Q Consensus 177 ~~L~~~l----------------~---~~~--~~~~~~~--~~~~i~~--------------------qi~~~l~~lH~- 212 (264)
.+|.... . +.. ...+... ....... .+...+..|-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 6665331 0 111 0011100 0000000 01111222211
Q ss_pred ------CCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 213 ------LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 213 ------~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..++|+|+.+.|||++.++.+.|+||+.|....
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 248999999999999998878899999886543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.9e-07 Score=71.64 Aligned_cols=76 Identities=14% Similarity=0.073 Sum_probs=44.4
Q ss_pred eecccCccE-EEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhcc-CCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 98 SKMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 98 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
+.|+.|+.. .||+.. ..+++|+... ......+.+|.++++.+... .+..+.++............|++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 588752 3477787554 22345788899999999754 343333222211111123458899999
Q ss_pred -CCCH
Q 024661 176 -GPSL 179 (264)
Q Consensus 176 -~~~L 179 (264)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 6554
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-07 Score=77.46 Aligned_cols=125 Identities=19% Similarity=0.324 Sum_probs=90.5
Q ss_pred EEEEEeCCCCcEEEEEEEe----chhhh-HHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-----CEEEEEEecC-C
Q 024661 108 VVECFDNEKKELVAIKIVR----SINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----NHICIVFEKL-G 176 (264)
Q Consensus 108 V~~~~~~~~~~~vaiK~~~----~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-----~~~~lv~e~~-~ 176 (264)
||++-++..|.+|..-.+. ++... .+....-..-+-++-|.|+ ++++.+|.+. ....+++||+ .
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnl-----vkfH~yw~d~K~~e~~rviFiteymss 156 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNL-----VKFHKYWTDKKYEEKPRVIFITEYMSS 156 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHH-----HHHHHhhcccccccccceEEEEecccc
Confidence 5555556666555433221 11111 1122223345666777777 9999888764 3578999999 9
Q ss_pred CCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEecc
Q 024661 177 PSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 177 ~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l~D 237 (264)
|+|..+|++.+ ...+.+..-.+|+.||+.||.|||++. |+|+++..+.|++..+|-+|+.-
T Consensus 157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecc
Confidence 99999998542 346788888999999999999999984 99999999999999999998763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.5e-06 Score=63.19 Aligned_cols=128 Identities=21% Similarity=0.287 Sum_probs=94.2
Q ss_pred CCeEEEeecccCcc-EEEEEEEeCCCCcEEEEEEEec----------------hh------hhHHHHHHHHHHHHHHhcc
Q 024661 92 PRYRILSKMGEGTF-GQVVECFDNEKKELVAIKIVRS----------------IN------KYREAAMIEIDVLQRLARH 148 (264)
Q Consensus 92 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~----------------~~------~~~~~~~~e~~~l~~l~~~ 148 (264)
.+++.++.||.|.- |.||++... |+.+|+|+++. .. .....+..|.+...+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 999999865 67899999431 00 2234678899999999887
Q ss_pred CCCCcceEEEceeeeeC------------------CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 024661 149 DIGGTRCVQIRNWFDYR------------------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209 (264)
Q Consensus 149 ~~~~~~~~~~~~~~~~~------------------~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 209 (264)
+-.+...++.++++.-. ...-||.||+ ... .++.. -+.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 76555568888886321 1246777777 322 12222 35678888999
Q ss_pred HHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 210 lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999987 2488899864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.3e-06 Score=81.08 Aligned_cols=147 Identities=15% Similarity=0.229 Sum_probs=88.1
Q ss_pred EeecccCccEEEEEEEeCCCC--cEEEEEEEechh--hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeC---CEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR---NHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~---~~~ 168 (264)
.+.++.|.+..+|+......+ ..+++|+..... .....+.+|.++++.+. |.+++. .+++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpV---P~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPV---PKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCC---CcEEEEecCCCcCCCc
Confidence 567899999999998765432 357777653221 22356789999999997 555533 4455555443 467
Q ss_pred EEEEecC-CCCHH--------------------HHHH---hcCCC---------C--CCHHHHHHHHHH-----------
Q 024661 169 CIVFEKL-GPSLY--------------------DFLR---KNSYR---------S--FPIDLVRELGRQ----------- 202 (264)
Q Consensus 169 ~lv~e~~-~~~L~--------------------~~l~---~~~~~---------~--~~~~~~~~i~~q----------- 202 (264)
|+|||++ |..+. +.+. ..... . +-...+..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 8999999 43321 1111 10000 0 111223222221
Q ss_pred ----HHHHHHHHHH-----------CCCeecCCCCCCEEeecC-Cc-EEeccCCCCCcCCC
Q 024661 203 ----LLESVAFMHE-----------LRLIHTDLKPENILLVSA-EY-VKVPDYKVPSPRHA 246 (264)
Q Consensus 203 ----i~~~l~~lH~-----------~~ivH~dikp~Nili~~~-~~-v~l~Dfg~a~~~~~ 246 (264)
+...+++|.. ..+||+|+++.|||++.+ +. +-|.||+++...++
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 2234556643 249999999999999853 34 57999999887554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.5e-06 Score=68.36 Aligned_cols=137 Identities=23% Similarity=0.252 Sum_probs=98.8
Q ss_pred EEEeecccCccEEEEEEEeCCCCcEEEEEEEec---------------------------hhhhHHHHHHHHHHHHHHhc
Q 024661 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---------------------------INKYREAAMIEIDVLQRLAR 147 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------------------------~~~~~~~~~~e~~~l~~l~~ 147 (264)
.+...|..|.-+.||.|.. ..|..+|||+++. .+...--...|++.|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3445688899999999874 5677799998741 01222334568999999998
Q ss_pred cCCCCcceEEEceeeeeCCEEEEEEecCCCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCC
Q 024661 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY--DFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPEN 224 (264)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~--~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~N 224 (264)
..|+.|--+-+- .-.|||+|+|.+=+ -.|+. ..++...+..+-.|++.-+.-|. .+++||.||+--|
T Consensus 226 aGIP~PePIlLk-------~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILLK-------NHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceeee-------cceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 887554433332 33799999964322 22222 25777788888999999888875 7899999999999
Q ss_pred EEeecCCcEEeccCCCCCc
Q 024661 225 ILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~ 243 (264)
+|+. +|.+.++|.+-+..
T Consensus 296 ~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred heEE-CCEEEEEEcccccc
Confidence 9986 68899999987753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.7e-08 Score=90.51 Aligned_cols=146 Identities=16% Similarity=0.142 Sum_probs=107.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
+.+.+.+-+.+|.++.++.+....+|...++|+..+..+....-.+++.--+.+.+ ...++.++.....+......+|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCCCcchh
Confidence 44777778999999999999888888777777655333222111111111111111 01124446555556677889999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
++++ +++|...++... ..+.+-++.++..+..+++|||...++|+|++|.|+|+..++..+++|||.
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence 9999 889999988766 678888888999999999999999999999999999999999999999973
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.8e-06 Score=65.43 Aligned_cols=141 Identities=16% Similarity=0.250 Sum_probs=81.4
Q ss_pred EeecccCccEEEEEEEeCC-CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 97 LSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
.+.|..|-...+|++.... .++.+++|+........-...+|+.+++.+...++. +.++..+.. .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~----P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLA----PKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCC----CeEEEEeCC----cEEEEee
Confidence 3567778888999987543 356788997654332222335799999999876652 333333321 4799999
Q ss_pred -CCCHHH--------------HHH---hcC--C-------CCCC-HHHHHHHHHH----------------------HHH
Q 024661 176 -GPSLYD--------------FLR---KNS--Y-------RSFP-IDLVRELGRQ----------------------LLE 205 (264)
Q Consensus 176 -~~~L~~--------------~l~---~~~--~-------~~~~-~~~~~~i~~q----------------------i~~ 205 (264)
|.++.. .+. ... . ...+ .+.+..+... +..
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 654421 111 011 0 0111 1122222111 111
Q ss_pred HHHHH----HH----CCCeecCCCCCCEEeec-CCcEEeccCCCCCcCC
Q 024661 206 SVAFM----HE----LRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 206 ~l~~l----H~----~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~ 245 (264)
.+..| -. .+++|+|+.+.|||++. ++.+.|+||..|....
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~ 203 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY 203 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence 11122 11 25899999999999998 5789999999887644
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.2e-05 Score=65.24 Aligned_cols=143 Identities=16% Similarity=0.142 Sum_probs=80.3
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEc-e--eeeeCCEEEEEEe
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVFE 173 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~--~~~~~~~~~lv~e 173 (264)
.+.|+.|....+|+.... .| .+++|++.. ...+.+..|..+++.+...++.-+..+... + +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 345777777789988743 33 588898752 223455567788888877666434333211 1 1233567899999
Q ss_pred cC-CCCH-----------HHHHHh----cCCC--------CCCH-HHHH------------HHHHH-HHHHHHHHH----
Q 024661 174 KL-GPSL-----------YDFLRK----NSYR--------SFPI-DLVR------------ELGRQ-LLESVAFMH---- 211 (264)
Q Consensus 174 ~~-~~~L-----------~~~l~~----~~~~--------~~~~-~~~~------------~i~~q-i~~~l~~lH---- 211 (264)
++ |..+ ...+.+ .... .+.+ .... ..+.+ +...++.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99 5422 111110 0000 0001 0100 01111 111222332
Q ss_pred ---HCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 212 ---ELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 212 ---~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
..+++|+|+++.|||++.+....|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23899999999999999665568999998865
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.8e-06 Score=71.15 Aligned_cols=133 Identities=20% Similarity=0.206 Sum_probs=94.6
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---------h--------------hhhHHHHHHHHHHHHHHhccC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---------I--------------NKYREAAMIEIDVLQRLARHD 149 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~--------------~~~~~~~~~e~~~l~~l~~~~ 149 (264)
-+.++.+||-|.-+-||.+-+. .|...++|+-+. . .-.+-...+|+..++.+..+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3677899999999999999864 466788885321 0 012334567999999998866
Q ss_pred CCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
.+- ...++ .+.-++|||++ |-.|...-.- .+ +..+...+..-+--|..+|+||+|..--||++.
T Consensus 172 fpV---PkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPV---PKPID----HNRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCC---CCccc----ccceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 422 33333 35568999999 7677654321 12 233455566667778899999999999999999
Q ss_pred cCCcEEeccCCCC
Q 024661 229 SAEYVKVPDYKVP 241 (264)
Q Consensus 229 ~~~~v~l~Dfg~a 241 (264)
+++.++++||=-+
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.7e-05 Score=65.35 Aligned_cols=145 Identities=17% Similarity=0.197 Sum_probs=83.8
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEce---eeeeCCEEEEEE
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVF 172 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~lv~ 172 (264)
..+.++.|....+|++.. .++ .+++|+..... ....+..|.+++..|...+++.+.++...+ .....+..+++|
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 356677787788998864 233 57788775422 234556788888888776653333333211 112246789999
Q ss_pred ecC-CCCHH-----------HHHH---h-cCCC--------CCC-HHHH--H----------HHHHHHHHHHHHHHH---
Q 024661 173 EKL-GPSLY-----------DFLR---K-NSYR--------SFP-IDLV--R----------ELGRQLLESVAFMHE--- 212 (264)
Q Consensus 173 e~~-~~~L~-----------~~l~---~-~~~~--------~~~-~~~~--~----------~i~~qi~~~l~~lH~--- 212 (264)
+++ |..+. ..+. . .... ... +... . .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999 53321 1111 0 0100 000 0000 0 001123334555532
Q ss_pred ----CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 213 ----LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 213 ----~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5899999999999999988778999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.9e-05 Score=64.70 Aligned_cols=144 Identities=17% Similarity=0.125 Sum_probs=85.3
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEc-e--eeeeCCEEEEEEe
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVFE 173 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~--~~~~~~~~~lv~e 173 (264)
.+.|..|....+|+.... +..+++|+... .....+..|+++++.+.+.++.-+..+... + .....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 556777877889988643 34688898764 334567779999999987765333222211 1 1233466789999
Q ss_pred cC-CCCHHH-----------HHH---h-c---CCC----C-CCHHHH----------HHHHHHHHHHHHHHHH-------
Q 024661 174 KL-GPSLYD-----------FLR---K-N---SYR----S-FPIDLV----------RELGRQLLESVAFMHE------- 212 (264)
Q Consensus 174 ~~-~~~L~~-----------~l~---~-~---~~~----~-~~~~~~----------~~i~~qi~~~l~~lH~------- 212 (264)
++ |..+.. .+. . . ... . ..+... ......+..++.++..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 99 544321 111 0 0 000 0 000000 0011112334444443
Q ss_pred CCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 213 LRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 213 ~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 37999999999999998877889999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.1e-05 Score=65.76 Aligned_cols=137 Identities=14% Similarity=0.120 Sum_probs=77.7
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEechhhhH-HHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-C
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (264)
.+..|-.+.+|+.. .+++.+++|+........ -...+|..+++.+...++. |. ++.... -++||||+ |
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~---~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLA-PK---PILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCC-Cc---eEEEeC----CEEEEEeccC
Confidence 34567777888886 345678888754322211 2357799999999876552 22 222221 26899999 5
Q ss_pred CCHHH--------------HHH---hcC--CCCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCCeecC
Q 024661 177 PSLYD--------------FLR---KNS--YRSFPID-LVRELGRQL---------LESVAFMHE--------LRLIHTD 219 (264)
Q Consensus 177 ~~L~~--------------~l~---~~~--~~~~~~~-~~~~i~~qi---------~~~l~~lH~--------~~ivH~d 219 (264)
..+.. .+. +.. ...++.. .+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 44321 111 111 1112211 112222111 112222222 1489999
Q ss_pred CCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 220 LKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 220 ikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+.+.||+++.++ +.|+||+.|....+
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~gdp 178 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDGDI 178 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcCCH
Confidence 999999999877 78999998876543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.16 E-value=8.5e-05 Score=64.12 Aligned_cols=75 Identities=20% Similarity=0.208 Sum_probs=51.6
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEec--------hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.||.|.+..||++.....++.++||.-.. .....++...|.+.|+.+..... ..+++++.+ +.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p--~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP--DLVPKVYHY--DEELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC--CCCCeEEEE--CCCCC
Confidence 4679999999999999865446799997431 12244667778888888754211 234555554 44567
Q ss_pred EEEEecC
Q 024661 169 CIVFEKL 175 (264)
Q Consensus 169 ~lv~e~~ 175 (264)
++|||++
T Consensus 107 ~lVME~L 113 (401)
T PRK09550 107 VTVMEDL 113 (401)
T ss_pred EEEEecC
Confidence 8999999
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.8e-05 Score=62.98 Aligned_cols=79 Identities=16% Similarity=0.139 Sum_probs=54.0
Q ss_pred EEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccC-CCCcceEEEceeeee---CCEEEE
Q 024661 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDY---RNHICI 170 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~~~~~~~~~~~---~~~~~l 170 (264)
.-.+.||.|..+.||...... + .+.+|+.+ .......+..|.+.++.+.... +. +.++++.+.+ .+..++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vp---VP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVR---MPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCC---cCcEEEEeccCCcCCCeEE
Confidence 346689999999999986432 3 46778743 2223468889999999997653 32 3555555443 467899
Q ss_pred EEecC-CCCH
Q 024661 171 VFEKL-GPSL 179 (264)
Q Consensus 171 v~e~~-~~~L 179 (264)
|||++ +.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 99999 6543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.9e-05 Score=64.91 Aligned_cols=141 Identities=18% Similarity=0.220 Sum_probs=82.6
Q ss_pred eecccCccEEEEEEEeCC------CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 98 SKMGEGTFGQVVECFDNE------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
+.+..|-...+|++.... .++.+++|+............+|..+++.+...++. ..++.++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~----P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLG----PKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCC----CceEEEeCC----Cch
Confidence 455566667888887543 257899998765433334567799999999876652 334444332 358
Q ss_pred EecC-CCCHHHH--------------HH---hcCCC-------CCC--HHHHHH--------------------------
Q 024661 172 FEKL-GPSLYDF--------------LR---KNSYR-------SFP--IDLVRE-------------------------- 198 (264)
Q Consensus 172 ~e~~-~~~L~~~--------------l~---~~~~~-------~~~--~~~~~~-------------------------- 198 (264)
+||+ |..+... +. +.... ... +..+..
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 8888 5444321 11 11100 000 001111
Q ss_pred HHHHHHHHHHHHHH---------CCCeecCCCCCCEEeecC----CcEEeccCCCCCcCCC
Q 024661 199 LGRQLLESVAFMHE---------LRLIHTDLKPENILLVSA----EYVKVPDYKVPSPRHA 246 (264)
Q Consensus 199 i~~qi~~~l~~lH~---------~~ivH~dikp~Nili~~~----~~v~l~Dfg~a~~~~~ 246 (264)
+..++...+.++-. ..++|+|+.+.|||++.+ +.+.|+||+.|.....
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p 216 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR 216 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence 11222233334432 258999999999999985 8899999999876443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0002 Score=60.74 Aligned_cols=82 Identities=22% Similarity=0.175 Sum_probs=51.4
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEe--------chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVR--------SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
+.||.|....||++.+...++.++||.-. ......++...|.+.|+...... ...+.+++ +.+.+...
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~--P~~vP~vy--~~D~e~~~ 76 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHV--PHLVPRIF--HFDTEMAV 76 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccC--ccccCeEE--EEccccce
Confidence 36899999999999975444679999532 12334455667888887765421 12334443 33556667
Q ss_pred EEEecC-C-CCHHHHH
Q 024661 170 IVFEKL-G-PSLYDFL 183 (264)
Q Consensus 170 lv~e~~-~-~~L~~~l 183 (264)
+|||++ . ..|.+.+
T Consensus 77 ~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 77 TVMEDLSHHKIARKGL 92 (370)
T ss_pred ehHhhCccchHHHHHH
Confidence 999999 3 3444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.5e-05 Score=59.74 Aligned_cols=100 Identities=20% Similarity=0.161 Sum_probs=75.2
Q ss_pred HHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 024661 136 MIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVAFMHE- 212 (264)
Q Consensus 136 ~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~- 212 (264)
..|.-+++.+.+.. ++.+++|++.. +++.|+. .+++...... ......++.....|+.++++.+++++.
T Consensus 7 ~~E~lll~~l~~~~----~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 7 NNEPLLLQLLQGSE----PFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred ccHHHHHHHcCCCC----CCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 34778888888742 45888888754 5788999 4555422000 011246889999999999999999987
Q ss_pred --CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 213 --LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 213 --~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
..+.-.|++++|+-+++++++|++|...+..
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3577799999999999999999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0004 Score=58.92 Aligned_cols=139 Identities=14% Similarity=0.198 Sum_probs=77.3
Q ss_pred eecccCccEEEEEEEeCCC---CcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEec
Q 024661 98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 174 (264)
+.|..|-...+|++..... +..|++|+........-.-.+|..+++.+...++. ..++.++.. + +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~----P~~l~~~~~-G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG----AKLLGVFGN-G---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC----CceeEEeCC-c---Eeehh
Confidence 3454566677888865432 23788998764333222335689999999887764 344444432 2 47888
Q ss_pred C-CCCHHH--------------HHH---hcC--C-CCCC-HHHHHHHHHHH----------------------HHHHHHH
Q 024661 175 L-GPSLYD--------------FLR---KNS--Y-RSFP-IDLVRELGRQL----------------------LESVAFM 210 (264)
Q Consensus 175 ~-~~~L~~--------------~l~---~~~--~-~~~~-~~~~~~i~~qi----------------------~~~l~~l 210 (264)
+ +..|.. .+. +.. . ...+ ...+..+..++ ..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 8 543311 111 111 0 0011 12222222221 1111111
Q ss_pred ---H-HCC----CeecCCCCCCEEeec-CCcEEeccCCCCCcC
Q 024661 211 ---H-ELR----LIHTDLKPENILLVS-AEYVKVPDYKVPSPR 244 (264)
Q Consensus 211 ---H-~~~----ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~ 244 (264)
. ..+ ++|+|+.+.|||+++ ++.++++||+.|...
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1 112 689999999999985 478999999988653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00034 Score=59.64 Aligned_cols=141 Identities=17% Similarity=0.153 Sum_probs=80.9
Q ss_pred EeecccCccEEEEEEEeCC----CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 97 LSKMGEGTFGQVVECFDNE----KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
...|..|-...+|++.... .++.+++|+........-.-..|..+++.+...++. .++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~----P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG----PRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC----CceEEEECCc----eEE
Confidence 4456557778899987432 246789998764332222236699999999887763 3344444332 578
Q ss_pred ecC-CCCHHHH--------------HH---hcC--CCC-CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 024661 173 EKL-GPSLYDF--------------LR---KNS--YRS-FP-IDLVRELGRQL-----------------LESVAFM--- 210 (264)
Q Consensus 173 e~~-~~~L~~~--------------l~---~~~--~~~-~~-~~~~~~i~~qi-----------------~~~l~~l--- 210 (264)
+|+ +.+|... +. +.. ... .+ ...+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 888 5444211 01 111 000 11 22232332221 1111122
Q ss_pred -HH----CCCeecCCCCCCEEeec-CCcEEeccCCCCCcCC
Q 024661 211 -HE----LRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 211 -H~----~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~ 245 (264)
.. ..++|+|+++.|||+++ ++.+.|+||..|....
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 11 25899999999999986 4789999999987644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00015 Score=62.00 Aligned_cols=159 Identities=15% Similarity=0.166 Sum_probs=95.5
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEce--eeeeCC-EEEEE
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN--WFDYRN-HICIV 171 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~~~-~~~lv 171 (264)
.+..||+|+-+.+|..-.. +. .+.|++....-..+.- .+..|... .|+.+. ..++.-.. +..++. ..-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~-~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQ--KVAELAATPDAPLLN-YRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--hc-hhheeecCCCchHHHH--HHHHhccCCCCcchh-hhhcccHHHhhCCCccceeEEe
Confidence 4678999999999865432 22 3457776432211111 11112221 122110 00011100 111222 36788
Q ss_pred EecC-C-CCHHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc---CCCCC
Q 024661 172 FEKL-G-PSLYDFLR----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD---YKVPS 242 (264)
Q Consensus 172 ~e~~-~-~~L~~~l~----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D---fg~a~ 242 (264)
|..+ + ..+..+.+ ......+++..+++.++.++.+..-||+.|.+-+|++++|+|+.+++.|.|.| |.+..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence 9998 3 34555544 12223578999999999999999999999999999999999999999999986 44331
Q ss_pred c--CCCCcccceeeeeceeE
Q 024661 243 P--RHAFSFQTFLSMASRVY 260 (264)
Q Consensus 243 ~--~~~~~~~~~~y~ape~~ 260 (264)
. .+....+...|..||.-
T Consensus 169 ng~~~~cpVg~~eftPPElQ 188 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQ 188 (637)
T ss_pred CCceEecccCccccCCHHHh
Confidence 1 11223466678888853
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0025 Score=53.97 Aligned_cols=69 Identities=16% Similarity=0.100 Sum_probs=44.1
Q ss_pred EEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEce--eeeeCCEEEEEEecC
Q 024661 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKL 175 (264)
Q Consensus 106 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~lv~e~~ 175 (264)
..||+... .++..+++|+.+........+..|++.+..+....+.-+.-+..-+ ....++..+.+++++
T Consensus 39 N~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 39 NRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 46888764 3456789998764444556777899999998876553111122222 223356788999998
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00059 Score=58.64 Aligned_cols=75 Identities=23% Similarity=0.254 Sum_probs=50.7
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEe-------chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.+.||.|.-..||++.+...++.++||.-. ......++...|.+.|+...... ...+.+++ +.+.....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~--P~~VP~vy--~~D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELA--PGLVPKVY--LFDSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhC--CCcCCeEE--EECcHHhh
Confidence 568999999999999985445679998532 12345566777888888765421 12234444 34556677
Q ss_pred EEEecC
Q 024661 170 IVFEKL 175 (264)
Q Consensus 170 lv~e~~ 175 (264)
+|||++
T Consensus 110 ~vMEdL 115 (409)
T PRK12396 110 CVMEDL 115 (409)
T ss_pred HHHHhC
Confidence 899998
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00095 Score=55.09 Aligned_cols=33 Identities=24% Similarity=0.372 Sum_probs=27.3
Q ss_pred CCeecCCCCCCEEeecCCc-EEeccCCCCCcCCC
Q 024661 214 RLIHTDLKPENILLVSAEY-VKVPDYKVPSPRHA 246 (264)
Q Consensus 214 ~ivH~dikp~Nili~~~~~-v~l~Dfg~a~~~~~ 246 (264)
.++|+|+++.|||++.+++ .-|+||+.+....+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP 219 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP 219 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence 4899999999999997565 46999999876543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=8.5e-06 Score=72.52 Aligned_cols=152 Identities=18% Similarity=0.127 Sum_probs=108.0
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEe
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e 173 (264)
|.....+++++++++++.+...+.... .+++... ....-++++|.+++|||. .+..++-++.+.+.++.++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~----~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNP----VVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCC----cccccccCCcccccchhhh
Confidence 556677999999999999887776544 6665433 344558899999999982 2667777777889999999
Q ss_pred cC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 174 KL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 174 ~~-~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
++ ++ +-........ ..+.+-....+.+.-+.+++++|+.--+|+| ||+..+ +..++.||+.......
T Consensus 315 i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccc
Confidence 99 44 2221111110 1244445566677788899999988778888 766554 7889999998876544
Q ss_pred CcccceeeeeceeE
Q 024661 247 FSFQTFLSMASRVY 260 (264)
Q Consensus 247 ~~~~~~~y~ape~~ 260 (264)
...++..+|+||+.
T Consensus 389 t~~~~~~~~~pev~ 402 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVI 402 (829)
T ss_pred cCCCCCCCCCchhh
Confidence 34578889999953
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00079 Score=56.29 Aligned_cols=147 Identities=14% Similarity=0.140 Sum_probs=82.3
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEe---chhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC--EE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HI 168 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--~~ 168 (264)
..+.+++..|....+|...+. ++.++++ .. ..........+|..+++.+....++ +...++.+..+. ..
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP---~p~~~~~~~~~~~g~p 100 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVP---VPRAFGLCGEGYLGTP 100 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCC---CcccccccccCCCCCc
Confidence 334455544444445555443 6677777 22 1123345566788888887664432 234444444443 77
Q ss_pred EEEEecCCC-------------------CHHHHHHhc--------C--C--CCCCHHHHHHHHHHH--------------
Q 024661 169 CIVFEKLGP-------------------SLYDFLRKN--------S--Y--RSFPIDLVRELGRQL-------------- 203 (264)
Q Consensus 169 ~lv~e~~~~-------------------~L~~~l~~~--------~--~--~~~~~~~~~~i~~qi-------------- 203 (264)
|.||+++.| +|.++|..- . + ..+....+..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999933 222222210 0 0 001111122222222
Q ss_pred HHHHHHHHHC--------CCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 204 LESVAFMHEL--------RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 204 ~~~l~~lH~~--------~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.....+++.+ .++|+|+++.|++++.++-+-|.||+.+....+
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2223455443 489999999999999999899999999987655
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.005 Score=51.65 Aligned_cols=30 Identities=30% Similarity=0.282 Sum_probs=26.1
Q ss_pred CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 213 LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 213 ~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0036 Score=54.16 Aligned_cols=73 Identities=16% Similarity=0.142 Sum_probs=47.1
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEe-----ch---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.||.|....||+..+. +..++||.-. .. .....+...|.+.|+.+.... ...+.+++.+.. +.-
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CCC
Confidence 668999999999998863 4458888643 11 123445556777777665321 123466665555 456
Q ss_pred EEEEecC
Q 024661 169 CIVFEKL 175 (264)
Q Consensus 169 ~lv~e~~ 175 (264)
+++||++
T Consensus 111 vlvME~L 117 (418)
T PLN02756 111 LIGMRYL 117 (418)
T ss_pred EEEEeec
Confidence 7889999
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00062 Score=57.38 Aligned_cols=74 Identities=14% Similarity=0.139 Sum_probs=58.1
Q ss_pred eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
...+.|++|++-|++|.-.- ....+++..++.+.+..++-+..+ ..-|||+..+||||+ +|+|.|+||-+++
T Consensus 297 e~~y~yl~~kdhgt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred CceEEEEEEecCCceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34577899998888776431 234567778888877777766644 689999999999999 9999999999998
Q ss_pred cC
Q 024661 243 PR 244 (264)
Q Consensus 243 ~~ 244 (264)
..
T Consensus 370 l~ 371 (488)
T COG5072 370 LS 371 (488)
T ss_pred cc
Confidence 53
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0001 Score=66.29 Aligned_cols=62 Identities=15% Similarity=0.344 Sum_probs=49.3
Q ss_pred HHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--------Cc-------ccceeeeeceeEee
Q 024661 201 RQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--------FS-------FQTFLSMASRVYIC 262 (264)
Q Consensus 201 ~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--------~~-------~~~~~y~ape~~~~ 262 (264)
.+++.||.|+|. .++||++|.|++|.++..+.+||+.|+++....+ ++ .....|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445599999995 5899999999999999999999999998876444 11 12345999998653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.002 Score=53.41 Aligned_cols=75 Identities=16% Similarity=0.213 Sum_probs=49.4
Q ss_pred EEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEec
Q 024661 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 174 (264)
+-.+.++.|....+|+.. .+++.+.+|+-. ......+..|.+-|+.|...+- ..+.+++.+....+.-||||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~--~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANP--IRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTT--SBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCC--CCCCeEEEEEeecCCceEEEEe
Confidence 335678888899999887 567789999765 4445677889999999955432 3447777777777777999999
Q ss_pred C
Q 024661 175 L 175 (264)
Q Consensus 175 ~ 175 (264)
+
T Consensus 94 l 94 (288)
T PF03881_consen 94 L 94 (288)
T ss_dssp -
T ss_pred e
Confidence 9
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0061 Score=52.70 Aligned_cols=75 Identities=21% Similarity=0.278 Sum_probs=44.0
Q ss_pred EeecccCccEEEEEEEeCCC-Cc-----EEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 97 LSKMGEGTFGQVVECFDNEK-KE-----LVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~-~~-----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.+.|..|-...+|++..... +. .|.+++........-.-.+|+++++.+...++. .++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glg----P~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFG----PKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCC----CeEEEecCC----EE
Confidence 34565677788999875432 12 244443322222112235689999999887764 455555543 58
Q ss_pred EEecC-CCCH
Q 024661 171 VFEKL-GPSL 179 (264)
Q Consensus 171 v~e~~-~~~L 179 (264)
+.||+ |.+|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 89998 5443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0027 Score=50.14 Aligned_cols=30 Identities=33% Similarity=0.486 Sum_probs=21.5
Q ss_pred CCeecCCCCCCEEe-ecCCcEEeccCCCCCc
Q 024661 214 RLIHTDLKPENILL-VSAEYVKVPDYKVPSP 243 (264)
Q Consensus 214 ~ivH~dikp~Nili-~~~~~v~l~Dfg~a~~ 243 (264)
.++|+|+.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0076 Score=50.93 Aligned_cols=141 Identities=20% Similarity=0.194 Sum_probs=83.0
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcc-eEEEceee--eeCC--EEEEEEe
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNWF--DYRN--HICIVFE 173 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~-~~~~~~~~--~~~~--~~~lv~e 173 (264)
.|.+ .-..+|+..... |+ +++|+.+.. .....+..|...+..+....+.-+. +...-+-. .-.. +.+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 345688876543 33 499988876 6677888899999999876652211 22222211 1134 7888999
Q ss_pred cC-CCCHHH------------HHH---h-cCCC---------CCCHH-------------HHHHHHHHHHHHHHHHHHC-
Q 024661 174 KL-GPSLYD------------FLR---K-NSYR---------SFPID-------------LVRELGRQLLESVAFMHEL- 213 (264)
Q Consensus 174 ~~-~~~L~~------------~l~---~-~~~~---------~~~~~-------------~~~~i~~qi~~~l~~lH~~- 213 (264)
|+ |..+.. .+- . .... ...+. .-.....++...++.+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 99 554441 110 0 0000 01111 0011233444445544442
Q ss_pred -------C--CeecCCCCCCEEeecCCc-EEeccCCCCCc
Q 024661 214 -------R--LIHTDLKPENILLVSAEY-VKVPDYKVPSP 243 (264)
Q Consensus 214 -------~--ivH~dikp~Nili~~~~~-v~l~Dfg~a~~ 243 (264)
+ +||+|+.+.||+++.+.. +.++||+-|..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 3 999999999999998885 88999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.024 Score=55.31 Aligned_cols=143 Identities=17% Similarity=0.154 Sum_probs=77.9
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhcc--CCCCcceEEEc-e----eeee-CC--E
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--DIGGTRCVQIR-N----WFDY-RN--H 167 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~-~----~~~~-~~--~ 167 (264)
+.|+. ..-..|+... .+|..+++|+.+... .......|...+..+... .+.-+.++... + ...+ ++ .
T Consensus 31 ~~L~s-~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLDG-ERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecCC-cCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 45543 3456777753 456679999987532 233445566777777653 44333333322 1 1111 12 5
Q ss_pred EEEEEecC-CCCHHHH--------------HH-------hcCC----CCCCHH-----------------HHHHHHHHHH
Q 024661 168 ICIVFEKL-GPSLYDF--------------LR-------KNSY----RSFPID-----------------LVRELGRQLL 204 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~--------------l~-------~~~~----~~~~~~-----------------~~~~i~~qi~ 204 (264)
.+.+++|+ |..+.+. +. .... ..+.|. ..+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 77899999 6555541 10 0000 001111 1122233333
Q ss_pred HHHH-----HHH--HCCCeecCCCCCCEEeecCC--cEE-eccCCCCCc
Q 024661 205 ESVA-----FMH--ELRLIHTDLKPENILLVSAE--YVK-VPDYKVPSP 243 (264)
Q Consensus 205 ~~l~-----~lH--~~~ivH~dikp~Nili~~~~--~v~-l~Dfg~a~~ 243 (264)
+... .+. ..++||+|+.+.|||++.++ ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3322 121 24799999999999999875 565 999998765
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.026 Score=49.80 Aligned_cols=74 Identities=20% Similarity=0.170 Sum_probs=46.6
Q ss_pred EEeecccCccEEEEEEEeCCC--------CcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 96 ILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
-.+.|..|-.-.+|++..... ++.|++|+.-......-.-..|..+++.+...++.. ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P----~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAP----QLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCC----ceEEEeC----
Confidence 345666676778888875421 467888987543332224456899999998887743 3444443
Q ss_pred EEEEEecC-CC
Q 024661 168 ICIVFEKL-GP 177 (264)
Q Consensus 168 ~~lv~e~~-~~ 177 (264)
-+.|.||+ |.
T Consensus 181 gg~I~efi~g~ 191 (442)
T PTZ00296 181 GGRIEEWLYGD 191 (442)
T ss_pred CCEEEEeeCCc
Confidence 24578888 54
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.013 Score=46.35 Aligned_cols=99 Identities=16% Similarity=0.197 Sum_probs=63.8
Q ss_pred EEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHH
Q 024661 120 VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197 (264)
Q Consensus 120 vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~ 197 (264)
..+|.+.... ....-+..+.+++.++..- +++..- +...+-+++|+|...-. .. .
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~ArmhGi-------lrL~ND--n~~~yGvIlE~Cy~~~i-----------~~---~ 144 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMHGI-------LRLKND--NNYKYGVILERCYKIKI-----------NF---S 144 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhhhe-------eEeecC--CCceeEEEEeeccCccc-----------ch---h
Confidence 4555554322 1344557788888888543 666532 45567899999932110 00 1
Q ss_pred HHHHHHHHHHHHHHH--CCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 198 ELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 198 ~i~~qi~~~l~~lH~--~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
.++..=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.-
T Consensus 145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 112222456777784 37999999999999999999999997653
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.035 Score=44.16 Aligned_cols=72 Identities=19% Similarity=0.190 Sum_probs=48.3
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
+++..|.--..|...+. ...+.+|+=. ......+..|+.-|+.+...+- ..+.+++.+..+.++.|+||||+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~t--i~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ--REQLSMFTAEADGLELLARSNT--ITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecc--hhhHHHHHHHHHHHHHHHhcCC--ccccceEEecCCCCeeEEEEeec
Confidence 34544444445544432 3457778632 3445677889999998888773 23466777778889999999999
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.0039 Score=48.05 Aligned_cols=32 Identities=13% Similarity=0.314 Sum_probs=27.1
Q ss_pred CCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 214 RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 214 ~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
-.+|+|+.|.||++++++ ++|+||+.|....+
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp 109 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI 109 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence 368999999999998777 99999999876443
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0087 Score=49.18 Aligned_cols=47 Identities=19% Similarity=0.213 Sum_probs=35.2
Q ss_pred HHHHHHHHHHHHHHC--CCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 199 LGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 199 i~~qi~~~l~~lH~~--~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+..+-.++.-++.. -++|+|+.|+|+|.++.+.++|+||..|....
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D 185 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLND 185 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCcc
Confidence 344444444444433 58999999999999999999999999886543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.038 Score=47.69 Aligned_cols=60 Identities=25% Similarity=0.366 Sum_probs=44.2
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEeecC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSA 230 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~Nili~~~ 230 (264)
..++=+|. |-++..+++... ..++....++.-.+.|+..+- -.+++|.|++|.||++--.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45555666 778888887653 455667777777777776654 5689999999999999744
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.034 Score=46.57 Aligned_cols=135 Identities=21% Similarity=0.260 Sum_probs=94.1
Q ss_pred EeecccCccEEEEEEEeCC----------CCcEEEEEEEech--------------hhhH-------------HHHHHHH
Q 024661 97 LSKMGEGTFGQVVECFDNE----------KKELVAIKIVRSI--------------NKYR-------------EAAMIEI 139 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~----------~~~~vaiK~~~~~--------------~~~~-------------~~~~~e~ 139 (264)
-..|..|.-+.|+.|.-.+ ....+|||+++.. ..+. --..+|+
T Consensus 257 ~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkEm 336 (531)
T KOG2269|consen 257 DGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKEM 336 (531)
T ss_pred hhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHHH
Confidence 3467888888888873211 1345888876410 0001 1123477
Q ss_pred HHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecCCCC-H-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCe
Q 024661 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-L-YDFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLI 216 (264)
Q Consensus 140 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L-~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~iv 216 (264)
..|.+++.+.++.+.+|.+. .-.|||-|+|.+ + .--|+ ...++..+....-.|+..++.-| |++.+|
T Consensus 337 hNL~RMq~~GlpcP~vV~lk-------khvLVMsFiGd~~~aAPkLK---~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LV 406 (531)
T KOG2269|consen 337 HNLSRMQKHGLPCPQVVKLK-------KHVLVMSFIGDQGLAAPKLK---NVELTDDERRNAYDQVQSIMCRLYKECLLV 406 (531)
T ss_pred HHHHHHHhcCCCCCceeeee-------cceEEEEeecCCCCCCcccc---ccccChHHHHHHHHHHHHHHHHHHHhhhee
Confidence 78888998888777777764 347899999432 1 11122 23588888888889999999887 578999
Q ss_pred ecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 217 HTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 217 H~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
|.|++--|+|...+ .|.++|..-+.
T Consensus 407 HADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 407 HADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred ecchhhhhheecCC-ceEEEechhcc
Confidence 99999999999876 89999987664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 264 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-41 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-40 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-40 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-40 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-37 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-37 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-28 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-28 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-27 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-26 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-26 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-26 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-22 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-22 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-22 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-17 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 9e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-09 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 5e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 5e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 264 | |||
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-89 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 7e-89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-77 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-73 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-69 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-59 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-28 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-26 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-24 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-23 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-23 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-23 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-23 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 9e-23 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-22 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-22 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-22 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-22 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-22 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-22 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-22 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-22 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-22 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-21 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-21 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-21 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-21 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-21 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-21 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-21 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-21 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-20 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-20 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-20 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-20 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-20 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-20 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-20 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-20 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-20 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-20 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-20 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-20 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-20 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-20 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-20 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-20 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-19 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-19 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-19 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-19 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-19 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-19 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-19 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-19 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 8e-19 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-19 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-18 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-18 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-18 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-17 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-17 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-17 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-17 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-17 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 6e-17 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-17 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 9e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-16 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-15 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-15 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-15 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-15 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-15 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-15 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-15 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-15 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-15 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-14 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-14 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-14 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-14 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-14 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-14 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-14 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-14 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-14 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-13 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-13 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-13 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-12 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-12 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-12 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-12 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-12 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-12 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-12 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-12 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-12 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-12 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-04 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-12 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 7e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-12 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-11 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-11 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-11 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-11 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-11 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-11 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-11 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 7e-11 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-10 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-10 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-10 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-10 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-09 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-09 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-09 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-09 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-09 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-09 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-09 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-09 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-09 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 6e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-09 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-09 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 9e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-09 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-08 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-08 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-08 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-08 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-08 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-08 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-08 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-08 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-07 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-07 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-07 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-07 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-07 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-07 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-07 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-06 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-06 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-06 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-06 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-06 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 8e-06 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 3e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-05 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-04 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-04 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 6e-04 |
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 3e-96
Identities = 60/177 (33%), Positives = 104/177 (58%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ ++ DD+ H+ + G L + ++ KMG+GTFG+V+ C + K+ A+K+V
Sbjct: 9 SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68
Query: 126 RSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
R+I KY +A IE D+L+++ DI V+ F Y +H+C++FE LGPSLY+ + +
Sbjct: 69 RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242
N+Y F I+ ++ ++L+++ ++ ++ L HTDLKPENILL + K
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-89
Identities = 75/171 (43%), Positives = 116/171 (67%), Gaps = 2/171 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CV + +WF++ H+CI FE LG + ++FL++N+++ +P+
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 7e-89
Identities = 74/167 (44%), Positives = 109/167 (65%), Gaps = 2/167 (1%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIE 138
H + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EAA E
Sbjct: 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 139 IDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
I VL+ L D T RCVQ+ WF++ HICIVFE LG S YDF+++N + F +D +R
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244
++ Q+ +SV F+H +L HTDLKPENIL V ++Y + + K+
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-77
Identities = 62/166 (37%), Positives = 102/166 (61%), Gaps = 3/166 (1%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD G YV +++ RY +L +G+G+FGQVV+ +D++ + VA+K+VR+ ++ A
Sbjct: 81 DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
EI +L+ L + D T + + F +RNHIC+ FE L +LY+ ++KN ++ F +
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY--VKVPDY 238
LVR+ +L+ + +H+ R+IH DLKPENILL +KV D+
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-73
Identities = 64/167 (38%), Positives = 103/167 (61%), Gaps = 5/167 (2%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD + Y+ GE RY I S +G+G+FGQVV+ +D ++E VAIKI+++ + A
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
IE+ +L+ + +HD V ++ F +RNH+C+VFE L +LYD LR ++R ++
Sbjct: 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157
Query: 195 LVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEY--VKVPD 237
L R+ +Q+ ++ F+ EL +IH DLKPENILL + + +K+ D
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-69
Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 76 DDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
G++ GE RY ++ K+G G F V D VA+KIVR Y EA
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61
Query: 135 AMIEIDVLQRLARHD------IGGTRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLR 184
A EI +LQR+ D +G +++ + F+++ H+ +VFE LG +L ++
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEY 232
K +R P+ V+++ +QLL + +MH +IHTD+KPEN+L+ +
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-59
Identities = 57/169 (33%), Positives = 95/169 (56%), Gaps = 8/169 (4%)
Query: 72 PWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
K G+++ IG+ RY ++ K+G G F V +D + K+ VA+K+V+S Y
Sbjct: 17 DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76
Query: 132 REAAMIEIDVLQRLARHDI---GGTRCVQIRNWFDYR----NHICIVFEKLGPSLYDFLR 184
E A+ EI +L+ + D VQ+ + F HIC+VFE LG L ++
Sbjct: 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEY 232
K++Y+ P+ V+++ +Q+L+ + ++H + R+IHTD+KPENILL E
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 29 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 85
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 86 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 142
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+H+ ++H+DLKP N L+V +K+ D
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM-LKLID 169
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 67 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 123
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+H+ ++H+DLKP N L+V +K+ D
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGM-LKLID 150
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-28
Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 8/148 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ LS++G G++G+V + E L A+K S K R + E+ +++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
CV++ ++ + + E GPSL S P V R L ++A
Sbjct: 118 ----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+H L+H D+KP NI L K+ D
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGD 200
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 114 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 170
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+H+ ++H+DLKP N L+V +K+ D
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM-LKLID 197
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-26
Identities = 35/141 (24%), Positives = 64/141 (45%), Gaps = 10/141 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ L K+G G FG V +C + AIK + + + + A+ E+ L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLES 206
V+ + + +H+ I E G SL D + +N F +++L Q+
Sbjct: 72 ----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 207 VAFMHELRLIHTDLKPENILL 227
+ ++H + L+H D+KP NI +
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFI 148
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-25
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
+ ++ +G+G FGQVV+ + AIK +R + + E+ +L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVR 66
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ V+ ++ + I E +LYD + + + D L RQ+
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQI 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
LE+++++H +IH DLKP NI + + VK+ D
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-24
Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
T Y + +G G++ C A+KI I+K + EI++L R +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74
Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H I + +++ +D ++ +V E + G L D + + + F + + +
Sbjct: 75 HPNI-----ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITK 127
Query: 206 SVAFMHELRLIHTDLKPENILLVS----AEYVKVPD 237
+V ++H ++H DLKP NIL V E +++ D
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 31/145 (21%), Positives = 63/145 (43%), Gaps = 7/145 (4%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + + F+ + ++FE + G +++ + +++ + Q+ E+
Sbjct: 60 HR----NILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAE 231
+ F+H + H D++PENI+ +
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRR 139
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 87 GENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVL 142
EN Y + SK +G G F V +C + A K + R R + EI VL
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
+ R + + ++ + I ++ E G ++ + V L +
Sbjct: 83 ELAKSCP----RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAE 231
Q+LE V ++H+ ++H DLKP+NILL S
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIY 168
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 17/158 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
++ + +G G FGQV + + IK + E A E+ L +L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKL-DHVNIV 67
Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+ + I E +L ++ K L EL
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ + V ++H +LI+ DLKP NI LV + VK+ D
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-23
Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEG++G V +C + + ++VAIK ++ A+ EI +L++L +H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + F + + +VFE ++ L + R P LV+ + Q L++V
Sbjct: 62 PNL-----VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAV 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
F H+ IH D+KPENIL+ +K+ D
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCD 145
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-23
Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 14/178 (7%)
Query: 68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
PP +G N +RI K+G G F +V VA+K V+
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 128 IN----KYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181
+ K R + EID+L++L H + ++ F N + IV E L
Sbjct: 68 FDLMDAKARADCIKEIDLLKQL-NHPNV-----IKYYASFIEDNELNIVLELADAGDLSR 121
Query: 182 FLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ K R P V + QL ++ MH R++H D+KP N+ + + VK+ D
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGD 179
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-23
Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAM 136
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
E+++L++L +I +++ + + IV E G L+D + K F
Sbjct: 70 REVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHD 122
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+ +Q+ + +MH+ ++H DLKPENILL S E
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-23
Identities = 34/146 (23%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
N+ + + +G G F +V +L A+K ++ +R++++ EI VL+++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I V + + ++ H +V + + G L+D + + + + +Q+L
Sbjct: 65 HENI-----VTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE 231
+V ++HE ++H DLKPEN+L ++ E
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE 143
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-23
Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L +GEG++G V++C + + +VAIK + + AM EI +L++L RH
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQL-RH 83
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ + V + + +VFE + ++ D L +V++ Q++ +
Sbjct: 84 ENL-----VNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGI 137
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
F H +IH D+KPENIL+ + VK+ D
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCD 167
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-23
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 11/150 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEG+FG+ + E IK + K RE + E+ VL + +H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I VQ R F+ + IV + G L+ + F D + + Q+ ++
Sbjct: 84 NI-----VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+H+ +++H D+K +NI L V++ D
Sbjct: 139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLA 146
++ Y IL ++G G FG V C + + K + + EI ++ +L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL- 105
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H + + + + F+ + + ++ E L G L+D + Y V RQ E
Sbjct: 106 HHP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 160
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE--YVKVPD 237
+ MHE ++H D+KPENI+ + + VK+ D
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 16/158 (10%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-- 137
G + + K+G G FG V + IK INK R +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66
Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSF 191
EI+VL+ L +I ++I F+ +++ IV E G L + + + ++
Sbjct: 67 IEAEIEVLKSLDHPNI-----IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 192 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229
V EL +Q++ ++A+ H ++H DLKPENIL
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 29/147 (19%), Positives = 62/147 (42%), Gaps = 15/147 (10%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +GEG F QV E D + K+ +K+ + N + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL---RKNSYRSFPIDLVRELGRQ 202
+H ++ + ++N +V E +L + + + + P LV +
Sbjct: 126 QHMF-----MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 203 LLESVAFMHELRLIHTDLKPENILLVS 229
+L + +H+ +IH D+KP+N +L +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGN 207
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-22
Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
+ E+++L++L +I +++ + + IV E G L+D + K F
Sbjct: 68 ILREVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+ +Q+ + +MH+ ++H DLKPENILL S E
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 31/239 (12%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
+++ R++ R P + N P + F P
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLA--EAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---- 125
P W + +Y +G G V C A+KI+
Sbjct: 83 LPDWAA-----------AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 126 -----RSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPS 178
+ + REA E +L+++A H I + + + ++ + + +VF+ +
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHI-----ITLIDSYESSSFMFLVFDLMRKGE 186
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L+D+L + R + R LLE+V+F+H ++H DLKPENILL +++ D
Sbjct: 187 LFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-22
Identities = 32/146 (21%), Positives = 61/146 (41%), Gaps = 13/146 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
I V++ + H ++ E SLY L + + P + R ++
Sbjct: 69 I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE 231
+ + E ++H ++KP NI+ V E
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE 149
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G ++ + +L+ Y+ + K+G G +G+V+ C D AIKI+
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
+ E+ VL+ L +I +++ ++F+ + + +V E G L+D + F
Sbjct: 83 LLEEVAVLKLLDHPNI-----MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNE 135
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+ +Q+L V ++H+ ++H DLKPEN+LL S E
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE 173
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 5e-22
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 10/154 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLA 146
+++ Y I ++G G FG V + A K V + ++ +E EI + L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
RH V + + F+ N + +++E + G L++ + D E RQ+ +
Sbjct: 212 RHP----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 266
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE--YVKVPD 237
+ MHE +H DLKPENI+ + +K+ D
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-22
Identities = 40/157 (25%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI 137
G +V + RY+ +G+G+FG+V+ C D + A+K++ R + + + +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 138 --EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID 194
E+ +L++L +I +++ +F+ + + +V E G L+D + F
Sbjct: 74 LREVQLLKQLDHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEV 126
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+ RQ+L + +MH+ +++H DLKPEN+LL S
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-22
Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
P +R+ K+G G FG++ + E VAIK+ ++ +E ++L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GS 63
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G Q+ +F + +V E LGPSL D L R+F + V + QL+ + ++
Sbjct: 64 GDGIPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 211 HELRLIHTDLKPENILL 227
H LI+ D+KPEN L+
Sbjct: 122 HSKNLIYRDVKPENFLI 138
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-22
Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRL 145
+ L+ + + S++G G V C ++ A+K + K + ++ EI VL RL
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRL 105
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ +I ++++ F+ I +V E G L+D + + Y + + +Q+L
Sbjct: 106 SHPNI-----IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQIL 158
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAE 231
E+VA++HE ++H DLKPEN+L +
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPA 185
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 8e-22
Identities = 32/146 (21%), Positives = 61/146 (41%), Gaps = 13/146 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
I V++ + H ++ E SLY L + + P + R ++
Sbjct: 69 I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE 231
+ + E ++H ++KP NI+ V E
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE 149
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-22
Identities = 36/149 (24%), Positives = 69/149 (46%), Gaps = 15/149 (10%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDV 141
+ Y + ++G G F V +C + A K ++ RE E+++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
L+ + RH + + + F+ + + ++ E + G L+DFL + D +
Sbjct: 62 LREI-RHP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVS 229
+Q+L+ V ++H R+ H DLKPENI+L+
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLD 143
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-22
Identities = 36/153 (23%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL-RKNSYRSFPIDLVRE 198
+L+++ H++ + + + ++ R + ++ E + G L+DFL +K S +
Sbjct: 68 ILRQVLHHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATS 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+Q+L+ V ++H ++ H DLKPENI+L+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
RYR+ K+G G+FG + D E VAIK+ K+ + + E + + + G
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQ----G 63
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G IR W ++ +V E LGPSL D L R F + V L Q++ + ++
Sbjct: 64 GVGIPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 211 HELRLIHTDLKPENILL 227
H IH D+KP+N L+
Sbjct: 122 HSKNFIHRDVKPDNFLM 138
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-21
Identities = 34/149 (22%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQ 143
++ Y + + +G G++G+V + A K I KY + EI++++
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L +I +++ F+ I +V E G L++ + F + +
Sbjct: 62 SLDHPNI-----IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKD 114
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAE 231
+L +VA+ H+L + H DLKPEN L ++
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS 143
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 34/152 (22%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+++ +I + + + ++ R + ++ E + G L+DFL + +
Sbjct: 68 ILRQVLHPNI-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+Q+L+ V ++H ++ H DLKPENI+L+
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-----EID 140
E L +Y++ +G G FG V VAIK V I+ + E E+
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRE 198
+L+++ G +++ +WF+ + ++ E+ P L+DF+ + + +L R
Sbjct: 99 LLKKV-SSGFSG--VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARS 153
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILL 227
Q+LE+V H ++H D+K ENIL+
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILI 182
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+ + ++ + + ++ + + ++ E + G L+DFL + + E
Sbjct: 67 ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
+Q+L V ++H L++ H DLKPENI+L+
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-21
Identities = 46/150 (30%), Positives = 82/150 (54%), Gaps = 12/150 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
++ + K+GEGT+G V + + E+VA+K +R ++ E A+ EI +L+ L H
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL-NH 61
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + N + +VFE L L F+ ++ P+ L++ QLL+ +
Sbjct: 62 PNI-----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
AF H R++H DLKP+N+L+ + +K+ D
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLAD 146
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINKYREAAMI 137
Y +G G V C + A+KI+ + + REA +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 138 EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
E+D+L++++ H I +Q+++ ++ +VF+ + L+D+L +
Sbjct: 73 EVDILRKVSGHPNI-----IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKE 125
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
R++ R LLE + +H+L ++H DLKPENILL +K+ D
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 18/174 (10%)
Query: 66 PRTGSPPW-RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
P S + + ++ + Y + ++G+G F V C A KI
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 125 VRSINK----YREAAMI--EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP 177
IN R+ + E + ++L +I V++ + + +VF+ + G
Sbjct: 62 ---INTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGG 113
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
L++ + + + +Q+LES+A+ H ++H +LKPEN+LL S
Sbjct: 114 ELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------EAAMIEI 139
Y + +G+G F V C + E + A+KI ++ + E E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77
Query: 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLV 196
+ L I V++ + + +VFE + G L + R ++ + +
Sbjct: 78 SICHMLKHPHI-----VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
RQ+LE++ + H+ +IH D+KP +LL S E
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE 167
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-21
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA-------AMIEIDVLQRL 145
RY ++++G G +G V + D VA+K VR + + E+ +L+RL
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRL 68
Query: 146 --ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
H + V + D + +VFE + L +L K P + +++L RQ
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L + F+H ++H DLKPENIL+ S VK+ D
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 5e-21
Identities = 37/208 (17%), Positives = 77/208 (37%), Gaps = 52/208 (25%)
Query: 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINK 130
++ ++ L +Y + +G+G++G V +N+ + + AIKI+ K
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR 189
E E+ ++++L +I ++ ++ +IC+V E G L D L
Sbjct: 71 DVERIKTEVRLMKKLHHPNI-----ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 190 --------------------------------------SFPIDLVRELGRQLLESVAFMH 211
L+ + RQ+ ++ ++H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 212 ELRLIHTDLKPENILLVSAE--YVKVPD 237
+ H D+KPEN L + + +K+ D
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVD 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-21
Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 12/163 (7%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN 129
SP DD D I + + +G G G +V VA+K + +
Sbjct: 4 SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58
Query: 130 KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
+ A E+ +L+ H ++ ++ R I E +L +++ + +
Sbjct: 59 ECFSFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDF 113
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
++ L +Q +A +H L ++H DLKP NIL+
Sbjct: 114 AHLGLE-PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-21
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
Y++ ++GEG+FG + E + + VAIK + + E + L G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AG 64
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
T + +F H +V + LGPSL D L R F + V +Q+L V +
Sbjct: 65 CTGIPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 211 HELRLIHTDLKPENILL 227
HE L++ D+KP+N L+
Sbjct: 123 HEKSLVYRDIKPDNFLI 139
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-21
Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 11/145 (7%)
Query: 89 NLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLA 146
Y++ + GEG +V C + + A+KI+ + R E+++L +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
H + +++ +F+ + +VFEK+ G S+ + K R F + + +
Sbjct: 69 GHRNV-----LELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVA 121
Query: 205 ESVAFMHELRLIHTDLKPENILLVS 229
++ F+H + H DLKPENIL
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEH 146
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 7e-21
Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
++R+ K+G G+FG++ + + E VAIK+ K+ + E + + L G
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRILQ----G 61
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
GT +R WF ++ +V + LGPSL D L R + V L Q++ V F+
Sbjct: 62 GTGIPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 211 HELRLIHTDLKPENILL 227
H +H D+KP+N L+
Sbjct: 120 HSKSFLHRDIKPDNFLM 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 22/153 (14%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
++ + K+G G FG + F K E A +V+ + E+ QR+A+ D
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 152 GTRCVQIRN---------WF--------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+ + YR +V E+LG L +N +F
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKS 151
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
V +LG ++L+ + ++HE +H D+K N+LL
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLA 146
++L +G G+ G VV + + VA+K + + + A++EI +L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR---MLIDFCDIALMEIKLLTESD 66
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG----- 200
H + ++ + I E +L D + + + L +E
Sbjct: 67 DHPNV-----IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAE 231
RQ+ VA +H L++IH DLKP+NIL+ ++
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSS 152
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 10/154 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + ++G G FG V+ + E VAIK R K RE +EI ++++L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
+ + + E G L +L + +R L + +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 207 VAFMHELRLIHTDLKPENILLVSAE---YVKVPD 237
+ ++HE R+IH DLKPENI+L K+ D
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 32/149 (21%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-EIDVLQ 143
T Y++ ++G+G F V C + A I+ + ++ + E + +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L +I V++ + H ++F+ + G L++ + Y + +Q
Sbjct: 66 LLKHPNI-----VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAE 231
+LE+V H++ ++H +LKPEN+LL S
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKL 147
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-20
Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD-IGGTRCVQI 158
GEG+F +C + + A+KI I+K EA EI L+ H I V++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNI-----VKL 71
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F + H +V E L G L++ R + F + R+L+ +V+ MH++ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 218 TDLKPENILLVSAE 231
DLKPEN+L
Sbjct: 130 RDLKPENLLFTDEN 143
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 15/158 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + +G G FG V E + AIK +R + RE M E+ L +L H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64
Query: 150 -------IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFP-IDLVREL 199
+ + ++ I + L +L D++ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ E+V F+H L+H DLKP NI + VKV D
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 36/157 (22%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------------SINKYRE 133
+ Y + K+G G +G+V+ C + AIK+++ +I K+ E
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFP 192
EI +L+ L +I +++ + F+ + + +V E G L++ + F
Sbjct: 92 EIYNEISLLKSLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229
+ +Q+L + ++H+ ++H D+KPENILL +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 30/158 (18%), Positives = 59/158 (37%), Gaps = 29/158 (18%)
Query: 92 PRYRILSKMGEGTFGQV--------VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ 143
++++ S G + + C +K+ ++K+ + E + Q
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL----FNEQNFFQ 97
Query: 144 RLARHD-------IGGTRCVQIRN--WF-----DYRNHICIVFEKLGPSLYDFLRKNSYR 189
R A+ + T + I F YR +V LG SL L +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR---FLVLPSLGRSLQSALDVSPKH 154
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
V ++ +LL+++ F+HE +H ++ ENI +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 10/166 (6%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSK--MGEGTFGQVVECFDNEKKELVAIKIVR- 126
P P D V A + Y + +G G FGQV +C + +A KI++
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
K +E EI V+ +L H +Q+ + F+ +N I +V E + G L+D +
Sbjct: 125 RGMKDKEEVKNEISVMNQL-DHA----NLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
SY + +Q+ E + MH++ ++H DLKPENIL V+ +
Sbjct: 180 ESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-20
Identities = 34/149 (22%), Positives = 65/149 (43%), Gaps = 17/149 (11%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEIDV 141
+ Y + ++G+G F V C A KI IN + + E +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARI 58
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
++L +I V++ + + +VF+ + G L++ + + +
Sbjct: 59 CRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 111
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVS 229
+Q+LES+A+ H ++H +LKPEN+LL S
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLAS 140
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+T Y++ ++ G G G+V+ECF + A+K+ + A E+D + +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD-SPKARQEVDHHWQAS 79
Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
I V I + ++ + + I+ E + G L+ +++ ++F E+
Sbjct: 80 GGPHI-----VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAE 231
R + ++ F+H + H D+KPEN+L S E
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 16/149 (10%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+ Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68
Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
+ I V+I + ++ R + IV E L G L+ ++ ++F E+
Sbjct: 69 QCPHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVS 229
+ + E++ ++H + + H D+KPEN+L S
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTS 152
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 17/155 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHD-I 150
Y + K+GEG F V A+K + + RE A E D+ + H I
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 151 GGTRCVQIRNWF----DYRNHICIVFE--KLGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
+++ + ++ ++ K G +L++ + K+ D + L
Sbjct: 89 -----LRLVAYCLRERGAKHEAWLLLPFFKRG-TLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + +H H DLKP NILL + D
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-20
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 12/167 (7%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
PP P E YR+ +G+G FG V + VAIK++
Sbjct: 9 GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR 68
Query: 128 INKYREAAMI-----EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LY 180
+ + + E+ +L ++ G +++ +WF+ + +V E+ P+ L+
Sbjct: 69 VLGWSPLSDSVTCPLEVALLWKV-GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLF 127
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
D++ + R Q++ ++ H ++H D+K ENIL+
Sbjct: 128 DYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI 172
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 27/207 (13%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P P P P F ++G + D + V +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT--SQ 68
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
L G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 69 VL----------GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 114
Query: 149 D-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
I V+I + ++ R + IV E L G L+ ++ ++F E+ +
Sbjct: 115 PHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 203 LLESVAFMHELRLIHTDLKPENILLVS 229
+ E++ ++H + + H D+KPEN+L S
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTS 196
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-20
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 23/164 (14%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMI-----E 138
+ L Y + +G G G+V F+ + + VAIKI+ +I REA E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 139 IDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLV 196
I++L++L H I ++I+N+FD ++ IV E + G L+D + N
Sbjct: 66 IEILKKL-NHPCI-----IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LKEATC 116
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPD 237
+ Q+L +V ++HE +IH DLKPEN+LL S E +K+ D
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMI--E 138
+ L Y + +G G G+V F+ + + VAI+I+ S + A + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVR 197
I++L++L H ++I+N+FD IV E + G L+D + N +
Sbjct: 191 IEILKKL-NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPD 237
Q+L +V ++HE +IH DLKPEN+LL S E +K+ D
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-19
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 14/151 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
RY +G+G F + E D + KE+ A KIV + K + + EI + + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ V +F+ + + +V E SL + ++ ++ R RQ++
Sbjct: 75 QHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++H R+IH DLK N+ L VK+ D
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 158
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 8/153 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHD-- 149
R R+ + EG F V E D A+K + S + A + E+ +++L+ H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLVRELGRQLLES 206
+ + ++ E L +FL+K R D V ++ Q +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 207 VAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237
V MH + +IH DLK EN+LL + +K+ D
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-19
Identities = 31/151 (20%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+++ + +G+G+F V VAIK++ +++ K + E+ + +L +H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ N+F+ N++ +V E + +L+ + F + R Q++
Sbjct: 71 PSI-----LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITG 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++H ++H DL N+LL +K+ D
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIAD 155
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 66 PRTGSPPWRPDDKDGHYVFAI--------GENLTPRYRILSKMGEGTFGQVVECFDNEKK 117
P DKDG V + Y +G G+FG V + +
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 118 ELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWF------DYRNHIC 169
ELVAIK V ++ R E+ ++++L H V++R +F ++
Sbjct: 80 ELVAIKKVLQDKRFKNR-----ELQIMRKL-DHC----NIVRLRYFFYSSGEKKDEVYLN 129
Query: 170 IVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+V + + ++Y R + ++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 43/153 (28%), Positives = 81/153 (52%), Gaps = 14/153 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
RYR ++K+GEGT+G+V + D E VAIK +R + E A+ E+ +L+ L +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QH 92
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I +++++ + + + ++FE L ++ + + +++ QL+ V
Sbjct: 93 RNI-----IELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQLINGV 145
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
F H R +H DLKP+N+LL ++ + P K+
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 33/136 (24%), Positives = 54/136 (39%), Gaps = 12/136 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
++G G+FG+V D + A+K VR + E+ L
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP--- 110
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
R V + + I E L G SL +++ P D Q LE + ++H
Sbjct: 111 -RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH 167
Query: 212 ELRLIHTDLKPENILL 227
R++H D+K +N+LL
Sbjct: 168 TRRILHGDVKADNVLL 183
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 38/215 (17%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P K G+P A A P P D +
Sbjct: 2 PAPADPGK-------------AGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR------- 41
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQR 144
RY +G+G F + E D + KE+ A KIV + K + + EI + +
Sbjct: 42 ----RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 145 LARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L H + V +F+ + + +V E SL + ++ ++ R RQ
Sbjct: 98 L-AHQHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ ++H R+IH DLK N+ L VK+ D
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 184
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-19
Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 13/150 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L +H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + + +VFE L + + ++V+ QLL+ +
Sbjct: 61 KNI-----VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
F H ++H DLKP+N+L+ +K+ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLAN 144
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-19
Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 9/153 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRL-- 145
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 70
Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
H + V + D + +VFE + L +L K P + ++++ QLL
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ F+H R++H DLKP+NIL+ S+ +K+ D
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 24/159 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMI----------EID 140
+Y +S +G G FG V D EK + V +K I K + E I EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF---IKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRE 198
+L R+ H +++ + F+ + +V EK G L+ F+ ++ L
Sbjct: 82 ILSRV-EHA----NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASY 134
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ RQL+ +V ++ +IH D+K ENI++ +K+ D
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-19
Identities = 35/142 (24%), Positives = 68/142 (47%), Gaps = 11/142 (7%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIR 159
G+GT+G V D + +AIK + + Y + EI + + L +H VQ
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHK----NIVQYL 85
Query: 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAFMHELRLI 216
F I I E++ G SL L ++ + + + +Q+LE + ++H+ +++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 217 HTDLKPENILLVSAE-YVKVPD 237
H D+K +N+L+ + +K+ D
Sbjct: 145 HRDIKGDNVLINTYSGVLKISD 166
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-19
Identities = 39/151 (25%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + EI++ L RH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I +++ N+F R I ++ E LY L+K+ F +L ++
Sbjct: 74 PNI-----LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA 126
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + HE ++IH D+KPEN+L+ +K+ D
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIAD 157
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 9e-19
Identities = 34/170 (20%), Positives = 64/170 (37%), Gaps = 33/170 (19%)
Query: 84 FAIGENLT----PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSINKYREA 134
FA+GE +T +++ +G+G FG + N +K+ S N
Sbjct: 23 FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF- 81
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRN---------WF--------DYRNHICIVFEKLGP 177
E+ QR A+ + + YR ++ ++ G
Sbjct: 82 --TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR---FMIMDRFGS 136
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
L N+ + F V +L ++L+ + ++HE +H D+K N+LL
Sbjct: 137 DLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-18
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + +N E A+K +R + K E + EI +L+ L +H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + + + +VFE L L L + QLL +
Sbjct: 60 SNI-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
A+ H+ R++H DLKP+N+L+ +K+ D
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIAD 143
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 37/151 (24%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + E+++ L RH
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I +++ +F + ++ E ++Y L+K F +L +
Sbjct: 69 PNI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+++ H R+IH D+KPEN+LL SA +K+ D
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIAD 152
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-18
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y+ L K+GEGT+G V + D+ + +VA+K +R ++ E A+ EI +L+ L H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HH 78
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V + + + +VFE + L L +N ++ QLL V
Sbjct: 79 PNI-----VSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGV 132
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
A H+ R++H DLKP+N+L+ S +K+ D
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLAD 162
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-18
Identities = 32/159 (20%), Positives = 64/159 (40%), Gaps = 20/159 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
Y +L +G G++G+ + +++ K + + ++ + E+++L+ L +H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 150 -IGGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
I V+ + R + IV E G L + + + V + QL
Sbjct: 66 NI-----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 204 LESVAFMHELRL-----IHTDLKPENILLVSAEYVKVPD 237
++ H +H DLKP N+ L + VK+ D
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-18
Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 17/154 (11%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+++ L K+G GT+ V + + VA+K V+ ++ E A+ EI +++ L +H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KH 62
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR----KNSYRSFPIDLVRELGRQL 203
+ I V++ + N + +VFE + L ++ N+ R ++LV+ QL
Sbjct: 63 ENI-----VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L+ +AF HE +++H DLKP+N+L+ +K+ D
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD 151
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL- 69
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H I + + + F ++++I +VF+ + L ++ NS ++ L+
Sbjct: 70 SHPNI-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQ 123
Query: 206 SVAFMHELRLIHTDLKPENILL 227
+ ++H+ ++H DLKP N+LL
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLL 145
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 35/154 (22%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
G +N + + +V E S+ D ++ + + + + R++L
Sbjct: 85 TYYG---AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++ +H+ ++IH D+K +N+LL VK+ D+ V
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 22/175 (12%), Positives = 50/175 (28%), Gaps = 30/175 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQR 144
+ +++ + G V D E+ E A+K+ + + EA +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 145 LARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFLRKNS 187
R + + ++ ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 188 YRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ I + L QL+ A + L+H P+N+ ++ + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y L K+GEGT+ V + LVA+K +R ++ E A+ E+ +L+ L +H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KH 59
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V + + + +VFE L L +L + + V+ QLL +
Sbjct: 60 ANI-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGL 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
A+ H +++H DLKP+N+L+ +K+ D
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLAD 143
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-17
Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y I +GEG+FG+V + ++ VA+K + + + K + EI L +L RH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I +++ + I +V E G L+D++ + + D R +Q++ ++
Sbjct: 69 PHI-----IKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAI 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ H +++H DLKPEN+LL VK+ D
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIAD 151
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-17
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 21/151 (13%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQR 144
GE Y +G G+FG V + E E VAIK V ++ RE + +++
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRI 88
Query: 145 LARHDIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLR--KNSYRSFPIDLV 196
+ +H V ++ +F + +V E + ++Y R ++ P+ L+
Sbjct: 89 V-KHP----NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILL 227
+ QLL S+A++H + + H D+KP+N+LL
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-17
Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 74 RPDDKDGHYVFAIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--- 129
+ DD + A+G + R+ + ++G G+F V + D E VA ++
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66
Query: 130 KYREAAMIEIDVLQRLARHDIGGTRCVQ-IRNWFDY---RNHICIVFEKL-GPSLYDFLR 184
R+ E ++L+ L +H V+ +W + I +V E + +L +L+
Sbjct: 67 SERQRFKEEAEMLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAE-YVKVPD 237
+ ++ I ++R RQ+L+ + F+H +IH DLK +NI + VK+ D
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 32/141 (22%), Positives = 66/141 (46%), Gaps = 12/141 (8%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90
Query: 149 D--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I V+ +VFE + + DF K Y++ +R ++L++
Sbjct: 91 PNIITLADIVKDPVSRTP----ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKA 142
Query: 207 VAFMHELRLIHTDLKPENILL 227
+ + H + ++H D+KP N+++
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMI 163
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 10/169 (5%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
+ G + + RY I +G G++G V E +D +K +VAI
Sbjct: 24 QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83
Query: 123 K-IVRSINKYREAAMI--EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPS 178
K I+R + I EI +L RL HD + + I + + + +V E
Sbjct: 84 KKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
R ++ L LL V ++H ++H DLKP N L+
Sbjct: 143 FKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 32/172 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--RE------------ 133
E + +Y + +G G+FG V E FD E + A+K V +Y RE
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 134 ----------------AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP 177
D + +++ + ++ ++ E +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 178 SLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+L+ L+ S RS P++L+ QL +V F+H L + H D+KP+N+L+
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 36/143 (25%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + + VA+K V + +E A+ EI +LQ L +H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-KH 75
Query: 149 D-IGGTRCV---QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ + + + + + I +VF+ L L N F + ++ + + LL
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLL 134
Query: 205 ESVAFMHELRLIHTDLKPENILL 227
+ ++H +++H D+K N+L+
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLI 157
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 45/149 (30%), Positives = 65/149 (43%), Gaps = 12/149 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIG 151
RY + +G G FG D KELVA+K + E EI R RH +I
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSLRHPNI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V+ + H+ I+ E G LY+ + F D R +QLL V++
Sbjct: 79 ----VRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYC 132
Query: 211 HELRLIHTDLKPENILLVSAEY--VKVPD 237
H +++ H DLK EN LL + +K+ D
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICD 161
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ +V E + G L+D++ K+ R L +Q+L +
Sbjct: 71 PHI-----IKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
V + H ++H DLKPEN+LL + K+ D
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIAD 154
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 32/171 (18%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI------------- 137
YRI+ + +G F +++ C + + A+K + K R+
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----- 188
E+ ++ + +++ C+ + + I++E + S+ F
Sbjct: 90 FKNELQIITDI-KNE----YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 189 -RSFPIDLVRELGRQLLESVAFMHELRLI-HTDLKPENILLVSAEYVKVPD 237
PI +++ + + +L S +++H + I H D+KP NIL+ VK+ D
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEID 140
+ YR+L +G+G F +V VAIKI I+K + + E+
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFREVR 66
Query: 141 VLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE 198
+++ L H +I V++ + + ++ E G ++D+L + R
Sbjct: 67 IMKIL-NHPNI-----VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARS 118
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
RQ++ +V + H+ R++H DLK EN+LL + +K+ D
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIAD 157
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-15
Identities = 32/155 (20%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ K+GEG+ G V + VA+K++ + R + E+ +++
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
++ V++ + + ++ E L G +L D + + I V +L+
Sbjct: 101 HFNV-----VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV---CEAVLQ 152
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++A++H +IH D+K ++ILL VK+ D+
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF 187
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 4e-15
Identities = 26/182 (14%), Positives = 58/182 (31%), Gaps = 34/182 (18%)
Query: 90 LTPRYRILSK---MGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMI 137
L R R L + +G+ +E D E E + + + E +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLY 180
+ + + R + + ++ ++ +L
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 181 DFL-----RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
F ++++S +L Q++ +A +H L+HT L+P +I+L V +
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
Query: 236 PD 237
Sbjct: 253 TG 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-15
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I V + + + + +V E L G SL D + + I V R+ L+
Sbjct: 76 NPNI-----VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQ 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++ F+H ++IH D+K +NILL VK+ D+
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-15
Identities = 37/156 (23%), Positives = 78/156 (50%), Gaps = 20/156 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAM---IEIDVLQRLAR 147
+Y + +GEG++G+V E D+E A+KI+ + + + EI +L+RL R
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 148 H-DIGGTRCVQIRN--WFDYRNHICIVFE--KLGPS-LYDFLRKNSYRSFPIDLVRELGR 201
H ++ +Q+ + + + + + +V E G + D + + + FP+
Sbjct: 65 HKNV-----IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFC 116
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
QL++ + ++H ++H D+KP N+LL + +K+
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISA 152
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-15
Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 10/157 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQ 143
++ + L ++G G+FG V D E+VAIK + K E+ LQ
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L + +Q R + + +V E S D L + + + +
Sbjct: 110 KLRHPNT-----IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 163
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
L+ +A++H +IH D+K NILL VK+ D+
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 200
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-15
Identities = 36/150 (24%), Positives = 75/150 (50%), Gaps = 8/150 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+ I+ ++G+G FG+V + + E L A K++ + ++ I EI++L I
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V++ + + + I+ E G ++ + + R ++ + RQ+LE++ F+
Sbjct: 79 ----VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFL 133
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKV 240
H R+IH DLK N+L+ +++ D+ V
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGV 163
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 36/154 (23%), Positives = 62/154 (40%), Gaps = 12/154 (7%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEID 140
R+++ G+GTFG V + VAIK V ++ RE ++I
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70
Query: 141 VLQRLARHD-IGGTRCVQIRNWFDYRNHIC--IVFEKLGPSLYDFLRKNSYR--SFPIDL 195
+ H I + R I +V E + +L+ R R + P L
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 196 VRELGRQLLESVAFMHE--LRLIHTDLKPENILL 227
++ QL+ S+ +H + + H D+KP N+L+
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H ++ V+ N + E G L+D + + P + QL+
Sbjct: 64 HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
V ++H + + H D+KPEN+LL + +K+ D
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 22/176 (12%), Positives = 54/176 (30%), Gaps = 31/176 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------REAAMIEIDVLQ 143
+ +G+ +E D E E + + + E + +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 144 RLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFL--- 183
+ + R + + ++ ++ +L F
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 184 --RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++++S +L Q++ +A +H L+HT L+P +I+L V +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 14/151 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ + I +V E + G L+D++ KN R L +Q+L
Sbjct: 76 PHI-----IKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
V + H ++H DLKPEN+LL + K+ D
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIAD 159
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 30/153 (19%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
+ ++G G +G V + +++A+K +R+ +E + ++D+ R
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI--DLVRELGRQLLESVA 208
V + I E + SL F ++ + I D++ ++ +++++
Sbjct: 69 -----VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+H +L +IH D+KP N+L+ + VK+ D+ +
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 34/172 (19%), Positives = 72/172 (41%), Gaps = 17/172 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD-I 150
L +MG GT GQV + + ++A+K +R + + ++++DV+ + I
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ F + I E +G ++ P ++ ++ +++++ ++
Sbjct: 87 -----VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYL 140
Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRVYI 261
+ +IH D+KP NILL +K+ D+ + S + A
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGI-------SGRLVDDKAKDRSA 185
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-14
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H ++ V+ N + E G L+D + + P + QL+
Sbjct: 64 HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
V ++H + + H D+KPEN+LL + +K+ D
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-14
Identities = 38/151 (25%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
+ +L K+GEG++G V + E ++VAIK V + + + EI ++Q+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHV 86
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V+ + + IV E S+ D +R + ++ D + + + L+ + +
Sbjct: 87 -----VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEY 140
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+H +R IH D+K NILL + + K+ D+ V
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGV 171
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 11/151 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
+ L K+G+G+FG+V + DN +++VAIKI+ E EI VL + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ + + I+ E L G S D L I + R++L+ + +
Sbjct: 83 -----TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---REILKGLDY 134
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+H + IH D+K N+LL VK+ D+ V
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGV 165
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 18 PRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDD 77
P P P +P K C + G S G P GSP
Sbjct: 16 PDIDPLEALMTNPVVPESKRFCW-NCGRPVGRSDSETKGASE---GWCPYCGSPYSFLPQ 71
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSIN--KYREA 134
G+ + +Y + + G G + D N V +K + + +
Sbjct: 72 ------LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM 125
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC-----IVFEKL-GPSLYDFLRKNSY 188
AM E L + I VQI N+ ++ + IV E + G SL
Sbjct: 126 AMAERQFLAEVVHPSI-----VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---- 176
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ P+ ++L +++++H + L++ DLKPENI +++ E +K+ D
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENI-MLTEEQLKLID 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 29/173 (16%), Positives = 66/173 (38%), Gaps = 34/173 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+Y + ++G+G++G V ++ A+K+ ++K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKV---LSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 153 TRCVQIRNWFD--YR-------------------------NHICIVFEKL-GPSLYDFLR 184
C+Q R + Y+ +H+ +VFE + + +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
D R + L++ + ++H ++IH D+KP N+L+ ++K+ D
Sbjct: 131 LKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 7/142 (4%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLA 146
N++ +++ S +GEG +G V E+VAIK + +K A EI +L+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H+ I +Q + F+ N + I+ E + L+ + D ++ Q L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQTLR 123
Query: 206 SVAFMHELRLIHTDLKPENILL 227
+V +H +IH DLKP N+L+
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLI 145
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 33/154 (21%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
+ L ++G G +G V + +++A+K +RS +E + ++DV+ R + I
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESV 207
VQ I E + S F + P +++ ++ ++++
Sbjct: 84 -----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ L++IH D+KP NILL + +K+ D+ +
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 11/151 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
+ +S++G G G V + ++A K++ K I E+ VL I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI- 93
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
F I I E + G SL L+K P ++ ++ +++ + ++
Sbjct: 94 -VGFYGA---FYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYL 147
Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ +++H D+KP NIL+ S +K+ D+ V
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 7/143 (4%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ Y I +G G++G V +D ++ VAIK + R + I EI +L RL
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ D I + I + + + IV E L + + + + ++ + LL
Sbjct: 83 -KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTILYNLL 139
Query: 205 ESVAFMHELRLIHTDLKPENILL 227
F+HE +IH DLKP N LL
Sbjct: 140 LGENFIHESGIIHRDLKPANCLL 162
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V+ + + R ++ ++ E G SL D+L+K+ R I L+ + Q+ +
Sbjct: 72 ----NIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQICK 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++ R IH DL NIL+ + VK+ D
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGD 157
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-13
Identities = 29/149 (19%), Positives = 61/149 (40%), Gaps = 18/149 (12%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD----- 149
+G+G FGQ ++ E E++ +K + ++ + + E+ V++ L H
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
IG + + + E + G +L ++ +P + + +A
Sbjct: 73 IGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMA 122
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPD 237
++H + +IH DL N L+ + V V D
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVAD 151
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G C R ++ ++ E G SL D+L+K+ R I L+ + Q
Sbjct: 103 NIVKYKG--VCYS-----AGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQ 153
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + + ++ R IH DL NIL+ + VK+ D
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
IG+ + RY+I+ K+G G V D VAIK + + ++ RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
+L+ +I V + + + + +V E + GP+L +++ + +D
Sbjct: 65 S-----SQLSHQNI-----VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDT 112
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+L+ + H++R++H D+KP+NIL+ S + +K+ D
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFD 154
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 23/156 (14%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V C + E VA+K ++ S + EI++L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ G C + D N I ++ E G SL ++L KN + + +
Sbjct: 83 ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ + + ++ + +H DL N+L+ S VK+ D
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 169
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 41/149 (27%), Positives = 63/149 (42%), Gaps = 5/149 (3%)
Query: 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--E 138
V ++ PRY LS +GEG +G V +DN K VAIK + E
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75
Query: 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
I +L R +I G + + + IV + + LY L+ D +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICY 132
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILL 227
Q+L + ++H ++H DLKP N+LL
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLL 161
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 14/145 (9%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ +Y ++ K+G+G +G V + D E+VA+K I + +A EI +L L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65
Query: 146 ARHD-IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ H+ I V + N D + +VF+ + L+ +R N + + Q
Sbjct: 66 SGHENI-----VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQ 117
Query: 203 LLESVAFMHELRLIHTDLKPENILL 227
L++ + ++H L+H D+KP NILL
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILL 142
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 25/155 (16%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVL 142
+L RY L +G G G V DN+ + VAIK + + R EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-----EIKII 62
Query: 143 QRLARHD--IG--------GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
+RL HD + G++ N + IV E + L + L +
Sbjct: 63 RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-- 119
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+ R QLL + ++H ++H DLKP N+ +
Sbjct: 120 -EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI 153
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD 149
+ +S++G+G FG V C + LVA+K ++ ++ EI +L+ L D
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V+ R + R + +V E G L DFL+++ R L+ Q+ +
Sbjct: 85 ----FIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLL-LYSSQICK 138
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++ R +H DL NIL+ S +VK+ D
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-12
Identities = 39/185 (21%), Positives = 70/185 (37%), Gaps = 30/185 (16%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
G +PR + ++G F YR+ +G G G V E D ++ +VA+
Sbjct: 13 GLVPRGSHMDGTAESREG-TQFG-------PYRLRRLVGRGGMGDVYEAEDTVRERIVAL 64
Query: 123 KIVRS--------INKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173
K++ + REA RL + V I ++ + + +
Sbjct: 65 KLMSETLSSDPVFRTRMQREA-----RTAGRLQEPHV-----VPIHDFGEIDGQLYVDMR 114
Query: 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
+ G L LR+ + RQ+ ++ H H D+KPENIL+ + ++
Sbjct: 115 LINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF 172
Query: 233 VKVPD 237
+ D
Sbjct: 173 AYLVD 177
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-12
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 26/153 (16%)
Query: 95 RILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
+ ++G G+FG V + + + VA+K++ + +A E+ VL++ RH
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVN 81
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+G + + IV + G SLY L + F + + ++ RQ
Sbjct: 82 ILLFMGYST----------APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTA 130
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++H +IH DLK NI L VK+ D
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 38/171 (22%), Positives = 64/171 (37%), Gaps = 36/171 (21%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
+L+ RY + +G G +V D VA+K++R+ ++ REA
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA-- 63
Query: 137 IEIDVLQRLAR---------HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
Q A +D G + IV E + G +L D +
Sbjct: 64 ------QNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTE 110
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
E+ +++ F H+ +IH D+KP NI++ + VKV D
Sbjct: 111 --GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 159
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-12
Identities = 24/113 (21%), Positives = 45/113 (39%), Gaps = 7/113 (6%)
Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
S +A ++I + + + V + ++ I + +L D++ +
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNT-----VGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 186 NSYRSFP-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + Q+ E+V F+H L+H DLKP NI + VKV D
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 18/54 (33%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRL 145
+ + MG G FG V E + AIK +R N+ RE M E+ L +L
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
P + G Y + + + YR L +G G +G V D VAIK + R
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +L+ + RH+ IG D +V +G L ++
Sbjct: 64 SELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
D ++ L Q+L+ + ++H +IH DLKP N+ +
Sbjct: 123 EKLGE---DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 35/162 (21%), Positives = 66/162 (40%), Gaps = 13/162 (8%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
+ + Y +G++ + RY+ L +G G G V +D VAIK + R
Sbjct: 41 KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 100
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +++ + H I + + + +V E + +L ++
Sbjct: 101 NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 159
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+ + L Q+L + +H +IH DLKP NI++
Sbjct: 160 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 14/157 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
Y + +G G V + KKE VAIK + + + EI + + +I
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE------LGRQL 203
V F ++ + +V + L G S+ D ++ + V + + R++
Sbjct: 76 -----VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
LE + ++H+ IH D+K NILL V++ D+ V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-12
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 19/166 (11%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
K + + + Y + + G++G V D+E VAIK V +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRT 63
Query: 135 AMI------------EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
I EI +L H I G R + + + + +V E + L
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+ ++ +L + +HE ++H DL P NILL
Sbjct: 123 VIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 45/153 (29%), Positives = 67/153 (43%), Gaps = 26/153 (16%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G G FG V C + + VAIK + S R+A ++E+ L R+ H
Sbjct: 12 VEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-NHPNIVKLY 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVA 208
G N +C+V E G SLY+ L + Q + VA
Sbjct: 68 GACL-----------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 209 FMHELR---LIHTDLKPENILLVSAEYV-KVPD 237
++H ++ LIH DLKP N+LLV+ V K+ D
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 35/158 (22%), Positives = 63/158 (39%), Gaps = 13/158 (8%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYRE 133
K G Y + + Y + +G G +G V D E VAIK + R
Sbjct: 7 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66
Query: 134 A--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR 189
A A E+ +L+ + +H+ IG + +V + L +
Sbjct: 67 AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--- 122
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
F + ++ L Q+L+ + ++H ++H DLKP N+ +
Sbjct: 123 -FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 159
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 39/162 (24%), Positives = 67/162 (41%), Gaps = 13/162 (8%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
R + Y IG++ + RY+ L +G G G V +D + VAIK + R
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +++ + H IG + + + IV E + +L ++
Sbjct: 64 NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+ L Q+L + +H +IH DLKP NI++
Sbjct: 123 ELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 20/150 (13%)
Query: 93 RYRILS-KMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+ K+G GT+G V + D + + A+K + +A EI +L+ L +H
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL-KHP 78
Query: 150 -IGGTRCVQIRNWFDYRNHICI--VFE-------KLGPSLYDFLRKNSYRSFPIDLVREL 199
+ + ++ F + +F+ + P +V+ L
Sbjct: 79 NV-----ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVS 229
Q+L+ + ++H ++H DLKP NIL++
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMG 163
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V ++ E+VA+K +++ ++R EID+L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ G C + +V E LG SL D+L ++S L+ +
Sbjct: 93 EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Q+ E +A++H IH DL N+LL + VK+ D
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD 177
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 12/142 (8%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
GEG+F VV + AIKI+ I K + E DV+ RL H V
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPF----FV 93
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + L ++RK SF R +++ ++ ++H +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 216 IHTDLKPENILLVSAEYVKVPD 237
IH DLKPENILL ++++ D
Sbjct: 152 IHRDLKPENILLNEDMHIQITD 173
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 24/154 (15%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD--- 149
I K+G G+FG V + VA+KI+ + + + E+ +++RL RH
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIV 97
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLE 205
+G Q ++ IV E L SLY L K+ R + + +
Sbjct: 98 LFMGA--VTQ-------PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 206 SVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237
+ ++H ++H +LK N+L+ VKV D
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G G+FG+V+ E A+KI+ + K ++ + E +LQ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ F +++ +V E G ++ LR+ F R Q++ +
Sbjct: 102 F----LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H L LI+ DLKPEN+L+ Y++V D+
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-11
Identities = 29/188 (15%), Positives = 51/188 (27%), Gaps = 30/188 (15%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ +PP G + RYR+L G Q + D VA+ V
Sbjct: 11 RESSAPPDDVQLVPGARI------ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV 64
Query: 126 RSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175
RL+R I ++ + R +V E +
Sbjct: 65 DPQGVLPDDVLQETLSRT--------LRLSR--IDKPGVARVLDVVHTRAGGLVVAEWIR 114
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
G SL + P+ +R + L + H + + P + + V +
Sbjct: 115 GGSLQEVADT---SPSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL 170
Query: 236 PDYKVPSP 243
Sbjct: 171 AYPATMPD 178
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 34/161 (21%), Positives = 56/161 (34%), Gaps = 29/161 (18%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--------EIDVLQRLAR 147
++G+G FG V + + K +VAIK + + E MI E+ ++ L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81
Query: 148 HD-----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
H G N +V E + LY L + + L
Sbjct: 82 HPNIVKLYGLMH-----------NPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLML 129
Query: 202 QLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKV 240
+ + +M ++H DL+ NI L S + KV
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-11
Identities = 25/153 (16%), Positives = 57/153 (37%), Gaps = 11/153 (7%)
Query: 94 YRILSKMGEG--TFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARH 148
Y +L+ +G+G V E V ++ + N+ E+ V +
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I V R F N + +V + S D + + + + + +L+++
Sbjct: 87 NI-----VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
++H + +H +K +IL+ V + +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N+ + VA+K ++ + EA + E +V++ L +HD +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTL-QHD----K 244
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ + I I+ E G SL DFL+ + P+ + + Q+ E +AF+ +
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKG-SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 213 LRLIHTDLKPENILLVSAEYVKVPD 237
IH DL+ NIL+ ++ K+ D
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIAD 327
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 37/149 (24%), Positives = 66/149 (44%), Gaps = 19/149 (12%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEID 140
+ RY+ LS +G G +G V FD + VA+K + + YR E+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-----ELR 80
Query: 141 VLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
+L+ + +H+ IG + N + +V +G L + ++ D V+
Sbjct: 81 LLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQF 136
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILL 227
L Q+L + ++H +IH DLKP N+ +
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAV 165
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-11
Identities = 32/152 (21%), Positives = 66/152 (43%), Gaps = 26/152 (17%)
Query: 96 ILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD-- 149
I +G+G FGQV + E VAI+++ +A E+ ++ RH+
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENV 91
Query: 150 ---IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+G C+ H+ I+ G +LY +R ++ R++ +++++
Sbjct: 92 VLFMGA--CMS-------PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVK 141
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++H ++H DLK +N+ V + D
Sbjct: 142 GMGYLHAKGILHKDLKSKNV-FYDNGKVVITD 172
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 21/155 (13%), Positives = 53/155 (34%), Gaps = 25/155 (16%)
Query: 96 ILSKMGEGTFGQVVE--CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
L+K+ E G++ + N+ + +K+++ + + E L+ H
Sbjct: 14 FLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPN 68
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+G C H ++ + SLY+ L + + + +
Sbjct: 69 VLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 205 ESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237
+AF+H L + L ++++ ++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 32/150 (21%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+R +G+G FG+V C ++ A K + K A+ E +L+++
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + ++ ++ +C+V + G L + FP ++ +
Sbjct: 246 V-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H R+++ DLKPENILL ++++ D
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDL 330
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 32/150 (21%), Positives = 64/150 (42%), Gaps = 18/150 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 281
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G C + I+ E G +L D+LR+ + + ++ + Q+ ++
Sbjct: 282 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ + IH +L N L+ VKV D
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVAD 361
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 33/150 (22%), Positives = 66/150 (44%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + E M+E VL +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ + F + + V E + G L +++ F ++ +
Sbjct: 403 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLF 456
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+ +I+ DLK +N++L S ++K+ D+
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 35/160 (21%), Positives = 61/160 (38%), Gaps = 29/160 (18%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLARHD 149
+ +G G FG+V F + VA+K R + I E + L +H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
G C++ ++C+V E G L L + P D++ Q+
Sbjct: 67 NIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQI 114
Query: 204 LESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ ++H+ + +IH DLK NIL++ K+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 32/152 (21%), Positives = 64/152 (42%), Gaps = 15/152 (9%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SI--NKYREAAMIEIDVLQRLARHDI 150
+ +G G FG+V C + ++ A+K + I + A+ E +L +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL-----V 246
Query: 151 GGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
C V + F + + + + + G L+ L ++ F +R +++
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILG 304
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ MH +++ DLKP NILL +V++ D
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 4e-10
Identities = 44/193 (22%), Positives = 64/193 (33%), Gaps = 52/193 (26%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---------SINKYREAAMIEIDV 141
T + + K+GEG FG+V + VAIKI+ S K E + EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 142 LQRLARHDIG------------GTRCVQ-------IRNWFDYRN---------------- 166
+ L+ CVQ ++ W Y +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPEN 224
I + FE G L K S + + + QL S+A LR H DL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 225 ILLVSAEYVKVPD 237
+LL K+
Sbjct: 193 VLLKKTSLKKLHY 205
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 7e-10
Identities = 35/157 (22%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 92 PRYRI-----LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVL 142
P+Y + L +G G+FG+V A+K+++ + + ++ E +L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
+ H +++ F I ++ + + G L+ LRK + FP + +
Sbjct: 61 SIV-THPF----IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAA 113
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ ++ ++H +I+ DLKPENILL ++K+ D+
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF 150
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 33/150 (22%), Positives = 64/150 (42%), Gaps = 18/150 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 74
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G C + I+ E G +L D+LR+ + + ++ + Q+ ++
Sbjct: 75 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ + IH DL N L+ VKV D
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVAD 154
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLAR 147
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79
Query: 148 HDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
H +++ Y + +V E LG SL D LRK+ L
Sbjct: 80 HR----NLIRL-----YGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLS-RYAV 128
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
Q+ E + ++ R IH DL N+LL + + VK+ D+
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 22/149 (14%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + + KK++ VAIK+++ + E M E ++ +L +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 71
Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ + +V E G L+ FL ++ EL Q+ +
Sbjct: 72 IVRL-----IGVCQAEALMLVMEMAGGG-PLHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ E +H DL N+LLV+ Y K+ D
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISD 153
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 36/179 (20%), Positives = 67/179 (37%), Gaps = 27/179 (15%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G+G FG+V + E VA+KI S + EI L RH+ I
Sbjct: 46 LQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 102
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ +V + + G SL+D+L + + ++ + +L +A
Sbjct: 103 AADNKDN-----GTWTQLWLVSDYHEHG-SLFDYLNRYT---VTVEGMIKLALSTASGLA 153
Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRV 259
+H + H DLK +NIL+ + D + + + ++ RV
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G FG+V ++ A+KI+ + K E A E DVL I
Sbjct: 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI- 136
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+ F N++ +V + G L L K R P ++ R +++ ++ +
Sbjct: 137 ----TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSV 191
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H+L +H D+KP+NIL+ ++++ D+
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADF 219
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 27/157 (17%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+L +G+G +G+V + + E VA+KI S ++ E+ L RH+ I
Sbjct: 12 LLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFI 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ + ++ ++G SLYD+L+ + + + +A
Sbjct: 69 ASDMTSR-----HSSTQLWLITHYHEMG-SLYDYLQLTT---LDTVSCLRIVLSIASGLA 119
Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPD 237
+H H DLK +NIL+ + D
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 33/157 (21%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG V + + EK ++ VAIK +R + K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C+ + + ++ + G L D++R++ L+
Sbjct: 77 PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
Q+ + + ++ + RL+H DL N+L+ + ++VK+ D+
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 31/148 (20%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
++ +G G FG+V +++ A+K++ + K ++A E D++ +
Sbjct: 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV- 131
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ+ F ++ +V E + G L + + P R +++ ++ +
Sbjct: 132 ----VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAI 184
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H + IH D+KP+N+LL + ++K+ D+
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADF 212
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 33/150 (22%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ +L +G G++ +V+ + + A+K+V+ +N + E V ++ + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + + F + + V E + G L +++ R P + R ++ ++
Sbjct: 71 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++HE +I+ DLK +N+LL S ++K+ DY
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDY 154
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 32/150 (21%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ +L +G G++ +V+ + + A+++V+ +N + E V ++ + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + + F + + V E + G L +++ R P + R ++ ++
Sbjct: 114 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 167
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++HE +I+ DLK +N+LL S ++K+ DY
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 32/150 (21%), Positives = 64/150 (42%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + + + M+E VL +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ + F + + V E + G L F ++ +
Sbjct: 82 F----LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+ +I+ DLK +N++L S ++K+ D+
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-09
Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 18/149 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H R
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ----R 69
Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ Y + I I+ E + G SL DFL+ S I+ + ++ Q+ E +A
Sbjct: 70 LVRL-----YAVVTQEPIYIITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPD 237
F+ E IH DL+ NIL+ K+ D
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIAD 152
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240
Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
VQ+ Y I IV E + SL DFL+ + + + + ++ Q+ +A+
Sbjct: 241 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + +H DL+ NIL+ KV D
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVAD 323
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 41/184 (22%), Positives = 66/184 (35%), Gaps = 27/184 (14%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
++G R KD + E+L + ++G G FG+V LVA+
Sbjct: 91 PLTKKSGVVLHRAVPKDKWVLNH--EDLV----LGEQIGRGNFGEVFSGRLRADNTLVAV 144
Query: 123 KIVR--SINKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE-- 173
K R + + E +L++ H IG C Q + I IV E
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG--VCTQ-------KQPIYIVMELV 194
Query: 174 KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
+ G FLR R L+ ++ + ++ IH DL N L+ +
Sbjct: 195 QGG-DFLTFLRTEGARLRVKTLL-QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 234 KVPD 237
K+ D
Sbjct: 253 KISD 256
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 20/150 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 251
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G V+ + + IV E G SL D+LR D + + + E++
Sbjct: 252 LG--VIVE------EKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ +H DL N+L+ KV D
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G F +V + ++ A+KI+ + K E + E DVL R I
Sbjct: 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI- 123
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
Q+ F N++ +V E G L L K R P ++ R +++ ++ +
Sbjct: 124 ----TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSV 178
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H L +H D+KP+NILL ++++ D+
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADF 206
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 23/154 (14%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG+V E +K VA+K + +E M E +++ L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73
Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
V++ I+ E G L +L +N + LV Q+
Sbjct: 74 ----HIVKL-----IGIIEEEPTWIIMELYPYG-ELGHYLERNKNSLKVLTLV-LYSLQI 122
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+++A++ + +H D+ NIL+ S E VK+ D
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGD 156
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 20/150 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ ++G G FG V + K + VAIK +R E + E +V+ +L H
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQL 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C++ + IC+V E + G L D+LR L+ + + E +
Sbjct: 69 YG--VCLE-------QAPICLVTEFMEHG-CLSDYLRTQRGLFAAETLL-GMCLDVCEGM 117
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
A++ E +IH DL N L+ + +KV D
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSD 147
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 37/154 (24%), Positives = 63/154 (40%), Gaps = 23/154 (14%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76
Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
V++ N + I+ E LG L FL+ Y L+ QL
Sbjct: 77 ----HIVKL-----IGVITENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLI-LYAYQL 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++A++ R +H D+ N+L+ S + VK+ D
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 35/153 (22%), Positives = 62/153 (40%), Gaps = 16/153 (10%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHDI 150
+G G FG+V C +L A K + K + AM+E +L ++ I
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 151 GGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V + F+ + +C+V + +Y+ N F Q++
Sbjct: 248 -----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVS 300
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ +H+ +I+ DLKPEN+LL V++ D
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 34/150 (22%), Positives = 67/150 (44%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G+G+FG+V+ E +L A+K+++ I + + M E +L H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ F + + V E + G L R F R +++ ++
Sbjct: 85 F----LTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALM 138
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H+ +I+ DLK +N+LL + K+ D+
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 47/239 (19%), Positives = 82/239 (34%), Gaps = 29/239 (12%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPA-LYCVQEFGNGGMPNYACSSMFYGAIPRT 68
P + P L + Y + M
Sbjct: 259 ASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESP 318
Query: 69 GSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR 126
S P DK +F +NL ++G G FG V + + KK++ VAIK+++
Sbjct: 319 FSDPEELKDKK---LFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK 372
Query: 127 --SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPS 178
+ E M E ++ +L + V++ + +V E G
Sbjct: 373 QGTEKADTEEMMREAQIMHQL-DNP----YIVRL-----IGVCQAEALMLVMEMAGGG-P 421
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L+ FL ++ EL Q+ + ++ E +H +L N+LLV+ Y K+ D
Sbjct: 422 LHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD 479
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-09
Identities = 43/240 (17%), Positives = 75/240 (31%), Gaps = 27/240 (11%)
Query: 14 MDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPW 73
M R V + P+ P L + Y + +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 74 RPDDKDGHYVFAIGENLTPRYR----ILSKMGEGTFGQVVECF---DNEKKELVAIKIVR 126
+ V A+ + +G G FG V ++ KK A+K +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 127 SINKYREAA--MIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGP 177
I E + + E +++ H +G +V K G
Sbjct: 127 RITDIGEVSQFLTEGIIMKDF-SHPNVLSLLG---IC-----LRSEGSPLVVLPYMKHG- 176
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L +F+R ++ DL+ G Q+ + + F+ + +H DL N +L VKV D
Sbjct: 177 DLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 11/143 (7%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
G+G+FG+V+ ++ A+K+++ +I K +E M E +VL + +H V
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----LV 102
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
+ F + + V + + G L+ L++ R F R ++ ++ ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 216 IHTDLKPENILLVSAEYVKVPDY 238
++ DLKPENILL S ++ + D+
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDF 183
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD- 149
IL +G+G+FG+V N+ K++ A+K + + E E+ ++Q L H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + F + +V + LG L L++N F + V+ +L+ ++
Sbjct: 77 L-----VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALD 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ R+IH D+KP+NILL +V + D+
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDF 159
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 8e-09
Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 323
Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
VQ+ Y I IV E + SL DFL+ + + + + ++ Q+ +A+
Sbjct: 324 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + +H DL+ NIL+ KV D
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVAD 406
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 9e-09
Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 20/150 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L ++G G FG V + + VA+K+++ + + E + +L H
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKF 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C + I IV E G L ++LR + P L+ E+ + E +
Sbjct: 69 YG--VCSK-------EYPIYIVTEYISNG-CLLNYLRSHGKGLEPSQLL-EMCYDVCEGM 117
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
AF+ + IH DL N L+ VKV D
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSD 147
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 9e-09
Identities = 31/150 (20%), Positives = 64/150 (42%), Gaps = 11/150 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G+G+FG+V + + AIK ++ + + M+E VL H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ F + ++ V E L G L ++ F + +++ +
Sbjct: 79 F----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 132
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H +++ DLK +NILL ++K+ D+
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADF 162
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 30/158 (18%), Positives = 62/158 (39%), Gaps = 29/158 (18%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++ ++G+G +G+V + EK VA+K+ + + EI + RH+
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK---VAVKVFFTTEEASWFRETEIYQTVLM-RHENILGF 96
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I ++ + ++ + + G SLYD+L+ + + +L + +
Sbjct: 97 IAA--DIKGTG---SWTQLYLITDYHENG-SLYDYLKSTT---LDAKSMLKLAYSSVSGL 147
Query: 208 AFMHELRL--------IHTDLKPENILLVSAEYVKVPD 237
+H H DLK +NIL+ + D
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 26/157 (16%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
R L +G G FG V + + E ++ V IK++ S + +A + + L H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DH 74
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + +V + LG SL D +R++ P L+ G
Sbjct: 75 AHIVRLLG--LCPG--------SSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLL-NWGV 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
Q+ + + ++ E ++H +L N+LL S V+V D+
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R I E A + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----- 61
Query: 150 IGGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
TR ++ F + +C V E G L+ L + R F + R G +++
Sbjct: 62 ---TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVS 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ ++H +++ D+K EN++L ++K+ D+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 27/161 (16%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR---SINKYREAAMIEIDVL 142
+ LT + L G G FG V + + +K VA+KI++ + ++ + E +V+
Sbjct: 16 KLLTLEDKEL---GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 143 QRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
Q+L + V++ +V E +LG L +L++N R +
Sbjct: 73 QQL-DNP----YIVRM-----IGICEAESWMLVMEMAELG-PLNKYLQQN--RHVKDKNI 119
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
EL Q+ + ++ E +H DL N+LLV+ Y K+ D
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISD 160
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 37/174 (21%), Positives = 64/174 (36%), Gaps = 38/174 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
PR + +G G FG+VVE + VA+K+++ + +EA M E+ ++
Sbjct: 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
L +H+ +G C + ++ E G L +FLR+ S
Sbjct: 104 SHLGQHENIVNLLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPA 153
Query: 196 VRELGRQLLES------------VAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+AF+ IH D+ N+LL + K+ D
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 25/155 (16%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
IG + N + I+ E LG L FL+ + L+ Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLG-ELRSFLQVRKFSLDLASLI-LYAYQ 499
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L ++A++ R +H D+ N+L+ S + VK+ D
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 33/157 (21%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG V + + EK ++ VAIK +R + K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C+ + + ++ + G L D++R++ L+
Sbjct: 77 PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
Q+ + + ++ + RL+H DL N+L+ + ++VK+ D+
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
++ F + +C V E G L+ L + R F D R G +++ ++
Sbjct: 209 F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262
Query: 209 FMHELR-LIHTDLKPENILLVSAEYVKVPDY 238
++H + +++ DLK EN++L ++K+ D+
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 36/150 (24%), Positives = 66/150 (44%), Gaps = 20/150 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
L ++G G FG V + + VAIK+++ + + + E V+ L H+
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQL 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C + + I I+ E G L ++LR+ +R L+ E+ + + E++
Sbjct: 85 YG--VCTK-------QRPIFIITEYMANG-CLLNYLREMRHRFQTQQLL-EMCKDVCEAM 133
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ + +H DL N L+ VKV D
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSD 163
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 24/155 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
I +G G G+V ++ VAIK ++ + R + E ++ + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G + IV E + G SL FLR + + + LV + R
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENG-SLDTFLRTHDGQFTIMQLV-GMLRG 159
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + ++ +L +H DL N+L+ S KV D
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 36/150 (24%), Positives = 66/150 (44%), Gaps = 20/150 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 79
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G + + + + IV E G SL D+LR D + + + E++
Sbjct: 80 LG---VI-----VEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ +H DL N+L+ KV D
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 29/164 (17%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD- 149
+ ++L G FG V + E VA+KI +K E+ L + +H+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
IG + + + ++ + G SL DFL+ N + + + +
Sbjct: 80 ILQFIGA--EKRGTS---VDVDLWLITAFHEKG-SLSDFLKANV---VSWNELCHIAETM 130
Query: 204 LESVAFMHE----------LRLIHTDLKPENILLVSAEYVKVPD 237
+A++HE + H D+K +N+LL + + D
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 42/178 (23%), Positives = 63/178 (35%), Gaps = 42/178 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
PR R+ +G G FG+VVE ++ VA+K+++ + REA M E+ VL
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
L H +G C ++ E G L +FLR+
Sbjct: 81 SYLGNHMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKT 130
Query: 196 VRELGRQLLESV----------------AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++ AF+ IH DL NILL K+ D
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 41/173 (23%), Positives = 65/173 (37%), Gaps = 37/173 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
I +GEG FGQV++ + + AIK ++ + E++VL +L
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 146 ARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRE 198
H +G C R ++ + E G +L DFLRK+
Sbjct: 83 GHHPNIINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIA 132
Query: 199 LG-------RQLLE---SVA----FMHELRLIHTDLKPENILLVSAEYVKVPD 237
+QLL VA ++ + + IH DL NIL+ K+ D
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 185
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 35/166 (21%)
Query: 95 RILSKMGEGTFGQVVE-------CFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLA 146
+G+GTF ++ + + + V +K++ + Y E+ ++ +L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69
Query: 147 RHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVREL 199
H G CV + +V E K G SL +L+KN + + E+
Sbjct: 70 SHKHLVLNYG--VCVC-------GDENILVQEFVKFG-SLDTYLKKNKNCINILWKL-EV 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEY--------VKVPD 237
+QL ++ F+ E LIH ++ +NILL+ E +K+ D
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 23/155 (14%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
+G G FG V ++ KK A+K + I E + + E +++ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+G +V K G L +F+R ++ DL+ G Q
Sbjct: 87 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + + ++ + +H DL N +L VKV D
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 24/155 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
I +G G FG+V ++K+ VAIK ++ K R + E ++ + H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHP 106
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G + + IV E + G SL FLRK+ + I LV + R
Sbjct: 107 NIIRLEG--VVTK-------SKPVMIVTEYMENG-SLDSFLRKHDAQFTVIQLV-GMLRG 155
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + ++ ++ +H DL NIL+ S KV D
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD 190
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 17/148 (11%)
Query: 101 GEGTFGQVV---ECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHD-IG 151
G G +G+V + ++ +L A+K+++ K E E VL+ + + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL- 121
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + F + ++ + + G L+ L + F V+ +++ ++ +
Sbjct: 122 ----VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHL 175
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H+L +I+ D+K ENILL S +V + D+
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDF 203
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-07
Identities = 33/159 (20%), Positives = 55/159 (34%), Gaps = 29/159 (18%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L +G G +G V + D VA+K+ N+ I + + HD
Sbjct: 17 LLELIGRGRYGAVYKGSLDERP---VAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I G R D R +V E G SL +L ++ L + +
Sbjct: 73 IVG--D--ERVTADGRMEYLLVMEYYPNG-SLXKYLSLHT---SDWVSSCRLAHSVTRGL 124
Query: 208 AFMHE---------LRLIHTDLKPENILLVSAEYVKVPD 237
A++H + H DL N+L+ + + D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 25/156 (16%)
Query: 95 RILSKMGEGTFGQVVE----CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+G G FG+V + +K+ VAIK ++ K R + E ++ + H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SH 105
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
G + + I+ E + G +L FLR+ + LV + R
Sbjct: 106 HNIIRLEG--VISK-------YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLV-GMLR 154
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + ++ + +H DL NIL+ S KV D
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 39/176 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR R+ +G G FGQV+E VA+K+++ + E M E+ +L
Sbjct: 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+ H +G + ++ E K G +L +LR P +
Sbjct: 85 IHIGHHLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKV 135
Query: 196 VRELGRQLLESV--------------AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
E + ++ F+ + IH DL NILL VK+ D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 191
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 1e-06
Identities = 34/154 (22%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 95 RILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAA--MIEIDVLQRLA 146
+L +G+G +G+V + ++ A+K+++ + ++ A E ++L+
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-V 78
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+H I V + F + ++ E L G L+ L + F D ++
Sbjct: 79 KHPFI-----VDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEIS 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ +H+ +I+ DLKPENI+L +VK+ D+
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDF 165
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 33/178 (18%), Positives = 68/178 (38%), Gaps = 42/178 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR R+ +GEG FGQVV + VA+K+++S ++ + + E++
Sbjct: 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
+++ + +H +G C Q + ++ E G +L ++L+
Sbjct: 127 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEY 176
Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ L+ ++ + IH DL N+L+ +K+ D
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 34/169 (20%), Positives = 60/169 (35%), Gaps = 33/169 (19%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
R +I ++G+G+FG V E +E + VAIK V RE + E V+
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 143 QRLARHDIGGTR----CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
+ H + R Q ++ E G L +LR ++
Sbjct: 83 KEFNCHHV--VRLLGVVSQ-------GQPTLVIMELMTRG-DLKSYLRSLRPAMANNPVL 132
Query: 197 RELGRQLLESVA--------FMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ +A +++ + +H DL N ++ VK+ D
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 31/165 (18%), Positives = 57/165 (34%), Gaps = 24/165 (14%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVR---SINKYREAAMIEIDVLQ 143
P + +G+G FG V E ++ VA+K+++ + E + E ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
H +G ++ K G L+ FL + P +L
Sbjct: 81 EF-DHPHVAKLVG---VSLRSRAKGRLPIPMVILPFMKHG-DLHAFLLASRIGENPFNLP 135
Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ L + + ++ IH DL N +L V V D
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 37/184 (20%), Positives = 65/184 (35%), Gaps = 49/184 (26%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR + +G G FG+V+ VA+K+++ E M E+ ++
Sbjct: 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+L H+ +G C I ++FE G L ++LR + ++
Sbjct: 103 TQLGSHENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEI 152
Query: 196 VRELGRQLLESV---------------------AFMHELRLIHTDLKPENILLVSAEYV- 233
E ++L E F+ +H DL N+ LV+ V
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKVV 211
Query: 234 KVPD 237
K+ D
Sbjct: 212 KICD 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 96 ILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHD 149
+L +G+G+FG+V + ++ ++L A+K+++ + R +E D+L H
Sbjct: 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-VNHP 86
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ F + ++ + L G L+ L K F + V+ +L ++
Sbjct: 87 FI-----VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALAL 139
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H L +I+ DLKPENILL ++K+ D+
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDF 170
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 35/178 (19%), Positives = 73/178 (41%), Gaps = 42/178 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR ++ +GEG FGQVV ++ VA+K+++ ++ + + E++
Sbjct: 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNS--YRSF 191
+++ + +H +G C Q + ++ E G +L ++LR +
Sbjct: 139 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 188
Query: 192 PIDLVRELGRQLLES--------VA----FMHELRLIHTDLKPENILLVSAEYVKVPD 237
D+ R Q+ +A ++ + IH DL N+L+ +K+ D
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 32/178 (17%), Positives = 68/178 (38%), Gaps = 42/178 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR ++ +GEG FGQVV ++ VA+K+++ ++ + + E++
Sbjct: 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
+++ + +H +G C Q + ++ E G +L ++LR
Sbjct: 93 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 142
Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ L+ ++ + IH DL N+L+ +K+ D
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 38/174 (21%), Positives = 63/174 (36%), Gaps = 39/174 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQ 143
R I ++GEG FG+V + K LVA+K ++ + R+ E ++L
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 98
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
L +H G C + + +VFE + G L FLR + + +
Sbjct: 99 ML-QHQHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGG 147
Query: 197 RELGRQLLESVAFMH-------------ELRLIHTDLKPENILLVSAEYVKVPD 237
++ L + L +H DL N L+ VK+ D
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGD 201
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 32/165 (19%), Positives = 60/165 (36%), Gaps = 25/165 (15%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQ 143
R + +GEG FG V+E ++ VA+K ++ N + E + E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
H +G V I ++ K G L+ +L + + P +
Sbjct: 92 DF-SHPNVIRLLG----VCIEMSSQGIPKPMVILPFMKYG-DLHTYLLYSRLETGPKHIP 145
Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
++ L + + ++ +H DL N +L V V D
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 8e-06
Identities = 32/155 (20%), Positives = 57/155 (36%), Gaps = 23/155 (14%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
+G+G FG V + + AIK + I + ++ + E +++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHP 82
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
IG + ++ G L F+R DL+ G Q
Sbjct: 83 NVLALIG---IM-----LPPEGLPHVLLPYMCHG-DLLQFIRSPQRNPTVKDLI-SFGLQ 132
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + ++ E + +H DL N +L + VKV D
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVAD 167
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 3e-05
Identities = 21/130 (16%), Positives = 45/130 (34%), Gaps = 9/130 (6%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
++ F ++ E +++ ++ + K E L+R G Q
Sbjct: 83 RIETSEFDKMDEYLYGDER--FDMRRISPKEKVFIWTEKEFRNLERAKEA---GVSVPQP 137
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIH 217
+ Y ++ ++ L R V + ++E+V ++ E L+H
Sbjct: 138 ---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVH 194
Query: 218 TDLKPENILL 227
DL NI+
Sbjct: 195 ADLSEYNIMY 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 38/175 (21%), Positives = 63/175 (36%), Gaps = 40/175 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA-MIEIDVLQ 143
R I ++GEG FG+V + K LVA+K ++ E ++L
Sbjct: 13 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT 72
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
L +H+ G C + + +VFE K G L FLR + + +
Sbjct: 73 NL-QHEHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDG 121
Query: 197 RELGR-------QLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ Q+L ++ +H DL N L+ + VK+ D
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD 176
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 5e-05
Identities = 33/176 (18%), Positives = 62/176 (35%), Gaps = 41/176 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
+ + ++GE FG+V + E+ + VAIK ++ + RE E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
RL +H +G + + ++F G L++FL S S
Sbjct: 67 ARL-QHPNVVCLLG--VVTK-------DQPLSMIFSYCSHG-DLHEFLVMRSPHSDVGST 115
Query: 196 VRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ + V ++ ++H DL N+L+ VK+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD 171
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 41/211 (19%), Positives = 69/211 (32%), Gaps = 58/211 (27%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRI--LSKMGEGTFGQVVEC-----FDNEKKE 118
P P + K + PR I + +GEG FG+V + E
Sbjct: 26 PMYQRMPLLLNPKLLSLEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 78
Query: 119 LVAIKIVRSI--NKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIV 171
+VA+K+++ + E ++ + +G C +C++
Sbjct: 79 MVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLG--VCAV-------GKPMCLL 128
Query: 172 FE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV---------------------- 207
FE G L +FLR S + +L + S
Sbjct: 129 FEYMAYG-DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187
Query: 208 AFMHELRLIHTDLKPENILLVSAEY-VKVPD 237
A++ E + +H DL N LV VK+ D
Sbjct: 188 AYLSERKFVHRDLATRNC-LVGENMVVKIAD 217
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 38/184 (20%), Positives = 64/184 (34%), Gaps = 49/184 (26%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR + +GEG FG+VV+ VA+K+++ E + E +VL
Sbjct: 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+++ H G C Q + ++ E K G SL FLR++
Sbjct: 81 KQV-NHPHVIKLYGA--CSQ-------DGPLLLIVEYAKYG-SLRGFLRESRKVGPGYLG 129
Query: 196 VRELGRQLLESV----------------------AFMHELRLIHTDLKPENILLVSAEYV 233
++ E++L+H DL NIL+ +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 234 KVPD 237
K+ D
Sbjct: 190 KISD 193
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 4e-04
Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 24/91 (26%)
Query: 142 LQRLARHDIGGTRCVQIRNWFD-------YRNHICI---VFEKLGPSLYDFLRK---NSY 188
L++ RHD T + + Y+ +IC +E+L ++ DFL K N
Sbjct: 503 LEQKIRHD--STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTD 219
S DL+R +A M E I +
Sbjct: 561 CSKYTDLLR---------IALMAEDEAIFEE 582
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 37/171 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR I + +G G FG+V E ++ VA+K + + ++ ++E ++
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
+ H IG +Q I+ E G L FLR+ R
Sbjct: 88 SKF-NHQNIVRCIG--VSLQ-------SLPRFILMELMAGG-DLKSFLRETRPRPSQPSS 136
Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPD 237
+DL+ + R + ++ E IH D+ N LL K+ D
Sbjct: 137 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 264 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.98 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.98 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.92 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.84 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.99 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.94 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.71 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.68 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.31 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.03 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.54 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.75 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 87.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.86 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 81.87 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=310.03 Aligned_cols=166 Identities=23% Similarity=0.360 Sum_probs=145.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|+++++||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+++++.++|+|| |+++++|++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI-----VQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC-----CcEEEEEEECCEE
Confidence 6899999999999999999999999999999999753 3456788999999999999988 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
||||||| ||+|.+++...+...+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999 99999999877656789999999999999999999999999999999999999999999999999987653
Q ss_pred -----CcccceeeeeceeEee
Q 024661 247 -----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~~ 262 (264)
..+||+.|||||++.+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT
T ss_pred cccccccCCCccccCHHHHCC
Confidence 2359999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=306.29 Aligned_cols=164 Identities=23% Similarity=0.294 Sum_probs=149.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ...+.+.+|+++++.++|+|+ ++++++|++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEeCCE
Confidence 56999999999999999999999999999999998542 345678999999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
+||||||+ ||+|.+++.+.. .+++..++.|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999 999999998875 79999999999999999999999999999999999999999999999999997542
Q ss_pred -------CCcccceeeeeceeEee
Q 024661 246 -------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 -------~~~~~~~~y~ape~~~~ 262 (264)
...+||+.|||||++.+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcC
Confidence 23369999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=295.94 Aligned_cols=164 Identities=26% Similarity=0.421 Sum_probs=139.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||+||+|.++.+|+.||+|++++.. .....+.+|+++++.++|+|+ +++++++.+++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI-----IKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCE
Confidence 57999999999999999999999999999999997532 335678899999999999988 999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
+|+||||++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99999999999999998865 799999999999999999999999999999999999999999999999999976432
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
..+||+.|||||++.+
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp ---------CTTSCHHHHSS
T ss_pred CccCCeeECcccCChhhhcC
Confidence 3469999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=304.11 Aligned_cols=163 Identities=22% Similarity=0.307 Sum_probs=147.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+.|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++|+|| |+++++|.+++.+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEE
Confidence 56999999999999999999999999999999997543 344567899999999999988 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH---- 245 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~---- 245 (264)
||||| ||+|.+++... .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999 99999999864 59999999999999999999999999999999999999999999999999997543
Q ss_pred --CCcccceeeeeceeEee
Q 024661 246 --AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 --~~~~~~~~y~ape~~~~ 262 (264)
...+||+.|||||++.+
T Consensus 226 ~~~~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISR 244 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred cccccccCcCcCCHHHHCC
Confidence 23469999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=311.55 Aligned_cols=164 Identities=22% Similarity=0.305 Sum_probs=148.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.++|+++++||+|+||.||+|+++.+|+.||||+++... ...+.+.+|+.+++.++|+|| |+++++|.+++.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEECCEEE
Confidence 357999999999999999999999999999999997533 345668899999999999988 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
|||||| ||+|.+++... .+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999 99999999764 599999999999999999999999999999999999999999999999999975432
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
..+||+.|||||++.+
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISR 321 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTT
T ss_pred ccccccccCcCcCCHHHHCC
Confidence 3469999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=298.19 Aligned_cols=160 Identities=24% Similarity=0.271 Sum_probs=143.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
+.|++.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+++.++|+|+ |++++++.+++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnI-----V~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRI-----VPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEEE
Confidence 569999999999999999999999999999999986432 2469999999999888 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCcCCC---
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~~~--- 246 (264)
|||| ||+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+....
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999 999999998875 799999999999999999999999999999999999999987 699999999975432
Q ss_pred --------CcccceeeeeceeEee
Q 024661 247 --------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~~ 262 (264)
..+||+.|||||++.+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTT
T ss_pred ccceecCCccccCccccCHHHHCC
Confidence 2368999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=287.02 Aligned_cols=166 Identities=25% Similarity=0.382 Sum_probs=145.9
Q ss_pred ccCCCe-EEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++| ++.++||+|+||+||+|.++.+++.||+|++... ....+.+.+|+++++.++|||+ |+++++|.+
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~ 96 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWES 96 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEE
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEee
Confidence 444566 7888999999999999999999999999999743 3445778999999999999988 999999876
Q ss_pred ----CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeec-CCcEEec
Q 024661 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVS-AEYVKVP 236 (264)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~-~~~v~l~ 236 (264)
++.+||||||| +|+|.+++.+.. .+++..++.|+.||+.||+|||++| |+||||||+|||++. ++.+||+
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 46789999999 999999998865 7999999999999999999999998 999999999999984 7999999
Q ss_pred cCCCCCcCCC----CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
|||+|+.... ..+||+.|||||++.
T Consensus 175 DFGla~~~~~~~~~~~~GTp~YmAPE~~~ 203 (290)
T 3fpq_A 175 DLGLATLKRASFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp CTTGGGGCCTTSBEESCSSCCCCCGGGGG
T ss_pred eCcCCEeCCCCccCCcccCccccCHHHcC
Confidence 9999976433 336899999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=287.74 Aligned_cols=166 Identities=26% Similarity=0.316 Sum_probs=138.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC---
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--- 166 (264)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+++++.++|+|+ ++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEecCccc
Confidence 4599999999999999999999999999999998743 3445778999999999999988 99999987644
Q ss_pred ---------EEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEe
Q 024661 167 ---------HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 167 ---------~~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l 235 (264)
++|+||||| +|+|.+++..... ...++..++.|+.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999 9999999986541 23456778999999999999999999999999999999999999999
Q ss_pred ccCCCCCcCCC------------------CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA------------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~------------------~~~~~~~y~ape~~~~ 262 (264)
+|||+|+.... ..+||+.|||||++.+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTT
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence 99999976432 2358999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=293.79 Aligned_cols=164 Identities=26% Similarity=0.383 Sum_probs=140.0
Q ss_pred CCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
++|++++.||+|+||+||+|++. .+++.||+|++++.. .....+.+|+++++.++|+|+ ++++++|+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI-----VKLHYAFQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTE-----ECEEEEEEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEEC
Confidence 56999999999999999999874 467899999997432 233467889999999988887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+||||||| ||+|.+++.+.. .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999 999999999876 7999999999999999999999999999999999999999999999999999753
Q ss_pred C------CCcccceeeeeceeEee
Q 024661 245 H------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~------~~~~~~~~y~ape~~~~ 262 (264)
. ...+||+.|||||++.+
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHT
T ss_pred cCCCccccccccCcccCCHHHhcc
Confidence 2 23469999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=296.26 Aligned_cols=167 Identities=21% Similarity=0.374 Sum_probs=147.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~- 164 (264)
.+.++|++++.||+|+||+||+|.++.+|+.||||++++. ....+.+.+|+++|+.++|+|+ +++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~ 125 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI-----IAIKDILRPT 125 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCc-----ceEeeeeecc
Confidence 4567899999999999999999999999999999999743 2345678899999999999988 999988754
Q ss_pred -----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.+.+|||||||+|+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence 46899999999889999998765 89999999999999999999999999999999999999999999999999
Q ss_pred CCCcCC----------CCcccceeeeeceeEee
Q 024661 240 VPSPRH----------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~----------~~~~~~~~y~ape~~~~ 262 (264)
+|+... ...+||..|||||++.+
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~ 236 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLS 236 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTT
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcC
Confidence 997532 23479999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=284.23 Aligned_cols=166 Identities=21% Similarity=0.302 Sum_probs=140.7
Q ss_pred CCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
++|.+.++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|++++++++|+|+ |++++++.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-----VRFFGVCTEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEEC
Confidence 56999999999999999999865 35789999999743 3456789999999999999988 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNS-------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
+.+||||||| +|+|.+++.... ...+++..++.|+.||+.||+|||+++||||||||+|||++.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999 999999997642 13589999999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 232 YVKVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
++||+|||+|+.... ...+|..|||||++.+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence 999999999975422 2357889999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=282.34 Aligned_cols=166 Identities=20% Similarity=0.312 Sum_probs=143.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|.+.++||+|+||+||+|++. .++..||||+++.. ....+.+.+|++++++++|+|+ |++++++.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVE 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEee
Confidence 357999999999999999999875 35788999999753 3456789999999999999988 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~ 232 (264)
.+.+||||||| +|+|.+++.... ...+++..++.|+.||+.||+|||+++|+||||||+|||++.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999 999999997632 346999999999999999999999999999999999999999999
Q ss_pred EEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 233 VKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 233 v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+||+|||+|+.... ...+|..|||||++.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 203 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 203 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHc
Confidence 99999999975322 224788899999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=280.46 Aligned_cols=162 Identities=24% Similarity=0.367 Sum_probs=139.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
-.+++++.++||+|+||+||+|++.. .||||+++. .....+.+.+|+.+++.++|+|+ +++++++.. +
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~~-~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI-----LLFMGYMTK-D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS-S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEC-C
Confidence 34678999999999999999998753 489999873 23456789999999999999988 999998754 5
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+||||||| +|+|.+++.... ..+++..+..|+.||+.||+|||+++||||||||+|||+++++++||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 689999999 999999998654 469999999999999999999999999999999999999999999999999997543
Q ss_pred C--------CcccceeeeeceeEe
Q 024661 246 A--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--------~~~~~~~y~ape~~~ 261 (264)
. ...||+.|||||++.
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~ 207 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIR 207 (307)
T ss_dssp ----------CCCCTTSCCHHHHH
T ss_pred cCCcceeecccccCCCccCHHHhh
Confidence 2 236899999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=278.47 Aligned_cols=168 Identities=21% Similarity=0.249 Sum_probs=144.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
.-.+.+++.++||+|+||+||+|.+. .+++.||||+++.. ....+.+.+|+.++++++|+|+ |+++++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~ 97 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV-----VCLLGV 97 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCC-----CCcceE
Confidence 33466899999999999999999864 35788999998743 3445789999999999999998 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nil 226 (264)
+.+.+.+||||||| +|+|.++|.... ...+++..++.|+.||+.||+|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 99999999999999 999999997532 135899999999999999999999999999999999999
Q ss_pred eecCCcEEeccCCCCCcCC--------CCcccceeeeeceeEe
Q 024661 227 LVSAEYVKVPDYKVPSPRH--------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~~--------~~~~~~~~y~ape~~~ 261 (264)
+++++++||+|||+|+... ....+|..|||||++.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~ 220 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM 220 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh
Confidence 9999999999999997532 2335788999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=296.72 Aligned_cols=163 Identities=22% Similarity=0.279 Sum_probs=141.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHH---HhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQR---LARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~---l~~~~~~~~~~~~~~~~~~~ 164 (264)
++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+|..+++. +.|||| ++++++|++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~I-----V~l~~~f~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-----VCMSYAFHT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTB-----CCEEEEEEC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCE-----eEEEEEEEE
Confidence 67999999999999999999999999999999997542 223344455444444 455555 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+||||||+ ||+|.+++.+.. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999 999999999875 799999999999999999999999999999999999999999999999999976
Q ss_pred CCC----CcccceeeeeceeEe
Q 024661 244 RHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~----~~~~~~~y~ape~~~ 261 (264)
... ..+||+.|||||++.
T Consensus 342 ~~~~~~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 342 FSKKKPHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp CSSCCCCSCCSCGGGCCHHHHS
T ss_pred cCCCCCCCccCCcCccCHHHHh
Confidence 432 457999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=275.55 Aligned_cols=160 Identities=23% Similarity=0.233 Sum_probs=135.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC----E
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----H 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~----~ 167 (264)
.+|.+.++||+|+||+||+|++ +|+.||||+++...........|+..+..++|+|+ +++++++.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNI-----v~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCC-----CcEEEEEEecCCCceE
Confidence 5699999999999999999987 48899999998655444444456666667788877 99999987653 6
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEeecCCcEEeccC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
+||||||+ +|+|.+++... .++++.+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 89999999 99999999875 599999999999999999999987 9999999999999999999999999
Q ss_pred CCCCcCCC----------CcccceeeeeceeEe
Q 024661 239 KVPSPRHA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~----------~~~~~~~y~ape~~~ 261 (264)
|+|+.... ...||+.|||||++.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~ 185 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhc
Confidence 99975322 235899999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=277.44 Aligned_cols=163 Identities=23% Similarity=0.333 Sum_probs=142.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~ 164 (264)
.+.++|++.++||+|+||+||+|+++ .+++.||+|.+.+.. ....+.+|+++++.+ .|+|+ ++++++|.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nI-----v~l~~~~~~ 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNV-----MGVKYCFRK 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTB-----CCCSEEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCC-----ceEEEEEEE
Confidence 46688999999999999999999874 467899999887543 345678899999998 47777 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVPS 242 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a~ 242 (264)
.+++|+||||+ +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999 899999983 48999999999999999999999999999999999999987 899999999996
Q ss_pred cCCC----------------------------------CcccceeeeeceeEee
Q 024661 243 PRHA----------------------------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~----------------------------------~~~~~~~y~ape~~~~ 262 (264)
.... ..+||+.|||||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 4322 2258999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=288.33 Aligned_cols=168 Identities=24% Similarity=0.359 Sum_probs=150.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+.++|++++.||+|+||.||+|.++.+|+.||+|++... ....+.+.+|+.+|+.++|+|+ ++++++|.+.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~~~~ 228 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNE 228 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEECSSE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCE
Confidence 3457899999999999999999999999999999998754 3446778899999999999988 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC--CcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA--EYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~--~~v~l~Dfg~a~~~ 244 (264)
+||||||| ||+|.+++.... ..+++..+..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999 999999997543 369999999999999999999999999999999999999865 89999999999875
Q ss_pred CCC-----cccceeeeeceeEee
Q 024661 245 HAF-----SFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~~-----~~~~~~y~ape~~~~ 262 (264)
... .+||+.|||||++.+
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTT
T ss_pred cCCCceeeeEECccccCHHHhCC
Confidence 442 368999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.36 Aligned_cols=166 Identities=21% Similarity=0.275 Sum_probs=141.9
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEech--hhhHHHHHHHHHHHHHHhc-cCCCCcceEEEceee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWF 162 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~ 162 (264)
.++|+++++||+|+||+||+|.+..+ ++.||+|.++.. ....+.+.+|+.+++++.| +|+ |++++++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI-----V~l~g~~ 137 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGAC 137 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE-----EEEEEEE
Confidence 46899999999999999999997654 367999998753 3445678999999999987 466 9999988
Q ss_pred ee-CCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024661 163 DY-RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (264)
Q Consensus 163 ~~-~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nil 226 (264)
.. .+.+||||||| +|+|.++|+... ...+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 66 46799999999 999999998532 235899999999999999999999999999999999999
Q ss_pred eecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 227 LVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 227 i~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
++.++.+||+|||+|+.... ...+|..|||||++.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~ 260 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 260 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh
Confidence 99999999999999986432 224677899999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=260.37 Aligned_cols=189 Identities=34% Similarity=0.622 Sum_probs=166.0
Q ss_pred CCCCCCCceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCc
Q 024661 74 RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153 (264)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 153 (264)
...+....+.+..+..+.++|++.++||+|+||.||+|.+..+++.||+|+++...........|+.+++.+.+..+.|+
T Consensus 17 ~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 17 QGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp ---CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred ecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCC
Confidence 34444556678888999999999999999999999999999999999999998766777788889999999997766777
Q ss_pred ceEEEceeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec----
Q 024661 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---- 229 (264)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---- 229 (264)
+++++++++...+..|+|||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred CeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 8899999999999999999999999999999876567999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEeccCCCCCcCCC---CcccceeeeeceeEee
Q 024661 230 ---------------------AEYVKVPDYKVPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 230 ---------------------~~~v~l~Dfg~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
++.+||+|||++..... ...+|..|+|||++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILN 233 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTT
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcC
Confidence 78999999999975433 4458899999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=251.36 Aligned_cols=166 Identities=22% Similarity=0.349 Sum_probs=149.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.+. ....+.+.+|+.+++.++|+|+ +++++++.+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI-----VKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECC
Confidence 346799999999999999999999999999999999753 2445678899999999999888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999 899999998765 79999999999999999999999999999999999999999999999999997543
Q ss_pred C-----CcccceeeeeceeEee
Q 024661 246 A-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~-----~~~~~~~y~ape~~~~ 262 (264)
. ..++|..|+|||++.+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHT
T ss_pred CCCccccccCCcceeCcccccC
Confidence 2 3468899999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=252.61 Aligned_cols=164 Identities=22% Similarity=0.336 Sum_probs=147.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||.||+|+++.+|+.||+|++++.. .....+.+|+.+++.+.|+++ +++++++.+.+.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~l~~~~~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcC-----cceEEEEEeCCE
Confidence 57999999999999999999999999999999998542 345678889999999888877 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999 899999998765 79999999999999999999999999999999999999999999999999997532
Q ss_pred -----CCcccceeeeeceeEee
Q 024661 246 -----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 -----~~~~~~~~y~ape~~~~ 262 (264)
...+||..|||||++.+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS
T ss_pred CCCcccccccChhhCChhhhcC
Confidence 23458899999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=253.81 Aligned_cols=164 Identities=22% Similarity=0.306 Sum_probs=144.4
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|++.+.||+|+||.||+|+++.+++.||+|++++.. ...+.+.+|..+++.+ .|+++ +++++++.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCce-----eeEEEEEEeC
Confidence 367999999999999999999999999999999998532 3446678899999987 57776 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999 899999998765 7999999999999999999999999999999999999999999999999999753
Q ss_pred C------CCcccceeeeeceeEe
Q 024661 245 H------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~------~~~~~~~~y~ape~~~ 261 (264)
. ...+||..|||||++.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp CC---------CCGGGCCHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcC
Confidence 2 2345899999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.84 Aligned_cols=166 Identities=20% Similarity=0.278 Sum_probs=147.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~ 164 (264)
..++|++.+.||+|+||.||+|+++.+++.||+|++++.. ...+.+..|..+++.+ .|+++ +++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~i-----v~l~~~~~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEEC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCC-----CcEEEEEEe
Confidence 3467999999999999999999999999999999998642 3446678899999887 77777 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999 999999998765 799999999999999999999999999999999999999999999999999975
Q ss_pred CC------CCcccceeeeeceeEee
Q 024661 244 RH------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~------~~~~~~~~y~ape~~~~ 262 (264)
.. ...+||..|+|||++.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cccCCCcccCCCCCcccCChhhhcC
Confidence 32 23468999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=246.80 Aligned_cols=170 Identities=23% Similarity=0.388 Sum_probs=149.9
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----hhhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
+++.+.++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+.+|+.+++.++|+|+ ++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~~ 79 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-----VSMIDV 79 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTB-----CCEEEE
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCC-----ceEEEe
Confidence 567788999999999999999999999999999999999853 23445678899999999999888 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
+.+.+.+|+||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999 889999998775 799999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC-------CcccceeeeeceeEee
Q 024661 241 PSPRHA-------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~-------~~~~~~~y~ape~~~~ 262 (264)
+..... ...+|..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp STTC-------------CCSSCCHHHHHT
T ss_pred ccccccccccccCccccCccccCHhHhcC
Confidence 976432 2347889999997643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.49 Aligned_cols=165 Identities=19% Similarity=0.289 Sum_probs=145.9
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|++++.||+|+||+||+|+++.+++.||+|++++.. ...+.+.+|..+++.+ .|+++ ++++++|.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTB-----CCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCc-----CeeEEEEEEC
Confidence 367999999999999999999999999999999998543 2334577899999887 67777 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999 899999998765 7999999999999999999999999999999999999999999999999999752
Q ss_pred ------CCCcccceeeeeceeEee
Q 024661 245 ------HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ------~~~~~~~~~y~ape~~~~ 262 (264)
....+||..|||||++.+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred ccCCCccccccCCcccCCchhhcC
Confidence 223468999999998653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=247.55 Aligned_cols=167 Identities=20% Similarity=0.359 Sum_probs=150.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++.++|+|+ +++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCC-----CeEeEEEecCCEE
Confidence 35688999999999999999999999999999999998666666788999999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec--CCcEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~--~~~v~l~Dfg~a~~~~ 245 (264)
|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999 889999997643 46999999999999999999999999999999999999997 7899999999997654
Q ss_pred CC-----cccceeeeeceeEe
Q 024661 246 AF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~-----~~~~~~y~ape~~~ 261 (264)
.. ..+|+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQ 176 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHT
T ss_pred CCCccccccCChhhcCcHHhc
Confidence 32 24788899999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=257.90 Aligned_cols=167 Identities=21% Similarity=0.300 Sum_probs=147.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|++.++||+|+||+||+|+++.+++.||+|++++... ....+.+|+.+++.+.|+++ +++++++.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI-----TTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB-----CCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEee
Confidence 334789999999999999999999999999999999975332 22347889999999988887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999 999999998743 3699999999999999999999999999999999999999999999999999965
Q ss_pred CCC-------CcccceeeeeceeEe
Q 024661 244 RHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-------~~~~~~~y~ape~~~ 261 (264)
... ..+||..|||||++.
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred cccCCCcccccccCCcCeeChHHHh
Confidence 322 246899999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.55 Aligned_cols=164 Identities=20% Similarity=0.299 Sum_probs=146.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
..++|++.+.||+|+||.||+|+++.+++.||+|++++... ....+.+|+.+++.++|+++ +++++++.+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEEC
Confidence 34679999999999999999999999999999999975332 23457789999999998887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
..+|+||||+ +|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|...
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999 99999999864 5999999999999999999999999999999999999999999999999999654
Q ss_pred CC-------CcccceeeeeceeEe
Q 024661 245 HA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~-------~~~~~~~y~ape~~~ 261 (264)
.. ..+||..|||||++.
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~ 242 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLK 242 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHH
T ss_pred ccCCcccccCCcCCccccCHHHhh
Confidence 32 446899999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=261.41 Aligned_cols=149 Identities=26% Similarity=0.408 Sum_probs=125.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~- 164 (264)
.+.++|++++.||+|+||+||+|.+..+++.||||++.+. ....+.+.+|+.+++.++|+|+ +++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~~~~~~ 124 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV-----VKVLDIVIPK 124 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCC-----CceEEEEecC
Confidence 4568899999999999999999999999999999998642 3445678899999999999888 999998843
Q ss_pred ----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
...+|+|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 125 DVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CTTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CcccCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 36799999999999999998764 799999999999999999999999999999999999999999999999999
Q ss_pred CCcC
Q 024661 241 PSPR 244 (264)
Q Consensus 241 a~~~ 244 (264)
|+..
T Consensus 203 a~~~ 206 (458)
T 3rp9_A 203 ARTV 206 (458)
T ss_dssp CBCT
T ss_pred chhc
Confidence 9764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=256.08 Aligned_cols=167 Identities=23% Similarity=0.310 Sum_probs=148.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|++.+.||+|+||.||+|+++.+++.||+|++++.. ...+.+.+|..++..+.|+++ +++++++.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI-----TQLHFAFQD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB-----CCEEEEEEC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEee
Confidence 34478999999999999999999999999999999997532 233457889999999988887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 99999999999 999999998753 3699999999999999999999999999999999999999999999999999975
Q ss_pred CCC-------CcccceeeeeceeEe
Q 024661 244 RHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-------~~~~~~~y~ape~~~ 261 (264)
... ..+||..|||||++.
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred ccCCCccccceeccccCcCCHHHHh
Confidence 432 236899999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=248.72 Aligned_cols=165 Identities=19% Similarity=0.287 Sum_probs=146.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|++.+.||+|+||.||+|+++.+++.||+|++++.. ...+.+.+|..+++.+ .|+++ +++++++.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCcc-----CeEEEEEEeC
Confidence 367999999999999999999999999999999998542 3456678899999887 67777 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999 899999998765 7999999999999999999999999999999999999999999999999999752
Q ss_pred C------CCcccceeeeeceeEee
Q 024661 245 H------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~------~~~~~~~~y~ape~~~~ 262 (264)
. ...++|..|+|||++.+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cCCCCcccccCCCccccCccccCC
Confidence 1 23368999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=252.83 Aligned_cols=166 Identities=24% Similarity=0.384 Sum_probs=149.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|++++.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.+.|+|+ ++++++|.+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL-----VNLWYSFQD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEe
Confidence 34478999999999999999999999999999999997543 334678899999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999 999999998765 799999999999999999999999999999999999999999999999999975
Q ss_pred CC-----CCcccceeeeeceeEe
Q 024661 244 RH-----AFSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~-----~~~~~~~~y~ape~~~ 261 (264)
.. ....||..|||||++.
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTC
T ss_pred ccCCCceeccCCCccccCCeeec
Confidence 43 2346899999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=248.02 Aligned_cols=163 Identities=24% Similarity=0.349 Sum_probs=147.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|++..+|+.||+|++++.. ...+.+.+|+.+++.+.|+++ +++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCC-----ceEeEEEEeCCE
Confidence 57999999999999999999999999999999998542 345677889999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999 899999998765 799999999999999999999999999999999999999999999999999976443
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
..++|..|||||++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~ 176 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVS 176 (318)
T ss_dssp CBCCCCSCTTTCCHHHHT
T ss_pred ccccccCCccccCHhHhc
Confidence 346899999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=248.88 Aligned_cols=167 Identities=25% Similarity=0.350 Sum_probs=149.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.++|+|+ +++++++.+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI-----IKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEe
Confidence 44578999999999999999999999999999999997532 224578899999999998887 999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+.+|+||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 99999999999999999998765 7999999999999999999999999999999999999999999999999999764
Q ss_pred CC-----CcccceeeeeceeEee
Q 024661 245 HA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~-----~~~~~~~y~ape~~~~ 262 (264)
.. ..++|..|+|||++.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 159 TDGNFLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp TTSBTTCCCTTSTTTSCGGGSCC
T ss_pred cCCcccccccCCcCcCCHHHHcC
Confidence 32 3468899999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=250.09 Aligned_cols=164 Identities=24% Similarity=0.395 Sum_probs=148.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+.. ...+.+.+|+.+++.+.|+++ +++++++.+.+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcCC
Confidence 367999999999999999999999999999999997543 334677889999999988877 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999 999999998765 79999999999999999999999999999999999999999999999999997644
Q ss_pred C---CcccceeeeeceeEe
Q 024661 246 A---FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~---~~~~~~~y~ape~~~ 261 (264)
. ..++|..|+|||++.
T Consensus 193 ~~~~~~~gt~~y~aPE~~~ 211 (350)
T 1rdq_E 193 GRTWTLCGTPEALAPEIIL 211 (350)
T ss_dssp SCBCCCEECGGGCCHHHHT
T ss_pred CCcccccCCccccCHHHhc
Confidence 3 346899999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=250.43 Aligned_cols=167 Identities=24% Similarity=0.452 Sum_probs=149.3
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-------hHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++++... ..+.+.+|+.+++.+.|+|+ +++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~ 82 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI-----ITLHD 82 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCC-----CcEEE
Confidence 4567889999999999999999999999999999999975332 34678899999999998887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC----cEEe
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE----YVKV 235 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l 235 (264)
++.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 999999999999999 999999998754 799999999999999999999999999999999999998877 7999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+|||++..... ...||..|+|||++.
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHc
Confidence 99999976432 345899999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=249.86 Aligned_cols=165 Identities=21% Similarity=0.273 Sum_probs=144.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~ 164 (264)
..++|++.+.||+|+||.||+|+++.+++.||+|++++.. ...+.+..|..+++.+ .|+++ +++++++.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~l~~~~~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL-----TQLHSCFQT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTB-----CCEEEEEEC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEE-----eeEEEEEEc
Confidence 3467999999999999999999999999999999998542 3345677888888776 45555 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999 899999998765 799999999999999999999999999999999999999999999999999975
Q ss_pred CC------CCcccceeeeeceeEe
Q 024661 244 RH------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~------~~~~~~~~y~ape~~~ 261 (264)
.. ...+||..|||||++.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~ 194 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIA 194 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred cccCCcccccccCCccccChhhhc
Confidence 22 2346899999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=250.28 Aligned_cols=167 Identities=28% Similarity=0.363 Sum_probs=144.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.++|+|+ +++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI-----VRFKEVILTPTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCC-----CcEEEEEeeCCEE
Confidence 34578999999999999999999999999999999998766666788999999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc--EEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY--VKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~--v~l~Dfg~a~~~~ 245 (264)
|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999 999999998765 7999999999999999999999999999999999999987765 9999999987422
Q ss_pred -----CCcccceeeeeceeEee
Q 024661 246 -----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 -----~~~~~~~~y~ape~~~~ 262 (264)
....+|..|+|||++.+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp -----------CTTSCHHHHHC
T ss_pred ccCCCCCCcCCCCcCChhhhcC
Confidence 23468999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=254.69 Aligned_cols=163 Identities=24% Similarity=0.405 Sum_probs=133.9
Q ss_pred CCCeEEE-eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee----
Q 024661 91 TPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 91 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~---- 164 (264)
.++|.+. +.||+|+||+||+|.+..+++.||+|+++.. ..+.+|+.++.++ +|+|+ +++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~i-----v~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCc-----ceEeEEEeecccC
Confidence 3557776 7899999999999999999999999999753 3456788877554 56666 888888876
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CCcEEeccCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AEYVKVPDYKV 240 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~~v~l~Dfg~ 240 (264)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 67899999999 889999998765456999999999999999999999999999999999999998 78999999999
Q ss_pred CCcCCC-----CcccceeeeeceeEee
Q 024661 241 PSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+..... ..++|..|||||++.+
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp CEECC-----------CTTCCGGGSCC
T ss_pred ccccCCCCccccCCCCCCccCHhhcCC
Confidence 976432 3457889999998743
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=252.87 Aligned_cols=179 Identities=34% Similarity=0.615 Sum_probs=158.9
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccC-CCCcceEEEceee
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWF 162 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~~~~~~~~~ 162 (264)
....+.+..+|++.+.||+|+||.||+|.+..+++.||+|+++........+.+|+.+++.+.+.. ..+++++.+++.+
T Consensus 89 ~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp CCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred ccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 345567788999999999999999999999999999999999877777788899999999998764 3456789999999
Q ss_pred eeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc--EEeccCCC
Q 024661 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY--VKVPDYKV 240 (264)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~--v~l~Dfg~ 240 (264)
...+.+|+|||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 169 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999999889999999876567999999999999999999999999999999999999999987 99999999
Q ss_pred CCcCCC---CcccceeeeeceeEee
Q 024661 241 PSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
+..... ...+|..|||||++.+
T Consensus 249 a~~~~~~~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 249 SCYEHQRVYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp CEETTCCCCSSCSCGGGCCHHHHHT
T ss_pred ceecCCcccccCCCCCccChHHHhC
Confidence 965433 3458899999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=241.08 Aligned_cols=171 Identities=29% Similarity=0.476 Sum_probs=142.6
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh------hhHHHHHHHHHHHHHHh---ccCCCCcceE
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLA---RHDIGGTRCV 156 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~---~~~~~~~~~~ 156 (264)
+++.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+|+.+++.+. |+|+ +
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni-----v 77 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV-----V 77 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB-----C
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe-----E
Confidence 35667789999999999999999999999999999999987322 22346677888888776 7777 9
Q ss_pred EEceeeeeCC-----EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 157 QIRNWFDYRN-----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 157 ~~~~~~~~~~-----~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
++++++.... .+++|||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS
T ss_pred EeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence 9999987754 68999999988999999987655699999999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
.+||+|||++..... ...+|..|+|||++.
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 192 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHc
Confidence 999999999976432 235788999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=243.26 Aligned_cols=164 Identities=26% Similarity=0.345 Sum_probs=147.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++.+.+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCC-----CeEeEEEEECCEE
Confidence 4568999999999999999999999999999999987433 345678899999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999 99999999875 599999999999999999999999999999999999999999999999999865332
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...+|..|+|||++.
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~ 189 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVT 189 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHH
T ss_pred ccccCCccCCcCccChhhhc
Confidence 335888999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=241.87 Aligned_cols=164 Identities=26% Similarity=0.439 Sum_probs=145.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++|+|+ +++++++.+++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCE-----eeEEeEEEeCCEE
Confidence 5799999999999999999999999999999999743 2345678899999999998887 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9999999888888877643 479999999999999999999999999999999999999999999999999997533
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....+|..|+|||++.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~ 174 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLF 174 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHT
T ss_pred ccccCCccccCCcChHHHc
Confidence 2335788999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.95 Aligned_cols=164 Identities=17% Similarity=0.295 Sum_probs=147.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec-hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.. .....+.+.+|+++++.++|+|+ +++++++.+.+..++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV-----LKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCc-----ccEEEEEecCCeeEE
Confidence 679999999999999999999999999999998764 34556788999999999998887 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999 899999998743 4699999999999999999999999999999999999999999999999999975322
Q ss_pred -----------------CcccceeeeeceeEe
Q 024661 247 -----------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----------------~~~~~~~y~ape~~~ 261 (264)
...+|..|+|||++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhc
Confidence 335788899999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=250.02 Aligned_cols=183 Identities=35% Similarity=0.557 Sum_probs=158.7
Q ss_pred CceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCC---CcceE
Q 024661 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG---GTRCV 156 (264)
Q Consensus 80 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~---~~~~~ 156 (264)
+..++..++.+.++|++.++||+|+||.||+|.+..+++.||+|+++......+.+.+|+.+++.+.|.+.. +++++
T Consensus 25 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 25 GYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp -CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred CceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 345677788899999999999999999999999999999999999987777778889999999999976533 45679
Q ss_pred EEceeee----eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCC
Q 024661 157 QIRNWFD----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAE 231 (264)
Q Consensus 157 ~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~ 231 (264)
++++++. +...+|+|||+++++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 9999987 56789999999998999888876555799999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------------cEEeccCCCCCcCC---CCcccceeeeecee
Q 024661 232 -------------------------------------------------YVKVPDYKVPSPRH---AFSFQTFLSMASRV 259 (264)
Q Consensus 232 -------------------------------------------------~v~l~Dfg~a~~~~---~~~~~~~~y~ape~ 259 (264)
.+||+|||++.... ....+|..|||||+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChh
Confidence 79999999997543 23458999999998
Q ss_pred Eee
Q 024661 260 YIC 262 (264)
Q Consensus 260 ~~~ 262 (264)
+.+
T Consensus 265 ~~~ 267 (397)
T 1wak_A 265 LIG 267 (397)
T ss_dssp HHT
T ss_pred hcC
Confidence 653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.80 Aligned_cols=168 Identities=21% Similarity=0.337 Sum_probs=147.7
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
...+.++|++.+.||+|+||.||+|.+..+|+.+|+|++.... ...+.+.+|+.+++.++|+|+ +++++++.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~ 80 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI-----VRLHDSIS 80 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTB-----CCEEEEEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCC-----CeEEEEEE
Confidence 3466788999999999999999999999999999999987532 345678899999999999988 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CCcEEeccCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AEYVKVPDYK 239 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~~v~l~Dfg 239 (264)
+.+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999 999999998865 7999999999999999999999999999999999999994 5789999999
Q ss_pred CCCcCCC------CcccceeeeeceeEe
Q 024661 240 VPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
++..... ...||..|||||++.
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~ 186 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLR 186 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHT
T ss_pred eeEEecCCCceeecccCCcccCCHHHhc
Confidence 9976432 235899999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=243.75 Aligned_cols=170 Identities=28% Similarity=0.409 Sum_probs=147.3
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
..+.+.++|++.++||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.++|+|+ +++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI-----VSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCE-----eeeeeEE
Confidence 34577789999999999999999999985 58899999987432 234678899999999998887 9999999
Q ss_pred eeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
.+.+.+|+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 89 HSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 9999999999999889999988654 469999999999999999999999999999999999999999999999999997
Q ss_pred cCC------CCcccceeeeeceeEee
Q 024661 243 PRH------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~------~~~~~~~~y~ape~~~~ 262 (264)
... ....+|..|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTT
T ss_pred ecCCCcccccCCcccCCcCCHHHhcC
Confidence 543 23357889999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.08 Aligned_cols=171 Identities=22% Similarity=0.335 Sum_probs=149.3
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
......+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~ 95 (362)
T 2bdw_A 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHD 95 (362)
T ss_dssp ---CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred ecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEE
Confidence 3345567788999999999999999999999999999999997532 345678899999999999888 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEec
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKVP 236 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l~ 236 (264)
++.+.+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 96 SIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEe
Confidence 999999999999999 899999998765 799999999999999999999999999999999999998654 59999
Q ss_pred cCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
|||++..... ...+|..|+|||++.
T Consensus 174 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (362)
T 2bdw_A 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203 (362)
T ss_dssp CCTTCBCCTTCCSCCCSCSCTTTCCHHHHT
T ss_pred ecCcceEecCCcccccCCCCccccCHHHHc
Confidence 9999976543 235889999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=241.43 Aligned_cols=171 Identities=23% Similarity=0.280 Sum_probs=145.4
Q ss_pred eeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHH-hccCCCCcceEEEce
Q 024661 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (264)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~ 160 (264)
..++.+.++|++.++||+|+||+||+|.+..+++.||+|++... .........|+..+..+ .|+|+ +++++
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~i-----v~l~~ 124 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC-----VRLEQ 124 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcE-----EEEEE
Confidence 34566778899999999999999999999999999999988642 23334455566555555 67766 99999
Q ss_pred eeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 161 WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
++.+.+.+|+|||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 125 AWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 999999999999999999999988764 4699999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC-----CcccceeeeeceeEe
Q 024661 241 PSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+..... ...+|..|+|||++.
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~ 229 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQ 229 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGG
T ss_pred eeecccCCCCcccCCCccccCHhHhc
Confidence 875432 334788999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=245.35 Aligned_cols=168 Identities=26% Similarity=0.337 Sum_probs=146.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh------hHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ..+.+.+|+.+++.++|+|+ +++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~ 95 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI-----VELLETY 95 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCC-----CcEEEEE
Confidence 456789999999999999999999999999999999974321 35778999999999999888 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc---EEec
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVP 236 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~---v~l~ 236 (264)
.+.+.+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 9999999999999 89999888643 2235899999999999999999999999999999999999987654 9999
Q ss_pred cCCCCCcCCC------CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
|||++..... ...+|..|+|||++.
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHT
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHc
Confidence 9999976432 335889999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=252.94 Aligned_cols=165 Identities=25% Similarity=0.342 Sum_probs=146.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI-----IRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEecC
Confidence 5668899999999999999999999999999999999742 3445678899999999999887 9999998775
Q ss_pred -----CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
..+|+|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCcCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6799999999889999998764 799999999999999999999999999999999999999999999999999
Q ss_pred CCcCC----------------------------CCcccceeeeeceeE
Q 024661 241 PSPRH----------------------------AFSFQTFLSMASRVY 260 (264)
Q Consensus 241 a~~~~----------------------------~~~~~~~~y~ape~~ 260 (264)
|+... ....+|..|+|||++
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHH
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 97643 233578899999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=247.99 Aligned_cols=164 Identities=22% Similarity=0.355 Sum_probs=135.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHH-HHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~-l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++++.||+|+||.||+|+++.+++.||+|++++... ....+.+|..+ ++.+.|+++ +++++++.+.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~I-----v~l~~~~~~~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL-----VGLHFSFQTAD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTB-----CCEEEEEECSS
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCC-----CCEEEEEEeCC
Confidence 679999999999999999999999999999999976432 23344455544 344555555 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC-
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR- 244 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~- 244 (264)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999 899999998765 7999999999999999999999999999999999999999999999999999752
Q ss_pred -----CCCcccceeeeeceeEee
Q 024661 245 -----HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 -----~~~~~~~~~y~ape~~~~ 262 (264)
....+||..|||||++.+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTT
T ss_pred cCCCccccccCCccccCHHHhCC
Confidence 223468999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=241.62 Aligned_cols=179 Identities=42% Similarity=0.724 Sum_probs=157.9
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEe-CCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCC-CCcceEEEcee
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTRCVQIRNW 161 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~~~ 161 (264)
...++.+.++|++.+.||+|+||.||+|.+ ..+++.||+|+++......+.+.+|+.+++.+.|++. .++++++++++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 445778889999999999999999999998 5678999999998766777888999999999999763 34567999999
Q ss_pred eeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec------------
Q 024661 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS------------ 229 (264)
Q Consensus 162 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~------------ 229 (264)
+.+.+.+|+|||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 86 FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999999999999999998876567899999999999999999999999999999999999987
Q ss_pred -------CCcEEeccCCCCCcCCC---CcccceeeeeceeEee
Q 024661 230 -------AEYVKVPDYKVPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 230 -------~~~v~l~Dfg~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
++.+||+|||++..... ...+|..|+|||++.+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTT
T ss_pred cccccccCCCceEeeCcccccCccccccccCCccccChHHhhC
Confidence 66899999999976443 3468899999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=245.93 Aligned_cols=166 Identities=23% Similarity=0.363 Sum_probs=145.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++.+.+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCC-----CeEEEEEecCCe
Confidence 4578999999999999999999999999999999987433 334677899999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999 889999987654 69999999999999999999999999999999999999999999999999996432
Q ss_pred -------CCcccceeeeeceeEee
Q 024661 246 -------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 -------~~~~~~~~y~ape~~~~ 262 (264)
....+|..|+|||++.+
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHC
T ss_pred CCcccccCCCccCcCccCcHHhcc
Confidence 23468899999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=243.01 Aligned_cols=167 Identities=25% Similarity=0.458 Sum_probs=148.6
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-------hHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++|+|+ +++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 81 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE 81 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 3556789999999999999999999999999999999875321 35778899999999999887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC----cEEe
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE----YVKV 235 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l 235 (264)
++.+...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 999999999999999 899999997654 799999999999999999999999999999999999999887 8999
Q ss_pred ccCCCCCcCC-----CCcccceeeeeceeEe
Q 024661 236 PDYKVPSPRH-----AFSFQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~-----~~~~~~~~y~ape~~~ 261 (264)
+|||++.... ....+|..|+|||++.
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 190 (326)
T 2y0a_A 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190 (326)
T ss_dssp CCCTTCEECCTTSCCCCCCSCTTTCCHHHHT
T ss_pred EECCCCeECCCCCccccccCCcCcCCceeec
Confidence 9999997643 2345888999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=241.80 Aligned_cols=185 Identities=42% Similarity=0.794 Sum_probs=161.3
Q ss_pred CCCCceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCC-cEEEEEEEechhhhHHHHHHHHHHHHHHhccCC-CCcc
Q 024661 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTR 154 (264)
Q Consensus 77 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~ 154 (264)
+..+.+....++.+.++|++.+.||+|+||.||+|.+..++ +.||+|+++......+.+.+|+.+++.+.|++. .+..
T Consensus 4 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 83 (355)
T 2eu9_A 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83 (355)
T ss_dssp CTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSC
T ss_pred ccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCcee
Confidence 34456667788899999999999999999999999998776 689999998766777888999999999998763 3345
Q ss_pred eEEEceeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe-------
Q 024661 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL------- 227 (264)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili------- 227 (264)
++.+++++...+..|+|||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 6889999999999999999999999998887655679999999999999999999999999999999999999
Q ss_pred ------------ecCCcEEeccCCCCCcCCC---CcccceeeeeceeEe
Q 024661 228 ------------VSAEYVKVPDYKVPSPRHA---FSFQTFLSMASRVYI 261 (264)
Q Consensus 228 ------------~~~~~v~l~Dfg~a~~~~~---~~~~~~~y~ape~~~ 261 (264)
+.++.+||+|||++..... ...+|..|+|||++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL 212 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT
T ss_pred cccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeee
Confidence 6778999999999975432 346889999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=247.10 Aligned_cols=167 Identities=16% Similarity=0.193 Sum_probs=148.9
Q ss_pred CCCeEEEeecccC--ccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|++.+.||+| +||.||+|++..+++.||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCC-----CcEeEEEEEC
Confidence 3679999999999 9999999999999999999999754 3445678889999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999 899999998875557999999999999999999999999999999999999999999999999987532
Q ss_pred -------------CCCcccceeeeeceeEee
Q 024661 245 -------------HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 -------------~~~~~~~~~y~ape~~~~ 262 (264)
.....+|..|+|||++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ccccccccccccccccccccccccCHHHHhc
Confidence 122367888999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=256.89 Aligned_cols=168 Identities=21% Similarity=0.306 Sum_probs=149.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. .....+.+|+.+++.+.|+++ +++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEee
Confidence 34467999999999999999999999999999999997532 234567889999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ ||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 99999999999 99999999876545699999999999999999999999999999999999999999999999999976
Q ss_pred CCC-----CcccceeeeeceeEe
Q 024661 244 RHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~ 261 (264)
... ...||..|||||++.
T Consensus 336 ~~~~~~~~~~~GT~~Y~APEvl~ 358 (576)
T 2acx_A 336 VPEGQTIKGRVGTVGYMAPEVVK 358 (576)
T ss_dssp CCTTCCEECCCSCGGGCCHHHHT
T ss_pred cccCccccccCCCccccCHHHHc
Confidence 432 346899999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=248.46 Aligned_cols=168 Identities=24% Similarity=0.379 Sum_probs=138.8
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~ 162 (264)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+. ........+|+.+++.+. |+|+ +++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI-----VNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCC-----CeeeeEE
Confidence 445668899999999999999999999999999999998632 345567788999999997 8877 9999998
Q ss_pred eeC--CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 163 DYR--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 163 ~~~--~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
... ..+|+||||++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 754 479999999988999999874 599999999999999999999999999999999999999999999999999
Q ss_pred CCcCC---------------------------CCcccceeeeeceeEee
Q 024661 241 PSPRH---------------------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~---------------------------~~~~~~~~y~ape~~~~ 262 (264)
|+... ....+|..|+|||++.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 96532 12358899999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=252.98 Aligned_cols=173 Identities=23% Similarity=0.351 Sum_probs=143.9
Q ss_pred ceEEeeCC---ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcc
Q 024661 81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR 154 (264)
Q Consensus 81 ~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~ 154 (264)
.+.+..++ .+.++|++++.||+|+||.||+|.+..+++.||||++.+. ....+.+.+|+.+++.++|+|+
T Consensus 48 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI---- 123 (464)
T 3ttj_A 48 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI---- 123 (464)
T ss_dssp EEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB----
T ss_pred ceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC----
Confidence 44555554 4568899999999999999999999999999999999753 3445678899999999999888
Q ss_pred eEEEceeeeeC------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 155 CVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 155 ~~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
+++++++... ..+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 124 -v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 124 -ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp -CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred -CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 9999998654 46899999998888887753 589999999999999999999999999999999999999
Q ss_pred cCCcEEeccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 229 SAEYVKVPDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
.++.+||+|||+|+.... ...+|..|+|||++.+
T Consensus 199 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT
T ss_pred CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC
Confidence 999999999999986543 2457889999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=245.05 Aligned_cols=182 Identities=34% Similarity=0.605 Sum_probs=159.9
Q ss_pred ceEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEc
Q 024661 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (264)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~ 159 (264)
.+.+..++.+.++|++.+.||+|+||.||+|.+..+++.||+|+++........+.+|+.+++.+. |+++.+.+++.++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 456677888899999999999999999999999999999999999876666778888999999997 5556666789999
Q ss_pred eeeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEee--cCCcEEe
Q 024661 160 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLV--SAEYVKV 235 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dikp~Nili~--~~~~v~l 235 (264)
+++...+..|+|||+++++|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999999889999999875557999999999999999999999 57999999999999995 4678999
Q ss_pred ccCCCCCcCCC---CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
+|||++..... ...+|..|+|||++.+
T Consensus 203 ~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 203 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp CCCTTCEETTCCCCSSCSCGGGCCHHHHTT
T ss_pred EeccCceecccccccccCCccccChHHHcC
Confidence 99999976433 3468899999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=241.86 Aligned_cols=166 Identities=22% Similarity=0.315 Sum_probs=139.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
...++|++.+.||+|+||.||+|++. .+++.||+|++++.. .....+.+|+.+++.+.|+|+ +++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 88 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI-----VDLIY 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTB-----CCEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeE
Confidence 34478999999999999999999985 678999999987532 234567789999999998887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
++.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 999999999999999 899999998765 78999999999999999999999999999999999999999999999999
Q ss_pred CCCcCC------CCcccceeeeeceeEe
Q 024661 240 VPSPRH------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~------~~~~~~~~y~ape~~~ 261 (264)
++.... ....+|..|||||++.
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (327)
T 3a62_A 167 LCKESIHDGTVTHTFCGTIEYMAPEILM 194 (327)
T ss_dssp CC----------CTTSSCCTTSCHHHHT
T ss_pred cccccccCCccccccCCCcCccCHhhCc
Confidence 987532 2335889999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=242.50 Aligned_cols=167 Identities=25% Similarity=0.326 Sum_probs=146.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+ .|+++ +++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~~~~~ 79 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGI-----PQVYYFGPCGKY 79 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTS-----CCEEEEEEETTE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCC-----CEEEEEEecCCc
Confidence 45678999999999999999999999999999999987532 234678899999999 88877 999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc-----EEeccCCCCC
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY-----VKVPDYKVPS 242 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~-----v~l~Dfg~a~ 242 (264)
.|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999999999998753 47999999999999999999999999999999999999998887 9999999997
Q ss_pred cCC-------------CCcccceeeeeceeEee
Q 024661 243 PRH-------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~-------------~~~~~~~~y~ape~~~~ 262 (264)
... ....+|..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG 191 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcC
Confidence 532 23458899999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=255.05 Aligned_cols=167 Identities=23% Similarity=0.315 Sum_probs=148.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ...+.+.+|+.+++.++|+++ +++++++.+..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI-----VSLAYAFETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEeeCC
Confidence 467999999999999999999999999999999997543 234678889999999988887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+|+||||+ |++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999 899999998643 34699999999999999999999999999999999999999999999999999975
Q ss_pred CCC------CcccceeeeeceeEee
Q 024661 244 RHA------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~------~~~~~~~y~ape~~~~ 262 (264)
... ...||..|||||++.+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT
T ss_pred ccCCCcccccccCCccccChhhhcC
Confidence 332 2368999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=246.20 Aligned_cols=167 Identities=18% Similarity=0.283 Sum_probs=143.3
Q ss_pred cCCCeEEEeecccCccEEEEEEEeC-------CCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEc
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIR 159 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~ 159 (264)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ....+.+.+|+.+++.+ +|+|+ ++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~ 153 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLL 153 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTB-----CCEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCE-----eeEE
Confidence 3478999999999999999999874 34567999998753 34456789999999999 78887 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
+++.+.+.+|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 9999999999999999 889999998653 1358899999999999999999999999999999999
Q ss_pred EEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 225 ILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
||++.++.+||+|||+++.... ...++..|||||++.
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 278 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 278 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc
Confidence 9999999999999999975332 223567899999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=239.50 Aligned_cols=169 Identities=25% Similarity=0.350 Sum_probs=150.2
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
......++|.+.+.||+|+||.||+|.+..+++.+|+|++... ....+.+.+|+.+++.+.|+|+ ++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 109 (335)
T 2owb_A 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGF 109 (335)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEE
T ss_pred cCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEE
Confidence 3445667899999999999999999999999999999998753 2456778899999999988887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
+.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 110 FEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence 99999999999999 899999998765 799999999999999999999999999999999999999999999999999
Q ss_pred CCcCC------CCcccceeeeeceeEe
Q 024661 241 PSPRH------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~------~~~~~~~~y~ape~~~ 261 (264)
+.... ....++..|+|||++.
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 214 (335)
T 2owb_A 188 ATKVEYDGERKKVLCGTPNYIAPEVLS 214 (335)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHH
T ss_pred ceecccCcccccccCCCccccCHHHhc
Confidence 97543 2235788899999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=244.95 Aligned_cols=167 Identities=25% Similarity=0.413 Sum_probs=136.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|+++... ..+.+.+|+.+++.+.|+|+ +++++++.+.+.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~ 122 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNI-----IKLKEIFETPTE 122 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCC-----cceeeeEecCCe
Confidence 456788999999999999999999999999999999997543 34667889999999999887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~~v~l~Dfg~a~~ 243 (264)
.++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999 899999998765 6999999999999999999999999999999999999976 88999999999976
Q ss_pred CCC-----CcccceeeeeceeEee
Q 024661 244 RHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~~ 262 (264)
... ...+|..|+|||++.+
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp ------------CGGGSCHHHHTT
T ss_pred cCcccccccccCCCCccCHHHhcC
Confidence 433 3357889999998643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=245.74 Aligned_cols=170 Identities=18% Similarity=0.199 Sum_probs=141.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEE-----eCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
...++|.+.+.||+|+||.||+|. +..+++.||+|+++.. ....+.+|+++++.+.+. .|++++.+++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~--~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPS--MQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGG--GGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhh--hhhhhhhhheeee
Confidence 345789999999999999999994 6677899999998753 345677888888888732 1244599999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec----------
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKN---SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---------- 229 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---------- 229 (264)
..+..|+||||+ +|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 999999999999 89999999852 2346999999999999999999999999999999999999998
Q ss_pred -CCcEEeccCCCCCcCC--------CCcccceeeeeceeEee
Q 024661 230 -AEYVKVPDYKVPSPRH--------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 230 -~~~v~l~Dfg~a~~~~--------~~~~~~~~y~ape~~~~ 262 (264)
++.+||+|||+|+... ....||..|||||++.+
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 8999999999995422 23358999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=253.51 Aligned_cols=173 Identities=25% Similarity=0.435 Sum_probs=149.8
Q ss_pred eEEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--------------hhHHHHHHHHHHHHHHhc
Q 024661 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRLAR 147 (264)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~~ 147 (264)
+.......+.++|+++++||+|+||.||+|.+..+++.+|+|++.+.. ...+.+.+|+.+++.+.|
T Consensus 26 ~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 105 (504)
T 3q5i_A 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105 (504)
T ss_dssp GCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC
T ss_pred eeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC
Confidence 344455677889999999999999999999999999999999987532 235678899999999998
Q ss_pred cCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024661 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (264)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nil 226 (264)
+|+ +++++++.+...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 106 pni-----v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 106 PNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178 (504)
T ss_dssp TTB-----CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCC-----CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence 887 99999999999999999999 899999998765 7999999999999999999999999999999999999
Q ss_pred eecCC---cEEeccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 227 LVSAE---YVKVPDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 227 i~~~~---~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
++.++ .+||+|||++..... ...+|..|+|||++.
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK 221 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT
T ss_pred EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc
Confidence 99876 699999999975432 345899999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=252.44 Aligned_cols=166 Identities=23% Similarity=0.309 Sum_probs=140.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHHh---------ccCCC--
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLA---------RHDIG-- 151 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~---------~~~~~-- 151 (264)
++|++.+.||+|+||.||+|++ +|+.||+|++.... ...+.+.+|+.+++.++ |+|+.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 6799999999999999999998 57999999997532 22377889999999997 66652
Q ss_pred ----------CcceEEEceeeee-------------CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 024661 152 ----------GTRCVQIRNWFDY-------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207 (264)
Q Consensus 152 ----------~~~~~~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l 207 (264)
|+++++++++|.+ .+.+|+||||+ +|++.+.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 4566777777665 78999999999 7866666644 3689999999999999999
Q ss_pred HHHH-HCCCeecCCCCCCEEeecCC--------------------cEEeccCCCCCcCCC-CcccceeeeeceeEee
Q 024661 208 AFMH-ELRLIHTDLKPENILLVSAE--------------------YVKVPDYKVPSPRHA-FSFQTFLSMASRVYIC 262 (264)
Q Consensus 208 ~~lH-~~~ivH~dikp~Nili~~~~--------------------~v~l~Dfg~a~~~~~-~~~~~~~y~ape~~~~ 262 (264)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+|..|||||++.+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcC
Confidence 9999 99999999999999999987 999999999987543 4468999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=241.71 Aligned_cols=166 Identities=26% Similarity=0.321 Sum_probs=147.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+++++.++|+|+ +++++++.+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLRE 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEET
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEC
Confidence 445699999999999999999999999999999998742 2344678899999999999888 9999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+..|+||||+.|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9999999999889999887543 469999999999999999999999999999999999999999999999999997654
Q ss_pred C--CcccceeeeeceeEe
Q 024661 246 A--FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--~~~~~~~y~ape~~~ 261 (264)
. ...+|..|+|||++.
T Consensus 206 ~~~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 206 PANSFVGTPYWMAPEVIL 223 (348)
T ss_dssp SBCCCCSCGGGCCHHHHH
T ss_pred CCCcccCCcceeCHhhhc
Confidence 3 346899999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=242.12 Aligned_cols=168 Identities=26% Similarity=0.306 Sum_probs=141.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC-
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN- 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 166 (264)
+.++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~ 78 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLETPP 78 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTB-----CCEEEEEEECCS
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEecc
Confidence 446799999999999999999999999999999998742 3456788999999999998888 88988875532
Q ss_pred --------------------------------------------------------EEEEEEecC-CCCHHHHHHhcCC-
Q 024661 167 --------------------------------------------------------HICIVFEKL-GPSLYDFLRKNSY- 188 (264)
Q Consensus 167 --------------------------------------------------------~~~lv~e~~-~~~L~~~l~~~~~- 188 (264)
.+|+||||+ +++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 489999999 8999999986541
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC------------------ccc
Q 024661 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF------------------SFQ 250 (264)
Q Consensus 189 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~------------------~~~ 250 (264)
...++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..+
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 23566678999999999999999999999999999999999999999999999764332 358
Q ss_pred ceeeeeceeEee
Q 024661 251 TFLSMASRVYIC 262 (264)
Q Consensus 251 ~~~y~ape~~~~ 262 (264)
|..|+|||++.+
T Consensus 239 t~~y~aPE~~~~ 250 (332)
T 3qd2_B 239 TKLYMSPEQIHG 250 (332)
T ss_dssp CGGGSCHHHHHC
T ss_pred CcCccChHHhcC
Confidence 889999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.74 Aligned_cols=166 Identities=26% Similarity=0.455 Sum_probs=132.8
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.+++.++|+|+ +++++++.+++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI-----VRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTB-----CCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCc-----ceEEEEEEECCeE
Confidence 357999999999999999999999999999999987432 334678899999999999888 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 169 CIVFEKLGPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
|+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9999999889999987542 135899999999999999999999999999999999999999999999999999753
Q ss_pred C------CCcccceeeeeceeEe
Q 024661 245 H------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~------~~~~~~~~y~ape~~~ 261 (264)
. ....+|..|+|||++.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~ 181 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLM 181 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHT
T ss_pred CCCcccCCCCcccccccCchHhh
Confidence 2 2335788999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=242.56 Aligned_cols=168 Identities=21% Similarity=0.251 Sum_probs=142.3
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
...+.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++.+.|+|+ +++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 81 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTG 81 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTB-----CCEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCc-----ceEEEee
Confidence 356778999999999999999999999999999999999753 2334577889999988888877 9999988
Q ss_pred eeCC----EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 163 DYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 163 ~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
.... ..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 159 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 159 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECC
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEee
Confidence 7643 459999999 899999998765 799999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCC---------CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~---------~~~~~~~y~ape~~~ 261 (264)
||++..... ...+|..|+|||++.
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 192 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192 (311)
T ss_dssp CSCC------------------CCTTCCHHHHH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhc
Confidence 999975332 224788999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=252.94 Aligned_cols=167 Identities=26% Similarity=0.332 Sum_probs=149.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
....++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.. .....+.+|+.+++.++|+|+ +++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI-----IKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 345578999999999999999999999999999999997543 234678899999999998887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence 999999999999 999999998654 79999999999999999999999999999999999999999999999999997
Q ss_pred cCCC-----CcccceeeeeceeEe
Q 024661 243 PRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~-----~~~~~~~y~ape~~~ 261 (264)
.... ..++|..|+|||++.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~ 188 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVIS 188 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHT
T ss_pred hccccccccccCCCcCeEChhhcc
Confidence 6432 346889999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=240.64 Aligned_cols=168 Identities=21% Similarity=0.245 Sum_probs=144.5
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCc---EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
+...++|++.+.||+|+||.||+|.+..+++ .||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~ 119 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI-----IRLEGVV 119 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEE
Confidence 3455789999999999999999999986654 4999999753 3456778999999999998887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
.+.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 9999999999999 889999997653 46999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC---------cccceeeeeceeEe
Q 024661 242 SPRHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~~---------~~~~~~y~ape~~~ 261 (264)
...... ..+|..|+|||++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 227 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHH
T ss_pred cccccCccceeeccCCCCcccccCHhHhc
Confidence 764321 12355699999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=239.18 Aligned_cols=163 Identities=21% Similarity=0.398 Sum_probs=139.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh---------------------------hHHHHHHHHHHHH
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQ 143 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l~ 143 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3679999999999999999999999999999999875321 1246788999999
Q ss_pred HHhccCCCCcceEEEceeeee--CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 024661 144 RLARHDIGGTRCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (264)
Q Consensus 144 ~l~~~~~~~~~~~~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 220 (264)
.++|+|+ +++++++.+ ...+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||
T Consensus 92 ~l~h~~i-----v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNV-----VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp TCCCTTB-----CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hCCCCCC-----CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 9998887 999999887 67899999999 8888876443 36999999999999999999999999999999
Q ss_pred CCCCEEeecCCcEEeccCCCCCcCCC------CcccceeeeeceeEe
Q 024661 221 KPENILLVSAEYVKVPDYKVPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 221 kp~Nili~~~~~v~l~Dfg~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
||+|||++.++.+||+|||++..... ...+|..|+|||++.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 210 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS 210 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhc
Confidence 99999999999999999999976432 335889999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=238.57 Aligned_cols=169 Identities=20% Similarity=0.295 Sum_probs=146.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
....++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+++++.++|+|+ +++++++...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 79 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEET 79 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCc-----ceEEEEeecC
Confidence 456688999999999999999999999999999999997533 335677899999999998887 9999988775
Q ss_pred C--EEEEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe----ecCCcEEecc
Q 024661 166 N--HICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL----VSAEYVKVPD 237 (264)
Q Consensus 166 ~--~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili----~~~~~v~l~D 237 (264)
. ..|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 889999999 899999998653 2249999999999999999999999999999999999999 6677899999
Q ss_pred CCCCCcCCC-----CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
||++..... ...+|..|+|||++.
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhh
Confidence 999976433 235788999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=252.08 Aligned_cols=165 Identities=22% Similarity=0.342 Sum_probs=139.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.+.|+|+ +++++++.+.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~l~~~~~~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTS-----CCEEEEEEET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeE-----eeEEEEEeeC
Confidence 3467999999999999999999999999999999997532 233566778888888888877 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|..
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999 899999998765 79999999999999999999998 9999999999999999999999999999975
Q ss_pred CC------CCcccceeeeeceeEe
Q 024661 244 RH------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~------~~~~~~~~y~ape~~~ 261 (264)
.. ....||..|||||++.
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~ 322 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLE 322 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHH
T ss_pred ccCCCcccccccCCccccCHhhcC
Confidence 32 2345899999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=243.66 Aligned_cols=167 Identities=23% Similarity=0.388 Sum_probs=147.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCC-----CeEEEEEEeCCE
Confidence 3457899999999999999999999999999999999754 2345678899999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec--CCcEEeccCCCCCcC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~--~~~v~l~Dfg~a~~~ 244 (264)
+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999 899999987543 46999999999999999999999999999999999999984 468999999999865
Q ss_pred CCC-----cccceeeeeceeEe
Q 024661 245 HAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~-----~~~~~~y~ape~~~ 261 (264)
... ..+|..|+|||++.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~ 223 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVD 223 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHT
T ss_pred CCCcceeeeccCCCccCchhcc
Confidence 432 35788999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=244.31 Aligned_cols=166 Identities=22% Similarity=0.356 Sum_probs=140.1
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV-----IGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB-----CCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCC-----CCceeeEecC
Confidence 3457899999999999999999999999999999998542 3445678899999999999888 9999988765
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..+|+|||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 356999999999999999874 59999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---CcccceeeeeceeEee
Q 024661 240 VPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
+++.... ...+|..|+|||++.+
T Consensus 174 ~a~~~~~~~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 174 LARQADSEMTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp TCEECCSSCCSSCSCGGGCCTHHHHT
T ss_pred cccccccccCcCcCCCCcCCHHHHhC
Confidence 9976433 3357889999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=259.44 Aligned_cols=165 Identities=21% Similarity=0.270 Sum_probs=144.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 164 (264)
..++|++++.||+|+||.||+|.++.+++.||+|++++.. ...+.+..|..++..+. |++ ++.+++++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~-----i~~l~~~~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF-----LTQLHSCFQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTT-----BCCEEEECBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCe-----EEEEEEEEEe
Confidence 3467999999999999999999999999999999998532 33456777888888764 444 4999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+||||||+ +++|.+++.... .+++..++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+.
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999 999999999865 799999999999999999999999999999999999999999999999999975
Q ss_pred C------CCCcccceeeeeceeEe
Q 024661 244 R------HAFSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~------~~~~~~~~~y~ape~~~ 261 (264)
. ....+||..|||||++.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred cccCCcccccccCCCcccCHhhhc
Confidence 2 12346899999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=237.29 Aligned_cols=163 Identities=26% Similarity=0.436 Sum_probs=142.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|+||.||+|.+ .+++.+|+|++.... ...+.+.+|+.+++.++|+|+ +++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCE-----eeeeeEEccCCeE
Confidence 5799999999999999999998 678899999986432 234678899999999998887 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
|+|||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9999999779999998653 469999999999999999999999999999999999999999999999999986432
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....+|..|+|||++.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~ 173 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLM 173 (288)
T ss_dssp -------CCCTTCCHHHHT
T ss_pred cccccccccccccCchhee
Confidence 2335788999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=235.47 Aligned_cols=162 Identities=25% Similarity=0.431 Sum_probs=129.6
Q ss_pred CCeEEE---eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRIL---SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++. +.||+|+||.||+|.+..+++.||+|++.+. ......+|+.+++.+. |+|+ +++++++.+...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~ni-----v~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNI-----VKLHEVFHDQLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCe-----eEEEEEEEcCCE
Confidence 567775 7899999999999999999999999999753 3456778999999997 7777 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l~Dfg~a~~ 243 (264)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999 889999998865 799999999999999999999999999999999999998766 899999999975
Q ss_pred CCC------CcccceeeeeceeEee
Q 024661 244 RHA------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~------~~~~~~~y~ape~~~~ 262 (264)
... ...+|..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp CCC----------------------
T ss_pred cCCCCCcccccCCCcCccCHHHhcC
Confidence 332 3357889999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=241.30 Aligned_cols=171 Identities=18% Similarity=0.237 Sum_probs=138.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCC-----CcEEEEEEEechhhhHHHHHHHHHHHHHHhc----------cCCCC
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSINKYREAAMIEIDVLQRLAR----------HDIGG 152 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~----------~~~~~ 152 (264)
+...++|++.+.||+|+||.||+|.+..+ ++.||+|++.... ..+.+|+++++.+.+ ..+.|
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKY 107 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence 35556899999999999999999998765 5789999987543 234455555555543 34455
Q ss_pred cceEEEceeeeeC----CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 153 TRCVQIRNWFDYR----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 153 ~~~~~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
++++++++++... ...|+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence 6669999998774 5689999999999999998753 4799999999999999999999999999999999999999
Q ss_pred --cCCcEEeccCCCCCcCCC-------------CcccceeeeeceeEee
Q 024661 229 --SAEYVKVPDYKVPSPRHA-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 229 --~~~~v~l~Dfg~a~~~~~-------------~~~~~~~y~ape~~~~ 262 (264)
.++.+||+|||+++.... ...+|..|||||++.+
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 235 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG 235 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence 889999999999964321 2238889999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=239.79 Aligned_cols=163 Identities=23% Similarity=0.391 Sum_probs=141.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++.+... ...+|++++.++ .|+|+ +++++++.+.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNI-----ITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTB-----CCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCc-----CeEEEEEEcCCE
Confidence 456789999999999999999999999999999999976443 234688888888 57777 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC----CcEEeccCCCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA----EYVKVPDYKVPS 242 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~----~~v~l~Dfg~a~ 242 (264)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999 899999998765 79999999999999999999999999999999999998543 359999999997
Q ss_pred cCCC------CcccceeeeeceeEe
Q 024661 243 PRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~------~~~~~~~y~ape~~~ 261 (264)
.... ..++|..|||||++.
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHH
T ss_pred cCcCCCCceeccCCCccccCHHHhc
Confidence 5322 335788999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=234.21 Aligned_cols=167 Identities=23% Similarity=0.398 Sum_probs=144.1
Q ss_pred CccCCCeEEE-eecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~ 164 (264)
..+.++|++. +.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++++ .|+|+ +++++++.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i-----~~~~~~~~~ 82 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV-----LELIEFFEE 82 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCe-----eeEEEEEee
Confidence 3566889995 78999999999999999999999999997543 3456788999999985 57776 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc---EEeccCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKV 240 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~---v~l~Dfg~ 240 (264)
.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999 899999998765 7999999999999999999999999999999999999998775 99999999
Q ss_pred CCcCCC-------------CcccceeeeeceeEe
Q 024661 241 PSPRHA-------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~-------------~~~~~~~y~ape~~~ 261 (264)
+..... ...+|..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHH
T ss_pred ccccccCCccccccccccccccCCcCccChHHhh
Confidence 875321 224788999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.13 Aligned_cols=164 Identities=27% Similarity=0.443 Sum_probs=141.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL-----VNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCc-----cchhheeecCCe
Confidence 36799999999999999999999999999999988643 2345677889999999999887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC-
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH- 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~- 245 (264)
.++||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999 777888777654 69999999999999999999999999999999999999999999999999997543
Q ss_pred -----CCcccceeeeeceeEe
Q 024661 246 -----AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 -----~~~~~~~~y~ape~~~ 261 (264)
....+|..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~ 175 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLV 175 (311)
T ss_dssp -----------GGGCCHHHHH
T ss_pred cccccCCCcCCccccChHHHh
Confidence 2335788899999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=230.13 Aligned_cols=167 Identities=22% Similarity=0.342 Sum_probs=148.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 76 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQE 76 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCc-----CeEEEEEEc
Confidence 457789999999999999999999999999999999997533 345677899999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc---EEeccCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKV 240 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~---v~l~Dfg~ 240 (264)
.+..|+||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 99999999999 889999988765 7999999999999999999999999999999999999987655 99999999
Q ss_pred CCcCCC-----CcccceeeeeceeEe
Q 024661 241 PSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+..... ...++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLK 180 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHT
T ss_pred eEEcccCccccCCCCCcCCcCchhhc
Confidence 965432 235788999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=235.79 Aligned_cols=166 Identities=25% Similarity=0.345 Sum_probs=142.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.+++.+.|++ ++++++++++.+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~---~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS---DKIIRLYDYEITD 81 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTC---TTBCCEEEEEECS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcC---CceEEEeeeEeeC
Confidence 44577999999999999999999984 5888999998743 334567889999999998721 3449999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
+.+|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999999977999999999865 799999999999999999999999999999999999997 6889999999997643
Q ss_pred C--------CcccceeeeeceeEe
Q 024661 246 A--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--------~~~~~~~y~ape~~~ 261 (264)
. ...+|..|+|||++.
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~ 182 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIK 182 (343)
T ss_dssp -----------CCCCSSCCHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHh
Confidence 2 335899999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=233.74 Aligned_cols=169 Identities=20% Similarity=0.240 Sum_probs=151.5
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+...++|++.+.||+|+||.||+|.+..++..||+|++.......+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCC
Confidence 345578999999999999999999999999999999998777777889999999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+|||++ +++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999 89999999986656799999999999999999999999999999999999999999999999999976543
Q ss_pred Cc-------ccceeeeeceeEe
Q 024661 247 FS-------FQTFLSMASRVYI 261 (264)
Q Consensus 247 ~~-------~~~~~y~ape~~~ 261 (264)
.. .++..|+|||++.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~ 185 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLA 185 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHH
T ss_pred CccccccCCccccCcCChhhhc
Confidence 22 2455699999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=232.70 Aligned_cols=169 Identities=24% Similarity=0.291 Sum_probs=146.0
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
++.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+ .|+++ +.+++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGI-----PNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTC-----CCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCC-----CeEEeecCCC
Confidence 4567789999999999999999999999999999999987432 334678899999999 56666 8888999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc-----EEeccCCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY-----VKVPDYKV 240 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~-----v~l~Dfg~ 240 (264)
...|+|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999999999998754 35999999999999999999999999999999999999987776 99999999
Q ss_pred CCcCCC-------------CcccceeeeeceeEee
Q 024661 241 PSPRHA-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~-------------~~~~~~~y~ape~~~~ 262 (264)
+..... ...+|..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcC
Confidence 975322 2347889999998643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=230.03 Aligned_cols=163 Identities=25% Similarity=0.338 Sum_probs=144.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++|+|+ +++++++.+.+..|+|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCceEEE
Confidence 67999999999999999999986 46779999998766666789999999999998887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999 889999997654 4689999999999999999999999999999999999999999999999999975432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFS 180 (269)
T ss_dssp STTSTTCCGGGCCHHHHH
T ss_pred cccCcccccccCCHHHhc
Confidence 234566799999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=236.62 Aligned_cols=167 Identities=24% Similarity=0.462 Sum_probs=148.7
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-------hHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.+.|+|+ +++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 82 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV-----ITLHD 82 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCc-----ceEEE
Confidence 4556789999999999999999999999999999999875321 35678999999999999887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC----cEEe
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE----YVKV 235 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l 235 (264)
++.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++ .++|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEE
Confidence 999999999999999 899999998754 799999999999999999999999999999999999999888 8999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+|||++..... ...+|..|+|||++.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred ccCccceecCccccccccCCCCCccCccccc
Confidence 99999975432 335788999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=241.47 Aligned_cols=166 Identities=24% Similarity=0.410 Sum_probs=146.8
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh---------hHHHHHHHHHHHHHHhccCCCCcceEEEc
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 159 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ..+.+.+|+.+++.++|+|+ ++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-----v~~~ 95 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI-----IKVL 95 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB-----CCEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE-----eeEE
Confidence 455789999999999999999999999999999999975431 23456779999999998887 9999
Q ss_pred eeeeeCCEEEEEEecC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 160 NWFDYRNHICIVFEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
+++.+.+.+++|||++ ++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999999999 55 9999998765 799999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCC-----CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
||++..... ...+|..|+|||++.
T Consensus 174 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 202 (335)
T 3dls_A 174 FGSAAYLERGKLFYTFCGTIEYCAPEVLM 202 (335)
T ss_dssp CTTCEECCTTCCBCEECSCGGGCCHHHHT
T ss_pred cccceECCCCCceeccCCCccccChhhhc
Confidence 999976443 224788999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=248.77 Aligned_cols=167 Identities=26% Similarity=0.450 Sum_probs=148.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.+.|+|+ +++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCc-----CeEEEEEEcC
Confidence 56688999999999999999999999999999999997432 345678899999999999888 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee---cCCcEEeccCCCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV---SAEYVKVPDYKVP 241 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~---~~~~v~l~Dfg~a 241 (264)
..+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999 899999998765 799999999999999999999999999999999999995 4568999999999
Q ss_pred CcCCC-----CcccceeeeeceeEee
Q 024661 242 SPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 242 ~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
..... ...+|..|+|||++.+
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGS
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCC
Confidence 75432 3358999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=233.81 Aligned_cols=168 Identities=23% Similarity=0.335 Sum_probs=142.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEE----eCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
+...++|++.+.||+|+||.||+|+ +..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVC 80 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEE
Confidence 4456789999999999999999998 5668899999998753 3445678899999999998887 9999988
Q ss_pred ee--CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 163 DY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 163 ~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.. ...+++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 55 45689999999 899999998754 359999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---------CcccceeeeeceeEe
Q 024661 240 VPSPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~---------~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|+|||++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 9976432 223566799999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=235.52 Aligned_cols=168 Identities=23% Similarity=0.263 Sum_probs=139.2
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
+...++|++.+.||+|+||.||+|.+ ++..||+|++... ....+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~ 105 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI-----VLFMGAVTQ 105 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEE
Confidence 34557899999999999999999987 4788999998743 2345678899999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEeccCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
.+.+|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999 8899999986431 13899999999999999999999999 99999999999999999999999999
Q ss_pred CCcCCC------CcccceeeeeceeEee
Q 024661 241 PSPRHA------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~------~~~~~~~y~ape~~~~ 262 (264)
+..... ...+|..|+|||++.+
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp ----------------CCTTSCHHHHTT
T ss_pred CccccccccccccCCCCccccChhhhcC
Confidence 975332 3457889999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=239.52 Aligned_cols=173 Identities=24% Similarity=0.353 Sum_probs=142.5
Q ss_pred ceEEeeCC---ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcc
Q 024661 81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR 154 (264)
Q Consensus 81 ~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~ 154 (264)
.+.+..++ .+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni---- 86 (371)
T 2xrw_A 11 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI---- 86 (371)
T ss_dssp EEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTB----
T ss_pred ceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCc----
Confidence 34455554 3557899999999999999999999999999999999753 3445678899999999999888
Q ss_pred eEEEceeeeeCC------EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 155 CVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 155 ~~~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
+++++++...+ .+|+||||+.++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 87 -v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 87 -IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp -CCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred -cceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 99999887654 8899999998899998863 589999999999999999999999999999999999999
Q ss_pred cCCcEEeccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 229 SAEYVKVPDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
.++.+||+|||++..... ...+|..|+|||++.+
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp TTSCEEECCCCC----------------CTTCCHHHHTT
T ss_pred CCCCEEEEEeecccccccccccCCceecCCccCHHHhcC
Confidence 999999999999976443 2357889999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=234.66 Aligned_cols=169 Identities=22% Similarity=0.352 Sum_probs=146.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee--
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~-- 164 (264)
....++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.+ .|+|+ +++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~ 94 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKN 94 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTB-----CCEEEEEEECC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCe-----eeeeeEEeecc
Confidence 3566889999999999999999999999999999999986666667889999999999 67777 999999877
Q ss_pred ----CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 56899999999 7899999987644579999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC------CcccceeeeeceeEe
Q 024661 240 VPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|+|||++.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC
T ss_pred CceecCcCccccccccCCccccChhhhc
Confidence 9876432 235788999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=251.91 Aligned_cols=169 Identities=25% Similarity=0.446 Sum_probs=150.1
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
....+.++|++.+.||+|+||.||+|.+..+++.||+|++.+. ....+.+.+|+.+++.+.|+|+ ++++++
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~ 94 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI-----MKLYEF 94 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTB-----CCEEEE
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCC-----CcEEEE
Confidence 3456778899999999999999999999999999999998743 3346788999999999998887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe---ecCCcEEecc
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPD 237 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili---~~~~~v~l~D 237 (264)
+.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999 999999998765 79999999999999999999999999999999999999 4678999999
Q ss_pred CCCCCcCCCC-----cccceeeeeceeEe
Q 024661 238 YKVPSPRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~~-----~~~~~~y~ape~~~ 261 (264)
||++...... ..+|..|+|||++.
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 201 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLH 201 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHH
T ss_pred eeeeEEcccccccccCCCCccccCceeec
Confidence 9998754432 35899999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=250.77 Aligned_cols=167 Identities=19% Similarity=0.234 Sum_probs=149.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..++|++.+.||+|+||.||+|.+..++..||+|+++......+.+.+|+.+++.++|+|+ +++++++.+.+.+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCE-----eeEEEEEecCCcEE
Confidence 3467999999999999999999999999999999998766667889999999999999888 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC-
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF- 247 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~- 247 (264)
+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999 899999998765557999999999999999999999999999999999999999999999999999764332
Q ss_pred ------cccceeeeeceeEe
Q 024661 248 ------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ------~~~~~~y~ape~~~ 261 (264)
..++..|+|||++.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~ 392 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLA 392 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHH
T ss_pred eeecCCCcCCcceeCHhHHh
Confidence 22456799999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=240.75 Aligned_cols=167 Identities=26% Similarity=0.483 Sum_probs=140.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...++|++.++||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.+++.++|+|+ +++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI-----IELKSVIHHN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTB-----CCEEEEEEET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCc-----ceEEEEEecC
Confidence 44478999999999999999999999999999999987432 234566789999999998887 9999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee-----cCCcEEeccCCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-----SAEYVKVPDYKV 240 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~-----~~~~v~l~Dfg~ 240 (264)
+.+|+||||+.++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999999889999998876 699999999999999999999999999999999999995 445699999999
Q ss_pred CCcCC------CCcccceeeeeceeEee
Q 024661 241 PSPRH------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~------~~~~~~~~y~ape~~~~ 262 (264)
+.... ....+|..|+|||++.+
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTT
T ss_pred ccccCCcccccCCCcCCccccCHHHhcC
Confidence 86532 23356888999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=238.78 Aligned_cols=166 Identities=23% Similarity=0.398 Sum_probs=143.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|+ +++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCc-----ccHhheeecccc
Confidence 368999999999999999999999999999999886432 334567889999999999888 889888877
Q ss_pred -----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.+.+|+||||+.++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 45789999999889998887653 469999999999999999999999999999999999999999999999999
Q ss_pred CCCcCC----------CCcccceeeeeceeEee
Q 024661 240 VPSPRH----------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~----------~~~~~~~~y~ape~~~~ 262 (264)
++.... ....+|..|+|||++.+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred hcccccccccccccccCCcccccCccCchhhcC
Confidence 986432 22356888999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=227.51 Aligned_cols=165 Identities=18% Similarity=0.324 Sum_probs=134.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh----hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI-----LELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTB-----CCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCe-----EeEEEEEccCCe
Confidence 569999999999999999999999999999999975432 24678899999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999 889999998653 4689999999999999999999999999999999999999999999999999976432
Q ss_pred ------CcccceeeeeceeEee
Q 024661 247 ------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~~ 262 (264)
...++..|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp ----------------------
T ss_pred CCCcceeccCCCCcCCcchhcC
Confidence 2357889999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=238.15 Aligned_cols=168 Identities=18% Similarity=0.264 Sum_probs=144.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCC-------CcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQI 158 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~ 158 (264)
...++|.+.+.||+|+||.||+|.+..+ +..||+|+++.. ......+.+|+++++.+ +|+|+ +++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~ 140 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INL 140 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchh-----hhh
Confidence 4457899999999999999999997543 357999998753 34457788999999999 88887 999
Q ss_pred ceeeeeCCEEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024661 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (264)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 223 (264)
++++.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 99999999999999999 8899999987541 35899999999999999999999999999999999
Q ss_pred CEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 224 NILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 224 Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|||++.++.+||+|||++..... ...+|..|+|||++.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 266 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 266 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc
Confidence 99999999999999999975432 224567899999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=228.86 Aligned_cols=169 Identities=25% Similarity=0.350 Sum_probs=150.0
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
......++|.+.+.||+|+||.||+|.+..+++.+|+|++... ....+.+.+|+.+++.+.|+|+ ++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~ 83 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGF 83 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEE
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeeeee
Confidence 3446668899999999999999999999999999999998753 2455778889999999988887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
+.+.+..|+||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+|+||||+|||++.++.++|+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 84 FEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence 99999999999999 899999998765 799999999999999999999999999999999999999999999999999
Q ss_pred CCcCC------CCcccceeeeeceeEe
Q 024661 241 PSPRH------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~------~~~~~~~~y~ape~~~ 261 (264)
+.... ....++..|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLS 188 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHT
T ss_pred ceecccCccccccccCCCCcCCcchhc
Confidence 97543 2235788899999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=228.83 Aligned_cols=170 Identities=23% Similarity=0.307 Sum_probs=146.6
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~ 162 (264)
...+.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+..+..+ .|+|+ +++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~i-----v~~~~~~ 80 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV-----VRYFSAW 80 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTB-----CCEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeee
Confidence 345667899999999999999999999999999999998743 34456778899999988 78877 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---------
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA--------- 230 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~--------- 230 (264)
.+.+..|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 9999999999999 889999998642 1368999999999999999999999999999999999999844
Q ss_pred ----------CcEEeccCCCCCcCCC--CcccceeeeeceeEe
Q 024661 231 ----------EYVKVPDYKVPSPRHA--FSFQTFLSMASRVYI 261 (264)
Q Consensus 231 ----------~~v~l~Dfg~a~~~~~--~~~~~~~y~ape~~~ 261 (264)
..++|+|||++..... ...+|..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~ 203 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 203 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHT
T ss_pred cccccccCCceEEEEcccccccccCCccccCCCccccChhHhc
Confidence 4899999999976543 335889999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=240.04 Aligned_cols=165 Identities=25% Similarity=0.399 Sum_probs=140.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhh--HHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++.++|+|+ +++++++.+.+..|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTB-----CCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCC-----CeeeeEEeeCCEEE
Confidence 5799999999999999999999999999999998743321 1234579999999988887 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 999999889999998754 4699999999999999999999999999999999999999999999999999865332
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...+|..|+|||++.+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp -------CGGGCCHHHHTT
T ss_pred ccccccCcccccChhhhcC
Confidence 2356888999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=238.73 Aligned_cols=166 Identities=23% Similarity=0.335 Sum_probs=142.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
...+|++.+.||+|+||.||+|.+.. ++.||||++... ....+.+.+|+.+++.+.|+ +++++++++++...+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~---~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITDQ 129 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT---CTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccC---CCeEEEEEEEEecCC
Confidence 34569999999999999999999865 889999999743 34457789999999999862 134499999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.+|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 999999966999999998865 789999999999999999999999999999999999995 68999999999976432
Q ss_pred --------CcccceeeeeceeEee
Q 024661 247 --------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~~ 262 (264)
...+|..|||||++.+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhh
Confidence 3358999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=233.89 Aligned_cols=161 Identities=22% Similarity=0.321 Sum_probs=143.7
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
.|...+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++...+..|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV-----VEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEEE
Confidence 3888899999999999999999999999999997533 345678899999999998887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999 89999998753 599999999999999999999999999999999999999999999999999865332
Q ss_pred --CcccceeeeeceeEe
Q 024661 247 --FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 --~~~~~~~y~ape~~~ 261 (264)
...+|..|+|||++.
T Consensus 198 ~~~~~gt~~y~aPE~~~ 214 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVIS 214 (321)
T ss_dssp BCCCCSCGGGCCHHHHT
T ss_pred cccccCCccccCHhhhc
Confidence 335888999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=237.35 Aligned_cols=164 Identities=27% Similarity=0.463 Sum_probs=144.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 165 (264)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~ 99 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGINDIIRAPTI 99 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCEEECCSST
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC-----ccceeEEecCCc
Confidence 347899999999999999999999999999999998743 3445778899999999999888 8888888654
Q ss_pred ---CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 166 ---NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 166 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
...|+|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 479999999988999999874 59999999999999999999999999999999999999999999999999997
Q ss_pred cCCC---------CcccceeeeeceeEe
Q 024661 243 PRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~---------~~~~~~~y~ape~~~ 261 (264)
.... ...+|..|+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIML 204 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhc
Confidence 5432 236788999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=230.56 Aligned_cols=165 Identities=21% Similarity=0.275 Sum_probs=142.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
..++|++.+.||+|+||.||+|.+. ++..||+|+++......+.+.+|+++++.++|+|+ +++++++.+.+..|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCE-----eeEEEEEecCCCeE
Confidence 3467999999999999999999876 56789999998766666788999999999998887 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999 899999998643 3699999999999999999999999999999999999999999999999999975432
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~ 194 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLM 194 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHH
T ss_pred cccccCCccCcccCCHHHhc
Confidence 233566799999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=236.74 Aligned_cols=161 Identities=22% Similarity=0.227 Sum_probs=141.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC----CE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----NH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~----~~ 167 (264)
++|++.+.||+|+||.||+|++. ++.||+|++...........+|+.+++.++|+|+ +++++++.+. ..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI-----LQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCc-----hhhcceeccCCCCCce
Confidence 57999999999999999999876 7889999998766666667778888988888887 9999998874 35
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCCEEeecCCcEEec
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL----------RLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------~ivH~dikp~Nili~~~~~v~l~ 236 (264)
+|+||||+ +++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 89999999 88999999875 499999999999999999999999 99999999999999999999999
Q ss_pred cCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 237 DYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 237 Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
|||++..... ...+|..|+|||++.+
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred cCCcccccccccCccccccCccCccccCHhhccc
Confidence 9999964221 2357899999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=230.32 Aligned_cols=169 Identities=26% Similarity=0.377 Sum_probs=145.5
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
-.+.++|.+.+.||+|+||.||+|.+..++..+|+|++.... ...+.+.+|+++++.++|+|+ +++++++.+.
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~ 92 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI-----IKIFEVFEDY 92 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECS
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchH-----HhHHHheecC
Confidence 356688999999999999999999999999999999987543 345778899999999998887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee---cCCcEEeccCC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV---SAEYVKVPDYK 239 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~---~~~~v~l~Dfg 239 (264)
...|+||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999 88999998643 124799999999999999999999999999999999999994 55789999999
Q ss_pred CCCcCCC-----CcccceeeeeceeEe
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|+|||++.
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~ 199 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFK 199 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHT
T ss_pred cceecCCcccCcCcccccCcCChHHhc
Confidence 9976332 335788999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=230.01 Aligned_cols=165 Identities=22% Similarity=0.336 Sum_probs=145.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+.|+|+ +++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCC-----cchhheEecC
Confidence 3467999999999999999999999999999999987532 234678889999999998887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999 889999998765 7999999999999999999999999999999999999999999999999988654
Q ss_pred CC----CcccceeeeeceeEe
Q 024661 245 HA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~----~~~~~~~y~ape~~~ 261 (264)
.. ...++..|+|||++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~ 180 (279)
T 3fdn_A 160 PSSRRTDLCGTLDYLPPEMIE 180 (279)
T ss_dssp --------CCCCTTCCHHHHT
T ss_pred CcccccccCCCCCccCHhHhc
Confidence 32 335788999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=231.66 Aligned_cols=169 Identities=20% Similarity=0.242 Sum_probs=147.5
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCC-------cEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEc
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 159 (264)
+...++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.++|+|+ ++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~ 78 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL-----VLNY 78 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTB-----CCEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCE-----eEEE
Confidence 344578999999999999999999998776 46999998753 3456788999999999998887 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc------
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY------ 232 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~------ 232 (264)
+++.+.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 79 GVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp EEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999 899999998754 34999999999999999999999999999999999999999887
Q ss_pred --EEeccCCCCCcCCCCc--ccceeeeeceeEee
Q 024661 233 --VKVPDYKVPSPRHAFS--FQTFLSMASRVYIC 262 (264)
Q Consensus 233 --v~l~Dfg~a~~~~~~~--~~~~~y~ape~~~~ 262 (264)
+||+|||++....... .++..|+|||++.+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191 (289)
T ss_dssp CEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHC
T ss_pred ceeeeccCcccccccCccccCCcCcccCHHHhCC
Confidence 9999999997654432 47788999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=228.07 Aligned_cols=166 Identities=21% Similarity=0.256 Sum_probs=145.5
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.+.||+|+||.||+|.+. ++..||+|+++......+.+.+|+.+++.+.|+|+ +++++++.+.+..
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL-----VKFYGVCSKEYPI 78 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCce
Confidence 34578999999999999999999876 56679999998766666788999999999998887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999 899999998753 35999999999999999999999999999999999999999999999999999754332
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
..++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~ 178 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFH 178 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHh
Confidence 23455699999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=232.01 Aligned_cols=166 Identities=25% Similarity=0.389 Sum_probs=143.5
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-----
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~----- 164 (264)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.+.|+|+ +++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV-----VRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHH-----HHHHHHHHhhcchh
Confidence 4567999999999999999999999999999999998766667888999999999998887 888877654
Q ss_pred --------CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEe
Q 024661 165 --------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 165 --------~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l 235 (264)
.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 56789999999 889999998653 46888999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcCCC--------------------CcccceeeeeceeEe
Q 024661 236 PDYKVPSPRHA--------------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~~--------------------~~~~~~~y~ape~~~ 261 (264)
+|||++..... ...++..|+|||++.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHT
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence 99999976431 234778899999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=227.21 Aligned_cols=166 Identities=25% Similarity=0.455 Sum_probs=147.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----------hhHHHHHHHHHHHHHHh-ccCCCCcceEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQ 157 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~-~~~~~~~~~~~ 157 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.+++.+. |+|+ ++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----ee
Confidence 55688999999999999999999999999999999987431 33567789999999996 8877 99
Q ss_pred EceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
+++++.+.+..|+|||++ +++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999 889999998765 79999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
|||++..... ...++..|+|||++.
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred cccchhhcCCCcccccccCCccccCHHHhc
Confidence 9999875432 235788999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=238.67 Aligned_cols=166 Identities=29% Similarity=0.453 Sum_probs=138.5
Q ss_pred cCCCeEE--EeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
..+.|.+ .+.||+|+||.||+|.+..+|+.||+|+++... ...+.+.+|+.+++.++|+|+ +++++++.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~ 159 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL-----IQLYDAFESKN 159 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSS
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECC
Confidence 3344555 678999999999999999999999999998543 456778899999999998887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee--cCCcEEeccCCCCCc
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV--SAEYVKVPDYKVPSP 243 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~--~~~~v~l~Dfg~a~~ 243 (264)
.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 999999999 899999887543 3689999999999999999999999999999999999994 567899999999976
Q ss_pred CCC-----CcccceeeeeceeEe
Q 024661 244 RHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~ 261 (264)
... ...+|..|+|||++.
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~ 261 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVN 261 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHT
T ss_pred cCCccccccccCCCcEeChhhcc
Confidence 432 335889999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=228.46 Aligned_cols=166 Identities=21% Similarity=0.355 Sum_probs=148.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+.++|++.+.||+|+||.||+|.+..++..+|+|.+... ....+.+.+|+++++.++|+|+ +++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI-----IRLYETFEDNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCe
Confidence 4557899999999999999999999999999999998754 2445778899999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe---ecCCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili---~~~~~v~l~Dfg~a~~ 243 (264)
.|+||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+|+||||+|||+ +.++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999 889999998765 69999999999999999999999999999999999999 7889999999999965
Q ss_pred CCC-----CcccceeeeeceeEe
Q 024661 244 RHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-----~~~~~~~y~ape~~~ 261 (264)
... ...+|..|+|||++.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~ 181 (277)
T 3f3z_A 159 FKPGKMMRTKVGTPYYVSPQVLE 181 (277)
T ss_dssp CCTTSCBCCCCSCTTTCCHHHHT
T ss_pred ccCccchhccCCCCCccChHHhc
Confidence 332 335788999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=248.89 Aligned_cols=167 Identities=27% Similarity=0.454 Sum_probs=143.7
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..+.++|++++.||+|+||.||+|.+..++..+|+|++.+.. .....+.+|+.+++.+.|+|+ +++++++.+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~ 107 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI-----MKLYDFFED 107 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEe
Confidence 345678999999999999999999999999999999997532 335678899999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---CcEEeccCCC
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---EYVKVPDYKV 240 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---~~v~l~Dfg~ 240 (264)
...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 99999999999 899999998765 79999999999999999999999999999999999999764 4599999999
Q ss_pred CCcCCC-----CcccceeeeeceeEe
Q 024661 241 PSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+..... ...+|..|+|||++.
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~ 211 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLR 211 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHT
T ss_pred CeECCCCccccccCCCcCeeCHHHHc
Confidence 975432 345899999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=238.40 Aligned_cols=170 Identities=23% Similarity=0.332 Sum_probs=149.7
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.++...++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++++++.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 101 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFY 101 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCE-----EEEeEEEE
Confidence 4556678899999999999999999999999999999998753 4456778899999999988877 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
+.+..|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999999 889999998765 799999999999999999999985 9999999999999999999999999998
Q ss_pred CcC----CCCcccceeeeeceeEee
Q 024661 242 SPR----HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 242 ~~~----~~~~~~~~~y~ape~~~~ 262 (264)
... .....+|..|+|||++.+
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 180 GQLIDSMANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp HHHHHHC----CCCCTTCCHHHHTT
T ss_pred cccccccccCCCCCCCeECHHHHcC
Confidence 642 234468899999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-33 Score=229.70 Aligned_cols=167 Identities=22% Similarity=0.359 Sum_probs=146.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI-----VTLEDIYESTTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCe-----eehhhhcccCCE
Confidence 45678999999999999999999999999999999997543 234568899999999998887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe---ecCCcEEeccCCCCCc
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKVPSP 243 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili---~~~~~v~l~Dfg~a~~ 243 (264)
.|+||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999 899999998765 79999999999999999999999999999999999999 7788999999999976
Q ss_pred CCCC----cccceeeeeceeEee
Q 024661 244 RHAF----SFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~~----~~~~~~y~ape~~~~ 262 (264)
.... ..++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 159 EQNGIMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp CCCBTTHHHHSCCCBCCTTTBSS
T ss_pred cCCCccccccCCCCccChHHhcc
Confidence 5432 247889999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.10 Aligned_cols=166 Identities=24% Similarity=0.412 Sum_probs=147.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHH-hccCCCCcceEEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRL-ARHDIGGTRCVQI 158 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~ 158 (264)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.+++.+ .|+|+ +.+
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~ 165 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI-----ITL 165 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CCE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----eEE
Confidence 44578999999999999999999999999999999987432 2346778899999999 68877 999
Q ss_pred ceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
++++......|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999 889999998765 799999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCC-----CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
||++..... ...+|..|+|||++.
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILK 272 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred cCcccccCCCcccccCCCCCCccChhhcc
Confidence 999875432 345889999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=242.47 Aligned_cols=170 Identities=20% Similarity=0.291 Sum_probs=146.7
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+|+ +++++++.+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~ 78 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEE 78 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCC-----CeEEEeecc
Confidence 3456788999999999999999999999999999999997533 335677899999999999887 999999887
Q ss_pred CC--EEEEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe----ecCCcEEec
Q 024661 165 RN--HICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL----VSAEYVKVP 236 (264)
Q Consensus 165 ~~--~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili----~~~~~v~l~ 236 (264)
.+ ..|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 54 789999999 899999998643 2249999999999999999999999999999999999999 667789999
Q ss_pred cCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
|||++..... ...+|..|+|||++.
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhh
Confidence 9999976433 335888999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=231.88 Aligned_cols=167 Identities=25% Similarity=0.255 Sum_probs=132.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceee-----
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF----- 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~----- 162 (264)
...+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+. |+|+ +++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----v~~~~~~~~~~~ 100 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI-----VQFCSAASIGKE 100 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTB-----CCEEEEEEECTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCCh-----hhcccccccccc
Confidence 345799999999999999999999999999999988643 344567889999999996 8887 8888888
Q ss_pred ---eeCCEEEEEEecCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEec
Q 024661 163 ---DYRNHICIVFEKLGPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 163 ---~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l~ 236 (264)
.....+++||||++|+|.+++... ....+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 345678999999999999998752 2246999999999999999999999999 9999999999999999999999
Q ss_pred cCCCCCcCCC------------------CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA------------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~------------------~~~~~~~y~ape~~~ 261 (264)
|||++..... ...+|..|+|||++.
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 9999976543 234788899999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.11 Aligned_cols=169 Identities=19% Similarity=0.283 Sum_probs=142.5
Q ss_pred CccCCCeEEEeecccCccEEEEEEEe-----CCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+...++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ......+.+|+.+++.++|+|+ +++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~ 141 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIG 141 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCC-----CeEEE
Confidence 34457899999999999999999994 456788999998642 3445678889999999999888 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE--- 231 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~--- 231 (264)
++.+....|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 999999999999999 889999998653 13589999999999999999999999999999999999999555
Q ss_pred cEEeccCCCCCcC--------CCCcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPR--------HAFSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~--------~~~~~~~~~y~ape~~~ 261 (264)
.+||+|||+++.. .....+|..|||||++.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 259 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhc
Confidence 5999999998632 22334678899999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-33 Score=226.42 Aligned_cols=168 Identities=25% Similarity=0.322 Sum_probs=143.3
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~ 80 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI-----IKLYQVI 80 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCE-----eEEEEEE
Confidence 3455578999999999999999999999999999999997532 234678899999999988887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
.+.+..|+|||++ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccc
Confidence 9999999999999 889999998765 6899999999999999999999999999999999999999999999999998
Q ss_pred CcCCC-----CcccceeeeeceeEe
Q 024661 242 SPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~-----~~~~~~~y~ape~~~ 261 (264)
..... ...++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVIS 183 (276)
T ss_dssp GCCCC-------------CCTGGGT
T ss_pred cccCCCcceecccCCccccCHHHHc
Confidence 76543 335788899999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=229.54 Aligned_cols=167 Identities=22% Similarity=0.328 Sum_probs=142.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEE----eCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
....+|++.+.||+|+||.||+|. +..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~ 92 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGIC 92 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCe-----eeeeeEE
Confidence 344669999999999999999999 56789999999987432 344678899999999998887 9999998
Q ss_pred eeC--CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 163 DYR--NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 163 ~~~--~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.+. ..+++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+|+||||+|||++.++.++|+|||
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 876 6799999999 889999996654 369999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---------CcccceeeeeceeEe
Q 024661 240 VPSPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~---------~~~~~~~y~ape~~~ 261 (264)
++..... ...+|..|+|||++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeec
Confidence 9975432 234666799999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=238.67 Aligned_cols=163 Identities=23% Similarity=0.340 Sum_probs=143.1
Q ss_pred CCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEech-----hhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~ 162 (264)
++|++.+.||+|+||.||+|++. .+++.||+|++++. ....+.+.+|+++++.+. |+++ +.+++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~ 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCce-----eEEEEEE
Confidence 67999999999999999999984 47899999998642 233456677999999995 6766 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999 899999998765 7999999999999999999999999999999999999999999999999998
Q ss_pred CcCCC-------CcccceeeeeceeEe
Q 024661 242 SPRHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~-------~~~~~~~y~ape~~~ 261 (264)
+.... ...+|..|+|||++.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 233 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVR 233 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred eecccCCCCcccCcccCcCccChhhhc
Confidence 75321 235889999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=232.95 Aligned_cols=166 Identities=25% Similarity=0.396 Sum_probs=142.3
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL-----VNLLEVCKKK 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEET
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCE-----eeEEEEeecC
Confidence 3447899999999999999999999999999999998643 2345667889999999998887 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999 666666655544 6999999999999999999999999999999999999999999999999999753
Q ss_pred C------CCcccceeeeeceeEe
Q 024661 245 H------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~------~~~~~~~~y~ape~~~ 261 (264)
. ....++..|+|||++.
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~ 197 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLV 197 (331)
T ss_dssp ---------CCCCCTTCCHHHHT
T ss_pred cCCccccCCCcCCccccCccccc
Confidence 2 2345788899999764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=230.64 Aligned_cols=164 Identities=23% Similarity=0.364 Sum_probs=141.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++.+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV-----VPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCe-----eEEEEEEeeCC
Confidence 367999999999999999999999999999999987432 334678899999999988887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..|+|||++ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999 789999998765 79999999999999999999999999999999999999999999999999987643
Q ss_pred C-------CcccceeeeeceeEe
Q 024661 246 A-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~-------~~~~~~~y~ape~~~ 261 (264)
. ...++..|+|||++.
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp -----------CCGGGCCGGGTC
T ss_pred ccccccccccCCCcCccCHHHHc
Confidence 3 235788899999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=239.24 Aligned_cols=166 Identities=25% Similarity=0.425 Sum_probs=138.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee----
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~---- 164 (264)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+|+.+++.++|+|+ +++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnI-----v~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNI-----IKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTB-----CCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCc-----cchhheeeecCcc
Confidence 3457899999999999999999999999999999998754332 2369999999998887 899888843
Q ss_pred ----------------------------------CCEEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHH
Q 024661 165 ----------------------------------RNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVA 208 (264)
Q Consensus 165 ----------------------------------~~~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~ 208 (264)
..++++||||+.++|.+.+.. .....+++..++.++.||+.||.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 445899999998898888764 22347999999999999999999
Q ss_pred HHHHCCCeecCCCCCCEEee-cCCcEEeccCCCCCcCC-----CCcccceeeeeceeEee
Q 024661 209 FMHELRLIHTDLKPENILLV-SAEYVKVPDYKVPSPRH-----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 209 ~lH~~~ivH~dikp~Nili~-~~~~v~l~Dfg~a~~~~-----~~~~~~~~y~ape~~~~ 262 (264)
|||++||+||||||+|||++ .++.+||+|||+|.... ....+|..|+|||++.+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG 215 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC
Confidence 99999999999999999998 58899999999997532 23357888999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=227.37 Aligned_cols=164 Identities=23% Similarity=0.367 Sum_probs=146.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+|+ +++++++.+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI-----LRMYNYFHDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCE-----eeEEEEEEcCC
Confidence 367999999999999999999999999999999997532 234678899999999998887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999 889999998765 79999999999999999999999999999999999999999999999999986543
Q ss_pred C----CcccceeeeeceeEe
Q 024661 246 A----FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~----~~~~~~~y~ape~~~ 261 (264)
. ...++..|+|||++.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~ 185 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIE 185 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHT
T ss_pred ccccccccCCCCcCCHHHhc
Confidence 2 335788999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=236.57 Aligned_cols=168 Identities=21% Similarity=0.275 Sum_probs=141.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEE-----eCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEce
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~ 160 (264)
...++|++.+.||+|+||.||+|. +..+++.||+|+++.. ....+.+.+|+++++.+ .|+|+ +++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni-----v~~~~ 93 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLG 93 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce-----eeeee
Confidence 345789999999999999999999 5566789999999753 23456789999999999 56777 99999
Q ss_pred eeeeCC-EEEEEEecC-CCCHHHHHHhcCC--------------------------------------------------
Q 024661 161 WFDYRN-HICIVFEKL-GPSLYDFLRKNSY-------------------------------------------------- 188 (264)
Q Consensus 161 ~~~~~~-~~~lv~e~~-~~~L~~~l~~~~~-------------------------------------------------- 188 (264)
++.+.+ .+++||||+ +++|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 988754 599999999 8999999986531
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--------
Q 024661 189 --------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-------- 246 (264)
Q Consensus 189 --------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-------- 246 (264)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 1289999999999999999999999999999999999999999999999999975422
Q ss_pred CcccceeeeeceeEe
Q 024661 247 FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 254 ~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 254 DARLPLKWMAPETIF 268 (359)
T ss_dssp -CEECGGGCCHHHHH
T ss_pred ccCCCceeEChhhhc
Confidence 223566799999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=235.37 Aligned_cols=169 Identities=20% Similarity=0.303 Sum_probs=145.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+...++|++.+.||+|+||.||+|.+.. +++.||+|+++.. ....+.+.+|+.+++.++|+|+ +++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 117 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLG 117 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEE
Confidence 3455789999999999999999999873 4588999998753 3445778999999999998887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIH 217 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 217 (264)
++.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999 8899999987421 46899999999999999999999999999
Q ss_pred cCCCCCCEEeecCCcEEeccCCCCCcCC--------CCcccceeeeeceeEe
Q 024661 218 TDLKPENILLVSAEYVKVPDYKVPSPRH--------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 218 ~dikp~Nili~~~~~v~l~Dfg~a~~~~--------~~~~~~~~y~ape~~~ 261 (264)
|||||+|||++.++.+||+|||++.... ....++..|+|||++.
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 249 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 249 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence 9999999999999999999999986432 2234677899999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=229.33 Aligned_cols=167 Identities=26% Similarity=0.347 Sum_probs=145.1
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+++++.+.|+|+ +++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 77 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI-----VHYNGCWDGFD 77 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTB-----CCEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCE-----EEEeeeEeccc
Confidence 4466678999999999999999999999999999999997543 345679999999999888 888887754
Q ss_pred --------------CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 165 --------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 165 --------------~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 45689999999 789999998764457999999999999999999999999999999999999999
Q ss_pred CCcEEeccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 230 AEYVKVPDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
++.++|+|||++..... ...++..|+|||++.
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS 194 (284)
T ss_dssp TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH
T ss_pred CCCEEECcchhheeccccccccccCCcccccChhhhc
Confidence 99999999999876432 335788999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=237.76 Aligned_cols=166 Identities=25% Similarity=0.406 Sum_probs=140.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFG 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCC-----CeEEEEEe
Confidence 3478999999999999999999999999999999987422 113467789999999998887 99999999
Q ss_pred eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+.+..++||||+.++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eCCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999999999779999987653 4688999999999999999999999999999999999999999999999999976
Q ss_pred CCC------CcccceeeeeceeEe
Q 024661 244 RHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~------~~~~~~~y~ape~~~ 261 (264)
... ...+|..|+|||++.
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~ 185 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLF 185 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHT
T ss_pred ccCCcccCCcccccccccCchHhh
Confidence 432 335788999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=226.74 Aligned_cols=165 Identities=25% Similarity=0.478 Sum_probs=145.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-------hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
+.++|++.+.||+|+||.||+|.+..+++.+|+|+++... ...+.+.+|+.+++.+.|+|+ +++++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~ 77 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI-----ITLHDIF 77 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCe-----eehhhee
Confidence 3467999999999999999999999999999999987432 135778999999999998887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC----cEEecc
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE----YVKVPD 237 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l~D 237 (264)
.+.+..++|||++ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999 899999998765 799999999999999999999999999999999999999877 899999
Q ss_pred CCCCCcCCC-----CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
||++..... ...++..|+|||++.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (283)
T 3bhy_A 156 FGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184 (283)
T ss_dssp CTTCEECC--------CCCGGGCCHHHHT
T ss_pred cccceeccCCCcccccCCCcCccCcceec
Confidence 999976432 235788899999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=232.91 Aligned_cols=167 Identities=25% Similarity=0.340 Sum_probs=145.2
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.+++.++|+|+ +++++++..
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 80 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI-----ITIFNIQRP 80 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCc-----CCeeeeecc
Confidence 346778999999999999999999999999999999998642 3445677899999999999888 888887665
Q ss_pred C-----CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 165 R-----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 165 ~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
. ...|+|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp SCSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred cccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 3 789999999988999999874 59999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC----------------CcccceeeeeceeEe
Q 024661 240 VPSPRHA----------------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~----------------~~~~~~~y~ape~~~ 261 (264)
++..... ...+|..|+|||++.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeec
Confidence 9975431 124688899999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.91 Aligned_cols=165 Identities=19% Similarity=0.289 Sum_probs=144.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+++++.+.|+|+ +++++++.+.+.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTB-----CCEEEEECSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEecCCCc
Confidence 46799999999999999999999999999999998743 2334567889999999998887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999 899999998653 35899999999999999999999999999999999999999999999999999754321
Q ss_pred --------cccceeeeeceeEe
Q 024661 248 --------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 --------~~~~~~y~ape~~~ 261 (264)
..++..|+|||++.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~ 288 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALN 288 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhc
Confidence 12355699999753
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=230.66 Aligned_cols=165 Identities=28% Similarity=0.478 Sum_probs=144.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.+++.+.|+|+ +++++++.+.+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 77 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKL 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCe-----eeEEEEEecCCce
Confidence 57999999999999999999999999999999986432 233677889999999988887 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
|+|||++.++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 78 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 78 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEEEcccCCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 99999998899999987755579999999999999999999999999999999999999999999999999886432
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~ 176 (299)
T 2r3i_A 158 RTYTHEVVTLWYRAPEILL 176 (299)
T ss_dssp BCTTSCBCCCTTCCHHHHT
T ss_pred cccCcccccccccCcHHhh
Confidence 2335788899999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=242.33 Aligned_cols=166 Identities=30% Similarity=0.438 Sum_probs=138.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHHhccCCCCcceEEEc
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 159 (264)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+.+++.++|+|+ ++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB-----CCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE-----eeEE
Confidence 44578999999999999999999999999999999997532 112347789999999999888 8899
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC---cEEe
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE---YVKV 235 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~---~v~l 235 (264)
+++.. +..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence 98754 5689999999 899999887654 799999999999999999999999999999999999997544 5999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+|||++..... ...+|..|||||++.+
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC-
T ss_pred eecccceecCCCccccccCCCCCccCceeeec
Confidence 99999987543 3357889999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.80 Aligned_cols=168 Identities=21% Similarity=0.344 Sum_probs=135.9
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-------hHHHHHHHHHHHHHH----hccCCCCcce
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRL----ARHDIGGTRC 155 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l----~~~~~~~~~~ 155 (264)
.+.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ .|+|+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i----- 100 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV----- 100 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB-----
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe-----
Confidence 34667889999999999999999999999999999999875321 233455799999999 67776
Q ss_pred EEEceeeeeCCEEEEEEec-C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee-cCCc
Q 024661 156 VQIRNWFDYRNHICIVFEK-L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEY 232 (264)
Q Consensus 156 ~~~~~~~~~~~~~~lv~e~-~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~-~~~~ 232 (264)
+++++++.+.+..++|||+ + +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++ .++.
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 9999999999999999999 5 899999998765 699999999999999999999999999999999999999 7899
Q ss_pred EEeccCCCCCcCCC----CcccceeeeeceeEe
Q 024661 233 VKVPDYKVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 233 v~l~Dfg~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
++|+|||++..... ...++..|+|||++.
T Consensus 179 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp EEECCCSSCEECCSSCBCCCCSCTTTSCHHHHH
T ss_pred EEEEEcchhhhcccCcccccCCcccccCceeee
Confidence 99999999876443 234788899999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=230.98 Aligned_cols=164 Identities=20% Similarity=0.220 Sum_probs=137.1
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHH--HhccCCCCcceEEEceeeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~~~~~~~~~~~~~~~~~~~ 164 (264)
+..+.++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|.+++.. ++|+|+ +++++++.+
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni-----v~~~~~~~~ 73 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENI-----LGFIASDMT 73 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTB-----CCEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCe-----eeEEEeecc
Confidence 356778999999999999999999987 58889999987543 3455667777776 667776 888887544
Q ss_pred ----CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEeecCC
Q 024661 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~ivH~dikp~Nili~~~~ 231 (264)
...+|+||||+ +++|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||++.++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred ccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 45789999999 88999999653 6999999999999999999999 99999999999999999999
Q ss_pred cEEeccCCCCCcCC----------CCcccceeeeeceeEee
Q 024661 232 YVKVPDYKVPSPRH----------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~----------~~~~~~~~y~ape~~~~ 262 (264)
.+||+|||++.... ....+|..|+|||++.+
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence 99999999986422 12268899999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=229.91 Aligned_cols=168 Identities=23% Similarity=0.373 Sum_probs=143.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHhccCCCCcceEEEceee--
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-- 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-- 162 (264)
+.++|++.+.||+|+||.||+|.+..+++.+|+|+++... .....+.+|+.+++.++|+|+ +++++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 77 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV-----IQLVDVLYN 77 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCe-----eEEEEEEEc
Confidence 4578999999999999999999999999999999997542 345778899999999998887 9999988
Q ss_pred eeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
.+....|+||||+.++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 44568999999996669888887665679999999999999999999999999999999999999999999999999997
Q ss_pred cCCC--------CcccceeeeeceeEee
Q 024661 243 PRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~~--------~~~~~~~y~ape~~~~ 262 (264)
.... ...++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred ccCccccccccccCCCCCCCcChhhccC
Confidence 6432 2347888999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=228.84 Aligned_cols=167 Identities=26% Similarity=0.372 Sum_probs=138.6
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee---
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--- 162 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~--- 162 (264)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 80 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVFEILGPS 80 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECTT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCe-----eEEEEecccc
Confidence 456778999999999999999999999999999999998743 3455778899999999999887 8888776
Q ss_pred -----------eeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee-cC
Q 024661 163 -----------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SA 230 (264)
Q Consensus 163 -----------~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~-~~ 230 (264)
.+....|+||||+.++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 345789999999988999998753 589999999999999999999999999999999999998 56
Q ss_pred CcEEeccCCCCCcCCC---------CcccceeeeeceeEe
Q 024661 231 EYVKVPDYKVPSPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~---------~~~~~~~y~ape~~~ 261 (264)
+.+||+|||++..... ...++..|+|||++.
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhc
Confidence 7999999999976432 224577899999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=234.24 Aligned_cols=165 Identities=21% Similarity=0.346 Sum_probs=142.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 113 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV-----IGLLDVFTPA 113 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCc-----hhhhhheecc
Confidence 4668899999999999999999999999999999999753 3445778899999999999888 9999999876
Q ss_pred CEE------EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 NHI------CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ~~~------~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
+.. |+||||++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 654 99999998899888743 59999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---CcccceeeeeceeEee
Q 024661 240 VPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
++..... ...+|..|+|||++.+
T Consensus 190 ~a~~~~~~~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 190 LARHADAEMTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp CC--------CTTCCCTTSCHHHHSC
T ss_pred cccccccCcCCcccCccccCHHHhcC
Confidence 9976443 3357889999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=238.68 Aligned_cols=166 Identities=22% Similarity=0.358 Sum_probs=129.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEecC
Confidence 4457899999999999999999999999999999998642 3445678899999999999887 8898888653
Q ss_pred ------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..+|+|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CccccCCeEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 568999999999999988763 69999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---CcccceeeeeceeEee
Q 024661 240 VPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
+++.... ...+|..|+|||++.+
T Consensus 178 ~a~~~~~~~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 178 LARHTADEMTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp -------------CCCTTCCHHHHTT
T ss_pred ccccccccCCCcCcCcCccChHHHcC
Confidence 9976443 3357889999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=227.42 Aligned_cols=168 Identities=18% Similarity=0.180 Sum_probs=142.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec-hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee----
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD---- 163 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~---- 163 (264)
...++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+.+|+.+++.+.|+|+ +++++++.
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 100 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI-----LRLVAYCLRERG 100 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEEEET
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEEeccC
Confidence 345789999999999999999999999999999998864 34456778899999999988887 89988886
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
.....|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 345889999999 88999999863 234699999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCC---------------cccceeeeeceeEe
Q 024661 241 PSPRHAF---------------SFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~~---------------~~~~~~y~ape~~~ 261 (264)
+...... ..++..|+|||++.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhc
Confidence 8764321 12478899999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=236.56 Aligned_cols=168 Identities=24% Similarity=0.394 Sum_probs=143.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh------hhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++.+.. ...+.+.+|+.+++.++|+|+ +++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~ 97 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI-----ARLYEVY 97 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc-----ceeehhh
Confidence 45678999999999999999999999999999999987532 345778899999999998887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNS--------------------------------------YRSFPIDLVRELGRQL 203 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi 203 (264)
.+.+..|+||||+ +++|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999 999999985210 1124678899999999
Q ss_pred HHHHHHHHHCCCeecCCCCCCEEeecCC--cEEeccCCCCCcCC----------CCcccceeeeeceeEe
Q 024661 204 LESVAFMHELRLIHTDLKPENILLVSAE--YVKVPDYKVPSPRH----------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 204 ~~~l~~lH~~~ivH~dikp~Nili~~~~--~v~l~Dfg~a~~~~----------~~~~~~~~y~ape~~~ 261 (264)
+.||+|||++||+||||||+|||++.++ .+||+|||++.... ....+|..|+|||++.
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 9999999999999999999999998776 89999999997532 2335788899999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=227.61 Aligned_cols=169 Identities=25% Similarity=0.294 Sum_probs=138.7
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
....++|++.+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+.+++.++|+|+ +++++++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~ 102 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFI 102 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEE
Confidence 3445689999999999999999999999999999999874 23456778899999999988887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
..+..++|||++ +++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 999999999999 88999999742 234689999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC------CcccceeeeeceeEe
Q 024661 241 PSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~------~~~~~~~y~ape~~~ 261 (264)
+..... ...++..|+|||++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIH 209 (310)
T ss_dssp ----------------CCSSCCHHHHT
T ss_pred eeeecCCCccccccCCCeeEeChHHhC
Confidence 875432 234788899999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=235.83 Aligned_cols=177 Identities=23% Similarity=0.356 Sum_probs=151.7
Q ss_pred CceEEeeCCccCCCeEEE-eecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhc-cCCCCcc
Q 024661 80 GHYVFAIGENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTR 154 (264)
Q Consensus 80 ~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~-~~~~~~~ 154 (264)
....+...+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+.+ +++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i---- 91 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV---- 91 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB----
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE----
Confidence 344566677888999998 89999999999999999999999999987532 335678899999999865 555
Q ss_pred eEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---C
Q 024661 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---A 230 (264)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~ 230 (264)
+++++++.+.+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 92 -v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 92 -INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp -CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB
T ss_pred -EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC
Confidence 99999999999999999999 889999987654457999999999999999999999999999999999999997 7
Q ss_pred CcEEeccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 231 EYVKVPDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
+.+||+|||++..... ...+|..|+|||++.
T Consensus 171 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206 (327)
T ss_dssp CCEEECCGGGCEEC---------CCCGGGCCHHHHT
T ss_pred CcEEEeeCccccccCCccccccccCCcCccCCeeec
Confidence 8999999999976433 235888999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=226.72 Aligned_cols=164 Identities=23% Similarity=0.367 Sum_probs=145.9
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++.+.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCc-----eeeeeEEEcCCEE
Confidence 367999999999999999999999999999999987433 345778899999999988887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|+|||++ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999 789999887654 69999999999999999999999999999999999999999999999999986432
Q ss_pred ------CCcccceeeeeceeEe
Q 024661 246 ------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ------~~~~~~~~y~ape~~~ 261 (264)
....++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~ 180 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLK 180 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGT
T ss_pred cchhcccCCccccCccChHHHh
Confidence 2335788899999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=225.78 Aligned_cols=168 Identities=26% Similarity=0.316 Sum_probs=138.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+.|+++ +..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~----i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTT----CCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCC----CCeeeeecCCCCce
Confidence 45688999999999999999999999999999999876433 23457889999999999875 23444555778899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe---ecCCcEEeccCCCCCcCC
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili---~~~~~v~l~Dfg~a~~~~ 245 (264)
++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999999999998543 369999999999999999999999999999999999999 788999999999997532
Q ss_pred C-------------CcccceeeeeceeEee
Q 024661 246 A-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~-------------~~~~~~~y~ape~~~~ 262 (264)
. ...+|..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred CcccCccCCCCcccccCCCccccchHHhcC
Confidence 2 3357889999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=232.34 Aligned_cols=166 Identities=30% Similarity=0.438 Sum_probs=141.6
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHHhccCCCCcceEEE
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 158 (264)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.+.|+|+ +++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~ 80 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKI 80 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB-----CCE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC-----ceE
Confidence 345678999999999999999999999999999999986432 123457889999999999887 889
Q ss_pred ceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc---EE
Q 024661 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VK 234 (264)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~---v~ 234 (264)
++++..+. .|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEE
Confidence 99887665 89999999 889999987654 7999999999999999999999999999999999999987664 99
Q ss_pred eccCCCCCcCCCC-----cccceeeeeceeEe
Q 024661 235 VPDYKVPSPRHAF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 235 l~Dfg~a~~~~~~-----~~~~~~y~ape~~~ 261 (264)
|+|||++...... ..+|..|+|||++.
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHH
T ss_pred EccCccceecccccccccccCCcCccCchhhc
Confidence 9999999765443 24788999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=223.06 Aligned_cols=163 Identities=24% Similarity=0.320 Sum_probs=144.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+++++.++|+|+ +++++++.+.+..|+|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCeEEE
Confidence 67999999999999999999986 56789999998766666788999999999988887 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
||++ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999 889999998754 3689999999999999999999999999999999999999999999999999975432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFS 178 (267)
T ss_dssp STTSTTCCGGGCCHHHHH
T ss_pred ccccccccccccChhhhc
Confidence 234566799999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=235.70 Aligned_cols=164 Identities=13% Similarity=0.080 Sum_probs=128.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec----hhhhHHHHHHHHHHHHHHh--ccCCCCcceEEEc------
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLA--RHDIGGTRCVQIR------ 159 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~------ 159 (264)
..|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+.+|+.+++.+. |+|+ ++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~i-----v~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE-----ARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC---------------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhh-----hhhceeEEee
Confidence 349999999999999999999999999999999986 3345667788877777776 6665 5533
Q ss_pred -eeeeeC-----------------CEEEEEEecCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHHCCC
Q 024661 160 -NWFDYR-----------------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLV------RELGRQLLESVAFMHELRL 215 (264)
Q Consensus 160 -~~~~~~-----------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~------~~i~~qi~~~l~~lH~~~i 215 (264)
+.+... ..+|+||||+.++|.+++.... ..+.+... +.++.||+.||+|||++||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 444332 4489999999999999998642 13444444 6777999999999999999
Q ss_pred eecCCCCCCEEeecCCcEEeccCCCCCcCCCC---cccceeeeeceeEe
Q 024661 216 IHTDLKPENILLVSAEYVKVPDYKVPSPRHAF---SFQTFLSMASRVYI 261 (264)
Q Consensus 216 vH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~---~~~~~~y~ape~~~ 261 (264)
+||||||+|||++.++.+||+|||+|+..... ..+|..|||||++.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~ 264 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLN 264 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHT
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhcc
Confidence 99999999999999999999999999875543 35678899999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=228.96 Aligned_cols=167 Identities=20% Similarity=0.305 Sum_probs=143.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
..++|.+.+.||+|+||.||+|.+. .+++.||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 95 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV-----IKLYGAC 95 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEE
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCce-----eeEEEEE
Confidence 3477999999999999999999873 45588999998743 3445778899999999988887 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTD 219 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 219 (264)
.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 9999999999999 8999999987542 2389999999999999999999999999999
Q ss_pred CCCCCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 220 LKPENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 220 ikp~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|||+|||++.++.+||+|||++..... ...++..|+|||++.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 999999999999999999999975422 223566799999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=232.51 Aligned_cols=172 Identities=33% Similarity=0.490 Sum_probs=147.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCC------CCcceEEEceeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI------GGTRCVQIRNWFD 163 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~------~~~~~~~~~~~~~ 163 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.+.+.+. .|++++++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3468999999999999999999999999999999998776677888999999999985431 1344599999988
Q ss_pred eCC----EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecC------Cc
Q 024661 164 YRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSA------EY 232 (264)
Q Consensus 164 ~~~----~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~------~~ 232 (264)
..+ .+++|||+++++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 754 89999999999999999986655799999999999999999999998 99999999999999643 38
Q ss_pred EEeccCCCCCcCCC---CcccceeeeeceeEe
Q 024661 233 VKVPDYKVPSPRHA---FSFQTFLSMASRVYI 261 (264)
Q Consensus 233 v~l~Dfg~a~~~~~---~~~~~~~y~ape~~~ 261 (264)
+||+|||++..... ...+|..|+|||++.
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~ 208 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLL 208 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHh
Confidence 99999999975432 346889999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=225.57 Aligned_cols=167 Identities=17% Similarity=0.239 Sum_probs=132.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+.++...++.+.|+|+ +++++++.+.
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i-----v~~~~~~~~~ 78 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT-----VTFYGALFRE 78 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeE-----EEEeeeeecc
Confidence 44578999999999999999999999999999999987432 222333334444555666665 9999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 166 NHICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+..|+||||+.++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999999988998887642 234799999999999999999999998 99999999999999999999999999997
Q ss_pred cCCC-----CcccceeeeeceeE
Q 024661 243 PRHA-----FSFQTFLSMASRVY 260 (264)
Q Consensus 243 ~~~~-----~~~~~~~y~ape~~ 260 (264)
.... ...+|..|+|||++
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERI 181 (290)
T ss_dssp -----------CCCCCCSCHHHH
T ss_pred cccccccccccCCCccccChhhc
Confidence 5332 23588899999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=239.23 Aligned_cols=163 Identities=21% Similarity=0.300 Sum_probs=141.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC-EEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~ 169 (264)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+++.++|+|+ +++++++.... .+|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTB-----CCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCE-----EEEEEEEEcCCCceE
Confidence 467999999999999999999886 6789999997543 55778999999999999888 99999876654 899
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999 89999999977644589999999999999999999999999999999999999999999999999975432
Q ss_pred -CcccceeeeeceeEe
Q 024661 247 -FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -~~~~~~~y~ape~~~ 261 (264)
...++..|||||++.
T Consensus 344 ~~~~~~~~y~aPE~~~ 359 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALR 359 (450)
T ss_dssp ---CCCTTTSCHHHHH
T ss_pred cCCCCCcceeCHHHhc
Confidence 224567799999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=229.73 Aligned_cols=172 Identities=22% Similarity=0.326 Sum_probs=146.1
Q ss_pred EEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh-------hHHHHHHHHHHHHHHhc--cCCCCc
Q 024661 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLAR--HDIGGT 153 (264)
Q Consensus 83 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~--~~~~~~ 153 (264)
+...++.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.+.+ +++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i--- 110 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV--- 110 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB---
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc---
Confidence 345567788999999999999999999999999999999999975431 22456779999999976 555
Q ss_pred ceEEEceeeeeCCEEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee-cC
Q 024661 154 RCVQIRNWFDYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SA 230 (264)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~-~~ 230 (264)
+++++++.+.+..++|||++ + ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 111 --~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 111 --IRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp --CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred --eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 99999999999999999999 4 89999998765 799999999999999999999999999999999999999 78
Q ss_pred CcEEeccCCCCCcCCC----CcccceeeeeceeEe
Q 024661 231 EYVKVPDYKVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
+.+||+|||++..... ...+|..|+|||++.
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHH
T ss_pred CCEEEeeCccccccccccccCCCCCccCCChHHhc
Confidence 9999999999876443 235788999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-32 Score=223.26 Aligned_cols=168 Identities=26% Similarity=0.312 Sum_probs=142.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+.|+++ +..+..++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~----i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTT----CCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCC----CCccccccCCCCce
Confidence 56688999999999999999999999999999999987533 23467889999999999875 13344455678899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee---cCCcEEeccCCCCCcCC
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV---SAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~---~~~~v~l~Dfg~a~~~~ 245 (264)
++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999999999998543 4699999999999999999999999999999999999994 88999999999997533
Q ss_pred -------------CCcccceeeeeceeEee
Q 024661 246 -------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 -------------~~~~~~~~y~ape~~~~ 262 (264)
....+|..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred ccccccccccccccccccccccCChhhhcC
Confidence 23357888999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-33 Score=233.44 Aligned_cols=166 Identities=17% Similarity=0.243 Sum_probs=138.5
Q ss_pred eeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH--hccCCCCcceEEEceee
Q 024661 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL--ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l--~~~~~~~~~~~~~~~~~ 162 (264)
..+..+.++|++.+.||+|+||.||+|.+. ++.||+|++..... ....+|.+++..+ .|+|+ +++++++
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i-----~~~~~~~ 100 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENI-----LGFIAAD 100 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTB-----CCEEEEE
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCe-----eeEEEEE
Confidence 345567788999999999999999999886 88999999875443 3344455555443 56665 9999998
Q ss_pred eeC----CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEeec
Q 024661 163 DYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVS 229 (264)
Q Consensus 163 ~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~dikp~Nili~~ 229 (264)
... ..+|+||||+ +++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 886 7899999999 88999999765 599999999999999999999998 9999999999999999
Q ss_pred CCcEEeccCCCCCcCCC----------CcccceeeeeceeEee
Q 024661 230 AEYVKVPDYKVPSPRHA----------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 230 ~~~v~l~Dfg~a~~~~~----------~~~~~~~y~ape~~~~ 262 (264)
++.+||+|||++..... ...+|..|+|||++.+
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 99999999999964321 3358899999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=242.30 Aligned_cols=167 Identities=16% Similarity=0.101 Sum_probs=133.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEc------
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIR------ 159 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~------ 159 (264)
..++|++.+.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.+.. +.|+++++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG--IKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT--CCSHHHHHHHHCBCCC
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc--cCCHHHHHHHhhhhhh
Confidence 357899999999999999999999999999999998732 3345778899955554431 1224448877
Q ss_pred -eeeeeCC-----------------EEEEEEecCCCCHHHHHHhcCCCCCC-------HHHHHHHHHHHHHHHHHHHHCC
Q 024661 160 -NWFDYRN-----------------HICIVFEKLGPSLYDFLRKNSYRSFP-------IDLVRELGRQLLESVAFMHELR 214 (264)
Q Consensus 160 -~~~~~~~-----------------~~~lv~e~~~~~L~~~l~~~~~~~~~-------~~~~~~i~~qi~~~l~~lH~~~ 214 (264)
+++.+.+ ..|+||||++|+|.+++.... .++ +..++.|+.||+.||+|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 5555443 389999999889999998653 344 4788889999999999999999
Q ss_pred CeecCCCCCCEEeecCCcEEeccCCCCCcCCC---CcccceeeeeceeEe
Q 024661 215 LIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---FSFQTFLSMASRVYI 261 (264)
Q Consensus 215 ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---~~~~~~~y~ape~~~ 261 (264)
|+||||||+|||++.++.+||+|||+|+.... ...+ ..|||||++.
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~ 275 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEA 275 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhc
Confidence 99999999999999999999999999986443 2345 8899999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=225.64 Aligned_cols=167 Identities=23% Similarity=0.282 Sum_probs=134.4
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 162 (264)
+...++|++.+.||+|+||.||+|.+..+ +..+|+|++... ....+.+.+|+.+++.+.|+|+ +++++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~ 85 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVI 85 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCcc-----ceEEEEE
Confidence 34557899999999999999999998654 456999987642 3445678899999999988887 8999887
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
. ++..|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 4 56789999999 889999998654 46999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC-------cccceeeeeceeEe
Q 024661 242 SPRHAF-------SFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~~-------~~~~~~y~ape~~~ 261 (264)
...... ..++..|+|||++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp ---------------CCGGGCCHHHHH
T ss_pred cccCcccccccccCCCcccccChhhcc
Confidence 764332 23456799999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=240.27 Aligned_cols=169 Identities=24% Similarity=0.327 Sum_probs=143.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
..+.++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+.|++. +..+..++...+.
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~----i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTG----IPNVRWFGVEGDY 77 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTT----CCCEEEEEEETTE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCC----CCeEEEEEeeCCE
Confidence 3567899999999999999999999999999999998874332 3457889999999998654 2445566677889
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe---ecCCcEEeccCCCCCcC
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili---~~~~~v~l~Dfg~a~~~ 244 (264)
.||||||++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 78 ~~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999999999999998643 469999999999999999999999999999999999999 58899999999999753
Q ss_pred CC-------------CcccceeeeeceeEee
Q 024661 245 HA-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~-------------~~~~~~~y~ape~~~~ 262 (264)
.. ...+|..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG 187 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cCCccccccccccccccCCCccccCHHHhcC
Confidence 32 3357889999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=230.72 Aligned_cols=167 Identities=20% Similarity=0.304 Sum_probs=141.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEe-----CCCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEcee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~ 161 (264)
..++|++.+.||+|+||.||+|.+ ..++..||+|++... ....+.+.+|+.+++.+ .|+|+ ++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~ 117 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGA 117 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEE
Confidence 346899999999999999999997 345678999998743 23457788999999999 78887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTD 219 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 219 (264)
+.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999 8999999986532 2378999999999999999999999999999
Q ss_pred CCCCCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 220 LKPENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 220 ikp~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|||+|||++.++.+||+|||++..... ...+|..|+|||++.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 247 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence 999999999999999999999975432 223456799999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=226.53 Aligned_cols=167 Identities=25% Similarity=0.320 Sum_probs=144.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEe-----CCCCcEEEEEEEechh--hhHHHHHHHHHHHHHH-hccCCCCcceEEEcee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~ 161 (264)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++... ...+.+.+|+.+++.+ .|+|+ ++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~ 95 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGA 95 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCe-----eeEEEE
Confidence 346899999999999999999985 4567899999997532 3457789999999999 88887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY----------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
+.+.+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 99999999999999 8899999986542 248999999999999999999999999999999999
Q ss_pred EEeecCCcEEeccCCCCCcCCCC--------cccceeeeeceeEe
Q 024661 225 ILLVSAEYVKVPDYKVPSPRHAF--------SFQTFLSMASRVYI 261 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~~~~~--------~~~~~~y~ape~~~ 261 (264)
||++.++.+||+|||++...... ..++..|+|||++.
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 220 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence 99999999999999999764332 23456799999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.98 E-value=9.9e-33 Score=241.83 Aligned_cols=166 Identities=24% Similarity=0.334 Sum_probs=143.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.+.||+|+||.||+|.+. .+..||||+++......+.+.+|+.+++.++|+|+ +++++++. .+.+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~l~~~~~-~~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVT-KEPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SSSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCE-----eeEEEEEe-CCcc
Confidence 44577999999999999999999986 46779999998766667889999999999999887 88888876 5678
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
|+||||+ +|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999 89999999865333688999999999999999999999999999999999999999999999999986432
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHH
T ss_pred ceeccCCCcccccccCHHHhc
Confidence 223456799999763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-32 Score=225.06 Aligned_cols=164 Identities=27% Similarity=0.377 Sum_probs=146.0
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+++ +++++++.+...
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 94 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTK 94 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCe
Confidence 346799999999999999999999999999999999754 2445788999999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 99999999 88999998753 599999999999999999999999999999999999999999999999999965332
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~ 192 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIK 192 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHT
T ss_pred cccccCccCCCcCccCHHHHh
Confidence 335788899999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=233.70 Aligned_cols=168 Identities=21% Similarity=0.257 Sum_probs=144.8
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
....++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++.+.+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 108 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL-----VSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTB-----CCEEEECCCTT
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCC
Confidence 456688999999999999999999964 6889999988643 3445678899999999988887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
..|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999 899999987543 23589999999999999999999999999999999999999999999999999875
Q ss_pred CCC--------CcccceeeeeceeEe
Q 024661 244 RHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~--------~~~~~~~y~ape~~~ 261 (264)
... ...+|..|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 214 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFI 214 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHH
T ss_pred cccccccccccccCCCccccCHHHhc
Confidence 322 224788899999763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=228.60 Aligned_cols=170 Identities=24% Similarity=0.388 Sum_probs=144.9
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
......++|++.+.||+|+||.||+|.+..+++.+|+|++... ....+.+.+|+.+++.+.|+|+ +++++++.+
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 87 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-----VKLLGAYYH 87 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCE-----eeeeeeeee
Confidence 3445668899999999999999999999999999999998743 3345778899999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++..
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999 889999987643 3699999999999999999999999999999999999999999999999998743
Q ss_pred ------CCCCcccceeeeeceeEe
Q 024661 244 ------RHAFSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ------~~~~~~~~~~y~ape~~~ 261 (264)
......++..|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHH
T ss_pred ccccccccccccCChhhcCCeeec
Confidence 223446888999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=228.84 Aligned_cols=167 Identities=18% Similarity=0.284 Sum_probs=141.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeC-------CCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEc
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIR 159 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~ 159 (264)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ....+.+.+|+.+++.+ .|+|+ ++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~ 107 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLL 107 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE-----eeEE
Confidence 3478999999999999999999975 35678999998753 34456788999999999 78877 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 224 (264)
+++.+.+.+|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 9999999999999999 8899999986531 248999999999999999999999999999999999
Q ss_pred EEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 225 ILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 225 ili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
||++.++.+||+|||++..... ...++..|+|||++.
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 232 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence 9999999999999999975432 223566799999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-32 Score=222.17 Aligned_cols=164 Identities=25% Similarity=0.362 Sum_probs=143.6
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
...|++.+.||+|+||.||+|.+..++..|++|++... ....+.+.+|+.+++.+.|+|+ +++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeeccccC
Confidence 35589999999999999999999999999999998743 3455778899999999998887 889888765
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEee-cCCcEEeccCC
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLV-SAEYVKVPDYK 239 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~-~~~~v~l~Dfg 239 (264)
...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++| |+|+||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 46799999999 889999998765 7999999999999999999999999 99999999999998 78999999999
Q ss_pred CCCcCCCC----cccceeeeeceeEe
Q 024661 240 VPSPRHAF----SFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~~----~~~~~~y~ape~~~ 261 (264)
++...... ..++..|+|||++.
T Consensus 178 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 178 LATLKRASFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp GGGGCCTTSBEESCSSCCCCCGGGGG
T ss_pred CcccccccccccccCCcCcCCHHHHh
Confidence 99754432 34788999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-32 Score=226.54 Aligned_cols=167 Identities=25% Similarity=0.374 Sum_probs=140.7
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+.|+|+ +++++++.+.+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHV-----VKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCCE
Confidence 455678999999999999999999999999999999987543 34678889999999988887 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999 789999997433 4699999999999999999999999999999999999999999999999999965332
Q ss_pred ------CcccceeeeeceeEe
Q 024661 247 ------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~ 198 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQ 198 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHS
T ss_pred hccccCccCCCCCccChhhcC
Confidence 335788899999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=223.99 Aligned_cols=166 Identities=20% Similarity=0.234 Sum_probs=143.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhh--------hHHHHHHHHHHHHHHhccCCCCcceEEEc
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 159 (264)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++|+|+ ++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~ 89 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI-----VKLY 89 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB-----CCEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc-----hhhh
Confidence 4556789999999999999999999999999999999863221 11678899999999988887 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCc----
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEY---- 232 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~---- 232 (264)
+++.+.. ++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++| |+|+||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence 9987665 6999999 899999887654 46999999999999999999999999 999999999999988776
Q ss_pred -EEeccCCCCCcCCC---CcccceeeeeceeEe
Q 024661 233 -VKVPDYKVPSPRHA---FSFQTFLSMASRVYI 261 (264)
Q Consensus 233 -v~l~Dfg~a~~~~~---~~~~~~~y~ape~~~ 261 (264)
+||+|||++..... ...+|..|+|||++.
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHSVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CEEECCCTTCBCCSSCEECCCCCCTTSCGGGSS
T ss_pred eEEeCCCCccccccccccccCCCccccCchhhc
Confidence 99999999976443 235788999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=230.53 Aligned_cols=164 Identities=19% Similarity=0.279 Sum_probs=134.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEE----EEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+... ....+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTB-----CCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEec
Confidence 467999999999999999999998887654 67766432 2445778899999999999888 999999887
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.. .++|+|++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 65 77888999 999999998754 4699999999999999999999999999999999999999999999999999865
Q ss_pred CCC--------CcccceeeeeceeEe
Q 024661 244 RHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~--------~~~~~~~y~ape~~~ 261 (264)
... ...+|..|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHH
T ss_pred ccCCcccccccCCCccccccChHHhc
Confidence 322 223466899999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=228.41 Aligned_cols=164 Identities=24% Similarity=0.334 Sum_probs=142.1
Q ss_pred CCeEEEeecccCccEEEEEEE----eCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee--e
Q 024661 92 PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--Y 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~--~ 164 (264)
++|++.+.||+|+||.||+|. +..+++.||+|++... ....+.+.+|+++++.++|+|+ +++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI-----VKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCce-----eEEEEEEecCC
Confidence 679999999999999999999 5678899999998754 3445678999999999988887 88888876 4
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
...+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 67899999999 999999998743 2599999999999999999999999999999999999999999999999999975
Q ss_pred CCC---------CcccceeeeeceeEe
Q 024661 244 RHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~---------~~~~~~~y~ape~~~ 261 (264)
... ...++..|+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhc
Confidence 432 224666799999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=228.83 Aligned_cols=168 Identities=22% Similarity=0.299 Sum_probs=144.0
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCc-----EEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEce
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~ 160 (264)
...++|++.+.||+|+||.||+|.+..+++ .||+|++... ....+.+.+|+.+++.+ .|+|+ +++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~ 117 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI-----VNLLG 117 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCe-----eeEEE
Confidence 345789999999999999999999877654 7999998753 24457788999999999 78887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili 227 (264)
++.+.+.+|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999 889999997532 2358999999999999999999999999999999999999
Q ss_pred ecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 228 VSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 228 ~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+.++.+||+|||++..... ...++..|+|||++.
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 239 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc
Confidence 9999999999999975422 223456799999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-32 Score=225.97 Aligned_cols=161 Identities=17% Similarity=0.380 Sum_probs=141.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeee--CC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~--~~ 166 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.+++.+. |+|+ +++++++.+ ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI-----ITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCE-----EEeeeeeccCCCC
Confidence 3478999999999999999999999999999999987433 467889999999998 7777 999999988 67
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCcC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPR 244 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~ 244 (264)
..++||||+ +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 107 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 899999999 889998874 388999999999999999999999999999999999999777 8999999999753
Q ss_pred C-----CCcccceeeeeceeEee
Q 024661 245 H-----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~-----~~~~~~~~y~ape~~~~ 262 (264)
. ....++..|+|||++.+
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTT
T ss_pred CCCCccccccccccccChhhhcC
Confidence 3 23357888999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=233.51 Aligned_cols=169 Identities=21% Similarity=0.225 Sum_probs=136.1
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCC---CCcEEEEEEEechhh------------hHHHHHHHHHHHHHHhccCCC
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIG 151 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~~~~~~ 151 (264)
.+...++|++.+.||+|+||.||+|.+.. ++..+|+|++..... ....+.+|+..++.+.|+|+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni- 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI- 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC-
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc-
Confidence 34556789999999999999999999987 788899999874321 12234566777777777777
Q ss_pred CcceEEEceeeee----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe
Q 024661 152 GTRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (264)
Q Consensus 152 ~~~~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili 227 (264)
+++++++.+ ....|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 111 ----~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 111 ----PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184 (345)
T ss_dssp ----CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ----ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence 999999887 78999999999999999998765 79999999999999999999999999999999999999
Q ss_pred ecCC--cEEeccCCCCCcCC-------------CCcccceeeeeceeEee
Q 024661 228 VSAE--YVKVPDYKVPSPRH-------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 228 ~~~~--~v~l~Dfg~a~~~~-------------~~~~~~~~y~ape~~~~ 262 (264)
+.++ .+||+|||+++... ....+|..|+|||++.+
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG 234 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence 9887 99999999996532 22357889999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=235.96 Aligned_cols=166 Identities=22% Similarity=0.278 Sum_probs=136.2
Q ss_pred cCCCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..++|++.+.||+|+||.||+|++. .++..||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI-----IRLEGVVTK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEee
Confidence 3467999999999999999999886 45678999998743 3455778999999999998887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999 899999998653 4699999999999999999999999999999999999999999999999999976
Q ss_pred CCCCc---------ccceeeeeceeEe
Q 024661 244 RHAFS---------FQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~~---------~~~~~y~ape~~~ 261 (264)
..... .++..|+|||++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIA 223 (373)
T ss_dssp -----------------CTTSCHHHHH
T ss_pred cccCCccceeccCCCcCCCccChhhhc
Confidence 43221 2345699999764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=234.04 Aligned_cols=168 Identities=16% Similarity=0.132 Sum_probs=141.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCC--------CcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCC----------C
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG----------G 152 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~----------~ 152 (264)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... +.+.+|+++++.+.|+|+. .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57899999999999999999999874 789999998754 3577899999999987751 2
Q ss_pred cceEEEceeeee-CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 153 TRCVQIRNWFDY-RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 153 ~~~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.+++.+++++.. +...|+||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 344557777776 7899999999999999999976334799999999999999999999999999999999999999998
Q ss_pred --cEEeccCCCCCcCCC-------------CcccceeeeeceeEee
Q 024661 232 --YVKVPDYKVPSPRHA-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 232 --~v~l~Dfg~a~~~~~-------------~~~~~~~y~ape~~~~ 262 (264)
.+||+|||++..... ...+|..|+|||++.+
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 999999999965332 2257889999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=232.02 Aligned_cols=168 Identities=20% Similarity=0.302 Sum_probs=138.5
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh------------hhHHHHHHHHHHHHHHhccCCCCcce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------------KYREAAMIEIDVLQRLARHDIGGTRC 155 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~e~~~l~~l~~~~~~~~~~ 155 (264)
..+.++|++.+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|+.+++.++|+|+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i----- 91 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI----- 91 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB-----
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc-----
Confidence 4567899999999999999999999865 8899999885321 223778999999999999888
Q ss_pred EEEceeeee-----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC
Q 024661 156 VQIRNWFDY-----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (264)
Q Consensus 156 ~~~~~~~~~-----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~ 230 (264)
+++++++.. ...+|+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence 899888844 44789999999889999988643 469999999999999999999999999999999999999999
Q ss_pred CcEEeccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 231 EYVKVPDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+.+||+|||++..... ...+|..|+|||++.+
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp CCEEECCTTC---------------CGGGCCHHHHTT
T ss_pred CCEEEEecCcccccccccccceecccceecCcHHhcC
Confidence 9999999999975332 2357788999998653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=226.62 Aligned_cols=166 Identities=23% Similarity=0.371 Sum_probs=124.7
Q ss_pred CccCCCeEEEe-ecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--
Q 024661 88 ENLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 88 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-- 164 (264)
..+.++|.+.+ .||+|+||.||+|.+..+++.||+|++......... ....++.+.|+|+ +++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e---~~~~~~~~~h~~i-----~~~~~~~~~~~ 95 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---VDHHWQASGGPHI-----VCILDVYENMH 95 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHH---HHHHHHHTTSTTB-----CCEEEEEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHH---HHHHHHhcCCCCh-----HHHHHHHhhcc
Confidence 45668899965 699999999999999999999999999765433322 2233556677776 888888876
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---CcEEeccC
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---EYVKVPDY 238 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---~~v~l~Df 238 (264)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 56699999999 8899999997765679999999999999999999999999999999999999864 55999999
Q ss_pred CCCCcCCC----CcccceeeeeceeEe
Q 024661 239 KVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
|++..... ...+|..|+|||++.
T Consensus 176 g~~~~~~~~~~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 176 GFAKETTQNALQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp TTCEEC---------------------
T ss_pred ccceeccccccccCCCCcCccChhhhC
Confidence 99975432 335788999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=228.70 Aligned_cols=169 Identities=15% Similarity=0.189 Sum_probs=130.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCc---EEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
....++|++.+.||+|+||.||+|.+..++. .||+|+++.. ....+.+.+|+.+++.++|+|+ ++++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 93 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV-----AKLVGV 93 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTB-----CCCCEE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCce-----ehhhce
Confidence 3455789999999999999999999887765 7999998743 3446778899999999988887 999999
Q ss_pred eeeCCEE------EEEEecC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC
Q 024661 162 FDYRNHI------CIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (264)
Q Consensus 162 ~~~~~~~------~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~ 230 (264)
+...... ++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 8876655 9999999 889999997532 1258999999999999999999999999999999999999999
Q ss_pred CcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 231 EYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 231 ~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
+.+||+|||++..... ...++..|+|||++.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 212 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA 212 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhc
Confidence 9999999999976432 223456799999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=225.54 Aligned_cols=168 Identities=26% Similarity=0.453 Sum_probs=142.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeC-CCCcEEEEEEEechh---hhHHHHHHHHHHHHHH---hccCCCCcceEEEcee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNW 161 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~~~~~~~~~~~~~~~~ 161 (264)
...++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+|+.+++.+ .|+|+ ++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i-----~~~~~~ 82 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDV 82 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB-----CCEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCe-----Eeeeee
Confidence 34578999999999999999999995 678899999987432 2234566788888887 57766 899888
Q ss_pred ee-----eCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEec
Q 024661 162 FD-----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (264)
Q Consensus 162 ~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~ 236 (264)
+. .....++|||++.++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEe
Confidence 86 5678999999998899999998765569999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
|||++..... ...++..|+|||++.
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 192 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLL 192 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHT
T ss_pred cCcccccccCCCCccccccccceeCHHHHh
Confidence 9999976442 335788899999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=225.30 Aligned_cols=168 Identities=24% Similarity=0.331 Sum_probs=135.5
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
...++...++|++.++||+|+||.||+|.+.. .+|+|+++.. ....+.+.+|+.+++.+.|+|+ +.+++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 87 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMG 87 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE-----EEEEe
Confidence 44557778899999999999999999998753 4999998632 3455778899999999998887 88888
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
+ ......++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 88 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 88 Y-STAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp E-ECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred e-ccCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence 5 4556789999999 899999997543 469999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC--------CcccceeeeeceeEe
Q 024661 240 VPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
++..... ...+|..|+|||++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp ------------------CCCTTCCHHHHC
T ss_pred eccccccccccccccccCCCccccCchhhc
Confidence 9975332 234788999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=237.46 Aligned_cols=163 Identities=24% Similarity=0.369 Sum_probs=136.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee------C
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------R 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~------~ 165 (264)
.+|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+++++.++|+|+ +++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpni-----v~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTB-----CCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCc-----cceeeEEeccCCCCcc
Confidence 469999999999999999999999999999999875432 23469999999999888 888888743 2
Q ss_pred CEEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEeccCCCCC
Q 024661 166 NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKVPS 242 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~Dfg~a~ 242 (264)
.++++||||+.++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 35789999998788877763 223479999999999999999999999999999999999999965 678999999997
Q ss_pred cCC-----CCcccceeeeeceeEee
Q 024661 243 PRH-----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~-----~~~~~~~~y~ape~~~~ 262 (264)
... ....+|..|+|||++.+
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFG 230 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTT
T ss_pred hcccCCCceeeeeCCCcCCHHHHcC
Confidence 532 23457889999998643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=229.43 Aligned_cols=162 Identities=19% Similarity=0.213 Sum_probs=131.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee-----eC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-----YR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~-----~~ 165 (264)
.++|++.+.||+|+||.||+|.+ +++.||+|++............|+..+..+.|+|+ +++++.+. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i-----~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI-----ARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcch-----hhheecccccccCCC
Confidence 46799999999999999999976 57899999997544333333334433444667666 77776443 24
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEeecCCcEEe
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~ivH~dikp~Nili~~~~~v~l 235 (264)
..+|+||||+ +++|.+++.... .++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4789999999 899999998764 68999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCCcCCC--------------CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA--------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~--------------~~~~~~~y~ape~~~~ 262 (264)
+|||++..... ...+|..|+|||++.+
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 99999965322 2358899999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=246.39 Aligned_cols=155 Identities=17% Similarity=0.144 Sum_probs=123.6
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEech-----------hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
...+.|++|.+..++....|+.+++|++.+. +...+.+.+|+++|+++ .|+|+ ++++++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDA-----PAVLAHGENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCC-----CCEEEEEECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEEEC
Confidence 3567777777777777777999999998642 24456789999999999 56666 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+||||||+ |++|.+++.... .+++. .|+.||+.||+|+|++|||||||||+|||++.+|++||+|||+|+..
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred CEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999 999999998765 67765 47899999999999999999999999999999999999999999764
Q ss_pred CC------CcccceeeeeceeEee
Q 024661 245 HA------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~------~~~~~~~y~ape~~~~ 262 (264)
.. ..+||+.|||||++.+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC--
T ss_pred CCCCccccCceechhhccHHHhCC
Confidence 43 2358999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=229.44 Aligned_cols=169 Identities=18% Similarity=0.293 Sum_probs=144.2
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+|+.+++.+.|+|+ +++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~ 95 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLG 95 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE-----eeeEE
Confidence 355678999999999999999999876 357889999987432 345568899999999988887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
++.+.+..|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999 889999997532 13578999999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
.+||+|||++..... ...++..|+|||++.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhc
Confidence 999999999975432 223566799999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=229.60 Aligned_cols=167 Identities=23% Similarity=0.296 Sum_probs=132.1
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC---
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~--- 166 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|++...........+++..++.+.|+|+ +++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI-----VQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTB-----CCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCc-----ccHHHhhhcccccc
Confidence 3367999999999999999999999999999999987665555667788888899999888 99999886533
Q ss_pred ----EEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEeec-CCcEEecc
Q 024661 167 ----HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVS-AEYVKVPD 237 (264)
Q Consensus 167 ----~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dikp~Nili~~-~~~v~l~D 237 (264)
.+++||||+.++|.+.+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 3899999997787776653 23347899999999999999999999 999999999999999997 89999999
Q ss_pred CCCCCcCCC-----CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
||++..... ...+|..|+|||++.
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIF 204 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHT
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHc
Confidence 999976433 335788999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=239.78 Aligned_cols=166 Identities=24% Similarity=0.305 Sum_probs=140.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.++||+|+||.||+|.+.. +..||+|+++......+.+.+|+.+++.++|+|+ +++++++.+ +..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEcC-Cce
Confidence 344679999999999999999999875 4569999998655566789999999999999888 899988876 678
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999 899999998543346899999999999999999999999999999999999999999999999999864322
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
..++..|+|||++.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~ 354 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAAL 354 (452)
T ss_dssp ---------CCGGGSCHHHHH
T ss_pred ceecccCCcccccccCHhHHh
Confidence 12456799999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=243.97 Aligned_cols=164 Identities=24% Similarity=0.315 Sum_probs=142.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+++++.++|+|+ +++++++.+ +.+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEee-ccceE
Confidence 3569999999999999999999875 4569999998665566789999999999999888 899988866 67899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999 88999999854334689999999999999999999999999999999999999999999999999986543
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...++..|||||++.
T Consensus 419 ~~~~~~~~~~~y~aPE~~~ 437 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAAL 437 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHH
T ss_pred ecccCCcCcccccCHHHhc
Confidence 223456799999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=223.93 Aligned_cols=166 Identities=23% Similarity=0.334 Sum_probs=142.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
...++|++.+.||+|+||.||+|.+. ++..||+|++.......+.+.+|+++++.++|+|+ +++++++.+ +..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCc-----ceEEEEEcC-CCc
Confidence 34578999999999999999999975 56789999998665567788999999999999887 888888764 568
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF 247 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~ 247 (264)
++|||++ +++|.+++.......+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999 899999997543236899999999999999999999999999999999999999999999999999764332
Q ss_pred -------cccceeeeeceeEe
Q 024661 248 -------SFQTFLSMASRVYI 261 (264)
Q Consensus 248 -------~~~~~~y~ape~~~ 261 (264)
..++..|+|||++.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHH
T ss_pred ccccccCCCCccCccChhhhc
Confidence 23456799999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=223.18 Aligned_cols=172 Identities=24% Similarity=0.330 Sum_probs=144.0
Q ss_pred EeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+.......++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.+++.+.|++ ++++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~---~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS---DKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGC---TTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccC---CceEEEEE
Confidence 3344556678999999999999999999985 4888999998643 345577889999999998621 34499999
Q ss_pred eeeeCCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 161 WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
++.+.+..|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~ 172 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 172 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccc
Confidence 999999999999977999999998765 789999999999999999999999999999999999996 58999999999
Q ss_pred CCcCCC--------CcccceeeeeceeEee
Q 024661 241 PSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
+..... ...++..|+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTT
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhh
Confidence 976432 2357889999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=226.06 Aligned_cols=165 Identities=25% Similarity=0.382 Sum_probs=141.3
Q ss_pred ccCCCe-EEEeecccCccEEEEEEEe----CCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 89 NLTPRY-RILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 89 ~~~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
.+.++| ++++.||+|+||.||++.+ ..+++.||+|+++... ...+.+.+|+++++.++|+|+ ++++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 101 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI-----IKYKGC 101 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch-----hhEEEE
Confidence 566667 9999999999999988764 4478899999997542 446778999999999998887 999999
Q ss_pred eee--CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccC
Q 024661 162 FDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 162 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
+.+ ...+++||||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 987 47899999999 88999999775 4999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCCC---------CcccceeeeeceeEe
Q 024661 239 KVPSPRHA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~---------~~~~~~~y~ape~~~ 261 (264)
|++..... ...++..|+|||++.
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhc
Confidence 99976432 223566799999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=242.54 Aligned_cols=164 Identities=24% Similarity=0.331 Sum_probs=137.5
Q ss_pred CCCeEEEe-ecccCccEEEEEEEeCC--CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILS-KMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+++.+.+ +||+|+||.||+|.+.. ++..||||+++.. ....+.+.+|+++++.++|+|+ +++++++.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpni-----v~l~~~~~~- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEES-
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEecc-
Confidence 34566666 89999999999998753 4567999999753 3456788999999999998887 999999876
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999 899999997643 46999999999999999999999999999999999999999999999999999864
Q ss_pred CCC---------cccceeeeeceeEe
Q 024661 245 HAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~---------~~~~~~y~ape~~~ 261 (264)
... ..++..|||||++.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~ 512 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECIN 512 (613)
T ss_dssp C--------------CCTTSCHHHHH
T ss_pred cCCCceeeeccCCCCccceeCHhhhc
Confidence 321 12345799999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=226.41 Aligned_cols=168 Identities=20% Similarity=0.274 Sum_probs=139.3
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCC----cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
+...++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ......+.+|+.+++.+.|+|+ ++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 114 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGV 114 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEE
Confidence 344578999999999999999999987553 45999998743 3445678899999999998887 999999
Q ss_pred eeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
+.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999 889999998653 4699999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCC---------cccceeeeeceeEe
Q 024661 241 PSPRHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~~---------~~~~~~y~ape~~~ 261 (264)
+...... ..++..|+|||++.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223 (333)
T ss_dssp -----------------CCCGGGSCHHHHH
T ss_pred chhhccccccccccCCCCccccccCchhcc
Confidence 9764322 12356799999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-33 Score=239.04 Aligned_cols=168 Identities=21% Similarity=0.362 Sum_probs=131.9
Q ss_pred ccCCCeEE-EeecccCccEEEEEEEeC--CCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-
Q 024661 89 NLTPRYRI-LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (264)
Q Consensus 89 ~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~- 164 (264)
.+.+.|.+ +++||+|+||.||+|.++ .+++.||+|++... .....+.+|+.+++.++|+|+ +++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 90 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNV-----ISLQKVFLSH 90 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTB-----CCCCEEEEET
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCe-----eeEeeEEecC
Confidence 44566887 458999999999999965 56889999998753 233567889999999999888 999999854
Q ss_pred -CCEEEEEEecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe----ecCCc
Q 024661 165 -RNHICIVFEKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL----VSAEY 232 (264)
Q Consensus 165 -~~~~~lv~e~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili----~~~~~ 232 (264)
...+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 77999999999889999887321 1248999999999999999999999999999999999999 67789
Q ss_pred EEeccCCCCCcCCC---------CcccceeeeeceeEee
Q 024661 233 VKVPDYKVPSPRHA---------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 233 v~l~Dfg~a~~~~~---------~~~~~~~y~ape~~~~ 262 (264)
+||+|||+|+.... ...+|..|+|||++.+
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 99999999976432 2357889999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=231.02 Aligned_cols=171 Identities=20% Similarity=0.350 Sum_probs=148.5
Q ss_pred eeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhH------------------HHHHHHHHHHHHHh
Q 024661 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------------------EAAMIEIDVLQRLA 146 (264)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~~e~~~l~~l~ 146 (264)
..++...++|++.+.||+|+||.||+|.+ +++.||+|++....... +.+.+|+.+++.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34455668899999999999999999998 89999999997543211 78899999999999
Q ss_pred ccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeec
Q 024661 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF------LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHT 218 (264)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~------l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 218 (264)
|+|+ +++++++.+.+..|+||||+ +++|.++ +.......+++..++.++.||+.||.|||+ +||+|+
T Consensus 102 h~~i-----~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 102 NEYC-----LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp CTTB-----CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred CCCc-----ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 8887 99999999999999999999 7899998 655334579999999999999999999999 999999
Q ss_pred CCCCCCEEeecCCcEEeccCCCCCcCCC----CcccceeeeeceeEee
Q 024661 219 DLKPENILLVSAEYVKVPDYKVPSPRHA----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 219 dikp~Nili~~~~~v~l~Dfg~a~~~~~----~~~~~~~y~ape~~~~ 262 (264)
||||+|||++.++.++|+|||++..... ...++..|+|||++.+
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~ 224 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSN 224 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSS
T ss_pred CCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcC
Confidence 9999999999999999999999976432 3457889999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=222.59 Aligned_cols=168 Identities=26% Similarity=0.452 Sum_probs=147.0
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+++ +++++++.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~ 91 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILE 91 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCc-----cEEEEEEe
Confidence 3456678999999999999999999999999999999987532 345678899999999988887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC---CcEEeccCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---EYVKVPDYK 239 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---~~v~l~Dfg 239 (264)
+.+..|+|||++ +++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.+ +.+||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999 899999988765 79999999999999999999999999999999999999764 479999999
Q ss_pred CCCcCCC-----CcccceeeeeceeEe
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
++..... ...++..|+|||++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (287)
T 2wei_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLR 196 (287)
T ss_dssp GGGTBCCCSSCSCHHHHHTTCCHHHHT
T ss_pred cceeecCCCccccccCcccccChHHhc
Confidence 9875433 224788899999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=224.38 Aligned_cols=167 Identities=22% Similarity=0.322 Sum_probs=141.9
Q ss_pred ccCCCeEEEeecccCccEEEEEEE----eCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
...++|++.+.||+|+||.||+|. +..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 112 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCY 112 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEE
Confidence 344679999999999999999998 4667999999998753 3445678999999999998887 88988876
Q ss_pred eC--CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 164 YR--NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 164 ~~--~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
.. ..+++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 54 3789999999 889999998764 3699999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCC---------cccceeeeeceeEe
Q 024661 241 PSPRHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 241 a~~~~~~---------~~~~~~y~ape~~~ 261 (264)
+...... ..++..|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLT 221 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhc
Confidence 9764322 23456699999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=225.50 Aligned_cols=165 Identities=19% Similarity=0.272 Sum_probs=135.9
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEE----EEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
..++|++.+.||+|+||.||+|.+..+++.+ ++|.+.. .....+.+.+|+.+++.++|+|+ +++++++.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~ 87 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICL 87 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTB-----CCCCEEEE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEe
Confidence 3478999999999999999999998888765 5555542 23456788899999999999888 99999988
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+.. .++|+|++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 765 77888988 999999998754 469999999999999999999999999999999999999999999999999997
Q ss_pred cCCC--------CcccceeeeeceeEe
Q 024661 243 PRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~--------~~~~~~~y~ape~~~ 261 (264)
.... ...++..|+|||++.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp --------------CCCGGGSCHHHHH
T ss_pred EccCccccccccCCCccccccCHHHHc
Confidence 6432 223456799999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=230.05 Aligned_cols=165 Identities=21% Similarity=0.341 Sum_probs=141.4
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV-----IGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----ccHhheEecc
Confidence 3457899999999999999999999999999999998643 3345678899999999999887 9999998775
Q ss_pred CE------EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 166 NH------ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 166 ~~------~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.. +|+|||++.++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred cccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 43 599999998888877642 58999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCC---CcccceeeeeceeEee
Q 024661 240 VPSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
++..... ...+|..|+|||++.+
T Consensus 172 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 172 LARHADAEMTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp CTTC--------CCSBCCSCHHHHSC
T ss_pred cccCCCCCccccccCcCcCCHHHHhC
Confidence 9986443 2357889999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=229.16 Aligned_cols=168 Identities=21% Similarity=0.262 Sum_probs=144.0
Q ss_pred EEeeCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHH--HhccCCCCcceEEEce
Q 024661 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIRN 160 (264)
Q Consensus 83 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~~~~~~~~~~~~~~~ 160 (264)
++..++.+.++|++.+.||+|+||.||+|.+. ++.||+|++... ....+.+|.++++. +.|+|+ +++++
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni-----~~~~~ 103 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENI-----LGFIA 103 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTB-----CCEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcE-----EEEEe
Confidence 34456677789999999999999999999984 889999998743 34567788888888 567766 99999
Q ss_pred eeeeCC----EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEe
Q 024661 161 WFDYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILL 227 (264)
Q Consensus 161 ~~~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~ivH~dikp~Nili 227 (264)
++.... ..|+||||+ +++|.+++... .+++..++.++.|++.||.||| ++||+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 988865 899999999 88999999874 5999999999999999999999 8999999999999999
Q ss_pred ecCCcEEeccCCCCCcCCC----------CcccceeeeeceeEee
Q 024661 228 VSAEYVKVPDYKVPSPRHA----------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 228 ~~~~~v~l~Dfg~a~~~~~----------~~~~~~~y~ape~~~~ 262 (264)
+.++++||+|||++..... ...+|..|+|||++.+
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 9999999999999965322 2357889999998653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=226.20 Aligned_cols=165 Identities=21% Similarity=0.304 Sum_probs=140.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEE--EEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELV--AIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++.+.||+|+||.||+|.+..++..+ ++|.+... ....+.+.+|+++++.+ .|+|+ +++++++.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCch-----hhhceeeeeCC
Confidence 67999999999999999999998888765 89988742 33456788899999999 77777 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.+|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999 889999998642 23689999999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
.+||+|||++..... ...++..|+|||++.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 214 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 214 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhc
Confidence 999999999874332 223566799999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=250.71 Aligned_cols=167 Identities=23% Similarity=0.325 Sum_probs=142.2
Q ss_pred eeCCccCCCeEEEeecccCccEEEEEEEeCC-CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEcee
Q 024661 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (264)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 161 (264)
..++.+.++|++.+.||+|+||.||+|.+.. +++.||||++... ......+.+|+.+++.++|+|+ ++++++
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~ 147 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI-----VQIFNF 147 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCc-----CeEeee
Confidence 4567788999999999999999999999976 6899999988642 3445678899999999998887 999999
Q ss_pred eeeCCE-----EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEe
Q 024661 162 FDYRNH-----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (264)
Q Consensus 162 ~~~~~~-----~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l 235 (264)
+...+. .||||||+ +++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||
T Consensus 148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEE
T ss_pred EeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEE
Confidence 987655 79999999 8899887654 69999999999999999999999999999999999999875 9999
Q ss_pred ccCCCCCcCCC--CcccceeeeeceeEe
Q 024661 236 PDYKVPSPRHA--FSFQTFLSMASRVYI 261 (264)
Q Consensus 236 ~Dfg~a~~~~~--~~~~~~~y~ape~~~ 261 (264)
+|||++..... ...+|..|||||++.
T Consensus 223 ~DFG~a~~~~~~~~~~gt~~y~aPE~~~ 250 (681)
T 2pzi_A 223 IDLGAVSRINSFGYLYGTPGFQAPEIVR 250 (681)
T ss_dssp CCCTTCEETTCCSCCCCCTTTSCTTHHH
T ss_pred EecccchhcccCCccCCCccccCHHHHc
Confidence 99999976543 345899999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=218.99 Aligned_cols=164 Identities=25% Similarity=0.349 Sum_probs=139.3
Q ss_pred CCCeEEEe-ecccCccEEEEEEEeC--CCCcEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|.+.+ .||+|+||.||+|.+. .++..||+|+++. .....+.+.+|+++++.+.|+|+ +++++++ ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~-~~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVC-QA 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE-ES
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEe-cC
Confidence 35688877 9999999999999864 4678899999975 33456788999999999998887 9999988 45
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 6799999999 889999997543 46999999999999999999999999999999999999999999999999999754
Q ss_pred CC---------CcccceeeeeceeEe
Q 024661 245 HA---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~---------~~~~~~~y~ape~~~ 261 (264)
.. ...++..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhc
Confidence 32 223467799999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=221.68 Aligned_cols=165 Identities=12% Similarity=0.121 Sum_probs=143.4
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~- 165 (264)
..++|++.+.||+|+||.||+|.+. ++.+|+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 80 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV-----LPVLGACQSPP 80 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTE-----ECEEEEECTTT
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCch-----hheEEEEccCC
Confidence 3467999999999999999999985 788999998753 3445678899999999888777 9999999886
Q ss_pred -CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 166 -NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 166 -~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 7899999999 889999999766456999999999999999999999999 999999999999999999999888776
Q ss_pred CcCC-CCcccceeeeeceeEe
Q 024661 242 SPRH-AFSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~-~~~~~~~~y~ape~~~ 261 (264)
.... ....+|..|+|||++.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~ 181 (271)
T 3kmu_A 161 FSFQSPGRMYAPAWVAPEALQ 181 (271)
T ss_dssp CTTSCTTCBSCGGGSCHHHHH
T ss_pred eeecccCccCCccccChhhhc
Confidence 5433 3446889999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=229.66 Aligned_cols=164 Identities=23% Similarity=0.279 Sum_probs=136.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcE----EEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|++.+.||+|+||.||+|.+..+++. +++|.+.... ...+.+.+|+.+++.+.|+|+ +++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI-----VRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTB-----CCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEc-
Confidence 46799999999999999999999888776 6677664322 223456779999999988887 99999886
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
++..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 46689999999 899999998653 3689999999999999999999999999999999999999999999999999976
Q ss_pred CCC--------CcccceeeeeceeEe
Q 024661 244 RHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~--------~~~~~~~y~ape~~~ 261 (264)
... ...++..|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIH 190 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHH
T ss_pred cCcccccccccCCCCcccccChHHhc
Confidence 432 223556799999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=218.75 Aligned_cols=162 Identities=24% Similarity=0.365 Sum_probs=132.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..++|++.+.||+|+||.||+|.+. ++.+|+|+++... ...+.+.+|+++++.++|+|+ +++++++.+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 77 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI-----IALRGVCLK 77 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTB-----CCEEEEECC
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEec
Confidence 3468999999999999999999975 7889999986432 234678899999999999887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEeec--------CCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVS--------AEY 232 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~Nili~~--------~~~ 232 (264)
.+..|+||||+ +++|.+++... .+++..++.++.|++.||.|||++| |+||||||+|||++. ++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred CCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999999 89999998643 6999999999999999999999999 899999999999986 678
Q ss_pred EEeccCCCCCcCCC----CcccceeeeeceeEe
Q 024661 233 VKVPDYKVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 233 v~l~Dfg~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
++|+|||++..... ...++..|+|||++.
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187 (271)
T ss_dssp EEECCCCC-------------CCGGGSCHHHHH
T ss_pred eEEccCCcccccccccccCCCCccceeCHHHhc
Confidence 99999999975332 335788999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=220.87 Aligned_cols=163 Identities=22% Similarity=0.318 Sum_probs=138.9
Q ss_pred CCCeEEEe-ecccCccEEEEEEEe--CCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILS-KMGEGTFGQVVECFD--NEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.++|++.+ .||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.+.|+|+ +++++++ .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~-~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGIC-E 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE-E
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEE-C
Confidence 36799998 999999999999954 566789999998743 2345778899999999998887 8999988 5
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+..|+|||++ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 67789999999 899999998765 699999999999999999999999999999999999999999999999999975
Q ss_pred CCCC---------cccceeeeeceeEe
Q 024661 244 RHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~---------~~~~~~y~ape~~~ 261 (264)
.... ..++..|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 193 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECIN 193 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhc
Confidence 4321 12456799999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=218.35 Aligned_cols=150 Identities=16% Similarity=0.094 Sum_probs=133.3
Q ss_pred EeeCC-ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEE
Q 024661 84 FAIGE-NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (264)
Q Consensus 84 ~~~~~-~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 158 (264)
+..++ .+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~ 96 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV-----ARV 96 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTB-----CCE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCc-----cee
Confidence 34455 6778999999999999999999999999999999999754 2344778899999999988887 999
Q ss_pred ceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEecc
Q 024661 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
++++.+.+..|+||||+ +++|.+++.. ......+..++.||+.||+|||++||+||||||+|||++.+|.+||++
T Consensus 97 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp EEEEEETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECS
T ss_pred eEEEEECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEe
Confidence 99999999999999999 8999999854 246667899999999999999999999999999999999999999998
Q ss_pred CCCCC
Q 024661 238 YKVPS 242 (264)
Q Consensus 238 fg~a~ 242 (264)
+|...
T Consensus 173 ~~~~~ 177 (286)
T 3uqc_A 173 PATMP 177 (286)
T ss_dssp CCCCT
T ss_pred ccccC
Confidence 87654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=224.34 Aligned_cols=167 Identities=21% Similarity=0.281 Sum_probs=140.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEe-----CCCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEcee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~ 161 (264)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.+ +|+|+ ++++++
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~ 99 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGA 99 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe-----eeEEEE
Confidence 447899999999999999999985 456789999999753 23456788999999999 56776 999998
Q ss_pred eeeC-CEEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024661 162 FDYR-NHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (264)
Q Consensus 162 ~~~~-~~~~lv~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Ni 225 (264)
+... ..+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 8775 4599999999 8899999987542 1289999999999999999999999999999999999
Q ss_pred EeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 226 LLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 226 li~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|++.++.+||+|||++..... ...+|..|+|||++.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc
Confidence 999999999999999976432 223566799999763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=232.19 Aligned_cols=167 Identities=24% Similarity=0.372 Sum_probs=136.3
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~- 165 (264)
++....+|++.+.||+|+||.||+|.+..+++ +|+|.+...... ..+|+++++.++|+|+ +++++++...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~ni-----v~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNV-----VDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTB-----CCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCc-----ceEEEEEEecC
Confidence 34555679999999999999999999987776 788877643322 2369999999999888 9999988543
Q ss_pred -----CEEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee-cCCcEEecc
Q 024661 166 -----NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPD 237 (264)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~-~~~~v~l~D 237 (264)
..+|+||||+.+++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 34899999997777666552 1234799999999999999999999999999999999999999 789999999
Q ss_pred CCCCCcCC-----CCcccceeeeeceeEee
Q 024661 238 YKVPSPRH-----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 238 fg~a~~~~-----~~~~~~~~y~ape~~~~ 262 (264)
||+|+... ....+|..|+|||++.+
T Consensus 186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 186 FGSAKILIAGEPNVSYICSRYYRAPELIFG 215 (394)
T ss_dssp CTTCEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred CCCcccccCCCCCcccccCcCccCHHHHcC
Confidence 99996532 23457889999998643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=221.80 Aligned_cols=166 Identities=20% Similarity=0.279 Sum_probs=142.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--C
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--R 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~ 165 (264)
.++|++.+.||+|+||.||+|.+..+++.|++|++... ....+.+.+|+.+++.++|+|+ +++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEecCCC
Confidence 36799999999999999999999999999999999743 3456778899999999998887 999998744 6
Q ss_pred CEEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEeecCCcEEecc
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dikp~Nili~~~~~v~l~D 237 (264)
..+|+||||+ +++|.+++.... ...+++..++.++.|++.||+|||++| |+|+||||+|||++.++.+||+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 7899999999 789999998532 235999999999999999999999999 99999999999999999999999
Q ss_pred CCCCCcCCCC------cccceeeeeceeEe
Q 024661 238 YKVPSPRHAF------SFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~~------~~~~~~y~ape~~~ 261 (264)
||++...... ..++..|+|||++.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMN 189 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHH
T ss_pred CchheeeccccccccccCCCccccChHHhc
Confidence 9998764432 24788899999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=229.31 Aligned_cols=170 Identities=17% Similarity=0.211 Sum_probs=144.4
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
......++|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|+.+++.+.|+|+ +++++++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~ 97 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-----LRLRGFCM 97 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB-----CCCCEEEC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc-----cceEEEEe
Confidence 3446678899999999999999999985 468889999987533 223367889999999988887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEeecCCcEEecc
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~Nili~~~~~v~l~D 237 (264)
+.+..++||||+ +++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 999999999999 889999998653 23499999999999999999999999 999999999999999999999999
Q ss_pred CCCCCcCCC-------CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~-------~~~~~~~y~ape~~~ 261 (264)
||++..... ...+|..|+|||++.
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred CccccccCcccccccccccCCcCccCHHHhc
Confidence 999975432 223788999999763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=226.42 Aligned_cols=169 Identities=19% Similarity=0.286 Sum_probs=139.3
Q ss_pred CccCCCeEEEeecccCccEEEEEEE-----eCCCCcEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+...++|++.+.||+|+||.||+|. +..+++.||+|++.. .......+.+|+.+++.+.|+|+ +++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 100 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIG 100 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCC-----CeEEE
Confidence 4556789999999999999999999 456788999999863 23455678899999999998887 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CC
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AE 231 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~ 231 (264)
++.+....|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999 8999999987532 34899999999999999999999999999999999999994 44
Q ss_pred cEEeccCCCCCcC--------CCCcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPR--------HAFSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~--------~~~~~~~~~y~ape~~~ 261 (264)
.++|+|||++... .....++..|+|||++.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 218 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhc
Confidence 6999999988632 12234677899999763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=219.92 Aligned_cols=164 Identities=18% Similarity=0.212 Sum_probs=139.1
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCc---EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.|.+.+.||+|+||.||+|.+..++. .+|+|.+... ....+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV-----LALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEecCCC
Confidence 47788999999999999999765544 7999998743 2445778899999999998887 999999977655
Q ss_pred E-EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 168 I-CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 168 ~-~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
. ++|||++ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 4 9999999 999999998643 468999999999999999999999999999999999999999999999999997532
Q ss_pred C----------CcccceeeeeceeEee
Q 024661 246 A----------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~----------~~~~~~~y~ape~~~~ 262 (264)
. ...++..|+|||.+.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred CCcccccccCcCCCCCccccChhhhcc
Confidence 2 2245778999997643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=221.29 Aligned_cols=164 Identities=16% Similarity=0.185 Sum_probs=137.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceee-eeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~ 165 (264)
.+|++.+.||+|+||.||+|.+..+ +..+++|.+... ....+.+.+|+.+++.++|+|+ +++++++ ..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeEEEcCC
Confidence 4699999999999999999997544 345899988642 3445778899999999998887 9999974 556
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 7889999999 889999997643 46899999999999999999999999999999999999999999999999999754
Q ss_pred CC----------CcccceeeeeceeEe
Q 024661 245 HA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~----------~~~~~~~y~ape~~~ 261 (264)
.. ...++..|+|||++.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQ 205 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHH
T ss_pred cccchhccccccCCCCCccccChHHhc
Confidence 32 223456799999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=226.88 Aligned_cols=168 Identities=24% Similarity=0.298 Sum_probs=127.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++++++...+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI-----VSYYTSFVVKD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTB-----CCEEEEEESSS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCE-----eeEEEEEeecC
Confidence 4457899999999999999999999999999999988643 2344667789988888888777 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
..|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999 89999999741 22468999999999999999999999999999999999999999999999999
Q ss_pred CCCcCC-----------CCcccceeeeeceeEe
Q 024661 240 VPSPRH-----------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 240 ~a~~~~-----------~~~~~~~~y~ape~~~ 261 (264)
++.... ....++..|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhc
Confidence 875432 1235788899999763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=217.29 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=139.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCC---CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
..++|++.+.||+|+||.||+|.+.. ++..||+|++... ....+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI-----VKLIGIIEE 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTB-----CCEEEEECS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcC
Confidence 44679999999999999999998654 3456999998753 3456788999999999999888 889988765
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+..|+|||++ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4568999999 899999998754 3589999999999999999999999999999999999999999999999999876
Q ss_pred CCC-------CcccceeeeeceeEe
Q 024661 244 RHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~-------~~~~~~~y~ape~~~ 261 (264)
... ...++..|+|||++.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp C---------CCCCCGGGCCHHHHH
T ss_pred cccccccccccCCCCcceeCchhhc
Confidence 432 223566799999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.55 Aligned_cols=160 Identities=23% Similarity=0.347 Sum_probs=134.6
Q ss_pred eEEE-eecccCccEEEEEEEe--CCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 94 YRIL-SKMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 94 y~~~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
+.+. ++||+|+||.||+|.+ ..+++.||||+++... ...+.+.+|+++++.++|+|+ +++++++.+ +.
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~~-~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec-CC
Confidence 4443 4799999999999955 4567889999997532 345789999999999999888 999998865 55
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 88999999 899999998765 799999999999999999999999999999999999999999999999999875322
Q ss_pred ---------CcccceeeeeceeEe
Q 024661 247 ---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---------~~~~~~~y~ape~~~ 261 (264)
...++..|||||++.
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~ 545 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECIN 545 (635)
T ss_dssp -------------CGGGSCHHHHH
T ss_pred CccccccccCCCCceeeeChhhhc
Confidence 112456799999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=221.02 Aligned_cols=166 Identities=20% Similarity=0.311 Sum_probs=126.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHH-HHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+..|+. +++.+.|+|+ +++++++.+.+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~ni-----v~~~~~~~~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI-----VQFYGALFREG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTB-----CCEEEEEECSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcE-----eeeeeEEEeCC
Confidence 347899999999999999999999999999999999753 233344555555 5555666666 99999999999
Q ss_pred EEEEEEecCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 167 HICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
..|+||||+.++|.+++.. .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999997798888773 2234799999999999999999999998 99999999999999999999999999997
Q ss_pred cCCC-----CcccceeeeeceeE
Q 024661 243 PRHA-----FSFQTFLSMASRVY 260 (264)
Q Consensus 243 ~~~~-----~~~~~~~y~ape~~ 260 (264)
.... ...++..|+|||++
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERI 197 (327)
T ss_dssp C----------------------
T ss_pred ecccccccccCCCCccccCceee
Confidence 6433 22578899999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=218.50 Aligned_cols=163 Identities=24% Similarity=0.320 Sum_probs=140.1
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
|.....||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++.+.|+|+ +++++++.+.+..++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI-----VQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCE-----eeEeeEEEeCCcEEEEE
Confidence 33445899999999999999999999999998753 3445778899999999998887 99999999999999999
Q ss_pred ecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-CCcEEeccCCCCCcCCC---
Q 024661 173 EKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-~~~v~l~Dfg~a~~~~~--- 246 (264)
|++ +++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999 899999998653 235679999999999999999999999999999999999998 89999999999975432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 179 ~~~~~~~~~~y~aPE~~~ 196 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIID 196 (295)
T ss_dssp --CCCCCCGGGCCHHHHH
T ss_pred cccccCCCccccChhhhc
Confidence 335788999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=220.52 Aligned_cols=167 Identities=14% Similarity=0.180 Sum_probs=133.8
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCC---CCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
..++|.+.+.||+|+||.||+|.+.. ++..||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~ 106 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV-----IRLLGVCI 106 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCe-----eeeeEEEe
Confidence 34679999999999999999998765 4568999998743 3445678899999999998887 99999887
Q ss_pred eCC-----EEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 164 YRN-----HICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 164 ~~~-----~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
+.. ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 654 459999999 89999999632 23469999999999999999999999999999999999999999999
Q ss_pred EeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 234 KVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 234 ~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
||+|||++..... ...++..|+|||++.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 222 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 222 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhc
Confidence 9999999976432 223566799999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=220.12 Aligned_cols=163 Identities=21% Similarity=0.303 Sum_probs=133.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-CCEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~ 169 (264)
.++|++.+.||+|+||.||+|.+. ++.||+|+++.. ...+.+.+|+.+++.++|+|+ +++++++.. .+..|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCCceE
Confidence 367999999999999999999875 788999998753 345678899999999998887 999998654 45789
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC--
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA-- 246 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~-- 246 (264)
+||||+ +++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 999999 78999999865423489999999999999999999999999999999999999999999999999876443
Q ss_pred -CcccceeeeeceeEe
Q 024661 247 -FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 172 ~~~~~~~~y~aPE~~~ 187 (278)
T 1byg_A 172 DTGKLPVKWTAPEALR 187 (278)
T ss_dssp ----CCTTTSCHHHHH
T ss_pred cCCCccccccCHHHhC
Confidence 234667799999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=227.37 Aligned_cols=164 Identities=17% Similarity=0.181 Sum_probs=131.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee-eC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~-~~ 165 (264)
..|++.+.||+|+||.||+|.+..+ +..+|+|.++.. ....+.+.+|+.+++.++|+|+ +++++++. .+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTB-----CCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCC
Confidence 3589999999999999999987543 346899988642 3455778899999999998887 99999754 46
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 7889999999 889999998654 46899999999999999999999999999999999999999999999999999753
Q ss_pred CC----------CcccceeeeeceeEe
Q 024661 245 HA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~----------~~~~~~~y~ape~~~ 261 (264)
.. ...++..|||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 269 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQ 269 (373)
T ss_dssp ---------------CCGGGSCHHHHH
T ss_pred cccccccccccCCCCCcccccChHHhc
Confidence 22 123456799999764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=218.35 Aligned_cols=161 Identities=24% Similarity=0.336 Sum_probs=139.1
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
|...+.||+|+||.||+|.+ +++.+|+|++... ....+.+.+|+.+++.++|+|+ +++++++.+.+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL-----VELLGFSSDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEecCCce
Confidence 44458999999999999986 4788999998642 2346788999999999999887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence 9999999 999999997432 24699999999999999999999999999999999999999999999999999865432
Q ss_pred --------CcccceeeeeceeEe
Q 024661 247 --------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHT
T ss_pred ccccccccccCCCcCcCChHHhc
Confidence 235788999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=217.95 Aligned_cols=161 Identities=28% Similarity=0.368 Sum_probs=133.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++|+|+ +++++++.+ ..|+|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNI-----VKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTB-----CCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcC--CcEEE
Confidence 57999999999999999999875 678999998643 445678899999999999887 888888764 47999
Q ss_pred EecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEeecCCc-EEeccCCCCCcCC
Q 024661 172 FEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHE---LRLIHTDLKPENILLVSAEY-VKVPDYKVPSPRH 245 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~Nili~~~~~-v~l~Dfg~a~~~~ 245 (264)
|||+ +++|.+++..... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999 8999999986541 247899999999999999999999 89999999999999998886 7999999997643
Q ss_pred C---CcccceeeeeceeEee
Q 024661 246 A---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~---~~~~~~~y~ape~~~~ 262 (264)
. ...+|..|+|||++.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 158 THMTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp -------CCTTSSCHHHHTC
T ss_pred cccccCCCCCceEChhhhCC
Confidence 2 3357889999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=215.86 Aligned_cols=164 Identities=23% Similarity=0.310 Sum_probs=132.0
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-CC--cEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~ 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVL 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEc
Confidence 4679999999999999999998643 33 36899988643 2445778899999999998887 99999988
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
+.. .++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 765 88999999 899999998653 368999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC---------cccceeeeeceeEe
Q 024661 243 PRHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~~---------~~~~~~y~ape~~~ 261 (264)
..... ..++..|+|||++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhc
Confidence 64332 23456799999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=215.63 Aligned_cols=165 Identities=22% Similarity=0.253 Sum_probs=127.4
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.++..+++.+.|+|+ +++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i-----~~~~~~~~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI-----VQCFGTFITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCce-----eeEEEEEecCCc
Confidence 367999999999999999999999999999999997532 222333444456666777776 999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
.|+||||+++.+..+..... ..+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++.....
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999777776665432 4699999999999999999999995 999999999999999999999999999965432
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|+|||++.
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERID 197 (318)
T ss_dssp ---------CCTTCCHHHHC
T ss_pred CccccccCCCccccChhhcc
Confidence 335788899999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=235.21 Aligned_cols=166 Identities=22% Similarity=0.275 Sum_probs=140.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCC---CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
...++|++.+.||+|+||.||+|.+..+ +..+|+|.++.. ....+.+.+|+.+++.+.|+|+ +++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~ 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEe
Confidence 3457899999999999999999998654 457999987642 3445778899999999999888 99999885
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPS 242 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~ 242 (264)
++..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 46689999999 899999998654 468999999999999999999999999999999999999999999999999998
Q ss_pred cCCCC-------cccceeeeeceeEe
Q 024661 243 PRHAF-------SFQTFLSMASRVYI 261 (264)
Q Consensus 243 ~~~~~-------~~~~~~y~ape~~~ 261 (264)
..... ..++..|||||++.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp SCCC----------CCGGGCCHHHHH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhc
Confidence 65432 23456799999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=226.92 Aligned_cols=168 Identities=21% Similarity=0.182 Sum_probs=133.6
Q ss_pred CCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeC
Q 024661 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~ 165 (264)
.+.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++.+ .|+|+ +++++++.+.
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~ 81 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV-----IRYYCSETTD 81 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCc-----CeEEEEEecC
Confidence 34566778889999999999998754 4578999999987533 35678899999987 68877 9999999999
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC----------
Q 024661 166 NHICIVFEKLGPSLYDFLRKNSYRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA---------- 230 (264)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~---------- 230 (264)
+.+|+||||++++|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999999889999998654111 1233457899999999999999999999999999999764
Q ss_pred ---CcEEeccCCCCCcCCC----------CcccceeeeeceeEee
Q 024661 231 ---EYVKVPDYKVPSPRHA----------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 231 ---~~v~l~Dfg~a~~~~~----------~~~~~~~y~ape~~~~ 262 (264)
+.+||+|||++..... ...+|..|||||++.+
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 4899999999976432 2358889999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=207.48 Aligned_cols=148 Identities=24% Similarity=0.461 Sum_probs=128.7
Q ss_pred cCCCeEEE-eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHH-HHHhccCCCCcceEEEceeeee---
Q 024661 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL-QRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 90 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
+.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+|+.++ +...|+|+ +++++++.+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i-----~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCc-----hhHHhhhhhhcC
Confidence 34567776 7899999999999999999999999999753 3456788887 44567776 899988877
Q ss_pred -CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CCcEEeccCC
Q 024661 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AEYVKVPDYK 239 (264)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~~v~l~Dfg 239 (264)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 77899999999 889999999876557999999999999999999999999999999999999998 7899999999
Q ss_pred CCCcCCC
Q 024661 240 VPSPRHA 246 (264)
Q Consensus 240 ~a~~~~~ 246 (264)
++.....
T Consensus 166 ~a~~~~~ 172 (299)
T 3m2w_A 166 FAKETTG 172 (299)
T ss_dssp TCEECTT
T ss_pred ccccccc
Confidence 9976543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=225.76 Aligned_cols=161 Identities=19% Similarity=0.142 Sum_probs=131.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.+|.+.+.||+|+||+||. ....+++.||||++..... ....+|+.+++.+ .|+|+ +++++++.+....|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnI-----v~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTB-----CCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCc-----CeEEEEEecCCEEEE
Confidence 4699999999999999653 3345788999999864322 2356799999998 68877 999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CC--cEEeccCCCCCcCC
Q 024661 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AE--YVKVPDYKVPSPRH 245 (264)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~--~v~l~Dfg~a~~~~ 245 (264)
|||+++++|.+++.... ..+.+..++.++.||+.||.|||++||+||||||+|||++. ++ ++||+|||+|....
T Consensus 96 v~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999889999998664 34555567889999999999999999999999999999953 23 67899999987543
Q ss_pred C---------CcccceeeeeceeEe
Q 024661 246 A---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~---------~~~~~~~y~ape~~~ 261 (264)
. ...+|..|||||++.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp -----------CCSCTTSCCGGGTS
T ss_pred CCCcceeeccccCCCcCccChhhhh
Confidence 2 235889999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=234.49 Aligned_cols=168 Identities=26% Similarity=0.353 Sum_probs=141.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~~v~~~~~~ 86 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV-----VSAREVPDGLQK 86 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTB-----CCEEECCTTTCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----Cceeeeeccccc
Confidence 337899999999999999999999999999999988643 3456778899999999999988 888877655
Q ss_pred ---CCEEEEEEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCc---EEec
Q 024661 165 ---RNHICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVP 236 (264)
Q Consensus 165 ---~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~---v~l~ 236 (264)
.+..|+||||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 67889999999 999999998643 235889999999999999999999999999999999999997764 9999
Q ss_pred cCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 237 DYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 237 Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
|||++..... ...++..|+|||++.+
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC
T ss_pred ccccccccccccccccccCCcccCChHHhcc
Confidence 9999976433 2357889999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-31 Score=220.10 Aligned_cols=165 Identities=18% Similarity=0.268 Sum_probs=137.0
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
+...++|++.+.||+|+||.||+|.+.. .+++|+++... ...+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~ 100 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV-----VLFMGACMS 100 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTB-----CCCCEEEEC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCE-----eEEEEEEec
Confidence 3445789999999999999999999864 38999886432 233456779999999988887 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++.++|+|||++..
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred CCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999999999 899999997653 4689999999999999999999999999999999999998 68999999999764
Q ss_pred CC-----------CCcccceeeeeceeEee
Q 024661 244 RH-----------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~-----------~~~~~~~~y~ape~~~~ 262 (264)
.. ....++..|+|||++..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccccCCCcccccChHHhhh
Confidence 32 12347888999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=218.15 Aligned_cols=168 Identities=15% Similarity=0.049 Sum_probs=128.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccC-----------CCCcceE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHD-----------IGGTRCV 156 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~-----------~~~~~~~ 156 (264)
..|.+.+.||+|+||.||+|.+..+|+.||||+++.. ....+.+.+|+.+++.+.|.. +....++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3488999999999999999999999999999998732 223567888999988887621 1111111
Q ss_pred EE------ceeeee-----CCEEEEEEecCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 024661 157 QI------RNWFDY-----RNHICIVFEKLGPSLYDFLRK-----NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (264)
Q Consensus 157 ~~------~~~~~~-----~~~~~lv~e~~~~~L~~~l~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 220 (264)
.+ ...+.. ...++++|++++++|.+++.. .....+++..++.++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 111111 235789999999999999862 22235778889999999999999999999999999
Q ss_pred CCCCEEeecCCcEEeccCCCCCcCCC---CcccceeeeeceeE
Q 024661 221 KPENILLVSAEYVKVPDYKVPSPRHA---FSFQTFLSMASRVY 260 (264)
Q Consensus 221 kp~Nili~~~~~v~l~Dfg~a~~~~~---~~~~~~~y~ape~~ 260 (264)
||+|||++.++.+||+|||+++.... ...+ ..|||||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETT 279 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhh
Confidence 99999999999999999999876433 2346 889999987
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-29 Score=220.88 Aligned_cols=149 Identities=14% Similarity=0.074 Sum_probs=116.1
Q ss_pred EEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
...+.||+|+||.||+|.. .++.+++|...... ...+.+.+|+++++.++|+|+ +.+..++.+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGI-----PAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTC-----CCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCc-----CceEEEEEeC
Confidence 4467899999999999954 46778998764211 124567899999999999998 7445555567
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..|+||||+ +++|.+++.. +..++.|++.||+|||++||+||||||+|||++. ++||+|||+|+..
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 7789999999 8999999865 4679999999999999999999999999999998 9999999999876
Q ss_pred CC-------------CcccceeeeeceeEee
Q 024661 245 HA-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ~~-------------~~~~~~~y~ape~~~~ 262 (264)
.. ...+|..|||||++..
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 54 2358899999998753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=195.10 Aligned_cols=142 Identities=22% Similarity=0.259 Sum_probs=112.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-------------------hhHHHHHHHHHHHHHHhccCCCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGG 152 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------------~~~~~~~~e~~~l~~l~~~~~~~ 152 (264)
..|.+.+.||+|+||.||+|.+ .+|+.||+|+++... .....+.+|+.+++.+.| +
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--~-- 164 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--L-- 164 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--S--
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--C--
Confidence 3466779999999999999999 889999999986322 135678899999999983 2
Q ss_pred cceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.+.+++.. +..|+||||+ +++|.+ +. . .....++.|++.||.|||++||+||||||+|||++ ++
T Consensus 165 ----~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 165 ----AVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp ----SSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT
T ss_pred ----CcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC
Confidence 23333333 4569999999 889987 32 1 22457999999999999999999999999999999 99
Q ss_pred cEEeccCCCCCcCCCCcccceeeeeceeE
Q 024661 232 YVKVPDYKVPSPRHAFSFQTFLSMASRVY 260 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~~~~~~~~y~ape~~ 260 (264)
.+||+|||+|+.. ..++|||++
T Consensus 230 ~vkl~DFG~a~~~-------~~~~a~e~l 251 (282)
T 1zar_A 230 GIWIIDFPQSVEV-------GEEGWREIL 251 (282)
T ss_dssp EEEECCCTTCEET-------TSTTHHHHH
T ss_pred cEEEEECCCCeEC-------CCCCHHHHH
Confidence 9999999999643 335666654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=180.06 Aligned_cols=138 Identities=19% Similarity=0.137 Sum_probs=110.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcE--EEEEEEechh-------------------------hhHHHHHHHHHHHHHHh
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSIN-------------------------KYREAAMIEIDVLQRLA 146 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-------------------------~~~~~~~~e~~~l~~l~ 146 (264)
|.+.+.||+|+||.||+|.+..+|+. ||||+++... .....+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778888 9999875321 11236788999999999
Q ss_pred ccCCCCcceEEEceeeeeCCEEEEEEecCC--C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecC
Q 024661 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLG--P----SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTD 219 (264)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~--~----~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~d 219 (264)
|+++..+.++.. +..+|||||++ | +|.++... .++..+..++.|++.+|.||| ++||+|||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 987654444432 35689999994 3 67776432 234467889999999999999 99999999
Q ss_pred CCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 220 LKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 220 ikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
|||+|||++. .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999988 99999999997643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=159.48 Aligned_cols=134 Identities=19% Similarity=0.179 Sum_probs=100.0
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-----------------------hhHHHHHHHHHHHHHHhccCC
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~~~ 150 (264)
|.++..||.|++|.||+|.+. +|+.||||+++... ...-...+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999974 68999999875210 011123457888888877765
Q ss_pred CCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec
Q 024661 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (264)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~ 229 (264)
..+..+ +. . ..+|||||+ |++|.++. +......++.||+.+|.+||++|||||||||.|||++.
T Consensus 176 ~vp~p~---~~--~--~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPI---AQ--S--RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEE---EE--E--TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCeee---ec--c--CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 322221 11 1 237999999 66765432 11234668899999999999999999999999999998
Q ss_pred CC----------cEEeccCCCCCc
Q 024661 230 AE----------YVKVPDYKVPSP 243 (264)
Q Consensus 230 ~~----------~v~l~Dfg~a~~ 243 (264)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 87 489999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-14 Score=116.13 Aligned_cols=139 Identities=14% Similarity=0.126 Sum_probs=107.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+.|++...++.|+.+.||++... +..+++|+..... .....+.+|+.+++.+.. .+ .+.++++++.+.+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~---~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KL---PVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TS---CCCCEEEEEEETTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CC---CCCeEEEEEecCCceEE
Confidence 45899999999999999999754 6789999886422 223468889999999965 22 34677777888889999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE------------------------------------- 212 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------- 212 (264)
|||++ |.+|.+.+. +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999 778876521 112234678899999999998
Q ss_pred ----------------------CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 213 ----------------------LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 213 ----------------------~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998765667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-13 Score=109.49 Aligned_cols=137 Identities=14% Similarity=0.101 Sum_probs=98.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.++ .+.+++.+....+..|+|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~---~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGV---PCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTC---CBCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCC---CCCeEEEeccCCCCCEEE
Confidence 3466655555667799999964 45677999987643 23457789999999987654 235566667777789999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR------------------------------------ 214 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~------------------------------------ 214 (264)
||++ |.+|. .. ..+. ..++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 94 LGEVPGQDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EECCSSEETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEecCCcccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999 76663 11 1222 245667777777777643
Q ss_pred ----------------------CeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 215 ----------------------LIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 215 ----------------------ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
++|+|++|.|||++.++.+.|+|||.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766679999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.1e-12 Score=108.33 Aligned_cols=140 Identities=15% Similarity=0.216 Sum_probs=102.3
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEEe--chh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC---CEE
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHI 168 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~---~~~ 168 (264)
..+.|+.|.++.||++... +..+++|+.. ... .....+.+|..+++.+...++ .+.+++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~v---pvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDV---PVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSS---CCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCC---CCCcEEEECCCCCccCCe
Confidence 3567899999999998764 4568888765 322 224577889999999987554 235566666555 458
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE----------------------------------- 212 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------- 212 (264)
|+|||++ |..+.+. ....++......++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999 6555331 11246788888999999999999997
Q ss_pred -----------------------CCCeecCCCCCCEEeecCCc--EEeccCCCCCcC
Q 024661 213 -----------------------LRLIHTDLKPENILLVSAEY--VKVPDYKVPSPR 244 (264)
Q Consensus 213 -----------------------~~ivH~dikp~Nili~~~~~--v~l~Dfg~a~~~ 244 (264)
.+++|+|+++.|||++.++. +.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=4.1e-10 Score=93.01 Aligned_cols=135 Identities=17% Similarity=0.182 Sum_probs=96.0
Q ss_pred eecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhc-cCCCCcceEEEceeeeeCC---EEEEEEe
Q 024661 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRN---HICIVFE 173 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~~~---~~~lv~e 173 (264)
+.++.|....||++. ..+++|+... ......+.+|..+++.+.. ..+..+. ++......+ ..|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~---~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPE---VVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCC---EEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCc---eEeecCCCCCCCcceEEEc
Confidence 458889999999863 4588897653 3445678899999999854 3443333 333322222 4589999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024661 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE---------------------------------------- 212 (264)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------- 212 (264)
++ |.+|.+.... .++......++.|++..|..||+
T Consensus 97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99 7666643332 46777778888888888888885
Q ss_pred ------------------CCCeecCCCCCCEEeec--CCcEEeccCCCCCcCC
Q 024661 213 ------------------LRLIHTDLKPENILLVS--AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 213 ------------------~~ivH~dikp~Nili~~--~~~v~l~Dfg~a~~~~ 245 (264)
..++|+|+++.||+++. ++.+.|+||+.+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 13699999999999998 4567899999886543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=9.5e-09 Score=84.95 Aligned_cols=136 Identities=19% Similarity=0.184 Sum_probs=89.5
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhcc-CCCCcceEEEceeee-eCCEEEEEEec
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFD-YRNHICIVFEK 174 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~-~~~~~~lv~e~ 174 (264)
.+.++.|....||+. +..+++|+-. .......+.+|.++++.+.+. .+ .+..++.+.. ..+..|+|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v---~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKV---NIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSS---BCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCC---CCCCeEeecccCCCceEEEEec
Confidence 345788888899987 4568888753 234456788999999999874 22 2234444432 35667899999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 024661 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------------------------------------- 213 (264)
Q Consensus 175 ~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------------------------------------- 213 (264)
+ |.+|.+.... .++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9 6666553211 233444444444444444444432
Q ss_pred --------------------CCeecCCCCCCEEeec---CCcE-EeccCCCCCcCC
Q 024661 214 --------------------RLIHTDLKPENILLVS---AEYV-KVPDYKVPSPRH 245 (264)
Q Consensus 214 --------------------~ivH~dikp~Nili~~---~~~v-~l~Dfg~a~~~~ 245 (264)
.++|+|+++.|||++. ++.+ .|+||+.+....
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999997 4554 899999886544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=3.4e-08 Score=79.93 Aligned_cols=128 Identities=12% Similarity=0.156 Sum_probs=91.5
Q ss_pred EEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHHHHH
Q 024661 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR 184 (264)
Q Consensus 106 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~ 184 (264)
..||+......+..+.+|+-... ....+.+|...++.+.. .++ +.+++.+..+.+..|+|||++ |.++.+...
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~-~vP---VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA-FMP---LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT-TSC---CCCEEEEEEETTEEEEEEECCCSEEHHHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc-CCC---cCeEEEEEEECCeEEEEEEeeCCcccccccc
Confidence 46899887777788999986533 34567889999999864 342 466777788889999999999 767776544
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------C
Q 024661 185 KNSYRSFPIDLVRELGRQLLESVAFMHE---------------------------------------------------L 213 (264)
Q Consensus 185 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------------------~ 213 (264)
... .....+..++...|..||. .
T Consensus 113 ~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 186 (272)
T 4gkh_A 113 EYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL 186 (272)
T ss_dssp HCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred CCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence 321 1122344555555555553 1
Q ss_pred -------CCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 214 -------RLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 214 -------~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.++|+|+++.|||++.++.+-|+||+.+....
T Consensus 187 ~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 187 LPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp CCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred ccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 27899999999999987777899999986533
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.71 E-value=3.8e-07 Score=76.11 Aligned_cols=143 Identities=15% Similarity=0.116 Sum_probs=82.4
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEc-e--eeeeCCEEEEEEe
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVFE 173 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~--~~~~~~~~~lv~e 173 (264)
.+.|+.|..+.||++... +..+++|+..... ..+..|..+++.+...++..+.++... + +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345666778899998753 3358899887532 344567788888876554323333211 1 1234678899999
Q ss_pred cC-CCCHH-----------HHH---H-hcCCC--C---------CCHHH-------------------------------
Q 024661 174 KL-GPSLY-----------DFL---R-KNSYR--S---------FPIDL------------------------------- 195 (264)
Q Consensus 174 ~~-~~~L~-----------~~l---~-~~~~~--~---------~~~~~------------------------------- 195 (264)
++ |..+. ..+ + ..... . ..+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99 54321 111 1 11100 0 01110
Q ss_pred HHHHHHHHHHHHHHHHH-------------CCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 196 VRELGRQLLESVAFMHE-------------LRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 196 ~~~i~~qi~~~l~~lH~-------------~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+..+..++..++.+|++ .+++|+|+++.|||++.++.+.|+||+.+...
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 11122233445666652 57999999999999988889999999988543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.3e-07 Score=80.96 Aligned_cols=76 Identities=21% Similarity=0.225 Sum_probs=48.0
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechh--------hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.||.|..+.||++....+++.+++|...... ...+....|.++++.+..... ..+..++.+ +.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~--~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP--HLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCG--GGSCCEEEE--ETTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCC--CCcCeEEEE--cCCcc
Confidence 567999999999999876667889999764221 123456779999998865310 112334332 34456
Q ss_pred EEEEecCC
Q 024661 169 CIVFEKLG 176 (264)
Q Consensus 169 ~lv~e~~~ 176 (264)
++|||++.
T Consensus 111 ~lvmE~l~ 118 (397)
T 2olc_A 111 VTVMEDLS 118 (397)
T ss_dssp EEEECCCT
T ss_pred EEEEEeCC
Confidence 89999993
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-07 Score=79.71 Aligned_cols=81 Identities=7% Similarity=0.071 Sum_probs=52.7
Q ss_pred EEEeec-ccCccEEEEEEEeC---C---CCcEEEEEEEechh---h-hHHHHHHHHHHHHHHhcc-CCCCcceEEEceee
Q 024661 95 RILSKM-GEGTFGQVVECFDN---E---KKELVAIKIVRSIN---K-YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF 162 (264)
Q Consensus 95 ~~~~~l-g~G~~g~V~~~~~~---~---~~~~vaiK~~~~~~---~-~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~ 162 (264)
...+.| +.|....+|+.... . ++..+++|+..... . ....+.+|..+++.+... .+.- .+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpv---P~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPV---PRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCC---CCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCC---CcEEEEc
Confidence 335677 88888999988653 0 15678888765432 1 124677899999999875 4432 4445444
Q ss_pred eeC---CEEEEEEecC-CCC
Q 024661 163 DYR---NHICIVFEKL-GPS 178 (264)
Q Consensus 163 ~~~---~~~~lv~e~~-~~~ 178 (264)
.+. +..|+|||++ |..
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBC
T ss_pred cCCCccCCceEEEEecCCCC
Confidence 443 3568999999 544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.32 E-value=2.4e-06 Score=70.21 Aligned_cols=69 Identities=10% Similarity=-0.030 Sum_probs=44.8
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (264)
.+.|+.|....+|++ ..+++|+............+|..+++.+...++. +.+ +.. +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~---~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEV---LHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCE---EEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-Cce---EEE--ECCCCEEEEeecC
Confidence 567888888999998 4488887764322212235689999999887764 333 222 233347899999
Q ss_pred CC
Q 024661 176 GP 177 (264)
Q Consensus 176 ~~ 177 (264)
+|
T Consensus 91 ~g 92 (301)
T 3dxq_A 91 GA 92 (301)
T ss_dssp TC
T ss_pred CC
Confidence 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.31 E-value=1.2e-05 Score=66.40 Aligned_cols=76 Identities=21% Similarity=0.221 Sum_probs=56.7
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (264)
.+.|+.|....+|+... .+..+++|+.... ....+..|...++.+....- ..+.+++.+....+..|+|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~--v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNS--INVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTS--SBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCC--CCcceEEEEeecCCceEEEEEecc
Confidence 56789999999999875 3667888987643 35678889999999976521 23456666666678899999999
Q ss_pred CCC
Q 024661 176 GPS 178 (264)
Q Consensus 176 ~~~ 178 (264)
+..
T Consensus 115 G~~ 117 (312)
T 3jr1_A 115 KSK 117 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.20 E-value=2e-05 Score=65.18 Aligned_cols=145 Identities=12% Similarity=0.178 Sum_probs=82.1
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEc-e--eeeeCCEEEEEE
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVF 172 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~--~~~~~~~~~lv~ 172 (264)
-.+.|+.|....+|++... .| .+++|+.... ...+.+..|+.+++.+...++.-+.++... + +....+..+++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3566788888899998753 23 5889987652 223456678999999987765433333221 1 122346789999
Q ss_pred ecC-CCCH-----H------HH---HHhc-C---CCC---CC---HHHHHH------------HHHHHHHHHHHHHH---
Q 024661 173 EKL-GPSL-----Y------DF---LRKN-S---YRS---FP---IDLVRE------------LGRQLLESVAFMHE--- 212 (264)
Q Consensus 173 e~~-~~~L-----~------~~---l~~~-~---~~~---~~---~~~~~~------------i~~qi~~~l~~lH~--- 212 (264)
+++ |..+ . .. ++.. . ... .. +...+. +...+...++.+..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 999 5332 1 11 1111 0 000 11 111000 00113444555553
Q ss_pred ----CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 213 ----LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 213 ----~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999999776668999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.14 E-value=8e-06 Score=70.33 Aligned_cols=33 Identities=21% Similarity=0.260 Sum_probs=28.7
Q ss_pred HCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 212 ELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 212 ~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
...++|+|+++.|||++.++ ++|+||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45799999999999998777 9999999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.03 E-value=5.4e-05 Score=62.65 Aligned_cols=77 Identities=14% Similarity=0.177 Sum_probs=48.8
Q ss_pred ecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEce--eeeeCCEEEEEEecCC
Q 024661 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKLG 176 (264)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~lv~e~~~ 176 (264)
.++ |....||++.. .+|+.+++|+..........+..|..+++.+....+.-+.++...+ .....+..+++|+++.
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 66678998754 3456799998864333445677799999999876653222222111 1233567789999994
Q ss_pred C
Q 024661 177 P 177 (264)
Q Consensus 177 ~ 177 (264)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.94 E-value=3.3e-05 Score=64.23 Aligned_cols=140 Identities=13% Similarity=0.169 Sum_probs=72.6
Q ss_pred eecccCccEE-EEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-
Q 024661 98 SKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (264)
Q Consensus 98 ~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (264)
+.|+.|.... +|+... .++..+++|...... ...+..|+.+++.+...++.-+ +++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP---~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAP---EIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCC---CEEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCC---ceeeecCCCC--EEEEeeCC
Confidence 3455444333 566653 225567777543321 1344568888888887665333 3333322233 7899999
Q ss_pred CCCHHHHHHhcC------------------------CCCCCHHHHH-------H-HH------------HHHHHHHHHHH
Q 024661 176 GPSLYDFLRKNS------------------------YRSFPIDLVR-------E-LG------------RQLLESVAFMH 211 (264)
Q Consensus 176 ~~~L~~~l~~~~------------------------~~~~~~~~~~-------~-i~------------~qi~~~l~~lH 211 (264)
+..+.+.+.... ...++..... . +. ..+...++.+-
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 556654433110 0112221110 0 00 11122223331
Q ss_pred ------HCCCeecCCCCCCEEeecC----CcEEeccCCCCCcCC
Q 024661 212 ------ELRLIHTDLKPENILLVSA----EYVKVPDYKVPSPRH 245 (264)
Q Consensus 212 ------~~~ivH~dikp~Nili~~~----~~v~l~Dfg~a~~~~ 245 (264)
...++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 2369999999999999875 689999999886543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5.1e-05 Score=64.31 Aligned_cols=138 Identities=15% Similarity=0.203 Sum_probs=82.2
Q ss_pred eecccCccEEEEEEEeCC-------CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 98 SKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+.|..|-...+|++.... .++.+++|+.-..........+|..+++.+...++. .++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~----P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG----PQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS----CCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC----CeEEEEcCC----cc
Confidence 457667778899988642 356799998643222345667899999999988773 333444443 28
Q ss_pred EEecC-CCCHH--------------HHHH---hcC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 024661 171 VFEKL-GPSLY--------------DFLR---KNS---YRSFP--IDLVRELGRQLLE-------------------SVA 208 (264)
Q Consensus 171 v~e~~-~~~L~--------------~~l~---~~~---~~~~~--~~~~~~i~~qi~~-------------------~l~ 208 (264)
||||+ |..|. +.|. ... ..... +..+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999 53321 1111 111 01122 3455555554422 233
Q ss_pred HHHH----C----CCeecCCCCCCEEeecC----CcEEeccCCCCCc
Q 024661 209 FMHE----L----RLIHTDLKPENILLVSA----EYVKVPDYKVPSP 243 (264)
Q Consensus 209 ~lH~----~----~ivH~dikp~Nili~~~----~~v~l~Dfg~a~~ 243 (264)
.|.+ . .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3322 2 48999999999999987 7899999999865
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=3.1e-05 Score=63.04 Aligned_cols=77 Identities=12% Similarity=0.031 Sum_probs=52.8
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhcc-CCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~ 168 (264)
.....-.+.+|.|..+.||+.+. .+|+.+.+|+..... .....+..|...|+.+... .+..+ +++.. + .-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP---~v~~~--~--~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVP---QVAGW--D--DR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSC---CEEEE--E--TT
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcc---eEEec--c--Cc
Confidence 34566678899999999999985 567889999765322 2234677899999999654 33333 33322 2 23
Q ss_pred EEEEecC
Q 024661 169 CIVFEKL 175 (264)
Q Consensus 169 ~lv~e~~ 175 (264)
++|||++
T Consensus 86 ~lv~e~l 92 (288)
T 3f7w_A 86 TLAMEWV 92 (288)
T ss_dssp EEEEECC
T ss_pred eEEEEee
Confidence 7899998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0003 Score=58.63 Aligned_cols=72 Identities=14% Similarity=0.137 Sum_probs=44.7
Q ss_pred ccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCC-CcceEEEc-e--eeeeCCEEEEEEecC-
Q 024661 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRCVQIR-N--WFDYRNHICIVFEKL- 175 (264)
Q Consensus 101 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~-~~~~~~~~-~--~~~~~~~~~lv~e~~- 175 (264)
|.|....||++... +| .+++|+..... ...|+.+++.+....+. -+..+... + +....+..+++|+++
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 44446789998743 34 79999876533 14678888888776653 22222211 1 123457889999999
Q ss_pred CCCH
Q 024661 176 GPSL 179 (264)
Q Consensus 176 ~~~L 179 (264)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 5444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0011 Score=57.14 Aligned_cols=70 Identities=14% Similarity=0.192 Sum_probs=47.6
Q ss_pred EeecccCccEEEEEEEeCC-------CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.+.|+.|....+|++.... .+..+++|+.... .....+.+|..+++.+...++. .++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~----P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG----PKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS----SCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCC----CcEEEEeCC----C
Confidence 5578888889999998643 2567999987431 1114556799999999887763 233444332 3
Q ss_pred EEEecC
Q 024661 170 IVFEKL 175 (264)
Q Consensus 170 lv~e~~ 175 (264)
+|+||+
T Consensus 149 ~v~e~l 154 (429)
T 1nw1_A 149 RLEEYI 154 (429)
T ss_dssp EEECCC
T ss_pred EEEEEe
Confidence 899999
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00012 Score=61.71 Aligned_cols=71 Identities=20% Similarity=0.171 Sum_probs=42.3
Q ss_pred EeecccCccEEEEEEEeCC--------CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 97 LSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.|+.|....+|++.... .+..+++|+.............|..+++.+...++ .+ +++..+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P---~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-AP---QLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SC---CEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CC---ceEEec--CC--
Confidence 4567778888899987643 13678889765432222224678999999987765 22 333332 22
Q ss_pred EEEEecC
Q 024661 169 CIVFEKL 175 (264)
Q Consensus 169 ~lv~e~~ 175 (264)
++||||+
T Consensus 110 ~~v~e~i 116 (369)
T 3c5i_A 110 GRIEEWL 116 (369)
T ss_dssp EEEEECC
T ss_pred cEEEEEe
Confidence 6899999
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00054 Score=59.55 Aligned_cols=71 Identities=15% Similarity=0.113 Sum_probs=45.0
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (264)
.+.|+.|-...+|++.....+..+++|+........-...+|..+++.+...++. .++++.+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~----P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIA----KKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSB----CCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCC----CCEEEEeC--C--eEEEEee
Confidence 4578888889999998765457789998753221111125799999999877653 33444442 2 2599999
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.015 Score=49.96 Aligned_cols=74 Identities=16% Similarity=0.126 Sum_probs=46.5
Q ss_pred EeecccCccEEEEEEEeCCC-------CcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 97 LSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.+.+..|-...+|++..... ++.+++|+........-...+|..+++.+...++. .++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~----P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIA----PNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSS----CCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCC----CCEEEEcC--C--C
Confidence 45676777788999886521 57789998643222222235799999999877763 23333222 2 7
Q ss_pred EEEecC-CCC
Q 024661 170 IVFEKL-GPS 178 (264)
Q Consensus 170 lv~e~~-~~~ 178 (264)
+||||+ |..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 899999 543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.023 Score=48.38 Aligned_cols=29 Identities=28% Similarity=0.424 Sum_probs=25.2
Q ss_pred CeecCCCCCCEEee------cCCcEEeccCCCCCc
Q 024661 215 LIHTDLKPENILLV------SAEYVKVPDYKVPSP 243 (264)
Q Consensus 215 ivH~dikp~Nili~------~~~~v~l~Dfg~a~~ 243 (264)
++|+|+.+.|||+. .++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999994 456899999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=87.52 E-value=2 Score=33.08 Aligned_cols=60 Identities=15% Similarity=0.034 Sum_probs=46.5
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEecc
Q 024661 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPD 237 (264)
Q Consensus 177 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~D 237 (264)
-+|.++|...+ .+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|+|.+.+
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 37999999775 689999999999999999887632 2212333456899999999998774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.86 E-value=3 Score=32.03 Aligned_cols=77 Identities=13% Similarity=0.022 Sum_probs=55.9
Q ss_pred eeCCEEEEEEecC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHHCCCeecCCCCCCEEeecCCcEEeccCC
Q 024661 163 DYRNHICIVFEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVA-FMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~-~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg 239 (264)
.+++.+.+.++.- ++ ++.. ++ .++....++++.+|+.... ++ ..-+|--|+|+||+++.++.+++...|
T Consensus 58 ~~eD~~~i~y~~~~~~~~f~~-i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRG 129 (219)
T 4ano_A 58 VSEDEVKVVIKPPSSFLTFAA-IR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVG 129 (219)
T ss_dssp ECSSEEEEEEECCTTCEEHHH-HH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCE
T ss_pred EeCCEEEEEEEcCcccCcHHH-HH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcC
Confidence 5667777777776 33 4443 33 4777888888888776555 33 456777899999999999999999999
Q ss_pred CCCcCCCC
Q 024661 240 VPSPRHAF 247 (264)
Q Consensus 240 ~a~~~~~~ 247 (264)
+-....+.
T Consensus 130 i~~~lpP~ 137 (219)
T 4ano_A 130 VKESLPPD 137 (219)
T ss_dssp ETTTBSSC
T ss_pred CcccCCCC
Confidence 86554443
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=81.87 E-value=19 Score=29.49 Aligned_cols=77 Identities=16% Similarity=0.124 Sum_probs=43.7
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHH--HHHHHHHHHCC-----CeecCCCCCCEEeecCC-cEEecc
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL--LESVAFMHELR-----LIHTDLKPENILLVSAE-YVKVPD 237 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi--~~~l~~lH~~~-----ivH~dikp~Nili~~~~-~v~l~D 237 (264)
..+++|+|. |..|.+.-...-...+.++. ..++ +-+++.+..++ +.+.--.++|||++.++ .+.++|
T Consensus 156 ~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~~~ID 231 (342)
T 1cja_A 156 ANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPID 231 (342)
T ss_dssp SEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECS
T ss_pred cceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChhheEEeCCCCeEEEEc
Confidence 567999999 55544321100000133333 2332 33566666552 22233578999999765 489999
Q ss_pred CCCCCcCCCC
Q 024661 238 YKVPSPRHAF 247 (264)
Q Consensus 238 fg~a~~~~~~ 247 (264)
-+++...+..
T Consensus 232 hn~af~~~s~ 241 (342)
T 1cja_A 232 SKIIPLDASH 241 (342)
T ss_dssp CCCCCCCSSC
T ss_pred CCccccCCcH
Confidence 9999775543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 264 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-28 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-24 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-22 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-22 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-22 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-21 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-20 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-20 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-20 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-19 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-19 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-18 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-18 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-18 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-17 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-16 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-16 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-15 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-15 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-12 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-31
Identities = 39/151 (25%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLAR 147
N + I+ ++G+G FG+V + + E L A K++ + + + E M+EID+L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I V++ + F Y N++ I+ E D + R ++ + +Q L+++
Sbjct: 69 PNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H+ ++IH DLK NIL +K+ D+
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADF 154
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 113 bits (284), Expect = 8e-31
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----------SINKYREAAMIEIDVL 142
Y +G G V C + A+KI+ + + REA + E+D+L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
++++ H +Q+++ ++ +VF+ + L+D+L + + R++ R
Sbjct: 64 RKVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
LLE + +H+L ++H DLKPENILL +K+ D+
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 154
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-28
Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 16/173 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ E+++ L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I +++ +F + ++ E ++Y L+K F +L ++
Sbjct: 67 NI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANAL 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY----KVPSPRHAFSFQTFLSMA 256
++ H R+IH D+KPEN+LL SA +K+ D+ PS R T +
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 172
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-28
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 5/152 (3%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA 146
++ PRY LS +GEG +G V +DN K VAIK + Y + + EI +L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I G + + + +V +G LY L+ + D + Q+L
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H ++H DLKP N+LL + +K+ D+
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 153
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-28
Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 93 RYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP-- 65
Query: 152 GTRCVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
V+I + ++ R + IV E L G L+ ++ ++F E+ + + E+
Sbjct: 66 --HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 207 VAFMHELRLIHTDLKPENILLVS 229
+ ++H + + H D+KPEN+L S
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTS 146
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 9e-28
Identities = 33/150 (22%), Positives = 64/150 (42%), Gaps = 11/150 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ +S++G G G V + ++A K++ R + E+ VL
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSP- 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V F I I E + G SL L+K P ++ ++ +++ + +
Sbjct: 65 ---YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 119
Query: 210 MHE-LRLIHTDLKPENILLVSAEYVKVPDY 238
+ E +++H D+KP NIL+ S +K+ D+
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDF 149
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 1e-27
Identities = 30/149 (20%), Positives = 64/149 (42%), Gaps = 7/149 (4%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I + + F+ + ++FE + G +++ + +++ + Q+ E+
Sbjct: 61 RNI-----LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKV 235
+ F+H + H D++PENI+ + +
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI 143
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 105 bits (262), Expect = 5e-27
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
Y I ++G G FG V + A K V + + +E EI + L RH
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP-- 83
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + F+ N + +++E + G L++ + + D E RQ+ + + M
Sbjct: 84 --TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 140
Query: 211 HELRLIHTDLKPENILLVSAE--YVKVPDY 238
HE +H DLKPENI+ + +K+ D+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDF 170
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 104 bits (260), Expect = 1e-26
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
Y IL ++G G FG V C + + K + + + EI ++ +L H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP-- 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+ + + + F+ + + ++ E L G L+D + Y+ V RQ E + M
Sbjct: 87 --KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 211 HELRLIHTDLKPENILLVSAE--YVKVPDY 238
HE ++H D+KPENI+ + + VK+ D+
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDF 173
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-26
Identities = 37/149 (24%), Positives = 66/149 (44%), Gaps = 10/149 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++ +GEG +G+V + +E VA+KIV E EI + + L H+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V+ N + E G L+D + + P + QL+ V +
Sbjct: 64 ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H + + H D+KPEN+LL + +K+ D+
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDF 147
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (254), Expect = 2e-26
Identities = 37/172 (21%), Positives = 75/172 (43%), Gaps = 10/172 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
+Y K+G+G G V D + VAI+ + +E + EI V++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP-- 77
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + + + +V E L G SL D + + + + R+ L+++ F+
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFL 132
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRVYIC 262
H ++IH D+K +NILL VK+ D+ + + + + ++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (252), Expect = 6e-26
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQ 143
++ + L ++G G+FG V D E+VAIK + N+ + + E+ LQ
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L RH +Q R + + +V E S D L + + + +
Sbjct: 71 KL-RHP----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L+ +A++H +IH D+K NILL VK+ D+
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 3e-25
Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 7/153 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLARH 148
+Y ++++GEG +G+V + D + VA+K VR + + E+ VL+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 149 D---IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+ + V + D + +VFE + L +L K P + ++++ QLL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ F+H R++H DLKP+NIL+ S+ +K+ D+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 6e-25
Identities = 44/149 (29%), Positives = 80/149 (53%), Gaps = 8/149 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ + K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + N + +VFE L L F+ ++ P+ L++ QLL+ +AF
Sbjct: 63 I-----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H R++H DLKP+N+L+ + +K+ D+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADF 146
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 2e-24
Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L+K+G+GTFG+V + + + VA+K V N + A+ EI +LQ L +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 150 IG---GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + + + I +VF+ L L N F + ++ + + LL
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H +++H D+K N+L+ +K+ D+
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADF 161
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.4 bits (242), Expect = 2e-24
Identities = 38/160 (23%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQR 144
E++ Y +G G F +V+ D ++LVAIK + ++ + EI VL +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ +H V + + ++ H+ ++ + + G L+D + + + + L Q+
Sbjct: 64 I-KHP----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQV 116
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAE---YVKVPDYKV 240
L++V ++H+L ++H DLKPEN+L S + + + D+ +
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.4 bits (239), Expect = 3e-24
Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 6/147 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
RYR+ K+G G+FG + D E VAIK+ + IE + + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVG-- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
IR ++ +V E LGPSL D S R F + V L Q++ + ++H
Sbjct: 65 --IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYK 239
IH D+KP+N L+ + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYII 148
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 1e-23
Identities = 39/147 (26%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ--- 68
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
R V++ + I I+ E + SL DFL+ S I+ + ++ Q+ E +AF+
Sbjct: 69 -RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY 238
E IH DL+ NIL+ K+ D+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADF 153
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 2e-23
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 12/151 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ +GEG+F VV + AIKI+ E DV+ RL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V++ F + L ++RK SF R +++ ++
Sbjct: 68 P----FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H +IH DLKPENILL ++++ D+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDF 152
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.1 bits (233), Expect = 2e-23
Identities = 37/135 (27%), Positives = 59/135 (43%), Gaps = 6/135 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
Y++ ++GEG+FG + E + + VAIK E + LA
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTG-- 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ + H +V + LGPSL D L R F + V +Q+L V +HE
Sbjct: 63 --IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE 119
Query: 213 LRLIHTDLKPENILL 227
L++ D+KP+N L+
Sbjct: 120 KSLVYRDIKPDNFLI 134
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.8 bits (235), Expect = 3e-23
Identities = 31/151 (20%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG+V C + ++ A+K + + + A+ E +L ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
D V + F + + + + + G L+ L ++ F +R +++ +
Sbjct: 65 DC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 120
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
MH +++ DLKP NILL +V++ D
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDL 151
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 1e-22
Identities = 32/151 (21%), Positives = 65/151 (43%), Gaps = 11/151 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G+G+FG+V + + AIK ++ ++ E M+E VL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ F + ++ V E L G L ++ F + +++ +
Sbjct: 63 PF----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 116
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
F+H +++ DLK +NILL ++K+ D+
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (226), Expect = 2e-22
Identities = 36/169 (21%), Positives = 70/169 (41%), Gaps = 13/169 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
++L +G+G FG V+ + VA+K +++ + +A + E V+ +L ++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNL-- 62
Query: 153 TRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ+ + + + IV E + SL D+LR D + + + E++ ++
Sbjct: 63 ---VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY---KVPSPRHAFSFQTFLSMA 256
+H DL N+L+ KV D+ K S A
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 168
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 2e-22
Identities = 35/176 (19%), Positives = 73/176 (41%), Gaps = 12/176 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ ++ F + +C V E G L+ L + R F + R G +++ ++
Sbjct: 67 L-----TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRVYICIN 264
++H +++ D+K EN++L ++K+ D+ + + + Y+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (226), Expect = 2e-22
Identities = 32/158 (20%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
Y +L +G G++G+ + +++ K + ++ + E+++L+ L +I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLE 205
V+ + R + IV E G L + K + + + V + QL
Sbjct: 66 -----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDY 238
++ H ++H DLKP N+ L + VK+ D+
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.9 bits (225), Expect = 3e-22
Identities = 31/147 (21%), Positives = 64/147 (43%), Gaps = 6/147 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ K+G G +G+V E + VA+K ++ E + E V++ + ++
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-- 75
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
VQ+ I+ E + +L D+LR+ + + ++ + Q+ ++ ++
Sbjct: 76 ---VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY 238
+ IH DL N L+ VKV D+
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADF 159
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 4e-22
Identities = 36/168 (21%), Positives = 68/168 (40%), Gaps = 10/168 (5%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KY 131
+ G Y + + + YR L +G G +G V D VAIK + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 132 REAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
+ A E+ +L+ + ++ G D +V +G L ++
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EK 117
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
D ++ L Q+L+ + ++H +IH DLKP N+ + +K+ D+
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 4e-22
Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRL 145
+Y++ +G G FG V VAIK V +E+ +L+++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+ G +++ +WF+ + ++ E+ P F + +L R Q+LE
Sbjct: 65 SSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEY-VKVPDY 238
+V H ++H D+K ENIL+ +K+ D+
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.0 bits (225), Expect = 6e-22
Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ + +G G+FG+V+ E A+KI+ K E + E +LQ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ ++ D N ++ G ++ LR+ F R Q++ +
Sbjct: 102 FL----VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H L LI+ DLKPEN+L+ Y++V D+
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 8e-22
Identities = 39/170 (22%), Positives = 65/170 (38%), Gaps = 28/170 (16%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R +G G FG+VVE ++ VA+K+++ + REA M E+ VL L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK----------------NSY 188
H V + ++ E L +FLR+ +
Sbjct: 84 GNHM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++ + Q+ + +AF+ IH DL NILL K+ D+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 2e-21
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 85 AIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
A+G + R+ + ++G G+F V + D E VA ++ R+ E +
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60
Query: 141 VLQRLARHDIGGTRCVQIRNWF----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
+L+ L +H V+ + + + I +V E + +L +L++ + I +
Sbjct: 61 MLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKV 113
Query: 196 VRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEY-VKVPDY 238
+R RQ+L+ + F+H +IH DLK +NI + VK+ D
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 3e-21
Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHD 149
L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L+ +
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I + + + F ++++I +VF+ + L ++ NS P ++ L+ + +
Sbjct: 62 I-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H+ ++H DLKP N+LL +K+ D+
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADF 144
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-21
Identities = 38/166 (22%), Positives = 72/166 (43%), Gaps = 20/166 (12%)
Query: 65 IPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
+ G P RP + Y +G G+FG V + + ELVAIK
Sbjct: 7 VATPGQGPDRPQEVS--------------YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 52
Query: 125 VRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFL 183
V +++ E+ ++++L +I R ++ +V + + ++Y
Sbjct: 53 VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 184 RK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
R + ++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 4e-21
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 6/146 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
R+ K+G+G FG+V N VAIK ++ EA + E V+++L +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
VQ+ + SL DFL+ + + + + ++ Q+ +A++
Sbjct: 75 ---VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDY 238
+ +H DL+ NIL+ KV D+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADF 157
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.2 bits (218), Expect = 5e-21
Identities = 34/149 (22%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++IL +G G+FG+V A+K+++ K E E +L +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I +++ F I ++ + + L + S R FP + + ++ ++ +
Sbjct: 66 I-----IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
+H +I+ DLKPENILL ++K+ D+
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDF 148
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.5 bits (216), Expect = 7e-21
Identities = 30/156 (19%), Positives = 63/156 (40%), Gaps = 10/156 (6%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRS--INKYREAAMIEIDVL 142
E +I +G G FG+V +++ VAIK ++S K R + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ ++ + + + I+ E + D + + F + + + R
Sbjct: 82 GQFDHPNV-----IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ + ++ ++ +H DL NIL+ S KV D+
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF 172
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 86.9 bits (214), Expect = 1e-20
Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 10/173 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + +N + A+K +R + EI +L+ L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + + + +VFE L L L + QLL +A+
Sbjct: 62 I-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRVYIC 262
H+ R++H DLKP+N+L+ +K+ D+ + + + + Y
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 1e-20
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+ + +H + + ++ + + ++ E + G L+DFL + S + E
Sbjct: 66 ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVS 229
+Q+L V ++H L++ H DLKPENI+L+
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 2e-20
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 86 IGENLTP-RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR 144
GE RY ++ K+G G F V D VA+KIVR Y EAA EI +LQR
Sbjct: 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65
Query: 145 LARHDIGGTRCVQIRN----------WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+ D + + H+ +VFE LG +L ++K +R P+
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 195 LVRELGRQLLESVAFMHELR-LIHTDLKPENILL 227
V+++ +QLL + +MH +IHTD+KPEN+L+
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (212), Expect = 2e-20
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + + E E+VA+K VR + +A+ EI +L+ L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + + +VFE + ++V+ QLL+ + F
Sbjct: 63 I-----VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDY 238
H ++H DLKP+N+L+ +K+ ++
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANF 145
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 2e-20
Identities = 32/175 (18%), Positives = 65/175 (37%), Gaps = 33/175 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKEL-----VAIKIVR--SINKYREAAMIEIDVLQRL 145
+G G FG+V+ + VA+K+++ + + REA M E+ ++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR--------------- 189
H+ V + I ++FE L ++LR +
Sbjct: 98 GSHE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 190 ------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ + Q+ + + F+ +H DL N+L+ + VK+ D+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 85.6 bits (211), Expect = 2e-20
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 16/159 (10%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR 144
+L+ RY + +G G +V D VA+K++R + E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 145 LARHDIGGTRCVQIRNWFDYRNH----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
L I V + + + IV E + G +L D + E+
Sbjct: 64 LNHPAI-----VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+++ F H+ +IH D+KP NI++ + VKV D+
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 155
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.7 bits (211), Expect = 4e-20
Identities = 27/152 (17%), Positives = 66/152 (43%), Gaps = 15/152 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGP--- 90
Query: 153 TRCVQIRNWF--DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ + + +VFE + + +R ++L+++ +
Sbjct: 91 -NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 210 MHELRLIHTDLKPENILLVSAE-YVKVPDYKV 240
H + ++H D+KP N+++ +++ D+ +
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (209), Expect = 5e-20
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ + ++G G+FG V + + VA+K++ + +A E+ VL++ +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + + + IV + G SLY L + F + + ++ RQ + +
Sbjct: 66 I-----LLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++H +IH DLK NI L VK+ D+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDF 148
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 6e-20
Identities = 35/154 (22%), Positives = 69/154 (44%), Gaps = 7/154 (4%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL 145
+ RY+ LS +G G +G V FD + VA+K + + + E+ +L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 146 ARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
++ G + N + +V +G L + ++ + D V+ L Q+L
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ ++H +IH DLKP N+ + +K+ D+
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 165
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.2 bits (205), Expect = 2e-19
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 6/149 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ ++G G FG V + K+ VAIK +R E + E +V+ +L H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP--- 60
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ VQ+ + IC+VFE + + F + + + + E +A++ E
Sbjct: 61 -KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKVP 241
+IH DL N L+ + +KV D+ +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMT 148
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 3e-19
Identities = 33/178 (18%), Positives = 68/178 (38%), Gaps = 23/178 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ +GEG FGQV++ + + AIK ++ E++VL +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPI 193
+ + ++R ++ + E +L DFLRK+ +
Sbjct: 71 P----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQT 251
+ + + ++ + + IH DL NIL+ K+ D+ + + + +T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 4e-19
Identities = 32/151 (21%), Positives = 60/151 (39%), Gaps = 11/151 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLAR 147
R + +GEG FG V + VAIK ++ + RE + E +++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
H V++ N + I+ E + S + + QL ++
Sbjct: 67 HP----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
A++ R +H D+ N+L+ S + VK+ D+
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (204), Expect = 4e-19
Identities = 34/164 (20%), Positives = 66/164 (40%), Gaps = 8/164 (4%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
RY+ L +G G G V +D VAIK + + + A E+ +++ + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 150 IGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + + + +V E + +L ++ + + L Q+L +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIK 133
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTF 252
+H +IH DLKP NI++ S +K+ D+ + T
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 4e-18
Identities = 30/145 (20%), Positives = 60/145 (41%), Gaps = 6/145 (4%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
L ++G G FG V + + VAIK+++ + + + E V+ L+ +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL--- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ + I I+ E + + F + E+ + + E++ ++
Sbjct: 62 --VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
+ +H DL N L+ VKV D+
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDF 144
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 5e-18
Identities = 34/173 (19%), Positives = 64/173 (36%), Gaps = 9/173 (5%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G+G FG+V + E VA+KI S + EI L +I G
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLES 206
++ + + +V + SL+D+L + + + L +E
Sbjct: 62 FIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRV 259
V + + H DLK +NIL+ + D + + + ++ RV
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.4 bits (195), Expect = 5e-18
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 12/145 (8%)
Query: 99 KMGEGTFGQVVECFDNEKKE--LVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + +K+ VAIK+++ + E M E ++ +L I
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI---- 71
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + +V E G L+ FL P+ V EL Q+ + ++ E
Sbjct: 72 -VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
+H DL N+LLV+ Y K+ D+
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDF 153
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 7e-18
Identities = 33/157 (21%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 93 RYRILSKMGEGTFGQV---VECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQR 144
+ +L +G G +G+V + ++ +L A+K+++ K E E VL+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ + V + F + ++ + G L+ L + F V+ ++
Sbjct: 85 IRQSPF----LVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEI 138
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240
+ ++ +H+L +I+ D+K ENILL S +V + D+ +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.1 bits (194), Expect = 8e-18
Identities = 32/176 (18%), Positives = 63/176 (35%), Gaps = 35/176 (19%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ +GEG FG+V + E +VA+K+++ + + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-------------- 190
V++ +C++FE + L +FLR S +
Sbjct: 74 DNP-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 191 --------FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ RQ+ +A++ E + +H DL N L+ VK+ D+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 9e-18
Identities = 28/170 (16%), Positives = 64/170 (37%), Gaps = 28/170 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFD-------NEKKELVAIKIVR--SINKYREAAMIEIDVLQ 143
R + +GEG FGQVV + VA+K+++ + K + E+++++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--------------KNSY 188
+ +H + + + ++ E +L ++L+ N
Sbjct: 74 MIGKHKN----IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
+ Q+ + ++ + IH DL N+L+ +K+ D+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 179
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 1e-17
Identities = 30/155 (19%), Positives = 62/155 (40%), Gaps = 11/155 (7%)
Query: 93 RYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLA 146
+G G FG+V + +K+ VAIK ++ K R + E ++ + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H+I +++ + I+ E + D + F + + + R +
Sbjct: 68 HHNI-----IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241
+ ++ + +H DL NIL+ S KV D+ +
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 1e-16
Identities = 34/145 (23%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
++G G FG V + + KK + VA+KI++ + ++ + E +V+Q+L +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + + + ++ L +L++N R + EL Q+ + ++ E
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126
Query: 214 RLIHTDLKPENILLVSAEYVKVPDY 238
+H DL N+LLV+ Y K+ D+
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDF 151
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 2e-16
Identities = 31/152 (20%), Positives = 63/152 (41%), Gaps = 13/152 (8%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVR----SINKYREAAMIEIDVLQRL 145
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
++ +++ + +V E + F + + Q+ E
Sbjct: 69 DHRNL-----IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+ ++ R IH DL N+LL + + VK+ D
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 3e-16
Identities = 29/165 (17%), Positives = 67/165 (40%), Gaps = 21/165 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ + ++G+G+FG V E +E + VAIK V + + R + E V++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--------SYRSFPIDLV 196
H + V++ ++ E + L +LR + +
Sbjct: 81 NCHHV-----VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241
++ ++ + +A+++ + +H DL N ++ VK+ D+ +
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 1e-15
Identities = 29/151 (19%), Positives = 63/151 (41%), Gaps = 12/151 (7%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLAR 147
++ + +G G FG V + + E VAIK +R K + + E V+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ ++ I L D++R++ + + Q+ + +
Sbjct: 71 PHV-----CRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGM 124
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ + RL+H DL N+L+ + ++VK+ D+
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDF 155
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.5 bits (174), Expect = 3e-15
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 27/169 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R ++ +G G FGQV+E VA+K+++ + + A M E+ +L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 146 ARHDIGGTRCVQIRN-WFDYRNHICIVFEKL-GPSLYDFLRKN--------------SYR 189
H V + + ++ E +L +LR
Sbjct: 74 GHHLN----VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
++ + Q+ + + F+ + IH DL NILL VK+ D+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 8e-15
Identities = 26/166 (15%), Positives = 56/166 (33%), Gaps = 9/166 (5%)
Query: 99 KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
+G G FG V + KK A+K + I + E +++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV--- 90
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+ +V + +N + + + G Q+ + + F+
Sbjct: 91 -LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFSFQTFLSMASRV 259
+ +H DL N +L VKV D+ + + F + +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 60.6 bits (146), Expect = 7e-12
Identities = 20/144 (13%), Positives = 43/144 (29%), Gaps = 3/144 (2%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD-IG 151
I MGEG V C+ + E +K + +++ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ + + L + + ++ E+ +LE VA +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 212 ELRLIHTDLKPENILLVSAEYVKV 235
++H DL N+L+ +
Sbjct: 121 HRGIVHGDLSQYNVLVSEEGIWII 144
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 264 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.36 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.7 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=288.71 Aligned_cols=165 Identities=23% Similarity=0.361 Sum_probs=146.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... ...+.+.+|+.+++.++|+|+ +++++++.+++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTB-----CCEEEEEEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCE-----eeEeeeeccCcee
Confidence 467999999999999999999999999999999987543 334678899999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC--
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH-- 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~-- 245 (264)
|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999 889999997654 79999999999999999999999999999999999999999999999999997532
Q ss_pred ------CCcccceeeeeceeEee
Q 024661 246 ------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ------~~~~~~~~y~ape~~~~ 262 (264)
....||+.|||||++.+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHC
T ss_pred CccccccceeeCcCccCHhHhcC
Confidence 23468999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=281.43 Aligned_cols=164 Identities=22% Similarity=0.344 Sum_probs=149.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. ...+.+.+|+++++.++|+|+ +++++++.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEEECCE
Confidence 57999999999999999999999999999999997532 345678899999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|.....
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999 899999998765 799999999999999999999999999999999999999999999999999976543
Q ss_pred ----CcccceeeeeceeEee
Q 024661 247 ----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~~ 262 (264)
...||..|||||++.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTT
T ss_pred CcccccCCCCcccCHHHHcC
Confidence 2358999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=285.54 Aligned_cols=164 Identities=26% Similarity=0.347 Sum_probs=148.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.++|++.++||+|+||+||+|.++.+|+.||+|+++... ...+.+.+|+.+++.++|+|+ ++++++|.+.+.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCE-----eeEeEEEEECCEEE
Confidence 457999999999999999999999999999999997543 345778999999999999988 99999999999999
Q ss_pred EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
+||||+ +|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999 99999988764 59999999999999999999999999999999999999999999999999997542
Q ss_pred ---CCcccceeeeeceeEee
Q 024661 246 ---AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~~ 262 (264)
....||+.|||||++.+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~ 190 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTR 190 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSS
T ss_pred ccccccccCCCccChhhhcC
Confidence 23358999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=289.87 Aligned_cols=167 Identities=22% Similarity=0.312 Sum_probs=149.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
...++|+++++||+|+||+||+|+++.+|+.||+|+++.. ....+.+.+|+.+++.++|+|+ ++++++|.+.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTB-----CCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECC
Confidence 4567899999999999999999999999999999999743 3446788999999999999888 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
.+|+||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+..
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999 899999998765 79999999999999999999997 59999999999999999999999999999753
Q ss_pred ----CCCcccceeeeeceeEee
Q 024661 245 ----HAFSFQTFLSMASRVYIC 262 (264)
Q Consensus 245 ----~~~~~~~~~y~ape~~~~ 262 (264)
.....||..|||||++.+
T Consensus 156 ~~~~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 156 IDSMANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp HHHTC---CCSSCCCCHHHHHC
T ss_pred CCCccccccCCccccCchHHcC
Confidence 234479999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=282.65 Aligned_cols=164 Identities=26% Similarity=0.440 Sum_probs=148.2
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
+.|++++.||+|+||+||+|+++.+++.||+|++++. ....+.+.+|+++++.++|+|+ +++++++.+.+.+|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCeEEE
Confidence 5699999999999999999999999999999999753 3445678899999999999888 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC----
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH---- 245 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~---- 245 (264)
||||+ +|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|....
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999 999999987643 369999999999999999999999999999999999999999999999999997532
Q ss_pred --CCcccceeeeeceeEe
Q 024661 246 --AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 --~~~~~~~~y~ape~~~ 261 (264)
....||+.|||||++.
T Consensus 166 ~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHTCCCSCCTTCCHHHHT
T ss_pred cccccccccccCCHHHHh
Confidence 2456899999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-42 Score=284.59 Aligned_cols=164 Identities=25% Similarity=0.313 Sum_probs=146.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
.+|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLREHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEECCE
Confidence 4599999999999999999999999999999998743 2344678899999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999 777776666554 799999999999999999999999999999999999999999999999999986543
Q ss_pred --CcccceeeeeceeEee
Q 024661 247 --FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 --~~~~~~~y~ape~~~~ 262 (264)
...||+.|||||++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILA 185 (309)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred CCccccCccccCHHHHhc
Confidence 4469999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=280.55 Aligned_cols=163 Identities=23% Similarity=0.303 Sum_probs=147.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+++++.++|+|+ +++++++.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTB-----CCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCe-----eEEEEEEEECCE
Confidence 56999999999999999999999999999999997532 344678999999999999988 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999 899999998776 799999999999999999999999999999999999999999999999999975421
Q ss_pred --------CcccceeeeeceeEe
Q 024661 247 --------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 --------~~~~~~~y~ape~~~ 261 (264)
...||..|||||++.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~ 183 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLT 183 (288)
T ss_dssp ---------CCCCGGGCCHHHHH
T ss_pred CCcccccccccCCccccCceeec
Confidence 235899999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-42 Score=280.56 Aligned_cols=166 Identities=19% Similarity=0.247 Sum_probs=151.1
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.++|++.++||+|+||.||+|.++.+++.||||+++......+.+.+|+++++.++|+|+ +++++++.+.+.+|+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCE-----ecCCccEeeCCeeEE
Confidence 467999999999999999999999999999999998766667889999999999999988 999999999999999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCCc-
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAFS- 248 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~~- 248 (264)
||||+ +|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999 8999999987766689999999999999999999999999999999999999999999999999998754322
Q ss_pred ------ccceeeeeceeEe
Q 024661 249 ------FQTFLSMASRVYI 261 (264)
Q Consensus 249 ------~~~~~y~ape~~~ 261 (264)
.++..|||||++.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~ 189 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLA 189 (287)
T ss_dssp EEETTEEECGGGCCHHHHH
T ss_pred eeeccccccccccChHHHc
Confidence 2566799999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=282.93 Aligned_cols=164 Identities=22% Similarity=0.339 Sum_probs=149.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||.||+|+++.+|+.||+|++++.. ...+.+.+|+.+++.++|+|+ ++++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEeeeccccc
Confidence 56999999999999999999999999999999998542 345678899999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999 999999999876 799999999999999999999999999999999999999999999999999976432
Q ss_pred ------CcccceeeeeceeEee
Q 024661 247 ------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ------~~~~~~~y~ape~~~~ 262 (264)
..+||+.|||||++.+
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS
T ss_pred CCcccccceeCHHHhhhhhccC
Confidence 3468999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-42 Score=282.98 Aligned_cols=170 Identities=24% Similarity=0.402 Sum_probs=138.6
Q ss_pred eCCccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh--hhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
..+.+.++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+.+++.++|+|+ +++++++.
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~ 77 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI-----VALDDIYE 77 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 34567788999999999999999999999999999999997543 334567889999999999888 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee---cCCcEEeccCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV---SAEYVKVPDYK 239 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~---~~~~v~l~Dfg 239 (264)
+++.+|+||||+ ||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence 999999999999 899999998765 799999999999999999999999999999999999995 47899999999
Q ss_pred CCCcCCC-----CcccceeeeeceeEee
Q 024661 240 VPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 240 ~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+|..... ...||+.|||||++.+
T Consensus 156 ~a~~~~~~~~~~~~~GT~~y~APE~~~~ 183 (307)
T d1a06a_ 156 LSKMEDPGSVLSTACGTPGYVAPEVLAQ 183 (307)
T ss_dssp -----------------CTTSCHHHHTT
T ss_pred eeEEccCCCeeeeeeeCccccCcHHHcC
Confidence 9976432 3358999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-41 Score=282.12 Aligned_cols=167 Identities=24% Similarity=0.362 Sum_probs=148.3
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+.++|++++.||+|+||.||+|+++.+|+.||+|++.+. ....+.+.+|+.+++.++|+|+ +++++++.+++.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEEETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEE
Confidence 346899999999999999999999999999999998753 3445778899999999999988 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec--CCcEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~--~~~v~l~Dfg~a~~~~ 245 (264)
|+||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999 999999996543 36999999999999999999999999999999999999964 5789999999998654
Q ss_pred CC-----cccceeeeeceeEee
Q 024661 246 AF-----SFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~~-----~~~~~~y~ape~~~~ 262 (264)
.. ..||..|||||++.+
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHT
T ss_pred cccccceecCcccccCHHHHcC
Confidence 32 357899999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=271.43 Aligned_cols=166 Identities=25% Similarity=0.382 Sum_probs=144.8
Q ss_pred ccCCCe-EEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 89 NLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 89 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
...++| ++.++||+|+||+||+|++..+++.||+|.+... ....+.+.+|++++++++|+|+ +++++++.+
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~ 79 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWES 79 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEE
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEee
Confidence 444566 6778999999999999999999999999998753 3445678899999999999988 999999875
Q ss_pred ----CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEee-cCCcEEec
Q 024661 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLV-SAEYVKVP 236 (264)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~Nili~-~~~~v~l~ 236 (264)
+..+|+||||+ +|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 46789999999 999999998765 7999999999999999999999998 99999999999997 57899999
Q ss_pred cCCCCCcCCC----CcccceeeeeceeEe
Q 024661 237 DYKVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 237 Dfg~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
|||+|+.... ...||+.|||||++.
T Consensus 158 DFGla~~~~~~~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 158 DLGLATLKRASFAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp CTTGGGGCCTTSBEESCSSCCCCCGGGGG
T ss_pred ecCcceeccCCccCCcccCccccCHHHhC
Confidence 9999976443 235899999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-41 Score=278.22 Aligned_cols=164 Identities=24% Similarity=0.346 Sum_probs=148.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||+||+|+++.+|+.||+|++++.. ...+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcCh-----hheeeeEeeCCe
Confidence 46999999999999999999999999999999997532 345678899999999999988 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+|+||||+ |++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999 899999998776 789999999999999999999999999999999999999999999999999976443
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...||+.|||||++.+
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST 175 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT
T ss_pred ccccccCcccccCHHHHcC
Confidence 3468999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=273.66 Aligned_cols=168 Identities=24% Similarity=0.447 Sum_probs=149.9
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-------hhHHHHHHHHHHHHHHhccCCCCcceEEEce
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 160 (264)
+.+.++|++++.||+|+||+||+|+++.+|+.||+|++++.. ...+.+.+|+.+++.++|+|+ +++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~ 80 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE 80 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 346688999999999999999999999999999999997432 235788999999999999888 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC----cEEe
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE----YVKV 235 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~----~v~l 235 (264)
+|.+.+.+||||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence 999999999999999 899999998765 799999999999999999999999999999999999999776 5999
Q ss_pred ccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 236 PDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 236 ~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
+|||+|..... ...+|..|||||++.+
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcC
Confidence 99999976432 3357889999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-40 Score=268.99 Aligned_cols=165 Identities=26% Similarity=0.476 Sum_probs=148.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----------hhHHHHHHHHHHHHHHh-ccCCCCcceEEEc
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~ 159 (264)
.++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ...+.+.+|+.+++.+. |+|+ ++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe-----EEEE
Confidence 578999999999999999999999999999999987432 23456889999999997 8887 9999
Q ss_pred eeeeeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccC
Q 024661 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
+++.+++.+||||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999 899999998765 7999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCCC-----CcccceeeeeceeEee
Q 024661 239 KVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 239 g~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
|+|..... ...||..|+|||++++
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhc
Confidence 99976433 2357889999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-40 Score=280.32 Aligned_cols=166 Identities=23% Similarity=0.385 Sum_probs=147.6
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
+.++|++++.||+|+||.||+|.++.+|+.||+|++++.. .....+.+|+.+++.++|+|+ ++++++|.+++.+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEE
Confidence 3467999999999999999999999999999999997543 345677899999999999888 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee--cCCcEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV--SAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~--~~~~v~l~Dfg~a~~~~ 245 (264)
||||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++ .++++||+|||+|....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999 999999876543 4699999999999999999999999999999999999998 56899999999998754
Q ss_pred CC-----cccceeeeeceeEe
Q 024661 246 AF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~-----~~~~~~y~ape~~~ 261 (264)
.. ..+|..|||||++.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~ 201 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVD 201 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHT
T ss_pred CCCceeeccCcccccCHHHHc
Confidence 32 35888999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-40 Score=280.35 Aligned_cols=164 Identities=24% Similarity=0.398 Sum_probs=149.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...+.+.+|+.+++.++|+|+ +++++++.+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcE-----eecccccccccc
Confidence 57999999999999999999999999999999997532 334678899999999999888 999999999999
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA 246 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~ 246 (264)
+++||||+ +|+|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999 999999998876 799999999999999999999999999999999999999999999999999986543
Q ss_pred ---CcccceeeeeceeEee
Q 024661 247 ---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~~ 262 (264)
...||+.|||||++.+
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILS 212 (350)
T ss_dssp CBCCCEECGGGCCHHHHTT
T ss_pred ccccccCccccCCHHHHcC
Confidence 3458999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=274.44 Aligned_cols=167 Identities=20% Similarity=0.356 Sum_probs=149.7
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.++|++++.||+|+||+||+|.++.+++.||+|++++.......+.+|+++++.++|+|+ ++++++|.+++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCEE
Confidence 35678999999999999999999999999999999998776666778899999999999988 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC--CcEEeccCCCCCcCC
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA--EYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~--~~v~l~Dfg~a~~~~ 245 (264)
|+||||| |++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+ .++||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999 899999997654 369999999999999999999999999999999999999855 489999999998654
Q ss_pred CC-----cccceeeeeceeEe
Q 024661 246 AF-----SFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~~-----~~~~~~y~ape~~~ 261 (264)
.. ..+|+.|||||++.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~ 176 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQ 176 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHT
T ss_pred cCCcccccccccccccchhcc
Confidence 32 24778899999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=272.38 Aligned_cols=165 Identities=20% Similarity=0.281 Sum_probs=136.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee--CC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--~~ 166 (264)
++|++++.||+|+||+||+|+++.+|+.||+|+++.. ....+.+.+|+++++.++|+|+ +++++++.+ .+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTB-----CCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEeCCCC
Confidence 5799999999999999999999999999999998743 3445678899999999999888 999998865 46
Q ss_pred EEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEeecCCcEEeccC
Q 024661 167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dikp~Nili~~~~~v~l~Df 238 (264)
.+|+||||+ +|+|.+++.+. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 789999999 89999998742 2347999999999999999999999876 999999999999999999999999
Q ss_pred CCCCcCCC------CcccceeeeeceeEe
Q 024661 239 KVPSPRHA------FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~------~~~~~~~y~ape~~~ 261 (264)
|+|+.... ...||+.|||||++.
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~ 187 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMN 187 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHc
Confidence 99975332 345899999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=267.62 Aligned_cols=163 Identities=25% Similarity=0.338 Sum_probs=140.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.++||+|+||.||+|.+. +++.||||+++......+.+.+|+++++.++|+|+ +++++++.+++.+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCc-----ccccceeccCCceEEE
Confidence 56999999999999999999986 46789999998766667889999999999999988 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+ +|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+....
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999 999999987654 4689999999999999999999999999999999999999999999999999976432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 158 ~~~~~~gt~~y~aPE~l~ 175 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFS 175 (263)
T ss_dssp -------CTTSCCHHHHT
T ss_pred eecceecCcccCChHHhc
Confidence 234677899999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-39 Score=275.26 Aligned_cols=163 Identities=22% Similarity=0.291 Sum_probs=140.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHHHH---hccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l---~~~~~~~~~~~~~~~~~~~ 164 (264)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. .....+.+|...++.+ .|+|+ ++++++|.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnI-----v~l~~~~~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-----VCMSYAFHT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTB-----CCEEEEEEC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcE-----EEEEEEEEE
Confidence 56999999999999999999999999999999997432 2233445554444444 45555 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred CCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999 999999998875 789999999999999999999999999999999999999999999999999976
Q ss_pred CCC----CcccceeeeeceeEe
Q 024661 244 RHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~----~~~~~~~y~ape~~~ 261 (264)
... ...||+.|||||++.
T Consensus 157 ~~~~~~~~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 157 FSKKKPHASVGTHGYMAPEVLQ 178 (364)
T ss_dssp CSSSCCCSCCSCGGGCCHHHHS
T ss_pred cCCCcccccccccccchhHHhh
Confidence 433 346899999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=267.85 Aligned_cols=164 Identities=20% Similarity=0.292 Sum_probs=144.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh----hhHHHHHHHHHHHH-HHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQ-RLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~-~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++++.||+|+||+||+|+++.+++.||||++++.. ...+.+..|..++. .++|+|+ +++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I-----v~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcE-----EEEEEEEccCC
Confidence 56999999999999999999999999999999997532 33455667777665 5788887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999 999999998776 79999999999999999999999999999999999999999999999999997532
Q ss_pred ------CCcccceeeeeceeEee
Q 024661 246 ------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ------~~~~~~~~y~ape~~~~ 262 (264)
....||..|||||++.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~ 177 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLG 177 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cccccccccCCCCCcCCHHHHcC
Confidence 23468999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=267.05 Aligned_cols=164 Identities=23% Similarity=0.343 Sum_probs=143.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
.++|++.++||+|+||.||+|.++ ++..||||+++......+.+.+|++++++++|+|+ +++++++.+ +.+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCE-----eEEEeeecc-CCeEE
Confidence 367999999999999999999975 56789999998766667889999999999999988 999997754 56799
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999 99999987654434699999999999999999999999999999999999999999999999999976432
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 165 ~~~~~~~gt~~y~APE~~~ 183 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAIN 183 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHH
T ss_pred ccccccCCcccccChHHHh
Confidence 234677899999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=268.88 Aligned_cols=165 Identities=28% Similarity=0.478 Sum_probs=146.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh---hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|+++++||+|+||+||+|.+..+|+.||+|+++... ...+.+.+|+++++.++|+|+ +++++++.+.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~I-----v~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EEeccccccccce
Confidence 57999999999999999999999999999999996432 235678899999999999888 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
|+||||+++++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+|....
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999998888888776655679999999999999999999999999999999999999999999999999986532
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....+|..|+|||++.
T Consensus 157 ~~~~~~~gt~~y~apE~~~ 175 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILL 175 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHT
T ss_pred ccceeecccceeeehhhhc
Confidence 2336889999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-39 Score=263.75 Aligned_cols=168 Identities=22% Similarity=0.250 Sum_probs=143.6
Q ss_pred CccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
..+.++|++.+.||+|+||.||+|++..+|+.||||++++. ....+.+.+|+++++.++|+|+ +++++++.
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpni-----v~~~~~~~ 77 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTGE 77 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCC-----Ccccceee
Confidence 35678999999999999999999999999999999999743 2345678899999999999988 99999887
Q ss_pred eCC----EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccC
Q 024661 164 YRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 164 ~~~----~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
+.+ .+|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehh
Confidence 643 589999999 899999998776 7999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCC---------CCcccceeeeeceeEee
Q 024661 239 KVPSPRH---------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 239 g~a~~~~---------~~~~~~~~y~ape~~~~ 262 (264)
|.+.... ....||..|||||++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTT
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcC
Confidence 9876422 23358999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=267.89 Aligned_cols=165 Identities=24% Similarity=0.408 Sum_probs=141.8
Q ss_pred ccCCCeEEEe-ecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeee--
Q 024661 89 NLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY-- 164 (264)
Q Consensus 89 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~-- 164 (264)
.+.++|.+.. .||+|+||+||+|++..+++.||||++++. ..+.+|+.++.++ +|+|+ ++++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnI-----v~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCC-----CeEEEEEeecc
Confidence 3446799875 599999999999999999999999999754 3466789887665 67777 999999876
Q ss_pred --CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CCcEEeccC
Q 024661 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AEYVKVPDY 238 (264)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~~v~l~Df 238 (264)
+..+|+||||| ||+|.+++.+.....+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 57799999999 899999998765567999999999999999999999999999999999999986 467999999
Q ss_pred CCCCcCC-----CCcccceeeeeceeEee
Q 024661 239 KVPSPRH-----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 239 g~a~~~~-----~~~~~~~~y~ape~~~~ 262 (264)
|+|+... ....||+.|||||++.+
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCG
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcC
Confidence 9997533 24468999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=264.15 Aligned_cols=162 Identities=24% Similarity=0.332 Sum_probs=138.7
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEec---hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
-.++|++.+.||+|+||.||+|+.. ..||||+++. .....+.+.+|+.+++.++|+|+ +++++++. ++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~~~~~-~~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGYST-AP 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SS
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeEEEe-cc
Confidence 3467999999999999999999864 3599999863 23456788999999999999988 89988764 46
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|+||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 789999999 899999998654 369999999999999999999999999999999999999999999999999997643
Q ss_pred C--------CcccceeeeeceeEe
Q 024661 246 A--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~--------~~~~~~~y~ape~~~ 261 (264)
. ...+|..|||||++.
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~ 179 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIR 179 (276)
T ss_dssp ----------CCCCGGGCCHHHHT
T ss_pred ccCCcccccccccCcccCCHHHHh
Confidence 2 235788999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-39 Score=265.94 Aligned_cols=165 Identities=21% Similarity=0.306 Sum_probs=135.4
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCc---EEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|++.+.||+|+||+||+|.++.+++ .||||.+.. .....+.+.+|+++++.++|+|+ +++++++.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV-----IHLEGVVTKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeC
Confidence 3679999999999999999999987664 588888764 23455688999999999999988 9999999999
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999 999999888654 36999999999999999999999999999999999999999999999999999764
Q ss_pred CCC-----------cccceeeeeceeEe
Q 024661 245 HAF-----------SFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~~-----------~~~~~~y~ape~~~ 261 (264)
... ..+|..|||||++.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQ 206 (299)
T ss_dssp -----------------CGGGSCHHHHH
T ss_pred cCCCCcceeeecccccCCccccCHHHHh
Confidence 321 13567899999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=262.70 Aligned_cols=165 Identities=22% Similarity=0.349 Sum_probs=143.1
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-------hhHHHHHHHHHHHHHHh--ccCCCCcceEEEce
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLA--RHDIGGTRCVQIRN 160 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~ 160 (264)
+.++|++.+.||+|+||+||+|++..+|+.||||++++.. .....+.+|+.+++.++ |+|+ +++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nI-----v~~~~ 76 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV-----IRLLD 76 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB-----CCEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCc-----cEEEE
Confidence 3578999999999999999999999999999999987532 11234567999999997 5555 99999
Q ss_pred eeeeCCEEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecC-CcEEecc
Q 024661 161 WFDYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPD 237 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~-~~v~l~D 237 (264)
++.+.+..|+|||++ + +++.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence 999999999999999 4 58888888765 79999999999999999999999999999999999999954 7999999
Q ss_pred CCCCCcCCC----CcccceeeeeceeEe
Q 024661 238 YKVPSPRHA----FSFQTFLSMASRVYI 261 (264)
Q Consensus 238 fg~a~~~~~----~~~~~~~y~ape~~~ 261 (264)
||+|+.... ...||..|||||++.
T Consensus 155 FG~a~~~~~~~~~~~~GT~~y~aPE~~~ 182 (273)
T d1xwsa_ 155 FGSGALLKDTVYTDFDGTRVYSPPEWIR 182 (273)
T ss_dssp CTTCEECCSSCBCCCCSCGGGSCHHHHH
T ss_pred cccceecccccccccccCCCcCCHHHHc
Confidence 999975432 345899999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=257.40 Aligned_cols=163 Identities=21% Similarity=0.288 Sum_probs=145.7
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|+++++||+|+||+||+|+++ +++.||||++++.....+.+.+|+.+++.++|+|+ +++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnI-----v~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCce-----eeEEEEEeeCCceEEE
Confidence 46899999999999999999985 67889999998777777889999999999999888 9999999999999999
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCCC---
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHAF--- 247 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~~--- 247 (264)
|||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999 899999977554 36899999999999999999999999999999999999999999999999999754322
Q ss_pred ----cccceeeeeceeEe
Q 024661 248 ----SFQTFLSMASRVYI 261 (264)
Q Consensus 248 ----~~~~~~y~ape~~~ 261 (264)
..+|..|||||++.
T Consensus 157 ~~~~~~~t~~y~aPE~~~ 174 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLM 174 (258)
T ss_dssp CCCCSCCCGGGCCHHHHH
T ss_pred eecccCCCCCcCCcHHhc
Confidence 24677899999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=264.61 Aligned_cols=165 Identities=21% Similarity=0.316 Sum_probs=140.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCc-----EEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~ 163 (264)
++|++.++||+|+||+||+|++..+++ .||+|.+... ......+.+|+.+++.+ +|+|+ +++++++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~l~~~~~ 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGACT 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcE-----eEEEEEEe
Confidence 679999999999999999999876543 6899988643 34456788999999998 78887 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 221 (264)
+.+.+|+||||+ +|+|.+++..... ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999 9999999976431 248999999999999999999999999999999
Q ss_pred CCCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 222 PENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 222 p~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|+|||++.++++||+|||+|+.... ...+|..|||||++.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc
Confidence 9999999999999999999976432 223578899999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-39 Score=261.76 Aligned_cols=163 Identities=25% Similarity=0.317 Sum_probs=141.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv 171 (264)
++|++.+.||+|+||.||+|++..+ ..||||+++......+.+.+|+.+++.++|+|+ +++++++.+ +.+|+|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCE-----eEEEEEEec-CCeEEE
Confidence 6799999999999999999998765 569999998776667889999999999999988 999999854 567899
Q ss_pred EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC----
Q 024661 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA---- 246 (264)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~---- 246 (264)
|||+ +|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999 89999998765444799999999999999999999999999999999999999999999999999976432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 170 ~~~~~~gt~~y~aPE~~~ 187 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAAL 187 (285)
T ss_dssp ------CCGGGSCHHHHH
T ss_pred eeccccccccccChHHHh
Confidence 234778899999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=257.28 Aligned_cols=163 Identities=25% Similarity=0.342 Sum_probs=138.5
Q ss_pred CCeEEEe-ecccCccEEEEEEEeCCC--CcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILS-KMGEGTFGQVVECFDNEK--KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~-~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|.+.+ +||+|+||.||+|.++.+ +..||||+++.. ....+.+.+|++++++++|+|+ +++++++.+ +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~g~~~~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCE-----eeEeeeecc-C
Confidence 5688888 499999999999987643 557999998743 3456788999999999999988 999998865 4
Q ss_pred EEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH 245 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~ 245 (264)
.+|+||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 689999999 899999986543 469999999999999999999999999999999999999999999999999997533
Q ss_pred C---------CcccceeeeeceeEe
Q 024661 246 A---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ~---------~~~~~~~y~ape~~~ 261 (264)
. ...+|..|||||++.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred ccccccccccccccCccccChHHHh
Confidence 2 224678899999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=264.82 Aligned_cols=165 Identities=22% Similarity=0.357 Sum_probs=141.3
Q ss_pred cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC
Q 024661 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 166 (264)
+.++|+++++||+|+||+||+|.++.+|+.||||++++. ....+.+.+|+++++.++|+|+ ++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpni-----v~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV-----IGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB-----CCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCe-----eEEEEEeccCc
Confidence 678999999999999999999999999999999999743 3445678899999999999988 99999987654
Q ss_pred ------EEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 167 ------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 167 ------~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
++|+||||++.+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 57999999988898887654 599999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC---CcccceeeeeceeEee
Q 024661 241 PSPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~~---~~~~~~~y~ape~~~~ 262 (264)
|+.... ...+|..|||||++.+
T Consensus 168 a~~~~~~~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 168 ARQADSEMTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHT
T ss_pred eeccCCccccccccccccCHHHHcC
Confidence 987543 4458999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=257.20 Aligned_cols=165 Identities=20% Similarity=0.281 Sum_probs=138.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCC----cEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
.+.|++.+.||+|+||.||+|.++.++ ..||||.++.. ......+.+|+.+++.++|+|+ +++++++.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nI-----v~~~g~~~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVISK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCE-----eeeeEEEec
Confidence 356999999999999999999987654 46999998643 3445678899999999999988 999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.+..++||||+ ++++.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999 888988887654 4699999999999999999999999999999999999999999999999999976
Q ss_pred CCCC---------cccceeeeeceeEe
Q 024661 244 RHAF---------SFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~~~---------~~~~~~y~ape~~~ 261 (264)
.... ..+|..|||||++.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~ 186 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAIS 186 (283)
T ss_dssp --------------CCCGGGSCHHHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHc
Confidence 4321 23577899999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-39 Score=264.53 Aligned_cols=160 Identities=24% Similarity=0.406 Sum_probs=135.2
Q ss_pred EEeecccCccEEEEEEEeCCCCcEEEEEEEechhh------hHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
.+++||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.+++.++|+|+ +++++++.+++.+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCE-----eEEEeeeccCCcee
Confidence 46789999999999999999999999999874322 23467899999999999988 99999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
+||||+.+++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 77 ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred ehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 999999544444444332 4699999999999999999999999999999999999999999999999999976432
Q ss_pred ---CcccceeeeeceeEe
Q 024661 247 ---FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 156 ~~~~~~gt~~y~aPE~~~ 173 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLF 173 (299)
T ss_dssp CCCCSCCCCTTCCHHHHT
T ss_pred cccceecChhhccHHHHc
Confidence 335899999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-38 Score=254.44 Aligned_cols=156 Identities=23% Similarity=0.355 Sum_probs=133.5
Q ss_pred eecccCccEEEEEEEeC--CCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEE
Q 024661 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (264)
Q Consensus 98 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~ 172 (264)
++||+|+||.||+|.+. .+++.||||+++.. ....+.+.+|++++++++|+|+ +++++++.+ +..||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEES-SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCC-----ceEEEEecc-CCEEEEE
Confidence 46999999999999864 45678999998643 2345678999999999999988 999999865 4578999
Q ss_pred ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-----
Q 024661 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA----- 246 (264)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~----- 246 (264)
||+ +|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999 899999998765 799999999999999999999999999999999999999999999999999975332
Q ss_pred ----CcccceeeeeceeEe
Q 024661 247 ----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ----~~~~~~~y~ape~~~ 261 (264)
...+|..|||||++.
T Consensus 165 ~~~~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECIN 183 (277)
T ss_dssp EC----CCCGGGCCHHHHH
T ss_pred ccccccCCCceecCchhhc
Confidence 224677899999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=260.32 Aligned_cols=164 Identities=27% Similarity=0.473 Sum_probs=139.6
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC-
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~- 165 (264)
.++++|+++++||+|+||+||+|.++.+|+.||||++++. ....+.+.+|+++++.++|+++ +++++++...
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~i-----v~~~~~~~~~~ 79 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGINDIIRAPT 79 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCEEECCSS
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCC-----CcEEEEEeecc
Confidence 3557899999999999999999999999999999999743 3445678899999999999988 8888887654
Q ss_pred ----CEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
..+|+++++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 346777776699999999865 5999999999999999999999999999999999999999999999999999
Q ss_pred CcCC---------CCcccceeeeeceeE
Q 024661 242 SPRH---------AFSFQTFLSMASRVY 260 (264)
Q Consensus 242 ~~~~---------~~~~~~~~y~ape~~ 260 (264)
.... ....+|..|+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l 184 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIM 184 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred eeccCCCccceeeccccccceechHHHh
Confidence 6532 233578899999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-37 Score=252.64 Aligned_cols=167 Identities=26% Similarity=0.304 Sum_probs=144.1
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhcc-CCCCcceEEEceeeeeCCE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNH 167 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~~~~ 167 (264)
.++++|+++++||+|+||+||+|++..+|+.||+|++.... ....+.+|++.++.+.|+ ++ +.+++++.....
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~~~ 75 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGI-----PNVYYFGQEGLH 75 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTC-----CCEEEEEEETTE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCC-----CEEEEEeecCCc
Confidence 45789999999999999999999999999999999886532 334567899999999874 44 788899999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec-----CCcEEeccCCCCC
Q 024661 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-----AEYVKVPDYKVPS 242 (264)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~-----~~~v~l~Dfg~a~ 242 (264)
.|+|||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 76 ~~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999999999999987654 46999999999999999999999999999999999999974 5789999999997
Q ss_pred cCC-------------CCcccceeeeeceeEee
Q 024661 243 PRH-------------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 243 ~~~-------------~~~~~~~~y~ape~~~~ 262 (264)
... ....||+.|||||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC
Confidence 532 12358999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-37 Score=250.15 Aligned_cols=164 Identities=23% Similarity=0.289 Sum_probs=133.4
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCC---cEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
.++|++++.||+|+||.||+|.+..++ ..||+|.++. .....+.+.+|+.+++.++|+|+ +++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~-~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT-E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC-S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe-c
Confidence 368999999999999999999986553 4688888763 23446778999999999999888 99999886 5
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999 899999887654 46899999999999999999999999999999999999999999999999999764
Q ss_pred CC-------CcccceeeeeceeEe
Q 024661 245 HA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~-------~~~~~~~y~ape~~~ 261 (264)
.. ...+|..|||||++.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp ------------CCGGGCCHHHHH
T ss_pred cCCcceeccceecCcccchhhHhc
Confidence 32 224678899999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-37 Score=253.78 Aligned_cols=163 Identities=19% Similarity=0.281 Sum_probs=135.5
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCc----EEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 165 (264)
++|+++++||+|+||+||+|.+..+|+ .||+|.++.. ....+.+.+|+.+++.++|+|+ +++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTB-----CCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEecC
Confidence 459999999999999999999988876 4788877532 3446788999999999999988 9999999875
Q ss_pred CEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+ .+++||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 4 56677777 999999888654 47999999999999999999999999999999999999999999999999998753
Q ss_pred CC--------CcccceeeeeceeEe
Q 024661 245 HA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 245 ~~--------~~~~~~~y~ape~~~ 261 (264)
.. ...+|..|||||++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~ 186 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESIL 186 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHH
T ss_pred ccccccccccccccCccccChHHHh
Confidence 22 123678899999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=251.55 Aligned_cols=167 Identities=26% Similarity=0.465 Sum_probs=138.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCC-CcEEEEEEEech---hhhHHHHHHHHHHHHHH---hccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSI---NKYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l---~~~~~~~~~~~~~~~~~~ 163 (264)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ......+.+|+.+++.+ +|+|+ ++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnI-----v~~~~~~~ 80 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCT 80 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB-----CCEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCc-----ceeeeeec
Confidence 47899999999999999999999766 677999998643 22234566788888877 46666 99998885
Q ss_pred e-----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccC
Q 024661 164 Y-----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 164 ~-----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
. ...+|++||++.+++..+........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence 3 46789999999666665555555567999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCC-----CCcccceeeeeceeEee
Q 024661 239 KVPSPRH-----AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 239 g~a~~~~-----~~~~~~~~y~ape~~~~ 262 (264)
|++.... ....||..|||||++.+
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcC
Confidence 9987643 24468999999998643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-36 Score=250.44 Aligned_cols=168 Identities=26% Similarity=0.308 Sum_probs=142.2
Q ss_pred ccCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.++++|++.+.||+|+||.||+|++..+|+.||||++.... ..+.+..|+++++.+.|+++ ++.+..++.+.+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~----i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTT----CCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCc----ccEEEEEEecCCEE
Confidence 35578999999999999999999999999999999987543 23457889999999988764 35666777888999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeec---CCcEEeccCCCCCcCC
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS---AEYVKVPDYKVPSPRH 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~---~~~v~l~Dfg~a~~~~ 245 (264)
++||||++++|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|+...
T Consensus 79 ~ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9999999989888876544 47999999999999999999999999999999999999864 4579999999997532
Q ss_pred C-------------CcccceeeeeceeEee
Q 024661 246 A-------------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~-------------~~~~~~~y~ape~~~~ 262 (264)
. ...||..|||||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC
Confidence 1 2358999999998654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-36 Score=255.05 Aligned_cols=173 Identities=23% Similarity=0.342 Sum_probs=142.2
Q ss_pred ceEEeeCC-c--cCCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcc
Q 024661 81 HYVFAIGE-N--LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR 154 (264)
Q Consensus 81 ~~~~~~~~-~--~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~ 154 (264)
.+++.+|+ . +.++|+++++||+|+||+||+|.++.+|+.||||++.+. ......+.+|+.+++.++|+|+
T Consensus 3 ~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI---- 78 (355)
T d2b1pa1 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI---- 78 (355)
T ss_dssp EEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTB----
T ss_pred CEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCe----
Confidence 46788888 3 347899999999999999999999999999999999753 3445678899999999999888
Q ss_pred eEEEceeeee------CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEee
Q 024661 155 CVQIRNWFDY------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (264)
Q Consensus 155 ~~~~~~~~~~------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~ 228 (264)
++++++|.. ...+|+||||+.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 -v~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 79 -ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp -CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred -eEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 999999854 47899999999777777664 2689999999999999999999999999999999999999
Q ss_pred cCCcEEeccCCCCCcCCC-----CcccceeeeeceeEee
Q 024661 229 SAEYVKVPDYKVPSPRHA-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 229 ~~~~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~~ 262 (264)
.++.++++|||+++.... ...+|..|+|||++++
T Consensus 154 ~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 154 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp TTCCEEECCCCC---------------CCTTCCHHHHTT
T ss_pred cccceeeechhhhhccccccccccccccccccChhhhcC
Confidence 999999999999876433 3358889999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=249.88 Aligned_cols=167 Identities=22% Similarity=0.283 Sum_probs=130.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.++|++.++||+|+||.||+|.+.. +++.||+|+++.. ....+.+.+|..++.++.|+ ++++.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h----~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH----LNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCC----TTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCC----CeEEEeeeeec
Confidence 3679999999999999999999754 3468999998743 34456778888888888654 23378877765
Q ss_pred e-CCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEe
Q 024661 164 Y-RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (264)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili 227 (264)
. +..+++||||+ +|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 56789999999 999999997542 1348999999999999999999999999999999999999
Q ss_pred ecCCcEEeccCCCCCcCC--------CCcccceeeeeceeEe
Q 024661 228 VSAEYVKVPDYKVPSPRH--------AFSFQTFLSMASRVYI 261 (264)
Q Consensus 228 ~~~~~v~l~Dfg~a~~~~--------~~~~~~~~y~ape~~~ 261 (264)
+.++++||+|||+|+... ....||..|||||++.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 209 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 209 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh
Confidence 999999999999997532 1235888999999764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-37 Score=253.35 Aligned_cols=163 Identities=27% Similarity=0.442 Sum_probs=140.0
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|+++++||+|+||+||+|+++ +|+.||||+++.. ....+.+.+|+.+++.++|+|+ +++++++.+.+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EeeeeecccCCce
Confidence 68999999999999999999985 7789999999753 2335788899999999999888 9999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCC---
Q 024661 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRH--- 245 (264)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~--- 245 (264)
|++||++++++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9999999666555555433 479999999999999999999999999999999999999999999999999986532
Q ss_pred ---CCcccceeeeeceeEe
Q 024661 246 ---AFSFQTFLSMASRVYI 261 (264)
Q Consensus 246 ---~~~~~~~~y~ape~~~ 261 (264)
....++..|++||++.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~ 173 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLM 173 (286)
T ss_dssp -------CCCTTCCHHHHT
T ss_pred cccceecccchhhhHHHHh
Confidence 2334778899999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.2e-37 Score=255.00 Aligned_cols=160 Identities=18% Similarity=0.389 Sum_probs=138.2
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHh-ccCCCCcceEEEceeeee--CCE
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNH 167 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~--~~~ 167 (264)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++++.+. |+|+ ++++++|.. ...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnI-----v~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCC-----cEEEEEEEecCCCc
Confidence 368999999999999999999999999999999987533 467889999999996 7777 999999875 467
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCcCC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSPRH 245 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~~~ 245 (264)
+++||||+ +++|.++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 107 ~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999999 78876542 3699999999999999999999999999999999999999765 69999999997543
Q ss_pred C-----CcccceeeeeceeEee
Q 024661 246 A-----FSFQTFLSMASRVYIC 262 (264)
Q Consensus 246 ~-----~~~~~~~y~ape~~~~ 262 (264)
. ...+|..|+|||++.+
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVD 203 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTT
T ss_pred CCCcccccccCccccCcccccC
Confidence 2 3357889999998653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-37 Score=257.11 Aligned_cols=161 Identities=24% Similarity=0.396 Sum_probs=135.9
Q ss_pred CeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee------CC
Q 024661 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------RN 166 (264)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~------~~ 166 (264)
+|+.+++||+|+||+||+|++..+|+.||||++.+.... ..+|++++++++|+|+ ++++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~ni-----v~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTB-----CCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCC-----CcEEEEEEecCccCCce
Confidence 599999999999999999999999999999999765432 3469999999999888 888888744 34
Q ss_pred EEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC-cEEeccCCCCCc
Q 024661 167 HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE-YVKVPDYKVPSP 243 (264)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~-~v~l~Dfg~a~~ 243 (264)
++|+||||+++++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 6899999997666655542 2334799999999999999999999999999999999999999775 899999999975
Q ss_pred CC-----CCcccceeeeeceeEe
Q 024661 244 RH-----AFSFQTFLSMASRVYI 261 (264)
Q Consensus 244 ~~-----~~~~~~~~y~ape~~~ 261 (264)
.. ....++..|+|||++.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELIF 195 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHHT
T ss_pred ccCCcccccccccccccChHHhh
Confidence 32 2346888999999765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-36 Score=251.46 Aligned_cols=165 Identities=22% Similarity=0.394 Sum_probs=137.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee----
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~---- 164 (264)
++|+++++||+|+||+||+|+++.+|+.||||++... ......+.+|+.+++.++|+|+ +++++.+..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----i~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCc-----cceEeeeeccccc
Confidence 7899999999999999999999999999999998643 2345678899999999999988 777777644
Q ss_pred ----CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCC
Q 024661 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKV 240 (264)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~ 240 (264)
++.+|+|||++.+.+........ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccccCceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 45689999999666665554332 4799999999999999999999999999999999999999999999999999
Q ss_pred CCcCC----------CCcccceeeeeceeEee
Q 024661 241 PSPRH----------AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 241 a~~~~----------~~~~~~~~y~ape~~~~ 262 (264)
+.... ....+|..|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcC
Confidence 96432 22358899999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-36 Score=250.08 Aligned_cols=167 Identities=20% Similarity=0.307 Sum_probs=143.3
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.++|++.++||+|+||+||+|+++. +++.||||+++.. ....+.+.+|+++++.++|+|+ +.+++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLGVCA 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCc-----ccceeeec
Confidence 4679999999999999999999753 4678999998743 3345778999999999999988 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 220 (264)
+.+..+++||++ +|+|.+++.... ...+++..++.|+.||+.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999 999999997532 124889999999999999999999999999999
Q ss_pred CCCCEEeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEee
Q 024661 221 KPENILLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYIC 262 (264)
Q Consensus 221 kp~Nili~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~~ 262 (264)
||+|||++.++++||+|||+|+.... ...++..|||||.+..
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 99999999999999999999864321 2346778999998653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-37 Score=247.74 Aligned_cols=162 Identities=21% Similarity=0.306 Sum_probs=134.6
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-CCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~l 170 (264)
++|++.+.||+|+||.||+|.++ |..||+|++++. ...+.+.+|++++++++|+|+ +++++++.+ .+.+|+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEecCCcEEE
Confidence 56999999999999999999985 678999999754 345678999999999999888 999998854 567899
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC---
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA--- 246 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~--- 246 (264)
||||+ +|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 99999 99999999765434589999999999999999999999999999999999999999999999999986443
Q ss_pred CcccceeeeeceeEe
Q 024661 247 FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ~~~~~~~y~ape~~~ 261 (264)
...++..|||||++.
T Consensus 159 ~~~~~~~y~aPE~l~ 173 (262)
T d1byga_ 159 TGKLPVKWTAPEALR 173 (262)
T ss_dssp ---CCTTTSCHHHHH
T ss_pred cccccccCCChHHHh
Confidence 334677899999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-36 Score=245.56 Aligned_cols=163 Identities=27% Similarity=0.408 Sum_probs=143.9
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.++|+|+ +++++++.+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCE-----Eeeccccccccce
Confidence 5899999999999999999999999999999999743 2456788999999999999887 9999999999999
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
+++||++ +++|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999 777777766554 789999999999999999999999999999999999999999999999999976432
Q ss_pred -----CcccceeeeeceeEe
Q 024661 247 -----FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 -----~~~~~~~y~ape~~~ 261 (264)
...++..|++||++.
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~ 174 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLF 174 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHT
T ss_pred CccceeeccccchhhhhHhc
Confidence 223567789998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-36 Score=247.50 Aligned_cols=160 Identities=23% Similarity=0.234 Sum_probs=133.4
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCC----E
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----H 167 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~----~ 167 (264)
.+|.+.+.||+|+||.||+|++ +|+.||||+++...........|+..++.++|+|+ +++++++.+++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnI-----v~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcC-----cceEEEEEeCCCcceE
Confidence 5699999999999999999986 48899999997654433333345555556677776 99999987643 6
Q ss_pred EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCCEEeecCCcEEeccC
Q 024661 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--------LRLIHTDLKPENILLVSAEYVKVPDY 238 (264)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--------~~ivH~dikp~Nili~~~~~v~l~Df 238 (264)
+|+||||+ +|+|.+++++. .+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999 99999999875 58999999999999999999996 59999999999999999999999999
Q ss_pred CCCCcCCC----------CcccceeeeeceeEe
Q 024661 239 KVPSPRHA----------FSFQTFLSMASRVYI 261 (264)
Q Consensus 239 g~a~~~~~----------~~~~~~~y~ape~~~ 261 (264)
|++..... ...||..|||||++.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred CccccccCCCcceeccccceecccCcCChhhcc
Confidence 99875321 235789999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=244.25 Aligned_cols=164 Identities=23% Similarity=0.307 Sum_probs=132.3
Q ss_pred CCeEEEeecccCccEEEEEEEeCCC-C--cEEEEEEEech----hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 164 (264)
++|++.+.||+|+||.||+|++... + ..||||++++. ....+.+.+|+.+++.++|+|+ +++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~~~g~~~~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVLT 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEee
Confidence 5699999999999999999986543 2 46899988642 3445678999999999999988 999999976
Q ss_pred CCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 4678999999 899998887653 3699999999999999999999999999999999999999999999999999986
Q ss_pred CCCC---------cccceeeeeceeEee
Q 024661 244 RHAF---------SFQTFLSMASRVYIC 262 (264)
Q Consensus 244 ~~~~---------~~~~~~y~ape~~~~ 262 (264)
.... ..++..|||||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhC
Confidence 4322 235668999997653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-36 Score=248.00 Aligned_cols=165 Identities=21% Similarity=0.304 Sum_probs=140.1
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcE--EEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceeeeeCC
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~~~ 166 (264)
++|++.++||+|+||.||+|+++.++.. ||||.++.. ....+.+.+|+++++.+ +|+|+ +++++++.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCE-----eeEEEEEecCC
Confidence 5799999999999999999999888764 667776532 33456789999999998 58887 99999999999
Q ss_pred EEEEEEecC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCC
Q 024661 167 HICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (264)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~ 231 (264)
.+|+||||+ +|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999 99999999753 234799999999999999999999999999999999999999999
Q ss_pred cEEeccCCCCCcCCC-----CcccceeeeeceeEe
Q 024661 232 YVKVPDYKVPSPRHA-----FSFQTFLSMASRVYI 261 (264)
Q Consensus 232 ~v~l~Dfg~a~~~~~-----~~~~~~~y~ape~~~ 261 (264)
.+||+|||+|+.... ...+|..|+|||.+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~ 199 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 199 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred ceEEccccccccccccccccceecCCcccchHHhc
Confidence 999999999976432 334788899999763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=243.88 Aligned_cols=166 Identities=19% Similarity=0.281 Sum_probs=138.0
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCC-------cEEEEEEEechh--hhHHHHHHHHHHHHHH-hccCCCCcceEEEce
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~ 160 (264)
.++|++++.||+|+||.||+|++..++ ..||||++++.. .....+.+|...+.++ +|+|+ +++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnI-----v~~~~ 86 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG 86 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeE-----Eeccc
Confidence 368999999999999999999986554 369999987533 4457788899999888 68777 99999
Q ss_pred eeeeCCEEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024661 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (264)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Ni 225 (264)
++.+++.+|+||||+ +|+|.+++.... ...+++..++.++.||+.||+|||+++||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 999999999999999 999999997543 23589999999999999999999999999999999999
Q ss_pred EeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 226 LLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 226 li~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|++.++.+||+|||+++.... ...++..|||||.+.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 210 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc
Confidence 999999999999999986432 235778899999764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-36 Score=251.55 Aligned_cols=164 Identities=23% Similarity=0.354 Sum_probs=137.0
Q ss_pred CCCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEech---hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee---
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~--- 164 (264)
.++|+++++||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+++++.++|+|+ +++++++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~i-----v~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeeccc
Confidence 57899999999999999999999999999999999743 2345678899999999999988 888888754
Q ss_pred ---CCEEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 165 ---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 165 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
...+++++++.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred cccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 2345555554499999998653 6999999999999999999999999999999999999999999999999998
Q ss_pred CcCCC---CcccceeeeeceeEee
Q 024661 242 SPRHA---FSFQTFLSMASRVYIC 262 (264)
Q Consensus 242 ~~~~~---~~~~~~~y~ape~~~~ 262 (264)
..... ...++..|+|||++.+
T Consensus 169 ~~~~~~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 169 RHTDDEMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp -CCTGGGSSSCHHHHTSCHHHHTT
T ss_pred cccCcccccccccccccCchhhcC
Confidence 76443 3458889999997543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=244.25 Aligned_cols=166 Identities=25% Similarity=0.319 Sum_probs=143.5
Q ss_pred CCCeEEEeecccCccEEEEEEEeC-----CCCcEEEEEEEech--hhhHHHHHHHHHHHHHH-hccCCCCcceEEEceee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~ 162 (264)
.++|++.++||+|+||.||+|++. .+++.||||+++.. ......+.+|+.+++.+ +|+|+ +++++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI-----v~~~g~~ 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGAC 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE-----EEEEEEE
Confidence 368999999999999999999863 45678999999743 34556788999999999 57777 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNS----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Ni 225 (264)
.+...+|+||||+ +|+|.+++.... ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 9999999999999 999999997543 12589999999999999999999999999999999999
Q ss_pred EeecCCcEEeccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 226 LLVSAEYVKVPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 226 li~~~~~v~l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|++.++.++|+|||+++.... ...+|+.|||||++.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 220 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc
Confidence 999999999999999986432 235678899999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=247.12 Aligned_cols=163 Identities=23% Similarity=0.346 Sum_probs=143.5
Q ss_pred CCeEEEeecccCccEEEEEEEeC---CCCcEEEEEEEech-----hhhHHHHHHHHHHHHHHhcc-CCCCcceEEEceee
Q 024661 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF 162 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~ 162 (264)
++|+++++||+|+||+||+|.+. .+|+.||+|++++. ....+.+.+|++++++++|+ |+ +++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnI-----v~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeE-----EEeeeee
Confidence 67999999999999999999874 46899999998642 23456678899999999984 56 9999999
Q ss_pred eeCCEEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCC
Q 024661 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVP 241 (264)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a 241 (264)
.+...++++|||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999 999999998876 7889999999999999999999999999999999999999999999999998
Q ss_pred CcCCC-------CcccceeeeeceeEe
Q 024661 242 SPRHA-------FSFQTFLSMASRVYI 261 (264)
Q Consensus 242 ~~~~~-------~~~~~~~y~ape~~~ 261 (264)
..... ...++..|++||.+.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~ 203 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVR 203 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred hhhcccccccccccccccccchhHHhh
Confidence 65322 335788899999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=243.37 Aligned_cols=166 Identities=17% Similarity=0.283 Sum_probs=142.7
Q ss_pred CCCeEEEeecccCccEEEEEEEeCC-----CCcEEEEEEEech--hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeee
Q 024661 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (264)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 163 (264)
.++|++.+.||+|+||.||+|.+.. ++..||||++++. ......+.+|+.++++++|+|+ +++++++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVS 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE-----eeeeeEEe
Confidence 3789999999999999999998853 3568999999743 3344568899999999999988 99999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEE
Q 024661 164 YRNHICIVFEKL-GPSLYDFLRKN--------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (264)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~ 234 (264)
.++..++||||+ +|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 999999999999 99999998743 113478999999999999999999999999999999999999999999
Q ss_pred eccCCCCCcCCC--------CcccceeeeeceeEe
Q 024661 235 VPDYKVPSPRHA--------FSFQTFLSMASRVYI 261 (264)
Q Consensus 235 l~Dfg~a~~~~~--------~~~~~~~y~ape~~~ 261 (264)
|+|||+|+.... ...+|..|||||.+.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~ 208 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHc
Confidence 999999975432 224678899999753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=238.25 Aligned_cols=161 Identities=16% Similarity=0.175 Sum_probs=136.2
Q ss_pred EEEeecccCccEEEEEEEeCCCC---cEEEEEEEec--hhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeee-CCEE
Q 024661 95 RILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI 168 (264)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~ 168 (264)
.+.++||+|+||+||+|++..++ ..||||.+++ .....+.+.+|++++++++|+|+ +++++++.. ++..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCE-----eEEeEEEEecCCce
Confidence 34678999999999999986643 3589999864 34456789999999999999888 999998765 5789
Q ss_pred EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcEEeccCCCCCcCCC-
Q 024661 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKVPSPRHA- 246 (264)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~~~- 246 (264)
++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++....
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999 899999988654 4678889999999999999999999999999999999999999999999999975332
Q ss_pred ---------CcccceeeeeceeEe
Q 024661 247 ---------FSFQTFLSMASRVYI 261 (264)
Q Consensus 247 ---------~~~~~~~y~ape~~~ 261 (264)
...+|..|+|||++.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~ 207 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQ 207 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHH
T ss_pred ccccceecccccccccccChHHHh
Confidence 124678899999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-33 Score=235.70 Aligned_cols=180 Identities=31% Similarity=0.417 Sum_probs=150.1
Q ss_pred EEeeCCccC-CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCC------Ccce
Q 024661 83 VFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG------GTRC 155 (264)
Q Consensus 83 ~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~------~~~~ 155 (264)
++.+|+.+. +||+++++||+|+||+||+|+++.+|+.||||++++.....+...+|+.+++.+.|+++. ++++
T Consensus 3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 355688776 579999999999999999999999999999999998777778889999999999987753 5678
Q ss_pred EEEceeeee--CCEEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEeecC
Q 024661 156 VQIRNWFDY--RNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSA 230 (264)
Q Consensus 156 ~~~~~~~~~--~~~~~lv~e~~--~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~Nili~~~ 230 (264)
+++++++.. ....+++|+++ +++............+++..++.++.||+.||+|||+ +||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999988765 35666666666 5566666666555689999999999999999999998 899999999999999876
Q ss_pred C------cEEeccCCCCCcCC---CCcccceeeeeceeEee
Q 024661 231 E------YVKVPDYKVPSPRH---AFSFQTFLSMASRVYIC 262 (264)
Q Consensus 231 ~------~v~l~Dfg~a~~~~---~~~~~~~~y~ape~~~~ 262 (264)
+ .++|+|||.|.... ....+|..|+|||++.+
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT
T ss_pred CcccccceeeEeecccccccccccccccccccccChhhccc
Confidence 5 49999999987533 34458899999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.4e-26 Score=176.60 Aligned_cols=132 Identities=22% Similarity=0.276 Sum_probs=100.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEech-------------------hhhHHHHHHHHHHHHHHhccCCCCcc
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-------------------NKYREAAMIEIDVLQRLARHDIGGTR 154 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------------~~~~~~~~~e~~~l~~l~~~~~~~~~ 154 (264)
+.++++||+|+||.||+|.+. +|+.||||+++.. ........+|...+.++.+.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v---- 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV---- 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS----
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc----
Confidence 568899999999999999974 6889999987521 0112344567888888887766
Q ss_pred eEEEceeeeeCCEEEEEEecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEeecCCcE
Q 024661 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (264)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~Nili~~~~~v 233 (264)
+..+++. ..+++||++++ .+. .+++..+..++.|++.+|.|||++||+||||||+|||++++ .+
T Consensus 77 -~~~~~~~----~~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 77 -PKVYAWE----GNAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp -CCEEEEE----TTEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EE
T ss_pred -ceEEEec----CCEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CE
Confidence 4444332 12799999944 332 24455567899999999999999999999999999999865 58
Q ss_pred EeccCCCCCcCC
Q 024661 234 KVPDYKVPSPRH 245 (264)
Q Consensus 234 ~l~Dfg~a~~~~ 245 (264)
+|+|||.|....
T Consensus 142 ~liDFG~a~~~~ 153 (191)
T d1zara2 142 WIIDFPQSVEVG 153 (191)
T ss_dssp EECCCTTCEETT
T ss_pred EEEECCCcccCC
Confidence 999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=2.3e-08 Score=78.52 Aligned_cols=140 Identities=13% Similarity=0.114 Sum_probs=90.8
Q ss_pred CCeEEEeecccCccEEEEEEEeCCCCcEEEEEEEechh-hhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEE
Q 024661 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (264)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (264)
..|++.+..+.++.+.||+.. ..+..+.+|+..... .....+.+|...++.+... +. +.+++.+..+.+..|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~-vp---vP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK-LP---VPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT-SC---CCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhcc-CC---CCcEEEEEecCCceEE
Confidence 457777766656667899885 345667888775432 2334567789998888642 22 3566677778889999
Q ss_pred EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 024661 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE------------------------------------- 212 (264)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------- 212 (264)
||+++ |.++.+..... .. ...++.++...+..||+
T Consensus 88 v~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999 66665432111 11 11122333333333332
Q ss_pred ----------------C------CCeecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 213 ----------------L------RLIHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 213 ----------------~------~ivH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
. .++|+|+.+.|||+++++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 1 2789999999999997766779999988653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.48 E-value=2.1e-07 Score=77.54 Aligned_cols=75 Identities=21% Similarity=0.245 Sum_probs=47.1
Q ss_pred EeecccCccEEEEEEEeCCCCcEEEEEEEech--------hhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEE
Q 024661 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
.+.||.|....||++.+..+++.+++|.-... .....+...|.+.++.+.... ...+.+++. .+....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~--p~~vP~v~~--~d~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFY--SDTEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEE--EETTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC--CCCcceEEE--EcCCCC
Confidence 45789999999999998877888999964321 122344567888888775431 112344443 344556
Q ss_pred EEEEecC
Q 024661 169 CIVFEKL 175 (264)
Q Consensus 169 ~lv~e~~ 175 (264)
++|||++
T Consensus 107 ~lvmE~L 113 (392)
T d2pula1 107 VTVMEDL 113 (392)
T ss_dssp EEEECCC
T ss_pred EEEEecc
Confidence 7899999
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.36 E-value=4.5e-07 Score=70.53 Aligned_cols=134 Identities=16% Similarity=0.124 Sum_probs=81.2
Q ss_pred cEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEEEEEecC-CCCHHH--
Q 024661 105 FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD-- 181 (264)
Q Consensus 105 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~-- 181 (264)
.+.||+... .++..+.+|...... ...+..|...++.+....+. +.+++.+..+.+..++||+++ |.++.+
T Consensus 24 ~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvp---vP~v~~~~~~~~~~~~v~~~i~G~~~~~~~ 97 (255)
T d1nd4a_ 24 DAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLLLGEVPGQDLLSSH 97 (255)
T ss_dssp SCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEEEECCSSEETTTSC
T ss_pred CCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCC---CCceeeecccccceEEEEEeeecccccccc
Confidence 467898875 446668889765332 34567899999999887663 455566667778899999999 544321
Q ss_pred ------------HHHhc-----CCCCC--CHHHHHH-----H---------------HHHHHHHHHHHHHC-------CC
Q 024661 182 ------------FLRKN-----SYRSF--PIDLVRE-----L---------------GRQLLESVAFMHEL-------RL 215 (264)
Q Consensus 182 ------------~l~~~-----~~~~~--~~~~~~~-----i---------------~~qi~~~l~~lH~~-------~i 215 (264)
.+.+- ....+ ....... + .......+..+... .+
T Consensus 98 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (255)
T d1nd4a_ 98 LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVV 177 (255)
T ss_dssp CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEE
T ss_pred ccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceE
Confidence 11110 00000 0000000 0 00012223333332 37
Q ss_pred eecCCCCCCEEeecCCcEEeccCCCCCcC
Q 024661 216 IHTDLKPENILLVSAEYVKVPDYKVPSPR 244 (264)
Q Consensus 216 vH~dikp~Nili~~~~~v~l~Dfg~a~~~ 244 (264)
+|+|+.+.|||++.++.+.|+||+.+...
T Consensus 178 iHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 178 THGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp ECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred EeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 99999999999998777789999988653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.20 E-value=3.1e-06 Score=68.39 Aligned_cols=70 Identities=16% Similarity=0.222 Sum_probs=49.9
Q ss_pred EEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEE--ceeeeeCCEEEEEEecCC
Q 024661 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI--RNWFDYRNHICIVFEKLG 176 (264)
Q Consensus 106 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~lv~e~~~ 176 (264)
-.||++.. .+|..+++|+.+......+.+..|...+..|...++..+..+.. -..+..++..+.+++++.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 57999875 46778999998765556677888999999999877643322222 123355778899999983
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.77 E-value=3.8e-05 Score=63.47 Aligned_cols=70 Identities=14% Similarity=0.192 Sum_probs=48.0
Q ss_pred EeecccCccEEEEEEEeCC-------CCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEceeeeeCCEEE
Q 024661 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (264)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
++.|+.|-.-.+|++.... ..+.|.+++.-.. .......+|..+++.+...++. .++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~----Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG----PKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS----SCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCC----CeEEEEcCC----c
Confidence 4578888888999998643 2456778876532 2233456799999999887763 345555543 6
Q ss_pred EEEecC
Q 024661 170 IVFEKL 175 (264)
Q Consensus 170 lv~e~~ 175 (264)
+||||+
T Consensus 118 ~I~efi 123 (395)
T d1nw1a_ 118 RLEEYI 123 (395)
T ss_dssp EEECCC
T ss_pred eEEEEe
Confidence 889998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.70 E-value=0.00013 Score=58.21 Aligned_cols=147 Identities=14% Similarity=0.132 Sum_probs=78.9
Q ss_pred eEEEeecccCccEEEEEEEeCCCCcEEEEEEEechhhhHHHHHHHHHHHHHHhccCCCCcceEEEce---eeeeCCEEEE
Q 024661 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICI 170 (264)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~l 170 (264)
..-.+.|..|.--+.|+.... .| .+++|++... ...+.+..|++++..+...++.-+..+...+ ..........
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 333455667777788988754 33 4899988643 2345566788899999887764333222211 1122455666
Q ss_pred EEecC-CCCH-----HHH------H---Hhc----C---CCCC------------------CHHHHHHHHHHHHHHHHHH
Q 024661 171 VFEKL-GPSL-----YDF------L---RKN----S---YRSF------------------PIDLVRELGRQLLESVAFM 210 (264)
Q Consensus 171 v~e~~-~~~L-----~~~------l---~~~----~---~~~~------------------~~~~~~~i~~qi~~~l~~l 210 (264)
++.++ +... ... + ... . .... ........+..+...+.-.
T Consensus 97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (316)
T d2ppqa1 97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 176 (316)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence 67666 3211 111 0 000 0 0000 0011112222222222222
Q ss_pred HH----CCCeecCCCCCCEEeecCCcEEeccCCCCCc
Q 024661 211 HE----LRLIHTDLKPENILLVSAEYVKVPDYKVPSP 243 (264)
Q Consensus 211 H~----~~ivH~dikp~Nili~~~~~v~l~Dfg~a~~ 243 (264)
.. .|+||+|+.++||+++.+...-|.||+.|..
T Consensus 177 ~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 177 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 22 3799999999999999887778999998854
|